Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,embryonic skeletal system development (GO:0048706),-0.7613506734331192,-2.2781557462865503,0.0,0.0,0.0,18/35,10.85%,SULF1;COL1A1;PDGFRA;HOXC4;OSR1;SULF2;HOXA3;PCSK5;RBP4;DYNC2I1;WNT9A;HOXB4;HOXB3;SIX1;KIAA1217;XYLT1;SLC2A10;FUZ
prerank,collagen fibril organization (GO:0030199),-0.5834989930997666,-2.1132028241865957,0.0,0.006363053775625762,0.014,44/88,11.48%,COL1A2;COL3A1;COL4A5;COL1A1;ADAMTS2;COL8A1;COL4A6;COL5A1;COL12A1;COL22A1;COL25A1;COL4A3;LOXL1;COL4A4;COL6A2;COL6A3;COL11A1;PLOD2;COL6A1;COL8A2;TGFBR1;COL26A1;SERPINH1;COL13A1;COL18A1;COL23A1;LOXL3;COL27A1;CYP1B1;COL5A3;NF1;LUM;COL16A1;P4HB;LOX;COL14A1;COL9A2;DPT;DDR2;COL20A1;COL15A1;ADAMTS14;P4HA1;TGFB2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.8325859450831626,-2.1054417937699808,0.0,0.004848040971905344,0.016,9/17,7.49%,ATP1A2;ANK2;CACNA1C;CACNA2D1;CACNA1D;SLC8A1;CACNB2;CACNA1G;KCNJ2
prerank,retinoid metabolic process (GO:0001523),-0.6177210849982593,-2.103203895382006,0.0,0.0038632826494870705,0.017,25/71,16.06%,GPC6;ALDH1A1;LRP1;ALDH1A2;SDC2;GPC3;RBP1;HSPG2;ABCA4;RBP4;CYP26B1;AKR1B1;DHRS3;CYP1B1;GPC5;SDC4;APOE;GPC4;STRA6;SCPEP1;SDC1;RDH13;RDH10;RARRES2;GPC1
prerank,diterpenoid metabolic process (GO:0016101),-0.6390324420307806,-2.091661341299973,0.0,0.0036360307289290076,0.02,20/55,16.06%,GPC6;ALDH1A1;LRP1;SDC2;GPC3;RBP1;HSPG2;ABCA4;RBP4;AKR1B1;DHRS3;GPC5;SDC4;APOE;GPC4;STRA6;SDC1;RDH10;RARRES2;GPC1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.7932972557440439,-2.0724700522369703,0.0,0.004090534570045133,0.026,11/20,12.57%,ATP1A2;ANK2;CACNA1C;DMD;ATP1B1;SLC8A1;PRKACA;ATP2A2;RYR2;SLC9A1;GSTM2
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.6202225964582003,-2.0410899587843505,0.0,0.006492912015944655,0.045,22/55,11.64%,GPC6;SDC2;DCN;GPC3;OGN;CEMIP;FMOD;HSPG2;BGN;FGF2;CSPG4;PRELP;LUM;VCAN;ARSB;CD44;GPC5;SDC4;OMD;GPC4;SLC9A1;HEXA
prerank,cotranslational protein targeting to membrane (GO:0006613),0.6925699146105475,2.0342799120483046,0.0,0.016850810924212214,0.016,60/91,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;SEC63;RPL37A;RPL36;RPS18;TRAM1;RPL15;RPS8;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;RPL31;RPS23;RPL13;RPS12;SRP9;RPL6;RPL10;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;ARL6IP1;RPL11;RPL8;RPLP2;SEC62;SIL1;RPL18A;SSR1;RPL21;RPL3;RPS3;RPS28;RPL7
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.7933870807543738,-1.992380709101428,0.0,0.014203245034878935,0.1,7/16,9.11%,ATP1A2;ANK2;CACNA1C;DMD;SLC8A1;PRKACA;RYR2
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6797386507546468,1.987791392230697,0.0,0.035807973213950954,0.062,56/87,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;SEC63;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;ZFAND2B;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;RPL31;RPS23;RPL13;RPS12;SRP9;RPL6;RPL10;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;RPL11;RPL8;RPLP2;RPL18A;RPL21;RPL3;RPS3;RPS28;RPL7
prerank,regulation of striated muscle contraction (GO:0006942),-0.6962271619685394,-1.982960235283261,0.0,0.015857134012273726,0.127,7/27,9.11%,ATP1A2;ANK2;DMD;SLC8A3;P2RX4;PRKACA;RYR2
prerank,protein targeting to ER (GO:0045047),0.6591892589589691,1.9691991955312615,0.0,0.039318558823161834,0.095,61/99,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;SEC63;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;CHMP4A;CHMP4B;ZFAND2B;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;RPL31;RPS23;RPL13;RPS12;SRP9;RPL6;RPL10;SPCS1;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;RPL11;RPL8;RPLP2;SEC62;RPL18A;ZFAND2A;RPL21;RPL3;RPS3;RPS28;RPL7
prerank,cardiac muscle cell action potential (GO:0086001),-0.6720970750392599,-1.9499543831445152,0.0,0.025634016638949503,0.215,11/30,7.49%,ATP1A2;ANK2;CACNA1C;DMD;CACNA2D1;CACNA1D;ATP1B1;SLC8A1;KCND3;CACNA1G;KCNJ2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.7564322233115733,-1.9483431492790941,0.0,0.021740433733388027,0.218,4/21,1.86%,EYA2;EYA1;BCL2;EYA4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.7564322233115733,-1.9483431492790941,0.0,0.021740433733388027,0.218,4/21,1.86%,EYA2;EYA1;BCL2;EYA4
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.6526841675130922,1.9482900690967107,0.0,0.04949925708987337,0.149,62/110,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;SMG7;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;RPL31;RPS23;RNPS1;RPL13;RPS12;PNRC2;RPL6;RPL10;UPF2;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;CTIF;RPL11;RPL8;RPLP2;HELZ2;PPP2R2A;RPL18A;DHX34;PPP2R1A;RPL21;RPL3;RPS3;RPS28;RPL7
prerank,membrane lipid biosynthetic process (GO:0046467),0.7081799115011531,1.9414193009868084,0.0,0.04739290572434685,0.173,17/58,5.73%,ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;DEGS2;PRKD1;SPNS2;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;SPTLC3;ELOVL5;SPTSSA;PPM1L
prerank,establishment of endothelial barrier (GO:0061028),0.7944984171980906,1.9120760907534116,0.0,0.07828605908540259,0.292,14/29,7.53%,TJP1;PECAM1;PPP1R16B;ICAM1;F11R;TJP2;PDE2A;MSN;PDE4D;RAP1B;SOX18;ROBO4;RAPGEF2;RAP1A
prerank,cytoplasmic translation (GO:0002181),0.6550610800400263,1.9093196428568362,0.0,0.06981050240030776,0.3,54/91,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;DRG2;RPL31;RPS23;RPL13;RPS12;RPL6;RPL10;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;RPL11;RPL8;RPL18A;RPL21;RPL3;RWDD1;RPS3;RPS28;RPL7
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.7095624977776698,-1.888614141481106,0.0025252525252525255,0.05551939228403138,0.486,8/21,9.11%,ATP1A2;ANK2;CACNA1C;DMD;SLC8A1;AKAP6;PRKACA;RYR2
prerank,membrane depolarization during action potential (GO:0086010),-0.6829130640630291,-1.886208969972296,0.0,0.05311202029042728,0.501,7/26,7.49%,ATP1A2;CACNA1C;SCN7A;CACNA1D;SLC8A1;CACNA1G;KCNJ2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.7713862757346215,-1.8802893384856714,0.0,0.05490406400682801,0.532,6/16,3.80%,IGF1;IGFBP2;BMP5;IGFBP5;IGFBP6;IGFBP3
prerank,skeletal system morphogenesis (GO:0048705),-0.6101373591210634,-1.8794108824711366,0.0,0.05215431576807545,0.537,16/42,10.85%,FGFR2;PDGFRA;HOXC4;TGFBR1;HOXA3;WWOX;CYP26B1;DYNC2I1;FBN2;SFRP4;HOXB4;HOXB3;SIX1;LRP6;HHIP;FUZ
prerank,negative regulation of peptidase activity (GO:0010466),-0.6026092832369156,-1.8777894041852425,0.0,0.05004889356290516,0.543,13/47,12.41%,LRP1;TIMP3;SERPING1;VTN;TIMP2;SERPINH1;SERPINE2;SERPIND1;ECM1;SERPINF1;SERPINE1;CST3;SPOCK3
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.84586555378608,-1.877362307647683,0.0,0.04747040118323982,0.546,6/10,4.97%,PID1;PRKCB;APPL2;ENPP1;GRB10;SELENOS
prerank,sphingolipid metabolic process (GO:0006665),0.6293422762058192,1.8760750963442165,0.0,0.12848743329711812,0.501,23/108,5.73%,ST6GALNAC3;ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;UGCG;DEGS2;PRKD1;SPNS2;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;ESYT2;SPTLC3;ELOVL5;SPTSSA;GLTP;ENPP2;ASAH2;PPM1L
prerank,renal system development (GO:0072001),-0.5708440952813509,-1.8664620318304974,0.0,0.05329655568456466,0.613,28/52,18.48%,SULF1;GLI2;WNT4;GREB1L;SULF2;TGFBR1;BMP4;PCSK5;PKD1;RBP4;SALL1;SIX1;TBX18;IFT88;AGTR1;PYGO1;ARL3;VEGFA;TGFB2;STRA6;PYGO2;TRAF3IP1;PAX8;ITGA8;NPHP3;MYOCD;FOXC1;IFT27
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6615954339111948,-1.8573224173330694,0.0,0.057949239742306057,0.66,10/25,9.95%,ANK2;DMD;ACTN2;SLC6A9;ATP1B1;WNK4;ANK3;TRPC6;ATP1B2;WNK1
prerank,endodermal cell differentiation (GO:0035987),-0.6299293134747914,-1.8502212588207454,0.0,0.06064379822892309,0.687,13/31,9.56%,COL8A1;COL12A1;VTN;COL11A1;ITGB5;COL6A1;MMP14;ITGAV;CTR9;PAF1;MMP2;INHBA;LEO1
prerank,ureteric bud development (GO:0001657),-0.7262502261407245,-1.8480886147175142,0.002421307506053269,0.0595400031862125,0.695,10/17,10.91%,FGFR2;GPC3;BMP7;OSR1;BMP4;ROBO2;SALL1;SIX1;NPNT;SLIT2
prerank,embryonic digestive tract development (GO:0048566),-0.7268469241878694,-1.847901976671778,0.0,0.05710939568806973,0.696,12/18,15.46%,GLI3;FGFR2;RARB;GLI2;PDGFRA;PCSK5;SALL1;RBPMS2;TGFB2;STRA6;PKDCC;RARRES2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.8840002739638178,1.841997208641682,0.0,0.22970931836269845,0.729,3/14,2.38%,IL6ST;PTGS2;OSMR
prerank,sphingolipid biosynthetic process (GO:0030148),0.6518035543301233,1.8367417684982041,0.0013850415512465374,0.23075079209343102,0.763,18/71,5.73%,ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;DEGS2;PRKD1;SPNS2;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;SPTLC3;ELOVL5;SPTSSA;ASAH2;PPM1L
prerank,mesonephric tubule development (GO:0072164),-0.7395893213026097,-1.830271113387001,0.007211538461538462,0.07158435497578984,0.783,10/15,10.91%,FGFR2;BMP7;OSR1;BMP4;PKD1;ROBO2;SALL1;SIX1;NPNT;SLIT2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.803384336914095,1.8266965273371898,0.0,0.2536238530581713,0.819,6/18,5.39%,JAM2;SLC39A8;VCAM1;SELE;SELP;CX3CR1
prerank,regulation of cell junction assembly (GO:1901888),0.7419698141142479,1.8182018020651871,0.0,0.26873532838509273,0.869,12/27,11.57%,PRKCH;TJP1;MEF2C;CLDN5;OCLN;F11R;RAP1B;RAPGEF2;RAP1A;APLNR;MYO1C;CBFB
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.5694575579384429,-1.8157982204448353,0.0,0.08519219997880664,0.83,21/50,14.21%,ZIC1;GLI3;FGFR2;GPC3;DCDC2;IFT81;GAS1;TULP3;RORA;EVC;GLIS2;ARMC9;BTRC;GLI1;SFRP1;HHIP;SMO;FUZ;SUFU;INTU;KIF7
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.7901215763653212,-1.8105811153454285,0.002178649237472767,0.08890794368910064,0.858,7/12,9.73%,UST;DSE;DCN;BGN;CSPG4;VCAN;DSEL
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.8454035000722966,1.8030412212266083,0.0034071550255536627,0.300079842753047,0.918,2/14,0.42%,SLCO2B1;ABCG2
prerank,heme catabolic process (GO:0042167),0.8454035000722966,1.8030412212266083,0.0034071550255536627,0.300079842753047,0.918,2/14,0.42%,SLCO2B1;ABCG2
prerank,digestive tract development (GO:0048565),-0.6221275436329406,-1.8013414678037951,0.00554016620498615,0.09696081943810687,0.89,17/32,15.46%,GLI3;FGFR2;CLMP;RARB;GLI2;KIT;PCSK5;PKD1;COBL;SALL1;GLI1;SMO;TGFB2;STRA6;CCDC39;PKDCC;RARRES2
prerank,regulation of potassium ion transport (GO:0043266),-0.6322364012298118,-1.7995911902363837,0.0,0.09573798767510396,0.895,12/31,10.00%,ANK2;FHL1;KCNIP3;ACTN2;CACNA1D;KCNIP4;ANK3;DLG1;KCNAB1;DPP6;ADRA2A;CD63
prerank,bile acid and bile salt transport (GO:0015721),0.7683353835877504,1.792696848717778,0.0034129692832764505,0.332733304041007,0.95,6/24,5.12%,ABCC4;SLCO2B1;ATP8B1;STARD5;NCOA1;CEACAM1
prerank,negative regulation of blood pressure (GO:0045776),0.8602516692838194,1.7922021423845995,0.001851851851851852,0.31450458826517946,0.951,3/13,1.82%,NOS3;BMPR2;PRCP
prerank,dermatan sulfate metabolic process (GO:0030205),-0.7670980946000542,-1.7913033149989592,0.006802721088435374,0.10234172698235523,0.921,7/13,9.73%,UST;DSE;DCN;BGN;CSPG4;VCAN;DSEL
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.6010862973416489,-1.7910934095540474,0.0,0.09911213761938986,0.921,7/37,7.06%,PHLDB2;EPHA3;EFNA5;PHLDB1;BICD1;PRKAA2;MAP6
prerank,cell-substrate junction assembly (GO:0007044),0.7079112401263996,1.789210502047402,0.007621951219512195,0.3098195052646518,0.955,10/33,5.16%,THSD1;ITGA6;PEAK1;BCR;DST;TAOK2;LAMA3;SORBS1;ACTN1;PTPRK
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.6284756058370626,1.7881572215942547,0.0,0.29769765966108247,0.959,18/75,6.55%,NRP2;TEK;EGFL7;BMPR2;KDR;PPP1R16B;PRKD1;PLCG1;PDGFB;VEGFC;GATA2;PRKD2;JCAD;HIF1A;FLT4;VEGFD;WNT5A;NRAS
prerank,synaptic membrane adhesion (GO:0099560),-0.7590948718178729,-1.7861701294722907,0.0,0.1023659941507352,0.935,7/14,6.10%,GPC6;PTPRS;PTPRF;PTPRD;LRFN5;LRRC4C;NTNG1
prerank,extracellular structure organization (GO:0043062),-0.4456156767814519,-1.7853091281464293,0.0,0.10010447100582673,0.937,78/204,7.61%,LAMA2;COL1A2;COL3A1;COL4A5;FBN1;SMOC1;ADAMTS12;COL1A1;ADAMTS2;THSD4;DCN;COL8A1;COL4A6;ADAMTSL3;COL5A1;NID1;COL22A1;ADAMTS6;VTN;COL4A3;LAMC3;ADAMTSL5;LOXL1;COL4A4;ITGA9;COL6A2;COL6A3;COL11A1;ITGB5;HSPG2;SPARC;COL6A1;NID2;ADAMTS10;ADAMTS5;COL8A2;TGFBR1;BGN;MFAP5;COL13A1;VIT;COL18A1;DAG1;ITGA10;FBLN5;COL23A1;ITGA11;ADAMTSL1;THBS1;DDR1;COL27A1;FGF2;SMOC2;CDH1;RECK;MMP14;NDNF;FBN2;ITGA1;ADAMTS17;ADAMTSL4;MMP16;COL5A3;ITGB8;ITGAV;NF1;ADAM19;ADAMTS15;SPP1;LUM;TGFBI;ST7;COL16A1;VCAN;LOX;ADAMTS1;COL14A1;CD44
prerank,embryonic limb morphogenesis (GO:0030326),-0.5936997372781507,-1.7844038981135237,0.00303951367781155,0.09866865205320988,0.939,12/34,15.46%,CACNA1C;AFF3;GLI3;OSR1;CYP26B1;SALL1;LRP6;TGFB2;TBX2;WDPCP;INTU;TBX3
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7062952150005726,-1.7780880696283916,0.006741573033707865,0.10424179273598674,0.955,8/17,9.89%,ATP1A2;CACNA1C;GJA1;ATP1B1;SLC8A1;PRKACA;RYR2;ATP1B2
prerank,external encapsulating structure organization (GO:0045229),-0.44313435431266945,-1.7767091540149431,0.0,0.10300355622094602,0.958,77/205,7.61%,LAMA2;COL1A2;COL3A1;COL4A5;FBN1;SMOC1;ADAMTS12;COL1A1;ADAMTS2;THSD4;DCN;COL8A1;COL4A6;ADAMTSL3;COL5A1;NID1;COL22A1;ADAMTS6;VTN;COL4A3;LAMC3;ADAMTSL5;LOXL1;COL4A4;ITGA9;COL6A2;COL6A3;COL11A1;ITGB5;HSPG2;SPARC;COL6A1;NID2;ADAMTS10;ADAMTS5;COL8A2;BGN;MFAP5;COL13A1;VIT;COL18A1;DAG1;ITGA10;FBLN5;COL23A1;ITGA11;ADAMTSL1;THBS1;DDR1;COL27A1;FGF2;SMOC2;CDH1;RECK;MMP14;NDNF;FBN2;ITGA1;ADAMTS17;ADAMTSL4;MMP16;COL5A3;ITGB8;ITGAV;NF1;ADAM19;ADAMTS15;SPP1;LUM;TGFBI;ST7;COL16A1;VCAN;LOX;ADAMTS1;COL14A1;CD44
prerank,intestinal absorption (GO:0050892),0.823012348403001,1.7714726552326998,0.008576329331046312,0.3670040102934509,0.976,4/13,2.39%,UGCG;F11R;TJP2;KCNQ1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.7076375150132023,1.768026085838147,0.0,0.36724236057954995,0.979,13/34,5.63%,SEMA6A;FLT1;KDR;ERN1;PRKD1;VEGFC;DAB2IP;PRKD2;NOTCH1;FLT4;VEGFD;DLL4;RAMP2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.7362790375620105,1.7607637798893103,0.0031545741324921135,0.3887221293856217,0.989,6/26,5.50%,NOS3;ACER2;SPTLC2;GCH1;SPTLC3;ASAH2
prerank,odontogenesis (GO:0042476),-0.576714743545843,-1.7605848861533946,0.0,0.12324629158265614,0.976,13/35,11.48%,COL1A2;FGFR2;GLI2;EDA;OSR1;WNT6;BMP4;LRP6;AXIN2;BCOR;INHBA;TGFB3;TGFB2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6624144309303047,1.7605691225138962,0.0028776978417266188,0.3726327052104201,0.989,18/48,7.98%,NOS3;HDAC9;KDR;PTGS2;PRKD1;PLCG1;PDGFB;GATA2;PRKD2;JCAD;HDAC7;HIF1A;PIK3C2A;TMSB4X;RHOJ;CD40;TGFB1;MAP3K3
prerank,relaxation of cardiac muscle (GO:0055119),-0.7463236340998551,-1.7589817457939863,0.016355140186915886,0.12210184272146735,0.98,6/13,7.49%,ATP1A2;GSN;ATP1B1;SLC8A1;P2RX4;KCNJ2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.7654381452936734,1.7568289229761116,0.008333333333333333,0.3754342357815651,0.991,6/19,4.81%,PRKCH;TJP1;CLDN5;OCLN;F11R;IKBKB
prerank,leukocyte cell-cell adhesion (GO:0007159),0.7495327316260606,1.754977229502375,0.006734006734006734,0.36865537128725734,0.992,7/24,3.91%,PECAM1;VCAM1;ICAM1;F11R;MSN;SELE;SELP
prerank,regulation of gastrulation (GO:0010470),-0.7318308055651027,-1.7530176184898798,0.006928406466512702,0.1281940044495431,0.982,4/14,3.02%,PHLDB2;OSR1;PHLDB1;DAG1
prerank,sulfur compound catabolic process (GO:0044273),-0.5811553348693547,-1.7472240942258492,0.0030211480362537764,0.13397374762746111,0.984,14/38,11.64%,DCN;OGN;FMOD;BGN;CSPG4;GGT5;PRELP;LUM;VCAN;ARSB;OMD;NUDT7;ACAT1;HEXA
prerank,granulocyte differentiation (GO:0030851),0.7841638260244499,1.7434455114359146,0.003527336860670194,0.4155409973910732,0.997,4/18,3.41%,LEF1;CBFA2T3;TAL1;LBR
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.6397416312800102,-1.7433920836949963,0.002531645569620253,0.13680565617595392,0.986,4/26,1.86%,EYA2;EYA1;BCL2;EYA4
prerank,actomyosin structure organization (GO:0031032),0.6072905321357203,1.739206565543034,0.004225352112676056,0.4232956109567732,0.999,12/75,5.44%,PGM5;FRMD5;FLII;TJP1;FAM171A1;EPB41;F11R;MYH9;TMOD3;SORBS1;PDLIM1;CDC42BPB
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6635541518060072,-1.737634830054744,0.004728132387706856,0.1427585479486212,0.989,11/20,10.91%,IGF1;LRP1;BMPR1A;PDGFRB;VTN;NRP1;IGFBP5;IGFBP3;CCN4;SERPINE1;SLIT2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6234395942103966,1.737252773971299,0.004087193460490463,0.4182667720840916,0.999,19/67,5.08%,NRP2;CLEC14A;FLT1;KDR;PRKD1;VEGFC;DOCK1;ELMO1;WASF2;DAB2IP;PRKD2;PTK2B;FYN;NCK1;PXN;FLT4;PAK2;NCKAP1;VEGFD
prerank,relaxation of muscle (GO:0090075),-0.7367903225024924,-1.7371436623699106,0.015555555555555555,0.13998718306376676,0.99,6/13,7.49%,ATP1A2;GSN;ATP1B1;SLC8A1;P2RX4;KCNJ2
prerank,protein localization to synapse (GO:0035418),-0.7378976129211932,-1.7360283549804074,0.010706638115631691,0.13838056483470512,0.99,8/12,15.55%,NLGN2;DLG4;PCLO;NRXN1;NLGN1;SHANK1;NRXN2;BSN
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7186591853886551,-1.733031561608859,0.004282655246252677,0.13998718306376678,0.992,4/14,9.89%,ANK2;ACTN2;ATP1B1;ATP1B2
prerank,regulation of Notch signaling pathway (GO:0008593),0.6057787447784256,1.73023991662455,0.005442176870748299,0.44568138089506815,0.999,18/76,7.34%,EGFL7;NOS3;IL6ST;LFNG;MAML2;EPN2;GATA2;STAT3;PRAG1;MFNG;FBXW7;NOTCH1;TSPAN5;DLL1;DLL4;TSPAN14;ARRB1;ARRDC1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.7181011075368604,1.7302198958595174,0.003076923076923077,0.4305309558330513,0.999,6/30,3.69%,NOS3;TNFSF10;ICAM1;ARHGEF2;FAS;CASP8
prerank,modified amino acid transport (GO:0072337),-0.6859500236421505,-1.7268478076381322,0.007832898172323759,0.1478248493016804,0.994,3/15,1.60%,SLC6A13;SLC16A12;PDPN
prerank,carboxylic acid metabolic process (GO:0019752),0.7057817016404057,1.726485613530885,0.0032258064516129032,0.43780513132468857,0.999,6/33,4.12%,CSGALNACT1;SLC2A1;ST6GAL1;ST3GAL1;PLA2G4A;GLYAT
prerank,leukocyte tethering or rolling (GO:0050901),0.764540902698535,1.7261987849646305,0.012411347517730497,0.4252791353816301,0.999,5/17,5.39%,JAM2;VCAM1;SELE;SELP;CX3CR1
prerank,striated muscle cell development (GO:0055002),0.8193198555815716,1.725340834874717,0.007168458781362007,0.41748542299537483,0.999,3/14,3.98%,PGM5;FLII;TMOD3
prerank,neurotransmitter uptake (GO:0001504),-0.7482786852318778,-1.7242543257040803,0.0021645021645021645,0.14905749884951902,0.994,4/12,4.31%,ATP1A2;SLC1A3;GLUL;SNAP25
prerank,amino sugar metabolic process (GO:0006040),0.8601235864247425,1.7222876340953817,0.010291595197255575,0.4217809037393724,0.999,3/10,1.50%,CSGALNACT1;ST6GAL1;ST3GAL1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.6012169537159167,1.7206597346671584,0.0027100271002710027,0.41789391576938784,0.999,20/88,6.55%,NRP2;TEK;EGFL7;BMPR2;KDR;CAV1;TIE1;PPP1R16B;ACVRL1;PRKD1;PTPRM;PDGFB;VEGFC;PRKD2;HIF1A;FLT4;CAV2;VEGFD;WNT5A;NRAS
prerank,extracellular matrix organization (GO:0030198),-0.41889815812789594,-1.720458264817436,0.0,0.1517269205768514,0.995,105/276,10.53%,LAMA2;COL1A2;COL3A1;COL4A5;FBN1;SMOC1;ADAMTS12;COL1A1;ADAMTS2;THSD4;DCN;COL8A1;COL4A6;GSN;ADAMTSL3;COL5A1;NID1;COL12A1;COL22A1;ADAMTS6;VTN;COL25A1;COL4A3;LAMC3;TIMP2;ADAMTSL5;LOXL1;COL4A4;ITGA9;COL6A2;COL6A3;COL11A1;ITGB5;HSPG2;SPARC;PLOD2;COL6A1;NID2;ADAMTS10;ADAMTS5;COL8A2;TGFBR1;BGN;MFAP5;COL26A1;SERPINH1;COL13A1;VIT;COL18A1;DAG1;GPM6B;ITGA10;FBLN5;COL23A1;ITGA11;ADAMTSL1;THBS1;DDR1;LOXL3;COL27A1;FGF2;SMOC2;SH3PXD2B;CDH1;SCUBE1;RECK;MMP14;NDNF;HTRA1;FBN2;ITGA1;ADAMTS17;CYP1B1;ADAMTSL4;MMP16;COL5A3;ITGB8;ITGAV;NF1;ADAM19;ADAMTS15;SPP1;LUM;TGFBI;ST7;COL16A1;VCAN;P4HB;LOX;ADAMTS1;COL14A1;CD44;FLRT2;KLK2;COL9A2;TNC;MMP2;NPNT;ADAM12;DPT;DDR2;COL20A1;SERPINE1;COL15A1;ADAMTS14
prerank,cellular response to increased oxygen levels (GO:0036295),0.841509436260228,1.7182314662350813,0.0035650623885918,0.41835147192736144,0.999,3/11,2.41%,FOXO1;CAV1;FAS
prerank,keratan sulfate catabolic process (GO:0042340),-0.7501161190176353,-1.7156553653258757,0.008528784648187633,0.15750451860678413,0.997,6/11,11.64%,OGN;FMOD;PRELP;LUM;OMD;HEXA
prerank,regulation of protein neddylation (GO:2000434),0.864075584762206,1.7145902285901327,0.007352941176470588,0.4247223489543627,0.999,3/10,2.79%,EPAS1;DCUN1D3;HIF1A
prerank,response to lipid (GO:0033993),0.5749133366629903,1.71351399257674,0.0013157894736842105,0.41919238594742103,0.999,33/105,15.63%,FOXO1;NOS3;ACER2;ESR1;PPARD;GCH1;FOXP1;SOCS2;STAT3;TNFRSF11A;SELE;SELP;SOX9;TIRAP;RPS6KA3;PELI1;IFNAR1;WNT9B;HNRNPA0;TGFB1;CITED1;MAPKAPK3;OVCA2;CYP27B1;ASXL1;TRIB1;ADAM17;ABCG1;S100A9;PAQR8;STRN3;TRIM16;IRAK3
prerank,translation (GO:0006412),0.5330349810667138,1.7081588943356616,0.0,0.435460429673063,0.999,83/208,17.73%,GARS1;RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;FARS2;RPL34;RPS20;RPL39;IARS1;RPS7;RPS24;RPL37A;SRBD1;RPL36;RPS18;RSL24D1;RPL15;RPS8;RPL14;RPL23;RPL17;MRPS18A;NDUFA7;RPL9;DHPS;RPL4;RPL13A;LARS1;RPS11;RPL32;TNIP1;RPL22;RPS27;DRG2;RPL31;RPS23;MRPL13;RPL13;MRPS12;RPS12;EEF2K;MRPL35;APEH;HBS1L;RPL6;RPL10;FASTKD2;WARS1;MRRF;MRPL41;RPS29;RPS6;MRPL52;RARS1;RPL29;QRSL1;RPS25;RPL35A;RPS13;RPS21;MRPS16;RPL27;RPL18;AIMP1;MRPL23;RPL27A;MRPS5;KARS1;RPS10;MRPL37;EEFSEC;RPL11;RPL8;EEF2;WARS2;PTCD3;RPLP2;MRPL11
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.5618508989813299,-1.706085600562679,0.0,0.17187665665064925,0.998,21/37,20.44%,DYNC2H1;IFT81;WDR35;DYNC2I1;KIF3C;KIF3A;IFT80;IFT88;IFT20;IFT46;DYNC2LI1;IFT43;IFT22;PCM1;TRAF3IP1;KIFAP3;IFT74;IFT140;IFT27;IFT57;TTC21B
prerank,growth hormone receptor signaling pathway (GO:0060396),0.7755128298692631,1.7059565695288021,0.017953321364452424,0.43552865157963877,0.999,8/14,9.42%,SOCS2;LYN;STAT3;PXN;JAK3;GHR;PTK2;PTPN1
prerank,ceramide metabolic process (GO:0006672),0.635725904271489,1.7058276520476197,0.007385524372230428,0.4253249994839439,0.999,10/49,5.50%,ST6GALNAC3;ACER2;SPTLC2;SGMS1;DEGS2;PLPP1;CERS4;SPTLC3;SPTSSA;ASAH2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6984837801787998,-1.7055991105136468,0.009302325581395349,0.16927541058528994,0.999,5/15,6.10%,PIEZO2;ADGRV1;COL11A1;KIT;WHRN
prerank,tight junction assembly (GO:0120192),0.6424998985784798,1.704934908026281,0.004379562043795621,0.41944648106930066,0.999,9/49,5.63%,PECAM1;ESAM;LSR;CLDN5;OCLN;F11R;PARD3;PAK2;RAMP2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.6321264130552662,1.7045726579713867,0.004291845493562232,0.41124002850756,0.999,15/54,7.33%,NOS3;KDR;MEF2C;ACVRL1;PRKD1;PRCP;PLCG1;PDGFB;GATA2;PRKD2;HIF1A;TMSB4X;ATP2B4;CD40;TGFB1
prerank,kidney development (GO:0001822),-0.505915271427099,-1.7034421891014986,0.0,0.16984184713708092,0.999,31/65,18.48%,SULF1;GLI2;WNT4;BMP7;OSR1;GREB1L;SULF2;TGFBR1;BMP4;PCSK5;PKD1;ROBO2;KANK2;SALL1;NF1;SIX1;IFT88;AGTR1;PYGO1;ARL3;VEGFA;TGFB2;STRA6;PYGO2;TRAF3IP1;PAX8;ITGA8;NPHP3;FGF10;FOXC1;IFT27
prerank,lipid transport (GO:0006869),0.5798025180666637,1.703068684619762,0.0,0.40966084813717074,1.0,17/97,5.76%,ABCC4;SLCO2B1;ATP8B1;CERT1;PPARD;PLTP;ATP8A1;UGCG;SPNS2;SLCO2A1;SCARB1;PRELID2;STARD5;NCOA1;GLTP;CEACAM1;ABCA3
prerank,apical junction assembly (GO:0043297),0.6286365255998584,1.6985389235143855,0.002886002886002886,0.42306545892819725,1.0,10/53,5.63%,PECAM1;ESAM;CLDN5;OCLN;F11R;PARD3;PKN2;PAK2;CTNNA1;RAMP2
prerank,monocyte chemotaxis (GO:0002548),0.6791187521717905,1.6957206218758616,0.009316770186335404,0.426957421792227,1.0,5/32,4.40%,FLT1;PDGFB;IL6R;TNFRSF11A;RPS19
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.5477582788256424,-1.6946899172814982,0.0030581039755351682,0.1829727578831727,0.999,12/47,12.41%,TIMP3;SERPING1;VTN;TIMP2;SERPINH1;RECK;SERPINE2;SERPIND1;SERPINF1;BIN1;SERPINE1;SPOCK3
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.6525780711838312,-1.6943053303216622,0.006944444444444444,0.1802064852304579,0.999,10/19,13.91%,OBSL1;CUX2;CAPRIN2;PTPRD;IL1RAPL1;CUX1;FBXW8;DBN1;CDKL3;CAMK2B
prerank,T cell proliferation (GO:0042098),0.7955626294638162,1.690710271522269,0.012750455373406194,0.4426543184901073,1.0,5/13,7.41%,CADM1;CTPS1;MSN;PPP3CB;PIK3CG
prerank,hippo signaling (GO:0035329),0.6939234423424219,1.6903217481388695,0.018121911037891267,0.4350735969474792,1.0,7/26,5.85%,TJP1;TEAD4;TJP2;WWTR1;STK3;STK4;TEAD2
prerank,amide transport (GO:0042886),0.7053607831738593,1.689873443253808,0.01199400299850075,0.428554738244418,1.0,7/26,5.78%,ABCG2;CERT1;PLTP;SLC38A5;AQP11;GLTP;TAP2
prerank,organic hydroxy compound transport (GO:0015850),0.6741766207461618,1.6897447683622553,0.004739336492890996,0.42034605771022737,1.0,6/36,5.12%,ABCC4;SLCO2B1;ATP8B1;STARD5;NCOA1;CEACAM1
prerank,negative regulation of protein processing (GO:0010955),-0.7210080517721376,-1.6877177015463718,0.007009345794392523,0.1893092665626649,1.0,6/12,14.29%,GAS1;THBS1;SERPINE2;LRRK2;SERPINE1;CTSZ
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5883667267572591,1.6872086678078226,0.004048582995951417,0.4243244825853188,1.0,23/84,7.41%,NRP2;TEK;NOS3;BMPR2;KDR;PRKD1;PLCG1;PDGFB;FOXP1;GATA2;SCARB1;EDN1;PRKD2;PTK2B;HIF1A;FLT4;TMSB4X;WNT5A;CD40;RAC1;SASH1;TGFB1;PIK3CG
prerank,embryonic eye morphogenesis (GO:0048048),-0.7520414081519289,-1.6843384435124145,0.008547008547008548,0.19270962863323737,1.0,7/11,14.85%,FBN1;EFEMP1;MFAP5;FBN2;LRP6;TBX2;MFAP2
prerank,T-helper cell differentiation (GO:0042093),0.7907632243837304,1.6841952770433,0.016453382084095063,0.43112056331467935,1.0,4/14,9.03%,LEF1;FOXP1;TMEM98;ZFPM1
prerank,blood vessel morphogenesis (GO:0048514),0.6165851534824415,1.6817040258997271,0.016058394160583942,0.43423243535469935,1.0,18/54,7.50%,EGFL7;FLT1;KDR;ENG;CAV1;TBX1;RASIP1;LRP5;SOX17;SOX18;FLT4;CDH2;ID1;SMAD7;LAMA1;RAMP2;TGFB1;RASA1
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.6959794739017992,-1.6791499615347418,0.013953488372093023,0.19947848940985968,1.0,8/15,11.32%,LRP1;PDPN;DPP4;DDR1;FAP;DDR2;FGFR4;CST3
prerank,regulation of hydrolase activity (GO:0051336),0.593151713652511,1.6762972878220153,0.0013679890560875513,0.4548129250393504,1.0,11/71,4.33%,PRKG1;CHN2;FGD5;PLXNA4;CAV1;RASIP1;DAB2IP;FGD6;PLXND1;ARHGAP27;TBC1D15
prerank,calcium ion transmembrane transport (GO:0070588),-0.4687953194789412,-1.6737808585217633,0.0,0.20656800891147997,1.0,23/86,11.67%,SLC24A3;TRPM3;CACNA1C;NALCN;SLC8A3;CACNA2D1;CACNA1D;PKD1;SLC8A1;P2RX4;MCU;SLC35G1;CACNA1G;ITGAV;TRPC3;TRPC6;TRPC1;ATP2A2;SLC24A2;TRPC4;GRIN2A;MICU1;YME1L1
prerank,cardiac muscle contraction (GO:0060048),-0.5690093680226356,-1.6732127820926752,0.013227513227513227,0.20437000303980282,1.0,8/34,9.11%,ATP1A2;DMD;GSN;ATP1B1;SLC8A1;TPM1;GAA;RYR2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.8017041933464829,1.6717436342832468,0.018072289156626505,0.469891883792876,1.0,7/12,11.40%,ERN1;DAB2IP;XBP1;BOK;BCL2L11;PTPN1;ATF6
prerank,dicarboxylic acid transport (GO:0006835),-0.6047165757052776,-1.6694921896102515,0.013927576601671309,0.20827060760026406,1.0,13/28,15.94%,SLC1A3;SLC13A3;PDPN;SLC26A7;GJA1;SLC22A6;SLC1A2;SLC25A12;SLC25A13;SLC19A1;SLC26A6;SLC1A1;SLC25A18
prerank,hemopoiesis (GO:0030097),0.570966675159499,1.6693626558275012,0.005208333333333333,0.4741205437312437,1.0,20/87,7.33%,MECOM;TEK;FLT1;KDR;SNRK;ZBTB16;ETV6;KITLG;PDGFB;TAL1;CD34;FLT4;TOX;TIRAP;DLL1;HIPK1;WNT5A;LYL1;LCK;TGFB1
prerank,skeletal system development (GO:0001501),-0.4412922148977859,-1.6689853010246476,0.0,0.205738738745233,1.0,40/148,7.61%,BMP6;COL1A2;SOX5;IGF1;SULF1;FBN1;FGFR2;COL1A1;GLI2;CDH11;AKAP13;TRPS1;BMP5;BMP7;GJA1;SULF2;NPR3;TGFBR1;COL13A1;WWOX;PCSK5;PKD1;RBP4;SOX6;SH3PXD2B;EXT1;MMP14;GNAS;MMP16;TNFRSF11B;ITGB8;IGF2;EVC;ALPL;PRELP;PAPSS2;KIAA1217;VCAN;NOTUM;CD44
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6553445361151186,1.6669418707976973,0.015197568389057751,0.47802891972279693,1.0,11/36,6.10%,LEF1;NFATC1;FZD6;FZD4;PPP3CA;GNB1;PLCB1;TCF7L2;TNRC6C;PPP3CB;WNT5A
prerank,L-serine metabolic process (GO:0006563),0.8208667523551982,1.6668222191717577,0.01971326164874552,0.4701967504378864,1.0,2/10,2.40%,SERINC3;SERINC5
prerank,regulation of GTPase activity (GO:0043087),0.5345782692143962,1.6655179306852426,0.001177856301531213,0.46937134868530345,1.0,39/177,10.82%,PRKG1;CHN2;LRCH1;FGD5;DOCK9;PKP4;PLXNA4;TGM2;NET1;ITGA6;F11R;TBC1D30;RASIP1;SH3BP4;DAB2IP;FGD6;SRGAP2;PLXND1;ARHGAP27;CAV2;ADRB1;TBC1D15;RAP1GDS1;RAPGEF2;CD40;BCAR3;PTK2;RAP1A;TBC1D2;AGRN;RASA4;RSU1;ARHGEF7;CRK;OCRL;LARS1;CCL14;SEMA4D;EPHA4
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.6638671993172266,-1.6654350090462917,0.014354066985645933,0.21002547989149767,1.0,7/17,1.52%,IGF1;DOCK7;DOCK5;PDGFRB;VTN;NRP1;IGFBP5
prerank,heart contraction (GO:0060047),-0.5428225846596652,-1.6613370421185778,0.014326647564469915,0.21590398594438936,1.0,9/41,9.11%,ATP1A2;DMD;SGCD;ATP1B1;SLC8A1;TPM1;GAA;SGCZ;RYR2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.685848018441299,-1.6606103805314871,0.011848341232227487,0.2139486652720608,1.0,7/14,16.59%,SULF1;SULF2;THBS1;FGF2;FUZ;GPC1;CREB3L1
prerank,filopodium assembly (GO:0046847),0.7797000450883608,1.6604228689039922,0.006802721088435374,0.48847716201384245,1.0,6/16,4.52%,FGD5;DNM3;FGD6;SRGAP2;SPATA13;PPP1R9B
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6690778463220143,1.6603738499940046,0.010510510510510511,0.480528958188785,1.0,12/32,5.28%,HDAC9;KDR;PTGS2;MMRN2;GATA2;JCAD;HDAC7;NOTCH1;PIK3C2A;CARD10;RHOJ;DLL4
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.534233015447127,1.6589405881959818,0.001221001221001221,0.47973015608623004,1.0,29/151,8.79%,ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;DEGS2;PRKD1;GCH1;SPNS2;PLA2G4A;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;ALAS1;LPCAT3;SPTLC3;ELOVL5;GPHN;SPTSSA;CEPT1;LPIN3;PPM1L;PAM;B4GALT5;GSTO2;GSTA4;B3GNT6
prerank,positive regulation of epithelial cell migration (GO:0010634),0.574982148057286,1.6586493167072753,0.003911342894393742,0.4732665757656013,1.0,24/92,7.41%,NRP2;TEK;BMPR2;KDR;PRKD1;PLCG1;DOCK1;FOXP1;RAB11A;SCARB1;EDN1;PRKD2;PTK2B;HIF1A;PPM1F;RREB1;FLT4;PLCG2;SOX9;ENPP2;WNT5A;RAC1;SASH1;PIK3CG
prerank,modulation by symbiont of entry into host (GO:0052372),0.7732928154774177,1.6580660446647928,0.010830324909747292,0.4690309544649029,1.0,6/16,7.85%,CAV1;TRIM14;NECTIN2;FUCA2;TRIM68;TRIM25
prerank,regulation of T cell migration (GO:2000404),0.7350701451436487,1.6559292515043122,0.019230769230769232,0.4723492937193236,1.0,3/18,1.49%,LRCH1;APP;CD200
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.5116218124736145,-1.6557520588363557,0.0,0.2205479889016001,1.0,25/54,18.88%,GPC6;SDC2;GPC3;HSPG2;HS3ST3A1;EXT1;PXYLP1;HS3ST3B1;HS2ST1;GPC5;HS6ST2;GCNT2;SDC4;XYLT1;HS3ST5;HS6ST1;GPC4;HEXA;B4GALT7;SDC1;GPC1;HGSNAT;UGDH;B3GAT2;IDUA
prerank,response to interleukin-4 (GO:0070670),0.8164802641117771,1.6557155041807852,0.028469750889679714,0.4661517598938322,1.0,5/10,8.35%,LEF1;JAK3;XBP1;DCSTAMP;CITED1
prerank,lymphocyte differentiation (GO:0030098),0.5935901453328145,1.6547973292830935,0.004195804195804196,0.46419516078156564,1.0,22/68,13.43%,HDAC9;PBX1;LFNG;VCAM1;HHEX;TPD52;PTPRJ;ADGRG3;CHD7;PLCG2;TOX;JAK3;DLL4;LYL1;LCK;TCF3;SOX4;RELB;JAG2;DCAF1;KLF6;ADAM17
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.6351562031243703,-1.6535753348471163,0.009592326139088728,0.22221741647185358,1.0,11/21,10.63%,SULF1;SULF2;EXT1;HS3ST3B1;HS6ST3;HS2ST1;HS3ST4;HS6ST2;XYLT1;HS3ST5;HS6ST1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.5363156258316361,1.6501301218861568,0.0012106537530266344,0.4801695161398419,1.0,40/149,14.56%,PRKCH;RPS6KA5;NOD1;CAV1;APP;PRKD1;ARHGEF2;PRKD2;STAT3;AIM2;TNFRSF11A;TRIM14;NFKBIA;TRAF1;TIRAP;IKBKB;CX3CR1;TRIM68;WNT5A;MID2;CD40;TRIM25;NFKB1;MALT1;IKBKG;PSMA6;MAP3K13;RIPK1;CARD16;RELA;RIPK2;RNF25;MTPN;RAB7B;IL1RAP;NPM1;TRAF6;S100A9;ERC1;NFKB2
prerank,hematopoietic stem cell proliferation (GO:0071425),0.8079835291463314,1.6493456095146248,0.018518518518518517,0.4768717540041306,1.0,4/11,6.10%,MECOM;ETV6;CD34;WNT5A
prerank,inositol lipid-mediated signaling (GO:0048017),-0.5166842118909,-1.6487982250050166,0.009868421052631578,0.2288495704238045,1.0,15/50,7.82%,PLCL1;IGF1;PLCE1;PDGFRB;PDGFRA;ADAP2;IRS1;PI4KA;GAB2;OGT;PLCD3;NGF;PLCB3;PLCD1;EZR
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.6623810662321762,-1.6463535883232023,0.012165450121654502,0.23101005679654554,1.0,7/16,9.26%,FOXD1;FGF1;BMP4;FGF2;SALL1;SIX1;NPNT
prerank,positive regulation of angiogenesis (GO:0045766),0.5538318588591788,1.6461635201287872,0.00639386189258312,0.48630768736985996,1.0,26/108,8.10%,TEK;TJP1;NOS3;FLT1;KDR;TIE1;PRKD1;SMAD1;PLCG1;VEGFC;GATA2;PRKD2;HIF1A;CD34;PIK3R6;DLL1;HIPK1;XBP1;VEGFD;RAMP2;WNT5A;CD40;SASH1;JAK1;ITGA5;GAB1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.6666885759235684,1.645013206110514,0.011093502377179081,0.4850927194807591,1.0,11/33,7.98%,SEMA6A;TJP1;PPP1R16B;EPN2;SMAD1;DLL1;RHOJ;KLF2;CEACAM1;JAK1;ITGA5
prerank,regulation of microtubule-based process (GO:0032886),-0.5438934152325691,-1.644735579016438,0.0110803324099723,0.23107509992745154,1.0,8/36,7.06%,PHLDB2;EPHA3;EFNA5;PHLDB1;BICD1;PRKAA2;ATF5;MAP6
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5838414853330275,1.6444540961760103,0.005390835579514825,0.48131612048313194,1.0,23/70,13.99%,WIPF3;PLCG1;DOCK1;ELMO1;WASF2;LYN;YES1;FYN;NCK1;PLCG2;ARPC3;NCKAP1;ARPC1B;RAC1;PTK2;CRK;FCGR1A;MYO1C;CYFIP1;ACTR2;HSP90AB1;PLD2;ACTR3
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7826306196416749,1.6438355804263307,0.0106951871657754,0.47764442701321674,1.0,6/13,9.42%,EPN2;MMRN2;DAB2IP;HHEX;NEDD4;PTPN1
prerank,cellular response to sterol (GO:0036315),-0.680799402355977,-1.6434579088403276,0.007537688442211055,0.23032146823864433,1.0,9/13,20.56%,GRAMD1B;GRAMD1C;INSIG2;RORA;LRP6;SMO;INSIG1;GPLD1;PTCH1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6993394634185087,1.6431096998738077,0.019332161687170474,0.474434004488629,1.0,4/23,3.88%,CADM1;NECTIN2;PVR;PIK3R6
prerank,adenine nucleotide transport (GO:0051503),0.7468702877749804,1.6424612479106973,0.030303030303030304,0.47112533279070684,1.0,2/17,0.57%,ABCC4;LRRC8C
prerank,actin filament depolymerization (GO:0030042),-0.7389908015637181,-1.641324014902864,0.01366742596810934,0.23180994479325612,1.0,3/11,1.03%,MICAL3;GSN;MICAL2
prerank,brain morphogenesis (GO:0048854),0.7741673655885286,1.6400806363888274,0.027624309392265192,0.4770885842917583,1.0,1/12,0.09%,SHANK3
prerank,cytosolic calcium ion transport (GO:0060401),-0.5802504797464825,-1.6400037466461896,0.016304347826086956,0.23120802441453853,1.0,15/28,18.75%,CACNA1C;CACNA2D1;JPH1;SLC8A1;MCU;SLC35G1;ATP2A2;RYR2;MICU1;ADRA1A;JPH2;SLC25A23;CACNB3;SLC8A2;ATP2A3
prerank,regulation of endothelial cell migration (GO:0010594),0.5664642256552928,1.6399658634311833,0.005161290322580645,0.47140697863474595,1.0,23/85,7.46%,NRP2;TEK;BMPR2;KDR;ACVRL1;PRKD1;PTPRM;PRCP;FOXP1;DAB2IP;SCARB1;EDN1;PRKD2;PTK2B;FLT4;RHOJ;CEACAM1;DLL4;WNT5A;RAC1;SASH1;PIK3CG;PTK2
prerank,bicellular tight junction assembly (GO:0070830),0.62272306008413,1.6398672357798123,0.007407407407407408,0.4655857174189803,1.0,8/46,5.63%,PECAM1;ESAM;CLDN5;OCLN;F11R;PARD3;PAK2;RAMP2
prerank,maintenance of blood-brain barrier (GO:0035633),0.6695602798608429,1.6396741442713438,0.01848998459167951,0.4607373567042415,1.0,9/30,1.93%,TJP1;PECAM1;JAM2;ESAM;LSR;CLDN5;OCLN;F11R;TJP2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.5601969762116396,1.6394880939058756,0.006675567423230975,0.4557851065568761,1.0,27/94,18.42%,IL1R1;RPS6KA5;NOD1;NFKBIA;PLCB1;IKBKB;PELI1;PSMA2;NFKB1;MAP3K3;IKBKG;PSMA8;PSMA6;CUL1;IRAK4;RELA;RIPK2;IL1RAP;TRAF6;PSME1;IRAK3;RPS6KA4;TAB3;IRAK2;MAP3K8;PSMA4;PSMF1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5781783103812785,-1.6388991582188093,0.010723860589812333,0.23034507169899215,1.0,13/29,16.39%,SNTA1;KCNIP3;CACNA1D;KCNIP4;DLG1;SLMAP;KCNAB1;DPP6;WNK1;CD63;KCNN2;WNK3;DPP10
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.724778382527266,1.6387416304826936,0.02022058823529412,0.4539450486630356,1.0,3/17,3.16%,CADM1;NECTIN2;PVR
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5802298612382676,1.6383153580328012,0.005405405405405406,0.4506941813780617,1.0,23/71,13.99%,WIPF3;PLCG1;DOCK1;ELMO1;WASF2;LYN;YES1;FYN;NCK1;PLCG2;ARPC3;NCKAP1;ARPC1B;RAC1;PTK2;CRK;FCGR1A;MYO1C;CYFIP1;ACTR2;HSP90AB1;PLD2;ACTR3
prerank,peripheral nervous system development (GO:0007422),0.697121753189084,1.6380879540236923,0.01990049751243781,0.4463538354033133,1.0,1/23,0.01%,ADGRG6
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5689801160896942,-1.6372732530863785,0.005571030640668524,0.23065136024641095,1.0,10/31,5.77%,FGFR2;PDGFRA;HOXC4;OSR1;TGFBR1;HOXA3;DYNC2I1;HOXB4;HOXB3;SIX1
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.6184685057131004,-1.634996291086564,0.021686746987951807,0.232128623934363,1.0,6/19,10.19%,WNT4;BMP4;LARP6;RUNX1;RGCC;TGFB3
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.500226793634538,-1.6331725547537266,0.0,0.23277868726603507,1.0,9/53,4.96%,EYA2;EGFR;EYA1;DDX5;EYA4;PLA2R1;PRKCD;SPRED1;FXR2
prerank,regulation of plasminogen activation (GO:0010755),-0.7136744967088344,-1.6313880909234006,0.018306636155606407,0.233483407432313,1.0,8/12,24.82%,CLEC3B;THBS1;SERPINE2;RUNX1;SERPINE1;CTSZ;PLGRKT;ENO1
prerank,lipid translocation (GO:0034204),0.7042397308973838,1.6307519439714542,0.028960817717206135,0.47512181042635704,1.0,5/21,2.88%,ATP8B1;ATP8A1;ATP10A;ATP11C;ATP11B
prerank,cardiac conduction system development (GO:0003161),-0.5845762673110547,-1.630267970715099,0.02040816326530612,0.23258791370571202,1.0,7/24,5.92%,NOTCH2;BMPR1A;GJB6;GJA1;BMP4;CACNA1G;TBX18
prerank,endothelial cell development (GO:0001885),0.6949903995815958,1.629461213519632,0.024350649350649352,0.4755589719906022,1.0,11/25,7.53%,PECAM1;PPP1R16B;ICAM1;PDE2A;MSN;PDE4D;RAP1B;SOX18;ROBO4;RAPGEF2;RAP1A
prerank,phosphorylation (GO:0016310),0.48774046774314,1.6288662445690232,0.0,0.4724174403811494,1.0,93/384,11.79%,PRKG1;PRKCH;ERG;RPS6KA5;CDK17;BMPR2;APP;SNRK;ERN1;ACVRL1;PRKD1;CDK6;INSR;DAPK1;NEK7;PDGFB;PEAK1;DGKZ;LYN;PIM3;PRKD2;BCR;ADAM10;STAT3;PRAG1;PTK2B;FNIP2;STK10;MAP4K3;SIK1;FYN;TAOK2;STK24;STK3;PKN3;LIPE;PKN2;PAK2;PKN1;STK4;LMTK2;MARK3;JAK3;MAP3K9;IKBKB;HIPK1;DGKH;ACVR2A;CDC42BPB;MAPK8;RET;PLK2;MAST2;ULK1;LIMK2;PPP3CB;AURKA;SIK3;ACVR1;TSSK6;DYRK1A;STK26;BMX;TNIK;LCK;JAK1;TGFB1;PIK3CG;CERKL;CTBP1;HASPIN;CREB1;SGK3;NEK6;PXK;MAP3K11;AURKC;PANK2;CDK2;COPS2;CDK18;NUAK1;PRKAB1;GAS6;AKT3;GK5;DGKE;GMFG;PICK1;MAP3K13;SIK2;STK38;PIM1
prerank,hemidesmosome assembly (GO:0031581),0.7928149680424059,1.6280962011769453,0.02462121212121212,0.4704021433290986,1.0,3/11,3.59%,ITGA6;DST;LAMA3
prerank,diol biosynthetic process (GO:0034312),0.7604730487607935,1.6275876882131308,0.010714285714285714,0.467597897679271,1.0,5/15,5.50%,ACER2;SPTLC2;GCH1;SPTLC3;ASAH2
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.6522982178423812,-1.6273995292913397,0.01098901098901099,0.23580591592676134,1.0,8/16,18.29%,ANK2;LRRK2;RYR2;SEC16B;GBF1;MIA3;DDRGK1;SEC16A
prerank,determination of bilateral symmetry (GO:0009855),0.6782693071616601,1.6273324172460355,0.018302828618968387,0.4632776213609764,1.0,6/24,8.36%,TBX1;ZIC3;NOTCH1;DLL1;PKD2;CFAP53
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.716111514361682,1.6258067664600984,0.023972602739726026,0.46513681530759093,1.0,4/18,7.78%,GNAQ;GNB1;PLCB1;AGRN
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5727877899220774,1.625307613219313,0.004021447721179625,0.4623675286371341,1.0,23/73,13.99%,WIPF3;PLCG1;DOCK1;ELMO1;WASF2;LYN;YES1;FYN;NCK1;PLCG2;ARPC3;NCKAP1;ARPC1B;RAC1;PTK2;CRK;FCGR1A;MYO1C;CYFIP1;ACTR2;HSP90AB1;PLD2;ACTR3
prerank,sulfation (GO:0051923),-0.7310197991600308,-1.624846484066602,0.02696629213483146,0.23889642403172168,1.0,1/11,0.08%,UST
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7025446451347155,1.624480720258706,0.022569444444444444,0.46093217491662075,1.0,4/21,2.31%,PRKCH;FOXP1;ELF2;LYN
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.7982021652026975,1.6230844626560454,0.03409090909090909,0.4622639918006885,1.0,3/11,4.43%,SEMA6A;EPN2;KLF2
prerank,regulation of transferase activity (GO:0051338),0.7375037593106285,1.6229225467654345,0.02127659574468085,0.4579389060169983,1.0,4/17,8.83%,LDB2;NLRC5;HMBOX1;PINX1
prerank,cellular response to interleukin-4 (GO:0071353),0.7997139641705947,1.6229089887851111,0.038181818181818185,0.4531344395072066,1.0,4/10,6.49%,LEF1;JAK3;XBP1;DCSTAMP
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.7331344444398902,1.6213916975906328,0.026415094339622643,0.45502732525282263,1.0,3/16,3.16%,CADM1;NECTIN2;PVR
prerank,aminoglycan catabolic process (GO:0006026),-0.567694413289306,-1.6211693109522562,0.01818181818181818,0.24407992527538752,1.0,10/28,16.75%,GPC6;SDC2;GPC3;HSPG2;GPC5;SDC4;GPC4;SDC1;GPC1;HGSNAT
prerank,metanephros development (GO:0001656),-0.5723305297647948,-1.6202678430714443,0.010526315789473684,0.2428958305461094,1.0,8/26,5.77%,FOXD1;BMP7;OSR1;BMP4;PKD1;ROBO2;NF1;SIX1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.6255945257562673,1.6166235049716782,0.019726858877086494,0.4710437946958984,1.0,11/38,8.09%,CAV1;PTGS2;INSR;EDN1;CD34;KLF2;CX3CR1;ATP2B4;RAC1;NOS1AP;PKD2
prerank,regulation of macrophage migration (GO:1905521),0.808822205089152,1.6166011028520317,0.02697495183044316,0.4662962479137513,1.0,6/10,11.16%,MTUS1;CD200;PTK2B;CX3CR1;CSF1;P2RY12
prerank,regulation of lymphocyte migration (GO:2000401),0.8164683881115887,1.6152905004835112,0.020257826887661142,0.4673950693340801,1.0,3/10,2.80%,JAM2;STK10;MSN
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.720930839448573,1.6149639158522728,0.029605263157894735,0.4641632463669364,1.0,8/18,4.40%,HDAC9;KDR;PTGS2;GATA2;JCAD;HDAC7;PIK3C2A;RHOJ
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.71041228365259,1.6146788199398527,0.019642857142857142,0.4609328693181699,1.0,5/18,2.34%,RPS6KA5;PRKD1;CRTC1;CD200;PRKD2
prerank,purine ribonucleotide transport (GO:0015868),0.7481660238786608,1.613904011166807,0.029357798165137616,0.4597789641592136,1.0,2/16,0.57%,ABCC4;LRRC8C
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.6378163791658862,-1.6125882297084155,0.02386634844868735,0.2582025235921172,1.0,6/16,10.19%,WNT4;BMP4;LARP6;RUNX1;RGCC;TGFB3
prerank,regulation of phospholipase activity (GO:0010517),-0.7161079011928336,-1.6120830293551653,0.018711018711018712,0.2563839739886387,1.0,2/10,0.68%,LRP1;FGFR2
prerank,regulation of response to external stimulus (GO:0032101),0.5247072051532546,1.6110465627501056,0.003740648379052369,0.46834309602410645,1.0,30/121,11.16%,IL1R1;CAV1;PTGS2;SEMA7A;FOXP1;NMT2;SAMHD1;ADGRA2;CASP4;CNGB1;NLRP6;BST1;SELE;STK24;CASP8;TMSB4X;TIRAP;N4BP1;SBNO2;XIAP;WNT5A;GNAT1;ERAP1;CASP1;GUCA1B;BRD4;CYRIB;PSMA6;CXCR4;P2RY12
prerank,angiogenesis involved in wound healing (GO:0060055),0.8035767709631298,1.609703155992111,0.02448210922787194,0.47001287970464983,1.0,5/11,3.79%,ADIPOR2;KDR;PRCP;GATA2;CD34
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.6474982987526583,-1.6093170902263372,0.029748283752860413,0.2594784071972016,1.0,8/17,18.45%,IGF1;NTRK2;RTN1;BIN1;APOE;RTN4;ABCA7;CHRNA7
prerank,L-glutamate transmembrane transport (GO:0015813),-0.7286600553740261,-1.6088418303879786,0.012987012987012988,0.2575806945205414,1.0,7/10,18.52%,SLC1A3;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;PRAF2
prerank,glycerophospholipid catabolic process (GO:0046475),0.6622403674174939,1.6083778093407903,0.02358490566037736,0.4714378916861632,1.0,8/27,15.03%,GPCPD1;PLA2G4A;ENPP6;ENPP2;INPP5F;GDPD1;PNPLA6;PNPLA8
prerank,receptor clustering (GO:0043113),-0.5683891042977526,-1.6079202458899964,0.020618556701030927,0.25705891664986474,1.0,14/27,20.55%,MAGI2;PTN;DLG2;DLG4;DLG1;NRXN1;NLGN1;DLG3;NRXN2;DVL1;LRRC7;ITGA4;MUSK;ITGB2
prerank,platelet degranulation (GO:0002576),0.5340718873462613,1.6074940252997068,0.0037359900373599006,0.4708798628857539,1.0,23/118,9.14%,VWF;ABCC4;PECAM1;PCDH7;APP;PDGFB;VEGFC;LYN;ACTN4;SELP;SELENOP;TMSB4X;ACTN1;PROS1;VEGFD;QSOX1;TAGLN2;PPBP;SRGN;TGFB1;APOOL;TMX3;APLP2
prerank,chordate embryonic development (GO:0043009),-0.4749964959381586,-1.607084493061128,0.0033783783783783786,0.25611030237789606,1.0,18/55,10.19%,SULF1;ALDH1A2;FGFR2;COL1A1;ARNT2;BMP5;BMP7;SULF2;TGFBR1;PCSK5;PKD1;RBP4;DACT1;IGF2;KIAA1217;VEGFA;XYLT1;TGFB3
prerank,glial cell differentiation (GO:0010001),0.6673879898792048,1.6058292708893118,0.019726858877086494,0.47393899286311725,1.0,8/28,11.52%,ADGRG6;STAT3;SOX9;CDH2;EIF2B5;SOX4;NFIB;PICK1
prerank,heart morphogenesis (GO:0003007),0.6116694538104013,1.6045986480852994,0.007385524372230428,0.4752479875377702,1.0,13/50,7.46%,NOS3;ENG;TBX1;EPHB4;ACVRL1;INSR;NOTCH1;SOX17;CHD7;FKBP1A;SOX9;ACVR1;PTK2
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.7171756980053957,1.6042996738285902,0.024734982332155476,0.4723102872125546,1.0,10/18,16.68%,RNF125;SEC14L1;USP15;PUM1;PUM2;OASL;NOP53;BIRC3;GPATCH3;BIRC2
prerank,regulation of chemokine production (GO:0032642),0.6261116300281436,1.6039475640770058,0.0296875,0.4695134491056446,1.0,10/36,13.43%,APP;FOXP1;IL6R;HIF1A;ACKR1;SIGIRR;WNT5A;LPL;IL7;ADAM17
prerank,regulation of cell killing (GO:0031341),0.7258028486709819,1.6038831188280536,0.03292894280762565,0.4655323747545287,1.0,6/16,7.48%,CFH;ICAM1;MAPK8;WNT5A;RAC1;CR1L
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.712135707990353,-1.6025392107489318,0.030107526881720432,0.2642733243435219,1.0,5/10,16.85%,ADGRV1;IFT88;WHRN;PLS1;TSKU
prerank,regulation of defense response (GO:0031347),0.5555837699316433,1.6004592326333484,0.006944444444444444,0.47583615915549926,1.0,19/76,9.15%,IL1R1;PTGS2;SEMA7A;FOXP1;SAMHD1;CASP4;NLRP6;BST1;SELE;CASP8;TMSB4X;TIRAP;N4BP1;SBNO2;XIAP;WNT5A;ERAP1;CASP1;BRD4
prerank,regulation of angiogenesis (GO:0045765),0.5078164220150385,1.5999329395984094,0.0011534025374855825,0.47360934319691533,1.0,37/192,6.84%,SEMA6A;TEK;NOS3;FLT1;KDR;TIE1;PPP1R16B;CLDN5;PRKD1;PTPRM;PLCG1;VEGFC;ECSCR;GATA2;DAB2IP;HHEX;STAB1;PRKD2;NPR1;ADGRA2;HIF1A;PLXND1;CD34;PIK3R6;GTF2I;RHOJ;TSPAN12;HIPK1;XBP1;VEGFD;CEACAM1;ATP2B4;RAMP2;WNT5A;CD40;SASH1;EGLN1
prerank,regulation of immune response (GO:0050776),0.5172024098891944,1.5983054245434138,0.0063371356147021544,0.47638957388284464,1.0,22/135,6.60%,CLEC2D;VCAM1;IL15;ICAM1;CD200;B2M;AHR;FOXP1;LYN;SAMHD1;NECTIN2;ICAM2;DENND1B;PVR;CASP8;FKBP1A;CD34;TIRAP;SPPL2A;N4BP1;XIAP;CD40
prerank,B cell activation (GO:0042113),0.5674492569064996,1.5978914606507022,0.008287292817679558,0.47423392388847896,1.0,15/68,8.24%,HDAC9;MEF2C;VCAM1;HHEX;CTPS1;TPD52;PTPRJ;ADGRG3;CASP8;PLCG2;JAK3;CD40;LYL1;TCF3;MALT1
prerank,negative regulation of wound healing (GO:0061045),-0.5568388165103116,-1.597700636778021,0.01272264631043257,0.2725593146971896,1.0,11/28,10.33%,PHLDB2;VTN;TFPI;SLC12A2;FGF2;SERPINE2;CD109;CASK;APOE;AJAP1;SERPINE1
prerank,ceramide biosynthetic process (GO:0046513),0.610893998956569,1.5967534372200856,0.01694915254237288,0.4754218192981678,1.0,9/40,6.92%,ST6GALNAC3;SPTLC2;SGMS1;DEGS2;CERS4;SPTLC3;SPTSSA;ASAH2;ST8SIA4
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.5101469986979364,1.5960144426968284,0.002372479240806643,0.4751274985376474,1.0,76/168,20.57%,CNOT6;PAN3;CNOT6L;RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;SMG7;RPL9;RPL4;RPL13A;CNOT1;RPS11;RPL32;NBDY;RC3H1;RPL22;RPS27;RPL31;RPS23;CNOT2;DCP2;RNPS1;RPL13;RPS12;PNRC2;RPL6;ZFP36;RPL10;CNOT7;UPF2;MTPAP;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;XRN2;RPL27A;RPS10;ZFP36L1;CTIF;RPL11;CSDE1;RPL8;RPLP2;HELZ2;PPP2R2A;RPL18A;DHX34;PPP2R1A;RPL21;LSM1;RPL3;PAN2;RPS3
prerank,nitric oxide biosynthetic process (GO:0006809),0.7542436991121938,1.595307046960424,0.02491103202846975,0.47401007075752727,1.0,2/13,1.55%,NOS3;GCH1
prerank,vasculogenesis (GO:0001570),0.6407374702630706,1.5930613880613833,0.024922118380062305,0.47948054262210205,1.0,11/32,7.50%,EGFL7;KDR;ENG;CAV1;RASIP1;NOTCH1;SOX17;SOX18;RAMP2;TGFB1;RASA1
prerank,lung development (GO:0030324),-0.5456538146048491,-1.59279823672074,0.008849557522123894,0.2814287784191052,1.0,18/33,17.21%,FGFR2;GLI2;FGF1;PDPN;ERRFI1;BMP4;PKD1;RBP4;LOXL3;FGF2;RCN3;VEGFA;STRA6;FGF7;CCDC39;WNT11;NPHP3;FGF10
prerank,endothelial cell proliferation (GO:0001935),0.7082787774540926,1.5915587070368387,0.04092526690391459,0.4818234497562822,1.0,5/17,3.79%,TEK;BMPR2;ERN1;ACVRL1;CD34
prerank,aminoglycan biosynthetic process (GO:0006023),-0.5041977065408393,-1.5897366381016036,0.00949367088607595,0.2857180959877923,1.0,21/49,13.11%,GPC6;SDC2;B3GALT1;GPC3;HSPG2;HS3ST3A1;EXT1;PXYLP1;HS3ST3B1;HS2ST1;GPC5;HS6ST2;GCNT2;SDC4;XYLT1;HS3ST5;HS6ST1;GPC4;HEXA;B3GALT5;B4GALT7
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5806620015696322,1.5895038752744441,0.014245014245014245,0.48742725891088434,1.0,14/63,11.13%,CD38;IL6ST;MEF2C;VCAM1;IL15;BST1;NCK1;TIRAP;JAK3;CD40;TNFRSF13C;IL23A;CD320;IL7
prerank,homeostasis of number of cells (GO:0048872),0.7646011321361257,1.5875471273901882,0.04152249134948097,0.4918852674380191,1.0,4/12,5.39%,NOS3;NOTCH1;LPCAT3;CX3CR1
prerank,mRNA splice site selection (GO:0006376),-0.5547815944528713,-1.5875042865914282,0.016129032258064516,0.28802698852991704,1.0,7/30,12.29%,CELF2;SRSF5;CELF4;LUC7L3;PSIP1;CELF1;SF1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.6784137319857133,-1.5863197780180036,0.031746031746031744,0.287647172907666,1.0,4/13,5.06%,ANK2;CACNA1C;GJA1;CACNB2
prerank,nitric oxide metabolic process (GO:0046209),0.7493573104178837,1.585692009966259,0.02154398563734291,0.49586446224266073,1.0,2/14,1.55%,NOS3;GCH1
prerank,myeloid leukocyte differentiation (GO:0002573),0.56108552240156,1.585597917974924,0.014104372355430184,0.49225260164276435,1.0,12/65,9.46%,LEF1;CBFA2T3;IL15;PIR;FOXP1;MYH9;TNFRSF11A;CASP8;SBNO2;DCSTAMP;CDK2;CSF1
prerank,regulation of cell morphogenesis (GO:0022604),-0.538155177070723,-1.5847602155035005,0.017241379310344827,0.2882231273290667,1.0,13/30,16.14%,EFNA5;PDPN;SPARC;NTNG1;CD44;ZMYM6;ZMYM3;ZMYM4;MOV10;MFSD2A;CAPZB;MACF1;MYO9A
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.6245738794435344,-1.5836436903241746,0.02702702702702703,0.2878970857158315,1.0,8/18,13.26%,ASPA;NAALAD2;SMS;ASPG;SLC25A12;GOT1;MTHFD1;SLC25A13
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.7519543742258662,1.5827391138473075,0.040892193308550186,0.5010228510177815,1.0,2/11,1.55%,NOS3;GCH1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7325166816607573,1.582630480169579,0.043875685557586835,0.4975117671319035,1.0,5/13,10.01%,NECTIN2;PVR;STX7;IL23A;CYRIB
prerank,myeloid cell differentiation (GO:0030099),0.5899683653604517,1.582586156675864,0.028528528528528527,0.49373879032401563,1.0,10/47,5.14%,SNRK;ZBTB16;LYN;TAL1;MFHAS1;TIRAP;RPS19;JAK3;RPS14;KMT2E
prerank,regulation of trophoblast cell migration (GO:1901163),-0.6556587021053957,-1.5823691917861171,0.02178649237472767,0.2880796846274378,1.0,10/14,28.87%,GJA1;VEGFA;SYDE1;ACVR1B;ARHGDIB;SMURF2;TIMP1;CALR;C1QBP;ACVR1C
prerank,regulation of actomyosin structure organization (GO:0110020),-0.6784165035921947,-1.5822742301133152,0.018223234624145785,0.2853347000887382,1.0,6/13,11.28%,ROCK2;AKAP13;ALMS1;FHOD1;ASAP3;SLC9A1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.7572190929208954,1.581219454798004,0.04144144144144144,0.4959296484747358,1.0,1/12,0.05%,IL1R1
prerank,regulation of B cell proliferation (GO:0030888),0.6079566443450555,1.580949678305797,0.024963289280469897,0.49316596932394124,1.0,11/44,11.13%,CD38;MEF2C;AHR;LYN;BST1;TIRAP;CD40;TNFRSF13C;CD320;RC3H1;IL7
prerank,sodium ion transmembrane transport (GO:0035725),-0.44159592952822657,-1.5808120771066125,0.0,0.2858179869418837,1.0,13/84,3.39%,ATP1A2;SLC24A3;NALCN;SLC6A13;SLC8A3;SLC12A2;SLC6A1;SCN7A;SLC9A9;SLC6A12;SLC6A9;ATP1B1;SLC8A1
prerank,protein autophosphorylation (GO:0046777),0.5098897017624657,1.5796864890290383,0.004842615012106538,0.494617019880074,1.0,43/157,12.04%,TEK;FLT1;KDR;EPHB4;ERN1;PRKD1;INSR;DAPK1;PEAK1;LYN;PIM3;PRKD2;PTK2B;STK10;SIK1;TAOK2;STK24;SRMS;FLT4;PAK2;STK4;LMTK2;MARK3;MAP3K9;ULK1;AURKA;DYRK1A;STK26;BMX;TNIK;PTK2;MAP3K3;NEK6;MAP3K11;SLK;MAPKAPK3;EPHA4;MAP3K13;SIK2;PIM1;EEF2K;RIPK1;MKNK2
prerank,regulation of cellular component biogenesis (GO:0044087),0.6221461112195832,1.578990299764289,0.029874213836477988,0.49390698981034703,1.0,9/39,7.53%,TJP1;TIE1;DAB2IP;NOTCH1;MSN;RAP1B;RAPGEF2;SNCAIP;RAP1A
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.7720263409715692,1.5783238448767531,0.02158273381294964,0.4930791677498967,1.0,4/11,7.27%,IL6ST;STAT3;IL27RA;JAK1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.559305504867776,-1.5783160947459813,0.014044943820224719,0.28900016967939524,1.0,10/28,9.16%,PID1;PRKCB;APPL2;IRS1;ENPP1;GRB10;PRKCD;TNS2;PRKCZ;TSC2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6654313693689369,-1.578294400397737,0.029953917050691243,0.2861647084435352,1.0,6/13,4.62%,FSTL1;FBN1;LTBP1;NBL1;GREM2;FBN2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.6278163227336585,1.5782663025192025,0.03235294117647059,0.4895910562227434,1.0,6/38,3.69%,NOS3;TNFSF10;ICAM1;ARHGEF2;FAS;CASP8
prerank,regulation of T cell proliferation (GO:0042129),0.5740339894309804,1.5777952404732087,0.01291248206599713,0.4877866320166694,1.0,10/61,9.61%,IL6ST;VCAM1;IL15;TNFRSF1B;NCK1;JAK3;TNFSF8;PLA2G2D;TNFRSF13C;IL23A
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.683915407619418,-1.5776036935342044,0.02795698924731183,0.2850054086460269,1.0,6/13,9.51%,MGAT3;LARGE1;RENBP;PGM3;NAGK;CHST3
prerank,regulation of integrin activation (GO:0033623),0.7225249346762939,1.575984410894853,0.03782894736842105,0.49209240801112447,1.0,5/15,6.14%,PIEZO1;RASIP1;RAP1B;SELP;SKAP1
prerank,endocardial cushion development (GO:0003197),0.6966606679294598,1.575921944991003,0.025510204081632654,0.488681318103508,1.0,8/21,6.28%,NOS3;BMPR2;ENG;ACVRL1;NOTCH1;SOX9;FOXF1;ACVR1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.7827003802426212,1.5739049181374376,0.0425531914893617,0.4930953058819912,1.0,1/10,0.04%,PRKCH
prerank,cardiac muscle cell contraction (GO:0086003),-0.6136419401964582,-1.5738174636393762,0.035629453681710214,0.29145281607572116,1.0,6/19,7.49%,CACNA1C;GSN;CACNA2D1;CACNA1D;CACNA1G;KCNJ2
prerank,cellular response to mechanical stimulus (GO:0071260),0.5907742927449915,1.573326508501559,0.032116788321167884,0.4922097271238411,1.0,14/46,10.77%,PIEZO1;F11R;PDE2A;FAS;CASP8;SOX9;MAPK8;CD40;TNFRSF1A;NFKB1;CASP1;CRADD;TNFRSF8;BNIP3
prerank,positive regulation of vasculature development (GO:1904018),0.5389934752253515,1.573038267691725,0.011857707509881422,0.489764851024148,1.0,20/94,6.63%,TEK;NOS3;FLT1;KDR;TIE1;PRKD1;PLCG1;VEGFC;GATA2;PRKD2;HIF1A;CD34;PIK3R6;HIPK1;XBP1;VEGFD;RAMP2;WNT5A;CD40;SASH1
prerank,rRNA metabolic process (GO:0016072),0.5120445017750377,1.5720138313481182,0.002421307506053269,0.49046164242180984,1.0,82/160,26.58%,DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;RPL34;RPL39;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;RPL14;RPL23;RPL17;NIFK;RPL9;RPL4;RPL13A;RPL32;RPL22;RPS27;RPL31;EXOSC1;RPL13;NOP53;UTP4;RPL6;RPL10;RPS6;RPL29;RRP9;TRIR;PELP1;RPS25;RPL35A;RPL27;RPL18;XRN2;EMG1;RPL27A;RRP1B;UTP6;PIH1D1;PDCD11;RPL11;WDR18;HEATR1;ESF1;RPL8;NOP14;RPLP2;RPL18A;RPL21;RPL3;DIS3L;SBDS;RPS28;DDX47;RPL7;RPL26;NOL6;TEX10;RRP12;LAS1L;LYAR;NOLC1;RPS17;RPL28;WDR46;WDR74;RPL41;DIS3;EXOSC4;RPS2;RPS9
prerank,focal adhesion assembly (GO:0048041),0.6896261895074809,1.5711748725294377,0.039182282793867124,0.4905015288800933,1.0,7/21,5.16%,THSD1;PEAK1;BCR;TAOK2;SORBS1;ACTN1;PTPRK
prerank,alpha-amino acid catabolic process (GO:1901606),-0.5487590959439931,-1.570447151920014,0.03260869565217391,0.2963982816288367,1.0,13/29,24.84%,DDO;ACADSB;ALDH4A1;PRODH;FAH;ACAT1;CBS;HOGA1;BLMH;GSTZ1;GOT2;KYAT1;MTRR
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.6069740589406758,-1.5691635450538184,0.03488372093023256,0.2966249395376532,1.0,9/19,18.45%,IGF1;NTRK2;RTN1;BIN1;APOE;FLOT2;RTN4;ABCA7;CHRNA7
prerank,lamellipodium assembly (GO:0030032),0.6459327121997351,1.568340748273804,0.02593192868719611,0.4991828656365366,1.0,10/26,11.69%,PARVB;ABLIM1;SRGAP2;S1PR1;SPATA13;CCDC88A;RAC1;ARHGEF7;P2RY12;CYFIP1
prerank,regulation of neurotransmitter transport (GO:0051588),0.7307867094192935,1.5673468338926806,0.04440497335701599,0.4999172797251761,1.0,6/16,13.55%,MCTP1;MEF2C;KCNMB4;SNCAIP;MCTP2;FMR1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.7502310803819939,1.566730102290862,0.060034305317324184,0.49896959795252516,1.0,3/11,5.17%,AHR;CEACAM1;SMAD7
prerank,regulation of glucose import (GO:0046324),-0.5471601316174693,-1.5661677972839405,0.027855153203342618,0.30090751446693914,1.0,10/30,6.44%,PID1;IGF1;APPL2;IRS1;RHOQ;ENPP1;GRB10;SELENOS;OSBPL8;PRKAG2
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.5010699323306776,-1.566071069727754,0.019417475728155338,0.29832603065561863,1.0,12/40,4.62%,BMP6;BMPR1A;PTN;WNT4;BMP7;ADGRV1;OSR1;WNT6;BMP4;GPM6B;SLC8A1;FBN2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.6160572664284174,1.5658246788110115,0.027565084226646247,0.49922721478984444,1.0,6/35,2.59%,TEK;TJP1;ABI3;ESAM;F11R;PTK2B
prerank,neuron projection regeneration (GO:0031102),-0.706814869572765,-1.5655035323040964,0.023148148148148147,0.29696516392626726,1.0,3/10,11.38%,PTN;NREP;GAP43
prerank,positive regulation of neuron migration (GO:2001224),0.7726053841506323,1.5654751178830775,0.032846715328467155,0.49713523866711423,1.0,4/11,6.12%,SEMA6A;DAB2IP;ARHGEF2;RAPGEF2
prerank,monocarboxylic acid transport (GO:0015718),0.5846838815218431,1.5624132099849943,0.02894356005788712,0.5069237529486683,1.0,10/51,5.12%,ABCC4;SLCO2B1;ABCG2;ATP8B1;SLCO2A1;STARD5;SLC16A9;SLC16A2;NCOA1;CEACAM1
prerank,lung epithelium development (GO:0060428),-0.7095903036367871,-1.5610638987528171,0.042643923240938165,0.3049889108645174,1.0,6/10,17.21%,ERRFI1;BMP4;PKD1;RCN3;STRA6;FGF10
prerank,apical protein localization (GO:0045176),0.7762883019268387,1.5606928734621122,0.05017921146953405,0.5105824367878009,1.0,4/10,4.29%,ATP8B1;CELSR1;SHROOM2;MAL
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.7529100008421279,1.5564976222398734,0.0449438202247191,0.5250436581170396,1.0,3/12,7.33%,ESR1;STAT3;TGFB1
prerank,positive regulation of cellular senescence (GO:2000774),0.7804736000323489,1.5562629684483706,0.041353383458646614,0.5225871874457658,1.0,2/10,1.56%,ABI3;B2M
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.7184756010589315,1.5559350752853092,0.04401408450704225,0.5204021895382022,1.0,2/14,2.21%,NOS3;EDN1
prerank,peptide biosynthetic process (GO:0043043),0.5006895975819841,1.5535927041193307,0.006053268765133172,0.5269226257046292,1.0,66/153,17.73%,RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;RPL37A;SRBD1;RPL36;RPS18;RSL24D1;RPL15;RPS8;RPL14;RPL23;RPL17;MRPS18A;RPL9;DHPS;RPL4;RPL13A;RPS11;RPL32;TNIP1;RPL22;RPS27;RPL31;RPS23;MRPL13;RPL13;MRPS12;RPS12;MRPL35;HBS1L;RPL6;RPL10;WARS1;MRRF;MRPL41;RPS29;RPS6;MRPL52;RPL29;RPS25;RPL35A;RPS13;RPS21;MRPS16;RPL27;RPL18;MRPL23;RPL27A;MRPS5;RPS10;MRPL37;RPL11;RPL8;RPLP2;MRPL11
prerank,embryonic organ morphogenesis (GO:0048562),-0.5080539759663227,-1.553212182376743,0.026392961876832845,0.32168030574995093,1.0,16/42,10.85%,FBN1;FGFR2;PDGFRA;HOXC4;EFEMP1;MFAP5;HOXA3;RBP4;DYNC2I1;FBN2;HOXB4;HOXB3;SIX1;RBPMS2;RYR2;FUZ
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.6760726977309999,1.553195566699395,0.03523489932885906,0.5253891611637498,1.0,4/20,7.78%,GNAQ;GNB1;PLCB1;AGRN
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6760506065334089,-1.5524737841525291,0.031746031746031744,0.32069791029153843,1.0,8/12,14.96%,DMD;ATP1B1;WNK4;ANK3;ATP1B2;WNK1;FXYD1;WNK3
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7247217859765133,1.5512595066765895,0.03484320557491289,0.5303186990290676,1.0,2/15,2.18%,PLTP;SCARB1
prerank,nuclear migration (GO:0007097),-0.66275621388309,-1.5511043552791832,0.03325942350332594,0.3214283921406836,1.0,6/13,17.26%,DOCK7;CLMN;SYNE3;PCM1;SYNE2;DYNC1H1
prerank,cAMP-mediated signaling (GO:0019933),0.6699424644280539,1.5510616469821188,0.026101141924959218,0.5277025662926084,1.0,7/24,6.12%,ADGRG6;AHR;PDE2A;PDE7B;PDE4D;SOX9;RAPGEF2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.7314683058012227,1.549881263815671,0.04262877442273535,0.5260747557925932,1.0,5/13,7.27%,IL15;STAT3;PLCB1;JAK3;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),0.7314683058012227,1.549881263815671,0.04262877442273535,0.5260747557925932,1.0,5/13,7.27%,IL15;STAT3;PLCB1;JAK3;JAK1
prerank,heterochromatin organization (GO:0070828),0.7265540725678061,1.5476689834753983,0.05565529622980251,0.5323836616995137,1.0,3/14,8.56%,MECOM;SMCHD1;EZH1
prerank,positive regulation of developmental growth (GO:0048639),0.5844065916696878,1.5471383441698299,0.01859799713876967,0.5314604453316313,1.0,14/49,12.84%,NTN1;INSR;SEMA7A;SMURF1;NEDD4L;ITSN2;PLCB1;DLL1;GHR;AGRN;TWF2;SEMA4D;MAP3K13;DBNL
prerank,cellular response to fluid shear stress (GO:0071498),0.7438416529616159,1.5456945348705544,0.039568345323741004,0.5341521598075162,1.0,6/12,16.94%,MEF2C;MTSS1;KLF2;PKD2;HAS2;MAP2K5
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5831534103835673,-1.544956355387517,0.03482587064676617,0.33416583304061165,1.0,8/22,13.37%,ANK2;ATP1B1;AKAP6;RYR2;SLC9A1;GSTM2;HTT;JPH2
prerank,cellular response to drug (GO:0035690),0.6517000559857501,1.544890403649599,0.02258064516129032,0.5342299474296827,1.0,7/25,7.06%,ACER2;MEF2C;KCNQ1;AIM2;PPM1F;FBP1;KCNE2
prerank,regulation of epithelial cell differentiation (GO:0030856),0.7121526201942938,1.544358887221003,0.04745762711864407,0.5330965979303861,1.0,7/17,5.12%,CAV1;APOLD1;KLF7;MAFF;SOX9;DLL1;CEACAM1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.7580350282709215,1.5441329659983734,0.0737410071942446,0.5308720560417612,1.0,5/11,9.63%,TJP1;F11R;TJP2;RAPGEF2;TJP3
prerank,B cell differentiation (GO:0030183),0.5776126549588502,1.543923713207986,0.022556390977443608,0.5285262015339568,1.0,10/46,7.70%,HDAC9;VCAM1;HHEX;TPD52;PTPRJ;ADGRG3;PLCG2;JAK3;LYL1;TCF3
prerank,regulation of platelet activation (GO:0010543),0.6732413628807445,1.5438992798940103,0.04311774461028192,0.5253998078370512,1.0,5/21,3.91%,NOS3;PLA2G4A;PDGFB;LYN;SELP
prerank,regulation of mitochondrial fusion (GO:0010635),-0.6838767499337608,-1.5435719035092974,0.029545454545454545,0.3348446440081193,1.0,2/11,1.21%,PID1;PRKN
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.6343693816199804,1.5433069539289836,0.027649769585253458,0.5248963774062846,1.0,5/29,3.66%,SHANK3;TJP1;KANK3;HIP1R;SSH2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.5451413084624731,1.5428225373419975,0.023776223776223775,0.5238533912655415,1.0,18/67,7.46%,TEK;FLT1;ABI3;KDR;IL15;INSR;PDGFB;LYN;PTK2B;FYN;SRMS;FLT4;JAK3;GHR;DYRK1A;BMX;LCK;PTK2
prerank,response to lipopolysaccharide (GO:0032496),0.5030707759388386,1.541963748312135,0.011138613861386138,0.5244625706924627,1.0,36/138,14.35%,NOS3;MEF2C;GCH1;FOXP1;DAB2IP;SCARB1;TNFRSF11A;TNFRSF1B;SELE;SELP;TIRAP;RPS6KA3;XBP1;CX3CR1;SBNO2;MAPK8;PELI1;IFNAR1;WNT5A;IL36G;PPBP;HNRNPA0;NFKB1;CASP1;CITED1;DEFA6;MAPKAPK3;CYP27B1;CARD16;RELA;GSTP1;ZFP36;TRIB1;ADAM17;TRAF6;S100A9
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.6257542508976328,-1.541752076848381,0.050808314087759814,0.33688303128623165,1.0,6/15,28.59%,MOXD1;SAT1;ASMT;DDC;SRM;SAT2
prerank,neuron cell-cell adhesion (GO:0007158),-0.646094222296078,-1.5415611264777636,0.02522935779816514,0.334388356427419,1.0,9/14,12.65%,NLGN2;NRXN1;NLGN1;NRXN3;NCAM2;ASTN1;NLGN3;CNTN4;NRXN2
prerank,glucose transmembrane transport (GO:1904659),0.6856915756688321,1.541190201131411,0.05574324324324324,0.5243059607356447,1.0,4/18,6.85%,SLC2A1;PPARD;SLC2A9;PPBP
prerank,positive regulation of lymphocyte migration (GO:2000403),0.7415513092096606,1.5405978506421534,0.05169340463458111,0.5235591823175907,1.0,2/12,1.06%,JAM2;APP
prerank,protein phosphorylation (GO:0006468),0.45784639515050973,1.5398373676689465,0.0,0.5234283143333419,1.0,107/478,11.87%,PRKG1;PRKCH;ERG;TEK;RPS6KA5;CDK17;FLT1;BMPR2;ABI3;KDR;APP;SNRK;EPHB4;ERN1;ACVRL1;PRKD1;CDK6;INSR;DAPK1;NEK7;PDGFB;PEAK1;DAB2IP;LYN;PIM3;PRKD2;BCR;ADAM10;PRAG1;PTK2B;FNIP2;STK10;MAP4K3;SIK1;FYN;TAOK2;STK24;STK3;PKN3;SRMS;FLT4;LIPE;PKN2;PAK2;PKN1;RPS6KA3;STK4;LMTK2;MARK3;JAK3;MAP3K9;IKBKB;RPS6KA1;HIPK1;SMAD7;ACVR2A;CDC42BPB;MAPK8;RET;PLK2;MAST2;USP15;ULK1;LIMK2;PPP3CB;AURKA;SIK3;ACVR1;TSSK6;DYRK1A;STK26;BMX;TNIK;LCK;JAK1;TGFB1;PTK2;MAP3K3;CTBP1;HASPIN;CREB1;SGK3;AKT2;NEK6;PXK;MAP3K11;AURKC;SLK;CDK2;RICTOR;MAPKAPK3;COPS2;CDK18;NUAK1;PRKAB1;GAS6;EPHA4;AKT3;ABL2;GMFG;PICK1;MAP3K13;SIK2;STK38;PIM1;EEF2K;RIPK1
prerank,acidic amino acid transport (GO:0015800),-0.6170232208794959,-1.5396276876806967,0.034739454094292806,0.33674032862831316,1.0,10/17,18.52%,SLC6A13;SLC1A3;GJA1;SLC6A1;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;PRAF2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.40450601248145224,-1.537719434620628,0.005208333333333333,0.33895109532261924,1.0,32/152,11.62%,RNF220;ZEB2;SULF1;EGFR;WLS;LGR4;FGFR2;COL1A1;GPC3;PTK7;SULF2;SEMA5A;DAAM2;RSPO3;RSPO2;DACT1;CAPRIN2;LYPD6;LRRK1;PLEKHA4;SALL1;SFRP4;PSME4;AXIN2;LRRK2;GPC5;SFRP1;WNK1;SMARCA4;DKK2;SCEL;GPRC5B
prerank,sphingoid biosynthetic process (GO:0046520),0.7639438700681306,1.5376543506864866,0.06043956043956044,0.527010336277624,1.0,4/11,5.50%,ACER2;SPTLC2;SPTLC3;ASAH2
prerank,sphingosine biosynthetic process (GO:0046512),0.7639438700681306,1.5376543506864866,0.06043956043956044,0.527010336277624,1.0,4/11,5.50%,ACER2;SPTLC2;SPTLC3;ASAH2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7562847491713347,1.5375632354585247,0.060714285714285714,0.5243232092776552,1.0,2/10,1.06%,SHANK3;APP
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.634579343071949,-1.5366974527230655,0.03416856492027335,0.3388056514598023,1.0,2/15,1.21%,IGF1;PRKN
prerank,spermatid development (GO:0007286),0.6272578747853887,1.5357914844882585,0.03930817610062893,0.5285368216681247,1.0,7/32,11.22%,JAM2;GALNTL5;NECTIN2;CDYL;CEP57;TTC21A;TDRD5
prerank,ethanol metabolic process (GO:0006067),-0.6515081035718638,-1.5354933009682075,0.035634743875278395,0.3389529233923673,1.0,2/12,6.08%,ALDH1A1;ALDH2
prerank,innate immune response (GO:0045087),0.4810080701704704,1.5336597235666807,0.0011376564277588168,0.5342007970313204,1.0,41/217,12.40%,SERINC3;APP;GCH1;B2M;NLRC5;NRROS;LYN;SERINC5;MFHAS1;PTK2B;TRIM14;YES1;FYN;SRMS;PLCG2;LCN2;IKBKB;CX3CR1;TRIM68;RPL39;PTX3;MID2;ADAM15;PGLYRP2;CD40;CFB;LCK;PIK3CG;PTK2;TRIM25;MALT1;CITED1;ANG;DEFA6;RELB;IKBKG;CYP27B1;ADAR;IRAK4;RELA;RIPK2
prerank,ceramide transport (GO:0035627),0.748247094979396,1.5336585077562856,0.0449438202247191,0.531171549182749,1.0,4/12,9.21%,CERT1;PLTP;GLTP;PLEKHA8
prerank,presynapse assembly (GO:0099054),-0.6196118378117148,-1.5334385604942373,0.04640371229698376,0.34082485538896423,1.0,10/16,15.84%,NLGN2;LRRTM3;PTPRD;IL1RAPL1;PCLO;NLGN1;NLGN3;FZD1;BSN;DVL1
prerank,cellular response to fatty acid (GO:0071398),-0.6486795734896483,-1.5331858325918137,0.04148471615720524,0.3386016054014219,1.0,2/12,1.40%,PID1;IRS1
prerank,protein depolymerization (GO:0051261),-0.538661374237609,-1.533070015250693,0.034031413612565446,0.33619127565574947,1.0,3/27,1.03%,MICAL3;GSN;MICAL2
prerank,regulation of cardiac conduction (GO:1903779),-0.4632190892627098,-1.5319347556277425,0.01644736842105263,0.33625154905597743,1.0,15/54,9.89%,ATP1A2;ANK2;SLC8A3;ATP1B1;SLC8A1;ASPH;DMPK;ABCC9;STIM1;PRKACA;TRPC1;ATP2A2;RYR2;TMEM65;ATP1B2
prerank,phospholipid transport (GO:0015914),0.5638509379816294,1.5316606697723714,0.028089887640449437,0.536798290373845,1.0,12/52,10.69%,ATP8B1;PLTP;ATP8A1;SCARB1;PRELID2;ATP10A;ATP11C;ATP11B;ABCA3;ATP11A;PITPNC1;SCARB2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5363928280552324,-1.5307899734279562,0.041463414634146344,0.33625953535478537,1.0,13/30,15.27%,ANK2;CACNA1C;SNTA1;CACNA2D1;GJA1;CACNA1D;CACNA1G;KCNJ2;RYR2;GPD1L;SCN2B;SCN1A;GJC1
prerank,membrane fusion (GO:0061025),0.61685250842935,1.530567231587344,0.034375,0.53826744136913,1.0,2/33,0.33%,DNM3;MYOF
prerank,stress-activated MAPK cascade (GO:0051403),0.5619384272697634,1.5299705058349937,0.017167381974248927,0.5377197318385484,1.0,27/61,18.73%,NOD1;TNFRSF19;MAP4K3;TAOK2;SH2D3C;IKBKB;MAPK8;NFKB1;MAP3K11;IKBKG;MAP2K3;MAPK11;CCM2;MAP3K13;CUL1;RIPK2;ZFP36;TRIB1;TRAF6;MAP3K20;MAP4K2;TAB3;ZFP36L1;IRAK2;MAP3K8;MAP2K4;MINK1
prerank,positive regulation of integrin activation (GO:0033625),0.7391455135431142,1.5292757158645924,0.06434782608695652,0.5374355509140933,1.0,5/11,11.16%,PIEZO1;RASIP1;RAP1B;SKAP1;P2RY12
prerank,protein hydroxylation (GO:0018126),-0.6298771466938053,-1.5291387111493082,0.055299539170506916,0.3378745194549991,1.0,7/15,19.26%,PLOD2;ASPH;P3H3;EGLN3;P3H4;P3H1;VIPAS39
prerank,diol metabolic process (GO:0034311),0.6779697559956147,1.5284221965250262,0.04584040747028863,0.5381262246905795,1.0,6/19,5.50%,NOS3;DEGS2;GCH1;PLPP1;SGPP2;ASAH2
prerank,neuron projection organization (GO:0106027),0.7139338920221413,1.527883686295904,0.0427807486631016,0.5372237584416255,1.0,7/15,11.84%,APP;INSR;ATP1A3;PSEN1;PICK1;LGMN;ABCD1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4519161161265364,1.5277474342199913,0.0,0.5348290849757136,1.0,107/532,12.74%,IL1R1;RPS6KA5;FOXO1;ADIPOR2;NOD1;IL6ST;LIFR;INPP5D;MAOA;PTGS2;UGCG;LCP1;VCAM1;IL15;ICAM1;STX3;B2M;PDGFB;IRF2;IL6R;SOCS2;OSMR;STAT3;AIM2;TNFRSF11A;SAMHD1;PTK2B;S1PR1;HIF1A;MSN;PTPRJ;TNFRSF1B;NFKBIA;RAP1B;FYN;ACTN4;PLCB1;TRAF1;TMSB4X;PAK2;TNFRSF25;LCN2;JAK3;EDAR;IKBKB;ISG20;CEACAM1;GHR;CSF2RB;IL27RA;TRIM68;PELI1;IFNAR1;HNRNPF;CISH;IFNAR2;TNFSF8;CA1;IL36G;MTAP;CD40;CDKN1B;JUNB;BCL2L11;PPBP;LCK;JAK1;TNFRSF1A;TGFB1;STX1A;PSMA2;TRIM25;NFKB1;MAP3K3;TNFRSF13C;CASP1;IL7R;CRK;IKBKG;CSF1;TNFRSF8;IL23A;BCL2L1;PSMA8;TNFRSF9;FCGR1A;CCL14;PSMA6;FSCN1;POU2F1;IL4R;CBL;ABL2;IL7;ADAR;CUL1;CEBPD;IL17RB;IRAK4;PIM1;RIPK1;MUC1;OASL;RELA;RIPK2;ADIPOR1;BIRC3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5792535788094835,1.5273521519349376,0.04084720121028744,0.5334964449093234,1.0,9/45,8.27%,APP;STAT3;GBP5;AIM2;CASP8;WNT5A;LPL;MALT1;CASP1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.7480358049948095,1.5271217747281631,0.061420345489443376,0.5314893779376272,1.0,2/10,1.49%,LRCH1;CD200
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.5818296212685794,-1.526562714871814,0.02756892230576441,0.3420610336933332,1.0,7/22,6.34%,CACNA1C;ADGRV1;CACNA1D;NF1;CAP2;GRM3;STIM1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.6529058679824695,1.5252184720283544,0.03156146179401993,0.5365986726027363,1.0,3/24,1.39%,DACH1;BMPR2;ACVRL1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.6418636227241228,-1.5243326488372009,0.052132701421800945,0.3453871315442308,1.0,8/13,23.99%,DDX5;PLA2R1;SPRED1;SPRED2;SPRED3;ATR;MSX1;ATM
prerank,glycolipid metabolic process (GO:0006664),0.5742990410438418,1.5233521202750229,0.026825633383010434,0.541202765963293,1.0,6/47,4.87%,ST3GAL6;ST6GALNAC3;UGCG;PGAP1;ESYT2;GLTP
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.7533665722424729,1.5229790736788449,0.04789272030651341,0.5396797114381091,1.0,2/10,2.20%,RNF125;SEC14L1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.6659416106037307,1.522299236782052,0.04590163934426229,0.5396327317168105,1.0,7/21,9.43%,PRKCH;FOXP1;PRKD2;NECTIN2;TESPA1;LCK;IKBKG
prerank,regulation of cellular protein metabolic process (GO:0032268),0.574072222212591,1.5197735796868101,0.041968162083936326,0.5473575744517051,1.0,13/47,13.03%,NANOS3;APP;EDN1;NFKBIA;EIF4E;TGFB1;PM20D2;NFKB1;CSF1;RBM3;CYFIP1;RPL10;MTPN
prerank,cardiac myofibril assembly (GO:0055003),-0.6207628850396814,-1.5192998096421335,0.03827751196172249,0.3564233325277694,1.0,4/15,10.84%,PDGFRB;PDGFRA;OBSL1;FHOD3
prerank,negative regulation of platelet activation (GO:0010544),0.6981425790169069,1.5188066971059146,0.06197654941373534,0.5485556524817827,1.0,4/16,5.12%,PRKG1;NOS3;PDGFB;CEACAM1
prerank,regulation of inflammatory response (GO:0050727),0.4773399399225059,1.5170315294134393,0.0035087719298245615,0.5529885422209004,1.0,31/190,10.61%,IL1R1;TEK;PTGS2;APP;PPARD;IL15;CD200;SEMA7A;FOXP1;PDE2A;MFHAS1;CASP4;NFKBIZ;TNFRSF1B;NFKBIA;NLRP6;BST1;SELE;LPCAT3;TMSB4X;SBNO2;XIAP;WNT5A;TNFRSF1A;LPL;CASP1;BRD4;IL23A;TNIP1;PSMA6;NMI
prerank,protein localization to cell-cell junction (GO:0150105),0.711473742547282,1.5166185227035005,0.05975395430579965,0.55186405776795,1.0,7/15,9.63%,TJP1;LSR;F11R;TJP2;PAK2;JAK1;TJP3
prerank,striated muscle tissue development (GO:0014706),0.6247412863775279,1.516543079961011,0.04552845528455285,0.5492691197454714,1.0,4/29,1.15%,PGM5;BMPR2;CAV1;MEF2C
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5928654563524136,1.516514426694351,0.03303303303303303,0.546560373047573,1.0,9/42,6.61%,TEK;KDR;UTRN;CDK6;PTK2B;PTPRJ;PPM1F;SKAP1;RAC1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.5957479306836405,-1.5164773472023296,0.0412621359223301,0.3606857924243414,1.0,6/17,10.19%,WNT4;BMP4;LARP6;RUNX1;RGCC;TGFB3
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7051417052335051,1.5156858821243393,0.07564575645756458,0.5470764070876334,1.0,4/15,9.46%,PRKCH;NFKB1;LPL;CSF1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.6625350205016899,1.513115348351597,0.05853658536585366,0.5549487398438607,1.0,3/20,3.15%,IL1R1;B2M;DENND1B
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.61989184923243,1.512930004296454,0.046875,0.5528374474141403,1.0,6/29,10.01%,CADM1;NECTIN2;PVR;STX7;IL23A;CYRIB
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.6670610984006865,1.511795826805023,0.04215851602023609,0.5548065988715498,1.0,11/20,14.18%,ADAM10;SPPL2A;TGFB1;NFKB1;PSEN1;RHBDD1;MBTPS2;APH1A;RELA;ADAM17;TRAF6
prerank,inorganic cation transmembrane transport (GO:0098662),-0.36434532106311823,-1.5115509239151863,0.0,0.37112685955506924,1.0,44/268,8.01%,ATP1A2;SLC24A3;TRPM3;CACNA1C;KCNK2;NALCN;SLC6A13;SLC1A3;SLC8A3;SLC41A1;SLC12A2;SLC6A1;SCN7A;KCNB2;SCARA5;CACNA1D;SLC9A9;SLC30A10;KCNK5;SLC6A12;SLC6A9;PKD1;ATP1B1;SLC8A1;P2RX4;KCNQ3;ABCC9;KCND2;ATP6V0A4;SLC39A14;KCND3;CACNA1G;ITGAV;TRPC3;SLC39A13;KCNC2;SLC6A15;KCNS3;TRPC6;KCNJ2;KCNQ4;TRPC1;ATP2A2;KCNAB1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.6315453712165078,-1.5108974942708415,0.053811659192825115,0.37006327252769633,1.0,6/13,12.48%,RENBP;PGM3;NAGK;GFPT1;GFPT2;GNPDA1
prerank,actin filament polymerization (GO:0030041),-0.5254356368038389,-1.5096200507783062,0.0345821325648415,0.3706065638991901,1.0,5/29,3.84%,ARHGAP6;GAS7;GSN;SPIRE1;COBL
prerank,glycerolipid catabolic process (GO:0046503),0.6807933979443643,1.5077600691799746,0.04938271604938271,0.5686042852454721,1.0,5/19,9.99%,GPCPD1;PLA2G4A;ABHD2;ENPP6;GDPD1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7351376346388984,1.5074800994144317,0.0695970695970696,0.567122005967983,1.0,3/11,4.28%,LYN;MFHAS1;TIRAP
prerank,regulation of cell adhesion (GO:0030155),0.4939603302878975,1.5071923120647683,0.008871989860583017,0.5655344866798574,1.0,33/129,11.11%,FRMD5;PKP4;PLXNA4;TGM2;STX3;ACVRL1;PODXL;CYTH1;LYN;PRKD2;ADAM10;EFNA1;PTK2B;PPP3CA;PLXND1;PTPRJ;PPP1R12A;ADGRG1;DLL1;RET;CBLL1;ADAMDEC1;ATXN3;PIK3CG;PTK2;RASA1;RSU1;DSCAM;SEMA4D;CXCR4;NUAK1;EPHA4;ABL2
prerank,cellular response to interleukin-1 (GO:0071347),0.4910233604304574,1.507037489629051,0.014796547472256474,0.5633919216452898,1.0,32/143,16.22%,IL1R1;RPS6KA5;NOD1;DAB2IP;HIF1A;NFKBIA;PLCB1;SOX9;IKBKB;PELI1;CD40;PSMA2;NFKB1;MAP3K3;IKBKG;MAPK11;PSMA8;CCL14;PSMA6;RC3H1;CUL1;IRAK4;RELA;RIPK2;HAS2;GBP3;IL1RAP;TRAF6;PSME1;IRAK3;RPS6KA4;TAB3
prerank,regulation of heart contraction (GO:0008016),-0.4223548783367854,-1.5058915449715589,0.0125,0.3783795737123453,1.0,22/90,12.08%,CELF2;ATP1A2;ANK2;SLC8A3;ATP1B1;SLC8A1;P2RX4;ASPH;DMPK;ABCC9;TPM1;STIM1;PRKACA;TRPC1;ATP2A2;RYR2;TMEM65;ATP1B2;DES;TGFB2;S100A1;TBX2
prerank,regulated exocytosis (GO:0045055),0.4797285082758004,1.5058765559532803,0.007075471698113208,0.5655346911402888,1.0,36/173,12.22%,VWF;ABCC4;PECAM1;PCDH7;APP;PDGFB;VEGFC;MYH9;LYN;ACTN4;RAB11FIP1;SELP;SELENOP;TMSB4X;ACTN1;PROS1;VEGFD;QSOX1;RAB11FIP5;ARHGAP17;TAGLN2;PPP3CB;PPBP;SRGN;TGFB1;STX1A;APOOL;TMX3;APLP2;CYRIB;GAS6;SYT15;ITGB3;RAB26;MMRN1;RAB11B
prerank,response to molecule of bacterial origin (GO:0002237),0.5325478690986454,1.5054002587735074,0.0323943661971831,0.5646306020199827,1.0,15/69,10.26%,NOS3;GCH1;FOXP1;TNFRSF11A;SELE;SELP;TIRAP;RPS6KA3;PELI1;IFNAR1;HNRNPA0;CITED1;MAPKAPK3;CYRIB;CYP27B1
prerank,cellular response to cytokine stimulus (GO:0071345),0.4517976759839896,1.5046017826837648,0.0,0.5650236412991765,1.0,83/416,11.87%,IL1R1;LEF1;ST3GAL6;LRCH1;FOXO1;PTPN14;IL6ST;LIFR;INPP5D;MAOA;PTGS2;VCAM1;ICAM1;STX3;DAPK1;PTPN12;IL6R;DAB2IP;ARHGEF2;PDE2A;SOCS2;OSMR;STAT3;GBP5;AIM2;GBP4;S1PR1;HIF1A;PTPRJ;TNFRSF1B;FYN;SIGIRR;SOX9;LCN2;JAK3;GBP7;IKBKB;XBP1;GHR;CSF2RB;IL27RA;SBNO2;MAPK8;ASAH2;IFNAR1;WNT5A;IFNAR2;IL36G;DCSTAMP;CD40;INPP5K;CDKN1B;JUNB;BCL2L11;LCK;JAK1;TNFRSF1A;TGFB1;STX1A;NFKB1;CASP1;CRK;YBX3;CSF1;IL23A;BCL2L1;MAPK11;RPL13A;CCL14;CXCR4;GAS6;FSCN1;POU2F1;RC3H1;IL4R;CBL;RO60;ABL2;IL7;CEBPD;IRAK4;PIM1;RIPK1
prerank,"phototransduction, visible light (GO:0007603)",0.7060777329673399,1.504377358257533,0.059674502712477394,0.5630826683017326,1.0,4/14,6.96%,GNAQ;GNB1;CNGB1;GNAT1
prerank,regulation of epithelial cell migration (GO:0010632),0.5697293242752178,1.5039450332195874,0.034532374100719423,0.5620312537823186,1.0,17/51,7.46%,PTPRG;BMPR2;PLCG1;DOCK1;DAB2IP;RAB11A;HIF1A;PPM1F;RREB1;PLCG2;SOX9;EVL;RHOJ;CEACAM1;ENPP2;SASH1;PTK2
prerank,negative regulation of GTPase activity (GO:0034260),0.6586208411369188,1.5032868571068185,0.046251993620414676,0.561831433368456,1.0,4/22,2.14%,LRCH1;F11R;SH3BP4;DAB2IP
prerank,amino sugar biosynthetic process (GO:0046349),-0.6460226680854858,-1.5028058555658774,0.05066079295154185,0.38426603856513536,1.0,6/12,12.48%,RENBP;PGM3;NAGK;GFPT1;GFPT2;GNPDA1
prerank,positive regulation of bone mineralization (GO:0030501),-0.49817092040748256,-1.50267062830631,0.028125,0.3817966933180233,1.0,11/35,4.62%,BMP6;BMPR1A;PTN;WNT4;BMP7;ADGRV1;OSR1;BMP4;GPM6B;SLC8A1;FBN2
prerank,ribosomal small subunit biogenesis (GO:0042274),0.5818391540066206,1.5025287024027711,0.028528528528528527,0.5622503760489153,1.0,19/39,21.08%,RPS15;RPS19;RPS14;RPSA;RPS16;RPS7;RPS24;RPS27;UTP4;RPS6;NPM1;RIOK1;RPS25;SRFBP1;EMG1;NOP14;NOM1;RIOK2;RPS28
prerank,sphingosine metabolic process (GO:0006670),0.6842896864346939,1.5015268372485342,0.08089500860585198,0.563838315886192,1.0,6/17,5.50%,ACER2;SPTLC2;PLPP1;SGPP2;SPTLC3;ASAH2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.5315780740838267,-1.501334633693354,0.040865384615384616,0.38256524049946616,1.0,8/25,10.20%,ANK2;CACNA1C;CXADR;DLG1;TBX18;ATP2A2;RYR2;CTNNA3
prerank,regulation of programmed cell death (GO:0043067),0.48594372001135716,1.5006564342577513,0.009626955475330927,0.5649443010354768,1.0,37/161,14.20%,MECOM;ACER2;TGM2;PPP1R13B;DAPK1;HIP1;FAS;ANP32A;GLS2;ACTN4;AMIGO2;SOX9;TNFRSF25;ACTN1;JAK3;TOX3;STK26;BCL2L11;TIGAR;BCL3;MALT1;CASP1;CRADD;NF2;CITED1;RBM25;TRIM24;SLK;BNIP3;RIPK1;BID;NOP53;PRDX2;BIRC3;OMA1;ASAH1;BCL2L14
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5882842282237428,1.500400796438686,0.03945371775417299,0.5632957111883663,1.0,6/36,7.47%,SHANK3;EDN1;FBXW7;HIF1A;GREM1;TGFA
prerank,O-glycan processing (GO:0016266),0.5384522615502051,1.4999525526873148,0.035398230088495575,0.562405657358973,1.0,12/54,12.17%,ST6GAL1;ST3GAL1;GALNT14;GALNT15;B3GNT3;B3GNT4;ST6GALNAC2;B4GALT5;B3GNT6;ST6GALNAC4;C1GALT1;MUC1
prerank,peptidyl-tyrosine modification (GO:0018212),0.548125697398446,1.4994114314976368,0.032624113475177303,0.562018630746407,1.0,16/56,7.46%,TEK;FLT1;ABI3;KDR;INSR;PDGFB;LYN;TPST2;PTK2B;FYN;SRMS;FLT4;JAK3;DYRK1A;LCK;PTK2
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.6164880845957448,1.4990309283094099,0.050955414012738856,0.5609818287252061,1.0,8/28,7.34%,EGFL7;LFNG;GATA2;FBXW7;DLL1;DLL4;ARRB1;ARRDC1
prerank,lymphocyte proliferation (GO:0046651),0.6484848956977929,1.4988319335927534,0.05785123966942149,0.559216874170652,1.0,6/22,7.41%,MEF2C;CTPS1;MSN;PPP3CB;CD40;PIK3CG
prerank,camera-type eye development (GO:0043010),-0.5508332037224004,-1.498287446513073,0.07008086253369272,0.38808656448003215,1.0,10/25,13.00%,CACNA1C;FBN1;EFEMP1;TENM3;FBN2;CYP1B1;NF1;VEGFA;STRA6;NES
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5071876109328388,1.497756104049394,0.017948717948717947,0.5612363551283204,1.0,14/110,6.12%,ADGRG6;ADGRL4;CALCRL;GNAQ;ADGRL2;ADCY4;S1PR1;GNB1;ADGRG3;ADGRE5;ADGRG1;ADRB1;RAMP2;RAPGEF2
prerank,positive regulation of cell migration (GO:0030335),0.4682780716863946,1.4977140508535325,0.0022701475595913734,0.5588708019222244,1.0,51/253,8.75%,SEMA6A;LEF1;TJP1;PECAM1;FLT1;BMPR2;KDR;CAV1;ITGA6;SEMA5B;PODXL;INSR;SEMA7A;PLCG1;PDGFB;NEDD9;DOCK1;DAB2IP;RAB11A;EDN1;ARHGEF2;ADAM10;STAT3;PDGFD;PTK2B;PPP3CA;NOTCH1;HIF1A;PPM1F;RREB1;ACTN4;PLCG2;NUMB;SOX9;F7;SDCBP;XBP1;ENPP2;SEMA6B;RET;RAPGEF2;CBLL1;ACVR1;PDGFC;TGFB1;PTK2;GRB7;GAB1;SEMA6D;AKT2;ARHGEF7
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.6665406855890984,-1.49693377730189,0.05491990846681922,0.38891037372722187,1.0,6/11,15.32%,BMPR1A;BMP4;ZFPM2;JAG1;TGFB2;HEY2
prerank,sodium ion import across plasma membrane (GO:0098719),-0.5880168424695043,-1.4968900545431305,0.04491725768321513,0.3861974724764434,1.0,4/17,3.39%,SLC12A2;SLC6A1;SLC9A9;SLC8A1
prerank,phospholipid catabolic process (GO:0009395),0.649591580932296,1.496656624714838,0.04730831973898858,0.5606437132324402,1.0,5/24,9.99%,GPCPD1;PLA2G4A;ENPP6;ENPP2;GDPD1
prerank,cation transmembrane transport (GO:0098655),-0.47736198184161066,-1.4963496270335044,0.023952095808383235,0.38493228886527897,1.0,7/44,4.22%,ATP1A2;TRPM3;SLC7A2;SLC6A9;ATP1B1;SFXN2;ABCC9
prerank,regulation of blood circulation (GO:1903522),-0.5054661149393164,-1.4961365902388148,0.04261363636363636,0.38282761834266366,1.0,10/34,12.08%,CELF2;DMPK;TPM1;PER2;AGTR1;KCNMB2;BDKRB2;DES;S100A1;TBX2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6895330876864901,1.4948934050408138,0.0634648370497427,0.5650263710520773,1.0,2/17,1.15%,PRKG1;MEF2C
prerank,ribosome assembly (GO:0042255),0.5700342842335845,1.4935807613651109,0.03538461538461538,0.5676949012516482,1.0,18/47,21.08%,RPS15;RPS19;RPS14;RPSA;RSL24D1;RRS1;EIF6;RPS27;NOP53;RPL6;RPL10;NPM1;RPL11;MTERF3;RPL3;TRAF7;SBDS;RPS28
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6433451344531025,1.4935082276811804,0.06035889070146819,0.5654136588165948,1.0,5/23,8.50%,PLA2G4A;LPCAT3;PLA2G2D;MBOAT1;PLAAT3
prerank,energy reserve metabolic process (GO:0006112),-0.5954261856046476,-1.4934371784090685,0.04926108374384237,0.38735249895685603,1.0,9/19,12.04%,PID1;LEPR;PHKB;PYGM;PRKAG2;GFPT1;PPP1R3C;GFPT2;UGP2
prerank,sodium ion transport (GO:0006814),-0.4256323388168957,-1.4931686869480847,0.01652892561983471,0.38533026350737515,1.0,12/85,3.39%,ATP1A2;SLC24A3;NALCN;SLC6A13;SLC8A3;SLC12A2;SLC6A1;SCN7A;SLC6A12;SLC6A9;ATP1B1;SLC8A1
prerank,myelination in peripheral nervous system (GO:0022011),0.7074857503136908,1.4926737812893462,0.05328596802841918,0.5665050804292215,1.0,2/13,1.92%,ADGRG6;PARD3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.4025929416403276,-1.4924294991673703,0.004524886877828055,0.38475012661149827,1.0,26/129,11.62%,RNF220;ZEB2;EGFR;WLS;LGR4;FGFR2;COL1A1;GPC3;PTK7;SEMA5A;DAAM2;DACT1;CAPRIN2;LYPD6;LRRK1;PLEKHA4;SFRP4;PSME4;AXIN2;LRRK2;GPC5;SFRP1;WNK1;DKK2;SCEL;GPRC5B
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5813219723497521,1.492333269558133,0.04954954954954955,0.5652042830829513,1.0,10/39,5.40%,NOS3;IL6ST;MAML2;EPN2;STAT3;NOTCH1;TSPAN5;DLL1;DLL4;TSPAN14
prerank,smoothened signaling pathway (GO:0007224),-0.506455565771573,-1.4919106904788881,0.03216374269005848,0.383425709384062,1.0,20/32,25.56%,GLI3;GLI2;EVC2;CC2D2A;GLI1;HIPK2;SMO;TMEM231;DISP2;TTBK2;DISP3;PTCH2;IFT27;TCTN2;ULK3;TMEM17;PTCH1;STK36;STIL;MAP3K10
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5529850609422204,-1.4900418249166558,0.051470588235294115,0.3857990481474074,1.0,12/23,20.56%,GLI3;GPC3;ENPP1;TULP3;GLIS2;BTRC;HHIP;SUFU;KIF7;PTCH2;ULK3;PTCH1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.5944484947285162,1.4898910479329788,0.04510108864696734,0.572470884622725,1.0,9/36,7.93%,NOS3;CAV1;GCH1;SCARB1;HIF1A;NOSTRIN;ATP2B4;NOSIP;NOS1AP
prerank,striated muscle contraction (GO:0006941),-0.4652553926264218,-1.4896704788218667,0.02666666666666667,0.3843000029094405,1.0,8/53,9.11%,ATP1A2;DMD;ATP1B1;SLC8A1;TPM1;DTNA;GAA;RYR2
prerank,respiratory tube development (GO:0030323),-0.5327660164880049,-1.48949901948528,0.03418803418803419,0.3820534720646959,1.0,13/28,12.70%,FGFR2;GLI2;FGF1;PDPN;BMP4;PCSK5;RBP4;LOXL3;FGF2;VEGFA;STRA6;FGF7;CCDC39
prerank,embryonic digit morphogenesis (GO:0042733),-0.5961288653702463,-1.4889167791378708,0.030226700251889168,0.38095962897310715,1.0,7/18,15.46%,GLI3;OSR1;SALL1;TBX2;WDPCP;INTU;TBX3
prerank,heart trabecula morphogenesis (GO:0061384),0.6671312773488415,1.4884092812182856,0.06132879045996593,0.5757066561543834,1.0,7/18,5.28%,ADGRG6;TEK;ENG;S1PR1;NOTCH1;FKBP1A;DLL4
prerank,limb morphogenesis (GO:0035108),-0.5595455593212679,-1.4882824247203854,0.04975124378109453,0.38028033383625515,1.0,9/20,20.56%,GLI3;PCSK5;CYP26B1;LRP6;TGFB2;TBX3;IQCE;SKI;PTCH1
prerank,smooth muscle cell differentiation (GO:0051145),0.708819919257154,1.4881334977005984,0.0780399274047187,0.5743133289005353,1.0,3/12,4.28%,MRTFB;MEF2C;MRTFA
prerank,negative regulation of potassium ion transport (GO:0043267),0.6946892295605112,1.4870800513259788,0.07476635514018691,0.575944528837594,1.0,3/13,2.59%,CAV1;NEDD4L;PTK2B
prerank,apoptotic process (GO:0006915),0.4667008684031739,1.4870039409000249,0.00813953488372093,0.573756374895303,1.0,46/203,12.98%,SEMA6A;FOXO1;TBX1;APP;PPARD;ZBTB16;TNFRSF19;DAPK1;AHR;ELMO1;HIP1;FAS;PAEP;PTK2B;DDIT4;CASP4;BIK;NFKBIA;TAOK2;STK3;CASP8;TNFRSF25;MAL;STK4;IER3;NCKAP1;BOK;ADAM15;JADE1;BCL2L11;CASP7;BNIP2;CASP1;IKBKG;BCL2L1;SIAH1;CXCR4;BNIP3;CSRNP1;RIPK1;BID;RHOB;GLRX2;FASTKD2;TGFBR2;MAGI3
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7402213902372755,1.485729040722308,0.06043956043956044,0.576757301178718,1.0,4/10,13.10%,GNB1;CNGB1;GNAT1;PDE6B
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6467062321682501,-1.4849590708290223,0.06263498920086392,0.3867376194016328,1.0,6/11,12.48%,RENBP;PGM3;NAGK;GFPT1;GFPT2;GNPDA1
prerank,nuclear transport (GO:0051169),0.6745439297733061,1.4845424496925363,0.0726950354609929,0.5791603740630169,1.0,7/16,14.04%,ANP32A;RSRC1;XPO1;CITED1;NUP98;NUP205;NPM1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6768479942431948,1.4834742938367445,0.07476635514018691,0.578355476865149,1.0,8/15,19.01%,NANOS3;NANOS2;TNRC6C;CNOT1;ZFP36;CNOT7;ZFP36L1;DHX36
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6768479942431948,1.4834742938367445,0.07476635514018691,0.578355476865149,1.0,8/15,19.01%,NANOS3;NANOS2;TNRC6C;CNOT1;ZFP36;CNOT7;ZFP36L1;DHX36
prerank,positive regulation of cell motility (GO:2000147),0.4722450554715712,1.4834595132126795,0.011627906976744186,0.5759392057160532,1.0,37/205,7.60%,SEMA6A;LEF1;TJP1;PECAM1;FLT1;NTN1;KDR;CAV1;ITGA6;SEMA5B;PODXL;INSR;SEMA7A;PDGFB;NEDD9;EDN1;ADAM10;STAT3;PDGFD;PTK2B;PPP3CA;NOTCH1;PPM1F;ACTN4;NUMB;F7;SDCBP;XBP1;CAVIN1;SEMA6B;RET;CBLL1;ACVR1;PDGFC;TGFB1;PTK2;GRB7
prerank,negative regulation of locomotion (GO:0040013),0.7042682924320861,1.4833883483623285,0.06517690875232775,0.5737486914470646,1.0,2/12,2.30%,FRMD5;CCDC125
prerank,regulation of DNA biosynthetic process (GO:2000278),0.6164831282421763,1.483055391707618,0.054140127388535034,0.5727987018249026,1.0,6/27,4.03%,DACH1;BMPR2;ACVRL1;PDGFB;PRKD2;HMBOX1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5850664906745919,1.4828065456004922,0.052795031055900624,0.5713212572516058,1.0,8/39,6.60%,TEK;KDR;ICAM1;PLCG1;ECSCR;GATA2;RAMP2;CD40
prerank,pteridine-containing compound metabolic process (GO:0042558),0.6934793544441926,1.482145843617551,0.07279693486590039,0.5714954287583698,1.0,3/13,5.81%,NOS3;GCH1;MTHFD1L
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7330923527840151,1.4818383638240469,0.09481216457960644,0.5703648439284913,1.0,4/10,5.00%,PLPP1;PARD3;PRKD3;DGKH
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.6172568543246494,1.4816900200989653,0.05177993527508091,0.5685837679847644,1.0,8/28,8.18%,CTSC;SMURF1;ECSCR;DAB2IP;FBXW7;KCNE2;PTK2;RNF139
prerank,ncRNA processing (GO:0034470),0.4662226357691055,1.4813319928917894,0.008045977011494253,0.5676399331812427,1.0,77/200,21.42%,SMAD1;DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;FARS2;RPL34;RPL39;DROSHA;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;RPL14;RPL23;RPL17;DICER1;RPL9;RPL4;RPL13A;RPL32;INTS11;RPL22;RPS27;RPL31;EXOSC1;ADAR;RPL13;RPP30;NOP53;UTP4;RPL6;RPL10;INTS12;RPS6;RPL29;RRP9;ADAT1;PELP1;RPS25;RPL35A;RPL27;RPL18;XRN2;EMG1;RPL27A;RRP1B;KARS1;UTP6;PIH1D1;PDCD11;RPL11;WDR18;HEATR1;ESF1;RPL8;NOP14;RPLP2;RPL18A;SMAD2;RPL21;RPL3;MRPL44;SBDS;INTS8;RPS28;DDX47;PRKRA;RPL7
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.5310600827845682,-1.4810682317436559,0.046831955922865015,0.3947784482052476,1.0,9/27,9.16%,PID1;PRKCB;IRS1;ENPP1;GRB10;PRKCD;TNS2;PRKCZ;TSC2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5238351032293556,-1.4797644320173273,0.05319148936170213,0.3960897003860115,1.0,14/27,23.99%,DDX5;PLA2R1;SPRED1;KMT5A;CD44;MDM2;SPRED2;SPRED3;SNAI1;ATR;CD74;MSX1;TWIST1;ATM
prerank,negative regulation of RNA metabolic process (GO:0051253),0.6645076680201548,1.4793588453337179,0.07922535211267606,0.573035922830907,1.0,7/18,14.68%,ESR1;TMBIM6;PTBP3;TGFB1;NUDT16;RPS13;KAT2B
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.5698648632210066,-1.4788965087569268,0.055288461538461536,0.39571347413539065,1.0,4/21,2.57%,ANK2;SNTA1;CACNA2D1;CACNA1D
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7135346300455765,1.4783478520830642,0.08143939393939394,0.5745202838287056,1.0,5/10,9.42%,LYN;STAT3;JAK3;GHR;PTPN1
prerank,receptor metabolic process (GO:0043112),0.5500879867820822,1.4780336428799348,0.03918722786647315,0.5733617377250891,1.0,16/53,13.42%,DNM3;CALCRL;CAV1;SMURF1;LMTK2;RAMP2;SH3GLB1;SNX25;TGFB1;NEDD4;EHD3;PICALM;LGMN;RAB11B;KIF16B;RAB31
prerank,aortic valve development (GO:0003176),0.5909022133185272,1.477492459603483,0.03943217665615142,0.5732572239743241,1.0,12/34,7.33%,NOS3;BMPR2;TIE1;NFATC1;EFNA1;NOTCH1;TNFRSF1B;ELN;SOX9;DLL4;TNFRSF1A;TGFB1
prerank,receptor catabolic process (GO:0032801),0.6228911385929944,1.4772161821876295,0.06711409395973154,0.5719980479461205,1.0,11/24,12.65%,SMURF1;ZNRF3;AP2B1;SH3GLB1;SNX25;TGFB1;AP2A1;NEDD4;LGMN;KIF16B;MYLIP
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.6924664242651785,1.4770241841861753,0.07256637168141593,0.570413539148232,1.0,2/13,1.06%,SHANK3;APP
prerank,myeloid cell development (GO:0061515),0.6656686453364498,1.4768043877669552,0.06735751295336788,0.5689728755863332,1.0,4/18,2.95%,APP;FOXP1;NRROS;ALAS1
prerank,calcium ion transport into cytosol (GO:0060402),-0.5518983700974638,-1.4767958199592235,0.0748792270531401,0.3990954244598013,1.0,9/21,13.75%,CACNA1C;CACNA2D1;JPH1;SLC8A1;RYR2;GRIN2A;ADRA1A;JPH2;GRIN2D
prerank,regulation of neuron migration (GO:2001222),0.6326066400476463,1.4759661168758258,0.05756578947368421,0.5700039557278644,1.0,7/26,6.12%,SEMA6A;NEXMIF;DAB2IP;ARHGEF2;SRGAP2;ADGRG1;RAPGEF2
prerank,T cell activation involved in immune response (GO:0002286),0.7127885186074424,1.4758282479550937,0.08396946564885496,0.5683120604628982,1.0,2/12,1.30%,LCP1;ICAM1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.732293526477641,1.4751889254741732,0.09906542056074766,0.5684766503829658,1.0,1/10,0.83%,KDR
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.6008737951909388,1.4748918257500256,0.06645569620253164,0.5674244162745472,1.0,8/35,6.61%,NRP2;SEMA6A;PLXNA4;SEMA5B;SEMA7A;PLXND1;SEMA6B;RAC1
prerank,epithelial structure maintenance (GO:0010669),-0.6416307702151267,-1.4713005523209788,0.075,0.41099966576006186,1.0,2/11,3.26%,CXADR;RBP4
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6627829600800191,1.4706406712375955,0.0779896013864818,0.5813322450805426,1.0,6/18,6.84%,ERN1;NCK1;XBP1;BOK;ATXN3;BCL2L11
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.6242257439633381,-1.4705268466976915,0.07383966244725738,0.41067461720212495,1.0,5/13,10.45%,ADHFE1;IDH2;GPT2;IDH1;GOT1
prerank,regulation of interleukin-13 production (GO:0032656),0.7041801081419093,1.4699375983771974,0.07608695652173914,0.5818940200792115,1.0,1/13,0.13%,LEF1
prerank,mesenchyme morphogenesis (GO:0072132),0.6768916409930508,1.4693810451338225,0.06690140845070422,0.5817931714089764,1.0,6/17,6.28%,NOS3;ENG;ACVRL1;NOTCH1;SOX9;ACVR1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.6018156381701175,1.4689329378451024,0.06998444790046657,0.5814636218014093,1.0,10/30,16.50%,DACH1;BMPR2;ACVRL1;PINX1;ACD;DCP2;HNRNPC;ERCC4;NIBAN2;TERF1
prerank,cellular response to interferon-gamma (GO:0071346),0.4992007579200213,1.4681768717509114,0.032214765100671144,0.5823285931185789,1.0,16/88,10.41%,VCAM1;ICAM1;B2M;DAPK1;IRF2;GBP5;GBP4;GBP7;TRIM68;WNT5A;JAK1;TRIM25;CASP1;RPL13A;FCGR1A;CCL14
prerank,copper ion homeostasis (GO:0055070),0.6684474490754762,1.4675168216708128,0.08904109589041095,0.5825728714985607,1.0,4/17,10.25%,APP;SLC31A1;XIAP;ATP7B
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.584022878111783,-1.467443844301452,0.054373522458628844,0.4167570094507727,1.0,6/17,10.91%,FSTL1;SULF1;TWSG1;SFRP4;CASK;SLIT2
prerank,neuron projection morphogenesis (GO:0048812),-0.38208080749246676,-1.4670142222234526,0.0,0.4154393788979311,1.0,41/137,11.40%,ALCAM;DCLK1;GAS7;DOCK7;SDC2;FGFR2;NBL1;CTNND2;EPB41L3;BMP7;DCDC2;DLG4;NRK;MAP2;BRSK1;ALS2;IMPACT;FARP1;CNTNAP2;S100A6;ANK3;TAOK3;SHTN1;DOCK10;RYK;NGF;NLGN1;NTNG1;MAP6;S100B;LRRK2;CTNNA2;FLRT1;DCC;PLXNB1;NRCAM;DTNBP1;SHANK1;BAIAP2;RAB10;CNTN4
prerank,potassium ion transport (GO:0006813),-0.3923128473713336,-1.466777308940787,0.01990049751243781,0.4133314744090189,1.0,31/120,16.33%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;KCNB2;SLC9A9;KCNK5;KCNMA1;KCNQ3;ABCC9;KCND2;KCND3;KCNC2;KCNMB2;KCNS3;KCNJ2;KCNQ4;KCNJ13;KCNAB1;SLC24A2;KCNQ5;SLC9A1;KCNA6;ABCB8;KCNJ10;KCNN2;CCDC51;KCNJ8;KCNJ15;LRRC38
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.5443885025770784,-1.4667137027096646,0.05459057071960298,0.4108714723689778,1.0,5/23,8.66%,ATP1A2;ANK2;CACNA2D1;UBASH3B;CACNB1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.678635526556239,-1.4662944190610525,0.06181015452538632,0.409384515357919,1.0,4/10,9.56%,CPEB1;CPEB3;PAF1;LEO1
prerank,lipoprotein transport (GO:0042953),-0.661189465073474,-1.4653633667223822,0.06991525423728813,0.40931556351411397,1.0,4/10,15.06%,LRP1;PRKCB;MIA3;UNC119B
prerank,positive regulation of T cell activation (GO:0050870),0.5264524934267546,1.4652828003234548,0.05517241379310345,0.5889641965311374,1.0,12/62,11.30%,IL6ST;VCAM1;IL15;NCK1;JAK3;XBP1;LCK;TNFRSF13C;IL23A;CYRIB;IL7;ZMIZ1
prerank,myelination (GO:0042552),0.5535309275396598,1.4646326602015003,0.04992867332382311,0.5891367925636751,1.0,13/46,13.79%,ADGRG6;MPZ;PARD3;MAL;MALL;B4GALT5;EIF2B5;PLLP;CXCR4;DEGS1;ABCD1;CMTM8;EIF2B2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.616749061133693,1.464561454302365,0.07704918032786885,0.5871856406856629,1.0,6/25,8.09%,PTGS2;INSR;EDN1;KLF2;NOS1AP;PKD2
prerank,establishment of epithelial cell polarity (GO:0090162),0.6484419620381023,1.4639765835163039,0.08389261744966443,0.5871754766675943,1.0,5/19,5.94%,PARD3;CYTH1;MSN;SIPA1L3;OPHN1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.7003258000929946,1.4638515179178133,0.08727272727272728,0.5854898828816301,1.0,2/12,2.87%,CAV1;PDE4D
prerank,regulation of cell migration (GO:0030334),0.4429552091595958,1.4632414931306468,0.0031746031746031746,0.5855934993513908,1.0,72/382,8.62%,FRMD5;SEMA6A;LEF1;TJP1;LIMCH1;PECAM1;MCTP1;FLT1;DACH1;ABI3;PLXNA4;LDB2;KDR;ENG;CAV1;ITGA6;SEMA5B;ACVRL1;CLDN5;PODXL;INSR;SEMA7A;PDGFB;NEDD9;ADARB1;EDN1;ADAM10;STAT3;PDGFD;PTK2B;SRGAP3;SRGAP2;PPP3CA;NOTCH1;PLXND1;PTPRJ;PPM1F;ADGRG3;SPATA13;ACTN4;STK24;SRGAP1;ROBO4;NUMB;TMSB4X;FGF23;F7;SDCBP;XBP1;CEACAM1;PTPRK;SMAD7;ENPP2;SEMA6B;RET;PRR5L;DUSP22;ADAM15;CBLL1;ACVR1;RAC1;SASH1;STK26;PDGFC;TGFB1;PTK2;GRB7;NF2;SEMA6D;GNA12;SGK3;AKT2
prerank,hexose biosynthetic process (GO:0019319),-0.47778233318277497,-1.462913626759713,0.04398826979472141,0.41379803368738405,1.0,17/42,18.72%,RBP4;AKR1B1;PPARGC1A;SLC39A14;CHST15;PER2;ENO2;SLC25A12;GOT1;TPI1;SLC25A13;G6PC3;ENO3;PFKFB1;MDH1;CRY1;PCK2
prerank,hydrogen peroxide catabolic process (GO:0042744),0.7135324364825393,1.4627937012834054,0.10498220640569395,0.585050969696227,1.0,4/11,16.67%,PXDN;CAT;PRDX2;PRDX1
prerank,lipoxygenase pathway (GO:0019372),0.6894907602034156,1.462277982815866,0.08885017421602788,0.5848990627984456,1.0,4/14,8.64%,PTGS2;ALOX5AP;PON2;LTC4S
prerank,regulation of acute inflammatory response (GO:0002673),0.6582492760081258,1.4618053216383906,0.06920415224913495,0.5843985408933121,1.0,3/18,6.32%,IL6ST;OSMR;PLA2G2D
prerank,axonal fasciculation (GO:0007413),-0.6407080450167054,-1.461800149445763,0.0645879732739421,0.41437528379867306,1.0,7/12,17.35%,EPHA3;SEMA5A;NRCAM;CNTN4;RTN4;ARHGAP35;EPHB3
prerank,dephosphorylation (GO:0016311),0.4728541859803487,1.4611281151313538,0.01937046004842615,0.5850136432919522,1.0,26/147,8.37%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRM;PLPP1;PTPN12;PPP2R5A;SGPP2;PPP3CA;PTPRJ;PPM1F;MTM1;SSH2;PPP1R12A;PTPRK;PPM1L;PPP3CB;MTMR6;FBP1;INPP5K;PPM1D;DUSP23;DUSP16;PPP2R5E;PPP2R5B
prerank,rRNA processing (GO:0006364),0.47432506091062016,1.4609608771649192,0.007202881152460984,0.5834281230454327,1.0,88/172,26.58%,DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;RPL34;RPL39;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPL32;EIF6;RPL22;RPS27;RPL31;EXOSC1;RPL13;NOP53;UTP4;RPL6;RPL10;RPS6;RIOK1;RPL29;RRP9;PELP1;RPS25;SRFBP1;RPL35A;RPL27;RPL18;XRN2;EMG1;RPL27A;RRP1B;UTP6;PIH1D1;PDCD11;MAK16;RPL11;WDR18;HEATR1;ESF1;RPL8;NOP14;RPLP2;RPL18A;RPL21;SART1;RPL3;SBDS;RIOK2;RPS28;DDX47;RPL7;THUMPD1;RPL26;MRPL1;NOL6;RIOK3;TEX10;RRP12;LAS1L;LYAR;NOLC1;RPS17;RPL28;WDR46;WDR74;RPL41;DIS3;EXOSC4;RPS2;RPS9
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.7220005448191799,1.4608660738630892,0.09461966604823747,0.5816250148845591,1.0,5/11,13.55%,STAT3;PUM1;PUM2;ZFP36;FMR1
prerank,organic anion transport (GO:0015711),0.5135779418839994,1.4605135486810035,0.036635006784260515,0.5807760534414548,1.0,6/76,1.65%,ABCC4;SLCO2B1;ABCG2;LRRC8C;SLC39A8;SLCO2A1
prerank,negative regulation of angiogenesis (GO:0016525),0.5050758393949111,1.4604480223851686,0.03280839895013123,0.5788685624541875,1.0,13/84,5.49%,SEMA6A;TEK;CLDN5;EPN2;PTPRM;ECSCR;DAB2IP;HHEX;STAB1;NPR1;GTF2I;KLF2;ATP2B4
prerank,positive regulation of cell projection organization (GO:0031346),-0.3968320870688136,-1.4602443266666736,0.008928571428571428,0.4159586298195426,1.0,44/115,14.97%,ROBO1;PLXNA2;NTRK3;MAGI2;ROR1;DPYSL3;CAMK1D;EPHA3;PTN;PTK7;GRIP1;TIAM2;DLG4;TENM3;OBSL1;NDNF;CARMIL1;CUX2;CAPRIN2;PTPRD;NTRK2;ROR2;ROBO2;IL1RAPL1;NGF;CUX1;KIDINS220;MAP6;ARSB;PLXNB1;APOE;ATP1B2;FBXW8;FZD1;SLIT2;CAMK1;PLK5;CDKL3;PRKCI;CAMK2B;FUT9;P3H1;PLPPR5;CBFA2T2
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5428027322536908,1.45956875020059,0.06110283159463487,0.5801114595658596,1.0,9/51,8.27%,APP;STAT3;GBP5;AIM2;CASP8;WNT5A;LPL;MALT1;CASP1
prerank,organic substance transport (GO:0071702),0.4849654522876713,1.459547769561367,0.018726591760299626,0.578090047133633,1.0,28/120,14.28%,CALCRL;SLCO2B1;ABCG2;SLC6A2;PLTP;ATP8A1;SPNS2;SLCO2A1;MYH9;SCAMP1;RAMP2;ABCA3;TAP2;CHMP2B;ARRDC1;RAB38;PLEKHA8;CD320;SLCO1B1;PICK1;ABCD1;RILP;CHKA;RAB7A;ABCG1;TXNIP;TCN2;SLC22A5
prerank,regulation of cellular amide metabolic process (GO:0034248),0.5802888836440627,1.459210278194945,0.07987220447284345,0.5773997522210361,1.0,9/32,13.03%,NANOS3;APP;EIF4E;TIGAR;RBM3;CYFIP1;PICALM;RPL10;MTPN
prerank,plasma membrane tubulation (GO:0097320),0.6885272803151995,1.4589597032466437,0.08021390374331551,0.5762619940722528,1.0,4/13,9.19%,FNBP1L;CAVIN2;EHD2;CHMP4A
prerank,mesoderm development (GO:0007498),0.6433862907243978,1.4579639575053516,0.077834179357022,0.5780570673745156,1.0,5/18,9.32%,TBX1;TIE1;MESD;BMX;TCF15
prerank,positive regulation of cell aging (GO:0090343),0.7171490432641409,1.4577348076433154,0.08736059479553904,0.5767552421842258,1.0,2/11,1.56%,ABI3;B2M
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.575625176161725,1.4576878647290659,0.06168831168831169,0.5748797077780514,1.0,9/34,7.46%,TEK;FLT1;PRKD1;PDGFB;DAB2IP;PTK2B;PIK3IP1;TGFB1;PTK2
prerank,glial cell development (GO:0021782),0.6122328899661812,1.4576511640330698,0.07981220657276995,0.5729538071163802,1.0,11/25,14.35%,APP;CDK6;NRROS;DLL1;EIF2B5;PRDM8;SOX4;PICK1;CSPG5;EIF2B2;S100A9
prerank,regulation of platelet aggregation (GO:0090330),0.6664069170883173,1.4554713227314637,0.08760330578512397,0.5792204828610028,1.0,4/17,5.12%,PRKG1;F11R;LYN;CEACAM1
prerank,protein localization to cilium (GO:0061512),-0.49893970420842343,-1.4551978290985432,0.02702702702702703,0.42767994975061374,1.0,19/32,29.88%,TULP3;WDR35;INVS;ARL3;IFT20;RAB29;EHD1;BBS9;TCTN1;IFT140;TULP1;TCTN2;TTC21B;TULP2;IFT122;BBS1;ARL6;ODAD4;NPHP4
prerank,positive regulation of cytokine production (GO:0001819),0.44366814414533284,1.4551562136419471,0.007760532150776054,0.578319979777717,1.0,42/292,10.01%,IL1R1;NOD1;IL6ST;CADM1;PTGS2;APP;IL15;SPTBN1;CD200;LRRFIP1;FOXP1;IL6R;ARHGEF2;PRKD2;STAT3;GBP5;PAEP;HIF1A;PDE4D;AFAP1L2;PLCB1;CD34;FLT4;PLCG2;TIRAP;XBP1;WNT5A;TIGIT;CD40;TGFB1;PIK3CG;AGPAT1;NFKB1;LPL;MALT1;ZFPM1;G3BP1;CGAS;RFTN1;IL23A;MAPK11;CYRIB
prerank,regulation of anoikis (GO:2000209),0.6324546519625832,1.4544865562947442,0.07467532467532467,0.5785568696148865,1.0,6/19,9.01%,CAV1;NOTCH1;SIK1;PTK2;ITGA5;MYBBP1A
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6967915721359479,1.4541102221622195,0.10594795539033457,0.5779791193472061,1.0,2/12,3.84%,RAB27A;PLCG2
prerank,positive regulation of cell adhesion (GO:0045785),0.5143032944632239,1.4540624551664085,0.037396121883656507,0.5761496998232778,1.0,17/74,11.16%,FRMD5;TGM2;STX3;MAGI1;PDGFB;PRKD2;PPP3CA;PTPRJ;PPM1F;ADGRG1;SMAD7;RET;RAC1;RSU1;SFRP2;EPHA4;P2RY12
prerank,endothelial cell differentiation (GO:0045446),0.7096579128745037,1.453298639424502,0.1014760147601476,0.5769604636718453,1.0,5/12,3.69%,BMPR2;KDR;TIE1;ACVRL1;SOX18
prerank,regulation of osteoblast proliferation (GO:0033688),-0.5866381373356866,-1.4532866075097992,0.05,0.43056663881734325,1.0,6/17,8.67%,FGFR2;NPR3;MN1;CCN1;SFRP1;PLXNB1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.5185640525024762,-1.4530242350381921,0.0594059405940594,0.4286804926995754,1.0,6/25,4.96%,ARHGAP6;PHLDB2;ROCK2;THBS1;APOD;ROBO2
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6605486737505551,1.452810720163959,0.0880281690140845,0.5766795097930595,1.0,3/17,1.07%,ADIPOR2;CAV1;PPARD
prerank,activation of adenylate cyclase activity (GO:0007190),-0.4855475224358957,-1.45215516927442,0.051490514905149054,0.42869871714875624,1.0,8/35,5.97%,LGR4;ADCY5;ADCY1;ADCY2;EDNRA;ADCY7;ADCY6;CAP2
prerank,muscle tissue development (GO:0060537),0.6971205102617916,1.4506029658179724,0.09611829944547134,0.5828143036977368,1.0,3/13,5.61%,PGM5;ENG;SRPK3
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6076997855761787,1.4499082143940238,0.08469055374592833,0.5835210661356995,1.0,6/26,8.09%,PTGS2;INSR;EDN1;KLF2;NOS1AP;PKD2
prerank,macromolecule catabolic process (GO:0009057),0.6103154880335718,1.4496291652079596,0.0694006309148265,0.582587110589178,1.0,11/26,12.55%,SMURF1;SH3GLB1;SNX25;TGFB1;NEDD4;CTRL;TRIM24;SIAH1;LGMN;CLN6;KIF16B
prerank,adherens junction organization (GO:0034332),0.551042586395548,1.4492585532628242,0.05743740795287187,0.5820202286021405,1.0,11/48,8.77%,TJP1;CADM1;NECTIN2;PVR;PAK2;CDH2;SMAD7;CTNNA1;RAMP2;CDH15;ANG
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.41310382270725177,-1.4492087335805501,0.01818181818181818,0.4345800937886027,1.0,35/95,10.71%,GPC6;UST;DSE;SDC2;DCN;ANGPT1;GPC3;OGN;CEMIP;FMOD;HSPG2;HS3ST3A1;BGN;EXT1;CSPG4;PRELP;CHST15;PXYLP1;HS3ST3B1;LUM;CHSY3;HS2ST1;VCAN;GPC5;CHSY1;HS6ST2;GCNT2;SDC4;CHST3;DSEL;OMD;XYLT1;HS3ST5;HS6ST1;GPC4
prerank,hexose transmembrane transport (GO:0008645),0.6328019825183054,1.4488539743502764,0.09446254071661238,0.5815398886105899,1.0,4/21,6.85%,SLC2A1;PPARD;SLC2A9;PPBP
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.6489933971223599,1.44879226215331,0.06745362563237774,0.5798162001237382,1.0,4/17,2.82%,PBX1;MAML2;NOTCH1;PLXND1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5149566199770205,-1.4486101167305376,0.06091370558375635,0.43365479863701994,1.0,8/26,9.89%,ANK2;FHL1;ACTN2;CACNA1D;ATP1B1;DLG1;KCNAB1;ATP1B2
prerank,vasodilation (GO:0042311),0.6896828059046236,1.4484046795813792,0.10301953818827708,0.5792359152586142,1.0,3/13,4.43%,NOS3;ADRB1;KLF2
prerank,heart looping (GO:0001947),0.5679171540193821,1.447942747047478,0.060790273556231005,0.5791256526373153,1.0,13/39,14.03%,ENG;MEF2C;ZIC3;NOTCH1;SOX17;SOX18;DLL1;PKD2;IHH;APLNR;VANGL2;TGFBR2;SETDB2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.6196875056748427,1.4479249444850577,0.08387096774193549,0.5772608397206452,1.0,5/24,6.61%,TEK;KDR;PTPRJ;PPM1F;RAC1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.7145749633458329,1.4474474079805952,0.0928030303030303,0.5770554546361935,1.0,4/11,8.72%,FOXO1;NOTCH1;ATP2B4;GLRX3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.46947783711292423,-1.4474017419316023,0.037383177570093455,0.4344951633476841,1.0,12/43,9.16%,PID1;PRKCB;IRS1;ENPP1;GRB10;PRKCD;OGT;TNS2;IGF2;PRKCZ;NUCKS1;TSC2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6263807024061014,1.4472459628702234,0.0779436152570481,0.5758898481764056,1.0,5/24,5.63%,TEK;KDR;ICAM1;GATA2;RAMP2
prerank,positive regulation of cholesterol transport (GO:0032376),0.5946842951971204,1.4469079381331755,0.08688783570300158,0.575286684952605,1.0,6/27,5.76%,CAV1;PLTP;NFKBIA;LPCAT3;EEPD1;ABCA3
prerank,regulation of leukocyte activation (GO:0002694),0.6885956689728029,1.4465903170287095,0.09550561797752809,0.5745475725565024,1.0,4/14,7.19%,CD200;LYN;MFHAS1;LCK
prerank,serine family amino acid biosynthetic process (GO:0009070),0.6887396907870931,1.4463010812720758,0.10086956521739131,0.5736564247930747,1.0,2/12,2.40%,SERINC3;SERINC5
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.5605256332347972,-1.4462249150890267,0.06531531531531531,0.43506465958976837,1.0,5/19,10.45%,DDO;ASPA;ALDH7A1;PHYKPL;GOT1
prerank,positive regulation of vasculogenesis (GO:2001214),0.7392551874302611,1.445994736308829,0.09760589318600368,0.5728858614951851,1.0,5/10,7.53%,KDR;CD34;CEACAM1;RAPGEF2;RAP1A
prerank,muscle cell migration (GO:0014812),-0.6397756770739464,-1.4456724451334164,0.07066381156316917,0.43414206903412345,1.0,4/10,8.17%,DDR1;SIX1;CCN3;PLAT
prerank,positive regulation of B cell proliferation (GO:0030890),0.5974120927060227,1.44418890926312,0.07301587301587302,0.577344673382173,1.0,8/29,11.13%,CD38;MEF2C;BST1;TIRAP;CD40;TNFRSF13C;CD320;IL7
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.6493700869263674,1.442104975869861,0.09185441941074524,0.5832003506239389,1.0,5/19,6.61%,TEK;KDR;PTPRJ;PPM1F;RAC1
prerank,response to axon injury (GO:0048678),-0.5677955892802397,-1.441944224332557,0.07901234567901234,0.44220124850773257,1.0,5/18,11.38%,DPYSL3;P2RX4;APOD;NREP;GAP43
prerank,ribosome biogenesis (GO:0042254),0.4549553971153922,1.4418724105792706,0.01718213058419244,0.5821652300262761,1.0,71/187,21.42%,DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;RPL34;RPL39;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;XPO1;RRS1;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPL32;EIF6;RPL22;RPS27;RPL31;EXOSC1;RPL13;NOP53;UTP4;RPL6;RPL10;NOP16;RPS6;NPM1;RIOK1;RPL29;RRP9;PELP1;RPS25;RPL35A;RPL27;RPL18;XRN2;EMG1;RPL27A;RRP1B;UTP6;PIH1D1;PDCD11;RPL11;WDR18;HEATR1;ESF1;RPL8;NOP14;RPLP2;RPL18A;NOM1;RPL21;RPL3;SBDS;RIOK2;RPS28;DDX47;RPL7
prerank,negative regulation of cell adhesion (GO:0007162),0.5099209640288324,1.4416048413586322,0.038926174496644296,0.5811608666630583,1.0,17/72,9.25%,SEMA6A;ACER2;PLXNA4;NEXMIF;ACVRL1;PODXL;FZD4;ADAM10;NOTCH1;PLXND1;CBLL1;ADAMDEC1;TGFB1;PTK2;RASA1;NF2;DSCAM
prerank,icosanoid biosynthetic process (GO:0046456),0.7190220944494292,1.4407132464363168,0.10905730129390019,0.5825360898276463,1.0,3/10,8.64%,PLA2G4A;ALOX5AP;LTC4S
prerank,regulation of cytokine production (GO:0001817),0.47162237240272936,1.4401843844951714,0.03461538461538462,0.5824675026078573,1.0,18/126,8.30%,RPS6KA5;HDAC9;CADM1;IL15;FOXP1;LYN;TNFRSF1B;AFAP1L2;ACKR1;CASP8;IGF2BP3;N4BP1;MAST2;BTN2A2;SRGN;PIK3CG;AGPAT1;POLA1
prerank,positive regulation of chromatin organization (GO:1905269),0.6984350080537073,1.4395063818760587,0.10301953818827708,0.5831026074550733,1.0,6/12,16.50%,TAL1;H3-3A;ACD;MIER1;ATRX;TERF1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.5474209373313741,1.4393171566878764,0.05837173579109063,0.5818473937653325,1.0,11/45,13.03%,NANOS3;APP;EIF4E;PUM1;RBM3;YTHDC1;RC3H1;CYFIP1;PUM2;RPL10;MTPN
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5449261245455493,-1.4390521842039337,0.0728643216080402,0.4481767367968596,1.0,5/20,3.90%,SULF1;SULF2;THBS1;FGF2;SMOC2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6020624897526526,-1.438941645929445,0.0706401766004415,0.44596529704482074,1.0,6/15,8.61%,GPC3;DAAM2;RSPO3;DACT1;SFRP4;SFRP1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.626379526629389,-1.4380921442480532,0.09594882729211088,0.4458403377312755,1.0,4/11,12.35%,ITGB5;KIT;CCN3;PLEKHA7
prerank,phospholipid translocation (GO:0045332),0.5966277876703923,1.437103707105533,0.07051282051282051,0.5876045197201853,1.0,5/28,2.88%,ATP8B1;ATP8A1;ATP10A;ATP11C;ATP11B
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.6106165138926383,-1.435446110889282,0.09417040358744394,0.45083246008844347,1.0,2/12,2.50%,NUPR1;IL18
prerank,intraciliary retrograde transport (GO:0035721),-0.6296017509245844,-1.4352672732453238,0.07710280373831775,0.4489041529078996,1.0,7/12,20.44%,DYNC2H1;WDR35;DYNC2I1;DYNC2LI1;IFT43;IFT140;TTC21B
prerank,cation transport (GO:0006812),-0.37050434130011634,-1.435214267710873,0.006535947712418301,0.44658748300437806,1.0,26/166,8.01%,ATP1A2;TRPM3;PIEZO2;SLC47A1;SLC8A3;SLC41A1;SLC12A2;SCN7A;KCNB2;KCNK5;SLC6A9;ATP1B1;SLC8A1;SLC22A4;KCNMA1;ANO1;ABCC9;KCND3;KCNMB2;KCNS3;TRPC6;KCNJ2;KCNQ4;SLC5A5;KCNJ13;KCNAB1
prerank,skeletal muscle tissue development (GO:0007519),0.5765643527231898,1.4351308824581688,0.06807131280388978,0.5931633495578422,1.0,4/32,4.96%,CAV1;MEF2C;CAV2;FOXL2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.42935116590188266,1.435124353179984,0.0031479538300104933,0.591311188993997,1.0,65/417,11.57%,MECOM;LEF1;ELK3;RPS6KA5;FOXO1;CD38;HDAC9;ATP8B1;DACH1;ZHX3;SMARCA2;PPARD;CBFA2T3;ZBTB16;SOX7;AHR;PDGFB;FOXP1;DAB2IP;SOX13;HHEX;NR3C1;NOTCH1;PPM1F;PLCB1;SOX18;HMBOX1;SOX9;VGLL4;SCMH1;FOXL2;ID1;EPC1;PTPRK;SBNO2;TCF7L2;WNT5A;ATF7IP;RCOR1;KLF10;INPP5K;CDKN1B;TRIB3;TGFB1;BCL3;GATAD2A;CTBP1;CITED1;KAT6B;FOXK1;MYBBP1A;YEATS2;COPS2;SFRP2;FOXN3;SMARCE1;TFAP4;GAS6;POU2F1;SPEN;RBM15;RB1;ZMYND11;EID1;SP3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.6671519383456542,1.434802578143524,0.12478031634446397,0.5905941755747108,1.0,2/13,2.21%,KDR;EDN1
prerank,bone development (GO:0060348),-0.47967547114279646,-1.4346616057671235,0.054380664652567974,0.4455379456711575,1.0,12/39,7.12%,RANBP3L;SULF1;FGFR2;AKAP13;GJA1;SULF2;CYP26B1;SH3PXD2B;GNAS;SFRP4;LRP6;NOTUM
prerank,regulation of adaptive immune response (GO:0002819),0.6474390951205711,1.4338408628354629,0.09401709401709402,0.592474645408679,1.0,4/18,8.07%,IL6ST;AHR;SKAP1;SAMSN1
prerank,regulation of cell communication (GO:0010646),-0.48664419995970937,-1.433827920522368,0.049723756906077346,0.4454038837755182,1.0,13/35,9.29%,ANK2;CXADR;GRK3;SLC8A1;ANXA1;IGFBP7;YWHAG;MTCH1;TBX18;MGLL;RYR2;SCG5;GRK5
prerank,positive regulation of DNA repair (GO:0045739),-0.452774165203245,-1.4329704045660279,0.02280130293159609,0.4453548016333343,1.0,5/46,2.95%,EYA2;EGFR;EYA1;EYA4;SPIRE1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.6084485831983332,1.4329646112506378,0.07223113964686999,0.5937585226248736,1.0,8/26,6.60%,PDE8A;PLCG1;PTPN12;IQGAP1;DAB2IP;SOX9;DUSP22;INPP5K
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.647586993289396,1.4328911590978126,0.1003584229390681,0.5921993616684965,1.0,1/15,0.04%,PRKCH
prerank,positive regulation of lipid kinase activity (GO:0090218),0.5884933620562629,1.4328783450561982,0.08471760797342193,0.5903990626871124,1.0,6/29,2.59%,TEK;FLT1;PRKD1;PDGFB;DGKZ;PTK2B
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5954819650595992,1.4327229044506589,0.08852459016393442,0.5891267298937177,1.0,10/26,18.28%,NOD1;CASP8;IKBKG;RIPK2;IFIH1;TRAF6;TAB3;IRAK2;TIFA;AAMP
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.6092762943892921,-1.432509567490502,0.06783369803063458,0.44428972253620436,1.0,8/13,18.88%,DCN;BGN;CSPG4;VCAN;ARSB;HEXA;HYAL1;IDUA
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.5878749352408223,-1.4324636879051529,0.07575757575757576,0.4420353667582343,1.0,6/15,12.48%,MGAT3;LARGE1;RENBP;NAGK;CHST3;GNPDA1
prerank,determination of heart left/right asymmetry (GO:0061371),0.5563404300003767,1.432367305504691,0.07424242424242425,0.5885480369236387,1.0,13/42,14.03%,ENG;MEF2C;ZIC3;NOTCH1;SOX17;SOX18;DLL1;PKD2;IHH;APLNR;VANGL2;TGFBR2;SETDB2
prerank,regulation of phagocytosis (GO:0050764),0.5236126636681144,1.4321741963720966,0.0611353711790393,0.5873776651078366,1.0,5/53,2.18%,RAB27A;TGM2;IL15;GATA2;SCARB1
prerank,negative regulation of reproductive process (GO:2000242),-0.5665670023404512,-1.4309325264621011,0.08009153318077804,0.4437601439357,1.0,3/17,2.01%,IGF1;SULF1;GJA1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.47781394107094954,1.4291443888222584,0.03238341968911917,0.5964202364210769,1.0,18/113,8.40%,UNC13B;ESR1;PIEZO1;LCP1;RASIP1;DAB2IP;TAL1;GBP5;FNIP2;BIK;RAP1B;TIRAP;SKAP1;SH3GLB1;BCL2L11;RPA1;TGFB1;CDT1
prerank,ATP transport (GO:0015867),-0.6448616011264753,-1.4289439600384046,0.10284463894967177,0.44694320579089264,1.0,4/10,19.25%,ABCC6;SLC25A42;SLC17A9;SLC25A4
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.5333454908433248,-1.4289066117549802,0.07874015748031496,0.4447056951518541,1.0,10/24,20.34%,PID1;LEPR;PPARGC1A;GFPT1;GFPT2;SLC25A13;MT3;SDHAF4;NR4A3;MRAP2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.4169142425763448,-1.4281729554944462,0.032490974729241874,0.4444714421938977,1.0,16/69,7.82%,PLCL1;IGF1;PLCE1;PDGFRB;PDGFRA;IRS1;PI4KA;GAB2;OGT;PLCD3;SIRT2;NF1;NGF;PLCB3;PLCD1;EZR
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6214434255425924,1.4279971228869217,0.09849749582637729,0.598668615348531,1.0,8/21,6.60%,CAV1;CNKSR3;DDIT4;PDE4D;PPM1F;NCK1;SMAD7;INPP5K
prerank,regulation of cell motility (GO:2000145),0.47133987360784807,1.4278425866007949,0.03164556962025317,0.5974195769934452,1.0,28/121,10.01%,FRMD5;ABI3;PLXNA4;NTN1;LDB2;CDK6;CCDC125;PRAG1;PLXND1;ADGRG3;SPATA13;ROBO4;TMSB4X;PKN2;FGF23;PKN1;CAVIN1;CEACAM1;ENPP2;RAC1;TGFB1;SGK3;AKT2;SLK;CRK;SST;INPP5F;CYRIB
prerank,regulation of protein import into nucleus (GO:0042306),-0.47304744022307055,-1.4270103687716358,0.04120879120879121,0.44552739025408244,1.0,15/36,21.71%,ZIC1;PRKCD;BMP4;CDH1;APOD;SMAD3;SUFU;RAB23;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;BAG3
prerank,regulation of protein localization to membrane (GO:1905475),-0.5015485423736611,-1.4268107539310566,0.08527131782945736,0.4437370454602557,1.0,8/28,7.82%,GPC6;GSN;PRKN;GPC3;AR;MMP14;SLC5A3;GPC5
prerank,regulation of AMPA receptor activity (GO:2000311),0.6085172852919298,1.4267519233512946,0.07317073170731707,0.5993829569021981,1.0,2/25,1.15%,SHANK3;MEF2C
prerank,cellular protein modification process (GO:0006464),0.4175286250461066,1.4266581817353279,0.0,0.5979010400597485,1.0,178/982,11.79%,PTPRB;PRKG1;PRKCH;ERG;ST3GAL6;RPS6KA5;PTPRG;EPAS1;CDK17;PTPN14;BMPR2;TGM2;DCUN1D3;KLHL3;APP;SNRK;KLHL5;UGCG;ZBTB16;ERN1;ACVRL1;PRKD1;CTTNBP2NL;ST3GAL1;CDK6;INSR;MGAT4A;STT3B;PTPRM;DAPK1;GALNTL5;NEK7;PDGFB;PTPN12;PPP2R5A;PEAK1;RAB11A;SOCS2;LYN;PIM3;PRKD2;BCR;KLHL2;ADAM10;PRAG1;PTK2B;FNIP2;STK10;PPP3CA;NEURL2;YES1;FBXW7;HIF1A;PTPRJ;MAP4K3;PPM1F;SIK1;PGAP1;MTM1;MAN2A1;FYN;BTBD1;TAOK2;B3GNT3;FUCA2;STK24;STK3;SSH2;PKN3;LIPE;PPP1R12A;PKN2;PAK2;FGF23;CPE;UBA7;PTP4A2;CDH2;PKN1;STK4;LMTK2;MARK3;JAK3;MAP3K9;IKBKB;PADI4;HIPK1;PTPRK;ACVR2A;QSOX1;ALG10B;CDC42BPB;MAPK8;SPARCL1;FBXL4;RET;PLK2;MAST2;PPM1L;ULK1;LIMK2;KCTD6;PPP3CB;AURKA;MTMR6;VWA1;CISH;SIK3;ACVR1;TSSK6;B3GNT4;DYRK1A;STK26;ST8SIA4;BMX;TNIK;PPM1D;LCK;GOLM1;RNF7;JAK1;SIRT5;ST6GALNAC2;TGFB1;B4GALT5;PSMA2;FBXL7;PIGU;DUSP16;PPP2R5E;RAB2A;CTBP1;PPP2R5B;RAB38;HASPIN;CREB1;SGK3;AKT2;NEK6;PXK;PGGT1B;B3GNT6;MAP3K11;AURKC;RHBDD1;APLP2;FBXL2;CDK2;FBXW2;PTPN1;CSF1;ERO1A;COPS2;PARP2;PSMA8;PTAR1;ASB10;UBE2D3;PSMA6;CDK18;NUAK1;PRKAB1;ICMT;GAS6;COPS4;FBXO30;PPP2R3A;AKT3;ABL2;PIGK;GMFG;PICK1;MAP3K13;CUL1;SIK2;STK38;NUS1;PIM1
prerank,positive regulation of hydrolase activity (GO:0051345),0.4681442927763981,1.4259562203802212,0.02219482120838471,0.5987207429464997,1.0,27/137,10.42%,DOCK9;PKP4;TGM2;NET1;ITGA6;F11R;CD200;TBC1D30;SRGAP2;ARHGAP27;CAV2;ADRB1;PLIN5;MAPK8;RAP1GDS1;CHP2;RAPGEF2;CD40;BCAR3;RAP1A;TBC1D2;AGRN;RSU1;ARHGEF7;LARS1;CCL14;SEMA4D
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5665789259770213,1.4258989769752688,0.07469512195121951,0.597131405275413,1.0,2/36,0.30%,MECOM;FOXO1
prerank,positive regulation of protein binding (GO:0032092),0.5219361910517064,1.4258863503529715,0.07052186177715092,0.5953665963489986,1.0,15/56,6.76%,CAV1;APP;EPB41;CLDN5;B2M;HIP1R;STK3;FKBP1A;STK4;MARK3;RALB;DTX3L;TCF7L2;RAPGEF2;TRIB3
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5530634721662971,1.424594637064736,0.07473841554559044,0.5982769692013873,1.0,14/43,14.03%,ENG;MEF2C;ZIC3;NOTCH1;SOX17;SOX18;DLL1;ACVR1;PKD2;IHH;APLNR;VANGL2;TGFBR2;SETDB2
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.638821205053798,-1.4245483462648747,0.07111111111111111,0.44748948802178734,1.0,5/11,16.87%,WNT4;BMP5;FGFR4;DGKQ;NR1H4
prerank,regulation of metal ion transport (GO:0010959),-0.5842374447148713,-1.424434335375207,0.082039911308204,0.4455023342730978,1.0,7/16,6.34%,ANK2;BCL2;CACNA2D1;SLC30A10;IL16;DLG1;STIM1
prerank,cardiac muscle tissue development (GO:0048738),-0.44630419161179463,-1.4240615031650519,0.023890784982935155,0.44437026057695517,1.0,12/50,5.92%,NOTCH2;BMPR1A;GJB6;AKAP13;BMP5;SGCD;BMP7;GJA1;BMP4;RBP4;CACNA1G;TBX18
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.6042811954937743,1.4234706336807195,0.10272873194221509,0.6007288716754359,1.0,8/23,18.67%,NMT2;CNGB1;GNAT1;GUCA1B;PDE6B;CALM1;FNTA;CAMKMT
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.5180691984742377,-1.4233939400859064,0.06806282722513089,0.443854147052207,1.0,7/22,13.18%,NTRK3;MAGI2;NTRK2;NGF;KIDINS220;WASF1;EHD1
prerank,clathrin coat assembly (GO:0048268),0.6595418328657909,1.4228283860779176,0.10815307820299501,0.6012589460964683,1.0,4/15,3.93%,HIP1;HIP1R;PIK3C2A;FCHO2
prerank,negative regulation of cell death (GO:0060548),0.4881264657890398,1.4225514549355434,0.04111405835543767,0.6004078890138795,1.0,19/88,10.77%,MECOM;PDE8A;PRKD1;CD200;SRGAP2;TNFRSF1B;FYN;NCK1;CD34;AMIGO2;TIGAR;CHMP4A;CHMP4B;SOX4;IKBKG;CSF1;BTBD10;RAD18;BNIP3
prerank,cochlea morphogenesis (GO:0090103),0.715952805691276,1.421847133925897,0.10351201478743069,0.601105522601147,1.0,2/10,4.17%,TBX1;SOX9
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.6300648934841309,-1.421756244574382,0.09210526315789473,0.44592335950960027,1.0,3/11,2.95%,EGFR;DDX5;BMP4
prerank,regulation of water loss via skin (GO:0033561),0.668870359352228,1.4217188503237486,0.09705372616984402,0.5979787769811687,1.0,5/15,15.25%,UGCG;LSR;SFN;MET;FA2H
prerank,establishment of skin barrier (GO:0061436),0.668870359352228,1.4217188503237486,0.09705372616984402,0.5979787769811687,1.0,5/15,15.25%,UGCG;LSR;SFN;MET;FA2H
prerank,cell junction assembly (GO:0034329),0.48638622568736434,1.4213372856276112,0.04111405835543767,0.5975525637926771,1.0,10/100,4.22%,SHANK3;DNM3;TJP1;PKP4;ITGA6;CLDN5;LIMS2;PLXND1;PCDHB4;CDH2
prerank,triglyceride biosynthetic process (GO:0019432),-0.5503032109531997,-1.420906992690918,0.09130434782608696,0.44595277387422255,1.0,5/18,6.99%,AGMO;MOGAT3;LPGAT1;GK;LPIN1
prerank,stabilization of membrane potential (GO:0030322),-0.5720289325292746,-1.4205301099084011,0.102803738317757,0.44485926960764177,1.0,2/16,2.75%,KCNK2;KCNK5
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.6985346533451521,1.4196749985020607,0.10600706713780919,0.6017920412419571,1.0,3/11,6.12%,MEF2C;LYN;RAPGEF2
prerank,response to interleukin-1 (GO:0070555),0.5058785237552801,1.4196159970654443,0.047106325706594884,0.6002203094844715,1.0,17/73,14.18%,IL1R1;APP;DAB2IP;TNFRSF11A;HIF1A;SELE;SOX9;CD40;NFKB1;CITED1;MAPK11;CCL14;RC3H1;RELA;HAS2;GBP3;TRAF6
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.663066995135546,1.4195562324552256,0.10102739726027397,0.5987041234711397,1.0,2/15,1.44%,STOX2;NR5A2
prerank,long-term memory (GO:0007616),-0.5589417482002835,-1.4191637343558547,0.08788598574821853,0.4463137271234761,1.0,9/19,24.13%,RASGRF1;CPEB3;LDLR;APOE;SHANK1;NFATC4;PJA2;CAMK4;CALB1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.6666630025283767,1.4190659405625907,0.11466165413533834,0.5986965015792474,1.0,3/15,2.79%,STAT3;GBP5;HIF1A
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.4237353413567815,1.4190062855344792,0.0073145245559038665,0.5971782464741315,1.0,83/476,9.80%,MECOM;LEF1;FLI1;FOXO1;CD38;TBX1;ESR1;SMARCA2;PPARD;MEF2C;ZBTB16;ACVRL1;NR5A2;AHR;ZIC3;NFATC1;PDGFB;ELF2;MLLT3;FZD4;HHEX;LRP5;TAL1;STAT3;NOTCH1;HIF1A;RREB1;AFAP1L2;KDM3A;SOX17;PLCB1;SOX18;SOX9;NCOA1;KLF2;FOXF1;IKBKB;RPS6KA1;DTX3L;FOXL2;EPC1;KMT2E;SPIN1;FOXF2;ARID1B;RET;TCF4;TEAD2;PITX3;PPP3CB;ESRRG;WNT5A;CNBP;SKAP1;ATF7IP;ATMIN;ACVR1;SOST;INPP5K;HNF1B;DYRK1A;ETS2;LYL1;TGFB1;BCL3;TCF3;HNRNPD;NFKB1;PCBD2;ARID1A;NEUROD1;CITED1;KAT6B;PSEN1;CREB1;FOXK1;BRD4;SOX4;MAP2K3;MAFB;RNF4;EDRF1;NFIB
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6352697337096854,1.418783866562555,0.10590277777777778,0.5961954062749618,1.0,5/19,7.86%,APP;PDGFB;KLF2;MAPK8;NFKB1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.6124704605538094,-1.418495369813122,0.07142857142857142,0.44581426767854926,1.0,8/13,22.68%,SLC4A10;GRIK2;SHISA7;SYP;SLC8A2;PPFIA3;RAB3GAP1;CLN3
prerank,positive regulation of ion transport (GO:0043270),-0.4600572178999679,-1.4182619464706527,0.02903225806451613,0.4442763852234241,1.0,10/48,8.32%,ANK2;FHL1;ACTN2;CACNA1D;P2RX4;ANK3;DLG1;CACNB2;TRPC6;ADRA2A
prerank,regulation of ruffle assembly (GO:1900027),0.6046379326351563,1.4175408745823828,0.09246575342465753,0.5989852746929752,1.0,4/23,4.23%,ABI3;CAV1;EPS8;EVL
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.5596473506142734,1.4171484707122248,0.07291666666666667,0.5986847177455931,1.0,7/35,6.12%,ADGRG6;AHR;PDE2A;PDE7B;PDE4D;SOX9;RAPGEF2
prerank,lamellipodium organization (GO:0097581),0.5806873899980445,1.416892061854539,0.08196721311475409,0.5979245596746222,1.0,9/29,11.69%,PARVB;ABLIM1;S1PR1;SPATA13;CCDC88A;RAC1;ARHGEF7;P2RY12;CYFIP1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.49926979746290745,-1.4167264694766075,0.0641025641025641,0.4462247417357949,1.0,9/27,13.37%,ANK2;DMD;JPH1;CACNB2;PRKACA;ADRA2A;CACNB1;AHNAK;JPH2
prerank,regulation of dendrite development (GO:0050773),-0.46453963468796433,-1.4158410989515262,0.05341246290801187,0.4462828643216938,1.0,9/37,3.84%,CAMK1D;SDC2;PTN;BMP5;BMP7;HECW2;ADGRB3;CSMD3;COBL
prerank,negative regulation of cell activation (GO:0050866),0.6775085360793996,1.4157737432425594,0.09642857142857143,0.600186058131976,1.0,3/14,1.89%,NOS3;CD200;PDGFB
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5503506580222151,-1.4153515502516274,0.08585858585858586,0.4453166858034679,1.0,11/19,8.79%,BMPR1A;FGFR2;TGFBR3;TGFBR1;RBP4;ERBB4;FGF2;ZFPM2;RBPJ;GLI1;RUNX1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.45516989211902154,1.4132391955440058,0.02464788732394366,0.6075707142258578,1.0,41/163,16.38%,CD38;INPP5D;MEF2C;PLCG1;PRKD2;PDE4D;PTPRJ;NFKBIZ;DENND1B;FYN;NCK1;PLCG2;PAK2;SH2B2;IKBKB;SKAP1;BTN2A2;BMX;LCK;PSMA2;NFKB1;MALT1;EIF2B5;IKBKG;ICOSLG;RFTN1;PSMA8;PSMA6;RC3H1;CUL1;RELA;RIPK2;BTN3A3;EIF2B2;SLA2;TRAF6;PSME1;SPPL3;ERMAP;LAT;NFKBID
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.526665113385226,-1.4130645224879048,0.06315789473684211,0.44961188672962,1.0,12/22,24.15%,DMD;CACNB2;GNB5;CACNB1;AHNAK;PDE4B;CACNB3;STAC3;CBARP;HPCA;CACNB4;GPR35
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.5812953523572374,1.4130128711972707,0.09870550161812297,0.6066562749320535,1.0,5/29,6.76%,DCUN1D3;FBXW7;DTX3L;SMAD7;TRIB3
prerank,regulation of cellular senescence (GO:2000772),0.5822783245943001,1.4129487364030293,0.08386075949367089,0.6051739505191035,1.0,12/28,18.43%,ABI3;B2M;CDK6;MAP3K3;NEK6;CGAS;NUAK1;AKT3;YBX1;PNPT1;RBL1;YPEL3
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4696660044482182,-1.4123007006796646,0.04857142857142857,0.44960918436564457,1.0,10/38,10.20%,ANK2;CACNA1C;CACNA2D1;CACNA1D;KCND3;CACNB2;CACNA1G;KCNJ2;BIN1;CTNNA3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.4372343897612368,1.4121683930566482,0.009019165727170236,0.6062701561070613,1.0,34/234,8.26%,PRKCH;RPS6KA5;NOD1;CAV1;ESR1;APP;PRKD1;CRTC1;CD200;FZD4;EDN1;ARHGEF2;PRKD2;STAT3;AIM2;TNFRSF11A;TRIM14;NFKBIA;STK3;TRAF1;JMY;PLCG2;TIRAP;IKBKB;CX3CR1;TRIM68;WNT5A;MID2;CD40;TCF3;TRIM25;NFKB1;MALT1;NEUROD1
prerank,epithelial tube morphogenesis (GO:0060562),0.5683092714712369,1.4121366559711614,0.08721804511278196,0.6046869344345891,1.0,12/32,12.88%,MEF2C;ACVRL1;PODXL;RASIP1;PRKD2;SOX17;MTSS1;ACVR1;PKD2;CCM2;RHOB;MET
prerank,JNK cascade (GO:0007254),0.5602240569007295,1.4118265441683986,0.07644305772230889,0.6041093068216383,1.0,16/40,18.73%,NOD1;TNFRSF19;MAP4K3;SH2D3C;MAPK8;MAP3K11;IKBKG;MAP3K13;RIPK2;TRIB1;TRAF6;MAP4K2;TAB3;IRAK2;MAP2K4;MINK1
prerank,response to muramyl dipeptide (GO:0032495),0.6890709044086157,1.4117277446573053,0.10727272727272727,0.6027487600517684,1.0,2/12,2.26%,NOD1;ARHGEF2
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5743852936975495,-1.4115680209291992,0.09397590361445783,0.44935859667554817,1.0,6/16,10.31%,OGT;ARHGAP24;RASGRF1;AUTS2;ALS2;CADM4
prerank,multivesicular body organization (GO:0036257),0.5687350052052504,1.4104304946394204,0.07547169811320754,0.6058600200201834,1.0,6/31,9.89%,RAB27A;RAB11A;CHMP2B;CHMP4A;CHMP4B;VPS28
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5384002890235716,1.409757742957987,0.07142857142857142,0.6064020377322201,1.0,16/40,18.26%,SMURF1;PTK2B;FBXW7;FOXF2;RPS7;PTK2;RNF139;XPO1;GNA12;RPL23;RAD23A;UBE3A;RPL11;DESI1;CSNK2A2;CSNK2A1
prerank,regulation of intracellular signal transduction (GO:1902531),0.41810397027110563,1.4093864014936321,0.004259850905218318,0.606099663598742,1.0,78/420,10.69%,VWF;CHN2;TEK;ARHGAP31;NET1;SGMS1;PPP1R16B;PPP1R13B;MCF2L;ARHGEF3;ARAP3;RASGRF2;PIP5K1B;DAB2IP;ARHGEF2;PDE2A;LYN;PRKD2;BCR;SRGAP3;SRGAP2;DDIT4;RASD2;NFKBIA;BST1;TAOK2;STK3;SRGAP1;PRKAR2B;TRAF1;JMY;PLCG2;TMSB4X;PAK2;PLEKHG5;RHOJ;KALRN;STK4;ARHGAP8;IER3;PREX1;HIPK1;CEACAM1;ARHGAP17;PHF20;XIAP;OPHN1;AURKA;WNT5A;RAC1;TNIK;RPA1;BCL3;PTPMT1;NF2;WWC2;PPP2R5B;GNA12;SLC15A2;DEPDC1B;TAF3;RRS1;TAF4B;ARHGEF7;CRK;ARHGEF26;FBXL2;CDK2;IKBKG;RICTOR;ARHGAP28;BRIP1;MAPK11;OCRL;ARAP2;NUAK1;PRKAB1;HUS1
prerank,regulation of vasculogenesis (GO:2001212),0.6753917405321452,1.4091969866742178,0.1045045045045045,0.6050890338469859,1.0,7/14,13.27%,KDR;CD34;CEACAM1;RAPGEF2;RAP1A;XDH;ASB4
prerank,neurotransmitter secretion (GO:0007269),-0.4565713671472639,-1.409179452197995,0.05263157894736842,0.4535688617858299,1.0,16/44,16.70%,SYT1;BRSK1;SNAP25;NAAA;PCLO;NRXN1;LIN7A;SNPH;PTPRN2;NRXN2;GAD2;SNCA;RIMS1;DVL1;SYN1;PDZD11
prerank,cellular copper ion homeostasis (GO:0006878),0.6672182315274419,1.4089548318218377,0.12313432835820895,0.6043209832335836,1.0,3/14,10.25%,APP;SLC31A1;ATP7B
prerank,muscle cell differentiation (GO:0042692),0.5595880731939532,1.4087227741712887,0.09657320872274143,0.6034813357600011,1.0,5/32,6.81%,MRTFB;TBX1;MEF2C;MRTFA;SYNE1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.47271669832004387,1.4084161507154045,0.04071246819338423,0.602803430777624,1.0,20/113,6.55%,NRP2;TEK;EGFL7;BMPR2;KDR;TBX1;PPP1R16B;PRKD1;PDGFB;VEGFC;PRKD2;HIF1A;RREB1;FLT4;SOX9;XBP1;VEGFD;TCF7L2;WNT5A;NRAS
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.6396599101924971,1.4081379203563584,0.10051107325383304,0.6020944450838739,1.0,10/16,25.23%,CAV1;BCL3;NF2;INPP5F;ADIPOR1;PPP2R1A;PIBF1;LEPROT;VHL;PPP2CA
prerank,anion transport (GO:0006820),0.5740436661432102,1.407575029507272,0.09034267912772585,0.6025814109084918,1.0,4/33,2.47%,SLCO2B1;ABCG2;LRRC8C;LRRC8B
prerank,gluconeogenesis (GO:0006094),-0.4640554535916502,-1.4075614753747703,0.06027397260273973,0.4558522743129918,1.0,20/39,28.11%,RBP4;PPARGC1A;SLC39A14;PER2;ENO2;SLC25A12;GOT1;TPI1;SLC25A13;G6PC3;ENO3;PFKFB1;MDH1;CRY1;PCK2;ALDOA;GOT2;ENO1;ALDOC;MDH2
prerank,signal release from synapse (GO:0099643),-0.45751015068137524,-1.4070638797414792,0.05604719764011799,0.45503552485479004,1.0,16/43,16.70%,SYT1;BRSK1;SNAP25;NAAA;PCLO;NRXN1;LIN7A;SNPH;PTPRN2;NRXN2;GAD2;SNCA;RIMS1;DVL1;SYN1;PDZD11
prerank,cellular potassium ion homeostasis (GO:0030007),-0.6006045571337021,-1.4069184562609833,0.09615384615384616,0.45329183087314956,1.0,6/13,9.89%,ATP1A2;SLC12A2;ATP1B1;KCNMA1;KCNJ2;ATP1B2
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5398059329142058,1.4068107644776853,0.07606973058637084,0.6035302598927692,1.0,8/41,7.27%,TJP1;PIEZO1;PODXL;MAGI1;SMAD7;SKAP1;LCK;JAK1
prerank,ganglion development (GO:0061548),0.688123506204436,1.4063897282151196,0.12104283054003724,0.603230831300756,1.0,1/11,0.07%,NRP2
prerank,positive regulation of cholesterol efflux (GO:0010875),0.5970865821844923,1.4061606038193961,0.11447811447811448,0.6025169296383979,1.0,5/21,5.76%,CAV1;PLTP;NFKBIA;EEPD1;ABCA3
prerank,amino acid import (GO:0043090),-0.5170191913129667,-1.4054398523553915,0.09900990099009901,0.45511126213743064,1.0,6/21,3.63%,SLC6A13;SLC1A3;SLC47A1;SLC6A1;SFXN2;SLC22A4
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5233043796736861,1.4053344799492817,0.05965909090909091,0.6038875022279245,1.0,13/57,8.27%,NOD1;TNFSF10;SOX7;DAPK1;AIM2;PPM1F;FYN;CASP8;FOXL2;CYCS;GRAMD4;MALT1;CASP1
prerank,metanephric mesenchyme development (GO:0072075),-0.6467352084825928,-1.405332253610507,0.11494252873563218,0.4532988774443297,1.0,3/10,5.77%,WNT4;OSR1;SIX1
prerank,establishment of vesicle localization (GO:0051650),0.6249509601221854,1.4051959933942142,0.1035653650254669,0.6027532784282995,1.0,6/18,12.51%,RAB27A;RAB11A;LIMK2;SYNJ1;IKBKG;CCDC186
prerank,ameboidal-type cell migration (GO:0001667),0.524052864452608,1.4050736156175265,0.0629575402635432,0.6015540250490266,1.0,10/51,5.54%,SEMA6A;TBX1;SEMA5B;SEMA7A;SRGAP2;PKN3;PKN2;PDLIM1;PKN1;SEMA6B
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.45743954374347806,1.4050695572191967,0.026862026862026864,0.5999467793707645,1.0,24/138,5.59%,TEK;PTPRG;FLT1;BMPR2;KDR;IL6ST;TIE1;LIFR;EPHB4;INSR;NEDD9;LYN;NPR1;PTK2B;YES1;MPZL1;MTSS1;FYN;SRMS;FLT4;LMTK2;JAK3;ACVR2A;RET
prerank,ganglioside biosynthetic process (GO:0001574),0.6466774467307989,1.4048363673781263,0.10363636363636364,0.5991833544392006,1.0,5/15,10.19%,ST6GALNAC3;ST3GAL1;ST8SIA4;B4GALT5;ST6GALNAC4
prerank,vesicle transport along actin filament (GO:0030050),0.6240852993460962,1.4048228630708983,0.11222780569514237,0.5976164941312099,1.0,5/19,10.61%,FNBP1L;MYO1D;ACTN4;MYO1E;MYO1C
prerank,endocardial cushion morphogenesis (GO:0003203),0.635412085301062,1.4047035991197883,0.11418685121107267,0.5964606975752275,1.0,6/18,6.28%,NOS3;ENG;ACVRL1;NOTCH1;SOX9;ACVR1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6799974298896849,1.404246441221856,0.12781954887218044,0.5964625373473651,1.0,3/10,6.14%,PIEZO1;PODXL;SKAP1
prerank,detection of visible light (GO:0009584),0.6370910576004314,1.4042407073803709,0.10714285714285714,0.5948986088051169,1.0,3/16,6.96%,GNAQ;CNGB1;GNAT1
prerank,lipoprotein localization (GO:0044872),-0.6284112686323541,-1.404236070287955,0.09333333333333334,0.4543355063601569,1.0,8/11,30.46%,LRP1;PRKCB;MIA3;UNC119B;PPARG;ZDHHC3;CD36;UNC119
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4179451663285332,1.403978984480853,0.003121748178980229,0.5942704420235105,1.0,76/497,11.57%,MECOM;LEF1;ELK3;RPS6KA5;FOXO1;NANOS3;CD38;HDAC9;ATP8B1;DACH1;ZHX3;BMPR2;SMARCA2;PPARD;CBFA2T3;ZBTB16;SOX7;ACVRL1;DAPK1;AHR;PDGFB;FOXP1;DAB2IP;SOX13;HHEX;NR3C1;NOTCH1;PPM1F;PLCB1;SOX18;HMBOX1;SOX9;IGF2BP3;VGLL4;SCMH1;FOXL2;ID1;EPC1;PTPRK;NANOS2;SBNO2;TCF7L2;WNT5A;ATF7IP;RCOR1;KLF10;INPP5K;CDKN1B;TRIB3;TGFB1;BCL3;GRB7;GATAD2A;RNF139;CTBP1;CITED1;KAT6B;FOXK1;MYBBP1A;YEATS2;BTG2;RPL13A;CNOT1;SFRP2;FOXN3;SMARCE1;TFAP4;GAS6;POU2F1;SPEN;RBM15;RB1;ZMYND11;MRPL13;EID1;SP3
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.6486970805026216,1.4038834355590621,0.1252236135957066,0.5930688598112989,1.0,5/13,12.18%,IL6ST;STAT3;IL27RA;JAK1;OASL
prerank,positive regulation of protein phosphorylation (GO:0001934),0.4284397952189619,1.4028233182096317,0.00760043431053203,0.5951804233165351,1.0,60/348,7.98%,TEK;RPS6KA5;LIMCH1;PECAM1;BMPR2;KDR;ENG;CAV1;TBX1;APP;PDE8A;RBPMS;IL15;ACVRL1;PRKD1;INSR;PDGFB;VEGFC;IQGAP1;IL6R;ARHGEF2;LYN;PRKD2;FAS;EFNA1;PDGFD;PTK2B;FNIP2;PTPRJ;TAOK2;FLT4;PLCG2;PAK2;FGF23;SOX9;SH2D3C;STK4;RALB;SDCBP;VEGFD;GHR;ACVR2A;CX3CR1;ENPP2;ATP2B4;LIMK2;RAPGEF2;ACVR1;KRAS;CD40;RAC1;BCAR3;PDGFC;ARRB1;TNIK;TGFB1;PTK2;RAP1A;NIBAN1;ITGA5
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.4164042462179064,1.4027481357239093,0.0010362694300518134,0.5938275656961568,1.0,109/509,12.95%,VWF;TEK;FLT1;NOD1;TNFSF10;TGM2;KDR;ENG;CAV1;TBX1;ESR1;APP;TNFRSF19;PRKD1;INSR;KITLG;PDGFB;HIP1;IQGAP1;DAB2IP;LYN;PRKD2;JCAD;MFHAS1;PDGFD;TRIM14;RASD2;PTPRJ;FYN;ACTN4;CASP8;FKBP1A;FLT4;PLCG2;CAV2;SELP;RPS15;FGF23;SOX9;PLEKHG5;TIRAP;F7;EDAR;IKBKB;CX3CR1;TRIM68;PELI1;RET;PLK2;TCF7L2;USP15;BOK;RPS20;WNT5A;RAPGEF2;MID2;CD40;RAC1;SASH1;TRIB3;BCL2L11;BCAR3;PDGFC;LCK;TNFRSF1A;TGFB1;ATP2C1;PIK3CG;PTK2;TGFA;NEDD4;TRIM25;NOS1AP;MAP3K3;GAB1;MALT1;CASP1;RPTOR;AKT2;NEK6;RPL23;BRD4;IKBKG;RICTOR;CGAS;PUM1;IL23A;BCL2L1;SIAH1;LARS1;SEMA4D;NMI;GAS6;CBL;MC1R;P2RY12;PUM2;IRAK4;RIPK1;BID;OASL;CARD16;MIER1;RELA;RIPK2;RACK1;BIRC3;MET;HSP90AB1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4847718605919082,1.4027287785023712,0.05555555555555555,0.5923242479742646,1.0,16/72,7.33%,NET1;HEG1;F11R;EPS8;ARHGEF3;RASIP1;ARHGEF2;CCDC125;BCR;PRAG1;ADGRG1;KCTD10;OPHN1;RAC1;ARRB1;ITGA3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4206785905242409,1.4021930582480082,0.00866738894907909,0.5925850128318595,1.0,94/366,18.01%,RPS6KA5;NANOS3;ENG;SLC39A8;APBB2;ESR1;SMARCA2;APP;MEF2C;SOX7;ACVRL1;NR5A2;INSR;AHR;IRF2;SOX13;STAT3;NR3C1;NOTCH1;HIF1A;RREB1;SOX17;WWTR1;CHD7;SOX18;TCF7L1;LIN54;SPIN1;EIF4E;SBNO2;MTF2;JMJD1C;TEAD2;CCDC88A;PITX3;ESRRG;CNBP;ASCC1;LYL1;FOXN2;TCF3;HNRNPD;WWC2;ZNF2;CREM;KAT6B;PRDM8;MYBBP1A;HINT1;SOX4;MAFB;BACH1;FOXN3;RBM3;BTG1;RB1;SP3;CYFIP1;PRDM2;RELA;UTP4;GLRX2;RPL6;RPL10;MTPN;ESRRB;DMTF1;ZSCAN21;ACVR2B;ERC1;NFKB2;RYBP;ZNF423;ORC5;YBX1;ATRX;HMG20A;DDIT3;RPS6KA4;NR2C2;ZFPL1;GPBP1L1;ORC3;ACTR5;HP1BP3;CHEK2;CASZ1;CXXC1;RFX3;ZSCAN26;PHF19;MLXIPL;MLX;PFDN5
prerank,negative regulation of proteolysis (GO:0045861),-0.4769895701527797,-1.4011636934107496,0.055710306406685235,0.4604898870972775,1.0,9/34,11.32%,TIMP3;TIMP2;GAS1;SERPINE2;LRRK2;ECM1;CAMK2N1;PLAT;CST3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7020694122827947,1.4006210699542514,0.12408759124087591,0.5963146711148642,1.0,2/10,2.14%,SEMA6A;DAB2IP
prerank,cellular metal ion homeostasis (GO:0006875),-0.3852438440909883,-1.4002784971697362,0.017699115044247787,0.46082519729164934,1.0,19/102,9.89%,ATP1A2;SLC24A3;ANK2;ATP13A5;ATP13A3;SLC8A3;SLC41A1;SLC12A2;ATP1B1;SLC8A1;KCNMA1;DMPK;STIM1;KCNJ2;ATP2A2;RYR2;CXCL12;SLC24A2;ATP1B2
prerank,ribosomal small subunit assembly (GO:0000028),0.6357435861673028,1.4002441654247917,0.11418685121107267,0.5961084070240359,1.0,5/16,10.96%,RPS15;RPS19;RPS14;RPSA;RPS27
prerank,endocrine system development (GO:0035270),-0.5183806334256913,-1.3998501298505388,0.095,0.45996618864953986,1.0,11/21,16.95%,GLI2;WNT4;DKK3;TGFBR1;SALL1;NF1;SIX1;STRA6;WNT11;PAX8;MDK
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.6290253695892795,1.3998127171574326,0.10217755443886097,0.5959907511151038,1.0,5/18,10.90%,IL6ST;IL6R;STAT3;JAK1;CBL
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5765226960903492,1.3994502644723474,0.10344827586206896,0.595639059462908,1.0,11/28,18.28%,NOD1;CASP8;IKBKG;RELA;RIPK2;TRAF6;OTULIN;TAB3;IRGM;IRAK2;AAMP
prerank,amide biosynthetic process (GO:0043604),0.5332776201922392,1.3993378409649926,0.0821917808219178,0.5944564417755155,1.0,8/47,5.90%,SPTLC2;SGMS1;DEGS2;CERS4;SPTLC3;SPTSSA;ASAH2;PAM
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5518265328047249,1.3989978556450344,0.09908536585365854,0.5940562299660741,1.0,9/35,9.93%,CDK6;LYN;TAL1;STAT3;HIF1A;ACVR2A;ZFPM1;MAFB;MAPK11
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5034539575472482,1.3985055987806156,0.07334273624823695,0.5941291620960151,1.0,16/66,15.21%,APP;FOXP1;STAT3;GBP5;AIM2;CASP8;CX3CR1;WNT5A;LPL;MALT1;CASP1;CARD16;RIPK2;GSTP1;PANX1;TRIM16
prerank,cellular response to interleukin-6 (GO:0071354),0.5895953493153345,1.3981975389924395,0.09470304975922954,0.5936859341755261,1.0,7/26,7.86%,ST3GAL6;IL6ST;IL6R;STAT3;SBNO2;JAK1;NFKB1
prerank,positive regulation of dendrite development (GO:1900006),-0.6258060558689335,-1.3976650201019967,0.11642411642411643,0.4639079387741287,1.0,5/10,10.02%,PTN;BMP5;BMP7;COBL;ALK
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.5515522242703916,1.3973893313201162,0.09006211180124224,0.5950388736733524,1.0,15/37,19.51%,ENTPD1;ISG20;RNASEH2A;MTREX;HNRNPD;NUDT16;RNASEH2C;RNASEH2B;NUDT15;XRN2;PNPT1;ENTPD3;NUDT1;ADPRM;NUDT9
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6540965350851097,1.3971612980419996,0.1140819964349376,0.5943322925063146,1.0,8/15,21.70%,JMY;ARPC3;ARPC1B;ACTR2;ACTR3;ARPC2;WHAMM;ARPC4
prerank,embryonic hemopoiesis (GO:0035162),0.6795011752871127,1.3971417557616117,0.10873440285204991,0.5928682336508015,1.0,3/12,2.32%,KDR;KITLG;TAL1
prerank,presynapse organization (GO:0099172),-0.6365347059784361,-1.397045593384083,0.11064718162839249,0.4634993153289854,1.0,6/10,15.84%,NLGN2;LRRTM3;NLGN1;NLGN3;FZD1;DVL1
prerank,protein oxidation (GO:0018158),-0.6376394617598331,-1.3969817309900556,0.10093896713615023,0.46155888722642396,1.0,3/11,6.86%,LOXL1;LOXL3;LOX
prerank,T cell receptor signaling pathway (GO:0050852),0.45744879483602185,1.396348379819958,0.04399524375743163,0.5940552379119484,1.0,46/138,21.40%,INPP5D;PLCG1;PRKD2;PDE4D;PTPRJ;NFKBIZ;DENND1B;FYN;NCK1;PLCG2;PAK2;IKBKB;SKAP1;BTN2A2;LCK;PSMA2;NFKB1;MALT1;EIF2B5;IKBKG;ICOSLG;RFTN1;PSMA8;PSMA6;RC3H1;CUL1;RELA;RIPK2;BTN3A3;EIF2B2;TRAF6;PSME1;SPPL3;ERMAP;LAT;NFKBID;PSMA4;PSMF1;PAK1;BCAR1;CD276;BCL10;PSMB7;PSMB1;PSMD2;BTNL9
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.6389597520451218,1.3960497624120856,0.10806174957118353,0.593639137761709,1.0,2/16,1.82%,BMPR2;PRCP
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5437870182832807,-1.3954316632326549,0.09620253164556962,0.4638181126582815,1.0,4/18,5.19%,IGF1;IGFBP2;IL18;IGF2
prerank,eye morphogenesis (GO:0048592),-0.5359411837696447,-1.3945423459673894,0.10321100917431193,0.4641417573897937,1.0,8/19,9.30%,FBN1;COL5A1;EFEMP1;MFAP5;TENM3;FBN2;NF1;VEGFA
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.4303462058146242,-1.3942361317500644,0.04220779220779221,0.46277783104151105,1.0,19/51,14.51%,DCLK1;GAS7;NBL1;EPB41L3;BMP7;NRK;ALS2;CNTNAP2;TAOK3;SHTN1;NGF;LRRK2;PLXNB1;DTNBP1;WASF1;DBN1;ANKRD27;CTTN;CNTNAP1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.6583534461483652,1.3936903860761447,0.12164579606440072,0.6001771624474385,1.0,7/14,19.51%,ENTPD1;NUDT16;NUDT15;ENTPD3;NUDT1;ADPRM;NUDT9
prerank,regulation of protein kinase A signaling (GO:0010738),-0.520414659436681,-1.3936099298301794,0.11825192802056556,0.4625401125723208,1.0,9/20,16.62%,ADGRV1;AKAP12;AKAP7;AKAP6;LRRK2;PRKAR1B;PRKAR1A;TCIM;PJA2
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.5345073486911098,-1.391832191687417,0.09925558312655088,0.46500748495090655,1.0,5/18,8.61%,PRKN;IRS1;CCN3;ADRA2A;SFRP1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6980482474587041,1.3917774359950459,0.13274336283185842,0.6050268806459748,1.0,5/11,18.16%,NFKBIZ;MALT1;IL23A;NFKBID;CARD9
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.5016934892219701,1.391225385438029,0.07052186177715092,0.6054225397255592,1.0,15/67,13.55%,TBC1D8;ATP8B1;CAV1;PPP1R16B;PODXL;TBC1D22A;TBC1D15;RAC1;TBC1D2;TWF2;FSCN1;TBC1D5;EVI5;RAB5A;FMR1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.46349393843581926,-1.390862893161212,0.06521739130434782,0.4655873558380806,1.0,16/38,18.63%,ANK2;FHL1;ACTN2;KCNMA1;DLG1;AKAP6;KCNMB2;KCNJ2;ADRA2A;GABBR1;KCNJ10;KCNN2;GNG2;KCNJ15;KCNJ6;KCNN3
prerank,substrate-dependent cell migration (GO:0006929),0.6584239494008721,1.3908333856315735,0.11131725417439703,0.6051906450332789,1.0,8/14,11.16%,NTN1;ANKS1A;CD2AP;VEGFC;SDCBP;OPHN1;P2RY12;ITGA2
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.6380254623271471,-1.390372289816735,0.11764705882352941,0.46482842182130535,1.0,3/10,2.47%,ATP1A2;OSR1;HECW2
prerank,response to estrogen (GO:0043627),0.565752071122858,1.3894670118560182,0.11410459587955626,0.6081905262213362,1.0,10/31,14.57%,CAV1;ESR1;SERPINB9;NCOA4;TRIM25;CITED1;TRIM24;CYP27B1;ASH2L;PELP1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6176270932136352,1.3894435102145202,0.11714770797962648,0.6067631383085997,1.0,7/18,12.88%,HEG1;RASIP1;CCDC125;KCTD10;ITGA3;ABL2;MET
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.5267282766889697,1.3888980438578689,0.09899569583931134,0.6072055580731519,1.0,10/47,7.86%,CAV1;FBXW7;SIK1;FYN;CD34;CEACAM1;ATP2B4;RAPGEF2;TRIB3;NFKB1
prerank,Golgi localization (GO:0051645),-0.630807750007855,-1.3886497346929,0.09782608695652174,0.4672220442527493,1.0,3/11,12.74%,ARHGAP21;COPG1;ARCN1
prerank,protein localization to chromatin (GO:0071168),0.6455061911729478,1.3885723645688566,0.12436115843270869,0.6067886069605939,1.0,9/18,22.93%,ESR1;TASOR;PPHLN1;MCM9;PIH1D1;RAD21;MSH2;PLK1;NIPBL
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.633103449063868,1.3884216424596287,0.125,0.6058106359340465,1.0,1/15,0.26%,ENTPD1
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.6269215983781895,-1.3878046045546784,0.12387387387387387,0.46743457377333447,1.0,3/10,4.58%,ACTN2;SEMA5A;CARMIL1
prerank,regulation of endopeptidase activity (GO:0052548),-0.42595805594807334,-1.3869091134250613,0.040268456375838924,0.467939131384981,1.0,11/59,12.41%,TIMP3;SERPING1;VTN;TIMP2;SERPINH1;SERPINE2;SERPIND1;SERPINF1;APH1B;SERPINE1;SPOCK3
prerank,peptidyl-serine phosphorylation (GO:0018105),0.44907260479745315,1.3857194224851883,0.040865384615384616,0.613509941065693,1.0,38/153,13.03%,PRKCH;RPS6KA5;ERN1;PRKD1;PDGFB;PRKD2;PKN3;PKN2;PAK2;PKN1;RPS6KA3;STK4;LMTK2;MARK3;IKBKB;RPS6KA1;HIPK1;MAPK8;PLK2;MAST2;ULK1;AURKA;DYRK1A;SGK3;AKT2;NEK6;CDK2;RICTOR;MAPKAPK3;GAS6;AKT3;MAP3K13;STK38;RIPK1;MKNK2;TGFBR2;TOP1;UHMK1
prerank,regulation of muscle contraction (GO:0006937),-0.5108713095879436,-1.3851911125251015,0.09302325581395349,0.4705928869595843,1.0,7/26,9.30%,ATP1A2;PLCE1;KCNB2;TPM1;ANXA6;MYL9;PPP1R12B
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.615657950600728,1.385086592440417,0.12283737024221453,0.6142322916119825,1.0,6/17,11.16%,PIEZO1;PODXL;RET;SKAP1;SFRP2;P2RY12
prerank,blood circulation (GO:0008015),0.5180906744339302,1.384803930977484,0.08357348703170028,0.6136106871097117,1.0,7/49,5.28%,TBC1D8;NOS3;MYOF;ACVRL1;NPR1;ELN;DLL4
prerank,positive regulation of locomotion (GO:0040017),0.5819627023996518,1.3847167597525436,0.09618320610687023,0.6124216595268376,1.0,8/27,11.16%,NTN1;STX3;PDGFB;PPM1F;CAVIN1;TGFB1;AKT2;P2RY12
prerank,response to cytokine (GO:0034097),0.45364618246440797,1.384683018435573,0.04039167686658507,0.6110092711112004,1.0,30/141,10.51%,IL1R1;LEF1;PTPN14;IL6ST;LIFR;APP;GCH1;PTPN12;IL6R;OSMR;ADAM10;STAT3;TNFRSF11A;MAP4K3;SELE;CASP8;SIGIRR;SELP;JAK3;MAPK8;ASAH2;IFNAR2;CD40;CASP1;CITED1;RELB;BCL2L1;MAPKAPK3;CYP27B1;CXCR4
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.41961839308736576,1.384595034707771,0.015521064301552107,0.609878625561141,1.0,88/327,18.08%,RPS6KA5;ENG;SLC39A8;APBB2;ESR1;SMARCA2;MEF2C;SOX7;ACVRL1;NR5A2;INSR;AHR;IRF2;SOX13;STAT3;NR3C1;NOTCH1;HIF1A;RREB1;SOX17;ACTN4;WWTR1;CHD7;SOX18;TCF7L1;LIN54;SPIN1;SBNO2;MTF2;JMJD1C;TEAD2;PITX3;ESRRG;CNBP;ASCC1;LYL1;FOXN2;TCF3;HNRNPD;WWC2;ZNF2;CREM;KAT6B;PRDM8;MYBBP1A;HINT1;SOX4;MAFB;BACH1;COPS2;FOXN3;BTG1;ZMIZ1;RB1;SP3;PRDM2;RELA;UTP4;GLRX2;RPL6;ESRRB;DMTF1;ZSCAN21;ACVR2B;ERC1;NFKB2;RYBP;ZNF423;YBX1;ATRX;HMG20A;DDIT3;RPS6KA4;NR2C2;ZFPL1;GPBP1L1;ACTR5;HP1BP3;CHEK2;CASZ1;CXXC1;RFX3;ZSCAN26;PHF19;MLXIPL;MLX;PFDN5;RALY
prerank,regulation of interleukin-4 production (GO:0032673),0.6097021743150866,1.384278031656164,0.09965635738831616,0.6094376617590084,1.0,1/21,0.13%,LEF1
prerank,modulation by symbiont of host process (GO:0044003),0.6806717302786285,1.3839210675349212,0.12290502793296089,0.6091062011274592,1.0,1/10,1.56%,B2M
prerank,regulation of actin filament-based movement (GO:1903115),-0.6254678108001506,-1.383709297523291,0.1328976034858388,0.4725558013696869,1.0,2/10,1.60%,ANK2;PDPN
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.648538692845817,1.3836334802941308,0.12224108658743633,0.6086182417766163,1.0,4/13,3.07%,ESR1;PLPP1;NR3C1;ABHD2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6524239595080076,1.3835237206907234,0.15087040618955513,0.6075119274791732,1.0,2/11,2.36%,CAV1;NEDD4L
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.6556189358648608,1.383373108455672,0.12259194395796848,0.6065962022261555,1.0,3/14,3.22%,PRKD1;LIMS2;BST1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.6052328617313243,1.3827570700995406,0.12357723577235773,0.607153249440707,1.0,5/19,16.67%,MAOB;PXDN;CAT;PRDX2;PRDX1
prerank,negative regulation of cellular component movement (GO:0051271),0.6257247952940741,1.381586293961572,0.12093862815884476,0.6096094026377324,1.0,3/15,4.27%,FRMD5;CCDC125;ACTN1
prerank,positive regulation of nervous system process (GO:0031646),0.6144438791664655,1.3815399856097097,0.13079470198675497,0.6083273760711193,1.0,3/18,3.04%,UNC13B;PARD3;TNFRSF1B
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4862003165932311,1.3813006792189193,0.0642570281124498,0.6077376669616125,1.0,11/75,5.49%,SEMA6A;TEK;CLDN5;PTPRM;ECSCR;DAB2IP;HHEX;STAB1;NPR1;GTF2I;ATP2B4
prerank,regulation of cellular localization (GO:0060341),-0.44116376512956623,-1.3809446396340364,0.06172839506172839,0.47794076684653103,1.0,10/46,7.59%,ADCY5;GSN;EFNA5;PRKN;PARD6G;MAP2;BRSK1;HSP90AA1;STXBP4;LRRK2
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.5699306744245353,-1.3804475499696562,0.11722488038277512,0.47733302981354353,1.0,5/14,13.23%,SEC24D;SEC31A;SEC23A;MIA3;TBC1D20
prerank,cellular response to inorganic substance (GO:0071241),0.6037616224423231,1.380189360845063,0.10590277777777778,0.6098739773990103,1.0,9/21,16.92%,FOXO1;CDK2;AOC1;FMR1;DDI1;ATRX;MTR;DDI2;SPIDR
prerank,negative regulation of protein kinase activity (GO:0006469),0.4806775305584144,1.3801214742331958,0.06299212598425197,0.6086429852541206,1.0,23/88,14.04%,PTPRB;GNAQ;CAV1;ADARB1;DAB2IP;LRP5;PPM1F;WWTR1;PAK2;CEACAM1;INPP5K;CDKN1B;TRIB3;PTPN1;SFN;ADAR;RB1;CORO1C;GSTP1;WARS1;TRIB1;GSKIP;NPM1
prerank,cellular glucose homeostasis (GO:0001678),0.542229708009614,1.3800808184234177,0.08702290076335878,0.6073429568860242,1.0,12/41,13.47%,FOXO1;UNC13B;ERN1;HIF1A;KCNB1;XBP1;FOXA3;FOXK1;SOX4;GAS6;RACK1;IGF1R
prerank,regulation of sensory perception of pain (GO:0051930),-0.5882253330294283,-1.37994677485715,0.12222222222222222,0.47664220542770636,1.0,3/11,6.82%,CCN3;TMEM100;MGLL
prerank,receptor internalization (GO:0031623),0.5264712122403985,1.3795849435313843,0.09037037037037036,0.6075777983192351,1.0,11/44,13.44%,DNM3;CALCRL;CAV1;CEACAM1;RAMP2;ARRB1;NEDD4;SCYL2;PICALM;RAB31;RAB5A
prerank,modulation by host of symbiont process (GO:0051851),0.5585180822955527,1.379105924720768,0.10407239819004525,0.6078338871540458,1.0,11/31,19.88%,LEF1;CX3CR1;INPP5K;CHD1;TFAP4;SNW1;RRP1B;CTDP1;CARD9;SAP30BP;SP1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5252264080740259,-1.3790774256749916,0.09876543209876543,0.4769158456511632,1.0,9/20,11.80%,ATP1A2;SLC12A2;ATP1B1;SLC8A1;KCNMA1;KCNJ2;ATP1B2;SLC9A1;LACC1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.5855903633715522,-1.3788051716734107,0.11316397228637413,0.47576473209385933,1.0,8/14,20.84%,IRS1;PPARGC1A;IRS2;SLC45A3;PTPN2;DDB1;GPLD1;NNMT
prerank,cell-cell junction maintenance (GO:0045217),0.682773786039819,1.3785939644639442,0.1410488245931284,0.6081755029799791,1.0,1/11,0.28%,TJP1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.5034555285527171,1.3784993218524275,0.08123249299719888,0.6071211697056066,1.0,18/55,15.95%,TNFSF10;CAV1;DAB2IP;FAS;TPD52L1;PAK2;BOK;BCL2L11;LCK;CRADD;BCL2L1;SIAH1;RIPK1;BID;RACK1;S100A9;DDIT3;BMF
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.5274109809231314,-1.3779444779032022,0.10779816513761468,0.4760473231850303,1.0,9/20,20.34%,GRK3;BICD1;GPRASP1;RPGRIP1L;SNCA;PLEK;CRY1;RNF157;MRAP2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5538710869084875,1.3774918314417242,0.11388455538221529,0.6091153784899661,1.0,8/33,7.33%,MEF2C;ACVRL1;MMRN2;NOTCH1;CARD10;DLL4;ATP2B4;TGFB1
prerank,cellular response to growth factor stimulus (GO:0071363),0.45132701173163997,1.3766366700395711,0.039951573849878935,0.6105859841545447,1.0,32/151,7.53%,SEMA6A;FLT1;BMPR2;KDR;TBX1;PDE8A;MEF2C;ERN1;ACVRL1;PRKD1;PLCG1;PDGFB;PTPN12;IQGAP1;DAB2IP;PDE2A;PRKD2;NR3C1;NOTCH1;FLT4;SOX9;SMAD7;ACVR2A;DLL4;RAMP2;DUSP22;WNT5A;RAPGEF2;ACVR1;INPP5K;TGFB1;RAP1A
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.597777711598277,-1.3765853088159896,0.12045454545454545,0.4777533156110621,1.0,5/12,13.82%,NINL;BICD1;KIF3A;PCM1;BICD2
prerank,regulation of viral entry into host cell (GO:0046596),0.5520531900864691,1.376337720885321,0.10317460317460317,0.6101594185206224,1.0,8/30,7.85%,LY6E;TRIM14;NECTIN2;TRIM68;PTX3;MID2;SNX3;TRIM25
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5940053137727074,-1.3758830924054224,0.12903225806451613,0.4778300299866312,1.0,6/12,25.99%,INSIG2;KDELR3;GPAA1;INSIG1;RER1;HSPA5
prerank,negative regulation of cytokine production (GO:0001818),0.4400692849438145,1.375073286171231,0.037259615384615384,0.6128478282914908,1.0,24/163,7.85%,LEF1;RPS6KA5;HDAC9;RNF125;CD200;NLRC5;HDAC7;CD34;SIGIRR;HOMER2;TMSB4X;UBA7;DLL1;JAK3;CEACAM1;N4BP1;CUEDC2;BTN2A2;TIGIT;RAC1;SRGN;ARRB1;BCL3;TRIM25
prerank,actin filament-based transport (GO:0099515),0.5978021807624996,1.3747655863594257,0.1299342105263158,0.6123984456776816,1.0,5/21,10.61%,FNBP1L;MYO1D;ACTN4;MYO1E;MYO1C
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6982663484084718,1.3747428145301834,0.1400709219858156,0.6110491180699031,1.0,2/10,5.12%,PRKG1;CEACAM1
prerank,defense response to bacterium (GO:0042742),0.46508725538744766,1.374619185595118,0.04681404421326398,0.6100003283670435,1.0,16/105,9.61%,NOD1;IL6R;STAB1;GBP4;SELP;TIRAP;RPS19;LCN2;GBP7;RPL39;DROSHA;PGLYRP2;LYG2;ANG;DEFA6;IL23A
prerank,defense response to protozoan (GO:0042832),0.6673826879035855,1.3742402160910236,0.13082437275985664,0.6098178403848907,1.0,3/12,6.60%,GBP4;GBP7;CD40
prerank,replicative senescence (GO:0090399),-0.6012993570618403,-1.3734946501136993,0.12200435729847495,0.4821705934527092,1.0,8/12,23.99%,PLA2R1;SERPINE1;WNT16;ATR;TP53;CHEK1;TERT;ATM
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.6734451001872991,1.373303578639816,0.1615798922800718,0.6113430623620767,1.0,5/12,10.95%,SMCHD1;CDYL;PCGF5;YTHDC1;RBM15
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5890328636285209,-1.3727393792085254,0.11751662971175167,0.4822658298374158,1.0,5/13,14.40%,DDO;GLUL;ASPA;GOT1;QPRT
prerank,regulation of DNA repair (GO:0006282),-0.4369399129871452,-1.372710324564563,0.06725146198830409,0.48036047188133635,1.0,4/44,1.86%,EYA2;EGFR;EYA1;EYA4
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5741734166914438,-1.372460317119322,0.09544468546637744,0.4791320370595322,1.0,7/14,14.96%,DMD;ATP1B1;WNK4;ANK3;WNK1;SLC9A1;WNK3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.42399424122634816,1.3717641180201872,0.023622047244094488,0.6149724703548147,1.0,48/259,11.69%,ABCC4;FGD5;DNM3;PARVB;ABLIM1;FNBP1L;EXOC6;NTN1;EHD4;CD2AP;FGD6;RAB11A;SRGAP2;S1PR1;NOTCH1;CNGB1;SPATA13;RAP1B;MTSS1;SSX2IP;PPP1R9B;DISC1;SDCBP;CEP41;CCDC88A;OPHN1;RAPGEF2;PCNT;INPP5K;RAC1;BBIP1;STK26;TNIK;RAP1A;EHD2;DYNLL1;EXOC5;ARHGEF7;TEKT5;EXOC4;OCRL;CEP83;ANO6;FSCN1;ARL13B;P2RY12;EHD3;CYFIP1
prerank,pyroptosis (GO:0070269),0.6211482968785353,1.371411045178847,0.1528776978417266,0.6146714066661042,1.0,4/15,8.27%,AIM2;CASP4;CASP8;CASP1
prerank,regulation of myotube differentiation (GO:0010830),0.5787979999242469,1.3713280972480113,0.12379421221864952,0.6135277344448082,1.0,6/24,8.15%,HDAC9;PIEZO1;NOTCH1;SIK1;XBP1;ATP11A
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6290375508065771,1.3708077836682035,0.1457975986277873,0.614018216285104,1.0,7/15,20.73%,DTX3L;SMAD7;RPS7;RPL23;MAD2L2;RPL11;BAG2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5822726399476599,1.3705996454020264,0.12351945854483926,0.613374304803519,1.0,8/24,18.28%,NOD1;CASP8;IKBKG;RIPK2;TRAF6;TAB3;IRAK2;AAMP
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.4866945682267482,-1.3699043773290276,0.11081794195250659,0.48428396324010725,1.0,9/23,16.95%,GJA1;BMP4;FGF2;SIX1;VEGFA;SMO;PIK3CD;PAX8;MDK
prerank,histone H3 acetylation (GO:0043966),0.5253854786365688,1.3697921457918016,0.11532625189681335,0.6146796586380682,1.0,10/40,15.21%,LEF1;JADE2;JADE1;KAT6B;JADE3;YEATS2;KAT2B;MBIP;KAT6A;TRIM16
prerank,positive regulation of B cell activation (GO:0050871),0.5130207204444944,1.3691886253659156,0.09064748201438849,0.615259515269306,1.0,11/50,11.13%,CD38;MEF2C;BST1;TIRAP;XBP1;SHLD1;CD40;TNFRSF13C;MAD2L2;CD320;IL7
prerank,endoderm development (GO:0007492),0.6489685048506371,1.3682928650335016,0.13120567375886524,0.6168827976051792,1.0,4/13,14.85%,SOX7;SOX17;KIF16B;DUSP2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4414219054388002,1.3682716075910695,0.05608591885441527,0.6155716985059133,1.0,16/152,6.96%,ADGRG6;ADGRL4;CALCRL;GNAQ;ADGRL2;ADCY4;WASF2;PDE2A;S1PR1;ADGRG3;ADGRE5;ADGRG1;GNAI2;RAMP2;MCHR1;GNAT1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5320978234649535,1.3679792025502535,0.11232449297971919,0.6151374327762104,1.0,14/36,14.10%,NLRC5;EDN1;HIF1A;CASP4;WNT5A;AGPAT1;CASP1;CSF1;CXCR4;GAS6;IL7;RIPK1;ADAM17;UBE2K
prerank,icosanoid secretion (GO:0032309),0.6611693078091785,1.3668260232123264,0.13773584905660377,0.6175859985811051,1.0,1/12,0.17%,ABCC4
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.45839525033127054,1.3668013050381946,0.05851755526657997,0.6149276534505556,1.0,32/104,21.23%,RPS6KA5;LYN;ICAM2;FYN;PLCG2;PAK2;IKBKB;KRAS;NRAS;PSMA2;NFKB1;MALT1;RELB;IKBKG;PSMA8;PSMA6;CUL1;MUC1;RELA;TRAF6;PSME1;TAB3;PSMA4;CARD9;PRKACB;PSMF1;PAK1;BCL10;PSMB7;PSMB1;MUC6;PSMD2
prerank,cellular response to lectin (GO:1990858),0.45839525033127054,1.3668013050381946,0.05851755526657997,0.6149276534505556,1.0,32/104,21.23%,RPS6KA5;LYN;ICAM2;FYN;PLCG2;PAK2;IKBKB;KRAS;NRAS;PSMA2;NFKB1;MALT1;RELB;IKBKG;PSMA8;PSMA6;CUL1;MUC1;RELA;TRAF6;PSME1;TAB3;PSMA4;CARD9;PRKACB;PSMF1;PAK1;BCL10;PSMB7;PSMB1;MUC6;PSMD2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5160074167822116,1.3661155665558586,0.10294117647058823,0.6156339626394084,1.0,9/46,7.27%,LCP1;MSN;RAP1B;PLCB1;PAK2;HNRNPF;CA1;MTAP;JAK1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.4569485364867809,1.365611240157128,0.0609597924773022,0.6160164991906696,1.0,32/105,21.23%,RPS6KA5;LYN;ICAM2;FYN;PLCG2;PAK2;IKBKB;KRAS;NRAS;PSMA2;NFKB1;MALT1;RELB;IKBKG;PSMA8;PSMA6;CUL1;MUC1;RELA;TRAF6;PSME1;TAB3;PSMA4;CARD9;PRKACB;PSMF1;PAK1;BCL10;PSMB7;PSMB1;MUC6;PSMD2
prerank,determination of left/right symmetry (GO:0007368),0.5345029531480114,1.3653838880535165,0.09662576687116564,0.6154702645242821,1.0,6/36,8.36%,TBX1;ZIC3;NOTCH1;DLL1;PKD2;CFAP53
prerank,phasic smooth muscle contraction (GO:0014821),0.6707725518818897,1.3646299991070079,0.14953271028037382,0.6166716428130329,1.0,2/10,15.59%,EDN1;HTR1D
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.514712131104978,-1.3644449841402604,0.0870712401055409,0.4976487178401414,1.0,5/22,9.84%,AEBP1;AKAP13;MAP2;EFEMP2;APOE
prerank,ureteric bud morphogenesis (GO:0060675),-0.5332016128356007,-1.3630478896384484,0.11032863849765258,0.4997497897650678,1.0,7/16,15.88%,BMP4;FGF2;SALL1;SIX1;NPNT;WNT11;PAX8
prerank,positive regulation of interferon-gamma production (GO:0032729),0.5142005669374256,1.3626573056639775,0.10218978102189781,0.6219037280084049,1.0,5/48,10.01%,IL1R1;PDE4D;ZFPM1;IL23A;CYRIB
prerank,glucose import (GO:0046323),0.6597571862585838,1.3621579604347285,0.14156079854809436,0.622303880691092,1.0,1/13,0.52%,SLC2A1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5769636755996613,1.3618889711947573,0.13333333333333333,0.6218389018682055,1.0,8/25,11.77%,APP;ANKRD13A;RIN3;SDCBP;RAC1;PSEN1;PICALM;ITGB3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5700415450007076,1.3615694387570338,0.12769485903814262,0.6215353245360127,1.0,7/27,7.46%,TEK;FLT1;PRKD1;PDGFB;PTK2B;TGFB1;PTK2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6023472416521461,1.3607219670459554,0.14262295081967213,0.622892345992122,1.0,6/20,10.42%,SEMA6A;SEMA5B;SEMA7A;SEMA6B;SEMA6D;SEMA4D
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5661889713834305,1.3606173912987871,0.12418300653594772,0.6218427529160977,1.0,7/27,13.77%,PRKCH;NFKBIA;NFKB1;LPL;CSF1;ITGB3;ABCG1
prerank,lipid oxidation (GO:0034440),0.6532778154615514,1.3603127745343666,0.14414414414414414,0.6215044393530215,1.0,1/12,0.58%,ADIPOR2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5487254508664718,1.3600304434903412,0.1238390092879257,0.6211080693972808,1.0,11/33,13.84%,DGKZ;PRKD2;NECTIN2;PTPRJ;TESPA1;CEACAM1;LCK;IKBKG;RC3H1;RELA;SLA2
prerank,response to muscle stretch (GO:0035994),-0.5534529010485961,-1.3584407309618463,0.13228699551569506,0.5103641812046623,1.0,5/15,11.28%,DMD;GSN;SLC8A1;RYR2;SLC9A1
prerank,positive regulation of GTPase activity (GO:0043547),0.4294303760421664,1.3582741165042325,0.03859250851305335,0.6257005828588581,1.0,36/188,10.42%,TBC1D8;DOCK9;PKP4;TGM2;NET1;ITGA6;RALGAPA2;F11R;TBC1D30;ARHGEF15;TBC1D4;CCDC125;BCR;SRGAP2;RALGAPA1;ARHGAP27;SGSM1;TBC1D22A;CAV2;ADRB1;TBC1D15;SIPA1L3;RAP1GDS1;RAPGEF2;TBC1D12;CD40;BCAR3;RAP1A;TBC1D2;AGRN;RSU1;ARHGEF7;ARHGEF26;LARS1;CCL14;SEMA4D
prerank,prostaglandin biosynthetic process (GO:0001516),0.6061341599876526,1.3580150949504224,0.1392857142857143,0.6251737477722439,1.0,5/18,7.17%,PTGS2;PLA2G4A;EDN1;PTGS1;CBR1
prerank,macrophage activation (GO:0042116),0.5496323512605463,1.3577564150351684,0.10685805422647528,0.6246878579486539,1.0,5/34,5.42%,APP;CD93;FOXP1;PLCG2;SBNO2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5379651029534871,1.357477657665413,0.1140215716486903,0.6242766952834595,1.0,8/36,7.33%,MEF2C;ACVRL1;PTPRM;DAB2IP;NOTCH1;DLL4;ATP2B4;TGFB1
prerank,contractile actin filament bundle assembly (GO:0030038),0.6117695065995924,1.357085541935396,0.14335060449050085,0.6229398561525463,1.0,4/15,7.06%,FAM171A1;SORBS1;PDLIM1;ARRB1
prerank,stress fiber assembly (GO:0043149),0.6117695065995924,1.357085541935396,0.14335060449050085,0.6229398561525463,1.0,4/15,7.06%,FAM171A1;SORBS1;PDLIM1;ARRB1
prerank,T cell homeostasis (GO:0043029),0.6755960286475802,1.3567843808390132,0.14097744360902256,0.6226117544359722,1.0,2/10,4.62%,FAS;JAK3
prerank,electron transport chain (GO:0022900),0.6282458415477143,1.3564779313653468,0.12788632326820604,0.6222400473556755,1.0,6/15,19.21%,PDIA5;CYB561;ENOX2;ETFDH;ETFB;ETFA
prerank,positive regulation by host of viral transcription (GO:0043923),0.6415658455173898,1.3562876070922,0.1416382252559727,0.6215241064992916,1.0,6/15,16.04%,LEF1;CHD1;TFAP4;SNW1;RRP1B;CTDP1
prerank,glycoprotein metabolic process (GO:0009100),0.5063358353216874,1.356219085868644,0.09482758620689655,0.6204190723178634,1.0,11/53,13.21%,ST6GALNAC3;MGAT4A;STT3B;HIF1A;MAN2A1;ST8SIA4;B4GALT5;B3GNT6;TNIP1;OGA;ERP44
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5453999166081946,-1.3559808627841772,0.12053571428571429,0.5152045493308461,1.0,3/17,1.99%,ANK2;SNTA1;CACNA2D1
prerank,response to exogenous dsRNA (GO:0043330),0.6089751606342247,1.3557314011914787,0.13095238095238096,0.6207341448785838,1.0,7/18,15.63%,CAV1;SLC3A2;RALB;CGAS;RFTN1;IFIH1;IRAK3
prerank,amino acid import across plasma membrane (GO:0089718),-0.4835534173875917,-1.3555257470182647,0.11576354679802955,0.5144550620633481,1.0,7/24,3.63%,SLC7A2;SLC6A13;SLC1A3;SLC47A1;SLC1A5;SLC6A9;SLC22A4
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.5314277728095013,1.3545273998655956,0.10664605873261206,0.6235067798488035,1.0,10/36,8.28%,SGMS1;DAB2IP;FAS;TPD52L1;TRAF1;TMBIM6;CX3CR1;ASAH2;PTPMT1;CRADD
prerank,prostanoid biosynthetic process (GO:0046457),0.6266345035438007,1.354515432933033,0.16304347826086957,0.6222264356770449,1.0,4/15,5.09%,PTGS2;PLA2G4A;EDN1;PTGS1
prerank,chromatin organization (GO:0006325),0.449601549987787,1.3542266986745541,0.05481120584652863,0.6218335839829245,1.0,34/132,18.55%,MECOM;ESR1;SMARCA2;BAZ2B;SOX9;KDM6A;PADI4;TCF7L1;MTF2;CHD1;ARID1A;KDM4C;SMARCA5;EZH1;NPM3;SMARCE1;RB1;PADI1;TOP1;SETDB2;NPM1;KAT2B;ATRX;HMG20A;JARID2;PIH1D1;HP1BP3;KDM5C;BAZ1A;KDM4A;PHF19;EHMT1;CHRAC1;PAK1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5421797547841272,1.35415207667206,0.11061285500747384,0.6207727883881594,1.0,8/35,7.50%,HEG1;RASIP1;DAB2IP;CCDC125;KCTD10;FBP1;ITGA3;SYNGAP1
prerank,vesicle organization (GO:0016050),0.507081514260911,1.3530700084350085,0.09024745269286755,0.6230175804191764,1.0,7/46,7.03%,FNBP1L;CAV1;CD34;CAV2;ALS2CL;CHMP2B;SRGN
prerank,regulation of cell cycle (GO:0051726),0.4147790862502021,1.3525758122057208,0.028089887640449437,0.62333207385886,1.0,54/271,13.03%,MECOM;NANOS3;DCUN1D3;APBB2;ERN1;PPP1R13B;CDK6;NEK7;ADARB1;IQGAP1;DAB2IP;PIM3;ADAM10;STAT3;NOTCH1;SIK1;AFAP1L2;TTC28;JMY;SOX9;PPP1R9B;SDCBP;UHRF2;LIN54;PTPRK;ASAH2;XIAP;TCF7L2;LIN9;CDKN1B;JUNB;TGFB1;RNF167;PKD2;NF2;CTBP1;AKT2;NEK6;MYBBP1A;RPL23;PUM1;DDIAS;RAD23A;TFAP4;CDC26;RB1;RNF112;RPRD1B;NOP53;RHOB;RACK1;BIRC3;HSP90AB1;UHMK1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.4259444286744068,-1.352218154359104,0.0851063829787234,0.5216302858874506,1.0,14/43,9.22%,IGF1;BMPR1A;PDGFRB;IGFBP5;GJA1;IL18;BMP4;CDH13;THBS1;FGF2;ADAMTS1;RBPMS2;CCN4;MMP2
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3953023336335424,-1.3521854131998599,0.0391304347826087,0.5196839864566613,1.0,19/85,8.33%,EYA1;ROR1;COL1A1;PIEZO2;CEMIP;COL4A3;ADGRV1;COL11A1;EML2;DCDC2;CACNA1D;GRM7;P2RX4;GSDME;ATP6V0A4;PCDH15;WHRN;ALDH7A1;RIPOR2
prerank,positive regulation of cell communication (GO:0010647),-0.4759670196895392,-1.351976298335205,0.09944751381215469,0.5182698388407162,1.0,6/28,6.83%,WLS;CLSTN2;DLG4;SYT1;ANK3;PTPN23
prerank,cellular response to peptide (GO:1901653),0.49793698927513425,1.3518772029770525,0.09618104667609619,0.6243569161660187,1.0,17/56,12.40%,NOD1;CAV1;APP;VCAM1;ICAM1;ARHGEF2;CASP4;FYN;XBP1;ATP1A3;CACNA1A;PSEN1;RPL23;EPHA4;GRIN1;LGMN;RIPK2
prerank,calcineurin-mediated signaling (GO:0097720),0.671106894110354,1.351758738294785,0.15947467166979362,0.6221657287084036,1.0,3/10,5.98%,NFATC1;PPP3CA;PPP3CB
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.671106894110354,1.351758738294785,0.15947467166979362,0.6221657287084036,1.0,3/10,5.98%,NFATC1;PPP3CA;PPP3CB
prerank,spliceosomal complex assembly (GO:0000245),-0.4273156251093085,-1.3514374550880583,0.09064327485380116,0.5177792977465115,1.0,8/46,12.29%,CELF2;SRSF5;CELF4;DDX39B;LUC7L3;SRPK2;CELF1;SF1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.5604743221252851,1.3512503514043457,0.11935483870967742,0.6225319271259216,1.0,7/26,11.70%,GCH1;SCARB1;HIF1A;FGF23;NOS1AP;CYP27B1;NUS1
prerank,positive regulation of inflammatory response (GO:0050729),0.4697517234544262,1.3507892529373329,0.08155080213903744,0.6227895404702228,1.0,16/86,11.87%,IL6ST;APP;IL15;PDE2A;OSMR;NFKBIZ;NFKBIA;RPS19;WNT5A;TNFRSF1A;LPL;IL23A;TNIP1;VAMP8;NMI;RIPK1
prerank,positive regulation of neuron projection development (GO:0010976),-0.39229610842528523,-1.3486713005982969,0.05734767025089606,0.5235318330478171,1.0,32/85,14.97%,NTRK3;MAGI2;ROR1;DPYSL3;CAMK1D;EPHA3;PTN;PTK7;BMP5;BMP7;COBL;TENM3;NDNF;CUX2;CAPRIN2;NTRK2;ROR2;KIDINS220;ARSB;APOE;ATP1B2;ALK;FZD1;CAMK1;PLK5;DBN1;PRKCI;CAMK2B;FUT9;P3H1;PLPPR5;CBFA2T2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.43258929534301893,-1.3485665262045083,0.07756232686980609,0.5218267821707534,1.0,18/44,18.63%,ANK2;ACTN2;ATP1B1;KCNMA1;WNK4;AKAP6;KCNMB2;KCNJ2;ATP1B2;WNK1;GABBR1;KCNJ10;KCNN2;GNG2;WNK3;KCNJ15;KCNJ6;KCNN3
prerank,regulation of interleukin-12 production (GO:0032655),0.5030955826375529,1.3485054298404626,0.09925925925925926,0.6289552094534473,1.0,11/47,12.40%,FOXP1;PLCB1;PLCG2;TIRAP;JAK3;MAST2;TIGIT;CD40;IL23A;MAPK11;RIPK2
prerank,retinal metabolic process (GO:0042574),-0.5898289995991497,-1.3484007622297511,0.12026726057906459,0.5202647559500476,1.0,4/12,15.16%,ABCA4;CYP1B1;RDH13;RDH10
prerank,potassium ion transmembrane transport (GO:0071805),-0.3513389139857804,-1.3479727951302352,0.028089887640449437,0.5194139819942951,1.0,26/135,12.44%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;SLC12A2;KCNB2;SLC9A9;KCNK5;ATP1B1;KCNQ3;ABCC9;KCND2;KCND3;KCNC2;KCNS3;KCNJ2;KCNQ4;KCNJ13;KCNAB1;SLC24A2;ATP1B2;KCNQ5;SLC9A1;KCNA6;ABCB8
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.4853978083623128,-1.3478401585220876,0.1099476439790576,0.5177512721863853,1.0,5/25,6.95%,ERRFI1;CBLB;SLC6A9;PPARA;SNX6
prerank,positive regulation of synapse assembly (GO:0051965),-0.4871253304721198,-1.34763819605402,0.10335917312661498,0.5164065703771481,1.0,10/27,12.91%,NLGN2;CLSTN2;CUX2;PTPRD;IL1RAPL1;NRXN1;NLGN1;NLGN3;SRPX2;GRID2
prerank,cellular response to alcohol (GO:0097306),-0.434710656111958,-1.3476164059834044,0.09815950920245399,0.5145121733553516,1.0,13/42,9.49%,ADCY5;ADCY1;ADCY2;GRAMD1B;ADCY7;CDH1;GRAMD1C;ADCY6;LRP6;GNAI1;SFRP1;PTGFR;SMO
prerank,cardiac atrium morphogenesis (GO:0003209),0.6096094563156723,1.3470762799687521,0.16198347107438016,0.632429821516524,1.0,5/16,9.03%,BMPR2;ENG;NOTCH1;DLL4;ZFPM1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.615429697086008,-1.3466223626031013,0.1412556053811659,0.515465890411285,1.0,2/10,9.62%,ALDH7A1;HNMT
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.5392816960400572,1.346570816200139,0.1273031825795645,0.632808752099256,1.0,4/31,3.49%,SHANK3;ABI3;EFNA1;PPFIA2
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5374653714515583,-1.3465637351563113,0.16097560975609757,0.5136476541615919,1.0,5/17,3.81%,ATP1A2;BMP7;TFPI;BMP4;AR
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5194878213777456,1.3452240952056262,0.12296296296296297,0.6359339149959353,1.0,9/40,9.16%,GBP4;TIRAP;GBP7;RPL39;DROSHA;PGLYRP2;LYG2;ANG;DEFA6
prerank,negative regulation of cell motility (GO:2000146),0.4547953867057437,1.3448680192801128,0.06314432989690721,0.6357915630500024,1.0,19/108,6.77%,FRMD5;LIMCH1;MCTP1;DACH1;ENG;ACVRL1;CLDN5;ADARB1;CCDC125;SRGAP3;SRGAP2;PTPRJ;STK24;SRGAP1;PTPRK;SMAD7;DUSP22;ADAM15;STK26
prerank,positive regulation of cellular process (GO:0048522),0.39922361782539617,1.3446958979639014,0.0051387461459403904,0.6351037833502841,1.0,111/565,13.64%,FRMD5;LEF1;TJP1;TBC1D8;RAB27A;FLT1;ACER2;TGM2;KDR;IL6ST;CAV1;TBX1;LIFR;IL15;STX3;CLDN5;INSR;KITLG;PDGFB;PARD3;VEGFC;GATA2;IL6R;EDN1;LRP5;LYN;TAL1;PRKD2;OSMR;ADAM10;FASN;PDGFD;TNFRSF11A;PTK2B;PPP3CA;NOTCH1;CNOT6;PTPRJ;ACACB;TNFRSF1B;BST1;AQP11;ACTN4;WWTR1;CNOT6L;FLT4;ADGRG1;FGF23;SOX9;DLL1;RPS19;RPS6KA3;SLC6A6;SDCBP;RPS6KA1;XBP1;VEGFD;GNAI2;GREM1;MAPK8;H3-3A;CHP2;WNT5A;CNBP;FOSL1;KRAS;RAC1;CDKN1B;PDGFC;TGFB1;PTK2;TGFA;AGPAT1;KDM4C;NEUROD1;RPTOR;AKT2;IL7R;RPL23;CDK2;SOX4;CSF1;DICER1;RAD18;DHPS;RAD23A;SFRP2;CCL14;GAS6;EPHA4;MCTS1;IL7;GRIN1;SINHCAF;LGMN;RPRD1B;RELA;RIPK2;PA2G4;ZFP36;PHIP;TGFBR2;HSP90AB1;MTPN;CNOT7;HAS2;ADAM17;IGF1R;NSMCE4A;FMR1;RPS6
prerank,neural crest cell development (GO:0014032),0.5246544793885087,1.3444591548443416,0.11010558069381599,0.6346126526707053,1.0,8/44,8.32%,SEMA6A;TBX1;SEMA5B;SEMA7A;CDH2;SEMA6B;CYP26C1;SEMA6D
prerank,membrane protein proteolysis (GO:0033619),0.5273888437326656,1.3440768208981124,0.1144578313253012,0.6344717193828954,1.0,15/37,15.15%,MYH9;ADAM10;SPPL2A;RET;TGFB1;NFKB1;ERAP1;PSEN1;RHBDD1;MBTPS2;APH1A;RELA;ADAM17;TRAF6;SPPL3
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.546370528514478,1.344003252676513,0.15409309791332262,0.6334326216459977,1.0,12/29,17.56%,RPS19;RPS14;RPS16;RRS1;RPS8;HELB;UTP4;NOL10;RPS21;UTP6;HEATR1;NOP14
prerank,negative regulation of hydrolase activity (GO:0051346),0.5091829945479311,1.3438388011366231,0.10903873744619799,0.6326824478141431,1.0,9/49,8.00%,LRCH1;F11R;SH3BP4;DAB2IP;PLIN5;PTX3;EGLN1;GNAT1;RASA4
prerank,response to interferon-gamma (GO:0034341),0.4765098883563101,1.343833478281407,0.1012311901504788,0.631405525053969,1.0,12/67,10.41%,GCH1;DAPK1;GBP5;GBP4;GBP7;WNT5A;CD40;CASP1;CITED1;RPL13A;CYP27B1;CCL14
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.575462470394235,1.3436015393827843,0.13754045307443366,0.630822386891068,1.0,8/24,14.53%,CTSC;EFNA1;PTK2B;UCHL5;EPHA4;UBE3A;NUDT15;PSME1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.6344064357584713,1.3433306214189922,0.1590909090909091,0.630367134872831,1.0,3/13,3.41%,NOS3;GLS2;GLS
prerank,rRNA transcription (GO:0009303),0.600879320366656,1.3423855746878737,0.13774597495527727,0.6322324037207514,1.0,10/17,24.54%,CAVIN1;SPIN1;TAF1B;ANG;NIFK;POLR1G;GTF3C1;TCOF1;SIRT7;BRF1
prerank,regulation of interleukin-10 production (GO:0032653),0.5056621773431977,1.3419195497766696,0.10914454277286136,0.6323737231909373,1.0,7/44,9.61%,STAT3;CD34;PLCG2;DLL1;JAK3;TIGIT;IL23A
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5680254675566822,1.341888230821264,0.1232,0.6312244406421954,1.0,11/25,18.42%,EFNA1;OPHN1;RPS7;RPL23;EPHA4;HSP90AB1;PRKCG;RPL11;CSNK2A2;CSNK2A1;PSMF1
prerank,cartilage development (GO:0051216),-0.4180841792381643,-1.341716521062378,0.05828220858895705,0.5254747867725147,1.0,14/49,8.79%,SOX5;SULF1;OSR1;SULF2;BMP4;PKD1;SOX6;RUNX2;FGF2;SLC39A14;ITGB8;CCN3;CD44;RUNX1
prerank,calcium ion transport (GO:0006816),-0.36082104030058204,-1.3416394003500158,0.05116279069767442,0.5237484375540351,1.0,21/113,7.92%,SLC24A3;TRPM3;ANK2;CACNA1C;NALCN;SLC8A3;CACNA2D1;CACNA1D;PKD1;GRIN3A;SLC8A1;P2RX4;RAMP1;CACNB2;CACNA1G;ITGAV;TRPC3;STIM1;TRPC6;TRPC1;ATP2A2
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.6787284084042604,1.3413627337158114,0.1854043392504931,0.6316289246590764,1.0,2/10,1.50%,ST6GAL1;ST3GAL1
prerank,positive regulation of JNK cascade (GO:0046330),0.48292493114280355,1.341213034552844,0.09562841530054644,0.6308859355970432,1.0,14/70,6.08%,APP;TNFRSF19;DAB2IP;MFHAS1;PTK2B;TPD52L1;TAOK2;PLCB1;TRAF1;FLT4;TIRAP;EDAR;SDCBP;DUSP22
prerank,negative regulation of inflammatory response (GO:0050728),0.42571646972819516,1.340845571297609,0.052995391705069124,0.6308837661812655,1.0,21/182,5.63%,TEK;CALCRL;CYSLTR1;PPARD;ADCY4;CD200;PLCG1;MYH9;LYN;MFHAS1;YES1;GNB1;TNFRSF1B;LPCAT3;FYN;PRKAR2B;PLCG2;ADRB1;RPS19;RAMP2;PLK2
prerank,cellular response to interleukin-12 (GO:0071349),0.49932437087726356,1.3407624325886538,0.11773255813953488,0.6298640950377814,1.0,9/48,7.27%,LCP1;MSN;RAP1B;PLCB1;PAK2;HNRNPF;CA1;MTAP;JAK1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5386307905187565,1.3400333415397259,0.13333333333333333,0.6310092681227242,1.0,7/33,7.33%,PDGFB;GATA2;STAT3;NR3C1;HIF1A;FOSL1;TGFB1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5877132883206543,1.3399559558585277,0.15371621621621623,0.63000593208726,1.0,8/21,7.33%,NOS3;PTK2B;NOTCH1;FGF23;SOX9;GREM1;SRGN;TGFB1
prerank,positive regulation of cartilage development (GO:0061036),0.6100781878463075,1.339386154525713,0.16464471403812825,0.6305769484501953,1.0,4/17,4.17%,BMPR2;ZBTB16;ACVRL1;SOX9
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.547343677953233,-1.3392129221201114,0.14945054945054945,0.5289101900904875,1.0,6/15,24.58%,GGT5;ALDH4A1;PRODH;HOGA1;GGT1;GOT2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6440378882571761,1.3389247582394357,0.14444444444444443,0.6307981182286496,1.0,3/13,2.82%,NRP2;PLXNA4;PLXND1
prerank,regulation of monooxygenase activity (GO:0032768),0.5743777521480851,1.3388314250370648,0.16,0.6299174626591326,1.0,5/23,7.93%,NOS3;CAV1;NOSTRIN;NOSIP;NOS1AP
prerank,protein localization to phagophore assembly site (GO:0034497),-0.6070583098433873,-1.3381325143505705,0.11963882618510158,0.5300528550628414,1.0,6/11,26.92%,WIPI1;PACS2;ATG9A;STX17;WDR45;WIPI2
prerank,positive regulation of ERAD pathway (GO:1904294),0.6400303692864608,1.3380485259471133,0.1577981651376147,0.6311652842273547,1.0,2/13,6.79%,CAV1;ATXN3
prerank,negative regulation of growth (GO:0045926),0.4399425270889642,1.3380336372829538,0.07160493827160494,0.6299666559944036,1.0,18/121,7.33%,BMPR2;DCUN1D3;APBB2;SMARCA2;ACVRL1;SH3BP4;NPR1;NOTCH1;PTPRJ;SOX17;PPP1R9B;VGLL4;ADAM15;JADE1;FBP1;DCSTAMP;CDKN1B;TGFB1
prerank,regulation of cation channel activity (GO:2001257),-0.3722356929913887,-1.3378893951519149,0.04680851063829787,0.5288270025715304,1.0,30/89,15.47%,ANK2;DMD;DLG2;NLGN2;ACTN2;DLG4;FGF14;JPH1;GRIA2;ANK3;DLG1;GRIA3;GRIA1;SLMAP;CACNB2;NLGN1;PRKACA;KCNAB1;CACNB1;DLG3;GRIA4;SHANK1;GRIN2A;PRRT1;AHNAK;JPH2;CAMK2B;CACNG4;SHISA7;NETO1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5856780319555179,1.337389197859438,0.1568627450980392,0.6308212582198194,1.0,6/21,8.50%,PLA2G4A;LPCAT3;PLA2G2D;OSBPL10;MBOAT1;PLAAT3
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.5403946863193511,-1.3369716014663156,0.13559322033898305,0.529418149510868,1.0,4/16,5.51%,SOX5;PTN;SOX6;HOXB4
prerank,positive regulation of fat cell differentiation (GO:0045600),0.503727588230558,1.3368942931335526,0.11210762331838565,0.6311222261756684,1.0,13/47,12.67%,PTGS2;PPARD;ZBTB16;SOX13;LRP5;RREB1;XBP1;LPL;CREB1;SFRP2;CCDC71L;PIM1;ZFP36
prerank,endoderm formation (GO:0001706),-0.44772885909466703,-1.3368103041661044,0.08985507246376812,0.5278627662362736,1.0,10/35,9.38%,COL8A1;COL12A1;VTN;COL11A1;ITGB5;COL6A1;MMP14;ITGAV;MMP2;INHBA
prerank,sodium-independent organic anion transport (GO:0043252),0.6474833807900754,1.336794741548959,0.1731123388581952,0.6302227969460433,1.0,3/10,4.03%,SLCO2B1;SLCO2A1;SLC16A2
prerank,calcium ion import (GO:0070509),-0.46604252313866223,-1.336687586960279,0.08505154639175258,0.5262322055507309,1.0,9/28,11.30%,CACNA1C;CACNA1D;SLC8A1;MCU;CACNB2;CACNA1G;ATP2A2;TRPC4;MICU1
prerank,positive regulation of protein modification process (GO:0031401),0.4207145904340749,1.3362110023466887,0.054906542056074766,0.63087481668964,1.0,34/203,7.93%,TEK;LIMCH1;PECAM1;KDR;ENG;TBX1;APP;PDE8A;PPP1R16B;INSR;VEGFC;PPP2R5A;LYN;FAS;EFNA1;FLT4;FGF23;SOX9;STK4;RALB;VEGFD;ACVR2A;ALG10B;LIMK2;KRAS;CD40;RAC1;DYRK1A;ARRB1;TNIK;TGFB1;PTK2;NIBAN1;NOS1AP
prerank,regulation of dopamine secretion (GO:0014059),-0.49205006201183105,-1.336120209578808,0.11794871794871795,0.5257979107919328,1.0,12/25,26.66%,PRKN;SYT1;SYT9;SYT12;SYT11;DTNBP1;SNCA;SYT3;SYT2;SYT6;SYT5;KCNA2
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6699590569212713,1.335940448705564,0.16538461538461538,0.6305366910663512,1.0,2/10,5.47%,PLA2G4A;ENPP2
prerank,organic acid transport (GO:0015849),0.4558690048944603,1.3358935318947853,0.07840616966580977,0.6294391380590988,1.0,14/94,6.70%,ABCC4;SLCO2B1;ABCG2;ATP8B1;PPARD;SLC7A7;SLC38A5;SLC3A2;STARD5;NCOA1;SLC6A6;CEACAM1;SLC43A2;SLC26A1
prerank,sphingoid metabolic process (GO:0046519),0.6520443583333652,1.3356454917665534,0.17509025270758122,0.6289561095385918,1.0,5/12,5.50%,DEGS2;PLPP1;SGPP2;SPTLC3;ASAH2
prerank,regulation of stress fiber assembly (GO:0051492),-0.3772636962165179,-1.3345975170580795,0.06097560975609756,0.5281301578944575,1.0,26/74,11.29%,ARHGAP6;PHLDB2;LPAR1;CGNL1;ROCK2;PPM1E;TMEFF2;ARHGEF10L;NRP1;CCN2;TGFBR1;ARAP1;ARHGEF10;TPM1;RHPN2;CARMIL1;ALMS1;SFRP1;FHOD1;ASAP3;RGCC;TGFB3;S100A10;PFN2;SLC9A1;ARHGEF18
prerank,regulation of cell-matrix adhesion (GO:0001952),0.48149019831224227,1.3344914689650513,0.10354223433242507,0.6314531756123614,1.0,15/64,9.46%,LIMCH1;ACER2;UTRN;NEXMIF;CDK6;PEAK1;PTK2B;BST1;SKAP1;ADAM15;PTK2;RASA1;NF2;SLK;CSF1
prerank,positive regulation of DNA replication (GO:0045740),-0.5500404231413625,-1.3342766287555785,0.14146341463414633,0.5271025959691894,1.0,3/16,8.40%,EGFR;GLI2;GLI1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3910418359646685,1.334151245520848,0.0,0.6313828881319539,1.0,149/834,12.41%,ERG;LEF1;MRTFB;ELK3;RPS6KA5;FOXO1;EPAS1;PBX1;BMPR2;LDB2;ENG;ITGA6;TBX1;ESR1;SMARCA2;APP;PPARD;MEF2C;LMO2;ACVRL1;PRKD1;NR5A2;CRTC1;MAML2;AHR;SMAD1;ZIC3;NFATC1;PDGFB;NLRC5;IRF2;GATA2;DAB2IP;EDN1;HHEX;ARHGEF2;LRP5;TAL1;PRKD2;STAT3;NR3C1;PPP3CA;NOTCH1;HIF1A;PLXND1;KLF7;RREB1;NFKBIA;CCNK;SOX17;NCK1;WWTR1;SOX18;TCF12;PPP1R12A;FOSL2;MAFF;SOX9;MRTFA;NCOA1;DLL1;RPS6KA3;KLF2;FOXF1;SS18;ELK4;IKBKB;RPS6KA1;XBP1;TET3;EPC1;SMAD7;ACVR2A;GREM1;FOXF2;SBNO2;HOXA10;MTF2;LPIN3;TCF7L2;TCF4;PPP3CB;CHP2;WNT5A;CNBP;SKAP1;TOX3;ATMIN;KLF10;ACVR1;NR1I3;BTBD18;FOXA3;FOSL1;IRF2BPL;CD40;HNF1B;JUNB;ARRB1;RBM14;TNFRSF1A;TGFB1;HOXD8;TCF3;AGRN;NFKB1;PKD2;NEUROD1;CITED1;NRL;KAT6B;SMARCA5;CREB1;ZFPM1;SUB1;BRD4;PCGF5;IER2;TCF15;SOX4;IKBKG;RNF4;NFIB;CREB3L4;NRIP1;SMAD5;SFRP2;USF2;TNIP1;GLYR1;POU2F1;GABPB1;CSRNP1;MC1R;GLMP;ZMIZ1;ATF6;SP3;GRIN1;RIPK1;PRDM2;ACTR2;RPRD1B;MUC1;ASXL1;RELA;RIPK2;MAX;TET2
prerank,positive regulation of autophagy (GO:0010508),0.46516349387480677,1.3341011174581994,0.08969210174029452,0.6303144853125121,1.0,16/81,11.40%,FOXO1;KDR;PRKD1;DAPK1;SH3BP4;TRIM14;PIK3C2A;TRIM68;PLK2;ULK1;MID2;SH3GLB1;IKBKG;NPRL2;BNIP3;ATF6
prerank,secondary palate development (GO:0062009),0.6271105345498798,1.3334575884248436,0.1694915254237288,0.6311054012066283,1.0,3/14,6.10%,LEF1;CHD7;WNT5A
prerank,regulation of cell differentiation (GO:0045595),-0.3453706400239584,-1.333027617426907,0.02631578947368421,0.5288226027750206,1.0,30/148,11.46%,PHLDB2;SMOC1;FGFR2;EPHA3;ZFHX3;DDX5;PRKCB;TRPS1;CCN2;PHLDB1;TGFBR1;DAG1;RUNX2;AR;IGF2;YWHAG;NF1;NGF;SIX1;DDX17;NLGN1;ST7;PRKACA;BCL6;RUNX1;BIN1;ALK;NREP;FLOT2;CAMK1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.6004323726501627,1.3328086468190516,0.16554054054054054,0.6319316885137659,1.0,2/15,2.58%,NLRC5;SAMHD1
prerank,regulation of protein transport (GO:0051223),0.5522100674333958,1.3326934923867122,0.12218649517684887,0.6310983784834268,1.0,12/27,18.65%,LCP1;PPM1F;DNAJA1;SNX3;LLGL1;PTPN1;GAPVD1;RHBDF2;NDEL1;CHP1;NDFIP2;STXBP5
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.667745609039424,1.332199281686359,0.1922365988909427,0.6314966244503081,1.0,5/10,16.38%,NFKBIZ;SMAD7;MALT1;RC3H1;NFKBID
prerank,cellular component maintenance (GO:0043954),0.6593126318033062,1.3321883873626048,0.16606498194945848,0.630323636256556,1.0,5/12,13.47%,INSR;FYN;ITGA3;PICK1;IGF1R
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.608615242799907,-1.3315526966845714,0.1487603305785124,0.5308997241653142,1.0,6/10,22.93%,GABRG2;GABRA2;GABRG3;GABRA1;GABRA5;GABRA3
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.4035574824561393,1.3313830812684935,0.02516411378555799,0.6316747140322099,1.0,97/306,17.73%,ALAS1;RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;EPC1;RPL38;RPL34;RPS20;RPL39;RPS7;PWP1;RNASEH2A;RPS24;TAF1B;MCM10;RPA1;RPL37A;B4GALT5;BCL3;SRBD1;RPL36;RPS18;RSL24D1;RPL15;POLA1;B3GNT6;RPS8;RPL14;RPL23;RPL17;DUT;CDK2;MRPS18A;BRIP1;RPL9;DHPS;RPL4;RPL13A;HELB;RPS11;RPL32;TNIP1;HUS1;RPL22;RPS27;RPL31;RPS23;MMS19;RNPS1;MRPL13;RPL13;MRPS12;RPS12;MCM9;EEF2K;RMI1;MRPL35;HBS1L;RPL6;RPL10;WARS1;PTMA;TOP1;MRRF;MRPL41;GRWD1;RPS29;RPS6;MEF2A;MRPL52;RPL29;TOPORS;RPS25;RPL35A;RPS13;RPS21;MRPS16;RPL27;RPL18;MRPL23;ORC5;RPL27A;MRPS5;RPS10;MRPL37;ORC3;EEFSEC;RPL11;RPL8;EEF2;RFC3;RPLP2;MRPL11
prerank,protein-containing complex subunit organization (GO:0043933),0.4405154593719818,1.3312860301004323,0.0858257477243173,0.6307561266885547,1.0,26/109,14.29%,SLC2A1;OCLN;CD2AP;MAGI1;PARD3;FAS;PTK2B;TRAF1;CARD10;SOX9;TEAD2;CD40;LLGL1;SKAP2;NIFK;IKBKG;TFAP4;PICALM;NUP98;NUP133;NUP205;CAPZA1;PEX14;IL1RAP;NUP54;APC
prerank,cellular response to nutrient levels (GO:0031669),0.4816851476816137,1.3305585993637592,0.10541310541310542,0.6318534503263606,1.0,11/62,8.46%,FOXO1;BMPR2;STK24;KCNB1;RALB;XBP1;ULK1;KLF10;STK26;LPL;RPTOR
prerank,inorganic anion transport (GO:0015698),-0.4157370155976004,-1.3302285325069925,0.05263157894736842,0.532528629553753,1.0,9/53,8.65%,SLC4A10;SLC13A4;ENPP1;SLC26A7;ANO1;CLCN2;ANO4;SLC5A5;ENPP3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5377321783404772,1.3300426458490915,0.13679245283018868,0.6323183023972232,1.0,6/33,5.65%,TEK;KDR;ICAM1;GATA2;RAMP2;TCF7L2
prerank,positive regulation of exocytosis (GO:0045921),0.5185394471867524,1.3298212130527218,0.12732919254658384,0.6317142851484207,1.0,4/35,4.85%,RAB27A;CADPS2;EXPH5;SDCBP
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5606497766009502,-1.3295596671577783,0.1536697247706422,0.5324999467076611,1.0,7/13,12.17%,BMP6;BMPR1A;TGFBR1;BMP4;DAB2;TGFB3;NUP93
prerank,regulation of dendrite extension (GO:1903859),0.5800049130497069,1.329319083724658,0.153184165232358,0.6321498259013163,1.0,3/18,2.93%,SMURF1;NEDD4L;ITSN2
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.5298148196290857,-1.3292925319943105,0.12322274881516587,0.5294582937223193,1.0,4/16,4.51%,ARHGAP6;PHLDB2;THBS1;APOD
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.5298148196290857,-1.3292925319943105,0.12322274881516587,0.5294582937223193,1.0,4/16,4.51%,ARHGAP6;PHLDB2;THBS1;APOD
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5978050622335995,-1.3291654568322029,0.13973799126637554,0.5279664372303797,1.0,4/11,9.36%,CACNA2D1;CACNB2;CACNB1;BIN1
prerank,sympathetic nervous system development (GO:0048485),0.6157098118674164,1.3286919939056516,0.1683673469387755,0.6329288346152194,1.0,1/15,0.07%,NRP2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6352500897155727,1.3286730988177193,0.18726591760299627,0.6318064269810065,1.0,2/12,7.33%,ESR1;TGFB1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4752607078743222,1.3283836240827696,0.09861111111111111,0.6315201014813373,1.0,11/70,6.61%,TEK;PARVB;MEF2C;PEAK1;EFNA1;SRGAP2;PXN;ACTN1;SIPA1L3;OPHN1;RAC1
prerank,B cell receptor signaling pathway (GO:0050853),0.5343529143071196,1.3282660228958794,0.1321656050955414,0.6307122049986476,1.0,7/32,9.58%,CD38;MEF2C;PLCG2;SH2B2;BMX;LCK;RFTN1
prerank,neutrophil mediated immunity (GO:0002446),0.39694991824059417,1.3274742109314186,0.013713080168776372,0.6319880888704366,1.0,83/432,15.52%,PTPRB;CTSC;RAB27A;PECAM1;LRG1;ATP8A1;CD93;B2M;PRCP;OSTF1;IQGAP1;ADAM10;STK10;ATP11B;PTPRJ;STOM;TNFRSF1B;ADGRG3;BST1;RAP1B;ADGRE5;FUCA2;CAT;ENPP4;LCN2;SDCBP;MCEMP1;CEACAM1;KMT2E;QSOX1;TSPAN14;SCAMP1;PTX3;NRAS;RAC1;PPBP;RAP1A;ATP6V0A1;PSMA2;NFKB1;ARMC8;DYNLL1;ATP11A;DYNC1LI1;PSEN1;GDI2;SNAP23;VAMP8;ANO6;SPTAN1;CPPED1;PGM2;GMFG;DEGS1;CYFIP1;IRAK4;ACTR2;APEH;PA2G4;GSTP1;STXBP3;DBNL;HSP90AB1;ACTR10;IMPDH1;PFKL;ERP44;AOC1;RAB31;ADAM17;RAB7A;RAB5B;ASAH1;RAB18;S100A9;HMOX2;SVIP;DGAT1;GGH;RAB6A;ACE;CEP290;APAF1
prerank,spinal cord development (GO:0021510),-0.581170182315212,-1.3274647241962738,0.13986013986013987,0.5309213003178689,1.0,5/12,5.63%,GLI2;VIT;PKD1;LOXL3;NF1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5969046991812573,1.3270147761451347,0.16022099447513813,0.6323651915791643,1.0,6/15,13.14%,TENT4A;TNRC6C;BTG2;CNOT1;ZFP36;CNOT7
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.47520575026554507,1.3268213769631925,0.1115702479338843,0.6318132322704537,1.0,15/67,9.46%,UTRN;CDK6;LIMS2;PDGFB;NEDD9;DOCK1;PTK2B;PPM1F;RREB1;SKAP1;RAC1;RSU1;ARHGEF7;CRK;CSF1
prerank,regulation of fibrinolysis (GO:0051917),-0.5628896368368311,-1.3265233744085612,0.14081145584725538,0.5317025145924397,1.0,3/13,10.33%,THBS1;FAP;SERPINE1
prerank,retinol metabolic process (GO:0042572),-0.5442009207577072,-1.3262051725113626,0.13145539906103287,0.530777849361614,1.0,3/14,4.73%,RBP4;DHRS3;CYP1B1
prerank,regulation of cellular component size (GO:0032535),0.5409690810970246,1.3255584995726655,0.14009661835748793,0.6345422640161033,1.0,10/30,16.64%,EPS8;RIN3;MSN;RAC1;RPTOR;LARS1;PICALM;MTPN;RDX;HP1BP3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5867709673997423,1.325497741366274,0.1515650741350906,0.6335897091728782,1.0,5/20,10.54%,RPS6KA5;DIP2B;ARRB1;SOX4;GLYR1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5901037294063591,-1.3239038084209023,0.1557377049180328,0.5354245284797211,1.0,6/11,11.88%,PDK1;MAP3K5;PRKCD;CYP1B1;PRODH;DIABLO
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5684154190044597,1.3236415181771695,0.16033057851239668,0.6382829735146911,1.0,9/24,9.42%,EPN2;MMRN2;DAB2IP;HHEX;PRKD2;HIF1A;NEDD4;ITGA5;PTPN1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5104230384986405,-1.3227602801859801,0.1299559471365639,0.5367690363581448,1.0,3/17,4.64%,MAGI2;PDGFRB;ITGA1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.42461542340474673,1.3224733299889302,0.07064555420219244,0.6407143190193327,1.0,34/140,12.57%,CHN2;ARHGAP31;TGM2;NET1;MCF2L;ARHGEF3;ARAP3;CD2AP;RASGRF2;ARHGEF2;BCR;SRGAP3;SRGAP2;SRGAP1;PLEKHG5;RHOJ;KALRN;ARHGAP8;PREX1;ARHGAP17;OPHN1;RAC1;DEPDC1B;ARHGEF7;ARHGEF26;ARHGAP28;OCRL;CYRIB;ARAP2;ARHGAP23;RHOB;TRIO;GNA13;ARHGEF9
prerank,protein polymerization (GO:0051258),-0.41097033532864335,-1.321768868750521,0.08196721311475409,0.5376513085203113,1.0,6/55,3.84%,ARHGAP6;GAS7;GSN;PRKN;SPIRE1;COBL
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.6528678381552713,1.3216230904379085,0.16842105263157894,0.6421087777579394,1.0,4/11,12.61%,CAV1;BCL3;NF2;ADIPOR1
prerank,oogenesis (GO:0048477),0.6118724604855684,1.3204207086061848,0.16906474820143885,0.6448072966593231,1.0,4/15,8.15%,NANOS3;NANOS2;TRIP13;MARF1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.590048938335901,1.3200430441870565,0.1703958691910499,0.6448358515424725,1.0,5/18,4.50%,MTUS1;IL6R;LYN;PTK2B;F7
prerank,magnesium ion transport (GO:0015693),-0.5708013579574328,-1.3194590080764406,0.15090090090090091,0.5423202522382596,1.0,6/12,19.17%,SLC41A1;TUSC3;MAGT1;CNNM4;MRS2;NIPA1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6120527198991211,1.3193472263536834,0.17567567567567569,0.6458324502922237,1.0,4/16,10.91%,AHR;TNFRSF1B;TNFSF8;LST1
prerank,regulation of mast cell activation (GO:0033003),0.6597285586519236,1.3191782421979714,0.19099099099099098,0.645187768177203,1.0,2/10,2.78%,LYN;NECTIN2
prerank,cell-cell junction organization (GO:0045216),0.46518698598222263,1.3188168985614013,0.09811827956989247,0.6451981425899462,1.0,16/79,9.63%,TJP1;PKP4;CADM1;CLDN5;OCLN;LIMS2;TJP2;NECTIN2;PVR;CDH2;CTNNA1;TGFB1;TRPV4;CDH15;ANG;TJP3
prerank,negative regulation of response to stimulus (GO:0048585),0.4803150048410847,1.3181463007290897,0.11318051575931232,0.6461290469355692,1.0,13/60,9.42%,MCTP1;CDK6;LYN;PIM3;KLF7;AQP11;LPCAT3;KIF26A;SRMS;CD34;ACVR1;MAP3K3;PTPN1
prerank,negative regulation of DNA binding (GO:0043392),0.5377876193780701,1.31801915909188,0.15615141955835962,0.6453492260237229,1.0,4/28,10.60%,LEF1;NFKBIA;MAD2L2;TFAP4
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.46290640609798106,1.3178374432192907,0.0945945945945946,0.6447618124471809,1.0,29/72,19.71%,LIFR;CASP8;TRAF1;SIGIRR;SPPL2A;IKBKB;HIPK1;IFNAR2;JAK1;TNFRSF1A;AGPAT1;PTPN1;IKBKG;GAS6;IL7;CBFB;RIPK1;RACK1;BIRC3;HSP90AB1;IRAK3;OTULIN;BIRC2;IRAK2;STAT1;IFNGR1;CDC37;MADD;TAX1BP1
prerank,positive regulation of dendrite extension (GO:1903861),0.5843564424377369,1.3172859366525418,0.15236427320490367,0.6453979090129959,1.0,3/17,2.93%,SMURF1;NEDD4L;ITSN2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.549296827257291,1.3168868329452996,0.16823899371069181,0.6454421514499967,1.0,11/26,15.10%,LYN;STAT3;EFNA1;AIM2;FYN;APH1A;EPHA4;GRIN1;PICALM;PSME1;VSIR
prerank,negative regulation of endocytosis (GO:0045806),0.5600867149435909,1.316269641740108,0.16188870151770657,0.6462213619316134,1.0,3/24,1.41%,MCTP1;CAV1;PRKD1
prerank,adipose tissue development (GO:0060612),0.6473908546376228,1.316194643316583,0.18773946360153257,0.6453039335065419,1.0,3/11,4.97%,SPTLC2;LRP5;XBP1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6074520521690743,1.3153866209993783,0.1726078799249531,0.646750442750313,1.0,3/14,6.10%,ADAM10;PTK2B;WNT5A
prerank,cellular response to cAMP (GO:0071320),0.5342235645658682,1.3152545159113058,0.14169381107491857,0.646020994528375,1.0,8/30,8.09%,AHR;PDE2A;KCNQ1;RAP1B;RAPGEF2;INPP5K;RAP1A;PKD2
prerank,positive regulation of cell population proliferation (GO:0008284),0.39775722822403353,1.3150603785392088,0.022058823529411766,0.6455210615279369,1.0,64/423,9.46%,PRKCH;LEF1;TJP1;TBC1D8;FLT1;ACER2;KDR;IL6ST;TBX1;LIFR;MEF2C;IL15;STX3;CLDN5;CDK6;INSR;KITLG;PDGFB;VEGFC;FOXP1;IL6R;EDN1;LRP5;LYN;OSMR;ADAM10;PDGFD;TNFRSF11A;PTK2B;NOTCH1;CNOT6;BST1;AQP11;WWTR1;CNOT6L;FLT4;FGF23;TOX;SOX9;DLL1;SDCBP;XBP1;VEGFD;GNAI2;GREM1;DLL4;TCF7L2;CHP2;WNT5A;CNBP;FOSL1;KRAS;PDGFC;TGFB1;PTK2;TGFA;MAP3K3;KDM4C;AKT2;IL7R;RPL23;CDK2;SOX4;CSF1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.5308371508520332,1.3150066408543166,0.12619808306709265,0.6445321933814101,1.0,6/33,5.28%,PTPRG;ACVRL1;PTPRM;DAB2IP;EVL;DLL4
prerank,neutrophil activation (GO:0042119),0.6351593976395083,1.3148524918111737,0.18568665377176016,0.6438878735978049,1.0,3/12,5.14%,IL15;PREX1;KMT2E
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5415555530666826,1.3142277363278292,0.16747181964573268,0.6447560336585318,1.0,8/26,10.18%,ST3GAL6;ST3GAL1;B3GNT3;B4GALT4;B3GNT4;B4GALT5;B4GAT1;SLC35D2
prerank,phosphatidylserine metabolic process (GO:0006658),0.5359407708841288,1.3141651538188746,0.14652567975830816,0.6438188729071839,1.0,7/32,8.50%,PLA2G4A;SERINC5;LPCAT3;PLA2G2D;OSBPL10;MBOAT1;PLAAT3
prerank,neuronal action potential (GO:0019228),-0.4904003500114365,-1.3140525455756509,0.14102564102564102,0.5555536332554081,1.0,12/22,27.57%,SCN7A;ANK3;CACNA1G;KCNMB2;GPER1;SCN1A;SCN8A;SCN2A;SCN5A;KCNA2;SCN9A;CACNA1H
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.6627729899082122,1.3139904986601796,0.1840277777777778,0.6432204893243718,1.0,2/10,1.12%,ACER2;NEXMIF
prerank,positive regulation of ossification (GO:0045778),-0.42684753021921684,-1.3138626286042183,0.08571428571428572,0.5541242344007639,1.0,11/39,4.62%,BMP6;BMPR1A;PTN;WNT4;BMP7;ADGRV1;OSR1;BMP4;GPM6B;SLC8A1;FBN2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.43657783074383816,1.3136320493450806,0.08729139922978177,0.643155495903319,1.0,31/114,18.42%,AIM2;TNFRSF11A;PTK2B;TNFRSF1B;NFKBIA;ACTN4;TRAF1;TMSB4X;TNFRSF25;EDAR;IKBKB;TNFSF8;CD40;TNFRSF1A;PSMA2;TNFRSF13C;TNFRSF8;PSMA8;TNFRSF9;PSMA6;RIPK1;RELA;BIRC3;ADAM17;TRAF6;PSME1;BAG4;BIRC2;STAT1;PSMA4;PSMF1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5737796939401248,1.3134086668109775,0.1606837606837607,0.6427807557154283,1.0,3/20,2.79%,EPAS1;DCUN1D3;HIF1A
prerank,negative regulation of anoikis (GO:2000811),0.6141112018742945,1.3126963889571424,0.16974789915966387,0.6437960427205188,1.0,4/14,7.98%,CAV1;NOTCH1;PTK2;ITGA5
prerank,regulation of postsynapse organization (GO:0099175),0.5417453410318536,1.3123880784476256,0.14950166112956811,0.6436540867974762,1.0,4/28,6.10%,SHANK3;ABI3;PPFIA2;WNT5A
prerank,cellular response to hormone stimulus (GO:0032870),0.4760127796313151,1.3120968360835217,0.10526315789473684,0.6434216164183323,1.0,16/69,6.62%,CAV1;MEF2C;LMO2;SOCS2;STAT3;NR3C1;NCOA1;XBP1;GHR;SERPINB9;RAMP2;ATP1A3;ATP1A1;SOST;INPP5K;NCOA4
prerank,regulation of interleukin-2 production (GO:0032663),0.5085798755242449,1.3115863376256547,0.12314540059347182,0.6438908455970103,1.0,7/43,3.95%,SPTBN1;PRKD2;HDAC7;PDE4D;CD34;PLCG2;HOMER2
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.6064417080049618,-1.3112325925040516,0.17408906882591094,0.5598897863644103,1.0,3/10,16.21%,PRKN;SNCA;MT3
prerank,regulation of membrane repolarization (GO:0060306),0.6122584171574463,1.3108629635272155,0.18299445471349354,0.6450173543621671,1.0,4/13,7.06%,CAV1;NEDD4L;KCNQ1;KCNE2
prerank,regulation of protein binding (GO:0043393),0.4399324813915225,1.3108339443102384,0.09266409266409266,0.6439578043573698,1.0,25/114,9.03%,CAV1;APP;EPB41;CLDN5;B2M;PDGFB;HIP1R;BTBD1;STK3;FKBP1A;TMBIM6;STK4;MARK3;RALB;DISC1;DTX3L;MAPK8;TCF7L2;AURKA;RAPGEF2;TRIB3;CTNNBIP1;PSEN1;CRK;ZFPM1
prerank,positive regulation of programmed cell death (GO:0043068),0.4009403050135644,1.3104402396456802,0.03218645948945616,0.6440565854864071,1.0,54/272,12.71%,FOXO1;TNFSF10;UNC13B;TGM2;NET1;DCUN1D3;ITGA6;MCF2L;DAPK1;ARHGEF3;RASGRF2;HIP1R;DAB2IP;ARHGEF2;FAS;STK3;CASP8;JMY;PLEKHG5;KALRN;STK4;PREX1;FOXL2;MAPK8;BOK;CTNNBL1;DNAJA1;BCL2L11;SPDEF;STPG1;NEUROD1;CRADD;PSEN1;ARHGEF7;MAP3K11;ARHGEF26;SOX4;TNFRSF8;SIAH1;SFRP2;ANO6;TFAP4;APH1A;BNIP3;ATF6;RNPS1;RIPK1;BID;RHOB;TNFAIP8;TRIO;GNA13;ARHGEF9;RACK1
prerank,neutrophil degranulation (GO:0043312),0.391986098395633,1.3102595141646372,0.021141649048625793,0.6434590414924677,1.0,79/425,15.52%,PTPRB;CTSC;RAB27A;PECAM1;LRG1;ATP8A1;CD93;B2M;PRCP;OSTF1;IQGAP1;ADAM10;STK10;ATP11B;PTPRJ;STOM;TNFRSF1B;ADGRG3;BST1;RAP1B;ADGRE5;FUCA2;CAT;ENPP4;LCN2;SDCBP;MCEMP1;CEACAM1;QSOX1;TSPAN14;SCAMP1;PTX3;NRAS;RAC1;PPBP;RAP1A;ATP6V0A1;PSMA2;NFKB1;ARMC8;DYNLL1;ATP11A;DYNC1LI1;PSEN1;GDI2;SNAP23;VAMP8;ANO6;SPTAN1;CPPED1;PGM2;GMFG;DEGS1;CYFIP1;ACTR2;APEH;PA2G4;GSTP1;STXBP3;DBNL;HSP90AB1;ACTR10;IMPDH1;PFKL;ERP44;AOC1;RAB31;RAB7A;RAB5B;ASAH1;RAB18;S100A9;HMOX2;SVIP;DGAT1;GGH;RAB6A;CEP290;APAF1
prerank,protein glycosylation (GO:0006486),0.4341108206887773,1.309954296261146,0.08312655086848635,0.6432219937395871,1.0,24/125,12.80%,ST3GAL6;SLC39A8;ST3GAL1;MGAT4A;STT3B;GALNTL5;GALNT18;EOGT;AQP11;B3GNT3;TET3;ALG10B;B3GNT4;ST8SIA4;ST6GALNAC2;B4GALT5;B4GAT1;B3GNT6;NUS1;MGAT5;DPAGT1;TET2;OGA;PMM2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5385090527697597,-1.3095047377935187,0.1722488038277512,0.5627716030505707,1.0,10/16,8.40%,IGF1;BMPR1A;FGFR2;TGFBR3;ERBB4;FGF2;ZFPM2;AKAP6;RBPJ;GLI1
prerank,smooth muscle contraction (GO:0006939),-0.542215997853724,-1.309468640546541,0.16590909090909092,0.5609779138342724,1.0,7/14,16.82%,ROCK2;EDNRA;SLC8A1;BDKRB2;ACTA2;ADRA1A;MYH11
prerank,protein dephosphorylation (GO:0006470),0.42538913203382467,1.309401894105462,0.08837772397094432,0.6437490490869421,1.0,24/135,8.37%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRM;PTPN12;PPP2R5A;PPP3CA;PTPRJ;PPM1F;MTM1;NCK1;SSH2;PPP1R12A;PTPRK;PPP2R2C;PPM1L;PPP3CB;MTMR6;DUSP22;PPM1D;DUSP16;PPP2R5E;PPP2R5B
prerank,production of siRNA involved in RNA interference (GO:0030422),0.6298321739899436,1.309386487726553,0.1978798586572438,0.6426899286494538,1.0,5/10,21.33%,DROSHA;DICER1;HENMT1;MRPL44;PRKRA
prerank,error-prone translesion synthesis (GO:0042276),0.5613022481337163,1.3086591084597616,0.17616580310880828,0.6438066605591839,1.0,4/21,10.15%,POLK;RPA1;PRIMPOL;MAD2L2
prerank,regulation of bone mineralization (GO:0030500),-0.4037566677858629,-1.30865890029485,0.07534246575342465,0.5613061018346167,1.0,17/55,7.75%,BMP6;BMPR1A;PTN;WNT4;BMP7;ENPP1;ADGRV1;OSR1;BMP4;GPM6B;SLC8A1;FBN2;BMP2K;CCN1;NOTUM;BCOR;ECM1
prerank,sprouting angiogenesis (GO:0002040),0.4923602534801474,1.3086246611830927,0.13609467455621302,0.6427912671484262,1.0,13/51,5.63%,TEK;KDR;ENG;EPHB4;ACVRL1;VEGFC;PTK2B;ADGRA2;FLT4;DLL1;VEGFD;GREM1;RAMP2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.4820479030691751,-1.3086077663687867,0.13520408163265307,0.5595814564238623,1.0,5/25,7.90%,ANK2;CEMIP;CACNB2;AKAP6;TRPC1
prerank,myofibril assembly (GO:0030239),0.5100892145758696,1.3085225315973177,0.13488372093023257,0.6420035059103352,1.0,3/42,3.98%,PGM5;FLII;TMOD3
prerank,plasma membrane repair (GO:0001778),0.6190207642122851,1.3084491087163994,0.18761384335154827,0.6411220610993423,1.0,2/13,2.11%,MYOF;MYH9
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.5391192104420872,1.3082373516241417,0.15615141955835962,0.6406776367673188,1.0,2/28,1.06%,SHANK3;APP
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.555920599711558,1.308100947069908,0.16129032258064516,0.6400208443080977,1.0,6/22,14.18%,B2M;STX7;MALT1;IL23A;CYRIB;TRAF6
prerank,membrane organization (GO:0061024),0.4101840432584167,1.307879516096905,0.04664391353811149,0.6396305075784329,1.0,44/227,12.04%,DNM3;MYOF;FNBP1L;CERT1;SPTBN1;EPN2;HIP1;HIP1R;FZD4;REEP1;LPCAT3;PIK3C2A;FCHO2;ARPC3;GLTP;AP2B1;VAMP4;CCDC88A;CHMP2B;WNT5A;DCSTAMP;SH3GLB1;ARRB1;ATP2C1;TGFA;SNX3;AP2A1;IL7R;SYNJ1;CHMP4A;CHMP4B;PLEKHA8;SNAP23;GAPVD1;OCRL;VAMP8;A4GALT;SCARB2;CBL;PICK1;PICALM;M6PR;CORO1C;ACTR2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.5397685629513933,-1.3078077411032094,0.14965986394557823,0.5599273797256187,1.0,7/15,9.73%,UST;DSE;DCN;BGN;CSPG4;VCAN;DSEL
prerank,respiratory system development (GO:0060541),-0.44688862397143964,-1.3077759753760547,0.11602209944751381,0.5581611184853261,1.0,12/32,12.70%,FGFR2;GLI2;FGF1;PDPN;BMP4;RBP4;LOXL3;FGF2;VEGFA;STRA6;FGF7;CCDC39
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5792032702481595,1.3073671525358765,0.16958041958041958,0.6401519739663875,1.0,4/18,5.74%,ELOVL7;ACSL4;ELOVL5;ACSL5
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.529113760490814,-1.307181518945814,0.1728110599078341,0.5581882873771441,1.0,5/14,27.02%,MOXD1;DAGLA;SLC22A2;DAGLB;SLC5A7
prerank,regulation of lamellipodium assembly (GO:0010591),0.5165982265556865,1.3069768675239573,0.15615141955835962,0.640283927161585,1.0,11/34,15.76%,ABI3;OCLN;WASF2;NCKAP1;RAC1;TWF2;FSCN1;CYFIP1;ACTR2;ACTR3;ARPC2
prerank,regulation of macrophage cytokine production (GO:0010935),0.6234646156166528,1.3068614545091366,0.19521178637200737,0.6395278811807267,1.0,5/13,7.33%,SEMA7A;PLCG2;CUEDC2;WNT5A;TGFB1
prerank,neutrophil activation involved in immune response (GO:0002283),0.3906473211647705,1.3067458154588316,0.020105820105820106,0.6387923878428536,1.0,79/428,15.52%,PTPRB;CTSC;RAB27A;PECAM1;LRG1;ATP8A1;CD93;B2M;PRCP;OSTF1;IQGAP1;ADAM10;STK10;ATP11B;PTPRJ;STOM;TNFRSF1B;ADGRG3;BST1;RAP1B;ADGRE5;FUCA2;CAT;ENPP4;LCN2;SDCBP;MCEMP1;CEACAM1;QSOX1;TSPAN14;SCAMP1;PTX3;NRAS;RAC1;PPBP;RAP1A;ATP6V0A1;PSMA2;NFKB1;ARMC8;DYNLL1;ATP11A;DYNC1LI1;PSEN1;GDI2;SNAP23;VAMP8;ANO6;SPTAN1;CPPED1;PGM2;GMFG;DEGS1;CYFIP1;ACTR2;APEH;PA2G4;GSTP1;STXBP3;DBNL;HSP90AB1;ACTR10;IMPDH1;PFKL;ERP44;AOC1;RAB31;RAB7A;RAB5B;ASAH1;RAB18;S100A9;HMOX2;SVIP;DGAT1;GGH;RAB6A;CEP290;APAF1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.5379024238742158,-1.3066854984673124,0.1585081585081585,0.5577834215967264,1.0,8/16,20.81%,PYGB;PHKB;PYGM;GAA;AGL;AOAH;PHKA2;PHKG1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5923944080357357,1.3060552309379418,0.1623931623931624,0.6397907710306063,1.0,4/19,2.97%,TJP1;NEXMIF;NOTCH1;PPM1F
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.5236361070308401,1.3050684025794632,0.1500789889415482,0.6418138584284451,1.0,10/33,12.17%,ACER2;NEXMIF;LYN;EFNA1;RET;PIK3CG;PTK2;SFRP2;P2RY12;MUC1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5615593918160868,1.3047555342637798,0.1582608695652174,0.6416790230399343,1.0,3/21,3.70%,PPP1R16B;MFHAS1;FKBP1A
prerank,negative regulation of programmed cell death (GO:0043069),0.3944943679186794,1.3041553227063396,0.04148471615720524,0.6423675497879164,1.0,78/355,14.50%,MECOM;LEF1;TEK;TJP1;FOXO1;CD38;KDR;IL6ST;RNF144B;SOCS2;PIM3;ADAM10;FAS;PTK2B;NFKBIA;FLT4;AMIGO2;PAK2;BABAM2;CAT;SOX9;RPS6KA3;TMBIM6;IKBKB;RPS6KA1;XBP1;GREM1;MAPK8;SERPINB9;PLK2;XIAP;WNT5A;DNAJA1;AVEN;TIGAR;HNRNPK;PTK2;RASA1;BCL3;BNIP2;NFKB1;MALT1;PSEN1;AKT2;RHBDD1;BCL2L1;HIGD2A;EGR3;SEMA4D;GAS6;BNIP3;CBL;IL7;PIM1;THOC6;RIPK1;TMBIM4;TMIGD1;BID;RELA;TNFAIP8;RIPK2;PRDX2;PA2G4;GSTP1;RPL10;BIRC3;PHIP;MET;PTMA;IGF1R;RAB7A;HIGD1A;NPM1;TRAF6;PROC;ERC1;TOPORS
prerank,regulation of JNK cascade (GO:0046328),0.44734480662631904,1.3040405132880293,0.09056122448979592,0.6416406021366987,1.0,15/101,6.08%,MECOM;APP;TNFRSF19;DAB2IP;MFHAS1;PTK2B;TPD52L1;TAOK2;PLCB1;TRAF1;FLT4;TIRAP;EDAR;SDCBP;DUSP22
prerank,positive regulation of cellular catabolic process (GO:0031331),0.4281597707450165,1.303424961755881,0.07466340269277846,0.6424264924077248,1.0,30/132,11.84%,FOXO1;APP;PRKD1;INSR;DAPK1;SH3BP4;TRIM14;HIF1A;MSN;PFKFB3;TNFRSF1B;PIK3C2A;PLIN5;VGLL4;DTX3L;TRIM68;PLK2;ULK1;PRR5L;MID2;SH3GLB1;PSEN1;AKT2;PTPN1;NPRL2;CNOT1;BNIP3;RC3H1;ATF6;ABCD1
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.5089690933718369,-1.3027059655704263,0.15227272727272728,0.5674435306946641,1.0,6/18,9.97%,PDPN;SMAD3;EFEMP2;RUNX1;RGCC;DDR2
prerank,glycine transport (GO:0015816),0.6439608467868346,1.3022614158829422,0.20675944333996024,0.6449821930511889,1.0,2/10,2.68%,SLC6A5;SLC38A5
prerank,T cell activation (GO:0042110),0.45871098953874984,1.301648993028716,0.125,0.6456658414322437,1.0,16/69,10.70%,LFNG;LCP1;CTPS1;PPP3CA;MSN;NCK1;CHD7;CASP8;FKBP1A;DLL4;PPP3CB;LCK;PIK3CG;SOX4;ICOSLG;JAG2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3801734333500174,1.301284037955353,0.002008032128514056,0.6456639551741242,1.0,185/1082,12.41%,MECOM;ERG;LEF1;MRTFB;ELK3;FLI1;RPS6KA5;FOXO1;EPAS1;CD38;PBX1;BMPR2;LDB2;ENG;ITGA6;TBX1;ESR1;SMARCA2;APP;PPARD;MEF2C;ZBTB16;LMO2;ACVRL1;PRKD1;NR5A2;CRTC1;MAML2;AHR;SMAD1;ZIC3;NFATC1;PDGFB;NLRC5;IRF2;GATA2;DAB2IP;ELF2;MLLT3;FZD4;EDN1;HHEX;ARHGEF2;LRP5;TAL1;PRKD2;STAT3;NR3C1;PPP3CA;NOTCH1;HIF1A;KLF7;RREB1;AFAP1L2;NFKBIA;CCNK;KDM3A;SOX17;NCK1;WWTR1;PLCB1;SOX18;TCF12;PPP1R12A;FOSL2;MAFF;SOX9;MRTFA;NCOA1;DLL1;RPS6KA3;KLF2;FOXF1;SS18;ELK4;IKBKB;RPS6KA1;DTX3L;FOXL2;XBP1;TET3;EPC1;KMT2E;SMAD7;ACVR2A;SPIN1;GREM1;FOXF2;SBNO2;ARID1B;HOXA10;RET;MTF2;LPIN3;TCF7L2;TCF4;TEAD2;PITX3;PPP3CB;ESRRG;CHP2;WNT5A;CNBP;SKAP1;ATF7IP;TOX3;ATMIN;KLF10;ACVR1;NR1I3;FOXA3;FOSL1;IRF2BPL;SOST;CD40;INPP5K;HNF1B;DYRK1A;ETS2;JUNB;LYL1;ARRB1;RBM14;TNFRSF1A;TGFB1;HOXD8;BCL3;TCF3;AGRN;HNRNPD;NFKB1;PCBD2;ARID1A;PKD2;NEUROD1;CITED1;NRL;RPTOR;KAT6B;SMARCA5;PSEN1;CREB1;FOXK1;ZFPM1;BRD4;PCGF5;IER2;TCF15;SOX4;IKBKG;MAP2K3;MAFB;RNF4;EDRF1;NFIB;CREB3L4;NRIP1;MAD2L2;SMAD5;SFRP2;USF2;TNIP1;GLYR1;TFAP4;POU2F1;GABPB1;CSRNP1;MC1R;MMS19;GLMP;ZMIZ1;ENY2;ATF6;SP3;GRIN1;PICALM;RIPK1;PRDM2;ACTR2;RPRD1B;ASXL1;RELA;RIPK2;MAX;TET2
prerank,negative regulation of ossification (GO:0030279),0.5530941432262234,1.3004230133515546,0.1607717041800643,0.6472913168220851,1.0,8/23,7.03%,MEF2C;PTK2B;NOTCH1;FGF23;SOX9;GREM1;SOST;SRGN
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5218670381862851,1.3002307564160653,0.16639477977161501,0.6467980547398466,1.0,10/32,17.07%,CDK17;POLA1;CDT1;BRD4;BACH1;CDK18;RB1;ESRRB;E2F7;KLF11
prerank,negative regulation of cell growth (GO:0030308),0.4304160112711795,1.2992095422138206,0.09476309226932668,0.648872457363211,1.0,19/121,7.33%,BMPR2;DCUN1D3;APBB2;SMARCA2;ACVRL1;SH3BP4;NPR1;PTPRJ;SOX17;DIP2B;PPP1R9B;VGLL4;ULK1;ADAM15;JADE1;FBP1;DCSTAMP;CDKN1B;TGFB1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3897814950841641,1.2991802190932071,0.024704618689581095,0.6478946912256527,1.0,74/390,9.65%,NRP2;TEK;FOXO1;PTPRG;FLT1;KDR;TIE1;EPHB4;ANKS1A;PRKD1;INSR;PDGFB;NEDD9;VEGFC;DOCK1;ELMO1;WASF2;SOCS2;LYN;PRKD2;STAT3;EFNA1;PDGFD;PTK2B;DDIT4;YES1;PTPRJ;MPZL1;MTSS1;FYN;PIK3C2A;NCK1;PLCB1;PXN;SRMS;FLT4;CAV2;PAK2;FGF23;SH2B2;SORBS1;KALRN;LMTK2;GRB14;ARPC3;SDCBP;AP2B1;NCKAP1;VEGFD;GHR;RET;ARPC1B;HNRNPF;RAPGEF2;GTF2F2;RAC1;BCAR3;PDGFC;LCK;PTK2;RASA1;AP2A1;GRB7;ATP6V0A1;GAB1;SHOC2;PSEN1;AKT2;ARHGEF7;CRK;ATP6V1G2;CEP57;CSF1;MAPKAPK3
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.5989274509341053,1.299168626303818,0.18874773139745918,0.6468640149388055,1.0,6/15,22.83%,ERN1;TSEN34;RTCB;CPSF1;TSEN2;RTRAF
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5425329528301822,1.2991041422323624,0.15569823434991975,0.6460155104859278,1.0,9/26,20.57%,OCLN;RAC1;TRPV4;MET;PAK1;CDK5RAP2;CLIP1;NUMA1;RPS3
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5917923913370093,1.299027524195419,0.17281879194630873,0.6451610776783854,1.0,4/19,3.91%,KDR;VCAM1;PTPRJ;SELP
prerank,peptidyl-serine modification (GO:0018209),0.4169351622169182,1.298766550070809,0.07866507747318235,0.644941733532162,1.0,38/166,13.03%,PRKCH;RPS6KA5;PRKD1;PDGFB;PRKD2;PKN3;PKN2;PAK2;PKN1;RPS6KA3;STK4;LMTK2;MARK3;IKBKB;RPS6KA1;HIPK1;MAPK8;PLK2;MAST2;ULK1;AURKA;DYRK1A;SGK3;AKT2;NEK6;CDK2;RICTOR;MAPKAPK3;PARP2;GAS6;AKT3;MAP3K13;STK38;MKNK2;NAA11;TGFBR2;TOP1;UHMK1
prerank,mesoderm formation (GO:0001707),0.5872266390039079,1.2977442517531632,0.19137931034482758,0.6469863972079902,1.0,4/17,11.77%,BMPR2;ITGA3;ITGA2;ITGB3
prerank,regulation of chromatin binding (GO:0035561),0.6562067880794981,1.2977053030525332,0.18609022556390978,0.6460475571732783,1.0,8/10,29.97%,HMBOX1;DTX3L;CDT1;PARP9;MED25;GMNN;DDX11;BTAF1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4312255750921181,1.2969293620096225,0.10891089108910891,0.6474788540362445,1.0,20/117,11.15%,CALCRL;CYSLTR1;ADCY4;PLCG1;MYH9;LYN;YES1;GNB1;FYN;PRKAR2B;PLCG2;ADRB1;RAMP2;PLK2;PLA2G2D;CREB1;INSL3;FCGR1A;MC4R;MC1R
prerank,aortic valve morphogenesis (GO:0003180),0.5264741189530489,1.2962759503567176,0.16293929712460065,0.6484629970395228,1.0,9/30,7.33%,NOS3;TIE1;NFATC1;EFNA1;NOTCH1;ELN;SOX9;DLL4;TGFB1
prerank,positive regulation of lipid transport (GO:0032370),-0.551924460786971,-1.295780797865774,0.1875,0.5853079465715992,1.0,3/12,9.84%,LRP1;SPP1;APOE
prerank,regulation of transmembrane transport (GO:0034762),0.5279286360976378,1.2954856396070904,0.15877862595419848,0.6497851455090804,1.0,6/31,7.82%,SLC2A1;CTTNBP2NL;OCLN;NEDD4L;TRIB3;NEDD4
prerank,positive regulation of histone deacetylation (GO:0031065),0.6367060403575067,1.2953425175512823,0.19413919413919414,0.649147054250979,1.0,4/12,10.44%,PRKD1;PRKD2;CTBP1;APLNR
prerank,negative regulation of developmental process (GO:0051093),0.4641748239388568,1.2953162570319043,0.125,0.6481657515928178,1.0,16/69,11.75%,NOS3;TBX1;CDK6;ARHGEF15;NOTCH1;KLF7;SOX9;DLL1;GREM1;WNT9B;TGFB1;NFIB;GAS6;BNIP3;RC3H1;SINHCAF
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.4611141971477832,-1.295216203405177,0.14285714285714285,0.584979335241798,1.0,3/27,6.12%,LPAR1;GRM1;AGTR1
prerank,gliogenesis (GO:0042063),0.6093379799886187,1.2952119886768378,0.1808695652173913,0.6474686228161732,1.0,7/15,17.83%,CDK6;CDH2;NFIB;NDUFS2;CD9;MMP24;METTL14
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.507149294262533,1.2942844796728752,0.14599686028257458,0.6492914128000451,1.0,7/33,11.87%,LEF1;CASP8;DCSTAMP;CTNNBIP1;CSF1;IL23A;RIPK1
prerank,sensory perception of sound (GO:0007605),-0.3728397208831305,-1.2938277496542476,0.07792207792207792,0.5871802181323001,1.0,18/88,8.33%,EYA1;ROR1;COL1A1;CEMIP;COL4A3;ADGRV1;COL11A1;EML2;DCDC2;KIT;CACNA1D;GRM7;GSDME;ATP6V0A4;PCDH15;WHRN;ALDH7A1;RIPOR2
prerank,regulation of amyloid-beta formation (GO:1902003),-0.440431829988008,-1.293706763705921,0.11171662125340599,0.5856593907182048,1.0,8/34,9.84%,IGF1;ROCK2;SLC2A13;LRRTM3;NTRK2;RTN1;BIN1;APOE
prerank,positive regulation of signaling (GO:0023056),-0.42827637650396766,-1.293344781188747,0.10876132930513595,0.5847228927672405,1.0,10/37,15.20%,WLS;CLSTN2;DLG4;SYT1;ANXA2;PTPN23;RAB29;GRIK2;SNCA;RIMS1
prerank,regulation of apoptotic process (GO:0042981),0.38052708941722063,1.2928393091342643,0.01023541453428864,0.6527902442414332,1.0,131/676,12.98%,LEF1;TEK;TJP1;FOXO1;CD38;ACER2;TNFSF10;UNC13B;TGM2;NET1;KDR;IL6ST;DCUN1D3;ITGA6;MEF2C;PPP1R13B;MCF2L;DAPK1;ARHGEF3;RASGRF2;RNF144B;HIP1;HIP1R;DAB2IP;ARHGEF2;SOCS2;PIM3;ADAM10;FAS;ANP32A;PTK2B;NFKBIA;GLS2;ACTN4;STK3;CASP8;JMY;FLT4;PAK2;BABAM2;CAT;SOX9;TNFRSF25;PLEKHG5;ACTN1;RPS6KA3;TMBIM6;KALRN;STK4;JAK3;IKBKB;RPS6KA1;PREX1;FOXL2;XBP1;GREM1;MAPK8;SERPINB9;PLK2;XIAP;BOK;WNT5A;TOX3;CTNNBL1;STK26;DNAJA1;BCL2L11;AVEN;SPDEF;HNRNPK;PTK2;RASA1;BCL3;BNIP2;STPG1;NFKB1;MALT1;NEUROD1;CASP1;CRADD;NF2;CITED1;RBM25;PSEN1;AKT2;TRIM24;ARHGEF7;MAP3K11;SLK;ARHGEF26;RHBDD1;SOX4;TNFRSF8;BCL2L1;HIGD2A;SIAH1;SFRP2;EGR3;SEMA4D;ANO6;TFAP4;GAS6;APH1A;BNIP3;CBL;IL7;ATF6;RNPS1;PIM1;THOC6;RIPK1;TMBIM4;TMIGD1;BID;NOP53;RHOB;RELA;TNFAIP8;RIPK2;TRIO;GNA13;PRDX2;ARHGEF9;PA2G4;GSTP1;RPL10;RACK1;BIRC3;PHIP;PTMA;SIGMAR1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.5092318428465294,1.2918431129325452,0.14723032069970846,0.6547528039485226,1.0,17/36,20.12%,AQP11;SDCBP;N4BP1;EIF3H;UCHL5;OPHN1;NOP53;HSP90AB1;UBXN1;GIPC1;RYBP;PRKCG;RPL11;USP7;PSMF1;USP25;TAF9
prerank,prostaglandin metabolic process (GO:0006693),0.528859287252035,1.2917042687094626,0.16943521594684385,0.6540494986885462,1.0,4/26,5.09%,PTGS2;PLA2G4A;EDN1;PTGS1
prerank,regulation of cellular component organization (GO:0051128),0.421184250001525,1.2914810448069856,0.08491761723700887,0.6536545133274897,1.0,27/135,11.71%,TJP1;NET1;HIP1;HIP1R;DAB2IP;MLLT3;SOCS2;RAP1B;TAOK2;CEACAM1;OPHN1;AURKA;WNT5A;RAPGEF2;CISH;SNCAIP;RAP1A;NEDD4;CAMSAP2;RPTOR;SGK3;PTPN1;MAD2L2;SEMA4D;ABL2;IL17RB;PICALM
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5964020855780655,1.2912930007443062,0.1944954128440367,0.6531225469946637,1.0,9/14,22.93%,TIRAP;HNRNPA0;YBX3;ANGEL2;HNRNPC;ZFP36;DAZL;ELAVL1;MAPK14
prerank,positive regulation of signal transduction (GO:0009967),0.4008113203741361,1.29106421689125,0.05849268841394826,0.6527848731939054,1.0,40/238,9.08%,VWF;SHANK3;TEK;NOS3;IL6ST;ERN1;MAML2;EPN2;LIMS2;DAB2IP;HHEX;PRKD2;JCAD;FAS;STAT3;PTK2B;NOTCH1;HIF1A;TSPAN5;TPD52L1;CAV2;SORBS1;DLL1;KLF2;F7;DISC1;XBP1;SPIN1;DLL4;TSPAN14;UCHL5;SASH1;AGPAT1;ITGA5;PKD2;CRADD;DEPDC1B;IL7R;ZRANB1;IHH
prerank,axon guidance (GO:0007411),0.40689956916119696,1.2909731341516661,0.05895691609977324,0.6520195339255305,1.0,39/201,10.82%,NRP2;SHANK3;SEMA6A;RPS6KA5;PLXNA4;NTN1;SEMA5B;EPHB4;SPTBN1;PTPRM;SEMA7A;PLCG1;EFNA1;NOTCH1;PLXND1;KLF7;BSG;FYN;LAMA3;ROBO4;EVL;LAMA1;SEMA6B;RET;OPHN1;WNT5A;RAC1;PTK2;GRB7;GAB1;SEMA6D;FEZ2;DSCAM;NFIB;SIAH1;SEMA4D;CXCR4;SPTAN1;EPHA4
prerank,regulation of cholesterol efflux (GO:0010874),0.5158550628666992,1.290965014876855,0.1758957654723127,0.6509950682432702,1.0,5/30,5.76%,CAV1;PLTP;NFKBIA;EEPD1;ABCA3
prerank,neural crest cell migration (GO:0001755),0.5154268634463703,1.290492984397944,0.16843702579666162,0.6513645687304632,1.0,4/36,1.68%,SEMA6A;TBX1;SEMA5B;SEMA7A
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5903571098843394,1.2901628276208317,0.198943661971831,0.6513383635342828,1.0,2/18,2.59%,SHANK3;PTK2B
prerank,glycoprotein biosynthetic process (GO:0009101),0.4550229891553931,1.2898836481201237,0.11140939597315436,0.651119526528403,1.0,11/79,8.79%,ST3GAL6;CSGALNACT1;BMPR2;GALNTL5;B3GNT3;ALG10B;B3GNT4;ST8SIA4;ST6GALNAC2;B4GALT5;B3GNT6
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.5837942230527944,1.2894493339207258,0.18760757314974183,0.6513132096196484,1.0,7/18,13.92%,TEK;PTK2B;RAP1B;LLGL1;CYRIB;RACK1;CDH5
prerank,actin filament capping (GO:0051693),0.5755752401873716,1.288843550729147,0.20335820895522388,0.6511216598952136,1.0,2/18,1.54%,FLII;EPS8
prerank,barbed-end actin filament capping (GO:0051016),0.5755752401873716,1.288843550729147,0.20335820895522388,0.6511216598952136,1.0,2/18,1.54%,FLII;EPS8
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.4850661945943293,-1.2881728379499011,0.13861386138613863,0.598017855934008,1.0,9/21,12.17%,BMP6;BMPR1A;TGFBR1;BMP4;CCN3;DAB2;SLC2A10;TGFB3;NUP93
prerank,regulation of synapse assembly (GO:0051963),-0.41004783155619173,-1.2879784686811266,0.0990990990990991,0.5966620522364863,1.0,15/46,12.91%,GPC6;NLGN2;CLSTN2;CUX2;PTPRD;ROBO2;IL1RAPL1;LRFN5;NRXN1;NLGN1;NLGN3;GPC4;MDGA1;SRPX2;GRID2
prerank,cellular response to light stimulus (GO:0071482),0.4632794812080132,1.287953706857382,0.15083798882681565,0.6527287253504878,1.0,20/66,19.01%,POLK;GNB1;CNGB1;PTPRK;N4BP1;OPN4;GNAT1;NEDD4;RHBDD1;OPN5;EIF2AK4;ERCC4;PDE6B;FMR1;NPM1;YY1;BMF;KDM1A;BAK1;DHX36
prerank,positive regulation of interleukin-6 production (GO:0032755),0.454552570108258,1.287680983471407,0.14112903225806453,0.6524909693807591,1.0,9/68,8.24%,APP;IL6R;ARHGEF2;STAT3;PLCG2;TIRAP;XBP1;WNT5A;LPL
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4768247043587819,1.2875000737527191,0.14644351464435146,0.6520815097808472,1.0,5/49,4.28%,NOD1;PRKD2;STAT3;AFAP1L2;TIRAP
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5708995849399269,1.2874988600110873,0.1865546218487395,0.651049803180188,1.0,3/18,1.87%,FLT1;MEF2C;PLCG1
prerank,dendritic spine organization (GO:0097061),0.5433637226509509,1.287451158538297,0.18495297805642633,0.6501498841243372,1.0,7/26,13.47%,SHANK3;INSR;FYN;ITGA3;PICK1;LGMN;IGF1R
prerank,ceramide catabolic process (GO:0046514),0.6062015362688684,1.2874210308732248,0.2036697247706422,0.6491944883109151,1.0,2/14,5.50%,ACER2;ASAH2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6154822742201003,1.2874018885465308,0.21061946902654868,0.6482471024796023,1.0,4/12,13.34%,CAV1;RALB;CGAS;IFIH1
prerank,regulation of cell population proliferation (GO:0042127),0.3796543241442131,1.2873077708846181,0.01639344262295082,0.6474920775307778,1.0,109/691,10.70%,LEF1;TJP1;TBC1D8;NOS3;FLT1;ACER2;PTPN14;BMPR2;KDR;IL6ST;ENG;TBX1;LIFR;SMARCA2;APP;CBFA2T3;IL15;STX3;SOX7;ACVRL1;CLDN5;CD200;CDK6;INSR;KITLG;PLPP1;PDGFB;VEGFC;SH3BP4;ADARB1;IL6R;DAB2IP;EDN1;HHEX;ARHGEF2;LRP5;LYN;OSMR;ADAM10;STAT3;PDGFD;TNFRSF11A;PTK2B;NOTCH1;CNOT6;PTPRJ;BST1;AQP11;WWTR1;CNOT6L;ELN;FLT4;ADGRG1;FGF23;SOX9;TES;DLL1;PPP1R9B;SDCBP;XBP1;VEGFD;GNAI2;BTG3;PTPRK;GREM1;DLL4;XIAP;TCF7L2;BOK;CCDC88A;DUSP22;CHP2;CNBP;RAPGEF2;KLF10;FOSL1;KRAS;CDKN1B;JUNB;PDGFC;PPM1D;TGFB1;PTK2;TGFA;PKD2;KDM4C;RNF139;NF2;CTBP1;SGK3;AKT2;IL7R;PINX1;RPL23;CDK2;SOX4;CSF1;SST;TNFRSF8;BTG2;TNFRSF9;DHPS;CYP27B1;SFRP2;CCL14;NUAK1;TFAP4;NMI;JAG2
prerank,ncRNA transcription (GO:0098781),0.6040947056580009,1.2871825888252761,0.195578231292517,0.646880406885784,1.0,7/13,16.50%,CAVIN1;SPIN1;ANG;NIFK;SNAPC3;POLR1G;GTF3C1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.42885009238030825,1.2866696899182664,0.11567164179104478,0.6473288032259722,1.0,14/116,5.63%,CALCRL;CYSLTR1;ADCY4;PLCG1;MYH9;LYN;YES1;GNB1;FYN;PRKAR2B;PLCG2;ADRB1;RAMP2;PLK2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.5296911663210073,1.2865337053969177,0.15136876006441224,0.6467292293936807,1.0,9/27,14.48%,ERN1;RNASE1;RNASE4;KHNYN;NUDT16;DICER1;RPP30;ZC3H12C;TRIR
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.43236928808513614,1.2863438659631226,0.11959287531806616,0.6462685469866778,1.0,22/100,9.18%,TEK;FLT1;KDR;PPP1R16B;INSR;PDGFB;PIP5K1B;DAB2IP;LYN;PDGFD;SELP;SOX9;PIK3IP1;IER3;CEACAM1;PDGFC;PIK3CG;PTK2;NEDD4;GAB1;PPP2R5B;FBXL2
prerank,signal transduction by p53 class mediator (GO:0072331),0.5179655765803244,1.286200748067741,0.18760195758564438,0.6456692126732257,1.0,8/30,9.31%,ACER2;PPP1R13B;JMY;GREM1;BOK;BCL3;MYBBP1A;HINT1
prerank,positive regulation of organelle assembly (GO:1902117),0.48777936554359186,1.285961147955373,0.142433234421365,0.645366311353276,1.0,11/44,11.14%,LCP1;CNOT6;CNOT6L;RALB;SDCBP;CCDC88A;SH3GLB1;G3BP1;CNOT1;FSCN1;CNOT2
prerank,regulation of T cell cytokine production (GO:0002724),0.6095412011550535,1.285699756501966,0.20415879017013233,0.6451235038355406,1.0,4/15,8.24%,B2M;TNFRSF1B;SMAD7;MALT1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.41987318638444443,1.2856064964002882,0.08684863523573201,0.6444007977819577,1.0,41/136,19.86%,ESR1;CD200;NLRC5;DAB2IP;FZD6;AIM2;SIK1;ADGRG3;NFKBIA;SIGIRR;TMSB4X;ID1;SMAD7;TCF7L2;EGLN1;ARRB1;CTNNBIP1;PKD2;TAF3;MAD2L2;GAS6;RB1;NFKBIE;PIM1;EIF2AK4;TRIB1;LRRC14;PEX14;IRAK3;DDIT3;OTULIN;CHP1;MAP2K5;ERBIN;IRAK2;USP7;KDM1A;NLRP3;HAVCR2;TAX1BP1;HES1
prerank,keratan sulfate metabolic process (GO:0042339),0.5130497644905786,1.2855757776165206,0.17054263565891473,0.6435018075334852,1.0,8/31,10.18%,ST3GAL6;ST3GAL1;B3GNT3;B4GALT4;B3GNT4;B4GALT5;B4GAT1;SLC35D2
prerank,negative regulation of cartilage development (GO:0061037),-0.5380071159075238,-1.284988134576511,0.18763326226012794,0.6032233624950142,1.0,4/13,4.01%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.48722684144641254,1.284909783313606,0.14545454545454545,0.6443979702800521,1.0,9/45,12.18%,VCAM1;ICAM1;B2M;IRF2;TRIM68;JAK1;TRIM25;FCGR1A;OASL
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.6135531472947191,1.2849011120270508,0.19023569023569023,0.6434282946087493,1.0,6/14,12.36%,PRKD2;NECTIN2;TESPA1;LCK;IKBKG;RELA
prerank,maturation of SSU-rRNA (GO:0030490),0.5163071660575838,1.2847946878946719,0.1723027375201288,0.6427420331306011,1.0,18/34,26.03%,RPS19;RPS14;RPS16;RPS8;HELB;UTP4;NOL10;RIOK1;SRFBP1;UTP6;HEATR1;NOP14;RIOK2;RPS28;NGDN;RIOK3;MRPS11;WDR46
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5947563995373312,1.284690361526128,0.2250453720508167,0.6420399874027557,1.0,1/13,0.26%,ENTPD1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.5017543016874144,1.284585764545147,0.1563845050215208,0.6413531106516352,1.0,5/39,9.89%,MYRIP;ACSL4;TCF7L2;SOX4;UCN
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.455607575388819,1.2841658665703062,0.14479025710419485,0.6415852138916759,1.0,13/73,8.28%,ACER2;NOD1;TNFSF10;HIP1;HIP1R;FAS;CASP4;CASP8;BOK;CYCS;LCK;CASP1;CRADD
prerank,vasculature development (GO:0001944),0.5757451974750042,1.2836396663270022,0.18181818181818182,0.642161720537791,1.0,6/16,4.47%,BMPR2;ACVRL1;FBXW7;SOX18;FLT4;FOXF1
prerank,positive regulation of cell differentiation (GO:0045597),0.40488763218964674,1.28351177020081,0.060267857142857144,0.641537680034567,1.0,48/237,10.36%,PRKCH;LEF1;ZHX3;BMPR2;KDR;IL6ST;PPARD;MEF2C;ZBTB16;ACVRL1;PRKD1;KITLG;IL6R;ARHGEF2;LRP5;WWTR1;PLCB1;CD34;SOX9;CDH2;RPS6KA3;SLC6A6;SDCBP;RPS6KA1;XBP1;CEACAM1;ACVR2A;CTNNA1;TCF4;RAPGEF2;ACVR1;TGFB1;RAP1A;BRINP2;TCF3;BNIP2;NFKB1;CTNNBIP1;CDH15;LPL;NEUROD1;CREB1;TCF15;CSF1;SPAG9;MAPK11;SFRP2;CCDC71L
prerank,eye development (GO:0001654),-0.39279203758836295,-1.2834088530024998,0.0946372239747634,0.6060509128719459,1.0,14/54,11.96%,CACNA1C;FBN1;SMOC1;COL5A1;EFEMP1;MEIS1;RBP4;SH3PXD2B;FBN2;HIPK2;PBX4;PBX3;TGFB2;STRA6
prerank,actin filament organization (GO:0007015),0.4102108261715534,1.2832426489051962,0.11124546553808948,0.6412773809944496,1.0,24/151,8.54%,FLII;SHROOM4;LCP1;EPS8;MYO1D;CD2AP;NEDD9;ELMO1;HIP1;HIP1R;ARHGEF2;SHROOM2;SHROOM1;TMOD3;EVL;ACTN1;PLS3;PPP1R9B;ARHGAP17;RAC1;TPM3;TRPV4;RHOBTB1;MYO1E
prerank,vascular transport (GO:0010232),-0.36512646133975746,-1.2831932065796963,0.07407407407407407,0.6047348415219714,1.0,19/81,5.16%,ATP1A2;SLC24A3;SLC7A2;LRP1;SLC6A13;SLCO3A1;SLC1A3;SLC16A12;SLC13A3;LEPR;SLC2A13;SLC22A8;SLC12A2;SLC6A1;SLC1A5;SLC6A9;ABCC9;SLCO1C1;SLC5A3
prerank,primary alcohol metabolic process (GO:0034308),-0.45968130778181476,-1.2831416991900897,0.13432835820895522,0.6029334693308483,1.0,5/25,4.89%,IGF1;RBP4;DHRS3;CYP1B1;NAAA
prerank,heterocycle biosynthetic process (GO:0018130),0.5935043235036832,1.282910607716787,0.20222634508348794,0.6413452829676263,1.0,3/14,9.92%,GCH1;GPHN;MOCOS
prerank,nucleosome assembly (GO:0006334),0.5311941168097563,1.2825515670439527,0.17011128775834658,0.6414097565687666,1.0,11/31,16.51%,SOX9;PADI4;H3-3A;KAT6B;SMARCA5;HAT1;NAP1L4;GRWD1;NPM1;ATRX;ANP32B
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.33820819019351844,-1.28250396484804,0.0449438202247191,0.6029355318520948,1.0,29/142,13.08%,ATP1A2;CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;EDNRA;DLG4;ADRA1B;CCR9;SLC8A1;SLC35G1;CD55;SMAD3;TRPC3;AGTR1;PRKACA;TRPC6;TRPC1;BDKRB2;PTGDR;RYR2;PTGFR;TRPC4;TBXA2R;S1PR3;ADRA1A;TRPC5;GPER1
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5706756597358276,-1.2822297164688266,0.19721577726218098,0.6018669722300058,1.0,5/11,16.45%,ATP9A;LRRK2;SRC;MAP2K2;MAP2K1
prerank,positive regulation of defense response (GO:0031349),0.44094140525396497,1.2821212019243848,0.11857707509881422,0.6417296896910626,1.0,14/89,11.87%,APP;MEF2C;IL15;PDE2A;GBP5;NFKBIZ;NFKBIA;WNT5A;TNFRSF1A;LPL;IL23A;TNIP1;NMI;RIPK1
prerank,vitamin D metabolic process (GO:0042359),0.6036957462009266,1.2820479390354782,0.18374558303886926,0.6409746008651679,1.0,4/13,11.80%,FGF23;CYP27B1;CYP2R1;LGMN
prerank,receptor-mediated endocytosis (GO:0006898),0.419491940223718,1.2820269719855435,0.11594202898550725,0.6400615099226453,1.0,15/132,5.63%,DNM3;CALCRL;FNBP1L;CAV1;INSR;HIP1R;SCARB1;STAB1;ARHGAP27;CAV2;FCHO2;DLL1;AP2B1;SCARF1;RAMP2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5833858855156709,-1.2816759814292562,0.18410041841004185,0.6015358337171927,1.0,4/10,13.12%,ATP1A2;ADRA2A;BIN1;VDAC1
prerank,response to hydroxyurea (GO:0072710),0.6337122211496206,1.2816231480953688,0.2159090909090909,0.6402331802923308,1.0,9/11,29.27%,FMR1;DDI1;ATRX;DDI2;SPIDR;RTF2;TIMELESS;DDX11;KAT7
prerank,skeletal muscle organ development (GO:0060538),0.5266211231860541,1.28149357521853,0.17755443886097153,0.6396548009868186,1.0,3/26,4.96%,CAV1;MEF2C;FOXL2
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.41831749976438665,1.281012746288644,0.10275689223057644,0.6400866698481508,1.0,21/124,10.43%,LEF1;SMURF1;NFATC1;CELSR1;FZD6;FZD4;PPP3CA;GNB1;PLCB1;AP2B1;TCF7L2;TNRC6C;PPP3CB;WNT5A;WNT9B;RAC1;AP2A1;PSMA2;PSMA8;SFRP2;PSMA6
prerank,transport across blood-brain barrier (GO:0150104),-0.3630780181502878,-1.2803951176934683,0.07037037037037037,0.6032828776616722,1.0,19/83,5.16%,ATP1A2;SLC24A3;SLC7A2;LRP1;SLC6A13;SLCO3A1;SLC1A3;SLC16A12;SLC13A3;LEPR;SLC2A13;SLC22A8;SLC12A2;SLC6A1;SLC1A5;SLC6A9;ABCC9;SLCO1C1;SLC5A3
prerank,negative regulation of binding (GO:0051100),0.4490326064698473,1.280367874309311,0.12280701754385964,0.6410557696369434,1.0,18/81,15.04%,LEF1;CAV1;PDGFB;NFKBIA;TMBIM6;RALB;DISC1;MAPK8;AURKA;CTNNBIP1;ZFPM1;ARHGAP28;TFAP4;CARD16;RACK1;PEX14;ILRUN;STYX
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5770228424264097,1.2802193312890657,0.19099099099099098,0.6405169503993441,1.0,4/16,15.10%,DLL1;JAK3;IL23A;VSIR
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5097084530234951,1.2796891806600317,0.1705790297339593,0.6411218882573434,1.0,7/33,7.47%,HIP1;HIP1R;FBXW7;AFAP1L2;CCDC88A;BCAR3;TGFA
prerank,negative regulation of establishment of protein localization (GO:1904950),0.6340220180920106,1.2791152851398906,0.21616871704745166,0.6418376176782346,1.0,5/10,16.57%,PPM1F;DNAJA1;SNX3;TERF1;NDFIP2
prerank,negative regulation of vascular permeability (GO:0043116),0.6250971630446687,1.2786824806039032,0.17531305903398928,0.6421014172453713,1.0,5/12,5.63%,CLDN5;PDE2A;PTPRJ;CEACAM1;RAMP2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5488886028266213,1.2786789639720022,0.18985270049099837,0.6411420450378682,1.0,7/24,10.42%,SEMA6A;SEMA5B;SEMA7A;SEMA6B;SEMA6D;DSCAM;SEMA4D
prerank,response to retinoic acid (GO:0032526),0.4701121655299288,1.2783267399121765,0.14627285513361463,0.6411818821260753,1.0,15/59,12.24%,ACER2;TBX1;FZD4;LYN;PTK2B;SOX9;RET;WNT5A;WNT9B;BRINP2;CREB1;OVCA2;TWF2;ABL2;ASXL1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.5195555704380099,1.2782930604781597,0.1891025641025641,0.6403213554582429,1.0,5/30,9.61%,STAT3;CD34;PLCG2;TIGIT;IL23A
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.599162750347042,1.2781865893148154,0.19895287958115182,0.6396538860564046,1.0,8/14,14.62%,KDR;VEGFC;FLT4;VEGFD;GAB1;MYO1C;NUS1;PGF
prerank,positive regulation of MAPK cascade (GO:0043410),0.3951985759140202,1.2778207537181459,0.07361268403171008,0.6397775049106122,1.0,39/245,7.53%,TEK;FLT1;KDR;TBX1;APP;PDE8A;ICAM1;INSR;SEMA7A;PDGFB;HTR2A;IQGAP1;DAB2IP;EDN1;PRKD2;JCAD;MFHAS1;PDGFD;PTK2B;FBXW7;NOTCH1;PTPRJ;TPD52L1;TAOK2;FLT4;PLCG2;CAV2;PIK3R6;TIRAP;ARHGAP8;RET;RAPGEF2;CD40;BCAR3;PDGFC;ARRB1;TGFB1;PIK3CG;RAP1A
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.6124802022288688,1.2776587200337886,0.21611721611721613,0.6392823481214264,1.0,7/13,18.14%,KDR;ENG;DLL4;SFRP2;TGFBR2;CTNNB1;NRARP
prerank,phosphate-containing compound metabolic process (GO:0006796),0.4024973927062278,1.2775155492474677,0.08009153318077804,0.6387620221759481,1.0,30/198,9.24%,PTPRB;INPP5D;PLCB4;PLA2G4A;PLPP1;PLCG1;GPD2;STAT3;PPP3CA;PFKFB3;PLCB1;PLCG2;PAK2;LIMK2;PPP3CB;ITPKB;PLA2G2D;FBP1;INPP5K;TIGAR;TGFB1;PIK3CG;AGPAT1;CERKL;DUSP23;DUSP16;LPL;PLAAT3;SYNJ1;PANK2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.6339864668049722,1.2768786670022931,0.19343065693430658,0.6396860775549847,1.0,4/12,3.19%,PRKG1;MEF2C;PDGFB;DOCK4
prerank,melanosome localization (GO:0032400),0.553286095641011,1.2768775757570985,0.17487266553480477,0.6387401135695403,1.0,3/21,3.64%,RAB27A;RAB11A;SHROOM2
prerank,regulation of aerobic respiration (GO:1903715),0.5904019867971564,1.2768189413499629,0.20462046204620463,0.6379826234125697,1.0,4/15,12.25%,CBFA2T3;AK4;ABCD1;NOP53
prerank,regulation of coagulation (GO:0050818),0.6207018671128596,1.276734288334528,0.20818505338078291,0.6372678811077674,1.0,3/11,14.29%,CAV1;PROCR;PROC
prerank,regulation of cell development (GO:0060284),0.5055338222301796,1.2765814709848027,0.17905918057663125,0.63675904057409,1.0,6/36,5.39%,FOXO1;HDAC9;ADGRA2;DLL1;RPS19;CX3CR1
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.45258263884787053,-1.2757800558310315,0.1402116402116402,0.6151752367227624,1.0,11/28,21.71%,ZIC1;PRKCD;CDH1;SMAD3;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;BAG3
prerank,regulation of actin filament polymerization (GO:0030833),0.4616665067386804,1.2757256432032986,0.12777777777777777,0.638300578221286,1.0,13/69,10.19%,KANK3;ESAM;HIP1R;PTK2B;NCK1;SSH2;EVL;NCKAP1;CDC42EP3;RASA1;ARHGAP28;CYRIB;TWF2
prerank,regulation of calcium ion transport (GO:0051924),-0.3904919219566798,-1.2756616353472428,0.10989010989010989,0.6136058314915351,1.0,11/54,8.88%,ANK2;BCL2;CACNA2D1;CACNA1D;P2RX4;IL16;CACNB2;STIM1;TRPC6;ADRA2A;EFHB
prerank,positive regulation of chemokine production (GO:0032722),0.47822960763998806,1.2747368991569976,0.15279878971255673,0.6402873851950017,1.0,8/44,13.43%,APP;IL6R;HIF1A;TIRAP;WNT5A;LPL;IL7;ADAM17
prerank,defense response to symbiont (GO:0140546),0.44063695678108467,1.2747062254294859,0.1279683377308707,0.6394356157897153,1.0,29/92,19.42%,SERINC3;NLRC5;IRF2;SERINC5;SAMHD1;DDIT4;ISG20;IFNAR2;RNASE1;CD40;MLKL;G3BP1;CGAS;BCL2L1;BNIP3;NT5C3A;ZMYND11;OASL;RELA;CNOT7;IFIH1;IFITM3;STAT1;PLSCR1;BST2;ATG7;IFITM1;EIF2AK2;BNIP3L
prerank,establishment of melanosome localization (GO:0032401),0.5586072458698114,1.2732162148855668,0.1870748299319728,0.6428067832083226,1.0,3/19,3.64%,RAB27A;RAB11A;SHROOM2
prerank,negative regulation of viral transcription (GO:0032897),0.6083051773038626,1.272997134579221,0.20104895104895104,0.6424726841405812,1.0,5/13,19.39%,TRIM14;MID2;ZFP36;IFITM3;TRIM62
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.5089428836180074,-1.272752797479195,0.18543046357615894,0.6198921076002702,1.0,7/16,27.27%,LRP1;APOE;ABCA7;MYOCD;CYP51A1;HMGCR;TREM2
prerank,chromatin assembly (GO:0031497),0.4960847020733077,1.2727446493115713,0.18209408194233687,0.6422120366910322,1.0,15/38,22.14%,SOX9;PADI4;LIN54;H3-3A;KAT6B;SMARCA5;EZH1;NAP1L4;GRWD1;NPM1;ATRX;ANP32B;BAHD1;SART3;PRDM9
prerank,positive regulation of response to stimulus (GO:0048584),0.4852262440035655,1.2722227261143773,0.16468842729970326,0.6427389536695404,1.0,13/40,20.12%,ABI3;IL15;B2M;WNT5A;CGAS;IFIH1;NSMCE4A;FMR1;NSMCE1;YPEL3;IER5;HOMER1;TAF9
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.3510998083081028,-1.2711674460478053,0.057971014492753624,0.6226985803254238,1.0,18/107,9.52%,SLC24A3;ANK2;ATP13A5;ATP13A3;SLC8A3;SLC41A1;SLC30A10;ATP1B1;SLC8A1;DMPK;SLC39A14;SLC39A13;STIM1;ATP2A2;SLC39A10;RYR2;CXCL12;SLC24A2
prerank,ribosomal large subunit assembly (GO:0000027),0.5417000825052668,1.2711128573016262,0.18272425249169436,0.6449893878481994,1.0,9/24,20.42%,RSL24D1;RRS1;NOP53;RPL6;RPL10;FASTKD2;RPL11;RPL3;TRAF7
prerank,cellular response to hydroxyurea (GO:0072711),0.6425161503990672,1.271088026417124,0.22736030828516376,0.6441182559500598,1.0,8/10,28.07%,FMR1;DDI1;ATRX;DDI2;SPIDR;RTF2;TIMELESS;DDX11
prerank,regulation of glucose metabolic process (GO:0010906),-0.42795301842511185,-1.2706560550864878,0.12790697674418605,0.6221762364148359,1.0,6/34,4.97%,PRKN;IRS1;PDK1;OGT;RORA;SELENOS
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.4581253711632281,-1.2706358356844951,0.1291866028708134,0.6203006509716945,1.0,7/24,4.01%,SOX5;ADAMTS12;TRPS1;EFEMP1;TGFBR1;SOX6;WNT9A
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6291342504165356,1.2705697034062862,0.20917431192660552,0.6437811901040008,1.0,2/10,6.96%,CNGB1;GNAT1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6291342504165356,1.2705697034062862,0.20917431192660552,0.6437811901040008,1.0,2/10,6.96%,CNGB1;GNAT1
prerank,actin polymerization or depolymerization (GO:0008154),-0.3911039266523447,-1.270525606403248,0.1305732484076433,0.6187003676674918,1.0,9/50,6.67%,ARHGAP6;GAS7;MICAL3;GSN;MICAL2;SPIRE1;COBL;ABI2;VILL
prerank,glucan catabolic process (GO:0009251),-0.5240890100295285,-1.2703387386936704,0.20750551876379691,0.6173672513582854,1.0,7/15,20.81%,PYGB;PHKB;PYGM;GAA;AGL;PHKA2;PHKG1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.4597100136814188,1.2701473586083987,0.1473533619456366,0.6440467368686816,1.0,23/57,21.42%,RPS15;RPS19;RPS16;RPL38;TGS1;RPS7;RPS24;XPO1;RRS1;RPL14;NOP16;RPS6;NPM1;RIOK1;RPS25;RPL35A;EMG1;RPL11;NOP14;NOM1;RIOK2;RPS28;RPL7
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5032521923183015,1.270130530684778,0.16717791411042945,0.6431667577556788,1.0,6/35,5.28%,FLT1;CAV1;MEF2C;PTPRM;CAV2;DLL4
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.4126387573632228,-1.2700776268462015,0.12290502793296089,0.616248652843875,1.0,15/41,19.06%,ANK2;ACTN2;KCNMA1;ANK3;AKAP6;KCNMB2;KCNJ2;GABBR1;KCNJ10;KCNN2;GNG2;KCNJ15;KCNJ6;KCNN3;ACE2
prerank,supramolecular fiber organization (GO:0097435),-0.29778951035697376,-1.2688866656072155,0.0,0.6177332664769686,1.0,93/333,14.83%,COL1A2;COL3A1;CGNL1;COL4A5;COL1A1;ADAMTS2;COL8A1;TNXB;COL4A6;GSN;COL5A1;COL12A1;COL22A1;PRKN;COL25A1;COL4A3;LOXL1;COL4A4;COL6A2;FAT1;COL6A3;CLIP4;COL11A1;HSPG2;PLOD2;COL6A1;COL8A2;TGFBR1;MYO5A;COL26A1;SERPINH1;COL13A1;COL18A1;FBLN5;COL23A1;PPP1R9A;RHOBTB2;LOXL3;COL27A1;RND3;TPM1;CARMIL1;CYP1B1;DLG1;COL5A3;TMOD2;NF1;CLIP3;LUM;TGFBI;COL16A1;P4HB;LOX;SIAH2;COL14A1;SHROOM3;EFEMP2;MPRIP;RHOBTB3;COL9A2;KIF24;GGA2;APH1B;TUBGCP5;MDM2;KATNAL1;DPT;DDR2;COL20A1;TPM2;COL15A1;MYO1B;ADAMTS14;P4HA1;CST3;DES;TGFB2;MAP7D3;MFAP4;LMOD1;WDR73;B4GALT7;TSPAN15;DBN1;PCM1;TPM4;COL19A1;LAMC2;P3H4;GGA1;P3H1;HOOK2;SNCA
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.469750509956393,1.2685303264560415,0.15736766809728184,0.6470309023869634,1.0,16/54,16.77%,DCUN1D3;CAV1;SMAD7;N4BP1;DNAJA1;ARRB1;PINX1;SOX4;SPOPL;VPS28;NXN;UBXN1;PRKCG;CHP1;CTNNB1;RPL11
prerank,negative regulation of protein catabolic process (GO:0042177),-0.4172912940017115,-1.2683401005664987,0.14114114114114115,0.6173575558448265,1.0,15/40,21.75%,EGFR;TIMP3;SNRNP70;TIMP2;SIRT2;MDM4;CST3;RGP1;AZIN1;SNCA;PTPN3;CDK5RAP3;AGAP2;CYP51A1;BANP
prerank,positive regulation of myelination (GO:0031643),0.6268067585361176,1.2674380497295379,0.2167577413479053,0.6493817338850831,1.0,3/11,9.46%,PARD3;TNFRSF1B;DICER1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.570952933602859,1.2672442364774916,0.2136602451838879,0.6490191345693536,1.0,5/17,7.31%,CLDN5;F11R;PPP1R12A;IKBKB;TNFRSF1A
prerank,endochondral bone morphogenesis (GO:0060350),0.6305304905224907,1.2671357240024628,0.20471014492753623,0.6483965626040508,1.0,2/11,1.15%,BMPR2;MEF2C
prerank,muscle contraction (GO:0006936),-0.3336409865261301,-1.2669949829436682,0.058823529411764705,0.6195094575009049,1.0,29/126,15.27%,CALD1;DMD;ROCK2;SNTA1;ITGB5;EDNRA;ACTN2;SLC8A1;ASPH;GNAO1;SNTB1;TPM1;DTNA;ITGA1;TMOD2;BDKRB2;MYL9;SSPN;TPM2;MYOM1;ACTA2;DES;ADRA1A;TLN1;LMOD1;TPM4;ARHGEF11;FXYD1;GJC1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.5337915962245255,1.2669485621335965,0.18831168831168832,0.6479788405458284,1.0,9/27,18.42%,CTPS1;GSR;AK4;DCTD;DUT;RRM2B;CMPK1;TXNRD1;GLRX
prerank,positive regulation of vascular permeability (GO:0043117),0.6140683150166248,1.2669357714475395,0.20848708487084872,0.6470796133170816,1.0,7/12,9.63%,TJP1;OCLN;TJP2;PDE2A;TGFB1;TRPV4;TJP3
prerank,response to cAMP (GO:0051591),0.49839887938845995,1.2666543462691864,0.16429699842022116,0.6469520717081109,1.0,9/37,8.35%,AHR;PDE2A;KCNQ1;RAP1B;RAPGEF2;INPP5K;RAP1A;PKD2;CITED1
prerank,negative regulation of dephosphorylation (GO:0035305),0.5642259658794333,1.266642423079271,0.19962335216572505,0.6460538743818421,1.0,4/18,10.50%,PPP1R16B;MFHAS1;INPP5K;GPATCH2
prerank,protein O-linked glycosylation (GO:0006493),0.4291905429149457,1.2664061261714834,0.13404825737265416,0.645751882511455,1.0,20/96,12.66%,ST6GAL1;TMTC2;ST3GAL1;GALNT18;GALNT14;GALNT15;EOGT;B3GNT3;TET3;B3GNT4;ST6GALNAC2;B4GALT5;B4GAT1;B3GNT6;RXYLT1;ST6GALNAC4;C1GALT1;MUC1;TET2;OGA
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.5743908120879839,1.2663784333190828,0.21847246891651864,0.6449136338767739,1.0,5/16,11.70%,GCH1;SCARB1;HIF1A;NOS1AP;NUS1
prerank,regulation of fat cell differentiation (GO:0045598),0.44951734161475954,1.2662350832543179,0.13756613756613756,0.6443737477339243,1.0,18/74,12.67%,FOXO1;PPARD;ZBTB16;GATA2;LRP5;WWTR1;XBP1;WNT5A;TRIB3;TGFB1;LPL;CREB1;ZFPM1;SFRP2;CCDC71L;ASXL1;TRIO;ZFP36
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5670119931469935,-1.2657563134935577,0.1873589164785553,0.6211414766817019,1.0,4/10,15.88%,BMP4;SALL1;FZD7;PAX8
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.5416885051218607,-1.2650454676261458,0.18518518518518517,0.6214399437742887,1.0,4/12,9.11%,ANK2;ANXA6;UBASH3B;RYR2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.3136684517408502,-1.2648988015454496,0.031746031746031744,0.6199760949817535,1.0,41/248,8.61%,RNF220;BICC1;RBMS3;ZEB2;EGFR;WLS;LGR4;GLI3;FGFR2;COL1A1;IGFBP2;PRKN;GPC3;PTK7;CTNND2;DKK3;SEMA5A;IGFBP6;DAAM2;DACT1;CAPRIN2;LYPD6;INVS;LRRK1;LZTS2;PLEKHA4;SFRP4;PSME4;TMEM64;LRP6;SIAH2;AXIN2;NOTUM;AMFR;DAB2;LRRK2;GPC5;BTRC;GLI1;TLE2;SFRP1
prerank,acylglycerol metabolic process (GO:0006639),0.49471315988467485,1.2648220062178044,0.18597560975609756,0.6475785241277983,1.0,10/37,15.00%,CAV1;DGKZ;ABHD2;DGKH;LPL;PLAAT3;GK5;DGKE;PNPLA2;DGAT1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5087874852579953,-1.264821556578434,0.2144638403990025,0.6183436041418909,1.0,6/16,17.42%,DPYSL3;DPYD;UPB1;NT5E;NT5C1A;DPYSL2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.6029529728963912,1.2645110987881696,0.2,0.6476266409736304,1.0,5/13,16.25%,PRR5L;CNOT1;RC3H1;CNOT7;PNPT1
prerank,response to nitric oxide (GO:0071731),0.6050287804612047,1.2644682675060375,0.22867513611615245,0.6468278918107472,1.0,3/13,9.31%,FOXO1;EGLN1;CDK2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5664274979697445,1.2644258884777557,0.22357019064124783,0.6460433595326694,1.0,4/18,3.79%,PTGS2;CD200;HIF1A;CD34
prerank,nucleotide catabolic process (GO:0009166),0.5754161958749365,1.2640675498898233,0.19072164948453607,0.6462053276395001,1.0,5/16,14.45%,GDA;SAMHD1;NT5C2;XDH;NUDT15
prerank,neuron remodeling (GO:0016322),0.6339783120873517,1.2640444902802763,0.23977695167286245,0.6453523925268463,1.0,3/10,5.30%,APP;ANKS1A;SCARF1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5158298524367528,1.263906557231432,0.19614147909967847,0.6448157369894585,1.0,5/30,7.33%,FLT1;KDR;MLLT3;FLT4;TGFB1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5065867266373539,1.2636463443089683,0.1926751592356688,0.6446148188846469,1.0,8/29,14.10%,NLRC5;SAMHD1;WNT5A;IFNAR2;PTPN1;HSP90AB1;CNOT7;UBE2K
prerank,negative regulation of MAPK cascade (GO:0043409),0.43731518893536436,1.2632675505843844,0.1273209549071618,0.6448654039400744,1.0,7/87,2.90%,SEMA6A;FOXO1;CAV1;CNKSR3;DAB2IP;LYN;PTPRJ
prerank,positive regulation of lamellipodium organization (GO:1902745),0.5140620524483408,1.2631089799674926,0.1864406779661017,0.6444042794345494,1.0,14/32,15.76%,OCLN;WASF2;RREB1;NCKAP1;ENPP2;RAC1;ARHGEF7;TWF2;FSCN1;CYFIP1;CORO1C;ACTR2;ACTR3;ARPC2
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.4454830307701219,-1.2626615778235575,0.1810810810810811,0.622792733424004,1.0,13/30,11.64%,DSE;DCN;BGN;CSPG4;NDNF;CHST15;CHSY3;VCAN;ARSB;CHSY1;CHST3;DSEL;HEXA
prerank,glucose homeostasis (GO:0042593),0.4358835350848018,1.2626157862988185,0.14111261872455902,0.6448896458142725,1.0,13/83,9.33%,FOXO1;ADIPOR2;INSR;STAT3;HIF1A;KLF7;KCNB1;TCF7L2;FOXA3;INPP5K;NEUROD1;FOXK1;SOX4
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4321348963590213,1.2622722391940333,0.13446475195822455,0.6449748324364845,1.0,19/108,8.28%,ACER2;NOD1;TNFSF10;SOX7;DAPK1;HIP1;HIP1R;FAS;CASP4;PPM1F;CASP8;FOXL2;BOK;CYCS;LCK;GRAMD4;MALT1;CASP1;CRADD
prerank,positive regulation of histone acetylation (GO:0035066),0.5564405984358273,1.262262677365852,0.20454545454545456,0.6441024820960104,1.0,6/23,16.33%,RPS6KA5;ARRB1;GLYR1;MUC1;RPS6KA4;PIH1D1
prerank,positive regulation of protein import (GO:1904591),-0.43898505083540373,-1.262241009516698,0.1401098901098901,0.622127571175521,1.0,11/30,21.71%,ZIC1;PRKCD;CDH1;SMAD3;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;BAG3
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4903945453774495,1.2616350706719788,0.18263473053892215,0.6450310719084524,1.0,10/43,6.28%,ZHX3;BMPR2;IL6ST;MEF2C;PRKD1;IL6R;LRP5;WWTR1;ACVR2A;ACVR1
prerank,negative regulation of axon extension (GO:0030517),0.5108734411566616,1.2611641795141149,0.18445121951219512,0.6454569565368659,1.0,5/30,5.54%,SEMA6A;SEMA5B;SEMA7A;DIP2B;SEMA6B
prerank,chromatin remodeling (GO:0006338),0.4315048397822562,1.26039540162362,0.13548387096774195,0.6467923490509925,1.0,31/100,19.41%,ESR1;SMARCA2;BAZ2B;SOX9;KDM6A;PADI4;ARID1B;CECR2;ARID1A;KDM4C;SMARCA5;EZH1;NPM3;SRCAP;SMARCE1;RB1;HNRNPC;TOP1;NPM1;KAT2B;ATRX;JARID2;PIH1D1;ACTR5;KDM5C;BAZ1A;KDM4A;CHRAC1;PAK1;BAHD1;CHD1L
prerank,acylglycerol biosynthetic process (GO:0046463),-0.4613318811261709,-1.2597363467648,0.16786570743405277,0.6275426517210576,1.0,6/23,6.99%,AGMO;PLCE1;MOGAT3;LPGAT1;GK;LPIN1
prerank,regulation of interleukin-6 production (GO:0032675),0.42802189042963124,1.259679111753985,0.13144329896907217,0.6479362690408546,1.0,12/96,8.24%,APP;CD200;IL6R;ARHGEF2;STAT3;AFAP1L2;PLCG2;TIRAP;XBP1;WNT5A;ARRB1;LPL
prerank,cellular response to metal ion (GO:0071248),-0.3346470184814264,-1.2594857077591868,0.05759162303664921,0.6264384633144885,1.0,21/123,7.59%,BMP6;EGFR;PRKN;ADCY1;SLC41A1;ADGRV1;DLG2;SLC12A2;DLG4;SYT1;P2RX4;ADCY7;CDH1;ANK3;PRKAA2;RASGRP2;NLGN1;SYT9;SYT12;SYT11;LRRK2
prerank,cellular response to interferon-beta (GO:0035458),0.5997093779133954,1.259484038061205,0.2184115523465704,0.6475990456317071,1.0,6/14,17.69%,AIM2;UBE2K;IRGM;PNPT1;CDC34;STAT1
prerank,sulfate transport (GO:0008272),-0.5301538972114394,-1.2591252809205566,0.19325842696629214,0.6256554650725179,1.0,3/14,3.03%,SLC13A4;SLC26A7;SLC26A2
prerank,response to progesterone (GO:0032570),0.5644139637166459,1.2584141950761276,0.22899505766062603,0.6498547413290525,1.0,5/18,11.53%,CAV1;ABHD2;TGFB1;CATSPERD;UBE3A
prerank,canonical Wnt signaling pathway (GO:0060070),0.44436390917552493,1.2580639078895923,0.15724137931034482,0.6500767071525143,1.0,10/68,6.38%,LEF1;CAV1;DIXDC1;FZD6;FZD4;LRP5;TCF7L1;TCF7L2;WNT5A;WNT9B
prerank,positive regulation of cellular component movement (GO:0051272),0.5365441478975987,1.2580599275506907,0.1986970684039088,0.6491879934382615,1.0,6/24,8.62%,NTN1;LYN;ACTN4;RPS19;CAVIN1;AKT2
prerank,B cell proliferation (GO:0042100),0.5685677492742708,1.2579780140031742,0.22282608695652173,0.648511499261694,1.0,3/17,6.60%,MEF2C;CTPS1;CD40
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.5240695945046698,1.257852329240679,0.19141914191419143,0.647985249433186,1.0,6/26,9.68%,HTR2A;PLCG2;LCK;ITPR3;PKD2;ERO1A
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.558298157822566,1.2572853612808181,0.2079207920792079,0.6486676085592068,1.0,6/20,13.78%,ENTPD1;APP;CASP1;ANO6;HSP90AB1;TXNIP
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5637435122309276,1.2571000824792837,0.22,0.6483369812263595,1.0,4/16,5.28%,PPP1R16B;GATA2;JCAD;DLL4
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.48216297828678584,1.2565951077160806,0.16666666666666666,0.6488764593465022,1.0,9/43,7.33%,PPARD;PDGFB;GATA2;STAT3;NR3C1;HIF1A;SOX9;FOSL1;TGFB1
prerank,pancreas development (GO:0031016),0.6074390169884156,1.256297886196109,0.2328519855595668,0.6488227673972898,1.0,3/12,5.65%,ZIC3;FOXF1;TCF7L2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.5937161187878082,1.2562919685853482,0.22784810126582278,0.6479529754798158,1.0,5/15,7.98%,TJP1;SMAD1;DLL1;JAK1;ITGA5
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6207599602085789,1.25585145241209,0.23976608187134502,0.648334950309065,1.0,3/11,3.79%,PTGS2;CD200;CD34
prerank,regulation of cellular respiration (GO:0043457),0.5676388406474951,1.2556784318987841,0.22071307300509338,0.6479393250799449,1.0,4/17,16.25%,CBFA2T3;IFNAR1;NOP53;PNPT1
prerank,negative regulation of cellular process (GO:0048523),0.37082202097620776,1.255493666892545,0.030864197530864196,0.6475634847337949,1.0,85/521,10.77%,NOS3;PTPN14;BMPR2;JAM2;PLXNA4;DCUN1D3;TBX1;APBB2;SMARCA2;APP;PDE8A;CBFA2T3;SOX7;ACVRL1;PRKD1;PPP1R13B;CTTNBP2NL;PODXL;CD200;CDK6;PLPP1;SH3BP4;ADARB1;MYH9;DAB2IP;LYN;ADAM10;NPR1;PTK2B;SRGAP2;NOTCH1;PLXND1;PTPRJ;TNFRSF1B;SOX17;AQP11;LPCAT3;NCK1;CD34;ADGRG1;TES;ACTN1;DLL1;TMBIM6;PPP1R9B;VGLL4;BTG3;PTPRK;DLL4;TMEM98;RAPGEF2;ADAM15;CBLL1;JADE1;KLF10;BTN2A2;FBP1;BTBD18;DCSTAMP;ADAMDEC1;CDKN1B;PPM1D;TGFB1;RASA1;SNX3;RNF167;PKD2;RNF139;NF2;CTBP1;PINX1;CHMP4B;DSCAM;SOX4;SST;TNFRSF8;BTG2;RAD18;CYP27B1;SFRP2;SEMA4D;VAMP8;TFAP4;NMI;BNIP3
prerank,positive regulation of apoptotic process (GO:0043065),0.3832616825804177,1.2553398666778948,0.06174200661521499,0.6471153929836495,1.0,58/293,12.71%,FOXO1;TNFSF10;UNC13B;TGM2;NET1;DCUN1D3;ITGA6;MCF2L;DAPK1;ARHGEF3;RASGRF2;HIP1R;DAB2IP;ARHGEF2;FAS;SIK1;TPD52L1;STK3;CASP8;JMY;PLEKHG5;KALRN;STK4;PREX1;FOXL2;MAPK8;BOK;CTNNBL1;DNAJA1;BCL2L11;SPDEF;STPG1;NEUROD1;CRADD;PSEN1;ARHGEF7;MAP3K11;MYBBP1A;ARHGEF26;SOX4;TNFRSF8;SIAH1;SFRP2;ANO6;TFAP4;APH1A;BNIP3;BTG1;ATF6;RNPS1;RIPK1;BID;RHOB;TNFAIP8;TRIO;GNA13;ARHGEF9;RACK1
prerank,positive chemotaxis (GO:0050918),-0.49718130882914746,-1.2552995386236625,0.18446601941747573,0.6352435278806767,1.0,8/17,18.64%,ANGPT1;NRP1;SEMA5A;TSC2;VEGFA;FGF7;FGF10;SCG2
prerank,sodium ion homeostasis (GO:0055078),-0.47400750150977555,-1.2549857432628144,0.16923076923076924,0.6342494160695274,1.0,4/21,3.39%,ATP1A2;SLC12A2;ATP1B1;SLC8A1
prerank,clathrin-dependent endocytosis (GO:0072583),0.5319355058318591,1.254313488249181,0.1895424836601307,0.6490934089819649,1.0,8/26,11.71%,FNBP1L;ITSN2;FCHO2;DLL1;AP2B1;AP2A1;INPP5F;PICALM
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.5198016770840443,1.2538892904682906,0.20458265139116202,0.6494325456464753,1.0,7/29,9.03%,ENG;S1PR1;NOTCH1;FKBP1A;SMAD7;TGFB1;ZFPM1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5888301042090753,1.2534682846181642,0.2085661080074488,0.6497922249222798,1.0,4/14,12.18%,USP15;PUM1;PUM2;OASL
prerank,cellular response to dsRNA (GO:0071359),0.5762971303943739,1.2530781651992402,0.20926243567753003,0.6500280338218708,1.0,5/15,14.04%,CAV1;RALB;CGAS;IFIH1;NPM1
prerank,negative regulation of neuron projection development (GO:0010977),-0.39191773640943134,-1.2529399678128994,0.14696485623003194,0.6383872983831728,1.0,17/56,16.85%,LPAR1;DPYSL3;PTPN9;PTPRS;EFNB2;ADCY6;NLGN1;SEMA3A;DCC;RAB29;APOE;NGEF;RTN4;CBFA2T2;STX1B;MT3;TSKU
prerank,negative regulation of apoptotic process (GO:0043066),0.3753006309853876,1.2521552745267321,0.054910242872228086,0.6517387912826786,1.0,82/444,12.91%,PRKCH;LEF1;TEK;TJP1;FOXO1;CD38;KDR;IL6ST;CAV1;TBX1;MEF2C;RNF144B;SOCS2;PIM3;ADAM10;FAS;PTK2B;NOTCH1;NFKBIA;FLT4;PAK2;BABAM2;CAT;SOX9;DLL1;RPS6KA3;TMBIM6;FOXQ1;IKBKB;RPS6KA1;XBP1;GREM1;CX3CR1;MAPK8;ASAH2;SERPINB9;PLK2;XIAP;WNT5A;TOX3;DNAJA1;AVEN;HNRNPK;PTK2;RASA1;BCL3;BNIP2;NFKB1;ITGA5;MALT1;CITED1;PSEN1;AKT2;RHBDD1;BCL2L1;HIGD2A;EGR3;SEMA4D;GAS6;BNIP3;SFN;CBL;IL7;RB1;PIM1;LGMN;THOC6;RIPK1;TMBIM4;TMIGD1;BID;CARD16;RELA;TNFAIP8;RIPK2;PRDX2;PA2G4;GSTP1;RPL10;BIRC3;PHIP;PTMA
prerank,synaptic vesicle transport (GO:0048489),0.6154732410600333,1.251961094019234,0.23431734317343172,0.6514041237196183,1.0,1/11,0.41%,RAB27A
prerank,positive regulation of protein ubiquitination (GO:0031398),0.44277323556752257,1.2514954528325748,0.15331491712707182,0.6518616656359398,1.0,25/80,21.01%,DCUN1D3;CAV1;FBXW7;FKBP1A;SMAD7;XIAP;MYCBP2;TRIB3;MALT1;UBE3A;RIPK2;PRICKLE1;BIRC3;TRAF6;TOPORS;NDFIP2;BIRC2;CUL3;KDM1A;PTTG1IP;BCL10;PDCD6;UBE2L3;PLK1;PEF1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5554385492086059,1.251016255509642,0.21160409556313994,0.6524231480606172,1.0,3/17,7.63%,RAB27A;KCNB1;STX1A
prerank,positive regulation of cell junction assembly (GO:1901890),0.4608735267020419,1.2508880586719213,0.17579250720461095,0.6519313607470508,1.0,6/56,2.97%,TEK;KDR;CAV1;CLDN5;PTPRJ;PPM1F
prerank,dendritic spine morphogenesis (GO:0060997),0.5787421604697757,1.250574022274883,0.2288135593220339,0.6519738636506395,1.0,1/15,0.09%,SHANK3
prerank,cellular response to purine-containing compound (GO:0071415),-0.5702532756012189,-1.2502215735108795,0.21711899791231734,0.6445103679574622,1.0,4/10,18.30%,SLC8A1;RYR2;GSTM2;CASQ2
prerank,gene expression (GO:0010467),0.3754295310065598,1.2498462934362606,0.07462686567164178,0.6531784260028053,1.0,116/348,18.60%,RBPMS;ADARB1;HHEX;TSPAN5;DDX54;RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;EPC1;RPL38;EIF4E;TSPAN14;RPL34;RPS20;RPL39;DROSHA;HNRNPF;RPS7;PWP1;NXF2;RPS24;TAF1B;HNRNPK;RPL37A;BCL3;SRBD1;HNRNPD;RPL36;RPS18;WDR33;RSL24D1;RPL15;THOC2;RPS8;RPL14;RPL23;RPL17;MRPS18A;SMG7;RPL9;RNGTT;DHPS;RPL4;RPL13A;RPS11;RPL32;TNIP1;RBM3;YTHDC1;RPL22;RPS27;RPL31;RPS23;MMS19;ADAR;NUP214;RNPS1;MRPL13;RPL13;MRPS12;RPS12;THOC6;NUP98;MRPL35;HBS1L;RPL6;RPL10;FASTKD2;WARS1;PTMA;MRRF;UPF2;MRPL41;NUP133;NUP205;RPS29;RPS6;MEF2A;MRPL52;NUP54;RPL29;TOPORS;RPS25;RPL35A;RPS13;NUP43;NUP153;RPS21;MRPS16;RPL27;RPL18;XRN2;MRPL23;RPL27A;TSPAN33;MRPS5;RPS10;DDX20;HNRNPUL1;MRPL37;AGFG1;RPL11;ALYREF;CDC40;RPL8;THOC3;RPLP2;MRPL11;THOC1;PRPF4;RPL18A;CPSF1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.42179002553607403,1.2498280976789153,0.14267676767676768,0.6523539818071803,1.0,23/112,7.46%,ENG;MEF2C;ACVRL1;CLDN5;F11R;SMAD1;SMURF1;PARD3;NRROS;PDE2A;NR3C1;PXN;FKBP1A;SOX9;ID1;PTPRK;SMAD7;USP15;DUSP22;WNT5A;ACVR1;TGFB1;PTK2
prerank,regulation of neurotransmitter secretion (GO:0046928),0.5118609639363724,1.2497026886247267,0.21266968325791855,0.6518748064846154,1.0,10/32,17.27%,MCTP1;MEF2C;KCNMB4;SNCAIP;PNKD;MCTP2;RAB5A;FMR1;RIMS4;CPLX2
prerank,positive regulation of T cell migration (GO:2000406),0.5372337797702351,1.2495861615663197,0.22664359861591696,0.6513447487663113,1.0,3/20,6.10%,APP;ADAM10;WNT5A
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.6201299141245888,1.2494997996793664,0.23684210526315788,0.650734444959553,1.0,5/12,16.24%,INSR;BNIP3;IGF1R;FYCO1;IRGM
prerank,cellular response to superoxide (GO:0071451),0.6203123869511591,1.2494196611752386,0.2302025782688766,0.6500948364032526,1.0,1/10,0.31%,NOS3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5263742426145991,1.2483827867079633,0.2267536704730832,0.6521628928573485,1.0,5/25,11.99%,TNFSF10;BIK;BCL2L11;BNIP3;BID
prerank,cell junction maintenance (GO:0034331),-0.5160270094744422,-1.2476354438808754,0.18663594470046083,0.6503406681896958,1.0,7/14,32.38%,NLGN2;CLDN1;CHCHD10;MYADM;PRTN3;DCTN1;PARD6A
prerank,regulation of neuron apoptotic process (GO:0043523),-0.3377984068295206,-1.247587004037033,0.09009009009009009,0.6486139757714072,1.0,39/96,24.17%,EPHA7;PRKN;BCL2;NUPR1;SLC30A10;NRBP2;PPARGC1A;NDNF;NTRK2;NF1;NGF;SIX1;TRIM2;EGLN3;SNX6;CPEB4;SRPK2;RETREG1;APOE;TGFB3;NFATC4;TGFB2;GRID2;PRKCI;MT3;MDK;CLCF1;PPT1;TYRO3;BACE1;NTF3;CRLF1;AGAP2;FAIM2;CLN3;BAX;NSMF;AKT1S1;ERBB3
prerank,negative regulation of complement activation (GO:0045916),-0.5709380199275683,-1.2474794251517365,0.1960352422907489,0.6470738250909334,1.0,2/10,5.12%,SERPING1;CD55
prerank,ion transport (GO:0006811),-0.34493383356698176,-1.2473669359989088,0.07373271889400922,0.6455819848630447,1.0,22/111,11.28%,SLC24A3;TRPM3;SLC1A3;PIEZO2;SLC8A3;SLC26A7;SLC12A2;SLC9A9;SLC26A2;SLC8A1;WNK4;GLRB;ANO1;TRPC6;SLC1A2;SLC5A5;SLC20A1;SLC24A2;WNK1;SLC4A2;GABRB1;SLC9A1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.331914995663405,-1.247320552988658,0.0748663101604278,0.6438708363126822,1.0,21/140,9.25%,CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;CACNA2D1;EDNRA;DLG4;ADRA1B;CCR9;JPH1;SLC8A1;P2RX4;CD55;TRPC3;GRM1;AGTR1;BDKRB2;PTGDR;RYR2;PTGFR
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3983504619883465,-1.2472292690127065,0.11419753086419752,0.6422844539551901,1.0,10/46,7.09%,PLCL1;ALDH1A1;DOCK7;LGR4;NPR3;ADAMTS5;FOXC2;ACOT11;NOVA1;RBPJ
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4730608184951537,1.247139146694521,0.17251908396946564,0.6548817483881755,1.0,9/49,7.31%,IL6ST;IL15;IL6R;LYN;STAT3;GHR;CD40;STAP2;TNFRSF1A
prerank,regulation of B cell apoptotic process (GO:0002902),0.5984474596174814,1.2470754381367066,0.23191094619666047,0.6542195694365047,1.0,2/12,2.31%,FOXP1;LYN
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4049907199435627,1.2469470966695746,0.1218335343787696,0.6537633506542718,1.0,23/151,7.53%,TEK;KDR;APP;PDE8A;ICAM1;SEMA7A;PDGFB;HTR2A;PRKD2;MFHAS1;PDGFD;TNFRSF11A;PTK2B;FBXW7;NOTCH1;FLT4;TIRAP;ARHGAP8;RAPGEF2;PDGFC;ARRB1;TGFB1;RAP1A
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5197965200133828,1.2466416970239051,0.21169036334913113,0.6537064256481027,1.0,7/24,10.44%,PDE2A;RASD2;PDE4D;PRKAR2B;RAPGEF2;CGAS;APLNR
prerank,neural crest cell differentiation (GO:0014033),0.5648209779646657,1.2463844853784567,0.21783876500857632,0.6535073680993778,1.0,3/18,6.57%,MEF2C;CDH2;CYP26C1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.5800578100912619,1.2458748062140754,0.23247232472324722,0.6541850904707,1.0,1/14,1.32%,ERN1
prerank,anterograde axonal transport (GO:0008089),-0.41738741491557774,-1.245415113307918,0.1253731343283582,0.6456507058257548,1.0,17/37,28.46%,DLG2;KIF3A;KIF1A;KIF5C;RAB27B;AP3D1;DTNBP1;KIF1B;TRAK1;HSPB1;KIF5A;RAB21;SNAPIN;MAP1A;SPAST;BLOC1S4;AP3B2
prerank,defense response to virus (GO:0051607),0.4258841783069123,1.2450705345245379,0.15254237288135594,0.6556248181327676,1.0,30/100,19.42%,SERINC3;NLRC5;IRF2;SERINC5;SAMHD1;DDIT4;ISG20;IFNAR2;RNASE1;CD40;MLKL;G3BP1;CGAS;BCL2L1;BNIP3;NT5C3A;ZMYND11;OASL;RELA;CNOT7;IFIH1;IFITM3;STAT1;PLSCR1;ZDHHC1;BST2;ATG7;IFITM1;EIF2AK2;BNIP3L
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.45766525021646626,1.2449440404686498,0.16545718432510886,0.6551503030255429,1.0,12/57,9.97%,IL6ST;IL15;IL6R;LYN;STAT3;GHR;CD40;STAP2;TNFRSF1A;NF2;IL23A;INPP5F
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5046908278135198,-1.2444507547282604,0.18357487922705315,0.6465823587014135,1.0,6/16,15.07%,APPL2;PPARA;ADCY7;APOD;CHID1;SIRPA
prerank,regulation of response to cytokine stimulus (GO:0060759),0.5446253142753625,1.2442931232397543,0.21777003484320556,0.6561992171069952,1.0,8/19,20.12%,LIFR;WNT5A;CBFB;IFIH1;MAP2K5;IRAK2;PARP9;TAF9
prerank,intestinal lipid absorption (GO:0098856),0.6065210092483492,1.2440010980585612,0.24399260628465805,0.6561977382353791,1.0,3/11,13.49%,UGCG;SOAT2;LIMA1
prerank,regulation of nervous system process (GO:0031644),0.5591665171905343,1.243901078974047,0.21308724832214765,0.6556122420439432,1.0,2/18,1.06%,NOS3;APP
prerank,cellular component assembly (GO:0022607),0.38126305554403483,1.243527548265388,0.09921962095875139,0.6558299123726983,1.0,49/253,13.87%,PARVB;SLC2A1;LCP1;SPTBN1;OCLN;EPS8;LIMS2;CD2AP;MAGI1;NEDD9;PARD3;FAS;PTK2B;SHROOM2;TRAF1;SHROOM1;CARD10;SOX9;RHOJ;PLS3;RAD21L1;NCKAP1;QSOX1;STX7;ABCA3;TEAD2;OPHN1;WNT5A;RP1L1;CD40;RAC1;TGFB1;TRIP13;LLGL1;SKAP2;NIFK;IKBKG;TFAP4;GAS6;FSCN1;ACD;CYFIP1;PICALM;HAS2;LIMA1;CAPZA1;CFAP46;PEX14;IL1RAP
prerank,negative regulation of gene expression (GO:0010629),0.37908218325215803,1.243146695791782,0.06256983240223464,0.6559904194725532,1.0,56/302,11.80%,RPS6KA5;NANOS3;HDAC9;KDR;ENG;ESR1;APP;MEF2C;ERN1;ACVRL1;CLDN5;OCLN;DAPK1;PDGFB;FOXP1;GATA2;ADAM10;FBXW7;NOTCH1;HIF1A;CD34;IGF2BP3;TMBIM6;PTBP3;EPC1;DLL4;NANOS2;N4BP1;ATP2B4;H3-3A;MTF2;TNRC6C;AURKA;BTN2A2;TASOR;SRGN;PPM1D;TGFB1;GRB7;NFKB1;RNF139;PSEN1;NUDT16;DICER1;AEBP2;BTG2;RPL13A;CNOT1;SFRP2;APLNR;PPHLN1;DCP2;RB1;MRPL13;PICALM;LGMN
prerank,sensory perception (GO:0007600),-0.3953538190324809,-1.2421881435561564,0.14080459770114942,0.651481403254545,1.0,22/45,32.20%,ADGRV1;P2RX4;GNAS;PCDH15;WHRN;PTGES;ADORA2A;RETREG1;TTC8;CHRNA7;TRPA1;TMEM150C;CCR2;CCL2;KCNA2;SCN9A;GNAL;CHRNB2;ALOXE3;P2RX7;TRPV2;CLRN1
prerank,response to chemokine (GO:1990868),0.6038976746019212,1.2418631214824525,0.24528301886792453,0.6588427211983728,1.0,1/13,0.16%,LRCH1
prerank,Golgi ribbon formation (GO:0090161),0.5798764801370379,1.2416570142831347,0.2395644283121597,0.6585996272903497,1.0,5/13,8.42%,STX6;VAMP4;VTI1A;GCC2;TMED5
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5065632063310498,1.2415527930322339,0.19198664440734559,0.6580051929293614,1.0,9/29,10.61%,IL15;SOCS2;STAT3;JAK3;GHR;IFNAR1;IFNAR2;PKD2;NMI
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.36792897856588624,-1.2415310287589942,0.10472972972972973,0.6515131793826494,1.0,8/61,4.55%,EYA2;EGFR;EYA1;PDGFRB;EYA4;FGF2;SMOC2;PARP3
prerank,morphogenesis of an epithelium (GO:0002009),-0.4444632761679199,-1.2414020134817132,0.18233618233618235,0.650064097240103,1.0,5/25,6.69%,FGFR2;DAG1;TBX18;LRP6;AHI1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6072922076224717,1.2410640245204503,0.24358974358974358,0.6584599918339147,1.0,3/11,7.50%,NOVA2;IGF2BP3;RASA1
prerank,regulation of dendritic spine development (GO:0060998),0.5575573854274289,1.241048780036031,0.23208191126279865,0.6576341624704637,1.0,3/19,3.49%,SHANK3;MEF2C;PPFIA2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.4773047777797055,-1.2409827348377187,0.16864608076009502,0.6493807084041768,1.0,7/21,9.22%,IGF1;BMPR1A;IGFBP5;GJA1;FGF2;ADAMTS1;MMP2
prerank,regulation of axonogenesis (GO:0050770),-0.38215818972514326,-1.2406317057174399,0.10355987055016182,0.6485321710348552,1.0,13/51,10.91%,ROBO1;PLXNA2;KIF13B;TIAM2;BRSK1;NTRK2;ROBO2;LRRC4C;NGF;MAP6;PLXNB1;SIPA1L1;SLIT2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5802646067622244,1.2404501020657355,0.23978685612788633,0.6584621452424346,1.0,3/13,3.01%,PTGS2;SOX13;RREB1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.43586411638629496,1.240440347642291,0.16870748299319727,0.6576329870511749,1.0,21/73,22.49%,LMO2;KITLG;GATA2;TAL1;TCF12;PSMA2;TCF3;PSMA8;PSMA6;CBFB;PSME1;PSMA4;METTL14;PSMF1;DHX36;EIF2AK2;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3
prerank,import into cell (GO:0098657),-0.4057465329096257,-1.2397289003755823,0.13823529411764707,0.6494553482465542,1.0,9/41,5.16%,ATP1A2;SLC6A13;SLC1A3;SLC47A1;GLUL;SLC22A4;SNAP25;SLC39A14;SLC5A3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5397440433964993,1.2390738369930874,0.2087378640776699,0.6606129844296218,1.0,7/23,8.58%,APP;INSR;PDGFB;HIF1A;PFKFB3;NFKB1;PSEN1
prerank,regulation of intracellular protein transport (GO:0033157),0.4941893731860838,1.238437196348277,0.20247295208655333,0.6614611754184063,1.0,10/32,15.49%,PTPN14;LCP1;PRR5L;PCNT;TGFB1;GCC2;PTPN1;UHMK1;NDEL1;CEP290
prerank,mitotic sister chromatid cohesion (GO:0007064),0.5630880250601709,1.2383180339461048,0.23050259965337955,0.6609515317547627,1.0,6/16,17.01%,RAD21L1;HASPIN;RB1;PDS5A;RAD21;PDS5B
prerank,histone acetylation (GO:0016573),0.4397657427456267,1.238236217767628,0.18326118326118326,0.6603030537138616,1.0,16/69,15.21%,LEF1;EPC1;PHF20;JADE2;JADE1;KAT6B;HAT1;JADE3;YEATS2;EP400;PHF20L1;KAT2B;MBIP;KAT6A;ZZZ3;TRIM16
prerank,cellular response to glucose stimulus (GO:0071333),0.5127423606418252,1.2379528834823426,0.20926517571884984,0.660248745419756,1.0,10/30,13.47%,UNC13B;ERN1;KCNB1;XBP1;RAB11FIP5;SOX4;GAS6;RAB11B;RACK1;IGF1R
prerank,negative regulation of multicellular organismal process (GO:0051241),0.38997165770898046,1.237855837129945,0.11149425287356322,0.6596693464392571,1.0,29/199,7.33%,RPS6KA5;NOS3;PTPRG;HDAC9;BMPR2;NOVA2;MEF2C;IL15;DAB2IP;PAEP;EFNA1;NOTCH1;KLF7;RAB11FIP1;LAMA4;SOX9;EVL;RPS19;ID1;SMAD7;RAB11FIP5;N4BP1;ATP2B4;PGAM5;BTN2A2;WNT9B;SOST;SRGN;TGFB1
prerank,negative regulation of heart contraction (GO:0045822),-0.5597848572714684,-1.237838650302346,0.20704845814977973,0.653293890884295,1.0,1/11,0.03%,ATP1A2
prerank,nitrogen compound transport (GO:0071705),0.4019064545337854,1.2375682605739604,0.1325898389095415,0.6596593675476112,1.0,32/141,15.49%,CALCRL;ABCG2;CERT1;SLC6A2;MYH9;SEC14L1;EDN1;SLC7A7;SLC38A5;ATP11B;SLC3A2;SLC6A6;SCAMP1;RAMP2;SLC43A2;CHMP2B;SLC52A3;ARRDC1;SLC15A2;RAB38;SLC38A1;SCARB2;CD320;PICK1;RILP;RAB7A;TXNIP;TCN2;SLC22A5;SLC18A2;SLC7A5;CEP290
prerank,regulation of MAPK cascade (GO:0043408),0.39778756146551847,1.2369993016448968,0.1198547215496368,0.6604332044375892,1.0,23/157,5.59%,TEK;FLT1;KDR;CAV1;TBX1;INSR;PDGFB;IQGAP1;DAB2IP;LYN;JCAD;FAS;PTPRJ;TAOK2;STK3;FLT4;PLCG2;CAV2;PAK2;STK4;CEACAM1;GREM1;RET
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.4911250296318981,-1.2369634030684011,0.19811320754716982,0.6539929404520451,1.0,6/17,7.09%,NOTCH2;BMPR1A;BMP4;JAG1;HEYL;RBPJ
prerank,carboxylic acid transport (GO:0046942),-0.38546549992149803,-1.2368636366004602,0.15436241610738255,0.6524573552922687,1.0,13/55,11.59%,SLC6A13;SLC16A12;SLC13A3;SLC1A5;SLC6A12;SLC16A6;SLC6A9;SLC16A11;PSAP;SLC6A15;SLC66A1;SLC7A6;SLC6A7
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.41256349712346857,1.2368131632156294,0.14675324675324675,0.6601248397302528,1.0,39/109,23.11%,NFATC1;PLCG1;LYN;PPP3CA;PLCG2;PAK2;IKBKB;MAPK8;PPP3CB;RAC1;PSMA2;NFKB1;MALT1;IKBKG;PSMA8;PSMA6;CUL1;RELA;TRAF6;PSME1;LAT;SOS1;TAB3;CALM1;MAP2K4;PSMA4;GRB2;PSMF1;PAK1;BCL10;PSMB7;MAP3K1;PSMB1;MAP2K7;PSMD2;PSMA5;PSMC3;JUN;FCER1G
prerank,positive regulation of binding (GO:0051099),0.43191777351133354,1.2361918851421858,0.17024128686327078,0.6611404864312788,1.0,18/84,8.58%,CAV1;APP;EPB41;CLDN5;B2M;HIP1R;STK3;FKBP1A;HMBOX1;STK4;MARK3;RALB;DTX3L;TCF7L2;RAPGEF2;TRIB3;CDT1;PSEN1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.49737968328462245,1.2354634503616395,0.1934477379095164,0.6624043525735236,1.0,4/37,1.89%,PRKG1;MEF2C;ERN1;PDGFB
prerank,regulation of presynapse assembly (GO:1905606),-0.48515347831812516,-1.235443290765999,0.20689655172413793,0.6529470168198421,1.0,6/18,11.15%,GPC6;PTPRD;IL1RAPL1;LRFN5;GPC4;MDGA1
prerank,regulation of presynapse organization (GO:0099174),-0.48515347831812516,-1.235443290765999,0.20689655172413793,0.6529470168198421,1.0,6/18,11.15%,GPC6;PTPRD;IL1RAPL1;LRFN5;GPC4;MDGA1
prerank,glycogen catabolic process (GO:0005980),-0.515250559342816,-1.2354424061424185,0.2242152466367713,0.6511432957789034,1.0,7/15,20.81%,PYGB;PHKB;PYGM;GAA;AGL;PHKA2;PHKG1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5402248394003866,-1.2353389827261954,0.2243436754176611,0.6496625317692618,1.0,8/13,8.40%,BMPR1A;FGFR2;TGFBR3;ERBB4;FGF2;ZFPM2;RBPJ;GLI1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5943589289974918,1.2353185499067973,0.2539964476021314,0.6619505456001136,1.0,7/11,16.68%,ARHGEF2;CASP8;PELI1;YBX3;RIPK1;BIRC3;BIRC2
prerank,protein acetylation (GO:0006473),0.49268999673929403,1.2346412431788867,0.22512234910277323,0.6629693846176229,1.0,6/30,15.40%,FOXO1;HAT1;NAA11;KAT2B;KAT6A;NAA16
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4356716209354604,1.2344951935801518,0.16890080428954424,0.6624689978393735,1.0,20/76,17.22%,DCUN1D3;CAV1;FBXW7;RASD2;FKBP1A;SMAD7;XIAP;MYCBP2;MALT1;TNIP1;UBE3A;SAE1;RIPK2;PRICKLE1;BIRC3;TRAF6;NDFIP2;BIRC2;WDR48;CUL3
prerank,positive regulation of phagocytosis (GO:0050766),0.4663264885013769,1.2341423784754504,0.18262150220913106,0.6625964248412605,1.0,4/47,2.90%,RAB27A;IL15;GATA2;PTPRJ
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5183685315469804,-1.2340909664983744,0.21052631578947367,0.6513564470703065,1.0,5/13,12.06%,IRS1;IGF2;PRKCZ;ECHDC3;SNX5
prerank,protein modification process (GO:0036211),0.43842323602173994,1.2340482520128748,0.17246175243393602,0.662006671379684,1.0,15/76,11.60%,ST3GAL6;ST3GAL1;YES1;CPE;UBA7;PADI4;ST8SIA4;AKT2;FBXL2;FBXW2;ERO1A;UBE2D3;ICMT;ABL2;STK38
prerank,regulation of keratinocyte migration (GO:0051547),-0.5366169245065194,-1.2340181810552238,0.2214765100671141,0.6497935573076992,1.0,11/12,46.22%,IQSEC1;ADAM9;FGF7;FGF10;PTEN;MTOR;EPB41L4B;MAP4K4;ARF6;EPPK1;MMP9
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.34000293277023264,-1.2338959428680434,0.10256410256410256,0.6483435202832859,1.0,30/108,10.26%,TRABD2B;SULF1;WLS;LRP1;FGFR2;PRKN;GPC3;PTK7;CTNND2;RNF43;SULF2;DCDC2;GRB10;WWOX;DAAM2;RSPO3;RSPO2;DACT1;SALL1;SFRP4;CXXC4;NOTUM;LRRK2;FOXL1;BTRC;SFRP1;RUNX1;TSC2;SMARCA4;APCDD1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.45940781397109104,-1.2338869894994995,0.2051948051948052,0.6466016852874794,1.0,12/24,15.22%,DPYSL3;DOCK11;NRP1;RHOQ;ARAP1;TENM2;NLGN1;RIPOR2;TGFB3;PALM;PLPPR5;RALA
prerank,outflow tract septum morphogenesis (GO:0003148),0.5371194642668226,1.2337731855412983,0.2245557350565428,0.6618801010406954,1.0,4/24,0.88%,NRP2;BMPR2;ENG;TBX1
prerank,erythrocyte differentiation (GO:0030218),0.47045846658403273,1.2335986519756905,0.1937984496124031,0.661538672650632,1.0,8/44,5.14%,LYN;TAL1;MFHAS1;ALAS1;RPS19;JAK3;RPS14;KMT2E
prerank,cAMP biosynthetic process (GO:0006171),-0.5672061155921412,-1.2333790595113916,0.2288135593220339,0.6463316334924151,1.0,5/10,5.09%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3588432630200919,1.2328652499083583,0.002002002002002002,0.662794558548737,1.0,272/1668,12.44%,MECOM;DACH2;ERG;LEF1;MRTFB;ELK3;FLI1;RPS6KA5;FOXO1;LHX6;EPAS1;TEAD4;HDAC9;DACH1;ZHX3;PBX1;BMPR2;LDB2;ENG;CAV1;ITGA6;TBX1;ESR1;SMARCA2;APP;PPARD;TSHZ2;MEF2C;ZBTB16;TOX4;LMO2;ACVRL1;PRKD1;NR5A2;CRTC1;MAML2;AHR;ETV6;SMAD1;ZIC3;NFATC1;LRRFIP1;NLRC5;IRF2;FOXP1;GATA2;DAB2IP;SOX13;ELF2;MED13L;EDN1;HHEX;ARHGEF2;PDE2A;LRP5;TAL1;PRKD2;NEDD4L;STAT3;EFNA1;NR3C1;FNIP2;PPP3CA;NOTCH1;HIF1A;EBF1;KLF7;RREB1;KLF8;NFKBIA;CCNK;KDM3A;SOX17;TGIF1;PKNOX2;PITX1;NCK1;WWTR1;ARID3B;ZFP57;SOX18;BAZ2B;JMY;TCF12;TSHZ1;PPP1R12A;HMBOX1;FOSL2;MAFF;TOX;SOX9;RIPPLY3;MRTFA;PKN1;ZBTB46;NCOA1;DLL1;RPS6KA3;KLF2;ZNF292;FOXF1;FOXQ1;SS18;ELK4;RPS14;IKBKB;MCPH1;SDCBP;RPS6KA1;SP6;FOXL2;XBP1;ZFP92;TET3;ID1;EPC1;TCF7L1;SMAD7;ACVR2A;GREM1;DLL4;FOXF2;SBNO2;ARID1B;ATP2B4;HOXA10;PHF20;MTF2;LPIN3;TCF7L2;TCF4;JMJD1C;LIN9;TEAD2;TNRC6C;PITX3;PPP3CB;ESRRG;DUSP22;CHP2;WNT5A;CNBP;SKAP1;RCOR1;TOX3;ATMIN;KLF10;ACVR1;NR1I3;FBP1;FOXA3;ELF5;FOSL1;IRF2BPL;CD40;HNF1B;ETS2;JUNB;TRIB3;ASCL4;KLF13;LYL1;CHD1;SPDEF;ARRB1;PPM1D;HNRNPK;RBM14;TNFRSF1A;TGFB1;HOXD8;HOXD1;TGFA;GMEB2;TCF3;AGRN;NFKB1;GATAD2A;MAMSTR;ARID1A;PKD2;KDM4C;NEUROD1;CTBP1;WWC2;BACH2;CITED1;NRL;ZNF2;CREM;KAT6B;PHF6;SMARCA5;EZH1;PSEN1;CREB1;TAF3;FOXK1;CRK;ZFPM1;SUB1;RPL23;BRD4;PCGF5;CHD2;IER2;TCF15;SOX4;RELB;IKBKG;DICER1;AEBP2;MAFB;BRIP1;BACH1;MED27;RNF4;YEATS2;NFIB;CREB3L4;NRIP1;MAMLD1;MAD2L2;SP2;SKIL;CNOT1;KLF12;SMAD5;SRCAP;SFRP2;UBE2D3;USF2;EGR3;TNIP1;SEMA4D;SMARCE1;ZBTB10;PHF20L1;GLYR1;TFAP4;POU2F1;GABPB1;CSRNP1;SPEN;CNOT2;MC1R;GLMP;ZMIZ1;ENY2;RB1;ATF6;EID1;CBFB;SP3;CEBPD;GRIN1;RIPK1;PRDM2;DCAF1;ACTR2;ZNF319;RPRD1B;MUC1;ASXL1;NOP53;MIER1;SIRT6;RELA;RIPK2;MAX;TET2;LCORL
prerank,Notch signaling pathway (GO:0007219),0.44178766003307535,1.232235454724605,0.1765536723163842,0.6637526424244536,1.0,9/59,5.28%,SORBS2;PBX1;MAML2;ADAM10;NOTCH1;PLXND1;DLL1;DTX3L;DLL4
prerank,exit from mitosis (GO:0010458),0.5834716907542624,1.2322206126753974,0.23047619047619047,0.6629388089169291,1.0,6/12,23.45%,EPS8;CHMP4B;PPP2R2D;CTDP1;SIRT7;CLASP2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.591019985526429,1.232216319296191,0.26716141001855287,0.6621124031044862,1.0,4/12,11.57%,ELF2;LYN;RC3H1;CBFB
prerank,positive regulation of phosphorylation (GO:0042327),0.3810719180034364,1.2320575002895535,0.11990950226244344,0.6617675221761573,1.0,41/240,8.77%,TEK;LIMCH1;PECAM1;FLT1;KDR;ENG;ITGA6;TBX1;TIE1;APP;PDE8A;EPHB4;INSR;VEGFC;LYN;FAS;EFNA1;HIF1A;PFKFB3;FLT4;FGF23;SOX9;STK4;LMTK2;RALB;SDCBP;VEGFD;ACVR2A;RET;LIMK2;KRAS;CD40;RAC1;ARRB1;TNIK;TGFB1;PTK2;NIBAN1;PSEN1;AKT2;ANG
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5086560477298382,1.2312755986143462,0.22052067381316998,0.663137241681061,1.0,6/29,16.63%,PLA2G4A;LPCAT3;PLA2G2D;PLAAT3;PNPLA8;TMEM86B
prerank,regulation of glucose transmembrane transport (GO:0010827),0.5623798061526561,1.230521123348688,0.245,0.6644200561456832,1.0,4/18,6.76%,SLC2A1;OCLN;INPP5K;TRIB3
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.6129800575768457,1.230500161527993,0.2765957446808511,0.6636343117287442,1.0,5/11,7.92%,TBX1;LRP5;SOX9;WNT5A;CTNNBIP1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.5791569066825152,1.2304511369531164,0.25675675675675674,0.6629337888385907,1.0,7/13,28.68%,IRAK4;TRAF6;IRAK2;PIK3R4;TNIP2;PIK3AP1;IRAK1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.499213372320954,-1.2302032954984605,0.22327790973871733,0.6537415737003537,1.0,4/15,3.39%,ATP1A2;SLC12A2;ATP1B1;SLC8A1
prerank,negative regulation of cell projection organization (GO:0031345),-0.3973193062189427,-1.229909490152174,0.13595166163141995,0.6527117378381087,1.0,10/48,9.84%,LPAR1;DPYSL3;PTPN9;PTPRS;EFNB2;ADCY6;SEMA3A;DCC;RAB29;APOE
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.45808010801198373,-1.2298155016367316,0.2020460358056266,0.6512268244218604,1.0,11/22,26.52%,TIMP3;TIMP2;ADRA2A;APOE;ADAM9;GPLD1;PTPN3;PACSIN3;SNX33;NRDC;TIMP1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.562470815570566,1.2298072190599878,0.22837370242214533,0.6638688956991153,1.0,11/16,26.74%,CHMP4A;CHMP4B;VPS28;TMEM50B;STAM;VTA1;LEPROT;VPS36;VPS25;TMEM50A;CHMP4C
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5738170036952783,-1.2297819785210196,0.24036281179138322,0.6495592960260917,1.0,2/10,2.95%,GLI3;BMP4
prerank,neuron development (GO:0048666),0.40024091633407555,1.2296901302305214,0.15006002400960383,0.6633438241881039,1.0,19/141,7.82%,FRY;FRYL;PBX1;APP;MEF2C;UGCG;STX3;PTPRM;RAB11A;LYN;PPP1R9B;BICDL1;XBP1;ULK1;OPHN1;RAPGEF2;RP1L1;B4GALT5;NEDD4
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5911728747785061,1.2287638359053192,0.26356589147286824,0.6651159883442941,1.0,2/10,0.86%,ENG;CAV1
prerank,rRNA 3'-end processing (GO:0031125),-0.5435586312472955,-1.2286595437443355,0.23908045977011494,0.6510005955890119,1.0,4/10,19.17%,ERI3;EXOSC7;EXOSC3;EXOSC9
prerank,axon development (GO:0061564),-0.34798058180318847,-1.2282538387645776,0.11693548387096774,0.6504679116919007,1.0,20/78,11.40%,DOCK7;FGFR2;SEMA5A;GRM7;BRSK1;PLP1;S100A6;ANK3;SHTN1;RYK;NTNG1;S100B;CTNNA2;DCC;NRCAM;BAIAP2;NREP;RAB10;GAP43;CNTN4
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4310885540450952,1.2281358077258504,0.16710875331564987,0.6659764976322956,1.0,14/72,8.10%,TEK;FLT1;KDR;INSR;PDGFB;LYN;PDGFD;SELP;SOX9;PDGFC;PIK3CG;PTK2;NEDD4;GAB1
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.4061790395251241,-1.2280278924899763,0.18258426966292135,0.6493514558179735,1.0,9/34,12.59%,ANK2;ATP1B1;SLC8A1;P2RX4;PRKACA;ATP2A2;RYR2;SLC9A1;ADRA1A
prerank,regulation of response to biotic stimulus (GO:0002831),0.49869938550533816,1.2278929451305902,0.21405228758169934,0.6657961303820906,1.0,11/28,16.96%,FOXP1;SAMHD1;CASP8;TIRAP;N4BP1;XIAP;ERAP1;BIRC3;ZMPSTE24;BIRC2;ELMOD2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5710267274057722,1.2278503037835784,0.24561403508771928,0.6650745416842132,1.0,4/15,4.00%,KDR;PRKD1;PRKD2;TMSB4X
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5096595597398742,1.2278018867142189,0.22644628099173553,0.6643586777431071,1.0,3/26,4.28%,CAV1;MFHAS1;TIRAP
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.460318551631567,1.227374203781316,0.2054380664652568,0.6646977680287173,1.0,14/44,19.01%,NANOS3;NANOS2;TNRC6C;PRR5L;PUM1;BTG2;CNOT1;RC3H1;ZFP36;CNOT7;PNPT1;ZFP36L1;METTL14;DHX36
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.4814147651037427,1.227315718185481,0.2077727952167414,0.6640246546430744,1.0,9/39,13.90%,FNBP1L;MYO1D;ACTN4;PPFIA2;BICDL1;MYO1E;MYO1C;CCDC186;NDEL1
prerank,cellular response to retinoic acid (GO:0071300),0.4749482128837753,1.2270677161748327,0.21299093655589124,0.6638765346596116,1.0,12/42,11.11%,TBX1;FZD4;LYN;PTK2B;SOX9;RET;WNT5A;WNT9B;BRINP2;CREB1;TWF2;ABL2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.5114335982612255,-1.2268643202512357,0.23851203501094093,0.6509244452606041,1.0,4/14,4.01%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5893864531254488,1.2263951213007358,0.2644927536231884,0.6649566173161612,1.0,3/12,8.24%,FOXP1;TIRAP;LPL
prerank,cellular response to oxygen-containing compound (GO:1901701),0.37631327743128107,1.2259742247155372,0.0952914798206278,0.6652971973747414,1.0,48/291,10.32%,FOXO1;TGM2;TBX1;ESR1;MEF2C;PRKD1;DAPK1;AHR;PDGFB;SH3BP4;DAB2IP;FZD4;PDE2A;LYN;KCNQ1;PTK2B;GNB1;TNFRSF1B;RAP1B;PXN;SOX9;TIRAP;XBP1;PTPRK;CX3CR1;SBNO2;MAPK8;ATP2B4;RET;WNT5A;RAPGEF2;WNT9B;IL36G;INPP5K;PPBP;RAP1A;BRINP2;NFKB1;PKD2;LPL;CASP1;RPTOR;CREB1;DEFA6;CDK2;NRIP1;TWF2;LARS1
prerank,fatty acid biosynthetic process (GO:0006633),0.4383822891525117,1.2255198974794614,0.17265193370165746,0.6657721590517046,1.0,10/63,11.84%,ELOVL7;PTGS2;ABHD2;ELOVL5;XBP1;ASAH2;LPL;LTC4S;DEGS1;ABCD1
prerank,negative regulation of receptor internalization (GO:0002091),0.5807499705518099,1.225473918362003,0.27106227106227104,0.6650836901991647,1.0,3/12,4.85%,ANKRD13A;RIN3;SDCBP
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.422759927266088,1.2249235173481112,0.15217391304347827,0.6658145538084048,1.0,16/83,12.41%,CDK17;CDK6;EIF4E;PLK2;ACVR1;CDKN1B;POLA1;CDT1;BRD4;CDK2;BACH1;CDK18;RB1;EIF4EBP1;CUL1;MAX
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.4680167569200375,-1.2246833369087295,0.19471153846153846,0.6552571027146864,1.0,8/19,17.50%,RENBP;PGM3;NAGK;GFPT1;GFPT2;UGP2;GNPDA1;UGDH
prerank,metal ion homeostasis (GO:0055065),0.4702615378001653,1.2246374268283904,0.2260596546310832,0.6657689588868811,1.0,7/40,11.63%,TMTC2;CAV1;SLC12A7;TRPV6;SLC12A9;CYP27B1;GRIN1
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3876698290598544,-1.2238330879021182,0.15806451612903225,0.6559404244552386,1.0,16/44,11.20%,LPAR1;ROCK2;PPM1E;ARHGEF10L;NRP1;CCN2;TGFBR1;ARHGEF10;TPM1;CARMIL1;SFRP1;FHOD1;RGCC;TGFB3;S100A10;PFN2
prerank,regulation of extracellular matrix organization (GO:1903053),-0.4858957092561563,-1.2236476085376646,0.20309050772626933,0.6547013905512871,1.0,9/15,10.72%,LRP1;AEBP1;DDR1;FAP;EFEMP2;RUNX1;DDR2;SLC2A10;FGFR4
prerank,carbohydrate derivative catabolic process (GO:1901136),0.552503577536875,1.223129068209654,0.25996533795493937,0.6691443562197421,1.0,2/18,2.58%,STT3B;SAMHD1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.5153733997783536,1.2225899585477358,0.24437299035369775,0.6698352411186541,1.0,10/24,15.76%,OCLN;WASF2;NCKAP1;RAC1;TWF2;FSCN1;CYFIP1;ACTR2;ACTR3;ARPC2
prerank,neuron projection fasciculation (GO:0106030),-0.573258253617754,-1.2219499705270103,0.240990990990991,0.6578943100155923,1.0,7/10,23.19%,SEMA5A;NRCAM;CNTN4;RTN4;ARHGAP35;EPHB3;EPHB2
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5729337015135494,1.2219481436410518,0.25217391304347825,0.6707877265929164,1.0,5/13,12.94%,NOTCH1;CPE;FOXF1;SFRP2;TGFBR2
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4175501944607511,-1.2218634811060922,0.17318435754189945,0.6564586266224605,1.0,4/30,5.19%,IGF1;IGFBP2;IL18;IGF2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.42115403896456083,1.2214853696411783,0.17763157894736842,0.6712222497121557,1.0,19/87,8.35%,ENG;ACVRL1;CLDN5;F11R;SMAD1;SMURF1;PARD3;NRROS;PXN;FKBP1A;ID1;PTPRK;SMAD7;USP15;DUSP22;ACVR1;TGFB1;PTK2;CITED1
prerank,natural killer cell activation (GO:0030101),0.5288777360128248,1.2209646493552135,0.23832528180354268,0.6718900355795911,1.0,3/23,4.16%,PBX1;CASP8;TOX
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5740629980639833,1.220031298028294,0.2636363636363636,0.6735695026024388,1.0,5/15,7.03%,KDR;PTK2B;SRMS;DYRK1A;BMX
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.578641611654125,1.219662051734774,0.2718808193668529,0.6737742804901526,1.0,3/13,12.73%,PTGS2;NAXE;SLC5A8
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.34855905832581296,-1.219606266424052,0.1388888888888889,0.6611103411217099,1.0,23/80,17.02%,PLPP3;ATP9A;KIF3C;KIF3A;COPZ2;COPB1;KDELR3;COPA;COPG1;ERGIC1;TMED9;GBF1;ERGIC2;ARFGAP1;ARCN1;HTT;BICD2;KIFAP3;KLC1;GOLPH3L;ARFGAP2;KIF5A;SCFD1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.46537207378324974,1.2194222282937466,0.21693907875185736,0.6735731959277709,1.0,6/46,3.63%,TEK;PARVB;PEAK1;EFNA1;SRGAP2;PXN
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4390821456693416,1.2192434781678374,0.19420289855072465,0.673313663783537,1.0,24/59,23.27%,DAB2IP;NFKBIA;IKBKB;TNFRSF1A;BCL3;RELB;IKBKG;RIPK1;RELA;RIPK2;BIRC3;NKIRAS1;TRAF6;ERC1;TBKBP1;TAB3;BIRC2;IRAK2;TIFA;BCL10;REL;NLRC3;TANK;TRAF2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.5558659755222652,1.219143912426501,0.23720136518771331,0.6727873094601914,1.0,4/16,10.01%,CEACAM1;STX7;IL23A;CYRIB
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4265043193847307,1.2188557719830773,0.1868279569892473,0.6727351392524634,1.0,18/76,13.37%,CBFA2T3;SMURF1;RNF144B;FBXW7;NKD2;SMAD7;RNF144A;TRIB3;PTK2;RNF139;RAD23A;SUMO2;HECTD1;COP1;NOP53;PRICKLE1;RACK1;TRIB1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5934154225404634,1.2188028285451562,0.26497277676951,0.6720601261444046,1.0,3/12,5.49%,SEMA6A;DAB2IP;ATP2B4
prerank,negative regulation of phosphorylation (GO:0042326),-0.34368411935864174,-1.2182895542266499,0.10454545454545454,0.6632338401281302,1.0,13/85,4.40%,PID1;PTPN13;NTRK3;PLPP3;PRKN;BMP7;FBLN1;NUPR1;HDAC4;PPARA;BMP4;IGFBP3;IMPACT
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.49498820009917993,1.2178121734600889,0.23817292006525284,0.6739546600718196,1.0,5/29,5.74%,ELOVL7;ACSL4;FASN;ELOVL5;ACSL5
prerank,icosanoid metabolic process (GO:0006690),0.47205299200616113,1.2173614586957908,0.21116138763197587,0.6743546297710752,1.0,7/40,8.64%,PTGS2;PLA2G4A;PTGS1;EPHX1;ALOX5AP;PON2;LTC4S
prerank,regulation of interleukin-1 production (GO:0032652),0.555872565188253,1.2172310388433296,0.24280575539568344,0.6739599357439505,1.0,3/15,10.66%,FOXP1;CEACAM1;GAS6
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5028753931316364,-1.2170536155862193,0.24065420560747663,0.6652728958112119,1.0,4/14,7.11%,CPEB1;CPEB2;CPEB3;CPEB4
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4567486293406596,1.2170082721362616,0.2225392296718973,0.6737300777254275,1.0,7/52,5.49%,PRKCH;EPB41;STX3;SPTBN1;NKD2;SORBS1;ATP2B4
prerank,response to UV-A (GO:0070141),-0.514595981567802,-1.2165886808862891,0.21888412017167383,0.6648907178451369,1.0,3/14,13.53%,EGFR;MMP2;CERS1
prerank,regulation of ossification (GO:0030278),0.4805619115281263,1.2165396009596339,0.21625766871165644,0.6742481476505002,1.0,11/36,10.26%,BMPR2;MEF2C;ZBTB16;S1PR1;NOTCH1;SOX9;WNT5A;ACVR1;SOST;ANKH;CYP27B1
prerank,superoxide anion generation (GO:0042554),-0.5151599372588471,-1.2160573577310332,0.2357142857142857,0.664720109929971,1.0,6/13,24.49%,NOX4;ALOX12;CYBB;NOX1;NCF2;TAFA4
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5160908997571749,1.2154868909249854,0.23793677204658903,0.6763086144970599,1.0,6/24,9.68%,HTR2A;PLCG2;LCK;ITPR3;PKD2;ERO1A
prerank,acylglycerol catabolic process (GO:0046464),0.49926389986090625,1.2154183236180112,0.22468354430379747,0.6756780239728062,1.0,6/30,15.26%,ABHD2;LIPE;LPL;FABP12;PNPLA2;FAAH
prerank,regulation of hemopoiesis (GO:1903706),-0.5531029083217675,-1.2150858965446258,0.22323462414578588,0.6659268139466354,1.0,4/10,14.21%,PTN;PRKCB;RUNX1;IL17D
prerank,cellular calcium ion homeostasis (GO:0006874),-0.32358412176365076,-1.2150814123079268,0.0625,0.6642245645449518,1.0,22/133,10.29%,SLC24A3;ANK2;ATP13A5;ATP13A3;BCL2;SLC8A3;ATP1B1;SLC8A1;MCU;DMPK;SLC35G1;TRPC3;STIM1;PRKACA;TRPC6;ANXA6;TRPC1;ATP2A2;RYR2;CXCL12;SLC24A2;TRPC4
prerank,Rap protein signal transduction (GO:0032486),0.6187585990492359,1.2149395623679167,0.24721189591078066,0.6761615460318419,1.0,4/10,7.53%,RAP1B;PLK2;RAPGEF2;RAP1A
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.525363371072852,-1.214507457458939,0.26280623608017817,0.6641691503207701,1.0,5/12,11.08%,NBL1;BMP5;CCN3;SLIT2;MIA3
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3535247414567324,1.2144606457957596,0.007007007007007007,0.6765971849441387,1.0,240/1646,11.61%,MECOM;DACH2;ERG;LEF1;ELK3;FLI1;RPS6KA5;FOXO1;LHX6;EPAS1;CDK17;CD38;TEAD4;HDAC9;ATP8B1;DACH1;ZHX3;PBX1;ENG;TBX1;SLC39A8;APBB2;ESR1;SMARCA2;PPARD;TSHZ2;MEF2C;CBFA2T3;ZBTB16;TOX4;SOX7;ACVRL1;NR5A2;INSR;AHR;ETV6;SMAD1;ZIC3;NFATC1;LRRFIP1;PDGFB;IRF2;FOXP1;GATA2;DAB2IP;SOX13;ELF2;MLLT3;MED13L;FZD4;HHEX;LRP5;TAL1;STAT3;NR3C1;NOTCH1;HIF1A;EBF1;PPM1F;KLF7;RREB1;AFAP1L2;KLF8;CCNK;KDM3A;SOX17;TGIF1;PKNOX2;PITX1;WWTR1;PLCB1;ARID3B;CHD7;ZFP57;SOX18;BAZ2B;JMY;TCF12;TSHZ1;HMBOX1;FOSL2;MAFF;TOX;SOX9;PKN1;ZBTB46;NCOA1;RPS6KA3;KLF2;ZNF292;FOXF1;FOXQ1;ELK4;IKBKB;RPS6KA1;SP6;VGLL4;DTX3L;SCMH1;FOXL2;ZFP92;ID1;EPC1;TCF7L1;LIN54;KMT2E;PTPRK;SMAD7;SPIN1;FOXF2;SBNO2;ARID1B;ATP2B4;HOXA10;PHF20;RET;MTF2;TCF7L2;TCF4;JMJD1C;LIN9;TEAD2;PITX3;PPP3CB;ESRRG;WNT5A;CNBP;SKAP1;ATF7IP;RCOR1;TOX3;ATMIN;KLF10;ACVR1;FOXA3;ELF5;FOSL1;IRF2BPL;SOST;INPP5K;ASCC1;HNF1B;DYRK1A;CDKN1B;ETS2;JUNB;TRIB3;ASCL4;KLF13;LYL1;CHD1;SPDEF;ARRB1;HNRNPK;TGFB1;FOXN2;HOXD8;HOXD1;TGFA;BCL3;ZNF326;GMEB2;TCF3;HNRNPD;NFKB1;GATAD2A;MAMSTR;PCBD2;ARID1A;KDM4C;NEUROD1;CTBP1;POLA1;WWC2;BACH2;CITED1;NRL;CDT1;ZNF2;CREM;KAT6B;PHF6;SMARCA5;PSEN1;CREB1;FOXK1;PRDM8;CRK;MYBBP1A;SUB1;BRD4;PCGF5;CHD2;HINT1;TCF15;SOX4;RELB;MAP2K3;AEBP2;MAFB;BRIP1;BACH1;MED27;RNF4;YEATS2;EDRF1;NFIB;CREB3L4;MAMLD1;MAD2L2;SP2;KLF12;SMAD5;SRCAP;SFRP2;USF2;EGR3;FOXN3;SMARCE1;ZBTB10;CDK18;PHF20L1;TFAP4;GAS6;POU2F1;CSRNP1;SPEN;RBM15;BTG1;CNOT2;MMS19;ZMIZ1;ENY2;RB1;ZMYND11;ATF6;EID1;CBFB;SP3;CEBPD
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.41279932026006144,-1.2143612792598337,0.1794871794871795,0.6628367479391141,1.0,9/32,5.84%,SDC2;HECW2;ADGRB3;OBSL1;CUX2;CAPRIN2;PTPRD;IL1RAPL1;CUX1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.375638128964136,-1.2138310075617946,0.1644295302013423,0.6626689251751433,1.0,16/51,11.20%,LPAR1;ROCK2;PPM1E;ARHGEF10L;NRP1;CCN2;TGFBR1;ARHGEF10;TPM1;CARMIL1;SFRP1;FHOD1;RGCC;TGFB3;S100A10;PFN2
prerank,lipoprotein biosynthetic process (GO:0042158),0.5808716772555734,1.2137174978831717,0.29044117647058826,0.6778011662380653,1.0,1/11,1.17%,UGCG
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5051264761073703,-1.2133006605347723,0.23776223776223776,0.6626318168900833,1.0,5/15,7.51%,GRM7;GRM5;GRM1;GRM3;DAGLA
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.42896570543136026,-1.2131968608692296,0.1984924623115578,0.6612649243792893,1.0,6/27,10.20%,ANK2;CACNA1C;DLG1;ATP2A2;RYR2;CTNNA3
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.40364842472559026,1.2128248352060222,0.15355805243445692,0.6794885420905553,1.0,29/121,10.82%,PECAM1;IL6ST;IL15;PDGFB;NEDD9;IL6R;ARHGEF2;LYN;STAT3;EFNA1;PTK2B;PTPRJ;PLCG2;PAK2;GHR;GREM1;ENPP2;ACVR1;CD40;STAP2;TNFRSF1A;TGFB1;ITGA5;PTPN1;IL23A;FCGR1A;SEMA4D;GAS6;EPHA4
prerank,negative regulation of nuclear division (GO:0051784),-0.5339556318739898,-1.21260370726799,0.2605932203389831,0.6612569463020225,1.0,3/11,7.22%,BMP7;BMP4;TOM1L2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5917760939860447,1.2125563579872671,0.2760511882998172,0.6794757320743834,1.0,5/11,14.03%,ATF7IP;TASOR;PPHLN1;SIRT6;SETDB2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.41743540350094466,1.2123236046938584,0.18404118404118405,0.6793272211588007,1.0,24/93,12.95%,CAV1;APP;PRKD1;CNKSR3;PRKD2;FNIP2;DDIT4;PDE4D;PPM1F;NCK1;SH2D3C;STK4;SMAD7;ATP2B4;INPP5K;BCAR3;TGFB1;RPTOR;MAD2L2;SFRP2;GAS6;RIPK2;RACK1;HSP90AB1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3549644993010987,1.2112095742396989,0.03560528992878942,0.6815075992937033,1.0,135/807,12.75%,MECOM;LEF1;ELK3;RPS6KA5;FOXO1;CD38;HDAC9;ATP8B1;DACH1;ZHX3;LDB2;CAV1;ESR1;SMARCA2;PPARD;MEF2C;CBFA2T3;ZBTB16;SOX7;AHR;ETV6;LRRFIP1;PDGFB;IRF2;FOXP1;DAB2IP;SOX13;EDN1;HHEX;PDE2A;NEDD4L;STAT3;EFNA1;NR3C1;FNIP2;NOTCH1;PPM1F;KLF7;RREB1;KLF8;TGIF1;PLCB1;ZFP57;SOX18;HMBOX1;SOX9;RIPPLY3;KLF2;ELK4;RPS14;MCPH1;SDCBP;VGLL4;SCMH1;FOXL2;ID1;EPC1;PTPRK;SMAD7;DLL4;SBNO2;MTF2;TCF7L2;DUSP22;WNT5A;CNBP;ATF7IP;RCOR1;KLF10;NR1I3;FBP1;IRF2BPL;INPP5K;CDKN1B;ETS2;TRIB3;SPDEF;TGFB1;BCL3;TCF3;NFKB1;GATAD2A;CTBP1;WWC2;CITED1;CREM;KAT6B;PHF6;EZH1;PSEN1;CREB1;TAF3;FOXK1;MYBBP1A;ZFPM1;RPL23;DICER1;BACH1;YEATS2;NRIP1;MAD2L2;SP2;SKIL;CNOT1;KLF12;SFRP2;UBE2D3;FOXN3;SEMA4D;SMARCE1;TFAP4;GAS6;POU2F1;SPEN;RBM15;CNOT2;RB1;ZMYND11;EID1;CBFB;SP3;SAMD1;PRDM2;DCAF1;MUC1;NOP53;MIER1;SIRT6;RELA;MAX;PRICKLE1;PA2G4;ZFP36;RPL10;MIDEAS
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5635689631830626,1.2105343695297146,0.26287744227353466,0.6826057885384114,1.0,5/13,12.36%,PPARD;PDGFB;SOX9;NFIB;RELA
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.6103809135354317,1.2104738791958978,0.2698706099815157,0.6819744585857117,1.0,2/10,6.15%,ESR1;ATF7IP
prerank,mesonephros development (GO:0001823),-0.5304148696996409,-1.2103805104046723,0.25396825396825395,0.6657779380343445,1.0,4/11,2.95%,FGF1;BMP7;OSR1;BMP4
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5139044091405509,1.21037660332163,0.2537313432835821,0.6814059175503051,1.0,7/22,11.96%,KANK3;HIP1R;SSH2;TMSB4X;CYRIB;TWF2;PFN4
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4625702443539026,1.2103196262760376,0.21823617339312407,0.6807300346378763,1.0,4/46,2.31%,SEMA6A;CNKSR3;DAB2IP;LYN
prerank,protein neddylation (GO:0045116),0.580605040414039,1.2098264863691905,0.27549194991055453,0.6812050125899616,1.0,2/13,7.26%,DCUN1D3;RNF7
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4196737202658339,1.2094372617185118,0.18441558441558442,0.6815691864994583,1.0,15/93,6.63%,APP;TNFRSF19;DAB2IP;MFHAS1;PTK2B;TPD52L1;TAOK2;PLCB1;TRAF1;FLT4;TIRAP;EDAR;SDCBP;DUSP22;SASH1
prerank,negative regulation of metabolic process (GO:0009892),-0.3685248123307956,-1.2094184174894909,0.16831683168316833,0.6667732032349719,1.0,10/54,7.09%,PLCL1;ALDH1A1;DOCK7;LGR4;NPR3;ADAMTS5;FOXC2;ACOT11;NOVA1;RBPJ
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.3702734187646217,-1.2089568054099395,0.14006514657980457,0.6664171156709802,1.0,11/57,8.32%,LPAR1;ADCY5;ADCY1;ADCY2;AKAP12;GRM7;ADCY7;ADCY6;PSAP;GNAI1;ADRA2A
prerank,mitochondrial fission (GO:0000266),0.5683374012488738,1.2088909147808786,0.24778761061946902,0.6822723540420229,1.0,1/16,0.27%,DNM3
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.5559298120143393,1.208883466753126,0.2571912013536379,0.6814941928979601,1.0,7/16,22.35%,INSR;BNIP3;IGF1R;IRAK3;GLE1;TBC1D25;HDAC6
prerank,positive regulation of interleukin-12 production (GO:0032735),0.48702901303878887,1.2088065400638033,0.2173228346456693,0.6809190633375006,1.0,7/31,12.40%,PLCB1;PLCG2;TIRAP;CD40;IL23A;MAPK11;RIPK2
prerank,membrane repolarization (GO:0086009),-0.4930475177118473,-1.2081236716404429,0.2579908675799087,0.6672230584529732,1.0,5/15,9.89%,ATP1A2;ATP1B1;KCND3;KCNJ2;ATP1B2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5099894888595925,1.207989832105234,0.25,0.6823089836768472,1.0,6/23,8.15%,PIEZO1;MEF2C;EDN1;GREM1;TGFB1;ATP11A
prerank,negative regulation of JNK cascade (GO:0046329),0.48582283840317353,1.2070387191297545,0.23076923076923078,0.6841726602481762,1.0,1/31,0.03%,MECOM
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.41380787952089304,1.2068494568685522,0.18848167539267016,0.683829074694404,1.0,15/88,10.49%,EXOC6;CLINT1;APP;EXOC6B;SCAMP1;DOP1B;ARRB1;AP2A1;EXOC5;AP1S2;LLGL1;SNAP23;PUM1;EXOC4;VAMP8
prerank,positive regulation of heart rate (GO:0010460),0.5531957432998945,1.2068346339999658,0.25528169014084506,0.6830721949122066,1.0,4/17,4.08%,EDN1;KCNQ1;PDE4D;ADRB1
prerank,regulation of stem cell proliferation (GO:0072091),-0.49072567677279966,-1.2065726908342695,0.22325581395348837,0.6701459793467314,1.0,7/17,24.56%,FBLN1;GJA1;AGO3;HNRNPU;HMGB2;TERT;PTPRC
prerank,chondrocyte differentiation (GO:0002062),-0.4073651189956652,-1.2065090774241163,0.17287234042553193,0.6686683235692501,1.0,11/32,10.12%,SOX5;SULF1;OSR1;SULF2;BMP4;SOX6;RUNX2;SLC39A14;CCN3;RUNX1;EIF2AK3
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5013185079394964,1.2063632633140393,0.23208722741433022,0.6835184261486411,1.0,4/29,5.59%,TNFSF10;CAV1;PAK2;RET
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.37966546980511007,-1.2058929107408036,0.16718266253869968,0.6687893678029458,1.0,10/46,4.51%,IGF1;PDGFRB;OGN;IGFBP5;IL18;BMP4;CDH13;THBS1;IGFBP3;APOD
prerank,regulation of myeloid cell differentiation (GO:0045637),0.43605929857451464,1.2058025511589638,0.20441988950276244,0.6843101490763914,1.0,13/62,11.57%,MEF2C;ZBTB16;CDK6;LYN;PTK2B;KMT2E;H3-3A;TNRC6C;ZFPM1;MAFB;EIF6;RBM15;CBFB
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5199162254656965,1.2057149640774207,0.2520193861066236,0.6837696928424577,1.0,5/25,8.24%,SPTBN1;PRKD2;PDE4D;PLCG2;MALT1
prerank,regulation of protein phosphorylation (GO:0001932),0.3714383778260684,1.2055076599909973,0.12583518930957685,0.6835651533120047,1.0,42/256,8.62%,TEK;LIMCH1;PECAM1;KDR;ENG;TBX1;APP;PDE8A;OCLN;INSR;VEGFC;PPP2R5A;DAB2IP;LYN;FAS;EFNA1;FNIP2;BST1;FYN;WWTR1;FLT4;FGF23;SOX9;STK4;RALB;VEGFD;ACVR2A;LIMK2;CCDC88A;PRR5L;KRAS;CD40;INPP5K;RAC1;ARRB1;TNIK;TGFB1;PTK2;NIBAN1;PPP2R5E;PPP2R5B;AKT2
prerank,protein targeting to lysosome (GO:0006622),0.5196309761028524,1.2055050516601808,0.2413223140495868,0.682774901154227,1.0,9/20,18.80%,NCOA4;GCC2;NEDD4;SCARB2;M6PR;GNPTAB;RAB7A;NAGPA;GGA3
prerank,regulation of filopodium assembly (GO:0051489),-0.3996391523911189,-1.20518656895103,0.19667590027700832,0.6691359311405117,1.0,16/38,15.29%,DPYSL3;DOCK11;NRP1;RHOQ;PRKCD;ARAP1;TENM2;FXR2;NLGN1;RIPOR2;TGFB3;GAP43;PALM;PLPPR5;RALA;CAPZB
prerank,small GTPase mediated signal transduction (GO:0007264),0.4085729419835302,1.2049503741677907,0.17480719794344474,0.6835773018975878,1.0,22/103,10.10%,ARHGAP31;RAPGEF5;NTN1;PRKD1;BCR;GNB1;RREB1;GRAP;RASGRP3;RALB;PLK2;CCDC88A;RAPGEF2;KRAS;NRAS;RAC1;SHOC2;RAB38;CDK2;G3BP1;MAPK11;RGL2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5691114528199308,1.2046120677066596,0.2778761061946903,0.6836458834510808,1.0,4/15,4.20%,SCARB1;FBXW7;SIK1;PLIN5
prerank,positive regulation of transferase activity (GO:0051347),0.39228997051588543,1.204505399398584,0.17064439140811455,0.6831436312472777,1.0,21/142,7.80%,TEK;FLT1;KDR;DCUN1D3;TIE1;EPHB4;CD200;INSR;NEK7;SERINC5;FBXW7;FLT4;HMBOX1;LMTK2;DTX3L;GREM1;RET;TRIB3;TGFB1;HNRNPD;WRAP53
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3782663445297429,1.204380647671321,0.14755959137343927,0.6827379553589952,1.0,27/214,7.53%,SEMA6A;TEK;KDR;APP;PDE8A;ICAM1;SEMA7A;CNKSR3;PDGFB;HTR2A;DAB2IP;LYN;PRKD2;MFHAS1;PDGFD;PTK2B;FBXW7;NOTCH1;FLT4;TIRAP;ARHGAP8;CEACAM1;RAPGEF2;PDGFC;ARRB1;TGFB1;RAP1A
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.4011759213704593,1.2040944936209879,0.17385943279901356,0.6827021987375003,1.0,26/118,10.82%,SHANK3;ABI3;TBX1;LFNG;MEF2C;NEDD4L;ADGRA2;PLXND1;LZTS1;PPFIA2;FLT4;PAK2;CDH2;DLL1;TSPAN12;CEACAM1;FMNL2;EGLN1;TNIK;TGFB1;NEDD4;ZRANB1;CYRIB;SEMA4D;RC3H1;EPHA4
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.48966967010993867,1.2040323293509414,0.24036979969183359,0.6820587828149938,1.0,2/33,1.15%,PRKG1;MEF2C
prerank,regulation of brown fat cell differentiation (GO:0090335),0.5353965948855484,1.2038636400953928,0.2656514382402707,0.6817374410087045,1.0,3/16,3.01%,PTGS2;SOX13;RREB1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4363436482434938,-1.2036760272993374,0.22025316455696203,0.6701569136496659,1.0,10/23,18.65%,ZEB2;THBS1;TGFB1I1;DAB2;HIPK2;SLC2A10;CITED2;CDKN1C;FLCN;MEN1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4363436482434938,-1.2036760272993374,0.22025316455696203,0.6701569136496659,1.0,10/23,18.65%,ZEB2;THBS1;TGFB1I1;DAB2;HIPK2;SLC2A10;CITED2;CDKN1C;FLCN;MEN1
prerank,positive regulation of insulin secretion (GO:0032024),0.4813678978199934,1.2031444284900743,0.2287878787878788,0.6829205092045254,1.0,4/36,5.98%,MYRIP;ACSL4;TCF7L2;PPP3CB
prerank,central nervous system myelination (GO:0022010),-0.5319929968184995,-1.202947414677212,0.2635135135135135,0.6706726013411941,1.0,8/11,22.52%,PLP1;B4GALT6;CNTNAP1;MYRF;TENM4;PTEN;ABCA2;SOX10
prerank,epithelial cell differentiation (GO:0030855),-0.33718100922934674,-1.2029191963816357,0.12595419847328243,0.669114733659698,1.0,18/88,13.12%,FSTL1;MAF;FGFR2;BMP4;ERBB4;SCUBE1;ANXA1;SIX1;JAG1;DAB2;BDH2;GLI1;VEGFA;TAGLN;ANXA4;RAB10;FZD7;VDAC1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5119426599843333,1.2024327266172434,0.2655007949125596,0.6841446261164984,1.0,5/22,7.04%,PDGFB;PDGFD;TAOK2;GREM1;PDGFC
prerank,microvillus organization (GO:0032528),0.5824848961855276,1.2022709919741006,0.2767857142857143,0.6837503210078266,1.0,5/13,7.53%,RAP1B;RAPGEF2;STK26;TNIK;RAP1A
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.47565651582687946,1.201942723237547,0.24587706146926536,0.6838592455568522,1.0,6/34,9.42%,PTPRB;PTPN12;PTPRJ;DUSP22;DUSP16;PTPN1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5466528653867898,-1.2016351745723388,0.2660753880266075,0.6710665460300523,1.0,5/10,25.60%,GALNT13;POGLUT2;GALNT1;GALNT3;GALNT16
prerank,heme biosynthetic process (GO:0006783),0.5175404778858095,1.201172538439951,0.25493421052631576,0.6851834950319002,1.0,2/22,2.95%,ABCG2;ALAS1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5035040055501202,1.2006996589254004,0.24790619765494137,0.6856318960400261,1.0,5/25,9.93%,TAL1;STAT3;HIF1A;ACVR2A;MAPK11
prerank,carbohydrate derivative transport (GO:1901264),0.5505492560381541,1.2006553640096567,0.26465364120781526,0.684970470523341,1.0,4/18,8.48%,PLTP;SCARB1;SLC10A7;SLC15A2
prerank,C4-dicarboxylate transport (GO:0015740),-0.49724690557076134,-1.200393583836125,0.2511520737327189,0.6731268725729989,1.0,10/14,32.78%,SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;SLC25A14;SLC13A5;SLC25A10;LRRC8E;LRRC8D
prerank,lymphocyte migration (GO:0072676),0.4827756670711682,1.1996434086128709,0.25039123630672927,0.6869302157715034,1.0,4/32,10.41%,S1PR1;MSN;RET;CCL14
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.4742789644245576,-1.1995646255056456,0.234192037470726,0.6738991793839908,1.0,6/16,24.15%,SLC39A14;PRKCA;GPER1;MRAP2;ACP3;C3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.49108803996028855,1.1994030020948212,0.23548387096774193,0.6867248325679757,1.0,8/28,12.61%,ADIPOR2;TNFRSF1B;CX3CR1;RAC1;SIRT5;NOS1AP;EIF6;ADIPOR1
prerank,muscle organ development (GO:0007517),-0.3769500200222946,-1.1992642041757502,0.1836734693877551,0.6731445767039692,1.0,14/54,7.50%,LAMA2;IGF1;DMD;SGCD;COL6A3;FHL1;VAMP5;LARGE1;SGCE;ITGA11;SOX6;EVC;SPEG;MKX
prerank,blood vessel diameter maintenance (GO:0097746),0.47245120103637345,1.1991190867057466,0.2496124031007752,0.6867259754607404,1.0,5/34,5.56%,NOS3;EDN1;NPR1;KLF2;KCNMB4
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5001502404218381,1.198325009218093,0.2367549668874172,0.688124529418537,1.0,4/25,5.85%,ABI3;TBC1D30;EVL;LIMK2
prerank,regulation of biomineral tissue development (GO:0070167),0.4989584472919092,1.198306166006916,0.2465986394557823,0.6873834825816005,1.0,8/26,10.66%,NOS3;S1PR1;NOTCH1;SOX9;TGFB1;ANKH;CYP27B1;GAS6
prerank,negative regulation of cilium assembly (GO:1902018),0.5661843999166416,1.1983054512184448,0.27402135231316727,0.6865996929777446,1.0,2/12,5.85%,TBC1D30;LIMK2
prerank,artery development (GO:0060840),0.512801072333316,1.197554095773518,0.2617124394184168,0.6878640643009978,1.0,6/23,5.17%,BMPR2;ENG;TBX1;ACVRL1;PDE2A;SMAD7
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3897618160972254,1.1971393233262013,0.19095477386934673,0.6882197558076236,1.0,17/138,8.71%,TEAD4;HDAC9;ESR1;PPARD;NR5A2;MAML2;NR3C1;HDAC7;NOTCH1;WWTR1;TEAD2;ESRRG;NR1I3;GTF2F2;GTF2E2;TAF3;TAF4B
prerank,pigment granule transport (GO:0051904),0.5326829380906609,1.1970441206905846,0.2563667232597623,0.686886918372295,1.0,2/18,2.16%,RAB27A;RAB11A
prerank,melanosome transport (GO:0032402),0.5326829380906609,1.1970441206905846,0.2563667232597623,0.686886918372295,1.0,2/18,2.16%,RAB27A;RAB11A
prerank,sphingolipid catabolic process (GO:0030149),0.5706436792326257,1.1969887475748364,0.2643884892086331,0.6862573946103596,1.0,3/15,5.50%,ACER2;ENPP2;ASAH2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5569248476464845,1.1965945571230443,0.253448275862069,0.6865667781351467,1.0,4/14,5.28%,MMRN2;NOTCH1;CARD10;DLL4
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4607223219345614,-1.196435903952731,0.22760290556900725,0.6795661811257462,1.0,3/19,3.57%,CAMK1D;IL34;THBS1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.533552580335844,-1.196415804196576,0.24561403508771928,0.6779851448563857,1.0,4/11,10.12%,IGF1;IRS1;TSC2;EIF2AK3
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.5404290620300424,-1.1963576880305,0.2569593147751606,0.6765020054090838,1.0,6/10,32.74%,IQSEC1;ADAM9;FGF7;FGF10;MTOR;EPB41L4B
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3757571070120459,1.196180534526667,0.15040183696900114,0.6868635479451405,1.0,40/208,12.74%,NOD1;TNFSF10;ESR1;TNFRSF19;PRKD1;DAB2IP;TRIM14;CASP8;FKBP1A;TRAF1;PLCG2;PLEKHG5;TIRAP;EDAR;IKBKB;TRIM68;PELI1;PLK2;WNT5A;MID2;CD40;TNFRSF1A;ATP2C1;TRIM25;MAP3K3;MALT1;CASP1;NEK6;BRD4;IKBKG;TNIP1;ZMYND11;IRAK4;RIPK1;CARD16;MIER1;RELA;RIPK2;GSTP1;BIRC3
prerank,carboxylic acid catabolic process (GO:0046395),-0.5211593981189879,-1.1957278887495655,0.2588495575221239,0.6767057189951208,1.0,4/12,12.64%,RENBP;NAGK;GNPDA1;PON3
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5535706782191399,1.1954316597548011,0.27385159010600707,0.6880831096084726,1.0,2/13,2.87%,CAV1;PDE4D
prerank,Fc receptor signaling pathway (GO:0038093),0.39795932620451435,1.1952891668155472,0.18961038961038962,0.6876749847236511,1.0,39/110,23.11%,NFATC1;PLCG1;LYN;PPP3CA;PLCG2;PAK2;IKBKB;MAPK8;PPP3CB;RAC1;PSMA2;NFKB1;MALT1;IKBKG;PSMA8;PSMA6;CUL1;RELA;TRAF6;PSME1;LAT;SOS1;TAB3;CALM1;MAP2K4;PSMA4;GRB2;PSMF1;PAK1;BCL10;PSMB7;MAP3K1;PSMB1;MAP2K7;PSMD2;PSMA5;PSMC3;JUN;FCER1G
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4743827510142464,1.1950634521029726,0.23817034700315456,0.6875468063272387,1.0,8/39,8.29%,ACER2;NEXMIF;FZD4;NOTCH1;ACTN4;ADAM15;RASA1;NF2
prerank,regulation of cell growth (GO:0001558),0.3746303605159321,1.1949242820044623,0.15098722415795587,0.6871769708559494,1.0,36/204,11.67%,BMPR2;NET1;DCUN1D3;APBB2;SMARCA2;ACVRL1;SH3BP4;SOCS2;ADAM10;NPR1;PTPRJ;SOX17;KIF26A;TAOK2;RPS6KA3;PPP1R9B;SDCBP;RPS6KA1;VGLL4;CEACAM1;H3-3A;CISH;ADAM15;JADE1;FBP1;DCSTAMP;CDKN1B;TGFB1;RPTOR;SGK3;MAD2L2;CYP27B1;SFRP2;BTG1;RB1;IL17RB
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4733397712643682,1.194910030024894,0.23617339312406577,0.6864490110191542,1.0,7/35,8.29%,CAV1;NOTCH1;JAK3;GHR;BCL3;PIGU;NF2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4759204742292149,1.194342467982583,0.2472952086553323,0.6872018663768845,1.0,10/35,11.53%,ESR1;PLPP1;NR3C1;KDM3A;DDX54;NCOA4;NEDD4;ARID1A;ZMIZ1;UBE3A
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.44659586745138435,1.1942836350694566,0.24789915966386555,0.6865617997488371,1.0,8/52,7.37%,PRKCH;STX3;SPTBN1;NKD2;SORBS1;ATP2B4;ITGA3;ATP2C1
prerank,synaptic vesicle localization (GO:0097479),0.5623581940442139,1.1941556941618716,0.26887661141804786,0.686116801445038,1.0,1/13,0.41%,RAB27A
prerank,negative regulation of myoblast differentiation (GO:0045662),0.5754910355152032,1.1937431809408836,0.28421052631578947,0.6864853843753164,1.0,5/13,12.49%,NOTCH1;SOX9;DLL1;TGFB1;PRICKLE1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4474728606203771,1.193506091706999,0.22759601706970128,0.6863842792881449,1.0,2/53,1.96%,CALCRL;HTR2A
prerank,alpha-amino acid metabolic process (GO:1901605),-0.38385819352030837,-1.1933215376485649,0.17763157894736842,0.6819068978912347,1.0,13/45,13.85%,GLUL;ASPA;NOX4;NAALAD2;ASPG;SLC25A12;GPT2;GOT1;MTHFD1;RIMKLA;OAT;SLC25A13;CBS
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.44316811011050605,-1.1925828088295745,0.25647668393782386,0.6823435575071708,1.0,9/21,20.14%,DCDC2;EVC;ARMC9;GLI1;SFRP1;SMO;KIF7;ULK3;GAS8
prerank,organophosphate ester transport (GO:0015748),0.5013184443161912,1.191895046358861,0.24104234527687296,0.689967749924891,1.0,5/24,9.85%,PLTP;SCARB1;PRELID2;ABCA3;PITPNC1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5100345622342275,1.1917829658492585,0.2495921696574225,0.6894915514547636,1.0,2/24,2.95%,ABCG2;ALAS1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.38284350031173486,1.1915205586650028,0.17380660954712362,0.6894473127087325,1.0,22/166,8.71%,TEAD4;HDAC9;ESR1;PPARD;NR5A2;MAML2;NR3C1;HDAC7;NOTCH1;WWTR1;CAVIN1;TEAD2;ESRRG;NR1I3;GTF2F2;TAF1B;POLR1A;GTF2E2;RRN3;SMARCA5;TAF3;TAF4B
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4320204620836512,1.191261126692629,0.22752808988764045,0.6893468780214091,1.0,12/60,12.36%,LEF1;SOX9;TCF7L2;TNRC6C;ATF7IP;HNF1B;PPM1D;NFKB1;SUB1;MED27;CBFB;RELA
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.4990228038606165,1.1906456812790087,0.2567783094098884,0.6902588400629869,1.0,3/26,2.59%,SHANK3;APP;PTK2B
prerank,regulation of osteoblast differentiation (GO:0045667),0.41410533710516767,1.1906339294245571,0.2223667100130039,0.6895188002859208,1.0,19/82,8.35%,ZHX3;BMPR2;IL6ST;MEF2C;PRKD1;CDK6;IL6R;LRP5;HDAC7;NOTCH1;WWTR1;FGF23;SOX9;ACVR2A;GREM1;ACVR1;PTK2;CTNNBIP1;CITED1
prerank,regulation of muscle cell differentiation (GO:0051147),0.480725943342602,1.190546767846402,0.2689873417721519,0.6889837911951533,1.0,9/31,9.93%,HDAC9;MEF2C;CDH2;CTNNA1;TCF3;BNIP2;CDH15;SPAG9;MAPK11
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.35430059141588754,-1.190490254125447,0.1827956989247312,0.6868392290961688,1.0,10/61,5.64%,ROBO1;NOTCH2;IGF1;LPAR1;COL3A1;AKAP13;RASGRF1;AUTS2;ALS2;NGF
prerank,microtubule anchoring at centrosome (GO:0034454),-0.5553418983949338,-1.19046439385636,0.2894736842105263,0.6852917580648819,1.0,7/10,30.28%,NINL;KIF3A;PCM1;CCDC68;CEP19;DCTN1;NIN
prerank,cardiac ventricle development (GO:0003231),0.5235506692882703,1.1901670759515344,0.2676518883415435,0.689184389113964,1.0,4/20,5.28%,ENG;PDE2A;NOTCH1;DLL4
prerank,microvillus assembly (GO:0030033),0.5723782084738579,1.1900774564010408,0.2862190812720848,0.6886544342384808,1.0,5/14,7.53%,RAP1B;RAPGEF2;STK26;TNIK;RAP1A
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5043440712125565,1.1898755037518405,0.2519561815336463,0.688430886374762,1.0,6/26,12.61%,ADIPOR2;ELOVL5;CEACAM1;TRIB3;EIF6;ADIPOR1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5277668121311472,1.1898164113838166,0.28213689482470783,0.6878249653575607,1.0,5/19,10.12%,NFATC1;EDN1;PPP3CA;PPP3CB;NMUR2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.41761714878646794,1.1896451790455824,0.22143864598025387,0.6875168055336693,1.0,11/69,9.61%,APP;ARHGEF2;STAT3;PTPRJ;PLCG2;TIRAP;WNT5A;LPL;PSEN1;TNFRSF8;IL23A
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.3072206375435839,-1.1896276181476864,0.08235294117647059,0.6860838531444833,1.0,30/166,10.72%,SAMD4A;IGF1;ZEB2;EGFR;PLD1;PDGFRB;GLI2;IRS1;SLC6A9;LPGAT1;THBS1;P2RX4;FGF2;SMOC2;CPEB3;PPARGC1A;HSP90AA1;FXR2;SMAD3;IGF2;LDLR;SREBF1;PRR16;GLI1;LARP6;RGCC;ARNT;CIRBP;SLC27A1;FGFR4
prerank,negative regulation of calcium ion transport (GO:0051926),-0.4879988949047251,-1.189570021476208,0.25961538461538464,0.6846342860012576,1.0,1/15,0.03%,ATP1A2
prerank,response to glucose (GO:0009749),0.45273352843652187,1.189491801645307,0.2248939179632249,0.6871826184539284,1.0,14/46,13.79%,UNC13B;ERN1;KCNB1;XBP1;TCF7L2;LPL;NEUROD1;EIF2B5;SOX4;GAS6;RACK1;PFKL;IGF1R;EIF2B2
prerank,negative regulation of response to wounding (GO:1903035),-0.46280475756734224,-1.1894804826742504,0.26291079812206575,0.6832650167095341,1.0,8/19,16.95%,PTPRS;FGF2;CD109;CASK;AJAP1;SERPINE1;CERS2;MDK
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.5117026420280184,-1.1893665707939713,0.29295154185022027,0.6819474718251811,1.0,6/13,23.99%,RNF152;CASTOR2;SZT2;SESN2;ITFG2;ATM
prerank,regulation of myelination (GO:0031641),0.4957248059601469,1.189174521081686,0.2819314641744548,0.6872644063395934,1.0,4/25,5.32%,JAM2;PARD3;TNFRSF1B;TMEM98
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5678935629605838,1.1886447966622462,0.2823741007194245,0.6879508082303534,1.0,5/12,13.03%,PTPN14;TGFB1;NEDD4;NUP214;UHMK1
prerank,cellular response to hexose stimulus (GO:0071331),0.5194834368606843,1.1884285987298653,0.2762520193861066,0.6877989476788942,1.0,8/23,13.47%,UNC13B;ERN1;KCNB1;XBP1;SOX4;GAS6;RACK1;IGF1R
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5529398071344548,1.1877500658294846,0.27288428324697755,0.6889283411094377,1.0,2/14,1.15%,PRKG1;MEF2C
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.43956971065047057,-1.187375923913991,0.236318407960199,0.6858258811780846,1.0,2/22,1.34%,ALDH1A2;RBP1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.44143155873804274,-1.1870956028471749,0.2576112412177986,0.6850294756618507,1.0,6/22,11.45%,BMP7;CD44;MBP;GCNT2;WNK1;FLOT2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.5619065856449988,1.18688462716996,0.3017241379310345,0.6904525082768337,1.0,5/14,11.40%,PPP3CA;PPM1F;NCK1;PPP2R2C;PPP2R2D
prerank,cell junction organization (GO:0034330),0.42834646223143746,1.1867946207106792,0.2130257801899593,0.6899177407224129,1.0,13/71,9.63%,TJP1;APBB2;APP;OCLN;PPFIBP1;LIMS2;TJP2;PPFIA2;OPHN1;TGFB1;AGRN;PSEN1;TJP3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4815346928826154,1.1864175285189138,0.27044025157232704,0.6901285103957534,1.0,5/27,4.01%,SHANK3;TJP1;F11R;WASF2;PAK2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.4633018839383756,1.1853223012042677,0.2409090909090909,0.6923599958719198,1.0,11/39,12.94%,KDR;ENG;TIE1;RASIP1;LRP5;DLL4;PKD2;CITED1;SFRP2;MET;TGFBR2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5839522248082902,1.184930469543177,0.2892416225749559,0.6926849141534978,1.0,2/12,6.76%,CEACAM1;TRIB3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.5378544740406871,1.184564888646549,0.2613240418118467,0.6928793431344047,1.0,5/16,10.24%,SMCHD1;SHLD1;CGAS;MAD2L2;HELB
prerank,positive regulation of response to external stimulus (GO:0032103),0.38979250794976467,1.18441414453245,0.1900121802679659,0.692493987172221,1.0,24/128,12.18%,APP;IL15;STX3;PDGFB;PDE2A;GBP5;PPM1F;NFKBIZ;NFKBIA;SCARF1;USP15;WNT5A;SASH1;TNFRSF1A;TGFB1;LPL;PUM1;IL23A;TNIP1;NMI;P2RY12;PUM2;RIPK1;OASL
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.3981169607233046,-1.1843924088728894,0.1994459833795014,0.6910811110730891,1.0,2/33,1.21%,IGF1;PRKN
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4366780587893914,1.1833256598457227,0.22786647314949202,0.6947590260854161,1.0,19/54,16.68%,CASP4;CASP8;TRAF1;SPPL2A;IKBKB;HIPK1;TNFRSF1A;CASP1;IKBKG;GAS6;RIPK1;CARD16;GSTP1;RACK1;BIRC3;ADAM17;UBE2K;OTULIN;BIRC2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5208001626598875,1.183311654235635,0.2705479452054795,0.694037051160106,1.0,8/21,15.15%,MYH9;ADAM10;SPPL2A;ERAP1;PSEN1;APH1A;ADAM17;SPPL3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5168499228940966,1.182487347678991,0.26633986928104575,0.6954561572904969,1.0,4/22,4.28%,DAB2IP;LYN;MFHAS1;TIRAP
prerank,regulation of small molecule metabolic process (GO:0062012),-0.4159284055743937,-1.1824274650591273,0.232,0.6952607138358037,1.0,6/28,9.84%,PRKN;PDK1;PPARA;RORA;EPHX2;APOE
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5824201108406573,1.1821698161277894,0.2983425414364641,0.6955197338974036,1.0,3/10,11.87%,PDE8A;STK26;RIPK1
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5363305121254182,-1.1821318341289035,0.28153153153153154,0.6944180045170868,1.0,3/10,6.71%,MAGI2;NGF;KIDINS220
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5323225037596606,1.1821285794817091,0.2677966101694915,0.6948802949314005,1.0,5/18,12.67%,HDAC7;CD34;HOMER2;HOMER3;ZFP36
prerank,endothelial cell migration (GO:0043542),0.4766302134053032,1.1821112056768552,0.26033690658499237,0.6941727122005523,1.0,8/37,5.02%,NOS3;MYH9;ADGRA2;PLXND1;PXN;SOX18;PLEKHG5;ID1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4984420549648966,1.1819927082355275,0.2745762711864407,0.6937330843618429,1.0,5/23,9.38%,ELOVL7;ACSL4;ELOVL5;ACSL5;FAR2
prerank,purine nucleotide catabolic process (GO:0006195),0.5643678751906255,1.1816841664885311,0.27797202797202797,0.6938289552559371,1.0,5/13,14.45%,GDA;NT5C2;HINT1;XDH;NUDT15
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.47001341084481735,1.1816572823898133,0.26813880126182965,0.6931429743576588,1.0,13/37,15.95%,CAV1;NCK1;BOK;RPS7;BCL2L11;LCK;BCL2L1;SIAH1;BID;RACK1;S100A9;DDIT3;BMF
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5902741095129629,1.181597622768353,0.3087121212121212,0.6925492628736237,1.0,3/10,4.17%,TBX1;LRP5;SOX9
prerank,cellular response to interleukin-7 (GO:0098761),0.5306606043065498,1.1815789262126795,0.287215411558669,0.6911108697338141,1.0,7/17,11.13%,SOCS2;STAT3;JAK3;CISH;JAK1;IL7R;IL7
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.5306606043065498,1.1815789262126795,0.287215411558669,0.6911108697338141,1.0,7/17,11.13%,SOCS2;STAT3;JAK3;CISH;JAK1;IL7R;IL7
prerank,triglyceride catabolic process (GO:0019433),0.5328993763467249,1.1815181126917296,0.2820069204152249,0.6905427474839878,1.0,3/19,13.65%,LPL;FABP12;PNPLA2
prerank,protein N-linked glycosylation (GO:0006487),0.42850199136810174,1.1811459392702393,0.23300970873786409,0.6908787278253928,1.0,5/66,1.62%,ST6GAL1;SLC39A8;ST3GAL1;MGAT4A;STT3B
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.4769948230134309,-1.1808001022554457,0.23923444976076555,0.6966120904994566,1.0,3/16,4.15%,PID1;PPARA;PPARGC1A
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.5406238932290912,-1.1798272628124484,0.27157894736842103,0.6976157208851642,1.0,2/10,7.15%,IL18;PRKCZ
prerank,keratinocyte differentiation (GO:0030216),0.4900842739220594,1.1794058948800148,0.2539936102236422,0.6947336040062115,1.0,7/29,14.08%,UGCG;BCR;EXPH5;WNT5A;CLIC4;TXNIP;ASAH1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4883190140231759,1.1792740654228626,0.249597423510467,0.694323546616588,1.0,4/29,5.65%,LEF1;TLE4;TCF7L1;TCF7L2
prerank,regulation of mitotic cell cycle (GO:0007346),0.37377784296444566,1.1792317777914874,0.18106508875739644,0.6937082367829364,1.0,37/171,14.53%,APP;NEK7;IQGAP1;TAL1;PIM3;SIK1;AFAP1L2;TTC28;CAV2;PKN2;SDCBP;BTG3;EIF4E;ASAH2;CDKN1B;TGFB1;BRINP2;PSMA2;NEK6;ANAPC7;ANAPC1;BTG2;PSMA8;ANGEL2;PSMA6;TFAP4;BTG1;CDC26;RB1;EIF4EBP1;CUL1;LGMN;ANAPC16;CDC25C;BUB3;PDXP;PSME1
prerank,sterol transport (GO:0015918),0.5184625794910345,1.1791392034615202,0.27424749163879597,0.6932000093572409,1.0,1/19,0.86%,CAV1
prerank,negative regulation of cell migration (GO:0030336),0.38609177558447566,1.1790705609418757,0.20024420024420025,0.6926479072544278,1.0,23/137,6.77%,PTPRG;LIMCH1;MCTP1;DACH1;ENG;NEXMIF;ACVRL1;CLDN5;ADARB1;DAB2IP;SRGAP3;SRGAP2;PTPRJ;STK24;SRGAP1;ADGRG1;EVL;PTPRK;SMAD7;DUSP22;ADAM15;RAC1;STK26
prerank,regulation of cytokinesis (GO:0032465),0.4080081121692109,1.1789052570665057,0.21964529331514324,0.6923788022737677,1.0,22/78,21.87%,PKP4;RAB11A;PKN2;PLK2;AURKA;SH3GLB1;AURKC;BCL2L1;KIF23;PDXP;GIPC1;E2F7;CALM1;RHOA;CUL3;PRPF40A;CETN2;PRKCE;GIT1;PLK1;RACGAP1;PIK3R4
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4854700900724202,-1.1778167777790662,0.2680652680652681,0.7015298497197714,1.0,4/16,6.44%,APPL2;PPARA;PPARGC1A;PRKAG2
prerank,axonogenesis (GO:0007409),0.36761779413324164,1.177712044166723,0.15631929046563192,0.6948447138261618,1.0,41/237,10.82%,NRP2;SHANK3;SEMA6A;RPS6KA5;APP;SEMA5B;EPHB4;SPTBN1;SEMA7A;PLCG1;PARD3;EFNA1;NOTCH1;KLF7;BSG;FYN;TAOK2;LAMA3;ROBO4;EVL;LMTK2;LAMA1;SEMA6B;RET;ULK1;OPHN1;PPP3CB;WNT5A;PTK2;B4GALT5;GRB7;GAB1;SEMA6D;FEZ2;LLGL1;DSCAM;SIAH1;SEMA4D;CXCR4;SPTAN1;EPHA4
prerank,cellular response to osmotic stress (GO:0071470),0.5052396883898335,1.177424545502928,0.2878787878787879,0.6948382587013755,1.0,6/21,16.39%,ARHGEF2;TRPV4;PKD2;YBX3;MYLK;ZFP36L1
prerank,limb development (GO:0060173),-0.41179633109594027,-1.176961256476636,0.246684350132626,0.7023761053149887,1.0,5/28,5.42%,SMOC1;GLI3;PCSK5;RSPO2;SALL1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.49141132833704443,1.1766610643824293,0.2684458398744113,0.6961827025769558,1.0,6/25,10.90%,HIP1;HIP1R;AFAP1L2;CCDC88A;BCAR3;CBL
prerank,gene silencing by miRNA (GO:0035195),0.46697346440769666,1.1766254891340193,0.2680577849117175,0.695536450856247,1.0,10/32,13.14%,CNOT6;TNRC6C;DICER1;PUM1;CNOT1;EIF6;ADAR;PUM2;ZFP36;CNOT7
prerank,response to interferon-beta (GO:0035456),0.5191055903483287,1.176552677720289,0.28038897893030795,0.6949999027884223,1.0,11/22,19.12%,AIM2;IFNAR2;UBE2K;IFITM3;IRGM;PNPT1;CDC34;STAT1;PLSCR1;BST2;IFITM1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.41559783398693817,1.176451624907605,0.23465211459754434,0.6945236210419132,1.0,18/75,13.24%,HEG1;RASIP1;DAB2IP;HHEX;LRP5;LYN;PTPRJ;PRKAR2B;PKIG;INPP5K;CDKN1B;PTPN1;TFAP4;RB1;STK38;GSTP1;INCA1;DUSP7
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.572504395384943,1.1764309104360577,0.3046875,0.6938432845206576,1.0,5/10,17.61%,PDE2A;PDE4D;APLNR;PDE3A;CDC34
prerank,nuclear membrane disassembly (GO:0051081),-0.5043689805011395,-1.176346131929343,0.26018099547511314,0.702564041696399,1.0,5/14,13.50%,PRKCB;LPIN1;PRKCA;AKAP8L;CNEP1R1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.40612465059257136,1.1761584140553236,0.22793148880105402,0.6938412688114133,1.0,22/86,10.42%,PECAM1;APP;IL15;PDGFB;IL6R;ARHGEF2;EFNA1;PTK2B;PTPRJ;BST1;FYN;PLCG2;PAK2;GHR;ENPP2;ACVR1;TGFB1;ITGA5;SAMSN1;IL23A;SFRP2;SEMA4D
prerank,negative regulation of defense response to virus (GO:0050687),-0.5226721080818608,-1.1756343536052678,0.2784313725490196,0.70298623440032,1.0,7/10,31.51%,PCBP2;ITCH;TRAF3IP1;PPM1B;C1QBP;RNF26;MUL1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.3456868519485292,-1.174667149676683,0.18120805369127516,0.7042002923718865,1.0,18/72,17.23%,FGFR2;FGF1;HNRNPH1;SPRED1;FGF2;RBFOX2;FLRT2;FLRT1;TIA1;FGFBP1;FGFR4;SPRED2;FGF7;POLR2B;POLR2K;HNRNPA1;FGF10;GTF2F1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.46849923341497884,-1.1746060817566155,0.2534562211981567,0.7027465252788393,1.0,6/15,10.32%,PTN;NF1;LRRK2;SMARCD3;VEGFA;FZD3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4058338062762009,1.1744132748423586,0.23036649214659685,0.6977628094276254,1.0,20/85,13.55%,CBFA2T3;ECSCR;RNF144B;DAB2IP;FBXW7;NKD2;SMAD7;RNF144A;TRIB3;ATXN3;KCNE2;RAD23A;SUMO2;HECTD1;COP1;NOP53;PRICKLE1;RACK1;TRIB1;FMR1
prerank,positive regulation of protein metabolic process (GO:0051247),0.3986022900056095,1.1743618494277284,0.22997416020671835,0.6971634189208239,1.0,18/110,9.89%,FOXO1;APP;SMURF1;DAB2IP;NEDD4L;PAEP;NFKBIA;KLF2;MAPK8;PLK2;WNT5A;CDKN1B;TGFB1;NEDD4;PSEN1;CSF1;IL23A;VPS28
prerank,protein localization to lysosome (GO:0061462),0.4765177063767834,1.1740096018667792,0.2630718954248366,0.6973909635973623,1.0,13/28,22.89%,SH3BP4;NCOA4;GCC2;NEDD4;SCARB2;GLMP;M6PR;RAB7A;NAGPA;GGA3;KPTN;MFSD1;LMBRD1
prerank,positive regulation of T cell differentiation (GO:0045582),0.46464818247528916,1.1738249727980812,0.24537037037037038,0.6971579577500061,1.0,8/36,11.30%,LEF1;TESPA1;XBP1;IHH;SOX4;IL23A;IL7;ZMIZ1
prerank,I-kappaB phosphorylation (GO:0007252),0.5780753380133036,1.1735019749218238,0.3057553956834532,0.697249921920257,1.0,2/10,14.41%,DAB2IP;ERC1
prerank,intracellular lipid transport (GO:0032365),0.5171625865314341,1.173340847444797,0.27958833619210977,0.696944539453478,1.0,6/21,11.84%,CERT1;ACACB;ABCD4;PLEKHA8;CPT1A;ABCD1
prerank,negative regulation of protein modification process (GO:0031400),-0.3301592891529398,-1.17325258136646,0.16666666666666666,0.7050063434912854,1.0,12/79,6.16%,PID1;PTPN13;NTRK3;DMD;PLPP3;PRKN;SNTA1;FBLN1;IGFBP3;IMPACT;PRKAA2;LRP6
prerank,leukotriene biosynthetic process (GO:0019370),0.5556706611364772,1.173148977352171,0.29294755877034356,0.6967038946095047,1.0,3/14,8.64%,PLA2G4A;ALOX5AP;LTC4S
prerank,cellular senescence (GO:0090398),-0.41403137540121315,-1.1730420204208127,0.2582278481012658,0.7039796474338442,1.0,13/27,28.81%,PRKCD;ECRG4;TBX2;CDKN1A;TBX3;MAP2K1;ULK3;TERF2;SMC6;ID2;CALR;CDKN2B;SMC5
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5203758045662944,1.172798608285766,0.28125,0.696921896723639,1.0,3/18,4.89%,CTSC;MSN;VGLL4
prerank,cGMP metabolic process (GO:0046068),0.5609577206400846,1.1717873848570914,0.29876977152899825,0.698795850535451,1.0,2/12,2.54%,PDE2A;NPR1
prerank,regulation of nervous system development (GO:0051960),-0.38425583507001315,-1.1714147300689444,0.22,0.7070896812564015,1.0,12/37,18.37%,DOCK7;PTN;SIRT2;PER2;HEYL;LGI4;BHLHE41;HEY2;NPHP3;TENM4;HMGB2;HEY1
prerank,oligosaccharide metabolic process (GO:0009311),0.43621332352364534,1.17102650092322,0.2586466165413534,0.7000908235794533,1.0,2/46,0.45%,ST3GAL6;ST6GALNAC3
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.31352258911311603,-1.1707893616755662,0.16751269035532995,0.7073570623191082,1.0,23/122,11.57%,SAMD4A;IGF1;EGFR;PLD1;PDGFRB;GLI2;IRS1;SLC6A9;THBS1;AR;FGF2;SMOC2;CPEB3;FXR2;IGF2;PRR16;GLI1;LARP6;RGCC;CIRBP;FGFR4;TGFB2;IRS2
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5010044136161212,-1.1705896489196022,0.28846153846153844,0.7062948372413587,1.0,4/13,11.28%,ATP1A2;ATP1B1;ATP1B2;SLC9A1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.4586568591936817,1.1701344083806708,0.26766917293233083,0.7017022344519961,1.0,9/37,7.86%,ANKRD13A;RIN3;EDN1;PLIN5;SDCBP;PTX3;BTN2A2;SIRT5;NFKB1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5272609040349009,1.169955453846881,0.27956989247311825,0.7014446871247537,1.0,3/17,5.12%,DGKZ;PTPRJ;CEACAM1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4888386691815412,1.1699063997509518,0.2787682333873582,0.7008527253151459,1.0,7/26,11.80%,APP;TAL1;PKN2;EIF4E;PPP1R10;EIF4EBP1;LGMN
prerank,cell-cell junction assembly (GO:0007043),0.4251328408616734,1.1696343725012983,0.2393397524071527,0.7008335639788079,1.0,9/63,5.63%,TJP1;PKP4;CLDN5;PKN2;PAK2;CDH2;SMAD7;CTNNA1;RAMP2
prerank,nucleoside salvage (GO:0043174),0.5766333730910902,1.1696232317269266,0.30550621669627,0.7001448375857625,1.0,3/10,9.72%,UCK2;UPP1;HPRT1
prerank,N-glycan processing (GO:0006491),0.5295724874242499,1.1690395467887769,0.2995008319467554,0.700904838537207,1.0,5/18,15.08%,MGAT4A;MAN2A1;ST8SIA4;GNPTAB;MAN1A2
prerank,regulation of interleukin-8 production (GO:0032677),0.4119203021378494,1.1684005388362662,0.232620320855615,0.7018644909151577,1.0,8/69,7.51%,NOD1;PRKD2;STAT3;AFAP1L2;TMSB4X;TIRAP;ARRB1;BCL3
prerank,nitric oxide mediated signal transduction (GO:0007263),0.5310053000278981,1.1683217902621976,0.3175438596491228,0.7013527318843193,1.0,1/16,0.31%,NOS3
prerank,dopamine metabolic process (GO:0042417),0.5346598406706791,1.1682655891688398,0.30052724077328646,0.7007765510680883,1.0,4/18,7.01%,MAOA;GCH1;MAOB;SNCAIP
prerank,regulation of cholesterol storage (GO:0010885),0.5442150976262493,1.1680498006320763,0.28896672504378285,0.7006234875922939,1.0,5/15,15.52%,PPARD;SCARB1;LPL;ABCG1;TTC39B
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.5303011803624663,-1.1678496935241756,0.2943722943722944,0.7126846965310936,1.0,6/10,21.14%,IRS1;IRS2;SLC45A3;SNCA;GPLD1;PTH1R
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.40509518167865516,1.1676864748279518,0.25500667556742324,0.7008715355727647,1.0,16/78,13.37%,CAV1;CBFA2T3;RNF144B;NKD2;SMAD7;RNF144A;TRIB3;RAD23A;SUMO2;HECTD1;COP1;NOP53;SIRT6;PRICKLE1;RACK1;TRIB1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.41630692535712155,1.167503529302513,0.25298013245033113,0.7006305629153001,1.0,12/78,7.33%,PRKCH;ABI3;STX3;SPTBN1;PPP2R5A;NKD2;NUMB;SORBS1;STX7;ATP2B4;TGFB1;ITGA3
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5016941747053952,-1.1672786397264516,0.2552204176334107,0.7127854175780808,1.0,3/13,6.95%,ERRFI1;CBLB;SNX6
prerank,peptide catabolic process (GO:0043171),-0.43650512682128445,-1.1671511752396764,0.2532981530343008,0.7115827044934395,1.0,4/23,7.33%,CPQ;GGT5;NPEPPS;ENPEP
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3357517987525221,-1.1670072188209777,0.17647058823529413,0.7103874563499051,1.0,24/86,13.54%,BMP6;ZEB2;SULF1;BMPR1A;FOXD1;BMP5;BMP7;TGFBR1;BMP4;THBS1;TWSG1;CCN1;RBPJ;TGFB1I1;DAB2;INHBA;HIPK2;SLC2A10;TGFB3;TGFB2;ACVR1B;NUP93;GDF11;GDF1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.44186246777959304,1.1662651623640998,0.2619047619047619,0.7031496470213553,1.0,11/45,8.10%,RPS6KA5;PLCG1;IQGAP1;PTK2B;PIK3C2A;SOX9;TGFB1;PTK2;TGFA;GRB7;GAB1
prerank,RNA catabolic process (GO:0006401),0.43819083303703843,1.1662039350663225,0.2647058823529412,0.7025713264751199,1.0,13/46,16.25%,ERN1;ISG20;NANOS2;RNASEH2A;MTREX;HNRNPD;NUDT16;DCP2;RNASEH2C;RNASEH2B;ZFP36;XRN2;PNPT1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5394827481660399,1.1655492941473775,0.31693989071038253,0.703623311301287,1.0,3/14,9.42%,DAB2IP;BCL2L11;PTPN1
prerank,regulation of neutrophil migration (GO:1902622),0.5707404618503344,1.1654592386811748,0.28385899814471244,0.7031323745322469,1.0,2/10,6.61%,BST1;RAC1
prerank,dendritic cell migration (GO:0036336),0.5298508563881197,1.1650665776889062,0.3194192377495463,0.7034304344441826,1.0,3/16,10.51%,EPS8;PIK3CG;CXCR4
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5201441499604496,1.1645789353793146,0.28903654485049834,0.7039992859131509,1.0,5/19,4.59%,SEMA6A;DAB2IP;JCAD;DLL1;TSPAN12
prerank,cellular protein metabolic process (GO:0044267),0.34972357527208375,1.1643592621927665,0.15845824411134904,0.7038918578901551,1.0,112/396,15.89%,ST3GAL6;APP;ST3GAL1;MGAT4A;MSRB3;DAB2IP;ADAM10;YES1;FUCA2;RPS15;FGF23;CPE;UBA7;CDH2;IGF2BP3;RPS19;RPLP1;RPS14;PADI4;RPSA;RPS16;RPL38;QSOX1;CSF2RB;SPARCL1;RPL34;ABCA3;RPS20;RPL39;VWA1;RPS7;RPS24;ST8SIA4;GOLM1;UBE2G1;RPL37A;SRBD1;RPL36;RPS18;RSL24D1;RPL15;PSEN1;AKT2;RPS8;RPL14;RPL23;RPL17;APLP2;FBXL2;FBXW2;CSF1;MRPS18A;ERO1A;RPL9;DHPS;RPL4;RAB12;RPL13A;UBE2D3;RPS11;RPL32;TNIP1;ICMT;GAS6;APH1A;RPL22;RPS27;RPL31;RPS23;ABL2;MRPL13;RPL13;MRPS12;RPS12;STK38;LGMN;RIPK1;MRPL35;HBS1L;RPL6;RPL10;WARS1;MRRF;OMA1;MRPL41;SPCS1;ADAM17;RPS29;RPS6;PNPLA2;MRPL52;PROC;RPL29;RPS25;RPL35A;RPS13;MSRB2;RPS21;MRPS16;RPL27;LAMB1;RPL18;MRPL23;SPPL3;EVA1A;RPL27A;MRPS5;TMEM132A;RNF5;RPS10;NAGPA;CP
prerank,base conversion or substitution editing (GO:0016553),0.5567478470976113,1.163940395451025,0.2768361581920904,0.7042540469553233,1.0,3/11,11.21%,ADARB1;NUDT16;ADAR
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5805324406666021,1.163924632098077,0.3146853146853147,0.7035730985963745,1.0,2/10,5.39%,CEACAM1;CX3CR1
prerank,negative regulation of developmental growth (GO:0048640),-0.39813860773868404,-1.1634310703182988,0.24861878453038674,0.7192273053210841,1.0,15/30,20.56%,PTPRS;MAP2;DCC;DUSP10;WWC1;CDKN1A;CDKL3;RTN4;SEMA3G;BBS2;ULK2;MT3;NKD1;PTEN;PTCH1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.537624671685113,1.1633526963433656,0.30796460176991153,0.7043063919475516,1.0,4/15,7.33%,JAK3;SMAD7;CUEDC2;TGFB1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.43694460716038674,1.163272746830812,0.2533136966126657,0.7037838431814618,1.0,19/48,22.77%,ARID1B;TAF1B;POLR1A;ARID1A;SMARCA5;MYBBP1A;MYO1C;ZMIZ1;POLR1G;CDCA4;KAT2B;POLR1B;SERTAD2;TAF1A;ATAD2;DEK;POLR2L;ERCC6;PHF2
prerank,positive regulation of macrophage migration (GO:1905523),-0.450129047422001,-1.16286427170911,0.2839506172839506,0.7193797119298107,1.0,3/19,3.65%,IL34;THBS1;P2RX4
prerank,positive regulation of T cell proliferation (GO:0042102),0.4244875634222797,1.1627272088613836,0.25742574257425743,0.7045003796032042,1.0,9/55,9.61%,IL6ST;VCAM1;IL15;NCK1;JAK3;IL27RA;TNFRSF13C;ICOSLG;IL23A
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.33517517570685135,-1.1623156697369432,0.17870722433460076,0.7193748514138185,1.0,21/74,11.51%,PHLDB2;COL1A1;EPHA3;BMP5;PDPN;PHLDB1;TGFBR1;SPRED1;DAG1;SMAD3;AXIN2;TGFB1I1;DAB2;VASN;SFRP1;GCNT2;RGCC;TGFB3;SPRED2;TGFB2;SPRED3
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.42196761006222,-1.16209604195279,0.25340599455040874,0.7183818725491317,1.0,8/24,12.16%,IGF1;IRS1;ENPP1;SELENOS;IGF2;IRS2;PPP1R3C;PPP1R3F
prerank,positive regulation of calcium ion transport (GO:0051928),-0.38857207319772213,-1.1619698501423341,0.22969187675070027,0.7171463258013648,1.0,8/36,9.31%,ANK2;PDGFRB;CACNA1D;P2RX4;CACNB2;TRPC3;TRPC6;CXCL12
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.40669889940855386,1.1619425502844571,0.24407252440725244,0.7058864386843587,1.0,11/73,9.61%,APP;ARHGEF2;STAT3;PTPRJ;PLCG2;TIRAP;WNT5A;LPL;PSEN1;TNFRSF8;IL23A
prerank,regulation of synapse maturation (GO:0090128),0.5885411251655743,1.1618406689668546,0.3103448275862069,0.7054250086692662,1.0,2/10,2.14%,ARHGEF15;DAB2IP
prerank,cellular response to chemokine (GO:1990869),0.4404807313679514,1.1611534811036845,0.28761061946902655,0.7065426739143364,1.0,3/46,6.85%,LRCH1;PTK2B;PPBP
prerank,regulation of necroptotic process (GO:0060544),0.501716256338606,1.160216202959079,0.29431438127090304,0.7083740985102996,1.0,8/23,12.74%,ARHGEF2;CASP8;SDCBP;PELI1;MLKL;YBX3;RIPK1;BIRC3
prerank,negative regulation of viral entry into host cell (GO:0046597),0.5587837439900514,1.160163782879389,0.32710280373831774,0.7077960732225985,1.0,4/12,7.56%,LY6E;PTX3;MID2;SNX3
prerank,actin crosslink formation (GO:0051764),0.5653703818084781,1.1600831156145222,0.2949907235621521,0.707284376299222,1.0,2/12,1.54%,LCP1;EPS8
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4525701300330082,-1.160018792593611,0.27114427860696516,0.721150134605063,1.0,4/17,2.89%,PID1;NUPR1;HDAC4;PPARA
prerank,cellular macromolecule catabolic process (GO:0044265),0.43914258443909454,1.1599978384121679,0.2617960426179604,0.7067726492017461,1.0,16/49,16.65%,STT3B;DAB2IP;ISG20;RNASEH2A;MTREX;UBE2G1;HNRNPD;RAB12;RNASEH2C;RIPK1;RNASEH2B;OGA;XRN2;RNF5;PNPT1;CHEK2
prerank,heart development (GO:0007507),0.3728561642794653,1.158822404982902,0.22439024390243903,0.7091390037054576,1.0,26/150,7.46%,TEK;HDAC9;BMPR2;TBX1;MEF2C;EPHB4;HEG1;ACVRL1;INSR;PDGFB;NOTCH1;SOX17;CHD7;CASP8;SOX18;FKBP1A;SOX9;PDLIM1;KDM6A;FOXF1;RBM20;RAMP2;ACVR1;CDKN1B;TGFB1;PTK2
prerank,plasma membrane organization (GO:0007009),0.4261245755700418,1.1587619318461269,0.2697274031563845,0.7085806459430979,1.0,14/61,11.84%,MYOF;FNBP1L;UGCG;SPTBN1;CAVIN2;MYH9;EHD2;CHMP4A;ARL8B;CXCR4;ANO6;A4GALT;DEGS1;ABCD1
prerank,positive regulation of secretion (GO:0051047),0.5628687177955979,1.158558139894883,0.2956204379562044,0.7084287292420084,1.0,2/11,4.97%,NPR1;XBP1
prerank,epithelial to mesenchymal transition (GO:0001837),0.4402560613977103,1.1585558562162368,0.26253687315634217,0.7077170549713789,1.0,9/47,7.33%,LEF1;ENG;NOTCH1;HIF1A;SOX9;FOXF2;WNT5A;TASOR;TGFB1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.4078784682414451,1.1583345624201216,0.2510176390773406,0.7075089849814837,1.0,18/79,10.32%,BMPR2;EPN2;SMAD1;SMURF1;MMRN2;DAB2IP;HHEX;NOTCH1;SMAD7;ACVR2A;GREM1;ATP2B4;SOST;NEDD4;PTPN1;SKIL;SMAD5;UBE2D3
prerank,B cell homeostasis (GO:0001782),0.570447531510171,1.1579358695923327,0.3196428571428571,0.7078273916065235,1.0,2/10,2.31%,MEF2C;LYN
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.4587949856223943,-1.1579338910643606,0.27954545454545454,0.7254727830214561,1.0,5/15,15.88%,BMP4;SIX1;VEGFA;SMO;PAX8
prerank,regulation of phosphorylation (GO:0042325),0.3825079570207713,1.1577832950865063,0.2332065906210393,0.7074935448531431,1.0,30/120,14.81%,LDB2;ITGA6;APP;NLRC5;LYN;FNIP2;HIF1A;IKBKB;SDCBP;CCDC88A;CDKN1B;PTK2;DYNLL1;PSEN1;ANG;DSCAM;BTBD10;EIF6;NUP214;NUP98;CORO1C;NOP53;PHIP;SLC2A6;NUP133;NUP205;CDH5;NUP54;NUP43;NUP153
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5635095494693066,1.157713979853267,0.297244094488189,0.7069888973288071,1.0,3/10,13.43%,ADAM10;WNT5A;ADAM17
prerank,response to cholesterol (GO:0070723),-0.46681568488993297,-1.1577077062018577,0.2857142857142857,0.7245816877651972,1.0,8/17,20.95%,TGFBR1;GRAMD1B;GRAMD1C;LRP6;SMO;GPLD1;PTCH1;ABCA2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5155832533022993,1.1570542938485735,0.2977624784853701,0.7080248452755072,1.0,9/17,25.08%,NUS1;DPAGT1;ALG6;ALG8;MPDU1;DOLK;ALG12;ALG14;DOLPP1
prerank,ventricular septum morphogenesis (GO:0060412),-0.40914467269536525,-1.15689218295665,0.23342175066312998,0.7254744159187674,1.0,8/27,6.87%,ROBO1;BMPR1A;TGFBR3;TGFBR1;BMP4;ZFPM2;ROBO2;HEYL
prerank,multivesicular body assembly (GO:0036258),0.4713510950719762,1.156734097096348,0.29430379746835444,0.7081830053216014,1.0,15/30,26.74%,RAB11A;CHMP2B;CHMP4A;CHMP4B;VPS28;VPS37C;STAM;VTA1;TSG101;VPS36;STAM2;PDCD6IP;VPS25;CHMP3;CHMP4C
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4982724262089638,1.156689349417063,0.3042071197411003,0.7075905398861957,1.0,3/22,9.07%,ESR1;HNF1B;SUB1
prerank,circulatory system development (GO:0072359),0.3774089338021047,1.156415507103447,0.24936708860759493,0.7076128223769552,1.0,25/118,9.33%,TEK;HDAC9;TBX1;MEF2C;HEG1;ACVRL1;PDGFB;FBXW7;NOTCH1;SOX17;CASP8;SOX18;FLT4;SOX9;PDLIM1;KDM6A;FOXF1;RBM20;RAMP2;ACVR1;CDKN1B;TGFB1;PKD2;ZFPM1;SOX4
prerank,glycerophospholipid metabolic process (GO:0006650),0.4191736196521891,1.1561008100067933,0.2602739726027397,0.7077582818576165,1.0,16/75,14.63%,GPCPD1;PLA2G4A;PLCG1;SERINC5;PLCB1;DGKH;ENPP6;ABCA3;PLA2G2D;SYNJ1;GDPD1;PIGQ;PIGG;PDXP;PNPLA6;PIGF
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.4961446142903838,-1.155439627352509,0.2863961813842482,0.7281351756636776,1.0,5/13,19.82%,BMP5;DKK3;APOE;PLEK;REST
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.4887494428290807,-1.1554256968813936,0.31343283582089554,0.7265888196895163,1.0,5/13,23.37%,GAB2;STX4;SYK;ITGB2;SPHK2
prerank,basement membrane organization (GO:0071711),-0.48848406785390464,-1.1553368256364014,0.28728070175438597,0.7252625438336602,1.0,5/14,7.93%,NID1;NID2;NTN4;NTNG1;FLRT2
prerank,histone H4 acetylation (GO:0043967),0.4362996577138991,1.1553333042195475,0.27923976608187134,0.709053421760155,1.0,8/47,10.09%,LEF1;EPC1;PHF20;JADE2;JADE1;HAT1;JADE3;EP400
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5772907499117768,1.1552999494184295,0.32325141776937616,0.708429869497541,1.0,3/10,5.22%,LYN;FAS;GREM1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.46703902332743963,-1.1552928945117715,0.2938388625592417,0.7237869243290023,1.0,3/16,4.93%,PRKN;PDK1;RORA
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.4529694555445037,1.1550910107442496,0.2781954887218045,0.7082758720295808,1.0,9/38,10.82%,CAV1;APP;PDGFB;NEDD9;EFNA1;PTPN1;FCGR1A;GAS6;EPHA4
prerank,positive regulation of microtubule polymerization (GO:0031116),0.48142257824844203,1.154608301047694,0.29635761589403975,0.7088082140949504,1.0,9/28,20.87%,OCLN;RAC1;MET;PAK1;CDK5RAP2;CLIP1;NUMA1;RPS3;GIT1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.40647564796048624,1.1544706861756544,0.2608108108108108,0.7084917165469008,1.0,22/70,24.92%,LMO2;GATA2;TAL1;TCF12;PSMA2;TCF3;TCF15;PSMA8;PSMA6;CBFB;PSME1;PSMA4;PSMF1;EIF2AK2;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;PUS7;PSMD3;PSMA3
prerank,regulation of neuron differentiation (GO:0045664),-0.3313520044331355,-1.1543369501256378,0.17716535433070865,0.724949504443666,1.0,29/76,20.78%,ZFHX3;NBL1;BMP7;IMPACT;YWHAG;VWC2;NGF;SIX1;NLGN1;HEYL;LRRK2;DTX1;NRCAM;BIN1;ALK;NREP;CNTN4;BRINP3;GPRC5B;MMD2;DISP3;HEY1;CDK5RAP3;SOX2;REST;NTF3;ID2;TIAM1;KCTD11
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.32583045363565016,-1.1542479575136926,0.2,0.7236513118215164,1.0,20/75,11.40%,DOCK7;SDC2;FGFR2;DCDC2;MAP2;BRSK1;FARP1;S100A6;ANK3;SHTN1;RYK;NTNG1;MAP6;S100B;CTNNA2;DCC;NRCAM;BAIAP2;RAB10;CNTN4
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.4444222508259323,-1.1534305990265201,0.2702702702702703,0.7229056126948068,1.0,7/20,17.72%,ACADSB;MCCC2;IVD;BCKDHB;ACAT1;ACAD8;ALDH6A1
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.4444222508259323,-1.1534305990265201,0.2702702702702703,0.7229056126948068,1.0,7/20,17.72%,ACADSB;MCCC2;IVD;BCKDHB;ACAT1;ACAD8;ALDH6A1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.5039696391489921,1.1534037103404928,0.3021346469622332,0.7105407824804203,1.0,5/23,8.93%,DAB2IP;EDN1;TNFRSF11A;SASH1;MAP3K11
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.5325456169882892,-1.1533754158764198,0.2844638949671772,0.7214805779171958,1.0,6/10,29.92%,DLGAP4;NPTXR;DLGAP1;DLGAP2;NPTX2;BEGAIN
prerank,cell chemotaxis (GO:0060326),-0.34463293939656675,-1.1532031496284927,0.2087912087912088,0.7204150927127101,1.0,11/60,6.12%,LPAR1;PDGFRB;PDGFRA;NRP1;KIT;CCR9;PRKCD;SEMA5A;PARVA;CCN3;AGTR1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5035770339192094,1.153097546788909,0.2979452054794521,0.7106248012073377,1.0,6/20,12.36%,SMAD1;NOTCH1;HIF1A;XBP1;SMAD5;RELA
prerank,pyruvate metabolic process (GO:0006090),-0.36455907466487997,-1.151545755465626,0.2276923076923077,0.723572074125153,1.0,21/52,27.79%,ME1;ENO2;ME2;HK2;TPI1;LDHB;VDAC1;HOGA1;PDHA1;DLAT;ENO3;PFKFB1;PFKM;PCK2;NR4A3;HAGH;ALDOA;PKM;ENO1;ALDOC;LDHAL6B
prerank,chromatin assembly or disassembly (GO:0006333),-0.5075699844385149,-1.1513590681844306,0.29535864978902954,0.7225907325863383,1.0,5/11,28.02%,HDAC8;MTA2;TP53;RBBP4;HIRIP3
prerank,modification-dependent protein catabolic process (GO:0019941),0.3662074217382293,1.1512734392128192,0.21678321678321677,0.7147113477152196,1.0,51/193,18.42%,RNF125;KLHL3;SMURF1;RNF144B;NEDD4L;ZNRF3;DTX3L;XBP1;KCTD10;FBXL4;KCTD6;UBL7;AURKA;RNF144A;UBE3B;ATXN3;ARRB1;RNF7;UBE2G1;ARRDC1;RNF167;FBXL7;NEDD4;TRIM25;UBE2H;ANAPC7;RNF146;ANAPC1;SIAH1;RC3H1;CBL;CDC26;LONP1;MYLIP;ANAPC16;RNF215;KLHL8;UBE2K;BUB3;TOPORS;ELOC;ARIH2;RNF5;AREL1;NDFIP2;NEDD8;UBE2I;CUL3;CDC34;RNF40;PSMF1
prerank,regulation of tube diameter (GO:0035296),0.5402035577910319,1.151243595210748,0.337037037037037,0.7133794975758043,1.0,2/13,2.54%,NOS3;NPR1
prerank,vascular process in circulatory system (GO:0003018),0.5402035577910319,1.151243595210748,0.337037037037037,0.7133794975758043,1.0,2/13,2.54%,NOS3;NPR1
prerank,regulation of autophagy (GO:0010506),0.35800889647925616,1.1511016982003675,0.2165532879818594,0.7130374390354568,1.0,35/216,11.40%,FOXO1;ACER2;ERN1;PRKD1;DAPK1;RASIP1;SH3BP4;STAT3;TRIM14;FBXW7;PIK3C2A;EIF4E;TRIM68;MAPK8;PLK2;ULK1;BOK;DRAM2;MID2;SH3GLB1;TRIB3;ATP6V0A1;NEDD4;RPTOR;ATG101;FOXK1;FBXL2;ATP6V1G2;NPRL2;EXOC4;DEPP1;PRKAB1;BNIP3;ABL2;ATF6
prerank,long-chain fatty acid metabolic process (GO:0001676),0.4152147453634138,1.1509338957103483,0.26933701657458564,0.7127616198084439,1.0,13/64,15.26%,PTGS2;PLA2G4A;ACSL4;ELOVL5;EPHX1;ASAH2;ACSL5;LTC4S;CPT1A;ABCD1;GSTP1;PNPLA8;FAAH
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.32119133220528645,-1.1508819529301826,0.15454545454545454,0.7223529030531967,1.0,18/101,10.72%,SAMD4A;PLD1;CYFIP2;OGT;THBS1;ASPH;CPEB3;HSP90AA1;DACT1;FXR2;AGTR1;PRR16;EZR;BTRC;LARP6;INHBA;CIRBP;FGFR4
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4893826470461823,-1.1508612264928093,0.2777777777777778,0.7208664498092908,1.0,2/12,2.80%,PLEKHH2;SEMA5A
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.5099751863617326,1.150823995145873,0.2953795379537954,0.712358466948138,1.0,8/20,17.66%,ZBTB16;CDK6;PTK2B;MAFB;ZFP36;ZFP36L1;CDC73;CIB1
prerank,regulation of acrosome reaction (GO:0060046),0.5691335499993503,1.1508074802788748,0.31947069943289225,0.7116954119274249,1.0,1/10,3.54%,PLCB1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.567147039071882,1.150680497911669,0.3302238805970149,0.7112941039081058,1.0,3/10,12.39%,CAV1;KCNE2;KCNRG
prerank,inhibitory synapse assembly (GO:1904862),-0.5162717547280024,-1.1501208919624495,0.30620985010706636,0.7213830581120145,1.0,5/11,12.88%,GABRG2;GABRA2;PLXNB1;LGI2;GABRB3
prerank,response to interleukin-6 (GO:0070741),0.5739859569551558,1.149610202184923,0.3267857142857143,0.7133223167950398,1.0,4/10,8.35%,ST3GAL6;SBNO2;NFKB1;CITED1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.41386300688861627,1.1495633181270035,0.2795549374130737,0.7127379377737587,1.0,12/65,8.75%,HIP1;HIP1R;PTPN12;DAB2IP;MVB12B;PTPRJ;AFAP1L2;CEACAM1;CCDC88A;BCAR3;TGFA;ARHGEF7
prerank,positive regulation of cell development (GO:0010720),0.46978287124056806,1.1493780574218808,0.296875,0.7125240425214256,1.0,9/31,17.57%,TGM2;NUMB;CX3CR1;SPEN;PDE3A;SNW1;NIBAN2;RASSF10;RFX3
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.547577614502493,1.1490768105109759,0.30943396226415093,0.7126299304648517,1.0,2/13,3.86%,ELOVL7;ELOVL5
prerank,osteoclast differentiation (GO:0030316),0.4990974513914665,1.1489729295845676,0.31864406779661014,0.7122007627420442,1.0,5/22,9.46%,FOXP1;TNFRSF11A;SBNO2;DCSTAMP;CSF1
prerank,mammary gland epithelium development (GO:0061180),-0.47698531303847136,-1.1472533814031065,0.2986111111111111,0.7278612515354699,1.0,2/14,3.30%,WNT4;ERBB4
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.39597043007781124,1.1471226709886722,0.24967824967824967,0.7162234181402644,1.0,11/86,8.58%,APP;OCLN;EDN1;PTK2B;NCK1;EVL;NCKAP1;RAC1;CDC42EP3;TRPV4;PSEN1
prerank,regulation of protein export from nucleus (GO:0046825),0.4879994578417344,1.1470001534063987,0.29654036243822074,0.7158400078586115,1.0,6/23,16.75%,PTPN14;TCF7L2;GAS6;UHMK1;ANP32B;RAPGEF3
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.5046585594029344,-1.1466888423859414,0.3039443155452436,0.727973967168453,1.0,5/12,23.79%,IDH2;IDH1;IDH3A;ACO2;IDH3G
prerank,cellular response to glucagon stimulus (GO:0071377),-0.45369886911249635,-1.1466312618228136,0.2962962962962963,0.7265847010433836,1.0,9/17,14.56%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5554144705055485,1.1459530166722653,0.3333333333333333,0.7177119461261423,1.0,1/12,0.47%,CSGALNACT1
prerank,neutrophil migration (GO:1990266),0.41817572669990727,1.1459354931186807,0.27668539325842695,0.717053223720739,1.0,7/58,11.77%,PECAM1;EDN1;BSG;PPBP;PIK3CG;CCL14;IRAK4
prerank,response to ATP (GO:0033198),-0.44380225625298136,-1.1458281872965308,0.26136363636363635,0.7273813993855539,1.0,4/18,8.19%,P2RX4;ABCC9;TRPC3;TAF1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5885653546942013,1.1456291925046818,0.34629629629629627,0.7171366058149292,1.0,3/10,4.17%,ZBTB16;ACVRL1;SOX9
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5227872477480272,1.1455581373585806,0.3079526226734349,0.7166254893862067,1.0,3/17,8.50%,PLA2G4A;PLA2G2D;PLAAT3
prerank,lipoprotein catabolic process (GO:0042159),-0.5116447468557695,-1.145531799492676,0.2900232018561485,0.7266507478573339,1.0,6/11,18.96%,NOTUM;APOE;CTSD;ABHD10;ABHD17C;PPT1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4936085078819307,1.1454251534827267,0.30303030303030304,0.7162804718063474,1.0,4/21,6.57%,PPARD;CYP26A1;LPIN3;CYP26C1
prerank,histone deubiquitination (GO:0016578),0.5143972076224776,1.1451105655873637,0.31724137931034485,0.7163879255409416,1.0,8/18,21.21%,USP3;USP15;BRCC3;ENY2;USP7;USP21;TRRAP;ATXN7
prerank,actin-myosin filament sliding (GO:0033275),-0.387972624110468,-1.144548689518452,0.260233918128655,0.7264043053250535,1.0,6/38,13.64%,DMD;ACTN2;TPM1;TPM2;DES;TPM4
prerank,muscle filament sliding (GO:0030049),-0.387972624110468,-1.144548689518452,0.260233918128655,0.7264043053250535,1.0,6/38,13.64%,DMD;ACTN2;TPM1;TPM2;DES;TPM4
prerank,regulation of cell projection organization (GO:0031344),-0.48661368676043815,-1.1444700410232391,0.28604118993135014,0.7251074074606476,1.0,9/13,32.62%,NTNG1;MOV10;MFSD2A;MACF1;MYO9A;CCL19;TREM2;SPRY2;ERMN
prerank,superoxide metabolic process (GO:0006801),0.4700370530671496,1.1440053839366338,0.2969230769230769,0.7185677464768246,1.0,3/29,4.90%,NOS3;NRROS;PREX1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4831284018326707,1.1426563711927098,0.30287648054145516,0.7214018251775893,1.0,1/24,0.04%,PRKCH
prerank,mRNA methylation (GO:0080009),0.5322678724418302,1.1424577805400309,0.3344887348353553,0.7212251269471307,1.0,9/15,27.22%,CBLL1;WTAP;VIRMA;TRMT6;METTL14;TRMT10C;TRMT61B;METTL16;NSUN2
prerank,cellular response to ketone (GO:1901655),-0.38240928417795483,-1.1423559106513992,0.2808988764044944,0.7297426011842315,1.0,11/35,9.25%,ADCY5;ROCK2;ADCY1;ADCY2;AR;ADCY6;SPP1;GNAI1;SFRP1;SRC;PTGFR
prerank,MAPK cascade (GO:0000165),0.346870968186768,1.142196370381121,0.20021762785636563,0.7211753155200864,1.0,51/295,12.08%,SHANK3;TEK;RASAL2;KDR;MEF2C;SPTBN1;KITLG;RASGRF2;PDGFB;DAB2IP;FYN;TAOK2;RASGRP3;FGF23;SOX9;MARK3;JAK3;IKBKB;CSF2RB;MAPK8;RET;RAPGEF2;KRAS;NRAS;TNIK;JAK1;TGFB1;PTK2;TGFA;SYNGAP1;RASA1;PSMA2;NFKB1;MAP3K3;RASA4;SHOC2;IKBKG;ZDHHC9;BCL2L1;MAPK11;PSMA8;RGL2;PSMA6;RASA2;SPTAN1;ICMT;CCM2;CUL1;GRIN1;ABHD17B;PEBP1
prerank,regulation of response to oxidative stress (GO:1902882),0.5527382519974009,1.1420563175604868,0.34146341463414637,0.7208533857150714,1.0,1/11,0.56%,MCTP1
prerank,positive regulation of catabolic process (GO:0009896),0.41440200400961713,1.141941861464993,0.2909090909090909,0.7204383724446752,1.0,14/65,15.10%,FOXO1;SMURF1;DAB2IP;NEDD4L;PLK2;WNT5A;CDKN1B;NEDD4;VPS28;RILP;ASB11;RAB7A;APC;VSIR
prerank,cellular response to zinc ion (GO:0071294),-0.46675588076719443,-1.1416545673551752,0.28540305010893247,0.7302488493246543,1.0,2/15,16.21%,P2RX4;MT3
prerank,protein localization to chromosome (GO:0034502),0.45446155030115165,1.1415451740621179,0.2902208201892745,0.7207995426494543,1.0,12/34,20.94%,ESR1;RPA1;HASPIN;PINX1;ACD;RB1;MCM9;ATRX;RAD21;XRCC4;MSH2;PLK1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.509879948975692,1.141096760807854,0.30085470085470084,0.7212992869161341,1.0,1/17,0.19%,TEK
prerank,amino acid transport (GO:0006865),-0.3600825789230687,-1.1410734871661041,0.22580645161290322,0.7303677466179496,1.0,11/49,11.23%,SLC7A11;SLC7A2;PDPN;SLC1A5;SLC6A12;SLC38A11;SLC25A47;SLC6A15;SLC7A14;SLC7A6;SLC43A1
prerank,regulation of protein dephosphorylation (GO:0035304),0.4471398010091027,1.1405644163225088,0.29457364341085274,0.7219209547788417,1.0,4/37,2.51%,PPP1R16B;PPP2R5A;PPP1R2;MFHAS1
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.4882887605766034,1.1402863582023472,0.30756578947368424,0.7219194626904324,1.0,8/24,9.93%,MEF2C;CDH2;CTNNA1;TCF3;BNIP2;CDH15;SPAG9;MAPK11
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.45532124657601947,1.140284798852028,0.2908496732026144,0.7212297094813115,1.0,8/31,14.12%,PPP1R13B;HIP1R;CASP8;MAPK8;BOK;SFN;BID;YWHAQ
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5113507685584179,-1.1402123875201051,0.33185840707964603,0.7312701676317815,1.0,1/10,0.36%,ZEB2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.3316110471862162,-1.140199422780169,0.24096385542168675,0.7297933214967702,1.0,13/80,10.10%,SAMD4A;PLD1;ROCK2;SLC2A13;PRKCD;THBS1;CPEB3;LRRTM3;FXR2;PRR16;LARP6;SMPD3;CIRBP
prerank,negative regulation of chemotaxis (GO:0050922),0.4653559455867249,1.1400553421233282,0.2961832061068702,0.7211387573868527,1.0,5/31,5.54%,SEMA6A;SEMA5B;SEMA7A;NOTCH1;SEMA6B
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.36849056580643746,1.140023341935745,0.24187725631768953,0.7205198746466557,1.0,32/158,12.74%,NOD1;TNFSF10;TNFRSF19;PRKD1;TRIM14;CASP8;FKBP1A;PLEKHG5;TIRAP;EDAR;IKBKB;TRIM68;PELI1;PLK2;MID2;CD40;TNFRSF1A;ATP2C1;TRIM25;MAP3K3;MALT1;CASP1;NEK6;BRD4;IKBKG;IRAK4;RIPK1;CARD16;MIER1;RELA;RIPK2;BIRC3
prerank,protein localization to organelle (GO:0033365),-0.29915259303831687,-1.1397976729541588,0.14619883040935672,0.729420201841695,1.0,38/133,18.17%,ANK2;COL1A1;BMP7;BICD1;BMP4;TULP3;WDR35;MICALL1;OBSL1;SIX1;LMNA;ARL3;LAMP2;LRRK2;IFT20;OPTN;TIA1;PAF1;MDM2;GBF1;GET4;EHD1;CNEP1R1;BICD2;MTCH2;BBS9;SYS1;BBS2;ARFRP1;DVL1;ABCA7;GET1;SCG3;IFT140;DDRGK1;FAM83H;TULP1;RAB35
prerank,ephrin receptor signaling pathway (GO:0048013),0.39629996585601057,1.139781153263159,0.27466666666666667,0.7204125960190074,1.0,23/82,12.04%,EPHB4;ANKS1A;LYN;EFNA1;YES1;FYN;KALRN;ARPC3;SDCBP;AP2B1;ARPC1B;RAC1;PTK2;RASA1;AP2A1;PSEN1;ARHGEF7;CRK;APH1A;EPHA4;ANKS1B;GRIN1;ACTR2
prerank,positive regulation of vasoconstriction (GO:0045907),0.5412421456992845,1.1396636036185988,0.33865248226950356,0.7200349084501076,1.0,1/13,0.86%,CAV1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.4763767226200549,1.1396574541357136,0.2936241610738255,0.7193542989411945,1.0,12/25,27.40%,CHMP2B;CHMP4A;CHMP4B;RILP;TMEM50B;VTA1;LEPROT;CHMP3;TMEM50A;CHMP4C;LYST;SORT1
prerank,positive regulation of cell killing (GO:0031343),0.5257109477798088,1.1395788405366156,0.31907308377896615,0.7188453142259703,1.0,3/13,6.61%,MAPK8;WNT5A;RAC1
prerank,pulmonary valve development (GO:0003177),0.5057616157554532,1.1394611902858143,0.32653061224489793,0.718457119066845,1.0,5/18,3.04%,NOS3;BMPR2;NFATC1;NOTCH1;TNFRSF1B
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.329577302917556,-1.1391631251942944,0.19433198380566802,0.7296395762891685,1.0,15/75,9.89%,ATP1A2;SLC8A3;CACNA2D1;SLC12A2;SLC6A1;SLC9A9;ATP1B1;SLC8A1;ABCC9;SLC39A14;KCNJ2;KCNJ13;SLC39A10;SLC24A2;ATP1B2
prerank,endothelial tube morphogenesis (GO:0061154),0.567850482585469,1.1389512268706112,0.3363148479427549,0.7190735521042008,1.0,7/10,19.68%,ACVRL1;PRKD2;CCM2;RHOB;RHOA;CTNNB1;STARD13
prerank,second-messenger-mediated signaling (GO:0019932),0.39910563634345286,1.1387354113013788,0.26938239159001315,0.7189582183596448,1.0,8/82,5.39%,NOS3;MCTP1;PLCG1;EDN1;SELE;PLCG2;PPP1R9B;CX3CR1
prerank,negative regulation of viral life cycle (GO:1903901),0.5223020405684182,1.1385314306832308,0.3309608540925267,0.7188059572244567,1.0,4/15,7.56%,LY6E;PTX3;MID2;SNX3
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5755583867052841,1.1385284184779891,0.36007827788649704,0.7181314103669358,1.0,4/10,16.11%,DAB2IP;EFNA1;EPHA4;RIC1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5061897442484988,1.1384583104400932,0.31462585034013607,0.7176495425285614,1.0,2/18,2.59%,SHANK3;PTK2B
prerank,protein localization to cell surface (GO:0034394),-0.4102528785770574,-1.138456648760192,0.2801047120418848,0.7301284927972753,1.0,11/26,17.79%,ANK2;ANGPT1;FBLN5;GGA2;PRRT1;FGF7;JAM3;GGA1;WNT11;FGF10;UNC50
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.40282595591782533,1.1384383681336312,0.2855209742895805,0.7170144186830875,1.0,13/80,8.27%,NOD1;TNFSF10;SOX7;DAPK1;PPM1F;RPS6KA3;RPS6KA1;FOXL2;XIAP;CYCS;GRAMD4;MALT1;CASP1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.4192397913437098,-1.1381406734823252,0.28992628992628994,0.7294140036201717,1.0,10/26,17.21%,EGFR;ANXA1;CCND2;ADAMTS1;UBE2E2;TFDP1;RGCC;CDK10;HYAL1;FGF10
prerank,myotube cell development (GO:0014904),-0.5145974714049262,-1.1380466268736442,0.3333333333333333,0.7281413388745177,1.0,2/10,5.77%,IGF1;SIX1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5317277466392755,1.137371264038365,0.3274647887323944,0.7190759507851328,1.0,7/14,24.26%,WRAP53;MMS19;ACTR2;WDR48;FUS;ERCC6;ARID2
prerank,cholesterol homeostasis (GO:0042632),0.4180343748850764,1.1372293266121825,0.2922437673130194,0.7187494371155678,1.0,9/64,8.24%,HDAC9;CAV1;SCARB1;LRP5;MALL;XBP1;CNBP;SOAT2;LPL
prerank,positive regulation of immune response (GO:0050778),0.41015215385426296,1.1371762062215391,0.27461858529819694,0.7182019263140272,1.0,13/64,19.90%,IL6ST;IL15;GBP5;XBP1;SKAP1;IL23A;NMI;EIF2AK4;KARS1;POLR3B;PLSCR1;NLRP3;SLC15A4
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4829053868365051,-1.1370100970219374,0.3054945054945055,0.7297371815498814,1.0,8/13,35.42%,SEC16B;CD81;SEC16A;EDEM2;TMEM30B;TM9SF4;SAR1A;SORL1
prerank,nucleocytoplasmic transport (GO:0006913),0.4352587098871851,1.1370055438379743,0.29767441860465116,0.7179616313801112,1.0,10/40,15.88%,ANP32A;RSRC1;XPO1;MALT1;BACH2;CITED1;NUP98;NUP205;NPM1;DDX20
prerank,positive regulation of heart contraction (GO:0045823),-0.43418574579612024,-1.1367201399396458,0.3034825870646766,0.7290465137981896,1.0,5/19,12.59%,ATP1A2;ATP2A2;RYR2;TGFB2;ADRA1A
prerank,phosphatidylinositol metabolic process (GO:0046488),0.38683634704980635,1.1365063869844387,0.2593548387096774,0.7185976108218022,1.0,21/109,9.97%,INPP5D;PLA2G4A;PLCG1;PIP5K1B;PITPNM2;PGAP1;MTM1;PIK3C2A;PLCB1;PLCG2;PIK3R6;MTMR6;PLA2G2D;INPP5K;BMX;PIK3CG;PLAAT3;SYNJ1;PLEKHA8;OCRL;INPP5F
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4778497169571785,1.1363027489483308,0.3250825082508251,0.7184479811926985,1.0,6/26,11.84%,RAB27A;PLCG2;ABCB7;GRIN1;COA8;ABCD1
prerank,protein autoubiquitination (GO:0051865),-0.3361776514703635,-1.1360801756050543,0.22580645161290322,0.7293457528251661,1.0,13/61,13.27%,RNF220;PRKN;SH3RF1;SH3RF3;RNF13;SH3RF2;AMFR;RNF181;MDM2;LRSAM1;ITCH;DDB2;UBE2B
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5337781616788756,1.1352783357855425,0.3212996389891697,0.7203731615102448,1.0,4/14,10.58%,PLCG1;ECSCR;CD40;ANO6
prerank,regulation of cilium assembly (GO:1902017),0.41323207194529676,1.1351246427613315,0.2731034482758621,0.7201247700808193,1.0,7/62,7.59%,TBC1D8;TBC1D30;TBC1D22A;TBC1D15;LIMK2;CCDC88A;TBC1D2
prerank,inflammatory response (GO:0006954),0.3577091898679642,1.1349935107532396,0.23781902552204176,0.7197825474478088,1.0,31/195,12.40%,HDAC9;NOD1;F11R;NRROS;STAT3;MFHAS1;AFAP1L2;SELE;ADGRE5;ACKR1;IKBKB;PTX3;PLA2G2D;IL36G;CD40;RAC1;PPBP;HNRNPA0;TNFRSF1A;TGFB1;PIK3CG;LY75;NFKB1;PXK;RELB;IKBKG;CCL14;CXCR4;TACR1;RELA;RIPK2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.549734211556892,1.1349200719130002,0.3339517625231911,0.7193011408920078,1.0,5/13,14.04%,RPS15;XPO1;RRS1;EIF6;NPM1
prerank,positive regulation of histone methylation (GO:0031062),-0.40597887603453153,-1.1346874282856527,0.2914438502673797,0.7319199999093773,1.0,5/24,8.64%,OGT;AUTS2;TET1;CTR9;PAF1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4415718927656817,1.1346412304865419,0.28731942215088285,0.719373483013623,1.0,7/37,3.99%,CADM1;VCAM1;ICAM1;PVR;SELE;SELP;AMIGO2
prerank,regulation of secretion by cell (GO:1903530),0.41718990889282054,1.1345194472536704,0.27482014388489207,0.7189923484933691,1.0,14/54,17.27%,MCTP1;MEF2C;KCNMB4;SNCAIP;LLGL1;RAB12;VAMP8;RAB26;RHBDF2;MCTP2;FMR1;RIC1;RAB8B;CPLX2
prerank,fatty acid elongation (GO:0030497),0.5377385086176321,1.1344380031803976,0.34444444444444444,0.7185100732911583,1.0,2/13,3.86%,ELOVL7;ELOVL5
prerank,cellular response to interleukin-2 (GO:0071352),0.5497810091951096,1.1343874866233445,0.3351749539594843,0.7172738366743703,1.0,3/11,7.27%,PTK2B;JAK3;JAK1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5497810091951096,1.1343874866233445,0.3351749539594843,0.7172738366743703,1.0,3/11,7.27%,PTK2B;JAK3;JAK1
prerank,amino acid transmembrane transport (GO:0003333),-0.35881602879772057,-1.1341223812318186,0.25835866261398177,0.732025182439265,1.0,6/45,3.68%,SLC7A11;SLC6A13;SLC47A1;SFXN2;SLC22A4;SLC38A11
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.4035461378422268,-1.1339948574516172,0.2725060827250608,0.7308976038124276,1.0,5/24,11.48%,EPHA7;NUPR1;NF1;SRPK2;TGFB2
prerank,positive regulation of dendritic spine development (GO:0060999),0.49177786848312244,1.133655346256881,0.3177083333333333,0.7184709285116005,1.0,1/20,0.09%,SHANK3
prerank,sterol homeostasis (GO:0055092),0.4148918152021209,1.1330038649164917,0.30428769017980634,0.719476622860744,1.0,13/65,13.77%,HDAC9;CAV1;SCARB1;LRP5;MALL;XBP1;CNBP;SOAT2;LPL;CYP39A1;ABCD1;LIMA1;ABCG1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5171228489646168,1.132798249593708,0.32663316582914576,0.7193239127090041,1.0,2/17,8.24%,HDAC9;LPL
prerank,cellular response to organic substance (GO:0071310),0.3778811998855682,1.1326012062252264,0.2590738423028786,0.7191783712314777,1.0,18/116,7.33%,LEF1;PTPN14;BMPR2;ACVRL1;PDGFB;PTPN12;SOCS2;STAT3;SIGIRR;NCOA1;GHR;ACVR2A;MAPK8;ASAH2;RAMP2;ACVR1;INPP5K;TGFB1
prerank,negative regulation of hormone secretion (GO:0046888),0.5715161804365794,1.1324591100570671,0.3339449541284404,0.7188513498860819,1.0,3/10,5.36%,RAB11FIP1;FGF23;RAB11FIP5
prerank,regulation of interleukin-17 production (GO:0032660),0.46145643110603657,1.132237174324174,0.30326594090202175,0.7187202614424201,1.0,8/31,18.16%,IL15;TGFB1;RFTN1;IL23A;VSIR;SLC7A5;DDIT3;CARD9
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.4731017315639258,1.1321093334308523,0.31369426751592355,0.7183756440211467,1.0,8/23,18.52%,NLRC5;JAK1;HSP90AB1;IRGM;STAT1;IFNGR1;PARP9;CDC37
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.35941245118436976,-1.1320161619166749,0.2546583850931677,0.7349594466048412,1.0,12/48,14.83%,ANK2;DMD;CEMIP;JPH1;AKAP6;PRKACA;UBASH3B;TRPC1;GSTM2;GPER1;JPH2;SNCA
prerank,cellular response to tumor necrosis factor (GO:0071356),0.360941780165969,1.1318636099670396,0.24528301886792453,0.7183755418552149,1.0,43/175,17.83%,DAB2IP;ARHGEF2;AIM2;TNFRSF11A;PTK2B;TNFRSF1B;NFKBIA;ACTN4;TRAF1;TMSB4X;TNFRSF25;EDAR;IKBKB;TNFSF8;DCSTAMP;CD40;INPP5K;TNFRSF1A;PSMA2;TNFRSF13C;YBX3;TNFRSF8;PSMA8;TNFRSF9;CCL14;PSMA6;RIPK1;RELA;ZFP36;BIRC3;HAS2;ADAM17;GBP3;ASAH1;TRAF6;PSME1;BAG4;ZFP36L1;BIRC2;ERBIN;CIB1;STAT1;PSMA4
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.4207700113710113,1.131403155771864,0.29796511627906974,0.7189333489304607,1.0,14/49,16.68%,CAV1;SGMS1;BOK;BCL2L11;LCK;PTPMT1;BCL2L1;SIAH1;BID;RACK1;S100A9;DDIT3;BMF;BCL2L10
prerank,digestive tract morphogenesis (GO:0048546),-0.4719286993686307,-1.1313073917366734,0.31919642857142855,0.7355841052538247,1.0,5/14,11.96%,FGFR2;PDGFRA;RBPMS2;GLI1;STRA6
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.44550453639271376,1.1313067412176134,0.3093415007656968,0.7184858384194961,1.0,7/38,12.62%,ESR1;DAB2IP;CASP8;TNIP1;ZMYND11;RIPK1;GSTP1
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.30279406137493853,-1.1311203163729435,0.20853080568720378,0.7346508268843258,1.0,37/117,19.57%,IGF1;ALDH1A2;ABAT;ACADSB;PPARA;ME1;CYP26B1;ACOT11;GGT5;ALDH4A1;CPT1C;NAAA;MCCC2;CKB;PER2;ME2;PCCB;ACSL3;ECHDC3;MECR;AASDH;SLC5A6;LDHB;VDAC1;GPAM;SCPEP1;HOGA1;SCP2;PDHA1;ALOX12;DLAT;PDZD11;ACSF2;ANGPTL3;AOAH;SLC27A4;CYP2S1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.39901799079293654,-1.1309178498040666,0.28405797101449276,0.7337231444108375,1.0,10/33,9.53%,EGFR;ANXA1;CCND2;STXBP4;ADAMTS1;GLI1;PAF1;UBE2E2;TFDP1;RGCC
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.4173877696825944,-1.1304987188299682,0.2936708860759494,0.7334265383960066,1.0,6/21,7.01%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;GUCY1A1
prerank,neurotransmitter transport (GO:0006836),-0.33066362129188653,-1.1304863483723804,0.24535315985130113,0.7319866500423603,1.0,25/73,16.70%,ATP1A2;SLC1A3;GLUL;SYT1;APBA1;BRSK1;SNAP25;NAAA;NRXN1;SLC6A15;SLC1A2;LIN7A;GABRA2;SNPH;CASK;PTPRN2;SLC29A1;NRXN2;GAD2;SLC1A1;SLC22A2;RIMS1;DVL1;SYN1;PDZD11
prerank,anterior/posterior pattern specification (GO:0009952),-0.3442678719259449,-1.1304126414981472,0.2425249169435216,0.7307164820656844,1.0,12/53,6.87%,WLS;HOXC4;HOXC6;TGFBR1;HOXA3;HOXA5;PCSK5;HOXA7;HOXC5;HOXB4;HOXB3;HEYL
prerank,regulation of vasoconstriction (GO:0019229),0.4712865207253546,1.1302985451112795,0.3083067092651757,0.7204317622945328,1.0,3/27,5.56%,BMPR2;CAV1;KCNMB4
prerank,protein-containing complex assembly (GO:0065003),0.3460894485575891,1.1302456452545009,0.24303232998885171,0.719892918390761,1.0,42/259,14.29%,LEF1;CTSC;SLC2A1;OCLN;CD2AP;MAGI1;PARD3;ADAM10;FAS;AIM2;PTK2B;TLE4;CASP8;TRAF1;CARD10;SOX9;TCF7L1;TCF7L2;BOK;TEAD2;CD40;TNFRSF1A;TGFA;FBXL7;LLGL1;SKAP2;NIFK;IKBKG;ANO6;TFAP4;CUL1;PICALM;RIPK1;TRAPPC3;PREB;DBNL;CAPZA1;PEX14;IL1RAP;ASH2L;BCL9L;APC
prerank,regulation of innate immune response (GO:0045088),0.4113283785091751,1.1301631330208886,0.27926657263751764,0.7194194330822391,1.0,18/57,18.52%,GBP5;SAMHD1;CASP8;TIRAP;N4BP1;XIAP;IFNAR2;ERAP1;PTPN1;NMI;BIRC3;HSP90AB1;IRAK3;BIRC2;POLR3B;PLSCR1;PARP9;CDC37
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.4909937440552743,-1.1300815467282979,0.3230769230769231,0.7287774045738517,1.0,4/12,16.72%,IGF1;AKAP6;SLC9A1;CAMTA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.4909937440552743,-1.1300815467282979,0.3230769230769231,0.7287774045738517,1.0,4/12,16.72%,IGF1;AKAP6;SLC9A1;CAMTA1
prerank,regulation of focal adhesion assembly (GO:0051893),0.41968095244435943,1.1296844479901729,0.31285714285714283,0.7199434923565885,1.0,10/54,7.46%,TEK;LIMCH1;KDR;ACVRL1;PEAK1;PTPRJ;PPM1F;DUSP22;RAC1;PTK2
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3562350565785838,1.1293225398498679,0.2415795586527294,0.7202456301905164,1.0,40/190,12.71%,CAV1;ESR1;CD2AP;SH3BP4;DAB2IP;PDE2A;LYN;DDIT4;HDAC7;PDE4D;PTPRJ;ADGRG3;CASP8;TMSB4X;MARK3;PIK3IP1;TNFAIP8L1;VGLL4;ATP2B4;INPP5K;TRIB3;WWC2;PPP2R5B;UBR1;MAP2K3;BCL2L1;NPRL2;CYRIB;TNIP1;APLNR;NMI;ZMYND11;RIPK1;PEBP1;NOP53;RELA;XDH;ADIPOR1;GSTP1;RACK1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5324564818490537,1.1289678091639508,0.33583489681050654,0.7204694131488315,1.0,6/13,19.49%,BCL2L11;BNIP3;BMF;RHOT1;BNIP3L;RHOT2
prerank,regulation of protein processing (GO:0070613),-0.4212197232161828,-1.1287638109552498,0.3282051282051282,0.7310051460195133,1.0,5/21,8.79%,CCBE1;GAS1;SERPINE2;LRRK2;RUNX1
prerank,cardiac muscle cell development (GO:0055013),-0.4294992164137722,-1.128530594525942,0.30238726790450926,0.7302006303374095,1.0,7/20,10.84%,PDGFRB;PDGFRA;CXADR;SLC8A1;OBSL1;VEGFA;FHOD3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.43735551460672434,1.1284809094378718,0.3028919330289193,0.7210435179296195,1.0,16/42,22.56%,SMCHD1;SHLD1;WRAP53;CGAS;MAD2L2;HELB;MMS19;ACTR2;SIRT6;SPIDR;WDR48;KDM1A;FUS;RMI2;RIF1;ERCC6
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.4525502279840577,-1.128405449587139,0.3004694835680751,0.7291269655905183,1.0,5/17,6.69%,BMP4;FGF2;SFRP4;TMEM100;AHI1
prerank,glutamate receptor signaling pathway (GO:0007215),0.45237711933913155,1.128227202695705,0.29037267080745344,0.7210302804781952,1.0,6/37,4.04%,GNAQ;APP;PTK2B;PLCB1;HOMER2;KCNB1
prerank,activation of protein kinase A activity (GO:0034199),-0.45807017922905835,-1.1281924787032076,0.32054176072234764,0.7282663547458704,1.0,9/16,14.56%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.45256554015494677,1.1281155113629089,0.3086816720257235,0.7206291573930668,1.0,7/30,7.06%,NET1;F11R;ARHGEF3;PRAG1;ADGRG1;RAC1;ARRB1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.31959128054789354,-1.1279975057422615,0.2190082644628099,0.727389384488544,1.0,17/84,12.29%,CELF2;SON;DDX5;RBFOX1;CELF4;FXR2;DAZAP1;DDX17;RBFOX2;NOVA1;SRPK2;TIA1;U2AF2;CIRBP;RBM4;CELF1;SF1
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.3371079660004756,-1.1279557224359298,0.20677966101694914,0.7260945387582195,1.0,19/65,9.53%,CPEB1;BMP7;SLC8A3;CPEB2;SIRT2;NDNF;KCND2;RORA;EGLN3;LMNA;P4HB;NPEPPS;CPEB4;MDM4;SFRP1;MDM2;VEGFA;HIPK2;RGCC
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.399372366038787,1.1268922738048082,0.2835820895522388,0.7230637236307863,1.0,20/76,19.71%,CD200;NLRC5;DAB2IP;AIM2;NFKBIA;TMSB4X;ARRB1;LRRC14;IRAK3;DDIT3;G3BP2;OTULIN;CHP1;MAP2K5;ERBIN;IRAK2;USP7;NLRP3;HAVCR2;TAX1BP1
prerank,response to ethanol (GO:0045471),-0.45683185215746036,-1.125930846332597,0.2917547568710359,0.7304538799260604,1.0,3/14,10.69%,GRIN3A;ADCY7;GRIN2A
prerank,regulation of cell-substrate adhesion (GO:0010810),0.43942936381169806,1.1257665204130245,0.31398809523809523,0.7251511452690816,1.0,9/42,8.35%,PDGFB;FZD4;NOTCH1;PPM1F;BST1;RAC1;ATXN3;PTK2;RSU1
prerank,organelle assembly (GO:0070925),0.339052773637375,1.1256383400989687,0.21231422505307856,0.7248256785060546,1.0,55/384,12.96%,PGM5;ABCC4;FLII;ABLIM1;FNBP1L;EXOC6;EHD4;NEK7;RAB11A;NOTCH1;STARD9;CNGB1;CD34;TMOD3;SSX2IP;DISC1;STX7;CEP41;EDC3;ULK1;ABCA3;CHMP2B;PCNT;BBIP1;CDS2;RBM14;GRB7;EHD2;DYNLL1;RAB38;EXOC5;NEK6;ATG101;CHMP4A;CHMP4B;TEKT5;G3BP1;VPS28;EXOC4;OCRL;CEP83;RC3H1;RPS23;ARL13B;LSM3;EMC6;EHD3;GABARAPL1;ACTR2;RAB43;RILP;MYH6;WDR11;DBNL;EXOC8
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.46136035944114173,1.125401915547468,0.3174846625766871,0.7247510589314328,1.0,9/31,10.42%,CDK6;LRP5;HDAC7;NOTCH1;FGF23;SOX9;GREM1;CITED1;SEMA4D
prerank,regulation of intracellular pH (GO:0051453),-0.37788006743939495,-1.1253159743562386,0.2807017543859649,0.7308243178176336,1.0,12/34,22.68%,SLC4A10;SLC9A9;LRRK2;SLC4A3;SLC4A2;SLC9A1;SLC26A6;CFTR;SLC4A8;SLC9A8;NOX1;CLN3
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.48219861809250397,-1.1250708674545447,0.33774834437086093,0.730107840896927,1.0,4/12,12.06%,IRS1;IGF2;PRKCZ;SNX5
prerank,positive regulation of glycolytic process (GO:0045821),0.5001827202385117,1.1248365853530407,0.3338842975206612,0.7248037991184029,1.0,4/20,2.85%,APP;INSR;HIF1A;PFKFB3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5001827202385117,1.1248365853530407,0.3338842975206612,0.7248037991184029,1.0,4/20,2.85%,APP;INSR;HIF1A;PFKFB3
prerank,regulation of protein autophosphorylation (GO:0031952),0.4457326969264465,1.1245791202662168,0.3203732503888025,0.7247872182254621,1.0,8/36,8.37%,ENG;PDGFB;PPP2R5A;PDGFD;TAOK2;PDGFC;PPP2R5E;PPP2R5B
prerank,polyol metabolic process (GO:0019751),0.42232994339472707,1.1244032359543625,0.30858806404657935,0.724537698252592,1.0,9/46,10.62%,INPP5D;PLCB4;PLCG1;PLCB1;PLCG2;ITPKB;SYNJ1;OCRL;INPP1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5328669193565728,1.1240946485677816,0.34759358288770054,0.7246300745421205,1.0,7/12,15.21%,CYP26A1;KLF2;CYP26C1;CNOT1;ASXL1;SNW1;TRIM16
prerank,postreplication repair (GO:0006301),0.42665811042141794,1.1240780568420192,0.2922848664688427,0.7240198448310297,1.0,16/45,26.60%,POLK;RPA1;TRIM25;WDR33;PRIMPOL;RAD18;USP43;RFC3;NSMCE1;MSH2;UBE2V2;RFC5;ZBTB1;POLN;UBE2N;RPA3
prerank,regulation of microglial cell activation (GO:1903978),-0.45626727806764217,-1.1238819347721793,0.31100478468899523,0.7318650325172423,1.0,12/15,47.17%,LDLR;SYT11;SPHK1;TTBK1;PTPRC;TREM2;GRN;STAP1;CST7;TAFA3;CCL3;NR1D1
prerank,hyaluronan catabolic process (GO:0030214),-0.4390163328678848,-1.1238658113473259,0.30963302752293576,0.7304888707944879,1.0,6/18,16.41%,CEMIP;FGF2;CD44;SLC9A1;HEXA;HYAL1
prerank,cellular protein catabolic process (GO:0044257),0.41136030903000254,1.1231567426945,0.2834067547723935,0.725747491210429,1.0,17/59,13.71%,CTSC;DAB2IP;CASP8;AP2B1;UBE2G1;AP2A1;CTSK;CTSO;MALT1;RAB12;PSMA6;BNIP3;LONP1;LGMN;RIPK1;MYLIP;RAB7A
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.347182966479872,-1.1228257725834598,0.23728813559322035,0.7319691334073225,1.0,8/52,6.60%,CELF2;DDX5;RBFOX1;CELF4;FXR2;DDX17;RBFOX2;NOVA1
prerank,regulation of lipid storage (GO:0010883),0.49006873597132483,1.1228248251351916,0.3379073756432247,0.7259545736345551,1.0,6/22,11.77%,FBXW7;NFKBIA;PLIN5;NFKB1;LPL;ITGB3
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.54941849112777,1.1226746330301909,0.3525046382189239,0.7250080548791082,1.0,3/10,12.65%,AP2B1;AP2A1;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.54941849112777,1.1226746330301909,0.3525046382189239,0.7250080548791082,1.0,3/10,12.65%,AP2B1;AP2A1;MYLIP
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.44452916900765366,1.1223148772727851,0.3173076923076923,0.725266899043405,1.0,8/32,9.31%,PPP1R13B;DDIT4;JMY;HIPK1;BOK;BCL3;MYBBP1A;HINT1
prerank,regulation of peptidase activity (GO:0052547),0.490434399902786,1.121980725531589,0.3472949389179756,0.7254201470067649,1.0,1/19,0.86%,CAV1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.41688376115110776,1.120976882846063,0.3173913043478261,0.7273070853998361,1.0,8/50,14.18%,NOD1;APP;ACTN4;SASH1;IL23A;NMI;RELA;TRAF6
prerank,innate immune response in mucosa (GO:0002227),0.5510375898591021,1.1199435610195974,0.3553113553113553,0.7291467231061378,1.0,2/10,9.16%,RPL39;DEFA6
prerank,inositol phosphate metabolic process (GO:0043647),0.4196794306323967,1.1198562236245992,0.31486880466472306,0.7287089341567964,1.0,9/46,10.62%,INPP5D;PLCB4;PLCG1;PLCB1;PLCG2;ITPKB;SYNJ1;OCRL;INPP1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3404657059795508,1.1191395025490833,0.23085339168490154,0.7298678884463428,1.0,52/308,13.47%,PRKCH;LEF1;EPAS1;ADIPOR2;BMPR2;CAV1;CADM1;ZBTB16;IL15;PDGFB;NPR1;RREB1;KDM3A;WWTR1;PLCB1;ADRB1;SOX9;RPS19;LCN2;SDCBP;XBP1;GHR;SHLD1;GATM;ESRRG;WNT5A;ACVR1;INPP5K;PDGFC;TGFB1;PIK3CG;B4GALT5;AGPAT1;IL23A;UCN;MAD2L2;CYP27B1;VAMP8;CXCR4;PRKAB1;GAS6;IL4R;MAP3K13;UCP2;PEMT;SIRT6;ADIPOR1;TGFBR2;HADH;OMA1;ESRRB;IGF1R
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3958226994267756,1.1187310885359742,0.29603399433427763,0.7302978959154642,1.0,20/72,16.65%,ACER2;CNOT6;CNOT6L;PLK2;AURKA;CDKN1B;BCL3;CRADD;SOX4;BTG2;CNOT1;TFAP4;SFN;CNOT2;MUC1;CNOT7;CDC25C;ATRX;E2F7;CHEK2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5052881465915248,1.1184227810089038,0.3396880415944541,0.7304153567790944,1.0,5/16,16.72%,SELE;SELP;RELA;TRAF6;RHOA
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4091823058912114,1.118242726729108,0.31142857142857144,0.7302306131442159,1.0,15/63,12.79%,TNFSF10;CAV1;ITGA6;FAS;CASP8;TRAF1;PAK2;TCF7L2;ACVR1;ZMYND11;RIPK1;BID;RELA;GSTP1;PHIP
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.35736627388366754,1.1179327728897497,0.2738238841978287,0.730358359857895,1.0,23/182,5.99%,KDR;ENG;ESR1;APP;MEF2C;ACVRL1;CLDN5;OCLN;ANKRD13A;PDGFB;RIN3;FOXP1;GATA2;ADAM10;FBXW7;NOTCH1;HIF1A;CD34;SDCBP;DLL4;ATP2B4;TNRC6C;AURKA
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4008944934217036,-1.1177825234343626,0.32216494845360827,0.7444436902969255,1.0,3/26,8.32%,ATP1A2;GNB5;ADRA2A
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3627281128321024,1.1177147620525034,0.274818401937046,0.7302195018368451,1.0,25/150,8.62%,TEK;ENG;ESR1;INSR;KITLG;PDGFB;HIP1;MFHAS1;RASD2;PTPRJ;FYN;FGF23;F7;CX3CR1;RET;TCF7L2;RAC1;TRIB3;LCK;TGFB1;PIK3CG;PTK2;TGFA;GAB1;AKT2
prerank,positive regulation of RNA splicing (GO:0033120),0.4398251456241696,1.1176820085307835,0.3081664098613251,0.7296546983650747,1.0,8/29,14.92%,ERN1;RBM20;SF3B4;DYRK1A;HNRNPLL;RBM3;NUP98;SNW1
prerank,muscle cell development (GO:0055001),-0.3840402255668746,-1.1170465590958172,0.2925531914893617,0.7449362082479819,1.0,9/30,9.36%,ANK2;IGF1;DMD;CXADR;SLC8A1;EFEMP2;SGCZ;VEGFA;BIN1
prerank,negative regulation of cell communication (GO:0010648),0.48176758836861977,1.116985013294382,0.336283185840708,0.7307903738988624,1.0,5/21,9.42%,KIF26A;SRMS;FGF23;ACVR1;PTPN1
prerank,protein targeting to membrane (GO:0006612),0.3890044164384375,1.1169689671864291,0.3090418353576248,0.7301778565806472,1.0,26/83,19.74%,PARD3;AQP11;TAOK2;SDCBP;SEC63;TRAM1;ZDHHC18;PEX26;CHMP4A;CHMP4B;ZDHHC9;MYO1C;ICMT;ABCD1;PEX14;ALDH3A2;VPS37C;ARL6IP1;RAB8B;ZDHHC24;SEC62;SIL1;ZDHHC1;NACA;SSR1;ZDHHC6
prerank,regulation of T cell chemotaxis (GO:0010819),0.5376502645123439,1.1167908599557108,0.343811394891945,0.7300141556824016,1.0,3/11,13.43%,ADAM10;WNT5A;ADAM17
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.47648235849040305,1.1164259286788611,0.3252818035426731,0.7302810780038125,1.0,5/25,5.18%,BMPR2;ENG;ACVRL1;NOTCH1;ACVR2A
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5570358433093354,1.1153628025845566,0.38256227758007116,0.7322842722706192,1.0,3/11,7.33%,MEF2C;GREM1;TGFB1
prerank,negative regulation of immune response (GO:0050777),0.3583979216411014,1.1150913028315697,0.27239709443099275,0.7323103561224683,1.0,22/154,11.15%,CALCRL;CYSLTR1;ADCY4;PLCG1;MYH9;LYN;YES1;GNB1;FYN;PRKAR2B;PLCG2;ADRB1;RAMP2;PLK2;SAMSN1;CREB1;INSL3;FCGR1A;NMI;MC4R;RC3H1;MC1R
prerank,defense response to tumor cell (GO:0002357),0.5455723475879178,1.1146966479802063,0.3551912568306011,0.7326592166423102,1.0,2/10,1.66%,ABI3;DAPK1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4625078680392801,-1.1145310013880039,0.3173913043478261,0.7506377566024123,1.0,4/15,8.94%,PRKN;BCL2;CD44;MDM2
prerank,cardiac ventricle morphogenesis (GO:0003208),0.4383830184802809,1.1145050352269599,0.3172932330827068,0.7324865083681428,1.0,13/41,12.94%,ENG;MEF2C;NOTCH1;FKBP1A;CPE;FOXF1;SMAD7;DLL4;TGFB1;SOX4;SFRP2;MYH6;TGFBR2
prerank,long-chain fatty acid import into cell (GO:0044539),0.5610915646731397,1.1143510511989512,0.3404255319148936,0.7321994896419247,1.0,1/10,0.52%,SLC2A1
prerank,positive regulation of histone modification (GO:0031058),0.45381424507377094,1.1137480961111819,0.3385093167701863,0.7330421896178605,1.0,11/33,21.38%,RPS6KA5;ARRB1;CTBP1;APLNR;GLYR1;FMR1;RPS6KA4;KDM1A;SAP30BP;SART3;TADA2B
prerank,regulation of monocyte differentiation (GO:0045655),0.5296882230466105,1.1136976267355796,0.3541284403669725,0.7325282339735427,1.0,5/14,9.46%,CDK6;FOXP1;DCSTAMP;CTNNBIP1;CSF1
prerank,aorta development (GO:0035904),-0.46777488881405616,-1.1136441668178583,0.3420479302832244,0.751664957908689,1.0,6/14,7.87%,ROBO1;LRP1;PDGFRB;ROBO2;JAG1;EFEMP2
prerank,positive regulation of secretion by cell (GO:1903532),0.40336876787883,1.1133290434141399,0.31869688385269124,0.7328228773949105,1.0,10/70,8.77%,RAB27A;UNC13B;CADPS2;CD2AP;EDN1;KCNB1;EXPH5;TGFB1;STX1A;ANG
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.41345925625670293,1.1130014072291936,0.30428571428571427,0.7329503612088341,1.0,11/56,7.33%,BMPR2;ENG;RBPMS;ACVRL1;SDCBP;SMAD7;ACVR2A;GREM1;ACVR1;SNX25;TGFB1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5010830570634744,-1.1128149135610836,0.3477272727272727,0.7525916769270596,1.0,3/11,9.31%,AXL;SELENOS;CXCL12
prerank,regulation of lamellipodium organization (GO:1902743),-0.4622320798317995,-1.1127624637939146,0.3577586206896552,0.7512659502767927,1.0,3/14,7.61%,PDPN;CARMIL1;CD44
prerank,detection of calcium ion (GO:0005513),-0.4739856818697711,-1.112182340079261,0.3378076062639821,0.7514521776176503,1.0,4/13,9.11%,SYT1;KCNMB2;STIM1;RYR2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3771698324456999,1.1114522119521206,0.2925257731958763,0.7362203097887051,1.0,19/95,12.67%,MEF2C;DAB2IP;TNFRSF1B;TIRAP;XBP1;CX3CR1;SBNO2;MAPK8;WNT5A;IL36G;PPBP;NFKB1;CASP1;DEFA6;CYRIB;CARD16;RELA;GSTP1;ZFP36
prerank,epithelial cell migration (GO:0010631),0.4370292409425827,1.1109515070694287,0.33384146341463417,0.736787503339637,1.0,8/37,4.32%,NOS3;ADGRA2;PLXND1;PXN;PKN3;PKN2;PLEKHG5;PKN1
prerank,ganglioside metabolic process (GO:0001573),0.47540637456850243,1.1109500455042278,0.34375,0.7361399249271874,1.0,4/20,12.36%,ST6GALNAC3;ST8SIA4;ST6GALNAC4;CLN6
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.42428330441341777,1.1109078069981715,0.32305433186490456,0.7355979716992325,1.0,6/42,11.80%,POLK;RPA1;TRIM25;PRIMPOL;POLA1;USP43
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.4997869063214912,-1.1108845788595028,0.3446808510638298,0.7537523106325649,1.0,4/10,17.32%,CACNA2D1;CACNB2;PDE4B;CACNB3
prerank,neuron projection extension (GO:1990138),0.44528602162474457,1.1106454408985005,0.33798449612403103,0.7356133899660258,1.0,5/32,5.98%,NRP2;SEMA5B;IQGAP1;ULK1;PPP3CB
prerank,sensory perception of light stimulus (GO:0050953),-0.3106679719759522,-1.1103587953933067,0.1991701244813278,0.7538825608894717,1.0,11/87,6.10%,COL1A1;SLC4A10;ADGRV1;EYA4;COL11A1;EFEMP1;EML2;COL18A1;DHRS3;PCDH15;WHRN
prerank,regulation of tumor necrosis factor production (GO:0032680),0.3680144799177965,1.1100228252213367,0.30541237113402064,0.7365664891134638,1.0,24/112,15.63%,APP;FOXP1;ARHGEF2;STAT3;PTPRJ;CD34;PLCG2;TIRAP;CX3CR1;WNT5A;LPL;PSEN1;DICER1;TNFRSF8;IL23A;GAS6;MC1R;RIPK1;GSTP1;ZFP36;IFIH1;ILRUN;VSIR;IRAK3
prerank,positive regulation of DNA binding (GO:0043388),-0.38714250933520045,-1.1096372391273799,0.2972222222222222,0.7545511130220539,1.0,4/31,5.64%,IGF1;PRKN;SIRT2;NGF
prerank,endosome organization (GO:0007032),0.42276904171682067,1.1094566072231122,0.33234859675036926,0.7373541597110244,1.0,9/41,12.96%,RAB27A;ALS2CL;CLCN3;CHMP2B;EEA1;SNX3;CORO1C;RILP;EXOC8
prerank,response to metal ion (GO:0010038),0.39479269755719015,1.1091843270454618,0.3084507042253521,0.7373782121258303,1.0,9/67,7.82%,CAV1;NEDD4L;PPP3CA;HIF1A;GPHN;PAM;TRPV6;ITPR3;NEDD4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.4722073765227952,-1.1090102243038042,0.3488843813387424,0.7534582876486688,1.0,2/12,1.76%,EFNA5;FBLN1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.4722073765227952,-1.1090102243038042,0.3488843813387424,0.7534582876486688,1.0,2/12,1.76%,EFNA5;FBLN1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4712528065598337,1.1088892421302492,0.34856175972927245,0.7374690904174698,1.0,3/22,5.12%,DGKZ;PTPRJ;CEACAM1
prerank,protein K48-linked ubiquitination (GO:0070936),0.4144089012068889,1.108856047927901,0.31540697674418605,0.7369102729077723,1.0,17/54,17.61%,KLHL3;NEDD4L;ZNRF1;DTX3L;PELI1;UBE2G1;UBE2H;RNF146;RNF4;UBE2D3;UBE3A;UBE2K;TOPORS;ARIH2;RNF5;CUL3;CDC34
prerank,mitochondrion morphogenesis (GO:0070584),-0.49408311177210656,-1.1087881735254488,0.33653846153846156,0.7526376230704589,1.0,1/11,0.15%,PID1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.375158059112064,1.1086669350859713,0.2853470437017995,0.7367353279262442,1.0,19/101,12.67%,MEF2C;DAB2IP;LYN;TNFRSF1B;XBP1;CX3CR1;SBNO2;MAPK8;WNT5A;IL36G;PPBP;TGFB1;NFKB1;CASP1;DEFA6;CARD16;RELA;GSTP1;ZFP36
prerank,negative regulation of fat cell differentiation (GO:0045599),0.44611089978513363,1.1078762091022738,0.321875,0.7380714466461675,1.0,9/34,12.50%,FOXO1;GATA2;WWTR1;WNT5A;TRIB3;TGFB1;ZFPM1;ASXL1;TRIO
prerank,neuromuscular process controlling balance (GO:0050885),-0.4714390869463151,-1.1077921699316604,0.34851936218678814,0.7539899622748003,1.0,5/12,22.68%,NRXN1;PCDH15;SHANK1;TPP1;CLN3
prerank,activation of GTPase activity (GO:0090630),0.3810191560814634,1.1077381141447562,0.3040103492884864,0.7377745532479284,1.0,14/89,7.59%,TBC1D8;RALGAPA2;TBC1D30;ARHGEF15;TBC1D4;CCDC125;BCR;RALGAPA1;SGSM1;TBC1D22A;TBC1D15;SIPA1L3;TBC1D12;TBC1D2
prerank,hyaluronan metabolic process (GO:0030212),-0.40373546475113636,-1.107569452023122,0.2871046228710462,0.7531972233969005,1.0,7/23,16.41%,CEMIP;FGF2;CD44;SLC9A1;HEXA;ABCC5;HYAL1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.30361968962227154,-1.1071903270888614,0.22510822510822512,0.7527958289687933,1.0,33/94,23.27%,NINL;HSP90AA1;YWHAG;ALMS1;CC2D2A;AHI1;IQCB1;PRKACA;KIF24;SDCCAG8;NPHP1;CEP63;RPGRIP1L;CEP89;CEP192;ODF2;MKS1;RAB3IP;CEP152;PCM1;CEP43;TTBK2;TCTN1;DCTN3;DYNC1H1;TCTN2;C2CD3;TMEM67;CKAP5;HAUS6;B9D2;HAUS2;SFI1
prerank,regulation of developmental growth (GO:0048638),0.4608804600354512,1.1069398496372065,0.33974358974358976,0.7390713521132517,1.0,5/29,5.16%,APP;INSR;PLCB1;DLL1;GHR
prerank,response to growth factor (GO:0070848),0.4313271040526059,1.1068189852545467,0.3387334315169367,0.7387038907583804,1.0,13/41,17.66%,BMPR2;ACVRL1;PDGFB;ACVR2A;ACVR1;TWF2;RACK1;TGFBR2;ERBB2;ACVR2B;CTNNB1;MAP2K5;CIB1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.46364574220675275,1.105828244366403,0.34726688102893893,0.7405698797972989,1.0,9/27,14.40%,TAOK2;IKBKB;MAPK8;NFKB1;IKBKG;MAPK11;CCM2;CUL1;MAP3K20
prerank,positive regulation of innate immune response (GO:0045089),0.44828873469396324,1.1057811296700315,0.3323076923076923,0.7400458945410605,1.0,10/30,19.90%,NLRC5;GBP5;RPS19;WNT5A;NMI;UBE2K;POLR3B;PLSCR1;TRIM62;SLC15A4
prerank,mitochondrion localization (GO:0051646),0.4856205860143836,1.1053706274634039,0.35676625659050965,0.7404221257650403,1.0,7/19,18.92%,NECTIN2;MTM1;MEF2A;MFN1;MSTO1;TRAK2;ZBED3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.49493390349482236,-1.1051231602609803,0.3739130434782609,0.757337177788549,1.0,5/11,22.57%,STX4;TICAM1;MAVS;ITGB2;CAMK4
prerank,fatty acid metabolic process (GO:0006631),0.367543489975433,1.1048679486090323,0.3051702395964691,0.741018645189558,1.0,14/115,8.64%,ADIPOR2;PTGS2;PPARD;ACSL4;FASN;CRAT;XBP1;ALOX5AP;LPIN3;ACSL5;CYP4B1;PON2;LPL;LTC4S
prerank,cell projection assembly (GO:0030031),0.47269829406503194,1.1047726952362067,0.3401015228426396,0.7406225738499987,1.0,4/22,6.61%,PARVB;RHOJ;NCKAP1;RAC1
prerank,negative regulation of B cell proliferation (GO:0030889),0.5313407763950809,1.1042974121106408,0.3473491773308958,0.7411526282130765,1.0,2/11,10.79%,LYN;RC3H1
prerank,cAMP metabolic process (GO:0046058),-0.47643930686106106,-1.1042127651266374,0.3477272727272727,0.7585318173058918,1.0,5/13,5.09%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6
prerank,homocysteine metabolic process (GO:0050667),-0.48854534167801705,-1.1041463191069008,0.35634743875278396,0.7572837063691367,1.0,6/11,24.84%,NOX4;CBS;BLMH;CTH;MMUT;MTRR
prerank,positive regulation of protein catabolic process (GO:0045732),0.38712451233578804,1.1036812733590184,0.340080971659919,0.7420701570356857,1.0,11/84,7.82%,FOXO1;SMURF1;DAB2IP;NEDD4L;MSN;TNFRSF1B;VGLL4;PLK2;WNT5A;CDKN1B;NEDD4
prerank,negative regulation of hippo signaling (GO:0035331),0.5331224803914986,1.1036553507031064,0.37523452157598497,0.7414861376884664,1.0,4/12,9.51%,MARK3;VGLL4;WWC2;MAP2K3
prerank,neuron maturation (GO:0042551),0.4989779863818628,1.103524542802726,0.3681506849315068,0.7411836151189842,1.0,4/18,7.51%,APP;ANKS1A;SCARF1;B4GALT5
prerank,peptide metabolic process (GO:0006518),-0.31938394573675255,-1.103268472561728,0.24691358024691357,0.7582948907002699,1.0,12/75,10.56%,AEBP1;DMD;CPQ;MGAT3;PCSK5;GSTT1;NPEPPS;ENPEP;CPXM2;CPXM1;GSTM1;SPCS3
prerank,cellular response to cadmium ion (GO:0071276),-0.3930464112628392,-1.1031463729869684,0.2995049504950495,0.7572085060841974,1.0,1/24,0.38%,EGFR
prerank,DNA replication initiation (GO:0006270),0.4258983980036117,1.1028879463924777,0.3364341085271318,0.7421207027616042,1.0,16/37,26.60%,MCM10;RPA1;POLA1;CDT1;CDK2;PRIM2;ORC5;ORC3;CDC34;PURA;DBF4;ORC6;GMNN;PRIM1;MCM6;RPA3
prerank,Rac protein signal transduction (GO:0016601),0.4962417765484259,1.102231896894912,0.36724137931034484,0.743104657594408,1.0,6/18,12.84%,EPS8;ELMO1;NCKAP1;RAC1;CYFIP1;DBNL
prerank,negative regulation of double-strand break repair (GO:2000780),0.4405386184375653,1.1014327116824736,0.34365325077399383,0.7444653891832866,1.0,7/30,12.11%,RNF169;SMCHD1;SHLD1;CGAS;MAD2L2;HELB;CYREN
prerank,negative regulation of cell population proliferation (GO:0008285),0.3351758313554291,1.1010392773116766,0.255663430420712,0.7448080350632229,1.0,53/351,10.61%,NOS3;PTPN14;BMPR2;SMARCA2;APP;CBFA2T3;SOX7;ACVRL1;CD200;B2M;CDK6;PLPP1;SH3BP4;GATA2;ADARB1;DAB2IP;LYN;PTK2B;NOTCH1;PTPRJ;AQP11;MTSS1;ADGRG1;SLC16A2;SOX9;TES;DLL1;VGLL4;BTG3;PTPRK;GREM1;DLL4;WNT5A;RAPGEF2;KLF10;CDKN1B;PPM1D;TGFB1;CTNNBIP1;PKD2;RNF139;NF2;CTBP1;ANG;PINX1;SOX4;SST;TNFRSF8;BTG2;CYP27B1;SFRP2;TFAP4;NMI
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.4578853034516539,-1.1006682599215434,0.34553775743707094,0.7629004138013812,1.0,2/14,3.57%,IL34;THBS1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.47158481409588904,1.1003226080712312,0.3674496644295302,0.7458874926068618,1.0,6/20,13.14%,CNOT6;TNRC6C;HELZ;CNOT1;EIF6;CNOT7
prerank,carbohydrate biosynthetic process (GO:0016051),0.4749230360657149,1.1002488354253437,0.35906040268456374,0.7454131285685525,1.0,1/21,0.14%,ST3GAL6
prerank,oligosaccharide biosynthetic process (GO:0009312),0.47637875116111994,1.1000871656615043,0.37185929648241206,0.7451746365494728,1.0,1/20,0.14%,ST3GAL6
prerank,Notch signaling involved in heart development (GO:0061314),-0.4773780877276579,-1.0999981758802448,0.3649789029535865,0.7633900784501808,1.0,7/11,18.37%,NOTCH2;JAG1;HEYL;RBPJ;SNAI1;HEY2;HEY1
prerank,positive regulation of chemotaxis (GO:0050921),0.4295798620087308,1.0997452526577844,0.33134328358208953,0.7453616501724748,1.0,9/43,4.50%,KDR;STX3;PRKD1;PDGFB;IL6R;PRKD2;PPM1F;TMSB4X;F7
prerank,epithelium development (GO:0060429),-0.2910295025520357,-1.0996655166488087,0.2543859649122807,0.7629164364084674,1.0,22/107,12.08%,ALDH1A2;FGFR2;WNT4;ERRFI1;OSR1;MEOX2;DAG1;PKD1;LOXL3;DACT1;KANK2;SALL1;SIX1;RCN3;AHI1;BDH2;VEGFA;SMO;TAGLN;ANXA4;MTHFD1;TBX2
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.4097974982759862,-1.0992230085275654,0.327455919395466,0.7627165815803651,1.0,3/23,4.25%,FGFR2;TGFBR3;TPM1
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.4897240746151402,-1.0987687290159092,0.3470715835140998,0.7626658777461268,1.0,4/12,13.50%,PRKCB;LPIN1;PRKCA;CNEP1R1
prerank,lipid modification (GO:0030258),0.4394151526933097,1.0986365591752951,0.3266871165644172,0.7474245941981492,1.0,6/37,8.05%,PLPP1;DGKZ;SGPP2;LPCAT3;DGKH;MBOAT1
prerank,regulation of JUN kinase activity (GO:0043506),0.4475338816875162,1.0985871457425358,0.3446153846153846,0.7469069237938255,1.0,13/33,20.57%,DAB2IP;EDN1;TNFRSF11A;SASH1;DNAJA1;MAP3K11;AIDA;GSTP1;TRAF6;PAK1;HIPK3;DUSP19;RPS3
prerank,regulation of exosomal secretion (GO:1903541),-0.4286995225269804,-1.0984825999349614,0.33170731707317075,0.7620312401006549,1.0,7/19,17.69%,PRKN;ATP9A;SDC4;SMPD3;SDC1;SNF8;VPS4A
prerank,blood vessel endothelial cell migration (GO:0043534),0.47751006657250006,1.0984032161598765,0.3770491803278688,0.7467233489208661,1.0,6/22,5.22%,KDR;EPHB4;MYH9;SOX18;ID1;GREM1
prerank,regulation of type I interferon production (GO:0032479),0.3809181563037261,1.098033442500882,0.3157894736842105,0.7470154253894346,1.0,23/84,20.69%,RNF125;LRRFIP1;NLRC5;UBA7;TIRAP;TRIM25;NFKB1;POLA1;G3BP1;CGAS;RELA;IFIH1;ILRUN;NFKB2;GPATCH3;STAT6;CTNNB1;POLR3B;DHX36;TAX1BP1;NLRP4;POLR3A;POLR2L
prerank,response to insulin (GO:0032868),0.3838818326090862,1.0980154867027438,0.3238341968911917,0.7464332802477442,1.0,15/80,10.83%,FOXO1;HDAC9;INSR;TBC1D4;DENND4C;SORBS1;XBP1;CEACAM1;LPIN3;INPP5K;TRIB3;CITED1;AKT2;RAB12;EIF6
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.501519350088112,-1.0978418369910128,0.39359267734553777,0.7624608577795114,1.0,2/10,8.79%,SH3RF1;RUNX1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.5039583321553426,1.0974267491139784,0.35547576301615796,0.7472865560620128,1.0,1/16,1.41%,CLDN5
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.3983831937287486,-1.0973822290374848,0.3112244897959184,0.7623236953397888,1.0,10/23,21.06%,CAMK1D;DPP4;MCU;RIPOR2;DAPK2;SLIT2;JAM3;MDK;CCL19;CD74
prerank,regulation of chemotaxis (GO:0050920),0.44609495214336,1.097065063832434,0.35419847328244275,0.7475620144694525,1.0,10/30,11.16%,STX3;PDGFB;ADGRA2;PPM1F;ZSWIM6;MYCBP2;TGFB1;CYRIB;CXCR4;P2RY12
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5132743637551724,1.0970637975081388,0.3817204301075269,0.746922138363784,1.0,4/14,6.12%,PRKAR2B;PKIG;ATP2B4;RAPGEF2
prerank,positive regulation of nuclear division (GO:0051785),0.4672189360684941,1.096776986750131,0.358974358974359,0.7469833693819172,1.0,6/25,7.47%,INSR;PDGFB;EDN1;LRP5;AURKA;TGFA
prerank,leukotriene metabolic process (GO:0006691),0.4820349092321614,1.0961937911641322,0.3680672268907563,0.7478657378544447,1.0,3/19,8.64%,PLA2G4A;ALOX5AP;LTC4S
prerank,glycogen metabolic process (GO:0005977),-0.39678164261770277,-1.095826515990158,0.32741116751269034,0.7653543355882113,1.0,12/27,20.81%,PYGB;PHKB;PYGM;PER2;PRKAG2;GAA;PPP1R3C;UGP2;AGL;GYS1;PHKA2;PHKG1
prerank,gland development (GO:0048732),-0.3259426083890846,-1.09578744485908,0.27816901408450706,0.7640543763162897,1.0,23/59,17.35%,FGFR2;GLI2;TGFBR3;WNT4;DKK3;TGFBR1;IGSF3;COBL;ANXA1;SALL1;NF1;SIX1;EZR;TGFB3;STRA6;CITED2;WNT11;TBX3;PAX8;MDK;FGF10;ARHGAP35;EPHB3
prerank,cellular amino acid catabolic process (GO:0009063),-0.3107099511132414,-1.0957578428780121,0.25096525096525096,0.7627274973610313,1.0,24/87,17.72%,DDO;GLUL;ABAT;ACADSB;ASPA;ALDH4A1;MCCC2;IVD;PRODH;HMGCLL1;ALDH7A1;FAH;BCKDHB;HNMT;PHYKPL;ACAT1;GOT1;CBS;HOGA1;ACAD8;CARNS1;BLMH;GSTZ1;ALDH6A1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.45540223724568973,1.0957127272156382,0.3442088091353997,0.7484075594145887,1.0,4/27,5.49%,UTRN;NEDD4L;FXYD6;ATP2B4
prerank,regulation of T cell mediated immunity (GO:0002709),0.5461550896645521,1.0952776734107366,0.36900369003690037,0.7488394426507511,1.0,1/10,3.04%,TNFRSF1B
prerank,negative regulation of blood coagulation (GO:0030195),0.43630067294628316,1.0951075451882817,0.3264094955489614,0.7486053766595334,1.0,5/38,4.50%,NOS3;PDGFB;EDN1;CD34;F7
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.4591699902545253,-1.0950795334826167,0.36036036036036034,0.7632484668712336,1.0,5/14,17.07%,IL18;CD55;PTPN22;CD81;SYK
prerank,detection of mechanical stimulus (GO:0050982),0.4721223349711361,1.0949610954590816,0.3826955074875208,0.7483393327070887,1.0,5/19,8.29%,PIEZO1;CDH2;PTK2;PKD2;PKDREJ
prerank,engulfment of apoptotic cell (GO:0043652),-0.4534589464240833,-1.094839193887091,0.3698630136986301,0.7625477662209628,1.0,3/15,3.82%,RHOBTB2;THBS1;XKR4
prerank,neuron migration (GO:0001764),0.41316864439632073,1.0939842762806204,0.3282674772036474,0.7501324675747084,1.0,8/48,6.61%,MEF2C;CELSR1;NAV1;DDIT4;CEP85L;DISC1;RAPGEF2;RAC1
prerank,protein localization to cell periphery (GO:1990778),0.36617172187048347,1.0937192092862176,0.31585518102372034,0.7501636608973422,1.0,24/133,7.65%,CAV1;EHD4;SPTBN1;F11R;SMURF1;RAB11A;TSPAN5;DENND4C;BSG;PACS1;NKD2;FCHO2;KCNB1;IKBKB;TSPAN14;RAMP2;RAPGEF2;TMEM88;INPP5K;ATP1B3;TNIK;TNFRSF1A;RAP1A;EHD2
prerank,regulation of protein secretion (GO:0050708),-0.29801992557411316,-1.0935683424435703,0.2192513368983957,0.7648121917053039,1.0,23/119,11.83%,CACNA1C;BMP6;IGF1;RAPGEF4;SLC12A2;CACNA1D;DPP4;FRMD4A;SNAP25;KCNC2;PER2;KCNS3;PRKCA;ERP29;EZR;ADRA2A;RHBDF1;APOE;TGFB3;STXBP5L;MYOM1;TGFB2;ADAM9
prerank,organelle organization (GO:0006996),0.3277419018593369,1.0932854834856007,0.27009646302250806,0.750611944770095,1.0,63/388,13.91%,SEMA6A;FGD5;NOS3;FNBP1L;ATP8B1;CAV1;PRKD1;ARAP3;NEDD9;FGD6;NECTIN2;DST;ALAS1;VPS13D;FMNL3;CAV2;PLIN5;SIPA1L3;STX7;CDC42BPB;MAST2;DOP1B;ABCA3;CYCS;CHMP2B;CECR2;CYP26C1;FMNL2;SYNE1;TNIK;TMEM135;SIRT5;TMED7;PKD2;RAB2A;TMED5;RAB38;PLAAT3;ABCD4;ARHGEF7;ZRANB1;CHMP4A;CHMP4B;ANK1;MREG;HPS3;GABPB1;TFB2M;RNF112;LONP1;ABCD1;RAB43;SNX11;PHIP;BRWD3;CSPG5;PLD2;RAB31;RAB7A;ATL1;PITPNB;PEX14;RANBP10
prerank,cytoskeleton organization (GO:0007010),0.3677487673244407,1.093282836344418,0.3232704402515723,0.749979400331805,1.0,18/114,9.23%,SEMA6A;FGD5;ARAP3;NEDD9;FGD6;NECTIN2;DST;FMNL3;SIPA1L3;CDC42BPB;MAST2;CECR2;RAC1;FMNL2;TNIK;RHOBTB1;ZRANB1;ANK1
prerank,response to alcohol (GO:0097305),-0.3909712059091021,-1.0927920104421438,0.3392405063291139,0.7656046834153973,1.0,5/27,10.91%,TGFBR3;TGFBR1;GRIN3A;GRIN2A;SLIT2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.4322697900542748,1.0925984766991894,0.3597560975609756,0.751033370964805,1.0,6/32,14.35%,RPS19;RPL39;PPBP;ANG;DEFA6;S100A9
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5061751361860368,1.0925342721018452,0.3706293706293706,0.750575133871577,1.0,4/14,14.18%,CARD10;TIRAP;MALT1;TRAF6
prerank,atrioventricular valve development (GO:0003171),0.5098513627481805,1.0924523197045102,0.37937384898710863,0.750134661474579,1.0,6/14,12.94%,BMPR2;NOTCH1;ACVR1;ZFPM1;APLNR;TGFBR2
prerank,regulation of histone acetylation (GO:0035065),0.44575731895548704,1.092427661679166,0.34749620637329287,0.7495600511782567,1.0,4/33,10.54%,RPS6KA5;ARRB1;CTBP1;GLYR1
prerank,positive regulation of cytokinesis (GO:0032467),0.44569072301481794,1.0922807836719008,0.35927152317880795,0.7492970123719297,1.0,7/32,17.22%,PKP4;PKN2;AURKC;KIF23;GIPC1;RHOA;CUL3
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.36432251072967914,1.0922234782627092,0.3050632911392405,0.7487972092523068,1.0,15/124,8.09%,FRY;FRYL;APP;STX3;PTPRM;RAB11A;LYN;PPP1R9B;BICDL1;ULK1;OPHN1;RAPGEF2;RAC1;NEDD4;PKD2
prerank,regulation of TORC1 signaling (GO:1903432),-0.3698488488396931,-1.0921546806199571,0.31413612565445026,0.766042259453244,1.0,14/33,26.17%,RNF152;KLHL22;CASTOR2;SZT2;SMCR8;GPR137B;SESN2;DGKQ;FLCN;GPR137C;ITFG2;PIP4P1;ATM;RRAGD
prerank,cellular response to topologically incorrect protein (GO:0035967),0.4444727173867103,1.0915942029105328,0.36097560975609755,0.7496873388701348,1.0,6/31,9.42%,ERN1;DAB2IP;TMBIM6;ATXN3;RHBDD1;PTPN1
prerank,regulation of interferon-gamma production (GO:0032649),0.38443332325329205,1.0913903552992537,0.33062330623306235,0.7495592885311149,1.0,6/71,10.66%,IL1R1;PDE4D;ZFPM1;IL23A;CYRIB;GAS6
prerank,postsynaptic membrane organization (GO:0001941),0.49473947750115366,1.0912820887182657,0.3697916666666667,0.7491717185986076,1.0,2/17,4.30%,SHANK3;GPHN
prerank,post-translational protein modification (GO:0043687),0.3301314089284299,1.0911591036321568,0.29562433297758806,0.7488692345983602,1.0,60/332,15.53%,EPAS1;DCUN1D3;KLHL3;APP;KLHL5;ZBTB16;MGAT4A;STT3B;RAB11A;SOCS2;KLHL2;ADAM10;NEURL2;FBXW7;HIF1A;BTBD1;FUCA2;FGF23;PTP4A2;CDH2;QSOX1;SPARCL1;FBXL4;KCTD6;VWA1;CISH;GOLM1;RNF7;PSMA2;FBXL7;RAB2A;RAB38;RHBDD1;APLP2;FBXW2;CSF1;COPS2;PSMA8;ASB10;PSMA6;ICMT;GAS6;COPS4;FBXO30;CUL1;COP1;RAB11B;ASB11;ASB4;RAB5A;PNPLA2;FBXL3;PROC;PSME1;ELOC;SOCS6;LAMB1;EVA1A;DCAF17;TMEM132A
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.38410424286554234,1.0911399819412608,0.33060109289617484,0.7482875386486438,1.0,13/72,14.29%,SHANK3;KANK3;HIP1R;ARHGEF2;SSH2;DYRK1A;CAMSAP2;CYRIB;TWF2;PFDN1;LIMA1;CDH5;APC
prerank,covalent chromatin modification (GO:0016569),0.5121860385499746,1.0911376553453962,0.3822975517890772,0.7476633471500175,1.0,6/14,22.75%,CHD1;AURKC;PARP2;SETD5;SIRT7;HLCS
prerank,negative chemotaxis (GO:0050919),0.43875664116135055,1.0908507124745759,0.3572496263079223,0.7477237068588053,1.0,3/33,1.68%,SEMA6A;NTN1;SEMA7A
prerank,embryonic heart tube development (GO:0035050),0.5193957338493602,1.0908312783993728,0.3929236499068901,0.7471391274452471,1.0,3/14,6.28%,SOX17;SOX18;ACVR1
prerank,protein localization to cell junction (GO:1902414),0.47700229579584824,1.0903671336558427,0.3737704918032787,0.7476626925173729,1.0,6/22,9.63%,TJP1;HEG1;TJP2;PAK2;JAK1;TJP3
prerank,regulation of kinase activity (GO:0043549),0.3721313727973741,1.090084416067496,0.3246414602346806,0.7477335120781333,1.0,11/89,5.59%,TEK;FLT1;LDB2;KDR;TIE1;EPHB4;INSR;NLRC5;FLT4;LMTK2;RET
prerank,axon extension (GO:0048675),0.4583080772110768,1.0899665101826042,0.36044657097288674,0.7473977859566852,1.0,4/23,5.98%,NRP2;SEMA5B;ULK1;PPP3CB
prerank,mitochondrion transport along microtubule (GO:0047497),0.519070264114761,1.0899433073128781,0.3700361010830325,0.7468304473018557,1.0,6/13,24.26%,HIF1A;RHOT1;RHOT2;UXT;OPA1;NEFL
prerank,nervous system development (GO:0007399),0.32664281652748695,1.089698864677584,0.25078698845750264,0.746779180067498,1.0,40/429,7.33%,ADGRG6;SHANK3;SEMA6A;MPZ;DNM3;SLC2A1;RAPGEF5;LDB2;MEF2C;ZBTB16;ZIC3;CELSR1;NAV1;STAT3;GDA;ADGRA2;SNTG2;PLXND1;HAPLN3;BTBD1;WWTR1;CHD7;PCDHB4;CDH2;EVL;MAL;IGF2BP3;RPS6KA3;KALRN;MBNL1;NCKAP1;SEMA6B;OPHN1;CYP26C1;IRF2BPL;DYRK1A;ATXN3;ST8SIA4;PDGFC;TGFB1
prerank,regulation of signal transduction (GO:0009966),0.340931681238269,1.0896394593675156,0.302784222737819,0.7463014404515601,1.0,33/190,10.22%,RGS3;LIFR;ESR1;LFNG;APP;UGCG;PRKD1;SOCS2;PRAG1;GIT2;MFNG;BST1;FYN;KIF26A;NCK1;WWTR1;PLCB1;PXN;SRMS;DLL1;TSPAN12;TCF7L1;ACVR1;VWA2;TGFB1;ITGA3;SNX3;LLGL1;CRK;PTPN1;ZFAND2B;CDC42SE2;RGS12
prerank,carbohydrate catabolic process (GO:0016052),-0.3640425941234754,-1.0896145173438885,0.30376344086021506,0.7718762020685649,1.0,20/38,38.84%,ENO2;HK2;TPI1;ENO3;PFKFB1;NEU1;PFKM;ALDOA;NAGA;PKM;ENO1;MAN2C1;ALDOC;NEU2;HKDC1;GAPDH;NEU3;ALDOB;ENO4;HK3
prerank,metal ion transport (GO:0030001),0.37881069669069156,1.08957382089888,0.33155792276964047,0.7458579618349337,1.0,16/86,10.26%,CALCRL;CAV1;SLC39A8;SLC3A2;CACNA1E;FYN;RAMP2;CACNA1A;TRPV6;ATP2C1;TRPV4;PKD2;PSEN1;CDH23;NMUR2;CYP27B1
prerank,nucleotide biosynthetic process (GO:0009165),-0.42030932973334134,-1.0893860388289893,0.3260340632603406,0.7710805872309353,1.0,8/18,21.55%,NMNAT2;ME1;PRPS2;MTHFD1;NMNAT1;PRPSAP2;NMNAT3;PRPSAP1
prerank,camera-type eye morphogenesis (GO:0048593),-0.4965356124502664,-1.0892933902470452,0.3693304535637149,0.7699295068507174,1.0,5/10,12.08%,TENM3;NF1;LRP6;VEGFA;TBX2
prerank,T cell mediated immunity (GO:0002456),0.5126096187665594,1.0889311114594247,0.3992740471869328,0.7467701870685067,1.0,1/13,0.90%,CADM1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.37211348977815967,1.0888905563457367,0.3392857142857143,0.7462356299373636,1.0,11/98,5.49%,PRKCH;STX3;SPTBN1;PPP1R13B;FYN;CASP8;NKD2;KCNB1;SORBS1;MAPK8;ATP2B4
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.41821992248207285,1.0887404485387446,0.3348148148148148,0.7459531806957389,1.0,8/45,7.33%,BMPR2;ENG;RBPMS;ACVRL1;SDCBP;ACVR2A;ACVR1;TGFB1
prerank,Golgi to plasma membrane transport (GO:0006893),0.4069955580000152,1.0887293838363254,0.3592085235920852,0.7453649036084468,1.0,11/47,13.42%,EXOC6;SPTBN1;EXOC6B;VAMP4;GCC2;EXOC5;LLGL1;EXOC4;RAB26;EXOC8;RAB31
prerank,regulation of actin filament-based process (GO:0032970),-0.32020706519030934,-1.0886846296735602,0.27472527472527475,0.7702839213983025,1.0,14/70,8.24%,LRP1;EPHA3;PDGFRB;ROCK2;EFNA5;RHOQ;PRKCD;GPM6B;RHOBTB2;RND3;ARHGAP18;EZR;CNN2;RHOBTB3
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4469927548851516,1.0884768868669894,0.38650306748466257,0.7453476013321209,1.0,14/30,20.12%,SDCBP;N4BP1;EIF3H;UCHL5;NOP53;HSP90AB1;UBXN1;GIPC1;RYBP;SVIP;STYX;RPL11;USP7;TAF9
prerank,neural tube development (GO:0021915),-0.4388426727547089,-1.0882031583910767,0.35917312661498707,0.7702210444497035,1.0,3/15,4.70%,ALDH1A2;PKD1;DACT1
prerank,visual perception (GO:0007601),-0.3099532452993543,-1.0881640503177465,0.26666666666666666,0.768969817085483,1.0,9/84,4.63%,COL1A1;SLC4A10;ADGRV1;EYA4;COL11A1;EFEMP1;EML2;COL18A1;DHRS3
prerank,tRNA aminoacylation (GO:0043039),0.42389758309286507,1.087932490605626,0.37065052950075644,0.7460531813709634,1.0,10/37,17.58%,GARS1;FARS2;IARS1;LARS1;WARS1;RARS1;QRSL1;AIMP1;KARS1;WARS2
prerank,mRNA polyadenylation (GO:0006378),0.45731460083583736,1.087215814533381,0.36633663366336633,0.7464994963028097,1.0,12/26,27.57%,APP;WDR33;MTPAP;PNPT1;CDC73;CPSF1;TENT4B;CPSF2;PCF11;CPSF3;TUT1;PAPOLA
prerank,RNA polyadenylation (GO:0043631),0.45731460083583736,1.087215814533381,0.36633663366336633,0.7464994963028097,1.0,12/26,27.57%,APP;WDR33;MTPAP;PNPT1;CDC73;CPSF1;TENT4B;CPSF2;PCF11;CPSF3;TUT1;PAPOLA
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4296086481188213,1.0869356763670253,0.34328358208955223,0.7465809464283477,1.0,16/37,20.12%,SDCBP;N4BP1;EIF3H;UCHL5;RPS7;RPL23;NOP53;HSP90AB1;UBXN1;GIPC1;RYBP;RPL11;USP7;CSNK2A2;CSNK2A1;TAF9
prerank,regulation of cell cycle process (GO:0010564),0.36565243690446614,1.0867245596425135,0.32460732984293195,0.7464858589185878,1.0,29/104,21.87%,DCUN1D3;RAB11A;CAV2;SOX9;PLK2;AURKA;SH3GLB1;AURKC;NUDT16;BCL2L1;RPRD1B;MAD1L1;CDC25C;APC;PDXP;CALM1;CTNNB1;PRPF40A;CSNK2A2;CSNK2A1;CETN2;NUMA1;RMI2;DBF4;GIT1;PLK1;RACGAP1;TIPIN;PIK3R4
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4883675186027651,1.08631991564713,0.36363636363636365,0.7468149914227818,1.0,6/19,9.33%,BMPR2;EFNA1;NOTCH1;ACVR1;ZFPM1;SOX4
prerank,regulation of cell-cell adhesion (GO:0022407),0.42541978931343205,1.0859828005521912,0.3378787878787879,0.7470119320452661,1.0,8/39,8.29%,PTPRG;PODXL;MAGI1;CEACAM1;SMAD7;TGFB1;PTK2;NF2
prerank,positive regulation of dephosphorylation (GO:0035306),0.4484203835821082,1.085950124604224,0.3616,0.7464776830241743,1.0,8/27,16.26%,PPP1R16B;PPP2R5A;CHP2;TGFB1;CDH5;PPP1R7;SPPL3;CALM1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.41639593465190966,-1.0859040612704414,0.35121951219512193,0.7739229391638633,1.0,8/19,23.69%,CAMK1D;MCU;RIPOR2;DAPK2;MDK;CCL19;CD74;DNM1L
prerank,negative regulation of cell development (GO:0010721),-0.3859682781490854,-1.0855524025992194,0.360313315926893,0.7735541342574678,1.0,3/25,1.35%,IGF1;FBN1;APPL2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.396869068934572,1.0852426405819529,0.3526093088857546,0.7476302685448631,1.0,12/66,5.16%,CAV1;B2M;CDK6;PTPRM;DAB2IP;FBXW7;AQP11;MTSS1;CAV2;SOX9;CEACAM1;PTPRK
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.43521521954306236,-1.0849611265098578,0.35766423357664234,0.7738192141421297,1.0,3/16,5.96%,DDX5;CELF4;DDX17
prerank,response to glucagon (GO:0033762),-0.41424284754408414,-1.0847319811597966,0.3433874709976798,0.7730785691784505,1.0,9/19,14.56%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,positive regulation of interleukin-17 production (GO:0032740),0.4670856734524673,1.0845047859182262,0.3761904761904762,0.74881399816539,1.0,4/22,9.61%,IL15;TGFB1;RFTN1;IL23A
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5187969164245603,1.0840964917866047,0.3980392156862745,0.7491815618832844,1.0,4/12,8.54%,PODXL;IQGAP1;PROM1;MYO1E
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.42816296159679856,-1.083661147405692,0.33414634146341465,0.7747856494953699,1.0,8/17,23.69%,CAMK1D;MCU;RIPOR2;DAPK2;MDK;CCL19;CD74;DNM1L
prerank,nucleoside catabolic process (GO:0009164),-0.47387256240026776,-1.0827843693464527,0.35667396061269147,0.7758817279728075,1.0,4/11,15.61%,DPYD;UPB1;NT5E;NT5C1A
prerank,cellular response to unfolded protein (GO:0034620),0.4523590212478927,1.0827179499146842,0.3798319327731092,0.751953545645547,1.0,5/26,9.42%,ERN1;DAB2IP;TMBIM6;RHBDD1;PTPN1
prerank,microglial cell activation (GO:0001774),0.47625725212527287,1.0826186318597406,0.3840947546531303,0.7515805212207193,1.0,2/21,5.39%,APP;CX3CR1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.4795158411645343,1.0824182147222288,0.3819444444444444,0.7514785559414652,1.0,5/18,13.30%,HHEX;NXF2;THOC2;ENY2;NUP133
prerank,acute-phase response (GO:0006953),0.5290443613044435,1.0822274111645298,0.4028520499108734,0.7513680973840292,1.0,5/12,17.96%,IL6R;SIGIRR;ITIH4;IL22;PLSCR1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.43559642249032227,-1.0820142887833275,0.35648148148148145,0.77666068451897,1.0,8/15,25.10%,NLGN2;NLGN1;CNTNAP4;ADRA1A;CLN3;BAIAP3;ZDHHC12;ZDHHC3
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.432262153355605,1.0813008986350492,0.3774193548387097,0.75305436325924,1.0,7/34,8.99%,LIMS2;NEDD9;DOCK1;RREB1;RAC1;ARHGEF7;CRK
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.36562623045158077,1.0808993636222755,0.3509485094850949,0.7534028000819577,1.0,25/86,22.49%,EPAS1;HIF1A;KLF2;EGLN1;PSMA2;BACH1;PSMA8;PSMA6;MUC1;HIGD1A;PSME1;ELOC;DDIT3;PSMA4;PSMF1;CUL2;DNAJB1;PSMB7;PSMB1;EGLN2;PSMD2;ANKRD2;GCN1;PSMA5;PSMC3
prerank,positive regulation of ruffle assembly (GO:1900029),0.5221233122577192,1.080697938882827,0.3891992551210428,0.7532867149889336,1.0,3/13,13.90%,EPS8;P2RY12;NDEL1
prerank,protein deacetylation (GO:0006476),0.41261946219053874,1.0804392881463298,0.33695652173913043,0.753297719236526,1.0,8/41,12.75%,HDAC9;HDAC7;RCOR1;RBM14;SIRT5;MIER1;SIRT6;MIDEAS
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.33260816216184463,-1.0795656226635286,0.3354632587859425,0.7823042603687655,1.0,19/52,24.84%,ME1;ADHFE1;IDH2;ME2;ALDH1L1;GCLC;FPGS;GPT2;IDH1;GOT1;MTHFD1;SLC19A1;HOGA1;MTHFD2L;MDH1;ALDH18A1;GGT1;GOT2;MTRR
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.4675404498357668,-1.07941077204846,0.3621867881548975,0.7813685238784541,1.0,2/12,2.41%,DPYSL3;DPYD
prerank,fatty acid transmembrane transport (GO:1902001),0.47955864393983916,1.0793693289216688,0.37823834196891193,0.7552649728207375,1.0,5/19,11.84%,SLC2A1;ACACB;ABCD4;CPT1A;ABCD1
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.45064291508098486,-1.0789084879500426,0.37857142857142856,0.7813772219725397,1.0,12/15,51.94%,FAH;GSTZ1;KYAT1;HGD;HAAO;KYNU;AADAT;TDO2;KMO;QDPR;IDO1;ACMSD
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5459036033399955,1.0787407245154814,0.40480961923847697,0.7561749691486576,1.0,2/10,3.44%,TBX1;ACTN4
prerank,methylguanosine-cap decapping (GO:0110156),0.5386706381005143,1.0786915021027503,0.39186691312384475,0.7556677612123762,1.0,7/10,28.01%,EDC3;DCP2;PNRC2;LSM1;DCP1B;PATL2;DCPS
prerank,cellular response to amyloid-beta (GO:1904646),0.43658565969466434,1.0781449593463013,0.3873015873015873,0.7563771804457166,1.0,11/35,11.80%,APP;VCAM1;ICAM1;CASP4;FYN;ATP1A3;CACNA1A;PSEN1;EPHA4;GRIN1;LGMN
prerank,cellular response to insulin stimulus (GO:0032869),0.35918535434731297,1.0780143430539382,0.34610630407911,0.7560752525233725,1.0,22/124,10.12%,FOXO1;HDAC9;INSR;TBC1D4;DENND4C;PIK3C2A;CAV2;SH2B2;SORBS1;GRB14;XBP1;CEACAM1;LPIN3;INPP5K;TRIB3;BCAR3;GRB7;ATP6V0A1;GAB1;AKT2;ATP6V1G2;RAB12
prerank,regulation of protein metabolic process (GO:0051246),0.4082705096272986,1.0779004851525291,0.36199095022624433,0.7557497641905285,1.0,13/44,17.17%,APP;NEDD4L;FKBP1A;KLF2;MAPK8;PM20D2;SPOPL;HSP90AB1;MTPN;ACE;CHEK2;MAP2K5;NEDD8
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.43785723705452756,-1.0777991915881286,0.39260969976905313,0.7832279525722632,1.0,4/15,6.16%,GLI2;EDA;WNT6;LRP6
prerank,ether lipid biosynthetic process (GO:0008611),0.5390077195763658,1.0772452389812521,0.3915547024952015,0.756689990554554,1.0,1/10,1.67%,PLA2G4A
prerank,positive regulation of leukocyte migration (GO:0002687),0.4432848507408552,1.0770968748734244,0.3697068403908795,0.7564074134780395,1.0,4/27,9.46%,ICAM1;IL6R;F7;CSF1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.36464987349443845,1.0769590272783744,0.37926675094816686,0.7561630014822369,1.0,26/100,15.35%,CBFA2T3;RNF144B;NKD2;SDCBP;SMAD7;N4BP1;FOXF2;EIF3H;UCHL5;RNF144A;TRIB3;XPO1;GNA12;RAD23A;SUMO2;HECTD1;COP1;NOP53;PRICKLE1;RACK1;HSP90AB1;TRIB1;UBXN1;GIPC1;RYBP;ARIH2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5082181589801514,1.0767483689906798,0.395985401459854,0.7560799600981017,1.0,7/13,23.52%,UBA7;SAE1;DESI2;DESI1;ATG7;UBA3;SENP6
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4735327148092181,-1.0765852505854325,0.37894736842105264,0.7853634330610128,1.0,2/11,4.18%,NRP1;SIRT2
prerank,regulation of protein localization to nucleus (GO:1900180),0.4132194913590815,1.0763484138735402,0.36976047904191617,0.7564299593136794,1.0,7/43,7.33%,MFHAS1;WWTR1;CARD10;DTX3L;CTNNA1;LIMK2;TGFB1
prerank,motor neuron axon guidance (GO:0008045),0.4954020140309476,1.0763355801750494,0.3872113676731794,0.7558373452168899,1.0,3/15,10.82%,NTN1;RAC1;EPHA4
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5402111947931907,1.0757048710849453,0.40942028985507245,0.7567353423276696,1.0,3/10,16.94%,SIGIRR;IRAK3;MAP2K5
prerank,ketone body metabolic process (GO:1902224),-0.49066351751775217,-1.0754179772573171,0.3763213530655391,0.7873540179053872,1.0,6/10,14.65%,OXCT1;HMGCLL1;BDH2;ACAT1;BDH1;AACS
prerank,ERBB signaling pathway (GO:0038127),0.3881008321458146,1.0753185665560838,0.3594864479315264,0.7570967615232839,1.0,12/64,8.10%,RPS6KA5;PLCG1;PTPN12;IQGAP1;PTK2B;PIK3C2A;SOX9;TGFB1;PTK2;TGFA;GRB7;GAB1
prerank,mesenchymal cell differentiation (GO:0048762),0.4039411699118292,1.0750345365453484,0.36324786324786323,0.757175327286197,1.0,9/51,7.33%,LEF1;ENG;MEF2C;NOTCH1;HIF1A;SOX9;FOXF2;WNT5A;TGFB1
prerank,calcium ion homeostasis (GO:0055074),-0.30035808144853315,-1.074876574362895,0.2689075630252101,0.7874861131203574,1.0,14/95,9.52%,SLC24A3;ANK2;ATP13A5;ATP13A3;SLC8A3;ATP1B1;SLC8A1;DMPK;FAM20A;STIM1;ATP2A2;RYR2;CXCL12;SLC24A2
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.4830352058143121,1.0748350899309818,0.4103942652329749,0.7570824970590121,1.0,4/16,10.66%,ST6GALNAC3;ST8SIA4;ST6GALNAC4;A4GALT
prerank,cardiac cell development (GO:0055006),-0.46813153720717465,-1.0747871773391675,0.3964757709251101,0.7863537314699646,1.0,4/11,9.30%,CXADR;SLC8A1;JAG1;VEGFA
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.39766349986914407,1.0739907150892192,0.36005830903790087,0.7585197738345595,1.0,4/52,5.12%,PDIA5;ERN1;XBP1;EXTL3
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4792115626271203,-1.0730453704729956,0.37723214285714285,0.78973856412174,1.0,4/10,15.61%,DPYD;UPB1;NT5E;NT5C1A
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.38114879574850574,1.0728737830783903,0.3447802197802198,0.7605825506911474,1.0,13/70,11.99%,IL6R;DAB2IP;FAS;TNFRSF1B;CASP8;HIPK1;BOK;TNFRSF1A;TGFB1;CRADD;BCL2L1;RIPK1;BID
prerank,apoptotic DNA fragmentation (GO:0006309),0.4900009682319961,1.0728666932879332,0.37521815008726006,0.7599831329638801,1.0,6/16,22.76%,FOXL2;CECR2;DICER1;ENDOG;KPNB1;HMGB1
prerank,cell proliferation in forebrain (GO:0021846),-0.49035316144277663,-1.0724367288603078,0.39503386004514673,0.7899911318934906,1.0,3/10,15.23%,DOCK7;PCM1;NUMBL
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.5414345603558122,1.0723571756644217,0.400359066427289,0.7605525179779468,1.0,4/11,20.72%,WRAP53;TERF1;CCT7;CCT2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.37101806456382763,1.0720773033192579,0.3469656992084433,0.7606355570930861,1.0,19/87,11.11%,ABI3;ESAM;F11R;EPS8;HIP1R;CELSR1;IQGAP1;PTK2B;BST1;TAOK2;ARHGAP17;CCDC88A;RAC1;RHOBTB1;CRK;RICTOR;TWF2;FSCN1;ABL2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3945992226045456,-1.072027128350188,0.3797814207650273,0.7897867321599685,1.0,10/27,9.78%,DCN;BGN;CSPG4;CHST15;PXYLP1;CHSY3;VCAN;CHSY1;CHST3;XYLT1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.45457884640358937,-1.0716552300943758,0.4103139013452915,0.7894455065675123,1.0,2/13,2.50%,AXL;IL18
prerank,long-term synaptic potentiation (GO:0060291),-0.39522122999090864,-1.0713696412214992,0.35543766578249336,0.7888340259921411,1.0,8/21,13.75%,SLC8A3;TSHZ3;PRKCZ;SLC24A2;STX4;GRIN2A;NFATC4;GRIN2D
prerank,cholesterol transport (GO:0030301),0.40555735487231076,1.071266655351911,0.36795252225519287,0.7619531032258365,1.0,11/45,19.36%,CAV1;SCARB1;STARD5;SOAT2;LIMA1;ABCG1;STAR;STX12;CEL;OSBPL2;ABCA1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.4378369651414167,1.0711856025048199,0.3953488372093023,0.7615493874498243,1.0,2/30,1.62%,ST6GAL1;STT3B
prerank,negative regulation of organelle assembly (GO:1902116),0.41885837212406896,1.070875993130319,0.3726993865030675,0.7616729085759266,1.0,8/35,10.45%,TBC1D30;MTM1;LIMK2;RBM14;FEZ2;CHMP4A;CHMP4B;NBDY
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.39220861366973797,-1.0707251861326423,0.34554973821989526,0.7893684077017811,1.0,9/23,25.43%,ZWINT;PLK5;CHFR;ZFYVE19;VPS4A;SETMAR;CDK5RAP3;CHEK1;BUB1B
prerank,response to cadmium ion (GO:0046686),-0.3805301802572093,-1.0694391360099946,0.35805626598465473,0.7915019261883987,1.0,1/26,0.38%,EGFR
prerank,regulation of histone modification (GO:0031056),-0.4609135615673068,-1.0691907037596675,0.39675174013921116,0.7908523831566054,1.0,6/13,20.84%,IGF2;AKAP8L;CDK9;MYOCD;FLCN;NNMT
prerank,phagosome-lysosome fusion (GO:0090385),0.5329071304688178,1.0689575369867228,0.391304347826087,0.7656908664901335,1.0,4/10,15.28%,ARL8B;RAB7A;RAB7B;SYT7
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.33008984096743077,-1.0689490202818548,0.3254237288135593,0.7901721675812549,1.0,7/55,6.12%,PID1;PDGFRB;PRKN;THBS1;SIRT2;CYP1B1;AGTR1
prerank,epidermal cell differentiation (GO:0009913),0.4126686651804672,1.0688872063928687,0.3704268292682927,0.7652648370445203,1.0,7/41,14.08%,UGCG;BCR;WNT5A;USH2A;CLIC4;TXNIP;ASAH1
prerank,regulation of B cell activation (GO:0050864),0.455878009131219,1.0686098117522702,0.3941368078175896,0.7653715684160941,1.0,2/25,8.07%,AHR;SAMSN1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.48876192736565416,1.0682708248757522,0.41532976827094475,0.7655498594593761,1.0,3/14,10.15%,NECTIN2;SHLD1;MAD2L2
prerank,insulin receptor signaling pathway (GO:0008286),0.37864207973532743,1.067941446826292,0.3713892709766162,0.7657464157411963,1.0,13/69,9.30%,FOXO1;INSR;PIK3C2A;CAV2;SH2B2;SORBS1;GRB14;BCAR3;GRB7;ATP6V0A1;GAB1;AKT2;ATP6V1G2
prerank,in utero embryonic development (GO:0001701),-0.3832677550272521,-1.0678529758585822,0.36828644501278773,0.7920022785907046,1.0,7/25,10.19%,FGFR2;ARNT2;TGFBR1;PKD1;IGF2;VEGFA;TGFB3
prerank,mitotic recombination (GO:0006312),-0.42351412442204645,-1.0673902681661689,0.36538461538461536,0.7918815738159652,1.0,10/15,30.90%,TEP1;RAD50;DMC1;SMC6;TPRKB;RAD52;GEN1;XRCC3;SMC5;ERCC1
prerank,cellular response to heat (GO:0034605),-0.35783537746139593,-1.0668216535377677,0.3404255319148936,0.7921339294968056,1.0,6/35,8.91%,FGF1;THBS1;ANO1;HSP90AA1;PRKACA;RBBP7
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.363573944735622,-1.0667389293564762,0.358600583090379,0.7909907790224374,1.0,9/32,9.80%,PID1;IGF1;NUPR1;ZBTB20;PPARA;PPARGC1A;PRKAA2;PFKFB4;ARNT
prerank,negative regulation of immune system process (GO:0002683),0.4871592459829086,1.066452593750039,0.3896551724137931,0.7687660109033172,1.0,3/16,4.17%,CD200;LYN;SOX9
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.47300971021709576,1.0663522364824933,0.4058219178082192,0.7684082591625815,1.0,5/18,18.99%,LYN;SH2B2;SLA2;FPR3;BCAR1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.42381746085517824,-1.066171527788528,0.35784313725490197,0.7912795334385311,1.0,3/17,7.36%,BMP6;CD55;PRKCA
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4225891309738486,1.0660708066795161,0.401840490797546,0.7684657878652031,1.0,9/35,11.71%,B2M;HIP1;HIP1R;RAC1;SMAP1;HNRNPK;CBL;MKLN1;PICALM
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.44467794209686107,1.0659498396320972,0.3774193548387097,0.7681206140862218,1.0,10/25,24.49%,SF3B4;SCAF11;PRPF4;SRSF10;LSM1;PRPF3;TRA2B;DBR1;SRSF4;SLU7
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.4079702189420069,1.0649997743493222,0.37390029325513197,0.7698991392494918,1.0,5/47,5.22%,FOXO1;DAB2IP;FAS;TAOK2;GREM1
prerank,positive regulation of DNA recombination (GO:0045911),0.43035344457452934,1.064991439325379,0.36918138041733545,0.7693058142113539,1.0,12/27,24.26%,SHLD1;WRAP53;MAD2L2;MMS19;ACTR2;WDR48;KMT5B;FUS;RIF1;PRDM9;ERCC6;ARID2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4437392339759872,1.0649720384316586,0.41091492776886035,0.7687360738814254,1.0,1/26,0.09%,SHANK3
prerank,positive regulation of lipid storage (GO:0010884),0.46577509624432023,1.064968483964698,0.3865546218487395,0.768135401813004,1.0,4/21,8.24%,SCARB1;PLIN5;NFKB1;LPL
prerank,negative regulation of protein ubiquitination (GO:0031397),0.401954454343144,1.0643680259375088,0.38686131386861317,0.7689312680651736,1.0,14/50,16.45%,CAV1;DTX3L;SMAD7;N4BP1;DNAJA1;ARRB1;PINX1;SOX4;SPOPL;VPS28;NXN;UBXN1;PRKCG;CHP1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3849228853703663,1.0641273961528614,0.375886524822695,0.7688960445557819,1.0,13/66,7.41%,FLT1;PDGFB;DAB2IP;EDN1;PDGFD;TNFRSF11A;TPD52L1;PIK3R6;CD40;SASH1;PDGFC;TGFB1;PIK3CG
prerank,positive regulation of cell cycle process (GO:0090068),0.3635289240951447,1.0632552913999642,0.37231182795698925,0.7704565217014807,1.0,24/91,19.31%,PKP4;INSR;PDGFB;EDN1;LRP5;PKN2;AURKA;TGFA;DYNC1LI1;AURKC;NUDT16;KIF23;PHIP;MAP3K20;GIPC1;ATRX;E2F7;CEP295;RHOA;RAD21;CUL3;PLSCR1;NUMA1;BTC
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3212532265132594,1.0631383479274292,0.3394396551724138,0.7701495426585183,1.0,95/336,22.93%,FOXO1;ACER2;POLK;FOXP1;LYN;SAMHD1;FNIP2;TNFRSF1B;CCNK;TAOK2;USP3;BABAM2;UBA7;RNF169;DTX3L;HERC2;XIAP;BOK;BCL2L11;MCM10;RPA1;TIGAR;MTREX;BCL3;POLA1;PSEN1;RAD51D;IKBKG;CGAS;BCL2L1;BACH1;BTG2;PARP2;RECQL;RAD18;HELB;FAN1;HUS1;XRCC2;SFN;MMS19;UNG;MCM9;BID;NOP53;WDR76;ERCC4;NSMCE4A;FMR1;NPM1;ASH2L;APC;SUSD6;TOPORS;YY1;OARD1;ENDOV;DDIT3;GTF2H4;CHEK2;BCL2L10;PDS5A;SPIDR;WDR48;PDS5B;RFC3;CIB1;GRB2;KMT5B;PAK1;MGMT;BAK1;NUDT1;CHD1L;RBBP5;GTF2H1;TAF9;MSH2;HIC1;RAD17;RPS3;RMI2;TRRAP;SETX;RIF1;MAP2K6;SIRT7;CASP2;MBD4;RFC5;TAOK1;SUV39H1;PHF1;NIPBL;MAPK14
prerank,peptidyl-asparagine modification (GO:0018196),0.4323302282321806,1.0627206389111006,0.4105754276827372,0.7705574069931558,1.0,2/31,1.62%,ST6GAL1;STT3B
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.47904822489470644,-1.0620775884872613,0.3908523908523909,0.8015353626962499,1.0,2/11,7.61%,BCL2;CD44
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.3102846743318081,-1.0620774434039633,0.34146341463414637,0.8001698850766652,1.0,17/65,11.51%,FBN1;LTBP1;TGFBR1;HTRA3;SPRED1;PPARA;SMAD6;FBN2;SMAD3;CD109;SNX6;ASPN;TGFB1I1;VASN;SLC2A10;SPRED2;SPRED3
prerank,cell cycle G1/S phase transition (GO:0044843),0.3835883702218842,1.0619893194057137,0.3873239436619718,0.7716308862461296,1.0,23/61,24.17%,CDK6;EIF4E;PLK2;ACVR1;CDKN1B;MAP3K11;CDK2;RB1;EIF4EBP1;CUL1;MAX;CUL3;CDC34;CUL2;E2F3;TRIM71;DBF4;CCNH;CRLF3;LATS1;CCNA2;CUL4B;PLK3
prerank,organelle fission (GO:0048285),0.4589988878492892,1.0614832267753345,0.4085667215815486,0.7722785637736029,1.0,1/24,0.27%,DNM3
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3250804912673043,-1.0611395700212074,0.32413793103448274,0.801424767922346,1.0,22/57,16.31%,DLG2;NLGN2;ACTN2;DLG4;GRIA2;DLG1;GRIA3;GRIA1;NLGN1;DLGAP4;DLG3;GRIA4;SHANK1;GRIN2A;PRRT1;CAMK2B;CACNG4;SHISA7;NPTXR;NETO1;DLGAP1;LRRC7
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4160914197074518,-1.0611103060188705,0.3677581863979849,0.8001551697650103,1.0,8/18,23.69%,CAMK1D;MCU;RIPOR2;DAPK2;MDK;CCL19;CD74;DNM1L
prerank,dorsal/ventral pattern formation (GO:0009953),-0.40069047649518774,-1.0609963883233495,0.39054726368159204,0.7991348451971487,1.0,3/20,1.10%,BMPR1A;GLI2;NBL1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.36657527241961635,1.0609080779451368,0.3769230769230769,0.773070913545684,1.0,14/85,7.47%,TBX1;TIE1;ACVRL1;PRKD1;B2M;CDK6;DAB2IP;SGPP2;AQP11;MTSS1;SOX9;TCF7L2;TGFB1;TGFA
prerank,tyrosine metabolic process (GO:0006570),-0.472269076313095,-1.0608211064505086,0.39651416122004357,0.798228715556963,1.0,6/11,45.22%,FAH;GSTZ1;HGD;THAP4;DCT;IYD
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5180161773273761,1.0607079406556061,0.41697416974169743,0.7729918522089859,1.0,4/11,16.37%,LPCAT3;ATL1;MOSPD3;ARL6IP1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.4071766146993401,1.0603702967498772,0.39968895800933124,0.7731996920034846,1.0,6/46,5.94%,SHANK3;MEF2C;DGKZ;PTK2B;CDH2;OPHN1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3842288540292126,-1.0603522343748253,0.3640897755610973,0.798185519297403,1.0,2/26,1.35%,LGR4;APPL2
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.4790567964984185,-1.0600780071617921,0.4061855670103093,0.7962983812152694,1.0,3/10,18.26%,MBP;WNK1;MYADM
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.4790567964984185,-1.0600780071617921,0.4061855670103093,0.7962983812152694,1.0,3/10,18.26%,MBP;WNK1;MYADM
prerank,positive regulation of cellular component organization (GO:0051130),0.35963592084097995,1.0600520529409705,0.36363636363636365,0.7733972370126664,1.0,15/107,7.33%,SHANK3;INSR;DAB2IP;TAL1;NEDD4L;ATP10A;FNIP2;BIK;ABCB7;TIRAP;DLL1;CBLL1;SH3GLB1;BCL2L11;TGFB1
prerank,cellular response to reactive oxygen species (GO:0034614),-0.32059576004999446,-1.059983914976491,0.3221476510067114,0.7952136701128077,1.0,8/59,5.16%,EGFR;PDGFRA;MAP3K5;PRKCD;TPM1;IMPACT;CYP1B1;ANXA1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.45028364706989477,1.0599790664135764,0.4078303425774878,0.7729438089522619,1.0,5/24,7.33%,IL6ST;PTGS2;HIF1A;FLT4;TGFB1
prerank,regulation of gene expression (GO:0010468),0.30916027831083015,1.0593323849034872,0.31350806451612906,0.7738295402683149,1.0,123/903,10.79%,LEF1;RPS6KA5;NOS3;RAB27A;NOVA2;KDR;ENG;SLC39A8;APBB2;ESR1;SMARCA2;APP;MEF2C;SOX7;ACVRL1;CLDN5;OCLN;NR5A2;CDK6;INSR;AHR;SMAD1;PDGFB;IRF2;FOXP1;GATA2;SOX13;PDE2A;LYN;ADAM10;STAT3;NR3C1;TRIM14;FBXW7;NOTCH1;HIF1A;MSN;PPM1F;NFKBIZ;RREB1;SOX17;WWTR1;CHD7;CASP8;SOX18;CD34;PLCG2;FGF23;SOX9;KDM6A;IGF2BP3;RBM20;MBNL1;PTBP3;MBNL2;TCF7L1;LIN54;SPIN1;DLL4;TRIM68;SBNO2;MAPK8;ATP2B4;SERPINB9;MTF2;RAMP2;JMJD1C;TEAD2;TNRC6C;PITX3;AURKA;ESRRG;HNRNPF;WNT5A;CNBP;RPS7;UBAP2;BTN2A2;IL36G;KRAS;ASCC1;AFF1;MBNL3;LYL1;HNRNPK;TGFB1;FOXN2;ZNF326;TCF3;HNRNPD;NFKB1;NOS1AP;MARF1;WWC2;CITED1;ZNF2;CREM;KAT6B;PSEN1;PRDM8;MYBBP1A;IHH;YBX3;RPL23;CDK2;HINT1;SOX4;CSF1;DICER1;ICOSLG;PUM1;MAFB;BACH1;HNRNPLL;MAPK11;ATXN7L3B;SFRP2;FOXN3;APLNR;PRKAB1;GAS6;YTHDC1;RC3H1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.4554948782347467,1.0590951285067225,0.39297658862876256,0.7737593078950088,1.0,4/21,9.46%,MTUS1;PTK2B;PTK2;CSF1
prerank,central nervous system neuron development (GO:0021954),0.49773371605744426,1.0588978498541881,0.4114583333333333,0.7736320561369823,1.0,3/15,7.51%,LHX6;RAPGEF2;B4GALT5
prerank,positive regulation of protein kinase activity (GO:0045860),0.3445650053697415,1.058660596016458,0.3877068557919622,0.7736075917223798,1.0,38/148,16.72%,INSR;PDGFB;NEDD9;IQGAP1;IL6R;DAB2IP;EFNA1;PTK2B;TAOK2;STK3;PAK2;STK4;RALB;CCDC88A;RAPGEF2;TNIK;PTK2;RAP1A;RPTOR;PTPN1;CSF1;MAP2K3;IL23A;FCGR1A;GAS6;EPHA4;ITGB3;TGFBR2;HSP90AB1;TRAF6;PAK4;ACE;MMD;LAT;IRGM;CALM1;PIH1D1;RHOA
prerank,amyloid precursor protein catabolic process (GO:0042987),0.49160680976596194,1.0586250767703171,0.41238938053097346,0.773094604623567,1.0,6/14,13.77%,ADAM10;DYRK1A;PSEN1;APH1A;ADAM17;ABCG1
prerank,atrial septum development (GO:0003283),-0.4565482339017379,-1.058367194382711,0.378076062639821,0.7983054933069774,1.0,2/13,0.29%,ANK2;NOTCH2
prerank,potassium ion homeostasis (GO:0055075),-0.39851490325239,-1.0581095535689724,0.3631578947368421,0.7976900228682356,1.0,6/23,9.89%,ATP1A2;SLC12A2;ATP1B1;KCNMA1;KCNJ2;ATP1B2
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.4205779957759794,-1.0579865298659168,0.3877068557919622,0.7966920306858026,1.0,4/17,13.10%,CPEB1;CPEB3;CTR9;CDK9
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.4857174838661368,1.0579466165036877,0.3944153577661431,0.7740857788712853,1.0,5/14,15.90%,NFKBIA;TMSB4X;PKD2;NFKBIE;G3BP2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5198199099752542,1.0577949174658496,0.397459165154265,0.7738670537866673,1.0,4/12,4.39%,LFNG;PTK2B;MFNG;DLL1
prerank,mitochondrial protein processing (GO:0034982),0.5046940356379948,1.0577905702601094,0.4074803149606299,0.7732668229143044,1.0,2/11,13.22%,IMMP2L;OMA1
prerank,protein acylation (GO:0043543),0.4081935321560306,1.0576508075181223,0.3898573692551506,0.7730021083087231,1.0,10/38,20.92%,FOXO1;ZDHHC18;ZDHHC9;HHAT;KAT2B;KAT6A;ZDHHC1;ZDHHC6;SELENOK;ZDHHC8
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.42128220499739794,1.057247576029682,0.3818770226537217,0.7733660899307877,1.0,9/34,12.79%,INSR;PDGFB;EDN1;LRP5;AURKA;TGFA;ANAPC7;RB1;PHIP
prerank,negative regulation of protein localization to membrane (GO:1905476),0.44990031350899057,1.057149126406563,0.39052287581699346,0.7730103813106813,1.0,7/24,11.71%,ABI3;PPP2R5A;NUMB;INPP5K;TGFB1;BCL2L1;PICALM
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.3626764095561922,-1.0570934037801336,0.3898305084745763,0.797780955919179,1.0,8/31,9.11%,BMPR1A;FGFR2;TGFBR3;TGFBR1;ZFPM2;TPM1;RBPJ;RYR2
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.41437028999454717,1.0566406697335506,0.41756548536209553,0.7736286550681174,1.0,8/42,12.58%,SMARCA2;ARID1B;CECR2;ARID1A;SMARCA5;SRCAP;SMARCE1;HNRNPC
prerank,cardiolipin metabolic process (GO:0032048),0.5090451375071517,1.0560835862564748,0.3974121996303142,0.7743675477440667,1.0,3/13,7.71%,PLA2G4A;HADHA;PTPMT1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4540873823368275,-1.0559009176877225,0.38675213675213677,0.7997904092120468,1.0,5/12,10.20%,CACNA1C;DLG1;RYR2;BIN1;CTNNA3
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.5080005354185759,1.054488634671501,0.4163636363636364,0.777527674757103,1.0,3/13,12.88%,PDE8A;RACK1;MET
prerank,Wnt signaling pathway (GO:0016055),0.3566854762747923,1.0544798024010673,0.37032085561497324,0.7769475507472966,1.0,12/92,7.56%,LEF1;DIXDC1;FZD6;FZD4;LRP5;PLCG2;CPE;TCF7L1;TCF7L2;WNT5A;WNT9B;SNX3
prerank,regulation of organelle organization (GO:0033043),0.36773432302487313,1.0542230333391067,0.38303693570451436,0.7769617142412568,1.0,19/80,17.31%,TJP1;F11R;PDE2A;MSN;MTM1;PAK2;PTK2;CAMSAP2;CDT1;SCARB2;PJVK;EHD3;PREB;CLIC4;S100A9;RDX;ARL6IP1;RHOT1;ARMH3
prerank,t-circle formation (GO:0090656),-0.4815212824662558,-1.054133339262122,0.4080338266384778,0.800838782997467,1.0,8/10,32.55%,SMARCAL1;DNA2;SLX4;XRCC3;EXO1;ERCC1;BLM;WRN
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.4815212824662558,-1.054133339262122,0.4080338266384778,0.800838782997467,1.0,8/10,32.55%,SMARCAL1;DNA2;SLX4;XRCC3;EXO1;ERCC1;BLM;WRN
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.4815212824662558,-1.054133339262122,0.4080338266384778,0.800838782997467,1.0,8/10,32.55%,SMARCAL1;DNA2;SLX4;XRCC3;EXO1;ERCC1;BLM;WRN
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.44752368808624343,1.0541316621081165,0.40202702702702703,0.7765549130167659,1.0,4/24,6.96%,PLA2G4A;ABCA3;PLA2G2D;CDS2
prerank,regulation of neuroinflammatory response (GO:0150077),0.4634505813801932,1.054030735939179,0.40823327615780447,0.7761912965148489,1.0,3/19,3.04%,PTGS2;CD200;TNFRSF1B
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3469432286443254,1.0539681381711954,0.37453646477132263,0.7757268519448739,1.0,20/128,7.46%,BMPR2;ENG;ACVRL1;CLDN5;F11R;SMAD1;SMURF1;PARD3;NRROS;PXN;FKBP1A;ID1;PTPRK;SMAD7;ACVR2A;USP15;DUSP22;ACVR1;TGFB1;PTK2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.38013044791742934,1.0539061990103094,0.38651994497936726,0.7752851883156084,1.0,16/73,12.95%,CAV1;APP;PRKD1;PRKD2;FNIP2;SH2D3C;STK4;ATP2B4;BCAR3;TGFB1;RPTOR;MAD2L2;SFRP2;GAS6;RIPK2;HSP90AB1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.37673352990162434,1.0538211778288809,0.37273991655076494,0.7748874794448273,1.0,15/70,18.26%,PLA2G4A;LPCAT3;CEPT1;ENPP2;LPIN3;ABCA3;PLA2G2D;MBOAT1;PLAAT3;PEMT;CHKA;PNPLA8;TMEM86B;CSNK2A2;CSNK2A1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.3612000074922299,1.053416122111212,0.3730366492146597,0.7752588541611141,1.0,6/91,4.60%,ABCG2;SLC39A8;APP;SLC31A1;ABCB7;LCN2
prerank,iron ion transmembrane transport (GO:0034755),0.5198345794952957,1.0533143263686793,0.42568807339449544,0.7748878661678442,1.0,2/10,4.23%,SLC39A8;ABCB7
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.4544988800788595,1.0529490059091147,0.397212543554007,0.775190246380258,1.0,3/20,8.58%,TGM2;RAP1GDS1;PSEN1
prerank,response to calcium ion (GO:0051592),0.35706312344819985,1.0529475497989589,0.3715415019762846,0.7745936229495534,1.0,16/102,8.09%,CAV1;MEF2C;CPNE8;IQGAP1;PPP3CA;PLCG2;ALOX5AP;KCNMB4;CHP2;WNT5A;ITPKB;TRPV6;ITPR3;NEDD4;RASA4;PKD2
prerank,negative regulation of receptor binding (GO:1900121),0.519900140422604,1.0528329041933853,0.44234404536862004,0.7742427131307197,1.0,2/10,6.17%,B2M;ADAM15
prerank,neuropeptide signaling pathway (GO:0007218),0.3838448657158902,1.0527520216347195,0.3879310344827586,0.7738500877903846,1.0,13/58,19.80%,CYSLTR1;NXPH2;CPE;RAPGEF2;HCRTR1;MCHR1;NMUR2;LTB4R;AGRP;HCRTR2;OPRL1;GLRA3;PPY
prerank,ventricular septum development (GO:0003281),-0.3489327193304118,-1.0522333269880968,0.3558823529411765,0.8048510536363417,1.0,12/37,11.96%,ROBO1;BMPR1A;TGFBR3;TGFBR1;ZFPM2;ROBO2;SALL1;HEYL;MDM4;SLIT2;TGFB2;STRA6
prerank,glycosphingolipid metabolic process (GO:0006687),0.40865559850471556,1.0521822776048344,0.3937984496124031,0.7746379169741323,1.0,4/42,4.87%,ST6GALNAC3;UGCG;ESYT2;GLTP
prerank,mitochondrial translation (GO:0032543),0.3524486544561471,1.0520510260796834,0.37772087067861715,0.7743453922931325,1.0,46/104,26.45%,MRPS18A;NDUFA7;MRPL13;MRPS12;MRPL35;FASTKD2;MRRF;MRPL41;MRPL52;MRPL4;QRSL1;MTIF3;MRPS16;MRPL23;MRPS5;MTRF1L;MRPL37;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;NOA1;AURKAIP1;MRPL1;MRPL50;RARS2;MRPL17;MRPL39;MRPL32;MRPL14;MRPS11;MRPL9;MRPL46;MTIF2;DAP3;MRPL19;MRPL15;MRPL42;GFM1;MRPL24
prerank,mitotic metaphase plate congression (GO:0007080),0.3870059272744756,1.0520291751133601,0.38117283950617287,0.7737995504917763,1.0,9/51,12.46%,RAB11A;CHMP2B;CDT1;KIF22;RRS1;PINX1;CHMP4A;CHMP4B;MAD1L1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.519153354852576,1.0519333242955589,0.42124542124542125,0.7734441200699347,1.0,3/11,7.33%,MEF2C;GREM1;TGFB1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5407753549186182,1.05186053216339,0.42990654205607476,0.7730301416357966,1.0,4/10,7.33%,NOTCH1;TNFRSF1B;TNFRSF1A;TGFB1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.36394523354945396,1.0516816775650775,0.3680555555555556,0.7728699819002554,1.0,20/74,22.49%,EPAS1;NOTCH1;HIF1A;EGLN1;PSMA2;BACH1;PSMA8;PSMA6;HIGD1A;PSME1;ELOC;PSMA4;PSMF1;CUL2;PSMB7;PSMB1;EGLN2;PSMD2;PSMA5;PSMC3
prerank,negative regulation of protein polymerization (GO:0032272),0.43410164764645776,1.051651437160698,0.41550387596899224,0.7723374555720182,1.0,6/27,10.19%,KANK3;HIP1R;SSH2;DYRK1A;CYRIB;TWF2
prerank,regulation of receptor internalization (GO:0002090),0.4167696888425357,1.05151824958443,0.39747634069400634,0.7720318880197246,1.0,11/35,11.52%,ANKRD13A;INSR;RIN3;SELE;SDCBP;GREM1;ARRB1;SCYL2;MKLN1;TBC1D5;PICK1
prerank,macrophage activation involved in immune response (GO:0002281),0.4960058392405901,1.0514358935299286,0.4207650273224044,0.7716396294033435,1.0,4/13,10.61%,PLCG2;CX3CR1;SBNO2;NMI
prerank,calcium ion import across plasma membrane (GO:0098703),-0.44028986264888836,-1.0508518558176254,0.4253393665158371,0.8073956482790535,1.0,4/14,9.52%,SLC8A3;CACNA2D1;SLC8A1;SLC24A2
prerank,membrane lipid metabolic process (GO:0006643),0.4570811319830588,1.0508254416732852,0.4253472222222222,0.7724769452569196,1.0,4/22,10.19%,ST3GAL6;B4GALT4;CERKL;ST6GALNAC4
prerank,protein localization to plasma membrane (GO:0072659),0.35336485452149174,1.0508094567582007,0.37733499377334995,0.7719221755250659,1.0,24/129,7.65%,EHD4;SPTBN1;F11R;SMURF1;RAB11A;TSPAN5;DENND4C;BSG;PACS1;NKD2;FCHO2;KCNB1;IKBKB;TSPAN14;RAMP2;CCDC88A;RAPGEF2;TMEM88;INPP5K;ATP1B3;TNIK;TNFRSF1A;RAP1A;EHD2
prerank,calcium ion import into cytosol (GO:1902656),-0.42873151825677647,-1.049691554606976,0.41002277904328016,0.8092823394305244,1.0,4/15,9.52%,SLC8A3;CACNA2D1;SLC8A1;SLC24A2
prerank,response to iron ion (GO:0010039),-0.44785738665430813,-1.0492130889376292,0.41318681318681316,0.8093447987722211,1.0,2/12,1.56%,BMP6;BCL2
prerank,cellular response to alkaloid (GO:0071312),0.46128536776059326,1.04916479588033,0.42095238095238097,0.7752476121991889,1.0,2/17,7.68%,TGM2;CASP7
prerank,monocyte differentiation (GO:0030224),0.5162354429718303,1.0487292248106777,0.4267399267399267,0.7757173939326102,1.0,2/10,2.11%,PIR;MYH9
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.37698550985661117,1.0486858324007002,0.383638928067701,0.7752474437874554,1.0,10/59,12.36%,LEF1;SOX9;TCF7L2;TNRC6C;FOSL1;PPM1D;NFKB1;MED27;CBFB;RELA
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.322334813460038,-1.0482284159072988,0.3424657534246575,0.8107989706689752,1.0,10/59,15.08%,ALDH1A2;CYP7B1;CYP27A1;ABCD3;PER2;ACACA;OSBPL3;OSBPL6;HOGA1;SCP2
prerank,heart process (GO:0003015),-0.43277690938273305,-1.048080743305557,0.4,0.8099124112578688,1.0,3/14,7.91%,SGCD;NOX4;SGCZ
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.37543922795482854,-1.048057464055224,0.38480392156862747,0.8086368421720005,1.0,6/26,6.09%,IGF1;IRS1;RHOQ;C2CD5;CLIP3;OSBPL8
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.350161819425701,1.0476530696500792,0.3825,0.7771649267878232,1.0,28/119,14.80%,INPP5D;PIP5K1B;SOCS2;PITPNM2;MTM1;PIK3C2A;PLCG2;PIK3R6;MTMR6;CISH;ITPKB;INPP5K;BMX;PIK3CG;PIGU;SYNJ1;PLEKHA8;OCRL;INPP5F;MTMR12;PIGQ;RAB5A;SLA2;PGAP4;PIGG;PIGF;SOCS6;SOCS4
prerank,response to hydrogen peroxide (GO:0042542),0.3940791928533851,1.0473696003519737,0.3908701854493581,0.7772524838583359,1.0,9/45,12.46%,NET1;FYN;STK24;CAT;STK26;RIPK1;RHOB;RELA;GLRX2
prerank,amyloid fibril formation (GO:1990000),0.39541535616100904,1.047253725291834,0.39680232558139533,0.7769661224350872,1.0,11/51,11.87%,APP;B2M;ADAM10;TSPAN5;FKBP1A;TSPAN14;H3-3A;SNCAIP;SIAH1;APH1A;RIPK1
prerank,cyclooxygenase pathway (GO:0019371),0.5217526705302074,1.046991841770726,0.42857142857142855,0.7769879742424532,1.0,3/10,7.17%,PTGS2;PTGS1;CBR1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.36135496776320364,1.0468413894823958,0.39253539253539255,0.7767414933065944,1.0,16/102,8.62%,FOXO1;HDAC9;CAV1;ADCY4;INSR;TBC1D4;DENND4C;PRKAR2B;SORBS1;XBP1;CEACAM1;LPIN3;INPP5K;TRIB3;NFKB1;AKT2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3583932177606938,1.046463588275633,0.4099722991689751,0.7771020033505277,1.0,27/94,17.24%,ERN1;PPP1R13B;DAB2IP;FNIP2;CASP4;PPM1F;TNFRSF1B;STK24;JMY;BOK;TRIB3;BCL2L11;MYBBP1A;HINT1;BCL2L1;ERO1A;BNIP3;SFN;CUL1;GSKIP;TOPORS;APAF1;DDIT3;CHEK2;BCL2L10;CUL3;ARL6IP5
prerank,protein localization to mitochondrion (GO:0070585),-0.46202911286993653,-1.04631325217262,0.42217484008528783,0.8122779580368729,1.0,6/11,21.90%,LRRK2;HK2;MTCH2;RALA;COX18;MAIP1
prerank,myelin assembly (GO:0032288),-0.47516019765266126,-1.0462750158133993,0.4298056155507559,0.8110427954850126,1.0,6/10,23.47%,EPB41L3;CNTNAP1;GPC1;TENM4;ABCA2;NCMAP
prerank,cellular response to organonitrogen compound (GO:0071417),0.35393920735160483,1.0461949643531334,0.3986842105263158,0.7771644857755726,1.0,23/99,16.75%,MEF2C;AHR;SH3BP4;PDE2A;KCNQ1;RAP1B;SOX9;XBP1;CTNNA1;RAPGEF2;INPP5K;RAP1A;PKD2;RPTOR;LARS1;P2RY12;RELA;AOC1;PDE3A;PDXP;ZFP36L1;CTNNB1;RAPGEF3
prerank,nucleosome organization (GO:0034728),0.3880509084409064,1.0459384401704597,0.40825035561877665,0.7771589523448628,1.0,21/55,24.69%,SOX9;PADI4;LIN54;H3-3A;ARID1A;KAT6B;SMARCA5;NAP1L4;SRCAP;SMARCE1;GRWD1;NPM1;ATRX;ANP32B;VPS72;SART3;PRDM9;SMARCC1;ARID2;SMARCD1;SET
prerank,epithelial cell morphogenesis (GO:0003382),-0.41942769543322844,-1.045507299779252,0.3873239436619718,0.8119099432030746,1.0,4/17,13.06%,COL22A1;COL18A1;COL15A1;DACT2
prerank,lipid phosphorylation (GO:0046834),0.5210376026027158,1.045030957495254,0.4247104247104247,0.7786697128401794,1.0,3/10,11.26%,DGKZ;DGKH;DGKE
prerank,aorta morphogenesis (GO:0035909),0.4696488470123312,1.0445209772926392,0.4160839160839161,0.779267027766779,1.0,4/17,5.28%,ENG;TBX1;ACVRL1;DLL4
prerank,artery morphogenesis (GO:0048844),0.42474256121090426,1.0444904649865931,0.3936,0.7787353205730432,1.0,6/30,5.17%,BMPR2;ENG;TBX1;NOTCH1;FOXF1;SMAD7
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.4711293321793871,-1.0444696877628699,0.4182242990654206,0.813564836534941,1.0,3/10,6.16%,BMP5;BMP7;LRP6
prerank,protein prenylation (GO:0018342),0.520940749530032,1.0439740007978808,0.43289224952741023,0.77939780444373,1.0,6/10,27.18%,PGGT1B;PTAR1;FNTA;FNTB;RABGGTB;CHML
prerank,oxoacid metabolic process (GO:0043436),-0.3618964361082193,-1.0439255363753501,0.3487179487179487,0.8137525455019434,1.0,4/27,8.00%,DDO;ENPP1;TPST1;ABHD14B
prerank,positive regulation of protein secretion (GO:0050714),0.3803820579882099,1.0437881384103591,0.39094650205761317,0.7792648277708499,1.0,9/69,9.33%,MYRIP;UNC13B;CD2AP;ACSL4;EXPH5;TCF7L2;TGFB1;ANG;SOX4
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.4517641459450972,-1.0433907498280899,0.408983451536643,0.8139514503188221,1.0,9/12,33.02%,LRRK2;ATP6AP2;PPT1;CLN3;TMEM199;TMEM165;TMEM9;CCDC115;GRN
prerank,positive regulation of phospholipase C activity (GO:0010863),0.40286510624418626,1.0432957760864128,0.39445300462249616,0.7798376160405355,1.0,6/40,3.22%,GNAQ;FLT1;ESR1;PLCG1;HTR2A;SELE
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3155248436014816,1.0424932478453575,0.37794432548179874,0.7812409523763574,1.0,90/341,21.23%,RNF125;KLHL3;SMURF1;RNF144B;NEDD4L;MVB12B;FBXW7;ZNRF1;ZNRF3;DTX3L;XBP1;KCTD10;PELI1;FBXL4;KCTD6;UBL7;AURKA;RNF144A;UBE3B;ATXN3;ARRB1;RNF7;UBE2G1;ARRDC1;PSMA2;RNF167;FBXL7;NEDD4;TRIM25;ARMC8;UBE2H;ANAPC7;RNF146;ZRANB1;SPOPL;RNF4;ANAPC1;ZFAND2B;VPS28;PSMA8;RAD23A;SIAH1;UBE2D3;PSMA6;RC3H1;CBL;CDC26;COP1;MYLIP;ANAPC16;RNF215;KLHL8;UBE2K;BUB3;TOPORS;UBXN1;PSME1;ELOC;ARIH2;RNF5;DDIT3;VPS37C;UBE3D;AREL1;CRBN;NDFIP2;BIRC2;NHLRC1;CTNNB1;MAEA;NEDD8;UBE2I;CUL3;CDC34;PSMA4;RNF40;PSMF1;ZFAND2A;TSG101;FBXO8;APPBP2;PSMB7;TRIM71;PSMB1;UBE2L3;HACE1;PLK1;KCTD2;ARIH1;PSMD2
prerank,plasma membrane invagination (GO:0099024),0.42493909717565237,1.0422693219708503,0.4185303514376997,0.7811863115634791,1.0,3/29,2.11%,DOCK1;ELMO1;MYH9
prerank,cortical actin cytoskeleton organization (GO:0030866),0.46004324296070354,1.0411180474983281,0.42601626016260163,0.7833023902487041,1.0,6/20,8.82%,LCP1;FMNL3;IKBKB;NCKAP1;FMNL2;LLGL1
prerank,positive regulation of neurogenesis (GO:0050769),0.36995086828442886,1.0409182657147147,0.4037940379403794,0.7831852142823473,1.0,7/68,5.39%,SHANK3;PLXNA4;TGM2;PLXND1;NUMB;DISC1;CX3CR1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.343981624193446,-1.0399206503138747,0.4044943820224719,0.8224412747888116,1.0,2/40,1.56%,PID1;BCL2
prerank,positive regulation of metabolic process (GO:0009893),0.3557556003323419,1.0396256192811808,0.39703903095558546,0.7856555875681763,1.0,23/103,13.47%,EPAS1;ADIPOR2;CAV1;INSR;FASN;ACACB;KDM3A;ADRB1;LCN2;GATM;ESRRG;PDGFC;AGPAT1;CXCR4;PRKAB1;IL4R;UCP2;PEMT;SIRT6;ADIPOR1;HADH;OMA1;IGF1R
prerank,sulfur amino acid metabolic process (GO:0000096),-0.37993469481601755,-1.039621760843947,0.4122137404580153,0.8219547523532331,1.0,10/24,28.00%,NOX4;SMS;GCLC;MTHFD1;CBS;CTH;MMUT;ADI1;MTRR;CDO1
prerank,regulation of cartilage development (GO:0061035),0.47113589351345825,1.0395492496562178,0.44596912521440824,0.785250164652536,1.0,3/18,4.17%,BMPR2;ZBTB16;SOX9
prerank,glycerolipid metabolic process (GO:0046486),0.5071956352270337,1.0393388623567417,0.42723880597014924,0.7851365370014248,1.0,1/11,2.23%,DGKZ
prerank,translesion synthesis (GO:0019985),0.3990408450676608,1.0393043214646074,0.40874811463046756,0.7846190463483691,1.0,6/42,11.80%,POLK;RPA1;TRIM25;PRIMPOL;MAD2L2;USP43
prerank,negative regulation of kinase activity (GO:0033673),0.3823934492795793,1.039147518100812,0.4135546334716459,0.7843994019353926,1.0,16/62,13.61%,GNAQ;PPP2R5A;PPM1F;WWTR1;PAK2;CEACAM1;INPP5K;CDKN1B;TRIB3;NPRL2;SFN;RB1;GSTP1;WARS1;TRIB1;GSKIP
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4175355746050178,1.0388980220930877,0.4,0.7844493018977144,1.0,4/33,3.41%,SLC39A8;DGLUCY;GLS2;GLS
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.41743714125158937,1.0387736116672681,0.42496050552922593,0.7841299239428393,1.0,12/28,22.56%,SMCHD1;DTX3L;SHLD1;WRAP53;MAD2L2;ACTR2;CYREN;KMT5B;PARP9;RIF1;SIRT7;ERCC6
prerank,phospholipid dephosphorylation (GO:0046839),0.40745150857632484,1.0381915212010515,0.41317365269461076,0.7848988852081162,1.0,15/37,20.45%,PLPP1;SGPP2;MTM1;MTMR6;INPP5K;SYNJ1;OCRL;INPP5F;MTMR12;PLPP6;PLPP5;MTMR9;MTMR2;SACM1L;PLPPR2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.44821314940322093,1.0380468200907924,0.4207920792079208,0.7846473922804041,1.0,5/25,8.79%,CSGALNACT1;B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,metal ion export (GO:0070839),-0.36012924793122003,-1.0379574388560155,0.39402173913043476,0.8252453410580267,1.0,4/31,4.90%,ATP1A2;KCNK5;ATP1B1;KCND3
prerank,positive regulation of macroautophagy (GO:0016239),0.4004687799211798,1.0374096121203147,0.40059790732436473,0.7855281636409351,1.0,13/48,17.15%,KDR;SPTLC2;VPS13D;RALB;SH3GLB1;IKBKG;BNIP3;GNAI3;FYCO1;IRGM;RAB3GAP2;EPM2A;HSPB8
prerank,axonal transport of mitochondrion (GO:0019896),0.5067252334809469,1.0372921555353791,0.46938775510204084,0.7852112936600143,1.0,6/11,27.16%,HIF1A;ACTR10;TRAK2;OPA1;NEFL;HAP1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.4751159003674754,1.0367863541771722,0.44703770197486536,0.7857861661897018,1.0,7/15,24.34%,REEP1;ATL1;RAB18;ZFYVE27;ARL6IP1;REEP3;LNPK
prerank,reverse cholesterol transport (GO:0043691),0.493788297511073,1.0357772222617692,0.4658273381294964,0.7876371863070953,1.0,4/13,23.47%,SCARB1;ABCG1;ABCA1;CLU
prerank,positive regulation of telomere capping (GO:1904355),0.46883549530509017,1.035723345547043,0.42985611510791366,0.787174268700217,1.0,2/17,7.80%,NEK7;HNRNPD
prerank,L-amino acid transport (GO:0015807),-0.3607476204621582,-1.0356812453699287,0.425414364640884,0.8302465649910961,1.0,9/28,18.52%,SLC7A2;SLC1A3;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;SLC36A1;PRAF2
prerank,protein localization to membrane (GO:0072657),0.33146593894885157,1.0356507755236992,0.4117647058823529,0.7867590922520727,1.0,39/187,12.22%,SHANK3;CAV1;EHD4;SPTBN1;F11R;SMURF1;RAB11A;TSPAN5;DENND4C;BSG;PACS1;NKD2;FCHO2;KCNB1;CPE;IKBKB;TSPAN14;RAMP2;RAPGEF2;TMEM88;INPP5K;SH3GLB1;ATP1B3;TNIK;TNFRSF1A;RAP1A;EHD2;AGRN;RAB38;ARL5A;ANK1;RFTN1;RAB12;TM9SF1;GAS6;PICK1;EHD3;BID;RAB11B
prerank,response to amyloid-beta (GO:1904645),0.40389621592346847,1.0356040890615301,0.4304932735426009,0.7862920315644576,1.0,11/44,11.80%,APP;VCAM1;ICAM1;CASP4;FYN;ATP1A3;CACNA1A;PSEN1;EPHA4;GRIN1;LGMN
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.4367344170396441,1.035408451784398,0.43636363636363634,0.7861835102139413,1.0,2/24,7.13%,POLK;RPA1
prerank,RNA destabilization (GO:0050779),-0.39407369923231667,-1.0353381090943676,0.42444444444444446,0.8298142303415444,1.0,3/18,14.57%,ROCK2;CELF1;FTO
prerank,regulation of histone methylation (GO:0031060),-0.43692028090920987,-1.0353104863155322,0.434052757793765,0.828575116626116,1.0,5/13,22.22%,TET1;CTR9;PAF1;NNMT;AASS
prerank,myotube differentiation (GO:0014902),0.4659038012108138,1.0352242266148224,0.41737649063032367,0.7860086419909631,1.0,2/17,1.15%,JAM2;MEF2C
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.36914630031776424,1.034992750593585,0.4178082191780822,0.7859864975946995,1.0,9/74,6.28%,NOS3;TNFSF10;ITGA6;ICAM1;ARHGEF2;FAS;CASP8;TCF7L2;ACVR1
prerank,response to unfolded protein (GO:0006986),0.3912645371889752,1.0349098838934292,0.4002932551319648,0.7855846802807577,1.0,15/48,19.09%,ERN1;STT3B;DAB2IP;TMBIM6;DNAJA1;RHBDD1;DNAJB5;PTPN1;HSP90AB1;ERP44;DDIT3;HSPB8;HSPE1;BAK1;DNAJB1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.47019930965292556,-1.03486889853658,0.4212678936605317,0.8285408047564469,1.0,5/10,30.42%,MIA3;TICAM1;TREM2;CD36;TLR6
prerank,histone H4 deacetylation (GO:0070933),0.5232553785252899,1.03486723525758,0.4640151515151515,0.7851108528082769,1.0,2/10,6.18%,HDAC9;RCOR1
prerank,response to prostaglandin E (GO:0034695),-0.479298976357712,-1.0348077196132537,0.4315068493150685,0.8273849106887338,1.0,5/10,18.91%,TGFBR3;ADCY6;SFRP1;GNG2;CCL19
prerank,erythrocyte development (GO:0048821),0.527255922155688,1.0345726031078113,0.44712430426716143,0.7851767972259696,1.0,1/10,2.95%,ALAS1
prerank,regulation of protein ubiquitination (GO:0031396),0.34715785851501874,1.0340515132926347,0.4131812420785805,0.7857906695608697,1.0,29/108,17.22%,CAV1;FBXW7;FKBP1A;SMAD7;N4BP1;FOXF2;XIAP;MYCBP2;SASH1;DNAJA1;ARRB1;MALT1;PINX1;SOX4;SPOPL;VPS28;UBE3A;RIPK2;PRICKLE1;NXN;BIRC3;HSP90AB1;TRAF6;UBXN1;PRKCG;CHP1;NDFIP2;BIRC2;CUL3
prerank,negative regulation of innate immune response (GO:0045824),0.4095316960777816,1.0337865646988156,0.4283464566929134,0.785806159134417,1.0,7/34,15.63%,NLRC5;SAMHD1;RPS19;USP15;NMI;CNOT7;IRAK3
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4325490018086323,1.0337527162796625,0.4237012987012987,0.7852962055704826,1.0,5/26,7.33%,IL6ST;PTGS2;HIF1A;FLT4;TGFB1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.44826962010446336,-1.0335909019062948,0.4178794178794179,0.8296462211303557,1.0,2/12,7.61%,BCL2;CD44
prerank,carbohydrate homeostasis (GO:0033500),0.3699287258306365,1.033571892306659,0.4011299435028249,0.7851471384528168,1.0,13/67,14.55%,ADIPOR2;INSR;STAT3;KLF7;KCNB1;TCF7L2;INPP5K;NEUROD1;SOX4;ADIPOR1;IGF1R;RPS6;MBD5
prerank,regulation of cytoskeleton organization (GO:0051493),-0.2887141566149649,-1.03351569507148,0.3781094527363184,0.8285125834193722,1.0,19/108,8.67%,PHLDB2;LRP1;EPHA3;PDGFRB;ROCK2;EFNA5;RHOQ;PHLDB1;BICD1;PRKCD;GPM6B;RHOBTB2;RND3;ARHGAP18;PRKAA2;MAP6;EZR;RHOBTB3;PLXNB1
prerank,regulation of sodium ion transport (GO:0002028),-0.35233460777790604,-1.032549411209712,0.39775910364145656,0.8299008175097592,1.0,8/34,5.31%,SNTA1;P2RX4;WNK4;NKAIN4;ANK3;DLG1;SLMAP;NKAIN2
prerank,regulation of viral life cycle (GO:1903900),0.45173936394177105,1.0324861644760879,0.4355108877721943,0.7871248512630296,1.0,4/21,7.85%,TRIM14;NECTIN2;TRIM68;TRIM25
prerank,regulation of cellular protein localization (GO:1903827),-0.32715769324722155,-1.0322454413374478,0.39197530864197533,0.8295056966484836,1.0,9/45,11.11%,GPC6;GPC3;MAP2;HSP90AA1;PRKAA2;GPC5;GBF1;GPC4;CCDC66
prerank,sensory perception of pain (GO:0019233),-0.3996690270576976,-1.0322026300898264,0.4146868250539957,0.8283039858783918,1.0,11/21,31.71%,P2RX4;PTGES;RETREG1;TRPA1;CCR2;CCL2;KCNA2;SCN9A;CHRNB2;ALOXE3;P2RX7
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.4365662364173123,1.0321183402007497,0.4246100519930676,0.7874111486160538,1.0,7/24,10.84%,EPC1;H3-3A;MTF2;TASOR;PPM1D;AEBP2;PPHLN1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4394015668518436,1.0319455707109861,0.4391891891891892,0.7872538675537767,1.0,4/23,5.49%,TGM2;KCNQ1;GNB1;ATP2B4
prerank,regulation of tissue remodeling (GO:0034103),0.4538394030617153,1.0318893269814524,0.4567062818336163,0.7868215034243004,1.0,5/18,9.61%,IL15;FLT4;CEACAM1;TGFB1;IL23A
prerank,toll-like receptor signaling pathway (GO:0002224),0.3545419446808052,1.0318257150898664,0.4143646408839779,0.7863975252293985,1.0,23/84,17.54%,CASP8;PLCG2;TIRAP;RPS6KA3;IKBKB;CTSK;IKBKG;RFTN1;MAPKAPK3;UBE2D3;TNIP1;NMI;IRAK4;LGMN;RIPK1;RIPK2;BIRC3;TRAF6;S100A9;IRAK3;TAB3;BIRC2;IRAK2
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.49282310590993006,1.0312272431401044,0.44090056285178236,0.7872170727162795,1.0,4/12,14.45%,STX3;STX1A;SNAP23;STX11
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3529726762471103,1.0312168650794287,0.4144736842105263,0.7866649719818913,1.0,20/88,16.11%,NANOS3;DAPK1;DAB2IP;EDN1;IGF2BP3;NANOS2;GRB7;NFKB1;RNF139;BTG2;RPL13A;CNOT1;MRPL13;RACK1;CNOT7;FMR1;LSM14A;YBX1;PAIP2B;RIC1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.41668468531328606,-1.0308747932034918,0.4298850574712644,0.8307998355655299,1.0,4/15,17.07%,GLI3;CD55;HSPH1;SYK
prerank,cellular response to chemical stress (GO:0062197),0.35321675738606945,1.0306239489326123,0.43535620052770446,0.7874653347533321,1.0,14/96,12.62%,FOXO1;CAV1;PRKD1;FAS;CAT;GSR;CYCS;PRR5L;TRPV4;PKD2;ERO1A;LONP1;PRDX2;GSTP1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5095811084221515,1.030465027954901,0.4369287020109689,0.7872623449304318,1.0,5/11,16.06%,ARID1B;ARID1A;ZMIZ1;CDCA4;SERTAD2
prerank,peptidyl-lysine modification (GO:0018205),-0.28253665244691667,-1.030383306012499,0.38009049773755654,0.8308445462218595,1.0,18/99,12.17%,EYA1;LOXL1;HDAC4;PLOD2;LOXL3;SIRT2;NNAT;P3H3;SENP3;LOX;SENP7;RAE1;POM121;PIAS1;PIAS3;NDC1;SENP5;NUP93
prerank,renal filtration (GO:0097205),-0.46762739506907297,-1.0303241727348924,0.4584221748400853,0.8296723108014785,1.0,2/10,2.03%,SULF1;SULF2
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.4041537734325834,-1.0301670655942783,0.42857142857142855,0.8288125258116198,1.0,3/19,2.89%,IRS1;PRKCD;PPARA
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.4343570800583959,-1.030115826651851,0.4117647058823529,0.8276228193512593,1.0,7/12,31.36%,AKR1B1;FDX1;FDXR;TSPO;TSPOAP1;CACNA1H;FDX2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.42962891510799833,-1.0300872533372665,0.4292682926829268,0.8263953462611916,1.0,8/15,23.37%,PRKCD;SMPD3;SPHK1;NSMAF;ORMDL2;PLA2G6;SMPD2;SPHK2
prerank,positive regulation of viral life cycle (GO:1903902),-0.3870568647618469,-1.0299431589098014,0.4049382716049383,0.8255104671441887,1.0,8/22,21.06%,AXL;P4HB;LGALS1;DDB1;KPNA2;VPS4A;TYRO3;CD74
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.46392252014116075,1.0298632934001206,0.43915343915343913,0.7880780828972753,1.0,2/17,6.32%,PLA2G4A;PLA2G2D
prerank,regulation of chromosome segregation (GO:0051983),0.4765506973038433,1.029458035873186,0.44028520499108736,0.7884196610330069,1.0,7/16,20.62%,PUM1;RAD18;PUM2;CSNK2A2;CSNK2A1;NUMA1;RMI2
prerank,positive regulation of developmental process (GO:0051094),0.3314583138299541,1.0290185958456575,0.4165651644336175,0.7888324413519199,1.0,24/164,8.75%,SHANK3;BMPR2;KDR;ZBTB16;INSR;PDGFB;DAB2IP;FZD4;RREB1;PLCB1;SOX9;RPS6KA3;SLC6A6;RPS6KA1;XBP1;ENPP2;SHLD1;AURKA;WNT5A;ACVR1;B4GALT5;NEUROD1;PSEN1;ARHGEF7
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.4226604661352067,1.0289435572581882,0.42549668874172186,0.788414095886885,1.0,14/29,26.28%,CNOT6;EDC3;EXOSC1;DCP2;LSM3;HBS1L;CNOT7;LSM7;LSM1;DCP1B;LSM2;DDX6;DIS3;EXOSC4
prerank,negative regulation of signal transduction (GO:0009968),0.32004205641968,1.0287809956521188,0.4241379310344828,0.7882319408091715,1.0,40/249,8.35%,SEMA6A;EGFL7;NTN1;EPN2;NFATC1;MMRN2;GATA2;PTPN12;DAB2IP;HHEX;LYN;DDIT4;FBXW7;PTPRJ;KIF26A;NCK1;SRMS;SIGIRR;NKD2;CYP26A1;PLIN5;DLL1;TMBIM6;GRB14;VGLL4;DLL4;CX3CR1;ASAH2;KCTD6;ACVR1;CYP26C1;SOST;INPP5K;ARRB1;ARRDC1;GRB7;NEDD4;CTNNBIP1;MOSMO;CITED1
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.33214686136796245,-1.0284441463143494,0.38198757763975155,0.8284256495666741,1.0,12/45,12.53%,BMP7;BMP4;GAS1;ZWINT;SMAD3;TOM1L2;BCL6;TRIM35;RGCC;FZD3;BRINP3;CHFR
prerank,positive regulation of isotype switching (GO:0045830),0.45885318067111946,1.028189602034787,0.4457831325301205,0.7890486070217299,1.0,4/15,10.15%,SHLD1;CD40;TGFB1;MAD2L2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2811399308953914,-1.0280420767392047,0.3702127659574468,0.8282755469684179,1.0,22/95,11.51%,ZEB2;TGFBR3;DKK3;TGFBR1;HTRA3;SPRED1;PPARA;THBS1;SMAD6;SMAD3;CD109;SNX6;ASPN;TGFB1I1;DAB2;BCL9;VASN;HIPK2;SLC2A10;SPRED2;NREP;SPRED3
prerank,positive regulation of mitochondrion organization (GO:0010822),0.38204373757306553,1.0279598918234756,0.4281524926686217,0.7889585036819375,1.0,7/57,6.84%,TNFSF10;KDR;HIP1R;BIK;BOK;AURKA;BCL2L11
prerank,regulation of dephosphorylation (GO:0035303),0.48099031509040185,1.0275529861006802,0.44256756756756754,0.789281812978182,1.0,3/15,9.83%,PPP1R16B;INPP5K;SMG7
prerank,NIK/NF-kappaB signaling (GO:0038061),0.36177966706066295,1.0275427139238305,0.4101838755304102,0.7887326337946804,1.0,27/72,24.92%,CARD10;TIRAP;PSMA2;MALT1;RELB;DICER1;PSMA8;PSMA6;CUL1;RELA;BIRC3;TRAF6;PSME1;NFKB2;BIRC2;PSMA4;PSMF1;PSMB7;PSMB1;REL;PSMD2;PSMA5;PSMC3;TRAF2;COPS8;PSMD3;PSMA3
prerank,regulation of viral transcription (GO:0046782),0.39899754999189996,1.027511073350949,0.4294478527607362,0.788231812404841,1.0,13/39,22.30%,TRIM14;MID2;GTF2F2;NELFE;ZFP36;NELFCD;IFITM3;CTDP1;TRIM62;NELFB;POLR2L;NELFA;POLR2J
prerank,DNA dealkylation (GO:0035510),0.5104024172009907,1.0274548110106085,0.4489795918367347,0.7872300571897373,1.0,4/10,18.55%,ASCC1;ASCC3;MPG;MGMT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5104024172009907,1.0274548110106085,0.4489795918367347,0.7872300571897373,1.0,4/10,18.55%,ASCC1;ASCC3;MPG;MGMT
prerank,actin filament bundle assembly (GO:0051017),0.4099367394029614,1.0271707726479387,0.4428794992175274,0.787289388498669,1.0,6/33,4.52%,LCP1;EPS8;NEDD9;SHROOM2;SHROOM1;PLS3
prerank,response to interferon-alpha (GO:0035455),0.4805519587004541,1.0271640254250618,0.46218487394957986,0.7867329426926827,1.0,9/16,19.34%,IFNAR1;IFNAR2;GAS6;RO60;ADAR;IFITM3;BST2;IFITM1;EIF2AK2
prerank,striated muscle cell differentiation (GO:0051146),0.46264170675067906,1.026965209139264,0.4337979094076655,0.7866045361452423,1.0,2/16,3.05%,MEF2C;SIK1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.4039293380196505,1.0268437070178305,0.44144144144144143,0.7863228072633998,1.0,8/39,10.15%,NEXMIF;PODXL;NOTCH1;PPM1F;TGFB1;PTK2;NF2;MAD2L2
prerank,regulation of gluconeogenesis (GO:0006111),-0.35782270177754716,-1.026788107557931,0.4080604534005038,0.8304119475791503,1.0,10/27,20.84%,OGT;PPARGC1A;SELENOS;C1QTNF3;PTPN2;DDB1;DGKQ;CRY1;PDK2;NNMT
prerank,renal absorption (GO:0070293),0.5087256501250416,1.0260430438645247,0.44587155963302755,0.7876098026466604,1.0,3/10,8.48%,KLHL3;KCNQ1;SLC15A2
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.4329953523992426,1.0254151206908002,0.420265780730897,0.7884617670533997,1.0,7/25,9.87%,ITGA6;APP;SDCBP;PSEN1;ANG;DSCAM;BTBD10
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.3693317459525354,-1.0251688892135833,0.4182825484764543,0.8336623079712261,1.0,7/23,16.51%,MAP6;KIF1A;KIF5C;DYNC1I1;KIF1B;HOOK2;KIF5A
prerank,establishment of protein localization to membrane (GO:0090150),0.3679101344448931,1.0251283015061474,0.4328767123287671,0.788514615057341,1.0,14/66,12.22%,PARD3;RAB11A;REEP1;AQP11;TAOK2;SDCBP;SEC63;ZDHHC18;ZDHHC9;RFTN1;MYO1C;ICMT;BID;RAB11B
prerank,positive regulation of cyclase activity (GO:0031281),0.4811485965429037,1.0248659383361154,0.44525547445255476,0.7885597714829485,1.0,3/14,5.46%,NOS3;ORAI1;MAPK8
prerank,pinocytosis (GO:0006907),-0.47166849663067123,-1.0237347480604924,0.44766146993318484,0.8362856495449631,1.0,7/10,29.29%,CARMIL1;SNX5;PPT1;PYCARD;DOCK2;SNX33;AHSG
prerank,long-chain fatty acid transport (GO:0015909),-0.3653304840856998,-1.0234754976145386,0.44537815126050423,0.8357065487288816,1.0,19/30,31.71%,ACSL1;ABCD3;PRKAA2;PRKAG2;ACACA;ACSL3;APOE;SLC27A1;MFSD2A;PRKAB2;SLC27A4;CPT2;PPARG;RPS6KB1;ABCD2;SLC27A6;CD36;CPT1B;FABP5
prerank,atrial septum morphogenesis (GO:0060413),0.5153059847220435,1.0234551531438658,0.46545454545454545,0.7912667185338847,1.0,4/10,9.33%,BMPR2;ACVR1;ZFPM1;SOX4
prerank,cell part morphogenesis (GO:0032990),-0.4358088957759488,-1.023002249978801,0.4146919431279621,0.8356763502062,1.0,1/13,0.15%,PID1
prerank,DNA double-strand break processing (GO:0000729),-0.40598873034610866,-1.022847466630542,0.41545893719806765,0.8348134589265748,1.0,12/18,38.39%,RAD50;SETMAR;KAT5;DNA2;SLX4;BARD1;RAD52;ATM;BLM;EXD2;RNF138;NBN
prerank,thyroid hormone generation (GO:0006590),-0.47164826643816476,-1.0223239836484652,0.46357615894039733,0.8349355353013295,1.0,2/10,7.88%,CPQ;SLC5A5
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.479834253837978,1.0222195262007043,0.43133802816901406,0.7934671218877751,1.0,1/13,1.30%,STX3
prerank,extracellular transport (GO:0006858),0.4864572755465274,1.022021308586576,0.4561717352415027,0.7933399168576247,1.0,4/12,19.56%,ARRDC1;SPA17;CABYR;TSG101
prerank,negative regulation of ATPase activity (GO:0032780),-0.4124564497862522,-1.021705868176233,0.4376470588235294,0.8353625815124541,1.0,8/16,27.63%,IFIT1;TSC1;VCPKMT;ATP5IF1;TP53;PPIF;PAM16;PLN
prerank,T cell differentiation in thymus (GO:0033077),-0.4301737870359599,-1.0211601495402414,0.43838862559241704,0.8356014482581086,1.0,1/14,0.67%,GLI3
prerank,response to purine-containing compound (GO:0014074),-0.4063630221209521,-1.0211511980684003,0.42788461538461536,0.834332981694799,1.0,4/17,9.11%,P2RX4;ABCC9;TRPC3;RYR2
prerank,regulation of neuron projection arborization (GO:0150011),-0.40816284486361665,-1.0210937234763626,0.43559718969555034,0.833197281910984,1.0,8/15,16.14%,GRIP1;DLG4;NTNG1;MOV10;MFSD2A;MACF1;DVL1;MYO9A
prerank,arachidonic acid metabolic process (GO:0019369),0.4049447279760199,1.0210343811250244,0.41798107255520506,0.7950269087389248,1.0,5/35,7.17%,PTGS2;PLA2G4A;PTGS1;EPHX1;CBR1
prerank,regulation of translation (GO:0006417),0.32703719025119726,1.0208416166150884,0.4389086595492289,0.7948600658581895,1.0,44/173,18.21%,NANOS3;APP;DAPK1;IGF2BP3;RPS6KA3;RPS6KA1;NANOS2;EIF4E;EIF3H;BCL3;GRB7;NIBAN1;HNRNPD;EIF1;RNF139;SOX4;BTG2;RPL13A;CNOT1;RBM3;EIF6;MRPL13;CYFIP1;EIF5B;RPL10;RACK1;EIF2AK4;MTPN;CNOT7;FMR1;EIF2B2;PAIP1;NPM1;ERBB2;LARP4B;LSM14A;YBX1;PAIP2B;EIF5;CTIF;CSDE1;EEF2;METTL14;LARP4
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3016135220681562,1.0204546788900009,0.43005181347150256,0.7951779695196048,1.0,93/572,12.68%,HDAC9;DACH1;LDB2;CAV1;ESR1;SMARCA2;PPARD;MEF2C;ZBTB16;ETV6;LRRFIP1;PDGFB;IRF2;FOXP1;DAB2IP;SOX13;EDN1;HHEX;PDE2A;NEDD4L;STAT3;EFNA1;NR3C1;FNIP2;NOTCH1;KLF7;RREB1;KLF8;TGIF1;ZFP57;SOX18;HMBOX1;SOX9;RIPPLY3;KLF2;ELK4;RPS14;MCPH1;SDCBP;ID1;EPC1;SMAD7;DLL4;MTF2;TCF7L2;DUSP22;CNBP;KLF10;NR1I3;FBP1;IRF2BPL;ETS2;TRIB3;SPDEF;TCF3;NEDD4;NFKB1;GATAD2A;CTBP1;WWC2;CREM;PHF6;EZH1;PSEN1;TAF3;ZFPM1;RPL23;DICER1;BACH1;YEATS2;NFIB;NRIP1;MAD2L2;SP2;SKIL;CNOT1;KLF12;UBE2D3;SEMA4D;SPEN;CNOT2;RB1;EID1;CBFB;PRDM2;DCAF1;NOP53;MIER1;SIRT6;RELA;MAX;ZFP36;RPL10
prerank,actin filament bundle organization (GO:0061572),0.40586382123595127,1.020247529433082,0.46226415094339623,0.7950673263694487,1.0,6/33,4.52%,LCP1;EPS8;NEDD9;SHROOM2;SHROOM1;PLS3
prerank,neuromuscular junction development (GO:0007528),-0.3649890859981653,-1.0200765100896374,0.39416058394160586,0.8348704141427468,1.0,7/24,8.66%,PDZRN3;UNC13C;PPFIBP2;ANK3;CACNB2;LRRK2;CACNB1
prerank,central nervous system development (GO:0007417),0.3173699803949707,1.0200457044551114,0.4407158836689038,0.7949500280828122,1.0,36/250,10.51%,SLC2A1;PBX1;ADGRL2;SHROOM4;ZBTB16;LSR;ZIC3;CELSR1;STAT3;DDIT4;ADGRA2;SNTG2;HAPLN3;CHD7;SHROOM2;ADGRG1;AMIGO2;SOX9;CDH2;MAL;DLL1;RPS6KA3;NCKAP1;CX3CR1;SEMA6B;CYP26C1;PDGFC;DNAJC30;PKD2;EIF2B5;SYNJ1;SOX4;NFIB;NMUR2;SCYL2;CXCR4
prerank,regulation of viral genome replication (GO:0045069),0.37138752180353035,1.019798664488015,0.43459302325581395,0.794932768436045,1.0,16/56,19.34%,NR5A2;ADARB1;PKN2;ISG20;N4BP1;RAD23A;TNIP1;ADAR;OASL;CNOT7;IFIH1;IFITM3;PLSCR1;BST2;IFITM1;EIF2AK2
prerank,positive regulation of axon extension (GO:0045773),0.4371682741681412,1.019724551185203,0.4326923076923077,0.7945435576646357,1.0,6/22,12.84%,NTN1;SEMA7A;DSCAM;TWF2;MAP3K13;DBNL
prerank,synapse assembly (GO:0007416),0.3653669984510007,1.0196824515119096,0.4472934472934473,0.794071044110412,1.0,6/67,6.10%,SHANK3;DNM3;PLXND1;PCDHB4;CDH2;WNT5A
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.41833415630033655,1.0191051171968604,0.456752655538695,0.7947958269606955,1.0,2/29,1.06%,MCTP1;APP
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.440013922835757,1.018820062138383,0.43833333333333335,0.7948971717708788,1.0,4/23,12.62%,PTGS2;ASAH2;LTC4S;GSTP1
prerank,positive regulation of telomerase activity (GO:0051973),0.41355154994431814,1.0184696383321639,0.42924528301886794,0.7951506560215045,1.0,6/33,12.95%,NEK7;HMBOX1;GREM1;WRAP53;ACD;HSP90AB1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.3920125225074409,-1.0184603946955346,0.4226327944572748,0.838060400612865,1.0,3/18,2.95%,EGFR;DDX5;BMP4
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.38379968310539486,1.0183575955862414,0.4319526627218935,0.7948244556737419,1.0,17/48,20.20%,FNIP2;DDIT4;TNFRSF1B;HIPK1;BOK;BCL2L11;BCL3;BCL2L1;SFN;TOPORS;SNW1;TMEM109;CHEK2;BCL2L10;BAK1;MSH2;HIC1
prerank,regulation of BMP signaling pathway (GO:0030510),0.3603232063390162,1.0177783752597642,0.42021276595744683,0.795548133312018,1.0,15/73,10.32%,BMPR2;ENG;ACVRL1;SMAD1;SMURF1;NOTCH1;SMAD7;ACVR2A;GREM1;XIAP;SOST;ITGA3;SKIL;SMAD5;UBE2D3
prerank,"phagocytosis, engulfment (GO:0006911)",0.40486511097728417,1.0177719650052135,0.44285714285714284,0.7949926732072286,1.0,6/36,10.39%,DOCK1;ELMO1;MYH9;RAC1;RHOBTB1;FCGR1A
prerank,necroptotic process (GO:0070266),0.46563590837219887,1.0177031160799965,0.45,0.7945785798211304,1.0,5/16,17.87%,PGAM5;MLKL;RIPK1;TRPM7;IPMK
prerank,cellular response to starvation (GO:0009267),0.32924105293956235,1.0176528852987197,0.4438964241676942,0.7941350293447769,1.0,24/147,13.27%,FOXO1;BMPR2;PRKD1;FAS;SIK1;STK24;RALB;XBP1;MAPK8;KLF10;SH3GLB1;STK26;RPTOR;MYBBP1A;ATP6V1G2;NPRL2;LARS1;NUAK1;PICK1;SIK2;GABARAPL1;XPR1;EIF2AK4;AOC1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.37153702527818444,1.0174922418765373,0.42043795620437957,0.7939225637120161,1.0,12/56,17.79%,NOD1;PLCG2;RPS6KA3;CTSK;MAPKAPK3;IRAK4;LGMN;TRAF6;S100A9;TAB3;IRAK2;TIFA
prerank,positive regulation of endocytosis (GO:0045807),-0.3277126853318542,-1.0174850791939363,0.42857142857142855,0.8394337399524419,1.0,11/45,10.33%,LRP1;GPC3;VTN;APPL2;AXL;BICD1;NLGN1;CLIP3;DAB2;APOE;SERPINE1
prerank,regulation of spindle organization (GO:0090224),-0.40272303166943946,-1.0174248966696682,0.4439252336448598,0.8383166743928671,1.0,9/18,30.07%,PARP3;GNAI1;GPSM2;RAE1;DYNC1H1;TPX2;FSD1;DCTN1;MAP9
prerank,centromere complex assembly (GO:0034508),-0.33871048252945013,-1.017413099530732,0.41379310344827586,0.8370695926155932,1.0,23/36,41.08%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;CENPH;HELLS;KNL1;CENPF;CENPX;CENPQ;CENPA;NASP;DLGAP5;CENPC;CENPW;MIS12;CENPM;CENPL;CENPS
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.28562969482685124,-1.0172173596109626,0.40458015267175573,0.836300945633553,1.0,23/87,17.23%,FGFR2;FGF1;HNRNPH1;SPRED1;FGF2;NDNF;RBFOX2;CD44;FLRT2;FLRT1;TIA1;SFRP1;FGFBP1;FGFR4;SPRED2;FGF7;NR4A1;POLR2B;POLR2K;HNRNPA1;HYAL1;FGF10;GTF2F1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3589998314206832,1.0166244311303216,0.43502051983584133,0.795377928901227,1.0,13/76,12.61%,NOD1;APP;HDAC7;ADGRG3;NFKBIA;ACTN4;TMSB4X;SASH1;BCL3;IL23A;NMI;RELA;ADIPOR1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.40818608698252745,-1.016519085192961,0.45495495495495497,0.8369729804626731,1.0,2/17,1.71%,ANK2;SNTA1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3452004027974264,1.0160038030402285,0.43523316062176165,0.7962233039060256,1.0,19/101,9.04%,FLT1;PDGFB;DAB2IP;EDN1;PDGFD;TPD52L1;PIK3R6;RALB;ATP2B4;WNT5A;RAPGEF2;CD40;PDGFC;TGFB1;PIK3CG;CCNYL1;PKD2;RPTOR;CCNY
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3634737474834259,1.0157581258017783,0.431266846361186,0.7962195426214234,1.0,7/76,6.68%,TEK;EDN1;PTK2B;NCK1;EVL;NCKAP1;CDC42EP3
prerank,negative regulation of nervous system development (GO:0051961),0.4571803325878066,1.0157327299943313,0.46826758147512865,0.7956985554134236,1.0,2/17,2.77%,B2M;NOTCH1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.29332608588369874,-1.0155760420998645,0.4057377049180328,0.8384537434989924,1.0,10/77,6.94%,IGF1;PRKN;BCL2;TGFBR1;SH3RF1;BMP4;THBS1;AR;ITGAV;SIAH2
prerank,muscle tissue morphogenesis (GO:0060415),0.4562049335205838,1.0151628422664363,0.4666666666666667,0.7964730860188324,1.0,2/16,2.77%,TBX1;NOTCH1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4749200871892418,1.0150917997576325,0.4563279857397504,0.7960774847370499,1.0,2/13,4.00%,NOS3;TMSB4X
prerank,neuron projection development (GO:0031175),0.3283690041280954,1.0150759183670652,0.4388235294117647,0.7955502374316606,1.0,20/168,8.13%,SHANK3;FRY;FRYL;APP;STX3;PTPRM;DAB2IP;RAB11A;LYN;SRGAP2;TAOK2;PPP1R9B;BICDL1;NCKAP1;ULK1;OPHN1;RAPGEF2;TNIK;NEDD4;CAMSAP2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4493444101931549,1.0148875261746437,0.4698996655518395,0.7954223170640504,1.0,3/20,2.77%,ENG;ACVRL1;NOTCH1
prerank,neuron apoptotic process (GO:0051402),0.44640604982131593,1.0146345609271843,0.44880546075085326,0.7954027297805308,1.0,5/19,11.99%,APP;FAS;SIAH1;BNIP3;BID
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4279593033693415,1.0145526460087477,0.4290322580645161,0.7950567081201653,1.0,10/23,20.08%,MTM1;MTMR6;INPP5K;SYNJ1;OCRL;INPP5F;MTMR12;MTMR9;MTMR2;SACM1L
prerank,regulation of cell division (GO:0051302),0.35932272646879126,1.0142604371707817,0.449438202247191,0.7951841366732904,1.0,19/72,18.52%,RAB11A;MLLT3;TAL1;DLL1;PLK2;AURKA;SH3GLB1;AURKC;BCL2L1;SFRP2;SFN;RACK1;ESRRB;TXNIP;PDXP;CALM1;PRPF40A;CIB1;CETN2
prerank,protein homotetramerization (GO:0051289),0.37785474444627287,1.0140048175702097,0.44868035190615835,0.7952101611628378,1.0,5/49,3.41%,B2M;GBP5;SAMHD1;ACACB;GLS
prerank,regulation of macromolecule metabolic process (GO:0060255),0.32138307536184807,1.0138427958842482,0.42636579572446553,0.7950375628019072,1.0,26/170,11.20%,NOVA2;APP;CDK6;AHR;FOXP1;TRIM14;HIF1A;NFKBIZ;KDM6A;IGF2BP3;TRIM68;UBAP2;AFF1;HNRNPK;RASA1;HNRNPD;MARF1;PSEN1;IHH;YBX3;CDK2;ATXN7L3B;APLNR;SCARB2;RO60;MKLN1
prerank,proton transmembrane transport (GO:1902600),-0.34289341952356434,-1.0136959882262166,0.4247787610619469,0.8424387564211188,1.0,5/36,11.94%,ATP1A2;ATP6V0A4;SLC9A1;SLC25A27;ATP6V0D1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.4355692670263699,1.0135866598341745,0.4518900343642612,0.7950807485939219,1.0,4/21,14.04%,RAB11A;BRD4;CDC25C;NPM1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.4352335861085662,-1.0130479848983243,0.4251101321585903,0.8429825506423747,1.0,4/13,10.04%,IGF1;RAMP1;SOAT1;SLC2A10
prerank,intracellular protein transport (GO:0006886),0.3110767151166708,1.0128913252631606,0.4273224043715847,0.7960641558547616,1.0,80/304,19.28%,TBC1D8;RASSF9;STX3;TBC1D30;SMURF1;TBC1D4;ARHGEF2;STAT3;IPO11;SGSM1;TBC1D22A;TBC1D15;STX6;HERC2;STX7;PPP1R10;TBC1D12;ARL4A;TGFB1;AP2A1;TBC1D2;STX1A;TMED7;XPO1;TMED5;RAB38;AKT2;ARL5A;VPS28;AP3B1;IPO8;MYO1C;HOMER3;ACD;NUP214;TBC1D5;PICK1;STX8;RAB43;PRICKLE1;WDR11;STXBP3;PREB;EVI5;TBC1D8B;NUP133;RAB31;RAB5A;RAB7A;RABGAP1L;RAB5B;NPM1;SNX13;RAB18;STX11;GIPC1;TNPO3;RAB32;NUP153;AP1S3;RAB6A;STX12;RIC1;RAB3GAP2;CHP1;RPL11;TLK1;DESI1;SNX1;RAB1A;TRAK2;SIL1;CDC37;STAM;COG7;GGA3;VPS26B;PTTG1IP;ARL5B;MYO6
prerank,embryonic appendage morphogenesis (GO:0035113),-0.43198886100418843,-1.0128648176903507,0.4604651162790698,0.8422396906879258,1.0,5/12,20.56%,CYP26B1;LRP6;TGFB2;SKI;PTCH1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.3367178331173953,-1.0125975097421231,0.4114285714285714,0.8416984825244491,1.0,14/33,20.67%,APPL2;PKD1;MN1;STXBP4;TAF1;GLI1;PAF1;PLK5;CDKN1A;TCIM;E2F1;DDRGK1;PTEN;ID2
prerank,Ras protein signal transduction (GO:0007265),0.3337893811922913,1.0121008215796863,0.4434673366834171,0.7973089143327802,1.0,33/137,12.84%,NTN1;PRKD1;EPS8;ARHGEF3;ELMO1;CELSR1;GNB1;RREB1;GRAP;RAP1B;RASGRP3;ADGRG1;PLEKHG5;RALB;NCKAP1;PLK2;RAPGEF2;KRAS;NRAS;RAC1;CDC42EP3;RAP1A;GNA12;SHOC2;CDK2;G3BP1;MAPK11;RGL2;RB1;CYFIP1;RHOB;GNA13;DBNL
prerank,positive regulation of transport (GO:0051050),0.34477589535853637,1.0116421824048054,0.43535620052770446,0.7977954131534927,1.0,9/85,6.60%,RAB27A;IL15;HIP1R;GATA2;NEDD4L;DLL1;BOK;CBLL1;INPP5K
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.327303520921254,1.011528112810113,0.4534313725490196,0.7974970894055879,1.0,17/159,5.12%,MPZ;PECAM1;CADM1;VCAM1;ICAM1;CLDN5;PTPRM;NECTIN2;PVR;SELE;BSG;PCDHB4;SELP;ROBO4;AMIGO2;CDH2;CEACAM1
prerank,negative regulation of cell differentiation (GO:0045596),0.32410782582056336,1.0112858808128695,0.456242707117853,0.7974932153015319,1.0,36/181,12.83%,FOXO1;CAV1;TBX1;ZBTB16;CDK6;GATA2;DAB2IP;LRP5;EFNA1;PTK2B;HDAC7;NOTCH1;NFKBIA;WWTR1;FGF23;SOX9;DLL1;SMAD7;GREM1;WNT5A;TRIB3;TGFB1;CITED1;ZFPM1;USH2A;MAD2L2;SFRP2;SEMA4D;RB1;SINHCAF;ITGB3;ASXL1;TRIO;XDH;ADIPOR1;EIF2AK4
prerank,regulation of MAP kinase activity (GO:0043405),0.3435864884615626,1.0109883022638169,0.442838370565046,0.7975826004274382,1.0,15/92,7.41%,FLT1;PDGFB;DAB2IP;EDN1;LYN;PDGFD;PTPRJ;TPD52L1;PIK3R6;CD40;INPP5K;TRIB3;PDGFC;TGFB1;PIK3CG
prerank,negative regulation of cellular component organization (GO:0051129),-0.30125465761400727,-1.0109425669279877,0.4216417910447761,0.8450846691945508,1.0,20/74,16.87%,BMP6;EPHA3;TMEFF2;AR;FAP;IMPACT;CARMIL1;SYT11;PRKCZ;RTEL1;SRC;VEGFA;SCAMP5;LRSAM1;RUBCN;TRAF3IP1;XRCC5;LCMT1;ABCA7;NR1H4
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4800917296838789,1.0108998761415133,0.47619047619047616,0.7972377208791633,1.0,3/11,10.79%,JAK3;SMAD7;RC3H1
prerank,peptide cross-linking (GO:0018149),-0.37017013006488897,-1.0106055721127265,0.44686648501362397,0.8447437183082848,1.0,4/25,5.16%,COL3A1;THBS1;NDNF;ANXA1
prerank,early endosome to late endosome transport (GO:0045022),0.43588846617031063,1.0105763977688864,0.45614035087719296,0.7974417157980515,1.0,7/20,13.71%,LMTK2;EEA1;STX8;RILP;KIF16B;RAB5A;RAB7A
prerank,chloride transport (GO:0006821),-0.2983012477976841,-1.0101764812846696,0.44404332129963897,0.8446132494659255,1.0,18/74,15.13%,SLC4A10;SLC1A3;SLC26A7;SLC12A2;SLC6A1;GLRB;ANO1;CLCN2;GABRG2;ANO4;GABRA2;GABRB1;ANO3;GABRB3;GABRG3;SLC26A6;FXYD1;SLC1A1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3752142213087727,1.0101569586761314,0.4699140401146132,0.7978337554639706,1.0,15/53,14.86%,ECSCR;DAB2IP;FBXW7;FOXF2;UCHL5;OPHN1;KCNE2;XPO1;GNA12;RAD23A;HSP90AB1;FMR1;NUDT15;PSME1;PRKCG
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.40044875584204487,1.0096419175127744,0.4599358974358974,0.7984444420103728,1.0,4/33,5.18%,TAL1;STAT3;HIF1A;ACVR2A
prerank,glycolipid biosynthetic process (GO:0009247),-0.32838440433783445,-1.009196544703339,0.425531914893617,0.8461945679255806,1.0,13/38,21.02%,LARGE1;ST6GALNAC5;PIGN;GBGT1;ST3GAL5;B4GALT6;PIGA;ST8SIA1;PIGH;PGAP3;SCCPDH;PIGW;ST3GAL4
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.42654508312623385,-1.0089454363768122,0.4457274826789838,0.8456310114863473,1.0,3/13,8.00%,ENPP1;TPST1;ABHD14B
prerank,calcium-mediated signaling (GO:0019722),0.3483466469549137,1.0088743011165475,0.4604591836734694,0.7996354374257697,1.0,13/93,5.98%,MCTP1;KDR;VCAM1;PLCG1;EDN1;PPP3CA;PTPRJ;SELE;PLCG2;SELP;PPP1R9B;CX3CR1;PPP3CB
prerank,regulation of phospholipase C activity (GO:1900274),0.46372290030113605,1.0088587139338845,0.46332737030411447,0.7991119735846428,1.0,3/15,1.87%,FLT1;ESR1;PLCG1
prerank,cellular response to type I interferon (GO:0071357),0.3903769248513013,1.0081376422497488,0.46543778801843316,0.7996539959758232,1.0,12/41,19.12%,IRF2;SAMHD1;ISG20;IFNAR1;IFNAR2;JAK1;ADAR;OASL;IFITM3;STAT1;BST2;IFITM1
prerank,type I interferon signaling pathway (GO:0060337),0.3903769248513013,1.0081376422497488,0.46543778801843316,0.7996539959758232,1.0,12/41,19.12%,IRF2;SAMHD1;ISG20;IFNAR1;IFNAR2;JAK1;ADAR;OASL;IFITM3;STAT1;BST2;IFITM1
prerank,response to ketone (GO:1901654),0.42833363671829866,1.0078450133744004,0.45741324921135645,0.7997266012410712,1.0,5/24,11.53%,CAV1;ABHD2;TGFB1;CATSPERD;UBE3A
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.4461315363510339,1.0076791512953274,0.44655172413793104,0.7995367299332018,1.0,7/16,18.10%,SMCHD1;DTX3L;SHLD1;WRAP53;MAD2L2;KMT5B;PARP9
prerank,BMP signaling pathway (GO:0030509),0.3676250864865969,1.0073718751406617,0.44992947813822287,0.7996908376784351,1.0,10/62,7.33%,BMPR2;ENG;ACVRL1;SMAD1;SMURF1;SMAD7;ACVR2A;USP15;ACVR1;TGFB1
prerank,cellular response to organic cyclic compound (GO:0071407),0.32805396141814225,1.0072835841907868,0.46691635455680397,0.7993478665715978,1.0,21/141,8.09%,TGM2;ESR1;MEF2C;AHR;PDGFB;PDE2A;KCNQ1;NR3C1;MSN;GNB1;RAP1B;CTNNA1;ATP1A3;ATP1A1;RAPGEF2;INPP5K;NCOA4;TGFB1;RAP1A;CASP7;PKD2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.38476117919958625,1.0067405529726066,0.4495548961424332,0.8000952192856517,1.0,6/42,9.61%,IL6R;SELP;RPS19;DROSHA;DEFA6;IL23A
prerank,regulation of NMDA receptor activity (GO:2000310),0.40610506736911645,1.006445552411515,0.4647887323943662,0.800159202990603,1.0,4/32,2.59%,APP;MEF2C;DAPK1;PTK2B
prerank,protein transport (GO:0015031),0.30565611043903834,1.0064160681592533,0.4603854389721627,0.7996679466851614,1.0,87/332,20.13%,TBC1D8;CALCRL;STX3;SPTBN1;TBC1D30;TBC1D4;MYH9;ARHGEF2;SGSM1;TBC1D22A;TBC1D15;LMTK2;STX6;HERC2;STX7;SCAMP1;SLC10A7;RAMP2;VAMP4;CHMP2B;TBC1D12;ARL4A;ARRDC1;AP2A1;TBC1D2;GCC2;ATP6V0A1;STX1A;TMED7;TMED5;RAB38;ARL5A;NEURL1B;ATP6V1G2;AFM;RAB12;AP3B1;ACD;TBC1D5;PICK1;STX8;RAB26;RAB43;RAB11B;RILP;WDR11;STXBP3;PREB;EVI5;TBC1D8B;RAB31;RAB5A;RAB7A;RABGAP1L;ABCG1;TXNIP;RAB5B;NPM1;SNX13;RAB18;STX11;RAB32;RAB6A;CEP290;STX12;COPG2;RIC1;RAB3GAP2;RAB8B;TLK1;ARL6IP5;SNX4;SNX1;RAB1A;SIL1;COG7;GGA3;VPS26B;ARL5B;MYO6;ABCA1;ATP6V1F;PPY;PDCD6;MIA2;VPS35;TVP23B
prerank,negative regulation of catabolic process (GO:0009895),-0.3155348805581053,-1.0063286218228886,0.4440894568690096,0.8515303224149426,1.0,9/47,11.32%,EGFR;NUPR1;HDAC4;PPARA;SIRT2;MDM4;ADRA2A;ALK;CST3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.41662633939981847,-1.0060831615472996,0.4370860927152318,0.8509182811257693,1.0,2/13,8.79%,GLI3;RUNX1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.43716228277122,-1.0058188538918027,0.4523809523809524,0.8503991062002548,1.0,3/12,8.88%,BMP7;CD44;GCNT2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.3992261443724425,1.0057373460020347,0.45896656534954405,0.8005920976815911,1.0,6/33,8.10%,ESR1;PKN1;TRIM68;H3-3A;KCTD6;KDM4C
prerank,negative regulation of protein binding (GO:0032091),0.360122514349581,1.0054948141931725,0.45285714285714285,0.8005517482084429,1.0,11/71,9.03%,CAV1;B2M;PDGFB;TMBIM6;RALB;DISC1;MAPK8;AURKA;ADAM15;CTNNBIP1;ZFPM1
prerank,regulation of T cell activation (GO:0050863),0.38569995466001245,1.005136092710957,0.4511627906976744,0.800817686944888,1.0,6/42,10.01%,TNFRSF1B;JAK3;TNFSF8;TIGIT;LCK;CYRIB
prerank,ear morphogenesis (GO:0042471),-0.3809950329299521,-1.005026574574619,0.4679144385026738,0.851282980954736,1.0,4/20,5.77%,ZIC1;FGFR2;OSR1;SIX1
prerank,actin nucleation (GO:0045010),0.4333340916271625,1.004740074943906,0.45854483925549916,0.8011950015495647,1.0,7/21,17.86%,JMY;ARPC3;ARPC1B;ACTR2;ACTR3;ARPC2;WHAMM
prerank,regulation of exocytosis (GO:0017157),0.38117713246960605,1.0045566305282598,0.4696969696969697,0.8010725747847199,1.0,10/46,17.27%,RAB27A;CADPS2;EXPH5;RAB12;RAB26;RAB5A;STXBP6;RAB8B;SYTL4;CPLX2
prerank,regulation of amyloid fibril formation (GO:1905906),0.4596150068330486,1.004443353559687,0.4539130434782609,0.8007687104218986,1.0,7/15,23.47%,APP;PSEN1;PFDN1;PFDN5;PFDN2;IAPP;CLU
prerank,regulation of blood coagulation (GO:0030193),0.41799762301569265,1.0042805558053316,0.4611801242236025,0.8005840677649706,1.0,4/27,4.57%,CAV1;EDN1;CD34;ENPP4
prerank,protein insertion into ER membrane (GO:0045048),0.39691671189724026,1.0038521563853433,0.4602446483180428,0.8009896336753677,1.0,7/37,14.26%,APP;STX1A;TRAM1;TRAM1L1;EMC6;EMC3;ALDH3A2
prerank,mammary gland development (GO:0030879),-0.3796121158879289,-1.0038059479345676,0.47115384615384615,0.8534864142015415,1.0,8/21,17.21%,GLI2;WNT4;ERBB4;VEGFA;TGFB3;PRLR;TBX3;ARHGAP35
prerank,extracellular matrix assembly (GO:0085029),-0.36257536180326866,-1.003751460326592,0.42118863049095606,0.8523719044831712,1.0,6/23,7.87%,TNXB;GPM6B;FBLN5;NTN4;NTNG1;EFEMP2
prerank,response to laminar fluid shear stress (GO:0034616),0.4940855149992556,1.0035430390032605,0.487758945386064,0.801163915671973,1.0,4/10,19.36%,KLF2;SMAD7;MAP2K5;ABCA1
prerank,positive regulation of cell growth (GO:0030307),0.3397710558663343,1.0033149024117487,0.47126436781609193,0.8011386681788888,1.0,21/96,14.35%,NTN1;SEMA7A;SMURF1;EDN1;NEDD4L;ADAM10;ITSN2;RPS6KA3;SDCBP;RPS6KA1;H3-3A;RPTOR;TWF2;SFRP2;SEMA4D;MAP3K13;DBNL;MTPN;ADAM17;ERBB2;S100A9
prerank,transcription by RNA polymerase II (GO:0006366),0.3048902768541466,1.0032603783840697,0.48040313549832026,0.8007093384327818,1.0,50/305,14.92%,TEAD4;HDAC9;ESR1;PPARD;NR5A2;PIR;MAML2;MLLT3;NR3C1;HDAC7;NOTCH1;RREB1;CCNK;WWTR1;GTF2I;XBP1;TEAD2;ESRRG;NR1I3;GTF2F2;KLF13;GTF2E2;GMEB2;NFKB1;WDR33;TRIP13;NELFE;TAF3;TRIM24;TAF4B;MED27;COPS2;RNGTT;EAF1;POU2F1;INTS11;CBFB;CEBPD;SNAPC3;RPRD1B;RNMT;GTF2A2;BTF3;INTS12;ESRRB;RPRD2;NRBP1;KAT2B;ELOC;SNW1
prerank,defense response to fungus (GO:0050832),0.455032556399548,1.0030439106452707,0.4588045234248788,0.8006677337200576,1.0,5/17,19.53%,PLCG2;CX3CR1;S100A9;CARD9;BCL10
prerank,mononuclear cell differentiation (GO:1903131),0.4267848095126464,1.002998042837759,0.45792880258899676,0.8002364169933991,1.0,3/24,2.31%,PIR;MYH9;LYN
prerank,protein homotrimerization (GO:0070207),-0.4185988952332498,-1.0028708880243522,0.45474613686534215,0.852262135897056,1.0,4/14,12.21%,SLC1A5;SCARA5;SLC1A2;CLYBL
prerank,protein trimerization (GO:0070206),-0.4185988952332498,-1.0028708880243522,0.45474613686534215,0.852262135897056,1.0,4/14,12.21%,SLC1A5;SCARA5;SLC1A2;CLYBL
prerank,regulation of neurogenesis (GO:0050767),0.3710091778735324,1.0022851883083195,0.4521857923497268,0.8013419382347475,1.0,6/55,5.39%,TGM2;B2M;NOTCH1;NUMB;DLL1;CX3CR1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3441381077612921,1.0018218583021459,0.44761904761904764,0.8018465046707773,1.0,21/87,18.42%,DCUN1D3;CDK6;AURKA;JADE1;AVEN;PSMA2;FBXL7;PKD2;PINX1;PSMA8;PSMA6;RB1;CUL1;APC;PSME1;E2F7;ZFP36L1;CDC73;PSMA4;RBL1;PSMF1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3808344792822351,1.0013379508025582,0.4549483013293944,0.8024170154190094,1.0,10/41,10.82%,PDGFB;NEDD9;EFNA1;FBXW7;FYN;TGFA;PTPN1;FCGR1A;GAS6;EPHA4
prerank,positive regulation of kinase activity (GO:0033674),0.3356458436173913,1.0013194302589634,0.44625,0.8019075083222269,1.0,15/107,7.53%,TEK;FLT1;KDR;TIE1;EPHB4;INSR;IQGAP1;PTK2B;FLT4;LMTK2;RET;RAPGEF2;TIGAR;PTK2;RAP1A
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3692092832044877,1.0012972432241738,0.4837799717912553,0.8014138911317158,1.0,10/59,5.12%,PECAM1;CADM1;PTPRM;NECTIN2;PVR;BSG;ROBO4;AMIGO2;CDH2;CEACAM1
prerank,retina homeostasis (GO:0001895),0.4304553977091685,1.0012717944420515,0.4680511182108626,0.8009317940988044,1.0,2/23,3.14%,B2M;CNGB1
prerank,RNA transport (GO:0050658),-0.2941256485207182,-1.0011654618448749,0.4492753623188406,0.8557492587997761,1.0,13/71,11.21%,RBFOX1;SRSF5;SIDT1;HNRNPA2B1;DDX39B;SIDT2;KIF5C;SRSF2;ATXN2;SRSF11;U2AF2;RAE1;POM121
prerank,proteoglycan biosynthetic process (GO:0030166),0.41039907616697546,1.0011550289306943,0.44155844155844154,0.800649724968848,1.0,3/31,5.12%,CSGALNACT1;BMPR2;EXTL3
prerank,actin filament network formation (GO:0051639),0.48694464465883036,1.0010990704902731,0.47644927536231885,0.8002316132989449,1.0,3/11,4.52%,LCP1;ACTN1;PLS3
prerank,endocytic recycling (GO:0032456),0.37094652496591707,1.0008989286325471,0.4670406732117812,0.8001336338556199,1.0,9/50,13.71%,EHD4;DENND1B;LMTK2;STX6;SNX3;EHD2;EHD3;RAB11B;RAB7A
prerank,response to tumor necrosis factor (GO:0034612),0.34469017835651666,1.0008370707180705,0.46649484536082475,0.799718610372918,1.0,20/91,14.08%,GCH1;DAB2IP;ARHGEF2;ADAM10;TNFRSF11A;MAP4K3;SELE;CASP8;IKBKB;DCSTAMP;CD40;INPP5K;YBX3;CCL14;RIPK1;RELA;ZFP36;HAS2;GBP3;ASAH1
prerank,fatty acid oxidation (GO:0019395),0.37368878698204544,1.0007501025699224,0.46732954545454547,0.7993653857821456,1.0,9/57,14.26%,ADIPOR2;PPARD;HADHA;ECI1;ABCD4;ABCD1;ADIPOR1;HADH;ALDH3A2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4055810301814303,-1.000692901215415,0.4634703196347032,0.8558468690527107,1.0,5/17,9.53%,EGFR;PKD1;CCND2;SPDYA;RGCC
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.42495703545590213,1.0006893145957376,0.45874587458745875,0.7989399367930285,1.0,6/25,15.20%,B2M;PLCG2;WNT5A;MALT1;TRAF6;SLC7A5
prerank,negative regulation of signaling (GO:0023057),0.41794413931179203,1.0006020234964055,0.4812286689419795,0.7985906041595595,1.0,5/25,9.42%,KIF26A;SRMS;FGF23;ACVR1;PTPN1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.44368954698176305,1.0003164000759024,0.4693200663349917,0.7987198111126467,1.0,6/20,11.71%,ABI3;PPP2R5A;NUMB;TGFB1;BCL2L1;PICALM
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.39715583359168716,-1.0002513910382314,0.48498845265588914,0.8558367749702176,1.0,5/18,11.08%,PPARA;WNK1;PAG1;PTPN22;MIA3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.35671247720663635,-1.0002000578783248,0.49238578680203043,0.8547165950872476,1.0,3/27,2.95%,EGFR;DDX5;BMP4
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5131869630645698,1.0000816753210795,0.4740740740740741,0.7986922304035584,1.0,3/10,2.97%,NEXMIF;NOTCH1;PPM1F
prerank,histone H3 deacetylation (GO:0070932),0.4673910691273957,0.9999982069360742,0.48186528497409326,0.7983380377147573,1.0,2/15,4.62%,HDAC9;ELK4
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.38829425410466445,-0.9997348213517446,0.4271604938271605,0.8548313598691079,1.0,5/19,8.00%,ENPP1;SLC26A2;TPST1;PAPSS2;ABHD14B
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.42282061574032004,0.9995532349260388,0.4546979865771812,0.7988208417776452,1.0,8/20,21.33%,DROSHA;DICER1;PUM1;PUM2;HENMT1;TRIM71;MRPL44;PRKRA
prerank,positive regulation of lyase activity (GO:0051349),0.46852409413685037,0.999336152066912,0.4642857142857143,0.7987796268776041,1.0,2/14,3.49%,NOS3;ORAI1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.3926254524300181,-0.9988498742029386,0.47465437788018433,0.8560486273102003,1.0,7/18,12.93%,UNC13C;GRIA2;GRIK4;GRIK2;GRIK5;GRID2;GRIK1
prerank,microtubule anchoring (GO:0034453),-0.4372842863917741,-0.9987503697363749,0.4751131221719457,0.8550865745502342,1.0,4/12,13.82%,BICD1;DAG1;PCM1;BICD2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.45672501875918525,0.9982373256299208,0.46055045871559636,0.8006363336193587,1.0,5/13,13.14%,TNRC6C;BTG2;CNOT1;ZFP36;CNOT7
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.40081964013095794,0.9982025645061674,0.46411483253588515,0.8001593534565853,1.0,11/32,20.99%,CAVIN1;TAF1B;POLR1A;RRN3;POLR1G;POLR1B;GTF2H4;TAF1A;GTF2H1;POLR2L;CCNH
prerank,T cell migration (GO:0072678),0.47011466546708036,0.9982000977330692,0.4743362831858407,0.7996272145010607,1.0,3/13,7.41%,S1PR1;MSN;PIK3CG
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.3122188326830695,-0.9981393681181339,0.45161290322580644,0.8556068130407046,1.0,11/48,10.41%,ADCY5;AMPD3;ADCY1;ADCY2;SLC26A2;ADCY7;ADCY6;PAPSS2;GUCY1A1;DCAKD;ACAT1
prerank,antibacterial humoral response (GO:0019731),0.46205070307422547,0.9979100212855258,0.47755834829443444,0.7997092568175806,1.0,3/16,9.16%,RPL39;ANG;DEFA6
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.4033339685653222,0.9978830472930714,0.45799011532125206,0.7992260168751463,1.0,14/31,26.28%,CNOT6;EDC3;EXOSC1;DCP2;LSM3;HBS1L;CNOT7;LSM7;LSM1;DCP1B;LSM2;DDX6;DIS3;EXOSC4
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.34878237831678677,-0.9977718373606518,0.4189189189189189,0.8554001852591436,1.0,7/30,7.58%,FSTL1;TGFBR3;DKK3;TWSG1;SMAD3;SFRP4;BCL9
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.37411173217513677,0.9975996302520292,0.46131386861313867,0.7993125040507101,1.0,13/49,17.66%,MEF2C;KMT2E;H3-3A;TNRC6C;ZFPM1;EIF6;RBM15;CBFB;RAB7B;ASH2L;KAT2B;ITGA2B;CIB1
prerank,urogenital system development (GO:0001655),-0.43594066844007806,-0.9975051592299027,0.4762979683972912,0.8548499613750461,1.0,6/11,24.91%,OSR1;ANXA1;PAX8;EPHB3;EPHB2;LHX1
prerank,phosphate ion homeostasis (GO:0055062),-0.455363865237289,-0.9974483877599245,0.47072072072072074,0.8537413421710451,1.0,3/10,10.72%,ENPP1;SFRP4;FGFR4
prerank,negative regulation of transferase activity (GO:0051348),0.41490237897720245,0.997001087561378,0.4797507788161994,0.8001380949071624,1.0,8/28,12.93%,DTX3L;SMAD7;INPP5K;CDKN1B;PINX1;NPRL2;ZFP36;ERCC4
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4078521668614132,0.9968017993103934,0.4696485623003195,0.8000363151518189,1.0,3/31,6.76%,DCUN1D3;FBXW7;TRIB3
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4642520639415153,0.9967278861894002,0.4559322033898305,0.7996667475093252,1.0,3/16,6.76%,SOX9;CEACAM1;TRIB3
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3102679018728457,-0.9965378553198908,0.47604790419161674,0.854990629511847,1.0,12/48,10.52%,DOCK5;NRP1;OBSL1;CARMIL1;CUX2;CAPRIN2;PTPRD;IL1RAPL1;CUX1;P4HB;FBXW8;S100A10
prerank,vasoconstriction (GO:0042310),0.491315171037245,0.996469030695501,0.492619926199262,0.7996864787566715,1.0,2/11,3.43%,EDN1;PIK3C2A
prerank,regulation of cellular metabolic process (GO:0031323),-0.3227005387692694,-0.996367293506929,0.47575757575757577,0.8541933281538888,1.0,6/45,6.99%,PID1;PRKN;PPARA;TBC1D16;CYP1B1;ACACA
prerank,regulation of hormone secretion (GO:0046883),0.4616060345416726,0.99619124250782,0.47715736040609136,0.7997004904986419,1.0,2/15,4.06%,EDN1;FGF23
prerank,regulation of glycolytic process (GO:0006110),0.35509335214248583,0.9961592575954956,0.4642857142857143,0.7992408742674828,1.0,17/68,14.81%,APP;CBFA2T3;INSR;HIF1A;PFKFB3;FBP1;TIGAR;PSEN1;EIF6;NUP214;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3812014355350448,0.9958337390383704,0.4954682779456193,0.7994591228528797,1.0,10/42,17.58%,GARS1;FARS2;IARS1;TARS3;LARS1;WARS1;RARS1;AIMP1;KARS1;WARS2
prerank,regulation of neuron death (GO:1901214),0.34600700201604484,0.9957191157291976,0.46612466124661245,0.7991820916351365,1.0,12/82,9.87%,MEF2C;CD200;DDIT4;TNFRSF1B;FYN;CD34;WNT5A;CHMP4A;CHMP4B;IKBKG;CSF1;BTBD10
prerank,negative regulation of hemostasis (GO:1900047),-0.43079385158546435,-0.9956633460863102,0.4742990654205608,0.8548371662852717,1.0,5/12,10.33%,VTN;TFPI;SERPINE2;APOE;SERPINE1
prerank,protein secretion (GO:0009306),-0.30710351426911603,-0.995426459892744,0.4517241379310345,0.8542099549731568,1.0,9/56,11.37%,WLS;PCSK5;ANXA1;TANGO2;RCN3;COPG1;STEAP3;MIA3;RAB10
prerank,renal water homeostasis (GO:0003091),-0.3730624316925676,-0.995146745150078,0.4669926650366748,0.8537307933354646,1.0,9/23,14.56%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.4258857599723347,-0.9951065140684999,0.47123893805309736,0.8526057945684199,1.0,3/12,6.04%,EML2;MAP2;CLIP3
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.3414678630310585,-0.995089076089278,0.46380697050938335,0.8514249354716549,1.0,12/33,12.93%,NLGN2;LRRC4C;NGF;NLGN1;NRG3;GRIK4;NLGN3;IQSEC2;GRIK2;GRIK5;GRID2;GRIK1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.44108615165565923,0.994832369668827,0.4755700325732899,0.8005959084893457,1.0,5/21,10.01%,CD2AP;DAB2IP;FBP1;SYNGAP1;CYRIB
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3524473799648158,0.9947357427766262,0.48753462603878117,0.8002801875678516,1.0,28/70,25.41%,B2M;IKBKB;MFSD6;TAP2;PSMA2;IKBKG;SNAP23;PSMA8;FCGR1A;PSMA6;VAMP8;PSME1;PSMA4;PSMF1;SEC22B;PSMB7;PSMB1;PSMD2;LNPEP;PSMA5;PSMC3;TAP1;CYBA;FCER1G;PSMD3;PSMA3;VAMP3;TAPBP
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.37726704780606524,-0.9945039477296196,0.46733668341708545,0.8518149651172581,1.0,4/21,4.18%,PRKN;SLC30A10;PPARA;SIRT2
prerank,chromatin remodeling at centromere (GO:0031055),-0.34619192508869584,-0.994399365734091,0.4623955431754875,0.8509097791298111,1.0,14/31,26.49%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;CENPH;HELLS;KNL1;CENPX;CENPQ;CENPA
prerank,male gonad development (GO:0008584),0.39265995517089936,0.99401922876869,0.46048632218844987,0.8013022687696529,1.0,8/34,13.32%,KITLG;BIK;SOX9;WNT5A;NCOA4;MAMLD1;ADAM21;SRD5A2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.43163696678850505,-0.9935826204223239,0.49567099567099565,0.8519350790352928,1.0,6/12,20.95%,ROCK2;APOE;FLOT2;ABCA7;CHRNA7;ABCA2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.40823934674301326,0.9935430895725481,0.4608,0.8018257800375583,1.0,5/28,9.68%,ERN1;DAB2IP;CASP4;TRIB3;ERO1A
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4043190719457825,0.993282671056385,0.45588235294117646,0.801809967570841,1.0,7/29,12.74%,CASP8;IKBKB;CD40;IKBKG;UBE2D3;RIPK1;BIRC3
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.38610698027002294,-0.9932009674760555,0.4608294930875576,0.8517819917082743,1.0,14/19,46.13%,APOE;CHRNA7;CHRFAM7A;SLC5A7;CHRNB2;ACHE;COLQ;RAPSN;CHRNA5;CHRNA3;RIC3;CHRNE;CHRNB4;CHRNB3
prerank,negative regulation of cell aging (GO:0090344),0.45041175034348396,0.9926220668009967,0.47554806070826305,0.8027377199031427,1.0,5/16,18.00%,CDK6;MAP3K3;AKT3;YBX1;RBL1
prerank,receptor signaling pathway via STAT (GO:0097696),0.4175648630259898,0.9925981513068647,0.47019867549668876,0.8022435000025461,1.0,10/25,17.69%,SOCS2;STAT3;GHR;IFNAR1;IFNAR2;PKD2;NMI;SOCS6;STAT6;STAT1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.40646145096442404,0.9923489773932994,0.4724025974025974,0.8022387408747684,1.0,4/29,11.80%,JAM2;ANO6;GAS6;LGMN
prerank,pentose-phosphate shunt (GO:0006098),-0.44822258025052886,-0.9919671590272295,0.48423423423423423,0.8539129483213458,1.0,3/11,9.97%,H6PD;PGD;TKT
prerank,cellular glucan metabolic process (GO:0006073),-0.4448768522520532,-0.9915012701013174,0.486784140969163,0.8539567184166046,1.0,5/11,12.04%,PHKB;PYGM;PRKAG2;PPP1R3C;UGP2
prerank,bone morphogenesis (GO:0060349),0.4700199620530501,0.9913413133346526,0.4873524451939292,0.8038878692422791,1.0,2/14,2.28%,BMPR2;LRP5
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.29775569804256646,-0.9912664723713538,0.4808362369337979,0.853406062115625,1.0,25/56,27.27%,SON;ROCK2;SPIRE1;SNX18;ANK3;CIT;ARL3;JTB;RTKN;DCTN3;VPS4A;STAMBP;RAB35;NUSAP1;EFHC1;CKAP2;CUL7;ALKBH4;RHOC;SEPTIN9;SNX33;IST1;CENPA;CEP55;SPAST
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.42006892250731787,-0.9912334931384619,0.49665924276169265,0.8522596312128955,1.0,3/12,4.15%,IRS1;PPARA;PPARGC1A
prerank,negative regulation of cellular protein localization (GO:1903828),0.39466241863133156,0.990978998546408,0.47086614173228347,0.8041133892658494,1.0,6/34,8.40%,ANKRD13A;NEDD4L;MFHAS1;CTNNA1;DNAJA1;CDT1
prerank,glycolytic process (GO:0006096),-0.35240417172395444,-0.9908853539866427,0.45885286783042395,0.8520695676543117,1.0,15/28,38.84%,ENO2;HK2;TPI1;ENO3;PFKFB1;PFKM;ALDOA;PKM;ENO1;ALDOC;HKDC1;GAPDH;ALDOB;ENO4;HK3
prerank,macrophage differentiation (GO:0030225),0.46874303797561157,0.9906603452758622,0.48872180451127817,0.8042751630702121,1.0,3/13,9.46%,IL15;CASP8;CSF1
prerank,regulation of catecholamine secretion (GO:0050433),-0.34901600693143314,-0.9906296870222632,0.4702702702702703,0.8515692737301745,1.0,8/29,17.04%,PRKN;SYT1;SYT9;SYT12;SYT11;DTNBP1;SNCA;SYT3
prerank,neuromuscular process (GO:0050905),0.4430134557574432,0.9902987225906762,0.484375,0.8045430947210557,1.0,2/16,5.89%,GCH1;MYCBP2
prerank,protein-DNA complex assembly (GO:0065004),0.3303583493867757,0.9902937131528425,0.4806201550387597,0.8040165624457903,1.0,40/116,26.60%,SOX9;PADI4;H3-3A;TCF4;RPA1;PSMA2;CDT1;KAT6B;SMARCA5;NAP1L4;PSMA8;PSMA6;GRWD1;NPM1;PSME1;ORC5;ATRX;ORC3;GTF2H4;ANP32B;PSMA4;PSMF1;CETN2;CHD1L;GTF2H1;PSMB7;PSMB1;SART3;CCNH;PSMD2;PSMA5;PSMC3;CUL4B;PSMD3;PSMA3;GTF2H5;ORC6;GMNN;MCM6;RPA3
prerank,negative regulation of coagulation (GO:0050819),-0.4187909659362897,-0.9902204248376015,0.4855769230769231,0.8514673666428703,1.0,6/14,10.34%,VTN;TFPI;SERPINE2;APOE;SERPINE1;HS3ST5
prerank,DNA methylation (GO:0006306),0.4221825005645211,0.9896771699616054,0.49331103678929766,0.8048253189712948,1.0,10/23,18.39%,ZFP57;KMT2E;ATF7IP;PPM1D;GATAD2A;PICK1;SPOCD1;ATRX;TEX15;EHMT1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.42746713510023215,0.989424792601561,0.4658703071672355,0.8048624479525007,1.0,7/20,19.92%,ACSL4;FASN;FAR2;SLC25A1;DGAT1;CBR4;PPT2
prerank,organophosphate catabolic process (GO:0046434),0.4889103178760652,0.9891855154349046,0.4991596638655462,0.8048292688441542,1.0,3/11,14.45%,ENPP2;PDXP;NUDT15
prerank,negative regulation of lipid storage (GO:0010888),0.436933975250836,0.9890284143438918,0.47474747474747475,0.8046297322167425,1.0,6/19,15.52%,PPARD;NFKBIA;ITGB3;PNPLA2;ABCG1;TTC39B
prerank,cGMP-mediated signaling (GO:0019934),-0.4142433091174207,-0.9889828225813605,0.4911504424778761,0.8535465927792377,1.0,4/13,13.73%,IRAG1;KCNC2;APOE;GUCY1B1
prerank,actin cytoskeleton reorganization (GO:0031532),0.35726773334033346,0.9888200329712488,0.4894810659186536,0.8045385154616825,1.0,13/63,9.49%,PARVB;THSD7A;NEDD9;MYH9;S1PR1;CDC42BPB;TNIK;ATP2C1;PLEK2;TRPV4;GAB1;PTPN1;RICTOR
prerank,cellular response to calcium ion (GO:0071277),0.355963645524322,0.9887572656811026,0.48783977110157367,0.8041466129979707,1.0,14/67,13.74%,MEF2C;CPNE8;IQGAP1;PLCG2;ALOX5AP;CHP2;WNT5A;ITPKB;RASA4;PKD2;SYT15;LGMN;CLIC4;MEF2A
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3521427267959582,0.9886996024543727,0.48559670781893005,0.8037391155670093,1.0,16/71,14.79%,CTSC;CASP8;ATXN3;CTSK;CTSO;MALT1;ZRANB1;RHBDD1;CHMP4B;PSMA8;PSMA6;LONP1;LGMN;OMA1;DDI1;SOCS6
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.4431855544477701,-0.988348502240817,0.5173210161662818,0.8539914428093185,1.0,4/11,21.29%,PARP3;PARP11;PARP8;TIPARP
prerank,regulation of receptor recycling (GO:0001919),-0.4001532294875097,-0.9882291943640246,0.4892601431980907,0.8531049973212604,1.0,5/16,14.83%,TBC1D16;ANXA2;OPTN;RAB29;SNCA
prerank,potassium ion import across plasma membrane (GO:1990573),-0.32166647510429164,-0.9881468471993424,0.4570552147239264,0.8521169157210599,1.0,7/41,9.89%,ATP1A2;SLC12A2;ATP1B1;ABCC9;KCNJ2;KCNJ13;ATP1B2
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.288384861109614,-0.9879715758886182,0.4709897610921502,0.8513640128690012,1.0,13/63,12.39%,TIMP3;LEPR;BCL2;TIMP2;NUPR1;SIRT2;KLHL22;DAPL1;EIF4G3;PTPN22;CST3;RGP1;RUBCN
prerank,negative regulation of transport (GO:0051051),0.3738994316120046,0.9874189515045474,0.4780058651026393,0.8059938094691895,1.0,4/51,2.97%,MCTP1;PRKD1;CTTNBP2NL;PPM1F
prerank,regulation of vasculature development (GO:1901342),0.41874626796158354,0.9873068492112573,0.494195688225539,0.8057143865392374,1.0,8/26,16.74%,ADGRA2;PLXND1;TSPAN12;EGLN1;WARS1;ERBB2;PROK2;CTNNB1
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3415077521769858,-0.9872953059773176,0.4533333333333333,0.8519773864338668,1.0,12/30,22.50%,INSIG2;HMGCS1;NSDHL;ACAT2;INSIG1;FDFT1;MVK;FDPS;LSS;DHCR24;CYP51A1;DHCR7
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.38002973862894796,-0.9870386273373946,0.472289156626506,0.8514495718518077,1.0,8/21,9.51%,DCN;BGN;CSPG4;CHST15;CHSY3;VCAN;CHSY1;CHST3
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.4463430837433526,-0.9864504078861505,0.49780701754385964,0.8517785530061446,1.0,2/10,11.16%,CD55;CD81
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.4488864037734472,0.9863752171309091,0.48833333333333334,0.8072109077689107,1.0,7/17,19.34%,LYN;TAOK2;KLHDC10;MID1;ARL6IP5;CARD9;EIF2AK2
prerank,regulation of DNA binding (GO:0051101),0.3789347285664215,0.9862876344658849,0.468975468975469,0.8068688498766456,1.0,7/44,10.60%,LEF1;NFKBIA;MAPK8;TGFB1;BCL3;CDT1;TFAP4
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.4272318186326637,0.9861100287387965,0.4790322580645161,0.8067381601355603,1.0,9/22,23.49%,CCNK;BTBD18;BRD4;CDC73;ALYREF;THOC1;THOC5;ERCC6;EAPP
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4313254712966677,-0.9858609562491156,0.4789356984478936,0.8521781050423582,1.0,5/12,16.95%,PPARA;WNK1;MIA3;FUT9;MDK
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.45220823023395484,-0.9858122178336972,0.5063829787234042,0.851104020364616,1.0,5/10,18.16%,PFKP;HK2;GFPT1;GFPT2;PFKM
prerank,establishment of mitotic spindle localization (GO:0040001),-0.3586038132724985,-0.9856710398427734,0.4945652173913043,0.8502964801680746,1.0,16/28,33.68%,GJA1;GPSM2;HTT;UBXN2B;NUSAP1;NDC80;MISP;SPDL1;CENPA;FBXW11;CLASP1;DCTN1;INSC;ZW10;ESPL1;PKHD1
prerank,cellular protein localization (GO:0034613),0.3049895183956414,0.9854622754534823,0.4994462901439646,0.8076189435182697,1.0,55/285,14.72%,TBC1D8;ESAM;STX3;OCLN;TBC1D30;SMURF1;TBC1D4;CELSR1;HHEX;ARHGEF2;REEP1;SGSM1;TBC1D22A;CPE;TBC1D15;STX6;ID1;MESD;PTPRK;HERC2;STX7;WNT5A;TBC1D12;ARL4A;AP2A1;TBC1D2;STX1A;TMED7;PIGU;TMED5;RAB38;ARL5A;AP3B1;TM9SF1;ACD;PIGK;TBC1D5;PICK1;STX8;RAB43;CEP68;WDR11;STXBP3;EVI5;TBC1D8B;RAB31;RAB5A;RABGAP1L;AMOT;RAB5B;NPM1;SNX13;RAB18;STX11;RAB32
prerank,cell projection organization (GO:0030030),0.39718223101450945,0.9845931392310738,0.47435897435897434,0.808933779920369,1.0,7/30,13.00%,PARVB;RHOJ;NCKAP1;RAC1;P2RY12;CYFIP1;CSPG5
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.4436136677147269,0.9842754125374755,0.4897260273972603,0.8090982104998354,1.0,3/18,11.99%,HIP1R;BOK;BID
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.4118783732314252,-0.9839738472358601,0.47743467933491684,0.8536789908605769,1.0,4/14,15.61%,DPYD;UPB1;NT5E;NT5C1A
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.47528315013073463,0.9839609094118318,0.4891304347826087,0.8092415272356236,1.0,5/13,16.06%,ARID1B;ARID1A;ZMIZ1;CDCA4;SERTAD2
prerank,synapse organization (GO:0050808),0.3229322538747579,0.9838990319754178,0.49125,0.8088479734592623,1.0,11/125,4.30%,SHANK3;DNM3;UNC13B;APBB2;APP;PPFIBP1;PLXND1;PPFIA2;PCDHB4;CDH2;GPHN
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.42159455045087363,0.9829000640101462,0.48792270531400966,0.8105786815501591,1.0,10/25,24.31%,CCNK;ZNF326;EAF1;ZMYND11;ALYREF;THOC1;THOC5;SETD5;ERCC6;TCEA2
prerank,mitotic sister chromatid segregation (GO:0000070),0.3353252887605774,0.9828809791435459,0.477088948787062,0.8100804898865528,1.0,22/98,18.26%,TENT4A;RAB11A;RAD21L1;MCPH1;CHMP2B;KIF22;HASPIN;RRS1;PINX1;CHMP4A;CHMP4B;NCAPH;KIF23;RB1;PDS5A;RAD21;PDS5B;CUL3;WRAP73;SMC4;CSNK2A2;CSNK2A1
prerank,somite development (GO:0061053),-0.4321291978306504,-0.9828699768758719,0.503562945368171,0.855333063811281,1.0,4/11,11.33%,MEOX2;LOXL3;SMO;MTHFD1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4661209153750335,0.9826764386700635,0.48392857142857143,0.8100039478582245,1.0,2/14,4.39%,CAV1;DLL1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.4870400670090426,0.9825001930641571,0.498015873015873,0.8098643300862742,1.0,4/10,19.31%,FBXW7;TGFA;ADAM17;BTC
prerank,cellular response to lipid (GO:0071396),0.31253436575666677,0.9824269790716625,0.49471210340775557,0.8094938636537071,1.0,33/191,10.19%,TBX1;ESR1;MEF2C;AHR;DAB2IP;FZD4;LYN;NR3C1;PTK2B;MSN;TNFRSF1B;SOX9;XBP1;CX3CR1;SBNO2;MAPK8;RET;ATP1A3;ATP1A1;WNT5A;ADAM15;WNT9B;IL36G;NCOA4;PPBP;BRINP2;NFKB1;LPL;CASP1;CREB1;DEFA6;NRIP1;TWF2
prerank,positive regulation of protein polymerization (GO:0032273),0.3542496690995295,0.9823944446936231,0.4958791208791209,0.8090295914541941,1.0,7/65,6.68%,OCLN;PTK2B;NCK1;EVL;NCKAP1;RAC1;CDC42EP3
prerank,iron-sulfur cluster assembly (GO:0016226),0.4116566217859641,0.9818001113887376,0.47906197654941374,0.8098068759600944,1.0,11/24,24.30%,ABCB7;GLRX3;MMS19;NUBP2;NUBP1;HSCB;LYRM4;NUBPL;FXN;CIAPIN1;CIAO2B
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.4410484670505081,0.9817677179371056,0.48494983277591974,0.8093416236032686,1.0,6/20,11.71%,ABI3;PPP2R5A;NUMB;TGFB1;BCL2L1;PICALM
prerank,membrane assembly (GO:0071709),-0.3398494456514212,-0.9813695243291516,0.4738292011019284,0.8582211567893763,1.0,17/34,17.69%,NLGN2;ANK3;PTPRD;IL1RAPL1;TLCD2;NRXN1;NLGN1;ANXA2;STX4;S100A10;NLGN3;FLOT2;STX2;NRXN2;UBXN2B;TLCD1;VPS4A
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.37451861128520336,-0.98074162578151,0.47743467933491684,0.8587881728574513,1.0,5/21,15.22%,HK2;H6PD;PGD;TKT;G6PC3
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.3940925304477011,-0.9806985190715723,0.49160671462829736,0.8577151221823983,1.0,4/17,12.59%,AKAP13;ADRA1B;ADRA2A;ADRA1A
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.45942520896779826,0.9805485048826472,0.47731397459165154,0.8114268856325769,1.0,4/12,17.74%,SEC63;CHMP4A;CHMP4B;SEC62
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.44724006335712624,0.980469567722343,0.49733570159857904,0.8110649076338967,1.0,6/16,9.42%,PDGFB;PDGFD;PTPRJ;PIK3C2A;PDGFC;PTPN1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.3829843756843385,-0.9804562098762611,0.4860050890585242,0.85726746996386,1.0,4/18,5.63%,IL34;PTN;DAAM2;NF1
prerank,activation of protein kinase B activity (GO:0032148),-0.34831443323269035,-0.9804084979774991,0.4715447154471545,0.8562007657685933,1.0,6/29,8.32%,IGF1;NTRK3;FGF1;IL18;OSBPL8;ADRA2A
prerank,cellular response to BMP stimulus (GO:0071773),0.3565610271669167,0.9803489879104142,0.49719101123595505,0.8107759659886858,1.0,11/66,7.33%,BMPR2;ENG;ACVRL1;SMAD1;SMURF1;SOX9;SMAD7;ACVR2A;USP15;ACVR1;TGFB1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3306729653983842,0.9802693593178987,0.5057179161372299,0.810413508333793,1.0,28/110,17.02%,DAB2IP;TAL1;FNIP2;BIK;SELP;TIRAP;RALB;ULK1;ATF7IP;SOST;SH3GLB1;BCL2L11;TGFB1;CDT1;AIDA;RB1;BID;NOP53;RACK1;PREB;WARS1;CDH5;SVIP;BMF;IRGM;PIH1D1;SPIDR;TMC8
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.4909224840939259,0.9800845873363692,0.49171270718232046,0.8102599523640274,1.0,2/10,6.60%,LYN;CD40
prerank,negative regulation of viral process (GO:0048525),0.3621137642630612,0.9800043731369039,0.48206599713055953,0.8099093426068809,1.0,16/57,19.39%,TRIM14;ISG20;N4BP1;PTX3;MID2;TNIP1;OASL;ZFP36;IFIH1;IFITM3;STAT1;PLSCR1;BST2;IFITM1;EIF2AK2;TRIM62
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.399486090948824,0.9798765299504825,0.49417637271214643,0.8096625794282217,1.0,9/31,18.00%,DCUN1D3;CDK6;JADE1;PKD2;RB1;APC;E2F7;CDC73;RBL1
prerank,mitotic spindle assembly (GO:0090307),0.37107822099307647,0.979770092662237,0.4938837920489297,0.8093527693977267,1.0,17/42,21.61%,RAB11A;AURKC;STAG2;KIF23;STAG1;LSM14A;CHEK2;RHOA;ABRAXAS2;WRAP73;MZT1;BCCIP;PIBF1;KIF4A;RACGAP1;KPNB1;KIF2A
prerank,development of primary male sexual characteristics (GO:0046546),0.3908102342361419,0.9796311482008833,0.4821150855365474,0.8091411100646262,1.0,8/34,13.32%,KITLG;BIK;SOX9;WNT5A;NCOA4;MAMLD1;ADAM21;SRD5A2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.32449612968623665,-0.9796285602291634,0.4714285714285714,0.8570658249771635,1.0,11/35,18.34%,MAGI2;PDGFRB;ITGA1;PPP4R4;PPP6R2;CRY2;HTT;PTPA;BOD1L1;TSC1;CSNK2B
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.43999385828194926,0.9787512815529829,0.49012567324955114,0.8104940129923157,1.0,4/17,6.60%,PARD3;DDIT4;SMAD7;INPP5K
prerank,regulation of insulin secretion (GO:0050796),0.33538526078949443,0.9786221265049668,0.4831038798498123,0.8102179520512353,1.0,13/101,8.26%,MYRIP;SLC2A1;ACSL4;LRP5;CACNA1E;KCNB1;TCF7L2;CACNA1A;PPP3CB;RAP1A;STX1A;ITPR3;NEUROD1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3708604078591011,-0.9784510765857817,0.46153846153846156,0.8589732842763532,1.0,8/20,22.61%,SLC8A3;MCU;MICU1;YME1L1;SLC25A23;SLC8B1;MAIP1;SMDT1
prerank,regulation of myoblast differentiation (GO:0045661),0.39538760446988674,0.9784491057321472,0.5007751937984496,0.810070720839156,1.0,6/32,7.33%,MEF2C;NOTCH1;PLCB1;SOX9;DLL1;TGFB1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.3712210583666589,-0.9783189934349104,0.4806201550387597,0.8580994854208277,1.0,13/23,33.68%,GJA1;GPSM2;HTT;UBXN2B;NDC80;MISP;SPDL1;CENPA;FBXW11;DCTN1;INSC;ZW10;PKHD1
prerank,histone H3-K36 demethylation (GO:0070544),-0.4384622297530647,-0.978149315587394,0.4957081545064378,0.8573534774148667,1.0,3/10,12.49%,KDM7A;KDM2A;KDM8
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3387013276513591,-0.978129253901208,0.4864864864864865,0.8562251369813114,1.0,9/29,12.19%,NOTCH2;IGF1;RASGRF1;ITGAV;NGF;SHC1;SRC;IRS2;MMD2
prerank,regulation of endocytosis (GO:0030100),0.3554381155325541,0.9778765285887707,0.4948905109489051,0.8108072781317314,1.0,8/61,6.19%,MCTP1;PRKD1;HIP1;HIP1R;NEDD4L;DLL1;OPHN1;CBLL1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3117746029218481,0.977759270409241,0.516245487364621,0.810532924857784,1.0,30/172,13.57%,INPP5D;PLA2G4A;PIP5K1B;DGKZ;PITPNM2;MTM1;LPCAT3;PIK3C2A;PLCG2;PIK3R6;DGKH;CEPT1;LPIN3;MTMR6;PLA2G2D;INPP5K;CDS2;BMX;PIK3CG;AGPAT1;SYNJ1;PLEKHA8;OCRL;INPP5F;DGKE;MTMR12;PEMT;PLD2;RAB5A;CHKA
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.41462118807302006,0.9776172410916378,0.4866785079928952,0.810320638327324,1.0,6/24,12.17%,NOTCH1;HIF1A;KLF2;MBTPS2;ATF6;MUC1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.42272780691469103,-0.9765569776796047,0.5053763440860215,0.8592223192564038,1.0,5/11,17.97%,EGLN3;P4HB;P4HA1;P4HTM;P4HA2
prerank,vitamin transport (GO:0051180),0.40235381282014976,0.9762714220294241,0.5102685624012638,0.8127049082282568,1.0,6/29,13.94%,ABCG2;SLC52A3;AFM;CD320;SLC2A6;TCN2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.31659429949957824,0.9761338006377168,0.5210589651022864,0.812485322613626,1.0,24/150,8.07%,GNAQ;ENG;CAV1;OCLN;CNKSR3;PARD3;DAB2IP;LYN;DDIT4;PDE4D;PPM1F;NCK1;WWTR1;PAK2;CEACAM1;SMAD7;GREM1;PRR5L;INPP5K;TRIB3;SNX25;TGFB1;NIBAN1;SAMSN1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4605944228232625,0.9757435531487226,0.49110320284697506,0.8128264842734673,1.0,1/12,1.29%,LMO2
prerank,positive regulation of transmembrane transport (GO:0034764),-0.41076785085088063,-0.975595097079786,0.48364485981308414,0.8605830449625662,1.0,5/13,14.48%,ACSL1;C2CD5;CLIP3;AZIN1;SLC26A6
prerank,mesenchymal cell development (GO:0014031),0.4329314725886024,0.975516900480352,0.49663299663299665,0.812808849581953,1.0,3/18,6.57%,NOTCH1;CDH2;CYP26C1
prerank,macrophage chemotaxis (GO:0048246),-0.44771023016975886,-0.9752381980876602,0.49156118143459915,0.8603252708060358,1.0,4/10,34.15%,TAFA4;CCL2;CXCL17;CCL5
prerank,protein kinase A signaling (GO:0010737),0.4761744493178187,0.975074363390421,0.4904679376083189,0.8132395721372108,1.0,1/12,1.24%,LCP1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.2929957756369304,-0.9750718211866346,0.49538461538461537,0.8595651356148356,1.0,26/63,22.93%,SLC1A3;SLC12A2;SLC6A1;SLC26A2;GLRB;ANO1;GABRG2;ANO4;SLC5A5;GABRA2;SLC20A1;GABRB1;ANO3;SLC5A6;GABRB3;GABRG3;SLC1A1;CFTR;SLC4A8;SLC25A3;SLC25A14;CLCN1;GABRA1;SLC12A8;GABRA5;GABRA3
prerank,sensory organ development (GO:0007423),0.36827789263547817,0.9750057541069719,0.49045521292217326,0.8128583399867398,1.0,7/51,5.03%,PBX1;CHD7;SHROOM2;FREM2;SMCHD1;HIPK1;SIPA1L3
prerank,response to UV (GO:0009411),0.33446384110371524,0.9748046498266218,0.5053763440860215,0.812794305490905,1.0,18/95,14.61%,DCUN1D3;POLK;MAP4K3;CAT;PTPRK;N4BP1;MAPK8;BCL3;NEDD4;PRIMPOL;RHBDD1;MC1R;RELA;EIF2AK4;ERCC4;FMR1;NPM1;YY1
prerank,embryonic organ development (GO:0048568),0.35232263803934577,0.9746641169974283,0.5035765379113019,0.8125618731164104,1.0,11/61,9.03%,TEAD4;PBX1;KDR;KITLG;TAL1;SOX17;SOX18;TEAD2;TGFB1;NEUROD1;ZFPM1
prerank,xenobiotic transport (GO:0042908),0.44255192282416556,0.9742888137993738,0.49238578680203043,0.8128294036158407,1.0,3/16,8.48%,ABCG2;ABCA3;SLC15A2
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.3975757328062142,0.9742738066583849,0.4867986798679868,0.8123356583722923,1.0,7/30,12.74%,CASP8;IKBKB;CD40;IKBKG;UBE2D3;RIPK1;BIRC3
prerank,divalent inorganic cation homeostasis (GO:0072507),0.4102470558861292,0.9740526524564832,0.49322033898305084,0.8123048050350677,1.0,6/25,13.75%,TMTC2;CAV1;TRPV6;CYP27B1;GRIN1;TRPM7
prerank,brain development (GO:0007420),0.3208278206697619,0.9736976390205592,0.4963144963144963,0.8125549744779827,1.0,18/136,11.63%,SHANK3;PBX1;ADGRL2;SHROOM4;DDIT4;SHROOM2;ADGRG1;AMIGO2;CDH2;CX3CR1;RAPGEF2;DNAJC30;SYNJ1;NFIB;SCYL2;CXCR4;UBE3A;GRIN1
prerank,response to estradiol (GO:0032355),0.3850877247261328,0.9735380013751614,0.4945904173106646,0.8123764796090662,1.0,5/31,9.90%,ESR1;SOCS2;STAT3;TGFB1;NRIP1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.4261656499650989,0.9733873763552898,0.48776223776223776,0.8121730747333601,1.0,3/18,13.39%,RAB11A;BRD4;CDC25C
prerank,response to fatty acid (GO:0070542),0.4382392071675157,0.9733324690081734,0.48663101604278075,0.8117675811769884,1.0,3/17,8.24%,FOXO1;SOX9;LPL
prerank,protein insertion into membrane (GO:0051205),0.3894011978621017,0.9728883307690875,0.49763779527559054,0.8121925288880987,1.0,5/32,10.00%,APP;REEP1;STX1A;TRAM1;TRAM1L1
prerank,regulation of actin nucleation (GO:0051125),-0.4129370657160085,-0.9728356099859239,0.5067873303167421,0.8644302439385968,1.0,4/12,24.31%,GSN;ARFIP2;ARPIN;CORO1B
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.31546638213096195,-0.9726625461482351,0.48830409356725146,0.8636740286153521,1.0,8/40,14.26%,SLC7A11;SLC13A3;SLC38A11;SLC27A1;SLC7A6;SLC5A6;ABCC5;SLC19A1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4717738920953646,0.9724647867689901,0.5119266055045871,0.8125769181570291,1.0,2/12,3.59%,CELSR1;LAMA3
prerank,regulation of cellular catabolic process (GO:0031329),0.3483730407315782,0.9721588991061283,0.500709219858156,0.8126734597631352,1.0,11/62,11.84%,ACER2;DAPK1;BOK;DRAM2;TRIB3;RPTOR;FBXL2;DEPP1;SCARB2;ABL2;ABCD1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3819358028294967,0.9718988520305849,0.5087976539589443,0.8127048579938344,1.0,6/40,7.33%,LEF1;NOTCH1;WWTR1;SDCBP;TCF7L2;TGFB1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.41638329109667727,0.9714049120302457,0.48878205128205127,0.8132397908720363,1.0,4/22,5.28%,GATA2;SLC16A2;TOX;DLL4
prerank,stem cell development (GO:0048864),0.44756535209121084,0.9710442352337625,0.48336252189141854,0.8134831788502097,1.0,7/16,25.55%,CDH2;CYP26C1;KBTBD8;PDCD6;PEF1;TCOF1;NOLC1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.45660673600422885,0.9707138512779205,0.5028462998102466,0.8136721760513759,1.0,3/14,6.10%,SEMA7A;PLCG2;WNT5A
prerank,phospholipid homeostasis (GO:0055091),-0.43922436690767463,-0.9707055813210889,0.5276497695852534,0.8678803551196319,1.0,4/11,18.11%,TLCD2;RCN3;TLCD1;ANGPTL3
prerank,presynaptic endocytosis (GO:0140238),-0.357607253421745,-0.9705159212627733,0.5088607594936709,0.8672156205910944,1.0,8/24,14.83%,NLGN2;SYT1;SYNJ2;NLGN1;STON2;NLGN3;AMPH;SNCA
prerank,negative regulation of autophagy (GO:0010507),-0.298874509188967,-0.9704648477621438,0.5085324232081911,0.8661705406139137,1.0,15/54,16.21%,LEPR;SNRNP70;BCL2;NUPR1;NRBP2;SIRT2;KLHL22;LRRK2;DAPL1;EIF4G3;PTPN22;RUBCN;SMCR8;SNCA;MT3
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.36745643297452535,-0.9703061882449778,0.5058823529411764,0.8654197758173868,1.0,6/21,9.32%,ROCK2;ERRFI1;BMP4;SFRP4;RUNX1;MAFG
prerank,regulation of cell size (GO:0008361),0.4127141019631867,0.9702229896217284,0.49750415973377704,0.8142763913734509,1.0,8/23,16.72%,EDN1;MSN;RAC1;RPTOR;LARS1;MTPN;RDX;RHOA
prerank,cellular component disassembly (GO:0022411),0.3584889198114188,0.9701219915270253,0.49420289855072463,0.8139657295768685,1.0,4/53,3.25%,TLL1;LCP1;ADAM10;BSG
prerank,negative regulation of cellular senescence (GO:2000773),0.4606451290073893,0.9699989653076619,0.51010101010101,0.8137215844622233,1.0,5/13,18.00%,CDK6;MAP3K3;AKT3;YBX1;RBL1
prerank,regulation of response to interferon-gamma (GO:0060330),0.4513107396649261,0.9699745964642165,0.5173010380622838,0.8132478333183891,1.0,8/14,25.48%,JAK1;HSP90AB1;STAT1;IFNGR1;PARP9;CDC37;JAK2;SUMO1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.34898013823820273,0.9699034612494568,0.5070224719101124,0.8128784561716335,1.0,15/62,14.81%,STAT3;H3-3A;TGFB1;PUM1;IPO8;NUP214;PUM2;NUP98;ZFP36;NUP133;NUP205;FMR1;NUP54;NUP43;NUP153
prerank,positive regulation of behavior (GO:0048520),0.49099970704104795,0.9695030900919059,0.4888475836431227,0.8132166066599126,1.0,1/10,1.15%,MEF2C
prerank,positive regulation of wound healing (GO:0090303),-0.3208797305582681,-0.9693205854066347,0.4897959183673469,0.8668738811023522,1.0,9/36,11.47%,PLPP3;VTN;THBS1;FOXC2;SMOC2;ANXA1;ADRA2A;SERPINE1;CLDN1
prerank,negative regulation of type I interferon production (GO:0032480),0.37514123666364374,0.9692394775981612,0.5120845921450151,0.81327841316678,1.0,9/40,14.76%,RNF125;NLRC5;UBA7;TRIM25;RELB;IFIH1;ILRUN;YY1;GPATCH3
prerank,positive regulation of phosphatase activity (GO:0010922),-0.35547131041736835,-0.9684706322312236,0.49874686716791977,0.8679791647591403,1.0,3/21,4.64%,MAGI2;PDGFRB;ITGA1
prerank,mesenchyme development (GO:0060485),-0.3983070227460356,-0.9684311025936089,0.5146726862302483,0.8669190274786104,1.0,4/15,2.95%,FGFR2;BMP7;TGFBR1;BMP4
prerank,retinoic acid metabolic process (GO:0042573),-0.39878520710138854,-0.9683654772863216,0.4863731656184486,0.8659452858696386,1.0,2/14,3.70%,ALDH1A2;CYP26B1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.39562061025263306,0.9680975613738941,0.49765258215962443,0.8152097629591317,1.0,7/32,8.29%,ACER2;NEXMIF;ACVRL1;DUSP22;ADAM15;RASA1;NF2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.30966829989925876,0.9679791447487814,0.53309265944645,0.8149523168385197,1.0,26/161,10.43%,CAV1;DAB2IP;SOX13;MLLT3;FZD6;FZD4;TLE4;SOX17;WWTR1;STK3;NKD2;ZNRF3;SOX9;STK4;GREM1;TCF7L2;WNT5A;JADE1;TMEM88;SOST;PSMA2;PSMA8;MAD2L2;SFRP2;SCYL2;PSMA6
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.4710348517336852,0.9675571059737327,0.4926739926739927,0.8153359705224982,1.0,4/10,22.00%,ATRX;JARID2;KDM1A;RIF1
prerank,positive regulation of transporter activity (GO:0032411),-0.4143187052756457,-0.9675471978699448,0.510250569476082,0.8668645649375059,1.0,9/13,37.67%,TRPC6;WNK3;NR1H3;SGK2;SGK1;KCTD7;PDZK1;STK39;RXRA
prerank,negative regulation of neuron differentiation (GO:0045665),0.4212608263837996,0.9673063772290822,0.5221674876847291,0.8153472681608303,1.0,3/22,4.39%,B2M;SOX9;DLL1
prerank,anion transmembrane transport (GO:0098656),0.3510236563659207,0.9670817028615548,0.5210674157303371,0.8153183026550591,1.0,6/67,3.02%,LRRC8C;SLC6A5;SLC39A8;LRRC8B;SLC38A5;SLC3A2
prerank,regulation of autophagosome maturation (GO:1901096),-0.40641767877238744,-0.967080692282322,0.5,0.8668956349590259,1.0,6/13,25.44%,TMEM39A;RUBCN;SMCR8;ADRB2;CLN3;PHF23
prerank,cholesterol biosynthetic process (GO:0006695),-0.332388352423497,-0.9665181174511309,0.4959349593495935,0.8671982225652195,1.0,12/31,22.50%,INSIG2;HMGCS1;NSDHL;ACAT2;INSIG1;FDFT1;MVK;FDPS;LSS;DHCR24;CYP51A1;DHCR7
prerank,catecholamine metabolic process (GO:0006584),-0.40874778907204284,-0.9660327388741127,0.495260663507109,0.8673228380085959,1.0,1/14,1.21%,PRKN
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.4149149894375985,0.9659615322532118,0.5257548845470693,0.8166305485291944,1.0,6/23,14.12%,PPP1R13B;CASP8;MAPK8;SFN;BID;YWHAQ
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.4149149894375985,0.9659615322532118,0.5257548845470693,0.8166305485291944,1.0,6/23,14.12%,PPP1R13B;CASP8;MAPK8;SFN;BID;YWHAQ
prerank,heterochromatin assembly (GO:0031507),0.41786696684763064,0.9659346495236533,0.5235690235690236,0.8161729907506089,1.0,4/20,8.56%,SMCHD1;H3-3A;ZNFX1;EZH1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.37594508870312177,-0.965757659921605,0.4763092269326683,0.8669224567617083,1.0,1/19,0.34%,IGF1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3867052707415737,-0.9655998915038976,0.4752941176470588,0.8662087736119761,1.0,3/16,8.47%,AUTS2;BCOR;CTR9
prerank,response to thyroid hormone (GO:0097066),0.45083577604796965,0.964350481019501,0.5053956834532374,0.819004010113482,1.0,1/13,1.29%,LMO2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3404675653340106,0.9637934735973779,0.5055555555555555,0.8196348109642262,1.0,26/73,23.34%,ZFP57;EPC1;H3-3A;MTF2;TASOR;TAF1B;POLR1A;PPM1D;SMARCA5;MYBBP1A;AEBP2;MYO1C;PPHLN1;POLR1G;KAT2B;POLR1B;JARID2;PHF19;TAF1A;DEK;POLR2L;HDAC6;ERCC6;PHF1;PHF2;BMI1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3196446323230311,-0.9637221047549288,0.5,0.8698874961969072,1.0,13/39,15.47%,DMD;OSR1;HECW2;FGF14;WNK4;ANK3;SLMAP;WNK1;GPD1L;SCN2B;FXYD1;WNK3;NETO1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4415611733224116,0.9632876319108539,0.5104895104895105,0.8201986536967629,1.0,5/17,11.69%,WASF2;NCKAP1;GMFG;PICK1;CYFIP1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.4030402626492873,-0.9629497042321731,0.53125,0.8707503682692124,1.0,2/14,3.16%,NMNAT2;ME1
prerank,translational elongation (GO:0006414),0.3219008149642231,0.9626944977058844,0.5070422535211268,0.8209220617294886,1.0,42/101,26.45%,MRPS18A;MRPL13;MRPS12;EEF2K;MRPL35;RACK1;MRPL41;MRPL52;MRPL4;MRPS16;MRPL23;MRPS5;MRPL37;EEFSEC;EEF2;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;AURKAIP1;MRPL1;MRPL50;MRPL17;MRPL39;EEF1G;MRPL32;MRPL14;MRPS11;MRPL9;MRPL46;DAP3;MRPL19;MRPL15;MRPL42;GFM1;MRPL24
prerank,regulation of protein modification process (GO:0031399),0.35942641961894406,0.9624569751758718,0.523168908819133,0.8208930473066649,1.0,12/50,14.68%,PPP1R16B;LYN;FNIP2;CCDC88A;PTK2;PARG;CORO1C;NOP53;PHIP;WARS1;CDH5;KAT2B
prerank,integrin-mediated signaling pathway (GO:0007229),0.34140905764212487,0.9623916755582748,0.5040214477211796,0.8205052295345815,1.0,13/73,7.98%,PRKD1;SEMA7A;NEDD9;DOCK1;MYH9;ADAM10;PTK2B;DST;LAMA3;CEACAM1;ADAM15;PTK2;ITGA5
prerank,positive regulation of lipid localization (GO:1905954),-0.42591418390746694,-0.9620964800706825,0.4924078091106291,0.8717699215994986,1.0,2/11,4.67%,LRP1;IKBKE
prerank,negative regulation of macrophage activation (GO:0043031),-0.38580283251024466,-0.9620654299203781,0.5285714285714286,0.8706936144312839,1.0,4/16,6.74%,IL31RA;LRFN5;LDLR;SYT11
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.3572234192600735,-0.9619626496952868,0.4949238578680203,0.8698344137532044,1.0,7/22,23.33%,NFATC2;BCL6;RUNX1;DUSP10;MDK;LAG3;FANCA
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3923058897281227,0.9616205220964444,0.5155993431855501,0.8216256769713303,1.0,10/30,20.99%,CAVIN1;TAF1B;POLR1A;POLR1G;POLR1B;GTF2H4;TAF1A;GTF2H1;POLR2L;CCNH
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.4451198591869995,0.9614802769681208,0.49910873440285203,0.8213964289768417,1.0,4/15,4.00%,PRKD1;PRKD2;NOTCH1;TMSB4X
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.39060241351981,-0.9614372019925554,0.4928909952606635,0.8701270544410279,1.0,4/15,5.77%,FGFR2;PDGFRA;TGFBR1;SIX1
prerank,cellular lipid catabolic process (GO:0044242),0.40626681905313333,0.9614330060747082,0.5277337559429477,0.820966422094739,1.0,3/27,5.65%,PPARD;ENPP2;LPIN3
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.41245844166639256,0.9613119766806254,0.5025906735751295,0.8207145945689609,1.0,4/21,8.74%,TGM2;RAP1GDS1;MICU2;MCUB
prerank,cilium organization (GO:0044782),0.30399841088459806,0.9611245533557069,0.549645390070922,0.8205714610402421,1.0,28/209,12.96%,ABCC4;ABLIM1;FNBP1L;EXOC6;EHD4;RAB11A;NOTCH1;CNGB1;SSX2IP;DISC1;CEP41;PCNT;BBIP1;EHD2;DYNLL1;PKD2;EXOC5;TEKT5;EXOC4;OCRL;CEP83;ARL13B;EHD3;RTTN;ACTR2;RILP;WDR11;EXOC8
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.47893918399714913,0.9610532820870342,0.5314183123877917,0.8202218597700206,1.0,7/10,29.85%,NF2;INPP5F;PPP2R1A;PIBF1;PPP2CA;PARP14;SOCS3
prerank,pharyngeal system development (GO:0060037),0.4451008158969938,0.9606154278929341,0.4939550949913644,0.8206403356068702,1.0,2/15,0.88%,BMPR2;TBX1
prerank,synaptic vesicle endocytosis (GO:0048488),0.38678524174340767,0.9605069120334063,0.5186915887850467,0.8203488670476594,1.0,6/33,8.98%,DNM3;ITSN2;FCHO2;OPHN1;STX1A;SYNJ1
prerank,negative regulation of bone mineralization (GO:0030502),0.46550252144864523,0.9603623959497326,0.5082266910420475,0.8201267392996112,1.0,5/13,11.76%,PTK2B;FGF23;GREM1;SRGN;RFLNB
prerank,cellular protein-containing complex assembly (GO:0034622),0.3137914433983466,0.9603154673804212,0.5355450236966824,0.819714669974812,1.0,30/159,15.22%,SMAD1;HIP1;HIP1R;IMMP2L;PIK3C2A;NCK1;PXN;FKBP1A;FCHO2;TESPA1;RPL38;TCF4;VAMP4;TGFB1;CHMP4A;CHMP4B;TBCA;HIGD2A;VAMP8;POMP;PICALM;LONP1;NUP98;HSP90AB1;OMA1;NUP205;RAB5IF;HIGD1A;NUP153;STXBP6
prerank,protein catabolic process (GO:0030163),0.3530391135618225,0.9597207421326182,0.5027777777777778,0.8204351172415174,1.0,17/59,16.65%,STT3B;DAB2IP;CEACAM1;UBE2G1;CTRL;TRIM24;PSMA8;RAB12;SIAH1;RIPK1;CLN6;OGA;DDI1;SOCS6;RNF5;DDI2;CHEK2
prerank,positive regulation of neuron death (GO:1901216),-0.30044931001107594,-0.9595706055280951,0.5232198142414861,0.8737616034830685,1.0,9/46,14.83%,EPHA7;NUPR1;MAP3K5;EFNB2;NF1;SRPK2;TGFB2;C1QA;SNCA
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.49096312812788145,0.9594590950061729,0.5236363636363637,0.8204503352052727,1.0,3/10,20.72%,WRAP53;CCT7;CCT2
prerank,neuron differentiation (GO:0030182),0.3094530185035167,0.9592486817878444,0.5508982035928144,0.820372256556467,1.0,17/165,9.33%,LHX6;PBX1;MEF2C;UGCG;ACSL4;FZD4;DDIT4;XBP1;PITX3;OPHN1;WNT5A;WNT9B;NEUROD1;THOC2;USH2A;IER2;SOX4
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3302113895211907,0.9591962948878705,0.5216216216216216,0.8199597455547543,1.0,20/90,14.29%,EPAS1;ADIPOR2;CAV1;KDM3A;ADRB1;LCN2;GATM;ESRRG;PDGFC;CXCR4;PRKAB1;IL4R;UCP2;PEMT;SIRT6;ADIPOR1;HADH;OMA1;IGF1R;APC
prerank,positive regulation of immune system process (GO:0002684),0.440386369781633,0.9590628930171836,0.5287769784172662,0.81973869803756,1.0,1/16,1.27%,IL15
prerank,negative regulation of cell cycle (GO:0045786),0.33692491887819814,0.9585235525278393,0.5337837837837838,0.8203380181022002,1.0,18/73,14.95%,PPP1R13B;CDK6;HHEX;BTG3;PTPRK;CDKN1B;TGFB1;BRINP2;RNF167;BTG2;ANGEL2;TFAP4;BTG1;RB1;RHOB;INCA1;APC;GMNC
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3449513296951483,0.9584933376809046,0.5135520684736091,0.8198900103015575,1.0,15/63,13.39%,CNOT6;CNOT6L;PLK2;AURKA;CDKN1B;CRADD;CDK2;SOX4;BTG2;CNOT1;SFN;CNOT2;MUC1;CNOT7;CDC25C
prerank,protein polyubiquitination (GO:0000209),0.2933967029712638,0.9584523657715591,0.5811965811965812,0.8194755371281779,1.0,89/297,24.92%,RNF125;KLHL3;SMURF1;RNF144B;NEDD4L;TRIM14;FBXW7;ZNRF1;TRAF1;DTX3L;TRIM68;PELI1;FBXL4;RNF144A;UBE3B;SASH1;UBE2G1;PSMA2;RNF167;FBXL7;NEDD4;UBE2H;ANAPC7;RNF146;FBXW2;RNF4;ANAPC1;PSMA8;SIAH1;UBE2D3;PSMA6;RC3H1;FBXO30;CDC26;UBE3A;CUL1;CBFB;HECTD1;MYLIP;FBXL3;UBE2K;TRAF6;TOPORS;PSME1;ARIH2;RNF5;DCAF15;TPP2;UBE3D;AREL1;BIRC2;NHLRC1;CTNNB1;CUL3;HERC6;CDC34;PSMA4;FBXW10;UBE2Q1;PSMF1;PELI2;TRIM62;FBXO17;PSMB7;TRIM71;PSMB1;UBE2L3;HACE1;ARIH1;THOP1;PSMD2;UBE2V2;KLHL42;LNPEP;PSMA5;PSMC3;FBXO7;FBXO11;TRAF2;UBE2J2;UBE2D1;RFFL;TNKS;UBE2R2;PSMD3;LONRF1;UBE2E1;FZR1;PSMA3
prerank,acute inflammatory response (GO:0002526),0.41593597207830735,0.9578421119640113,0.5161839863713799,0.8202248211678296,1.0,7/23,17.96%,IL6R;SIGIRR;CTNNBIP1;ANO6;ITIH4;IL22;PLSCR1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.44061475309962606,0.9576226235129153,0.5009523809523809,0.820211772713827,1.0,4/14,20.55%,CSF1;IL23A;TRAF6;CCR1
prerank,response to histamine (GO:0034776),-0.43952059742719785,-0.9575934065458431,0.5193965517241379,0.8776734399658083,1.0,3/10,12.88%,GABRG2;GABRB1;GABRB3
prerank,negative regulation of axonogenesis (GO:0050771),-0.33581190946238226,-0.9574207710169416,0.5240384615384616,0.8769636564539587,1.0,12/27,22.86%,PTPRS;MAP2;DCC;CDKL3;RTN4;SEMA3G;ULK2;MT3;PTEN;THY1;GDI1;RNF6
prerank,female gamete generation (GO:0007292),0.39387702667244673,0.9573570292692739,0.5201938610662359,0.8202579817025469,1.0,4/29,8.15%,NANOS3;NANOS2;TRIP13;MARF1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4058147265200004,0.957334925252331,0.48881789137380194,0.8197897148624737,1.0,4/23,7.13%,CBFA2T3;SIK1;FBP1;TIGAR
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.41097093030337967,0.9573346737805929,0.5465313028764806,0.8192799581909291,1.0,4/23,12.09%,SLC12A7;CLCN3;SLC12A9;SLC9A7
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.4342839408777939,-0.9572444452667298,0.5135746606334841,0.8762581554584954,1.0,4/11,7.82%,PRKN;PTPN23;DAB2;EZR
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.2765415491556048,-0.9571855673751922,0.5686274509803921,0.8752687273476025,1.0,24/69,20.16%,PRKN;BCL2;SLC30A10;NRBP2;PPARGC1A;NDNF;NTRK2;NGF;SIX1;SNX6;CPEB4;RETREG1;APOE;TGFB3;NFATC4;PRKCI;NONO;MT3;MDK;CLCF1;PPT1;TYRO3;NTF3;CRLF1
prerank,translational termination (GO:0006415),0.3232783046686174,0.9571588023541269,0.5405405405405406,0.8191597832520977,1.0,41/95,26.45%,MRPS18A;MRPL13;MRPS12;MRPL35;APEH;MRRF;MRPL41;MRPL52;MRPL4;MRPS16;MRPL23;MRPS5;MTRF1L;MRPL37;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;AURKAIP1;MRPL1;N6AMT1;MRPL50;MRPL17;MRPL39;MRPL32;MRPL14;MRPS11;MRPL9;MRPL46;DAP3;MRPL19;MRPL15;MRPL42;GSPT2;MRPL24
prerank,autophagosome assembly (GO:0000045),0.3520662896380284,0.957124996771004,0.5087209302325582,0.8187101483114775,1.0,17/52,24.22%,SMURF1;ULK1;ATG101;EMC6;GABARAPL1;RAB43;RAB7A;ATG2A;ATG2B;STX12;IRGM;RAB1A;ATG7;UBXN2A;RAB1B;VMP1;RB1CC1
prerank,protein K48-linked deubiquitination (GO:0071108),0.40967531484760616,0.9569636639655785,0.546031746031746,0.818549138538841,1.0,7/23,19.17%,MINDY1;MINDY2;ATXN3;OTUD4;YOD1;USP8;USP25
prerank,extracellular matrix disassembly (GO:0022617),0.3589304301127765,0.9568482381401334,0.5180722891566265,0.8182853725005454,1.0,4/53,3.25%,TLL1;LCP1;ADAM10;BSG
prerank,transcription by RNA polymerase I (GO:0006360),0.37800086420035905,0.9566220552249202,0.5264797507788161,0.8182952230097227,1.0,12/34,22.00%,CAVIN1;TAF1B;POLR1A;RRN3;POLR1G;POLR1B;GTF2H4;TAF1A;GTF2H1;POLR2L;CCNH;TCOF1
prerank,peptide hormone secretion (GO:0030072),0.40373538304571527,0.9564651076030404,0.5150501672240803,0.8181216724665418,1.0,3/26,8.26%,EDN1;SNX19;NEUROD1
prerank,mitotic cytokinesis (GO:0000281),-0.3032414138488402,-0.9564186648225733,0.5667752442996743,0.8761263080381541,1.0,21/47,27.27%,SON;ROCK2;SNX18;ANK3;CIT;ARL3;JTB;RTKN;KLHDC8B;CNTROB;STAMBP;RAB35;NUSAP1;EFHC1;CKAP2;CUL7;RHOC;SNX33;CENPA;CEP55;SPAST
prerank,placenta development (GO:0001890),0.4625914393939917,0.9563859842836806,0.5140712945590994,0.8177814266480234,1.0,5/12,15.97%,PTK2;CITED1;ANG;PLAC1;E2F7
prerank,activation of phospholipase C activity (GO:0007202),0.3886866388203416,0.9561831250517441,0.5257234726688103,0.8177222322950589,1.0,4/29,3.22%,GNAQ;PLCG1;HTR2A;SELE
prerank,epidermis development (GO:0008544),-0.2946164117311029,-0.9557078220200053,0.5294117647058824,0.8769924077112603,1.0,11/56,14.15%,FGFR2;SVEP1;CCN2;ATP2A2;CRABP2;GLI1;FLOT2;SCEL;FGF7;EDA2R;LAMC2
prerank,regulation of cellular component movement (GO:0051270),0.35888659528560707,0.9554069053693197,0.5208333333333334,0.818871877312756,1.0,10/49,5.89%,CDK6;LYN;PRAG1;ACTN4;ZSWIM6;PKN2;ACTN1;PKN1;RPS19;MYCBP2
prerank,regulation of protein kinase B signaling (GO:0051896),0.3018124116066433,0.9553582895175748,0.5336426914153132,0.8184520924739597,1.0,27/193,8.62%,TEK;ENG;ESR1;INSR;KITLG;PDGFB;HIP1;MFHAS1;RASD2;PTPRJ;FYN;FGF23;F7;CX3CR1;RET;TCF7L2;INPP5K;RAC1;TRIB3;LCK;TGFB1;PIK3CG;PTK2;TGFA;GAB1;PPP2R5B;AKT2
prerank,androgen receptor signaling pathway (GO:0030521),0.4728858527927218,0.9552491085849313,0.5335689045936396,0.8181751668220945,1.0,5/11,14.08%,PLPP1;KDM3A;ARID1A;ZMIZ1;PMEPA1
prerank,canonical glycolysis (GO:0061621),-0.3537991537938562,-0.9551877850279438,0.516209476309227,0.8759967278220409,1.0,10/24,27.30%,PFKP;ENO2;HK2;TPI1;ENO3;PFKM;ALDOA;PKM;ENO1;ALDOC
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.3537991537938562,-0.9551877850279438,0.516209476309227,0.8759967278220409,1.0,10/24,27.30%,PFKP;ENO2;HK2;TPI1;ENO3;PFKM;ALDOA;PKM;ENO1;ALDOC
prerank,regulation of macroautophagy (GO:0016241),0.3208590725010086,0.9550625909736338,0.5334174022698613,0.818077376231184,1.0,16/105,10.77%,KDR;ERN1;LZTS1;QSOX1;MAPK8;ULK1;SH3GLB1;ATP6V0A1;NEDD4;RPTOR;ATG101;ATP6V1G2;IKBKG;EXOC4;PRKAB1;BNIP3
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.2894350471405043,0.9546979724875909,0.6051779935275081,0.8183148970223925,1.0,50/348,10.84%,LEF1;NOS3;RAB27A;APP;MEF2C;CLDN5;OCLN;INSR;SMAD1;PDGFB;GATA2;PDE2A;STAT3;NOTCH1;HIF1A;MSN;PPM1F;SELE;CD34;PLCG2;FGF23;SOX9;KLF2;DTX3L;GREM1;DLL4;MAPK8;SERPINB9;RAMP2;TNRC6C;WNT5A;RPS7;ATF7IP;IL36G;KRAS;TASOR;ARRB1;TGFB1;NOS1AP;CITED1;PSEN1;RPL23;PTPN1;CSF1;MAPK11;INPP5F;SCYL2;PRKAB1;GAS6;PPHLN1
prerank,mRNA modification (GO:0016556),0.41345369522270187,0.9545521722348583,0.5384615384615384,0.8181213385017885,1.0,12/22,27.22%,CBLL1;WTAP;VIRMA;TRMT6;METTL14;TRUB1;RPUSD2;PUS7;TRMT10C;TRMT61B;METTL16;NSUN2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3547987396031377,0.954326567449137,0.5297619047619048,0.8180947559192355,1.0,16/54,16.65%,CNOT6;CNOT6L;PLK2;AURKA;CDKN1B;CRADD;SOX4;BTG2;CNOT1;SFN;CNOT2;MUC1;CNOT7;CDC25C;E2F7;CHEK2
prerank,regulation of hippo signaling (GO:0035330),0.43698104670294735,0.9543122374937888,0.5190311418685121,0.817619727798822,1.0,5/17,9.51%,MARK3;VGLL4;NF2;WWC2;MAP2K3
prerank,primary miRNA processing (GO:0031053),0.46617018176115044,0.9530988324132401,0.5185185185185185,0.8196725178277449,1.0,2/10,5.95%,SMAD1;DROSHA
prerank,vesicle transport along microtubule (GO:0047496),-0.34594671173433,-0.9525747354622515,0.5211640211640212,0.881667069280702,1.0,8/23,17.26%,KIF3A;KIF1A;DYNC1I1;HTT;TRAK1;KIFAP3;KIF5A;DYNC1H1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.42687868200182405,-0.9522809135673184,0.5120350109409191,0.8812513768840907,1.0,5/11,21.00%,NECAB1;SOAT1;ABCA7;ABCA2;NECAB3
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3857330464111518,0.952050804100048,0.5176651305683564,0.8214055206262689,1.0,8/32,15.83%,ADIPOR2;SORBS1;CEACAM1;CREB1;EIF6;ADIPOR1;ASAH1;STAR
prerank,zymogen activation (GO:0031638),-0.3085014594905232,-0.9518274119338866,0.546583850931677,0.8812793785222746,1.0,6/39,10.69%,CYFIP2;ASPH;MMP14;KLK2;PLAT;GRIN2A
prerank,regulation of mitochondrion organization (GO:0010821),-0.2998962612512881,-0.9517738377129802,0.5286624203821656,0.8802770982470315,1.0,6/47,8.43%,PID1;PRKN;PPARGC1A;SREBF1;LRRK2;SQSTM1
prerank,nuclear body organization (GO:0030575),-0.40705071693560196,-0.9512983993968475,0.5381263616557734,0.8803549531363019,1.0,8/12,31.23%,AFF2;SRPK2;HIPK2;USP50;HABP4;USPL1;ETS1;ZPR1
prerank,mitochondrial translational termination (GO:0070126),0.3241641178419447,0.9509328418970812,0.5360419397116645,0.8232403384177881,1.0,38/88,26.45%,MRPS18A;MRPL13;MRPS12;MRPL35;MRRF;MRPL41;MRPL52;MRPL4;MRPS16;MRPL23;MRPS5;MTRF1L;MRPL37;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;AURKAIP1;MRPL1;MRPL50;MRPL17;MRPL39;MRPL32;MRPL14;MRPS11;MRPL9;MRPL46;DAP3;MRPL19;MRPL15;MRPL42;MRPL24
prerank,nucleotide metabolic process (GO:0009117),-0.3468013535947729,-0.9499556413918334,0.5324675324675324,0.8826488297413425,1.0,8/23,21.95%,NMNAT2;FHIT;ME1;ENPP3;NMNAT1;NMNAT3;GUK1;CTPS2
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.392830819518939,0.949077355871116,0.5025728987993139,0.8265701953516431,1.0,8/27,20.49%,TIRAP;TNIP1;IRAK4;TRAF6;IRAK3;TAB3;IRAK2;MAP3K1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3555512953206293,0.948860276838895,0.5007541478129713,0.8265067089059912,1.0,9/47,8.99%,LIMS2;NEDD9;DOCK1;RREB1;ACTN4;RAC1;PTK2;ARHGEF7;CRK
prerank,sister chromatid segregation (GO:0000819),-0.33104619561336146,-0.9485563147440367,0.5120643431635389,0.8851912075162657,1.0,16/31,33.42%,TOP2B;ZWINT;KLHL22;NUSAP1;CENPK;KNSTRN;KIF18B;KIFC1;NDC80;TOP2A;CDCA8;SGO1;INO80;DSN1;ZW10;ESPL1
prerank,regulation of synapse organization (GO:0050807),0.39147345545688655,0.9485439089284219,0.53156146179402,0.82665601100519,1.0,9/26,20.64%,MEF2C;WNT5A;NEDD4;EPHA4;ABHD17B;KLK8;PDLIM5;ABHD17A;SETD5
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3237857618563239,0.9479329550585587,0.5583224115334207,0.8273877785410692,1.0,22/98,13.55%,PPARD;INSR;PDGFB;FASN;ACACB;NFKBIA;SELE;GREM1;IFNAR1;ARRB1;CBR1;TGFB1;AGPAT1;CSF1;INPP5F;SCYL2;TBC1D5;PICK1;RIPK1;XDH;TGFBR2;FMR1
prerank,ion homeostasis (GO:0050801),-0.3282660907726331,-0.947844161653413,0.5338753387533876,0.8858498545305455,1.0,8/30,10.51%,SLC4A10;FHL1;WNK4;WNK1;UNC80;SLC4A3;AP3D1;SLC4A2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.3463772311038048,-0.9471576717096383,0.5207823960880196,0.8865138739501046,1.0,10/22,23.99%,DDX5;PLA2R1;SPRED1;SPRED2;SPRED3;CHD5;CDK5RAP3;ATR;MSX1;ATM
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.3708136202281828,0.9469906373086707,0.5296803652968036,0.8289218058011517,1.0,10/41,11.63%,HTR2A;PLCG2;ATP2B4;TRPV6;LCK;ITPR3;TRPV4;PKD2;ERO1A;GRIN1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.357545842727637,0.946895514806369,0.5523952095808383,0.8285825700290346,1.0,10/47,12.94%,RAB27A;PDGFB;PLCG2;CBR1;TGFB1;GRIN1;RIPK1;XDH;GSTP1;TGFBR2
prerank,CENP-A containing chromatin organization (GO:0061641),-0.3334678902485843,-0.9468827503058046,0.5231607629427792,0.8848895418758228,1.0,13/29,26.49%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;CENPH;KNL1;CENPX;CENPQ;CENPA
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.3334678902485843,-0.9468827503058046,0.5231607629427792,0.8848895418758228,1.0,13/29,26.49%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;CENPH;KNL1;CENPX;CENPQ;CENPA
prerank,thymus development (GO:0048538),0.4639574781574236,0.9461706639323431,0.5216606498194946,0.8296003292681577,1.0,1/13,0.88%,TBX1
prerank,negative regulation of transmembrane transport (GO:0034763),0.47042404236974134,0.9452775678338159,0.5152057245080501,0.8309485020166603,1.0,3/10,8.62%,CTTNBP2NL;INPP5K;AKT2
prerank,wound healing (GO:0042060),0.34040198947414907,0.9450390055362258,0.5369595536959554,0.830937522338793,1.0,6/62,2.90%,MYOF;PRCP;MYH9;SCARB1;PPP3CA;DST
prerank,anterograde trans-synaptic signaling (GO:0098916),0.2968909416387255,0.944993150181496,0.5801169590643275,0.8305081270367232,1.0,18/224,6.79%,MPZ;UNC13B;SLC6A2;SLC6A5;SLC12A7;HTR2A;PDE7B;CACNA1E;PRKAR2B;PCDHB4;SYPL1;RPS6KA3;SDCBP;RPS6KA1;KCNMB4;CACNA1A;HCRTR1;ATXN3
prerank,protein modification by small protein conjugation (GO:0032446),0.28548543644281826,0.9448337483321948,0.6095238095238096,0.8303393252338919,1.0,78/361,18.82%,EPAS1;DCUN1D3;KLHL3;SMURF1;NEDD4L;KLHL2;TRIM14;FBXW7;HIF1A;KLHL7;RNF38;ZNRF3;UBA7;DTX3L;UHRF2;KCTD10;HERC2;TRIM68;MYCBP2;RNF144A;CBLL1;ARRB1;RNF7;TRIM47;UBE2G1;ARRDC1;STX1A;FBXL7;NEDD4;RNF139;KLHL24;UBR1;TRIM24;UBE2H;ANAPC7;FBXL2;RAD18;UBE2D3;SUMO2;CBL;NUP214;CUL1;NUP98;SAE1;MYLIP;RACK1;RNF25;ASB11;ANAPC16;NUP133;IFIH1;NUP205;PEX14;FBXL3;KLHL8;UBE2K;NUP54;TOPORS;ELOC;NUP43;NUP153;MSL2;ARIH2;DCAF15;OTULIN;AREL1;CRBN;CDC73;NEDD8;UBE2I;CUL3;CDC34;KLHL18;USP7;RNF40;ABCB11;ATG7;CUL2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.33295913351779227,0.9448192979503831,0.5469387755102041,0.8298605173687194,1.0,18/80,14.29%,FNBP1L;OCLN;EPS8;WASF2;NCKAP1;CCDC88A;RAC1;CDC42EP3;AGRN;TWF2;FSCN1;P2RY12;CYFIP1;ACTR2;FMR1;NDEL1;ACTR3;APC
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.3780405820352632,0.9447335633716467,0.5444264943457189,0.8295331175362868,1.0,8/34,15.63%,DAB2IP;LYN;MFHAS1;GRAMD4;OTUD4;LRRC14;RAB7B;IRAK3
prerank,mitochondrion organization (GO:0007005),0.3013065940920112,0.9446447183052947,0.5719424460431655,0.8292260866615485,1.0,24/165,13.96%,DNM3;NOS3;IMMP2L;ALAS1;BIK;VPS13D;MTM1;CAV2;CYCS;SIRT5;RAB38;BCL2L1;HIGD2A;BNIP3;GABPB1;AKT3;TFB2M;PITRM1;LONP1;BID;OMA1;RAB5IF;MEF2A;HIGD1A
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.40743442968984667,0.9442986409966785,0.5365853658536586,0.8294318564623783,1.0,3/22,2.77%,IL6ST;EDN1;NOTCH1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4417091692531704,0.9441727055907001,0.527927927927928,0.8291767311328108,1.0,6/13,23.45%,DPAGT1;ALG6;ALG8;MPDU1;ALG12;ALG14
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.41206514523469234,0.9441356372885787,0.542314335060449,0.8287483169243136,1.0,1/21,0.86%,CAV1
prerank,zinc ion homeostasis (GO:0055069),-0.33375200640977265,-0.9439354748845862,0.553763440860215,0.8912508698108973,1.0,5/28,8.73%,PRKN;SLC30A10;SLC39A14;SLC39A13;SLC39A10
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.47917443662834364,0.9438046682312158,0.5458015267175572,0.8289700658907344,1.0,1/10,0.47%,CSGALNACT1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.36773968041804006,-0.9436410357284168,0.5673758865248227,0.8908557148723272,1.0,5/20,9.53%,EGFR;PKD1;CCND2;SPDYA;RGCC
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.3843500945370807,0.9419878039283128,0.5514018691588785,0.8322952017942661,1.0,8/29,22.19%,RAD21L1;TRIP13;MEIOB;TERB1;TERB2;RAD21;PRDM9;SIRT7
prerank,protein complex oligomerization (GO:0051259),0.3217144424711174,0.9418996183256787,0.5611038107752957,0.8319388343863778,1.0,25/85,23.71%,LRRC8C;EHD4;AQP11;MAT2A;BOK;PKD2;RNF112;EHD3;ATL1;G3BP2;LRRC8A;PNPT1;TIFA;CARD9;GLRA3;FUS;BCL10;HOMER1;ELAVL1;CPSF6;JMJD6;OPA1;PDCD6IP;ZBTB1;STOML2
prerank,tryptophan catabolic process (GO:0006569),-0.4235034304938005,-0.9412489906206599,0.5279642058165548,0.8959062424767238,1.0,9/11,51.94%,KYAT1;HAAO;KYNU;AADAT;AFMID;TDO2;KMO;IDO1;ACMSD
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.40734990616049765,-0.9410255342394608,0.5487528344671202,0.8953491389657208,1.0,3/12,5.19%,IGF1;IRS1;IGF2
prerank,regulation of transport (GO:0051049),0.3767595250825098,0.9408928822685535,0.5384615384615384,0.8335558416039434,1.0,3/36,2.16%,EPB41;ICA1;RAB11A
prerank,histone H3-K9 demethylation (GO:0033169),0.4573832910573294,0.9408101422002053,0.5413533834586466,0.8332254220341556,1.0,5/11,18.64%,KDM3A;JMJD1C;KDM4C;KDM4A;KDM1A
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3576835017768862,-0.9407371497892422,0.541371158392435,0.8949502352442175,1.0,4/20,8.32%,OSR1;ACTN2;HECW2;ADRA2A
prerank,positive regulation of viral genome replication (GO:0045070),0.37628099849855495,0.9404973191579337,0.5679214402618658,0.833370742851077,1.0,6/29,13.14%,NR5A2;ADARB1;PKN2;RAD23A;ADAR;CNOT7
prerank,membrane repolarization during action potential (GO:0086011),0.4449097694330958,0.9401630661010705,0.5435992578849722,0.8335594225158975,1.0,3/13,7.06%,KCNQ1;ATP1A1;KCNE2
prerank,regulation of telomerase activity (GO:0051972),0.3611053966640741,0.9393132168453248,0.5606508875739645,0.8348234429847252,1.0,10/45,16.74%,NEK7;HMBOX1;GREM1;WRAP53;PINX1;ACD;ERCC4;HSP90AB1;TERF1;CTNNB1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.374978949589996,0.939183522356863,0.5527156549520766,0.8345870555353164,1.0,9/33,18.00%,DCUN1D3;CDK6;JADE1;PKD2;RB1;APC;E2F7;CDC73;RBL1
prerank,neurotrophin signaling pathway (GO:0038179),-0.3548455804498799,-0.9389381083679933,0.5395348837209303,0.8984325812915267,1.0,4/21,6.71%,MAGI2;NTRK2;NGF;KIDINS220
prerank,modulation of chemical synaptic transmission (GO:0050804),0.31491310632370506,0.9388973231481453,0.5681818181818182,0.8346743207985154,1.0,14/107,7.10%,MCTP1;APP;MEF2C;DGKZ;BCR;BTBD9;CDH2;SYN3;CX3CR1;KCNMB4;CACNA1A;OPHN1;SNCAIP;CLSTN1
prerank,tRNA metabolic process (GO:0006399),0.4246077160177628,0.93884474883753,0.5249569707401033,0.8342837510458057,1.0,5/17,15.50%,FARS2;DTD1;RPP30;ADAT1;KARS1
prerank,cell-matrix adhesion (GO:0007160),0.31976264555756756,0.9385885109909952,0.559254327563249,0.8343340736328607,1.0,15/95,7.33%,THSD1;VCAM1;PEAK1;BCR;TAOK2;PPFIA2;CD34;SORBS1;ACTN1;PTPRK;BCAM;ADAM15;RAC1;VWA2;ITGA3
prerank,protein ubiquitination (GO:0016567),0.2805928451809025,0.9383159353613889,0.6462018730489074,0.8344060239170934,1.0,147/471,24.92%,EPAS1;RNF125;KLHL3;SMURF1;RNF144B;RNF141;NEDD4L;KLHL2;TRIM14;FBXW7;HIF1A;KLHL7;RNF38;ZNRF1;ZNRF3;DTX3L;UHRF2;KCTD10;HERC2;TRIM68;PELI1;FBXL4;MYCBP2;RNF144A;UBE3B;CBLL1;SASH1;ARRB1;RNF7;TRIM47;UBE2G1;ARRDC1;PSMA2;RNF167;FBXL7;NEDD4;TRIM25;RNF139;KLHL24;UBR1;TRIM24;UBE2H;ANAPC7;RNF146;FBXL2;FBXW2;RNF4;PSMA8;RAD18;SIAH1;UBE2D3;PSMA6;RC3H1;CBL;FBXO30;UBE3A;CUL1;CBFB;RNF112;MYLIP;RACK1;RNF25;ASB11;ANAPC16;ASB4;PEX14;FBXL3;KLHL8;UBE2K;TRAF6;TOPORS;PSME1;ELOC;MSL2;ARIH2;DCAF15;OTULIN;TPP2;UBE3D;AREL1;CRBN;BIRC2;NHLRC1;CTNNB1;CDC73;NEDD8;CUL3;HERC6;CDC34;PSMA4;KLHL18;FBXW10;USP7;RNF40;UBE2Q1;PSMF1;ABCB11;CUL2;KBTBD8;PELI2;OBI1;TRIM62;BCL10;FBXO17;PHC1;PSMB7;TRAF7;TRIM71;PSMB1;UBE2L3;HACE1;PLK1;ARIH1;THOP1;PSMD2;UBE2V2;VPS18;FBXO25;RNF111;RTF1;KLHL42;RNF103;LNPEP;PSMA5;PSMC3;FBXO7;UCHL3;FBXO11;TRAF2;PCNP;UBE2J2;CUL4B;DET1;UBE2D1;PEX10;TNKS;RNF11;MKRN2;UBE2R2;PSMD3;TSPAN17;SDE2;LONRF1;UBE2E1;TRIM33;VHL;PSMA3
prerank,regulation of establishment of cell polarity (GO:2000114),-0.3751919956522628,-0.938229070722553,0.525,0.8991089503087908,1.0,4/16,8.33%,GSN;ROCK2;SHTN1;RIPOR2
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4031629524348419,-0.9379887117280574,0.5606407322654462,0.8985424399419369,1.0,3/13,5.19%,IGF1;IRS1;IGF2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.42724298245500014,0.9379777554672643,0.5456140350877193,0.8345798895818789,1.0,4/18,15.40%,EDN1;ABL2;PDP1;RFK
prerank,histone monoubiquitination (GO:0010390),-0.3400406968236619,-0.9379163688255391,0.5476772616136919,0.8975595393866226,1.0,8/24,16.22%,BCOR;CTR9;PAF1;LEO1;DDB2;RING1;ATXN7L3;DDB1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.3882939886940608,0.9378119470185989,0.5483870967741935,0.834443262633939,1.0,5/24,6.60%,TJP1;F11R;WASF2;PAK2;INPP5K
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3867797696825952,0.9375066559805346,0.5475409836065573,0.8345767806336336,1.0,6/29,14.82%,ESR1;KCTD6;CNOT1;CNOT2;CBFB;STRN3
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.4147784793348915,-0.9367852288347048,0.5526315789473685,0.899306175690167,1.0,7/12,23.90%,ANO1;STX4;GPLD1;CFTR;PLA2G6;ADCY8;BAIAP3
prerank,positive regulation of cation channel activity (GO:2001259),0.35924574372835494,0.9367280251641872,0.5323076923076923,0.8356538590572186,1.0,2/40,4.00%,SHANK3;TMSB4X
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.3398311330032841,-0.9365415014309367,0.5729442970822282,0.8987891820802616,1.0,5/26,11.28%,IGF1;FHL2;AKAP6;EFHB;SLC9A1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33255949537957685,0.9361065591596001,0.5606060606060606,0.8364084689562609,1.0,7/75,4.52%,RGS3;EDN1;NMT2;GIT2;CNGB1;PLCB1;PPP1R9B
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.3416762338912564,-0.9360384293355453,0.5422885572139303,0.899021351662014,1.0,10/25,27.30%,PFKP;ENO2;HK2;TPI1;ENO3;PFKM;ALDOA;PKM;ENO1;ALDOC
prerank,positive regulation of defense response to virus by host (GO:0002230),0.3964397950920591,0.9355830905599191,0.5535714285714286,0.8369632277940462,1.0,8/24,18.36%,AIM2;DTX3L;CGAS;IL23A;EIF2AK4;STAT1;PARP9;ZDHHC1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.3014338388691442,-0.935491712081437,0.5775075987841946,0.8992841949612911,1.0,10/44,15.19%,CYP7B1;CYP27A1;INSIG2;PER2;PRKAG2;OSBPL3;OSBPL6;INSIG1;SCP2;ALOX12
prerank,mitotic chromosome condensation (GO:0007076),0.3933751141352892,0.9352727027629285,0.5564648117839607,0.837105067128943,1.0,7/26,18.26%,TENT4A;MCPH1;NCAPH;RB1;SMC4;CSNK2A2;CSNK2A1
prerank,regulation of complement activation (GO:0030449),0.3621943494907043,0.9352516468265829,0.5425038639876353,0.8366614262599956,1.0,4/40,7.48%,CFH;PROS1;CFB;CR1L
prerank,positive regulation of gene expression (GO:0010628),0.27859256694168594,0.9350071047063507,0.6624605678233438,0.8366852700803563,1.0,58/442,10.83%,LEF1;NOS3;RAB27A;CADM1;APP;TENT4A;MEF2C;IL15;ERN1;CLDN5;OCLN;SMAD1;PDGFB;GATA2;PDE2A;STAT3;NOTCH1;HIF1A;MSN;PPM1F;CD34;PLCG2;FGF23;SOX9;RBM20;DLL4;MAPK8;SERPINB9;RAMP2;TNRC6C;WNT5A;RPS7;IL36G;KRAS;DYRK1A;TAF1B;POLR1A;TGFB1;PIK3CG;BCL3;AGPAT1;NIBAN1;HNRNPD;NOS1AP;CITED1;SMARCA5;PSEN1;MYBBP1A;RPL23;SOX4;CSF1;HNRNPLL;MAPK11;RBM3;PRKAB1;MYO1C;GAS6;EIF6
prerank,metallo-sulfur cluster assembly (GO:0031163),0.39559180008112915,0.9349410897957409,0.554635761589404,0.8363096266233051,1.0,10/22,24.30%,ABCB7;MMS19;NUBP2;NUBP1;HSCB;LYRM4;NUBPL;FXN;CIAPIN1;CIAO2B
prerank,regulation of humoral immune response (GO:0002920),0.3535466295985619,0.9348558781667862,0.5391566265060241,0.8359895653391266,1.0,4/44,7.48%,CFH;PROS1;CFB;CR1L
prerank,negative regulation of catalytic activity (GO:0043086),0.3943180838405488,0.9347965132326315,0.5411954765751211,0.8356103589006417,1.0,3/24,7.32%,NOTCH1;PPP1R12A;NOSIP
prerank,genitalia development (GO:0048806),0.4472047578150639,0.9344853507649913,0.5435992578849722,0.8357423731285434,1.0,3/12,6.10%,CHD7;FOXF2;WNT5A
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3724852745191361,0.9343486416055156,0.5500794912559619,0.835561122496731,1.0,6/29,11.72%,SMAD1;DROSHA;DICER1;PUM1;ADAR;PUM2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3594264886860715,0.9341254907992423,0.5284431137724551,0.8354989352080298,1.0,10/39,18.35%,SOCS2;PIK3C2A;CISH;ITPKB;PIK3CG;SLA2;SOCS6;SOCS4;EFR3B;PIK3C2B
prerank,connective tissue development (GO:0061448),0.3689103256395033,0.9339648384978161,0.5577812018489985,0.8353249976366219,1.0,6/35,6.00%,SPTLC2;ZBTB16;LRP5;SOX9;XBP1;SNORC
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.3509707383309003,-0.9339526846976773,0.5544303797468354,0.9020987612479573,1.0,7/22,17.21%,NOTCH2;FGFR2;STXBP4;CASK;FGF7;MDK;FGF10
prerank,response to steroid hormone (GO:0048545),0.38125528467677655,0.9334529786295717,0.5437201907790143,0.8358824301586091,1.0,8/31,11.53%,CAV1;NR3C1;ABHD2;ATP1A3;ATP1A1;TGFB1;CATSPERD;UBE3A
prerank,positive regulation of phospholipase activity (GO:0010518),0.4081695024366432,0.932763830914593,0.5477815699658704,0.836800139268671,1.0,3/22,1.87%,FLT1;ESR1;PLCG1
prerank,nucleic acid metabolic process (GO:0090304),-0.2711473329881393,-0.9326983837473528,0.5986159169550173,0.9042212427974736,1.0,24/69,23.58%,ENPP1;HNRNPH1;HNRNPA2B1;DUSP11;RECQL5;RBFOX2;PCBP2;ATXN2;NT5E;RAD50;POLR2B;HNRNPR;HNRNPU;POLR2K;HNRNPA1;KPNA2;GTF2F1;SETMAR;DNA2;PDE12;POLR2I;POLG;DNASE2;DNASE1L2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4139061835028588,0.9325754928212667,0.5493716337522442,0.8366660962196287,1.0,3/18,5.95%,CAV1;NEDD4L;SLC43A2
prerank,DNA conformation change (GO:0071103),0.4163271095001826,0.932206366685803,0.552772808586762,0.8369223487024409,1.0,4/17,15.11%,HHEX;HAT1;TOP1;KAT6A
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.4087742711381731,-0.9321690342287364,0.5636363636363636,0.9043957371642765,1.0,4/13,17.10%,RHOQ;LRRK2;RAB23;ENTPD7
prerank,positive regulation of neuron differentiation (GO:0045666),0.36394172832642435,0.9321519797502565,0.5523672883787661,0.8365534440188256,1.0,6/40,8.26%,MEF2C;ARHGEF2;TCF4;BRINP2;TCF3;NEUROD1
prerank,nuclear membrane organization (GO:0071763),-0.3615271085872547,-0.9319602269341349,0.5609195402298851,0.9037690790242544,1.0,12/19,30.58%,AKAP8L;GPER1;UBXN2B;VPS4A;TMEM43;TARDBP;TOR1B;TOR1A;SPAST;TOR1AIP1;DCTN1;CHMP2A
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4515742663402141,0.9315024153464102,0.5530035335689046,0.8368556624176305,1.0,4/11,10.62%,INPP5K;SYNJ1;OCRL;INPP1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4515742663402141,0.9315024153464102,0.5530035335689046,0.8368556624176305,1.0,4/11,10.62%,INPP5K;SYNJ1;OCRL;INPP1
prerank,lysine metabolic process (GO:0006553),-0.40212154966369357,-0.9312754553663275,0.5774946921443737,0.9032835769665136,1.0,7/12,36.36%,ALDH7A1;PHYKPL;AASS;GCDH;SLC25A21;HYKK;CRYM
prerank,lysine catabolic process (GO:0006554),-0.40212154966369357,-0.9312754553663275,0.5774946921443737,0.9032835769665136,1.0,7/12,36.36%,ALDH7A1;PHYKPL;AASS;GCDH;SLC25A21;HYKK;CRYM
prerank,RNA processing (GO:0006396),-0.23953997295633425,-0.9311438702783728,0.6588235294117647,0.9025126387047868,1.0,34/176,16.06%,CELF2;SON;HNRNPH1;ATXN1;BICD1;SRSF5;PPARGC1A;HNRNPA2B1;DDX39B;LUC7L3;DUSP11;DDX17;RBMS1;NOVA1;APOBEC1;PRKACA;SRSF2;ADARB2;SRPK2;AKAP8L;WBP4;SRSF11;U2AF2;ZCRB1;RBM4;RNASEL;CELF1;LSM6;HNRNPR;HNRNPU;ELAVL4;RNPC3;SNRNP48;NONO
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.35094470612934436,-0.9309005774647017,0.5469879518072289,0.9019981211012931,1.0,1/20,0.34%,IGF1
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.35627771225204763,-0.9307990381452422,0.5522041763341067,0.9011242730384845,1.0,3/18,4.59%,ROCK2;SLC2A13;LRRTM3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.42760441682421413,-0.9304809030370237,0.56,0.8996412488030195,1.0,6/10,23.37%,PRKCD;SMPD3;NSMAF;PLA2G6;SMPD2;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.42760441682421413,-0.9304809030370237,0.56,0.8996412488030195,1.0,6/10,23.37%,PRKCD;SMPD3;NSMAF;PLA2G6;SMPD2;SPHK2
prerank,potassium ion export across plasma membrane (GO:0097623),0.43072250422535274,0.9304470561475731,0.5498220640569395,0.8385378498545086,1.0,2/13,7.06%,KCNQ1;KCNE2
prerank,peptidyl-lysine methylation (GO:0018022),-0.331513621603052,-0.9298632208972926,0.5687830687830688,0.9001069344880355,1.0,11/26,30.36%,KMT5A;EHMT2;SETD4;VCPKMT;EEF1AKMT1;METTL21A;ANTKMT;EEF2KMT;SETD7;EEF1AKMT3;METTL18
prerank,selective autophagy (GO:0061912),0.3452498366217705,0.9298225435302996,0.548621190130624,0.8392999573108434,1.0,11/56,15.30%,KLHL3;WDFY3;ULK1;PCNT;DYNLL1;DYNC1LI1;PJVK;ARL13B;RAB7A;ATG2A;ATG2B
prerank,negative regulation of gluconeogenesis (GO:0045721),0.45193282989295686,0.9295993309778651,0.5255198487712666,0.8392346924276258,1.0,1/11,3.05%,SIK1
prerank,response to reactive oxygen species (GO:0000302),0.34916951752902475,0.929493217703117,0.5776119402985075,0.8389535980419622,1.0,14/54,13.80%,HIF1A;FYN;STK24;PXN;CAT;PTPRK;MAPK8;STK26;PKD2;PJVK;COA8;GLRX2;GSTP1;SOD2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.4457844664091669,0.9288708524473173,0.5463917525773195,0.8397084507921021,1.0,2/12,9.45%,UCK2;UPP1
prerank,regulation of neuron projection development (GO:0010975),0.2981472767395894,0.9287369231412094,0.6142506142506142,0.8394687838025512,1.0,24/163,8.58%,SHANK3;ABI3;ITGA6;PRKD1;DAB2IP;LYN;PRAG1;PTK2B;PPFIA2;PAK2;TOX;CDH2;DISC1;SCARF1;RET;CCDC88A;WNT5A;RAPGEF2;RAP1A;SNX3;TRPV4;MBOAT1;CAMSAP2;PSEN1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.40308407134625895,0.9285010444141635,0.5448717948717948,0.839442417863636,1.0,7/21,12.53%,PDE2A;PDE4D;NT5C2;NUDT16;HINT1;HPRT1;XDH
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.3492570427020068,-0.9278386601410836,0.559322033898305,0.9041357200055509,1.0,5/20,22.75%,AKR1B1;FDX1;FDXR;TSPO;TSPOAP1
prerank,cellular defense response (GO:0006968),-0.3026121731885692,-0.9278349776503604,0.5632183908045977,0.9030132373290206,1.0,7/40,13.07%,DCDC2;CCR9;LBP;LSP1;ADORA2A;RAB23;IL1RL2
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.41708289771098395,-0.9275807366483232,0.5764462809917356,0.9025332750155527,1.0,4/10,30.36%,KMT5A;SETD4;SETD7;METTL18
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.2809293659872032,-0.9275631364685977,0.6127946127946128,0.9014541801936278,1.0,20/66,17.65%,EGFR;APPL2;FHL1;PKD1;DACT1;DLG1;KANK2;ANXA1;CCND2;ADAMTS1;UBE2E2;TFDP1;RGCC;PLK5;CDKN1A;RBL2;E2F1;HYAL1;FGF10;CDK2AP2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.44145462551833414,0.9271112316370328,0.5643224699828473,0.8417271840156586,1.0,4/15,5.08%,KDR;VEGFC;F7;VEGFD
prerank,positive regulation of receptor internalization (GO:0002092),-0.35398134155892635,-0.9269145662897851,0.5631067961165048,0.9019056346800484,1.0,7/22,10.00%,MAGI2;ANGPT1;SFRP4;ATAD1;AHI1;VEGFA;CD63
prerank,regulation of leukocyte migration (GO:0002685),-0.38445841386769575,-0.9265959607945298,0.5782312925170068,0.9016110991740881,1.0,5/16,11.16%,HOXA7;ANXA1;VEGFA;MIA3;CD81
prerank,protein localization to vacuole (GO:0072665),0.4327465446971297,0.926396140166903,0.5488029465930019,0.8427013698294283,1.0,3/13,11.29%,SH3BP4;SH3GLB1;GLMP
prerank,intermediate filament organization (GO:0045109),0.41713964560510197,0.9262280142526181,0.5523978685612788,0.84253679380319,1.0,5/17,24.26%,MTM1;KLHL24;BFSP2;DNAJB6;NEFL
prerank,programmed necrotic cell death (GO:0097300),0.4127641941916912,0.9262246461147802,0.5592334494773519,0.8420473974784444,1.0,5/18,17.87%,PGAM5;MLKL;RIPK1;TRPM7;IPMK
prerank,protein K63-linked deubiquitination (GO:0070536),0.3814830357685615,0.9260548651184428,0.5682182985553772,0.8418884018376541,1.0,10/31,19.17%,BABAM2;ATXN3;BRCC3;ZRANB1;OTUD4;ABRAXAS2;YOD1;USP8;USP7;USP25
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.2953261063180414,-0.926006640082928,0.5882352941176471,0.9020216642365888,1.0,11/44,14.48%,GSN;SPIRE1;CARMIL1;NCK2;BIN1;BAIAP2;PFN2;CDC42EP4;CDC42EP5;LMOD1;CTTN
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.3909035360033424,-0.9256472886391567,0.5517241379310345,0.9017491711994706,1.0,2/14,8.65%,ENPP1;ENPP3
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.35922159296137113,-0.9255582835349133,0.5610972568578554,0.9008378911031075,1.0,5/18,11.92%,HDAC4;SOX6;CCN3;BHLHE41;FZD7
prerank,regulation of immune effector process (GO:0002697),0.3552828909410523,0.9254255420044394,0.5487804878048781,0.8426472996437776,1.0,4/41,7.48%,CFH;PROS1;CFB;CR1L
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.4033088437682541,-0.9253607211423186,0.5327510917030568,0.9002115967421012,1.0,4/12,8.00%,CBLB;F3;APOD;IFT20
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.412774043175999,-0.9251678873603489,0.5665914221218962,0.8995756025195843,1.0,2/11,3.65%,CDH13;P2RX4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.4104912785128193,-0.9250179416697231,0.5627705627705628,0.8987939865196546,1.0,2/11,8.79%,TWSG1;RUNX1
prerank,regulation of cellular pH (GO:0030641),-0.32809658224180727,-0.9248860970419919,0.553072625698324,0.898024400521132,1.0,9/29,19.96%,SLC4A10;SLC9A9;SLC4A3;SLC4A2;SLC9A1;LACC1;SLC26A6;SLC4A8;SLC9A8
prerank,coenzyme A biosynthetic process (GO:0015937),0.4480261614626503,0.9241149072335407,0.5462962962962963,0.8437576184641234,1.0,4/11,19.84%,SLC25A16;PANK2;PANK3;PPCDC
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4480261614626503,0.9241149072335407,0.5462962962962963,0.8437576184641234,1.0,4/11,19.84%,SLC25A16;PANK2;PANK3;PPCDC
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4480261614626503,0.9241149072335407,0.5462962962962963,0.8437576184641234,1.0,4/11,19.84%,SLC25A16;PANK2;PANK3;PPCDC
prerank,histone H2A monoubiquitination (GO:0035518),-0.3621707133191986,-0.9240707394784583,0.5626423690205011,0.898933500915478,1.0,7/17,21.34%,BCOR;PCGF2;DDB2;RING1;DDB1;PCGF6;PCGF1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3735809786944027,-0.9237028843980793,0.5502392344497608,0.8987511201822371,1.0,5/15,7.53%,AAK1;SNAP91;DGKD;BMP2K;DAB2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.4433040895978372,0.9236836076498426,0.5738007380073801,0.8441312089508693,1.0,3/12,9.25%,STAT3;PROM1;DSCAM
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.40720459908979617,0.923211175861812,0.5536626916524702,0.8445834082619281,1.0,6/21,9.65%,NCK1;TMBIM6;XBP1;BOK;BCL2L11;BCL2L1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.37348286959415544,-0.9227012840326958,0.5817757009345794,0.9001099169982981,1.0,4/18,4.03%,DCN;PRKN;SPIRE1;MCU
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4084319445649283,0.9220276046557951,0.560530679933665,0.8464173275779944,1.0,3/18,4.89%,DAB2IP;MSN;VGLL4
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.3411842966306316,0.9209633321926604,0.571830985915493,0.8480345919653799,1.0,11/51,10.32%,BMPR2;SMAD1;SMURF1;NOTCH1;SMAD7;ACVR2A;GREM1;SOST;SKIL;SMAD5;UBE2D3
prerank,regulation of protein localization (GO:0032880),0.3393430038336441,0.9209418496181396,0.5704419889502762,0.8475752851825461,1.0,16/58,17.30%,TRIM14;FBXW7;PPM1F;FKBP1A;STX6;TRIM68;MAPK8;TRIM25;PICALM;ITGB3;RACK1;HSP90AB1;RABGAP1L;CEP290;MMD;USP8
prerank,generation of neurons (GO:0048699),0.29196550892688555,0.9204664468330418,0.625,0.8480473634009082,1.0,17/190,6.61%,LHX6;MEF2C;CDK6;ACSL4;CELSR1;FZD4;NAV1;DDIT4;CEP85L;DLL1;DISC1;CX3CR1;OPHN1;WNT5A;RAPGEF2;WNT9B;RAC1
prerank,cellular response to radiation (GO:0071478),0.35893980544331194,0.9204286063930667,0.5642965204236006,0.847622103364686,1.0,5/40,12.26%,NET1;OPN4;HUS1;OPN5;RHOB
prerank,carbohydrate transport (GO:0008643),0.4444119015915585,0.919890123007554,0.5579322638146168,0.8481692678366864,1.0,1/11,3.29%,AQP11
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.41850876660945846,0.9196812902445506,0.5601374570446735,0.8480723530340241,1.0,4/20,6.76%,FBXW7;SIK1;CEACAM1;TRIB3
prerank,excitatory postsynaptic potential (GO:0060079),0.4080378922160321,0.9194773406496829,0.5537190082644629,0.848000332853077,1.0,1/19,1.15%,MEF2C
prerank,cellular biogenic amine metabolic process (GO:0006576),0.44690709322588773,0.919366908319168,0.5704347826086956,0.8477042647257462,1.0,1/12,1.02%,MAOA
prerank,anterior/posterior axis specification (GO:0009948),-0.3706851151789351,-0.9190899698933698,0.5612009237875288,0.9077904606430218,1.0,1/15,0.48%,WLS
prerank,regulation of RNA metabolic process (GO:0051252),0.334301350256709,0.9179237525943096,0.5722713864306784,0.8500377709887305,1.0,14/59,12.18%,NOVA2;TNFRSF1B;IGF2BP3;RBM20;MBNL1;PTBP3;MBNL2;HNRNPF;MBNL3;RASA1;ZNF326;HNRNPLL;RC3H1;OASL
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4552348745517176,0.9177485443260067,0.5456171735241503,0.849892368005496,1.0,2/10,5.94%,MSN;OPHN1
prerank,negative regulation of defense response (GO:0031348),0.32386102320133636,0.9177047763136459,0.596514745308311,0.8494819875798092,1.0,4/77,3.34%,TEK;PPARD;MFHAS1;LPCAT3
prerank,transport along microtubule (GO:0010970),-0.39448944449731793,-0.9174415638154522,0.5831533477321814,0.9107933525380848,1.0,6/13,11.02%,ARHGAP21;APBA1;CLIP3;COPG1;DYNC1I1;SPG11
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3406545685439396,0.9173750499856035,0.5724743777452416,0.8496545780806308,1.0,11/52,15.35%,PPP1R13B;FBXW7;CASP8;MAPK8;SH3GLB1;UBE2D3;SFN;BID;SAE1;YWHAQ;ARIH2
prerank,mucosal immune response (GO:0002385),0.41750668294471055,0.9172038115603673,0.5898778359511344,0.8494837272798008,1.0,2/15,9.16%,RPL39;DEFA6
prerank,positive regulation of protein deacetylation (GO:0090312),0.4326571329980496,0.9171804256584464,0.5839285714285715,0.8490280343794777,1.0,6/14,22.93%,DYRK1A;CTBP1;APLNR;FNTA;SAP30BP;NIPBL
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.41404298067476597,-0.9167790488814617,0.577922077922078,0.9113347864579664,1.0,6/11,21.31%,FAP;SIRT2;FZD3;PTGIS;DFFA;TP53
prerank,regulation of protein catabolic process (GO:0042176),0.3122738781209493,0.916297244754137,0.6125166444740346,0.850288910162369,1.0,20/99,16.65%,FOXO1;SMURF1;DAB2IP;NEDD4L;PLK2;WNT5A;CDKN1B;SNX3;NEDD4;VPS28;MAD2L2;RAB26;RILP;ASB11;RAB7A;APC;PRKCG;IRAK3;AREL1;CHEK2
prerank,lymphocyte chemotaxis (GO:0048247),-0.31287397686627133,-0.9162242146358681,0.6011560693641619,0.9116167679297238,1.0,3/34,3.99%,CYP7B1;SLC12A2;CXCL16
prerank,regulation of establishment of planar polarity (GO:0090175),0.3139045459309234,0.916180470292139,0.6055172413793104,0.8500255502146146,1.0,13/88,12.59%,SMURF1;CELSR1;FZD6;FZD4;AP2B1;WNT5A;RAC1;AP2A1;PSMA2;PSMA8;PSMA6;PRICKLE1;VANGL2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.35963410783894745,0.915965805077949,0.5550387596899224,0.849997153223017,1.0,7/37,8.46%,APP;PARD3;DDIT4;SMAD7;INPP5K;TGFB1;RPTOR
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.4221449267326869,0.9159622245353743,0.5852372583479789,0.8495052936392876,1.0,2/15,3.86%,PPARD;ELOVL5
prerank,response to organophosphorus (GO:0046683),-0.36410361686033477,-0.9158239737949805,0.5914489311163895,0.9114868951161884,1.0,3/16,5.70%,P2RX4;ABCC9;TRPC3
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.41275272041365546,-0.9156158538408289,0.5545657015590201,0.9108379064911052,1.0,2/10,5.19%,DNMT3A;IGF2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.32562134050010905,-0.9150829881755552,0.5722070844686649,0.911060709338952,1.0,10/27,15.94%,SLC7A2;SLC1A3;SLC47A1;SLC6A9;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC22A2;SLC25A18
prerank,regulation of lipid kinase activity (GO:0043550),0.4377052784011221,0.9150282316197614,0.5626168224299065,0.8508570661027115,1.0,3/11,18.00%,PPP2R5A;RB1;RBL1
prerank,acyl-CoA metabolic process (GO:0006637),0.36161622802184457,0.914883403257084,0.5690690690690691,0.8506499374865285,1.0,3/35,4.12%,HMGCS2;ACACB;GLYAT
prerank,positive regulation of double-strand break repair (GO:2000781),0.354035166291751,0.9147182751458565,0.5797546012269938,0.8504657853916379,1.0,17/39,25.04%,SMCHD1;DTX3L;SHLD1;WRAP53;MAD2L2;MMS19;ACTR2;SPIDR;WDR48;KMT5B;PARP9;MGMT;FUS;RIF1;ERCC6;ARID2;FMN2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.30853085147561327,0.9145953609737698,0.5967540574282147,0.8502063141685896,1.0,22/104,14.33%,BMPR2;CAV1;SMAD1;SMURF1;NOTCH1;FKBP1A;SMAD7;ACVR2A;GREM1;ACVR1;SOST;SNX25;TGFB1;SKIL;SMAD5;UBE2D3;TGFBR2;ADAM17;PMEPA1;FAM89B;BCL9L;ACVR2B
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.38935658157966113,0.9143344090900695,0.5681444991789819,0.8502147354514452,1.0,4/24,7.96%,B2M;MFSD6;TAP2;ERAP1
prerank,phagolysosome assembly (GO:0001845),0.4367272202962195,0.913967365736355,0.5731292517006803,0.8504390571406879,1.0,4/12,15.28%,ARL8B;RAB7A;RAB7B;SYT7
prerank,lytic vacuole organization (GO:0080171),-0.31444043266207655,-0.9139220051504439,0.5808383233532934,0.912757754119853,1.0,13/32,25.88%,ARSB;LRRK2;GAA;CLVS2;HPS4;HPS1;HOOK2;TPP1;CLN3;ACP3;SNAPIN;LAMTOR1;MTOR
prerank,protein autoprocessing (GO:0016540),0.4140317438936417,0.913780707724209,0.581151832460733,0.850300820348038,1.0,3/17,13.22%,CASP4;CASP1;OMA1
prerank,positive regulation of ATPase activity (GO:0032781),-0.3044853864007548,-0.9137492789436664,0.5924855491329479,0.912056507268644,1.0,11/41,20.45%,ATP1B1;TPM1;RYR2;ATP1B2;DNAJB11;PFN2;HNRNPU;FGF10;MSH6;SETMAR;DNAJB2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.35155082336542615,0.9136173032989204,0.5796460176991151,0.8501216956570986,1.0,10/44,13.24%,DAB2IP;LYN;PTPRJ;INPP5K;DNAJA1;PTPN1;AIDA;STK38;GSTP1;DUSP7
prerank,glycine metabolic process (GO:0006544),0.432183004463077,0.9134226240206538,0.5706521739130435,0.8500033980835867,1.0,1/12,4.12%,GLYAT
prerank,regulation of protein kinase C signaling (GO:0090036),-0.38150875049164695,-0.9133755583376767,0.5600961538461539,0.9118341107363008,1.0,8/14,18.26%,ADGRV1;DGKD;ULK4;VEGFA;ADRA1A;GPD1L;WNT11;MYADM
prerank,protein homooligomerization (GO:0051260),0.30154788813913985,0.9129152206566359,0.6188055908513341,0.8505944945899525,1.0,27/114,19.75%,EHD4;B2M;GBP5;SAMHD1;ACACB;AQP11;GLS;ALOX5AP;MLKL;PKD2;HPRT1;RNF112;EHD3;SIGMAR1;SOD2;ATL1;G3BP2;PNPT1;APIP;TIFA;CBR4;CARD9;GLRA3;FUS;OSBPL2;BCL10;ALDH1A3
prerank,embryonic axis specification (GO:0000578),-0.37411679231800177,-0.9125561537214005,0.6080760095011877,0.9127970528493244,1.0,8/15,28.82%,COBL;SMAD6;CXXC4;TBX3;PTCH1;FZD5;STIL;RIPPLY2
prerank,TOR signaling (GO:0031929),0.38276954238420857,0.912084865104711,0.5728476821192053,0.8517218896192298,1.0,8/26,18.72%,CCDC88A;PRR5L;RPTOR;RICTOR;EIF4EBP1;RPS6;TIPRL;SYAP1
prerank,negative regulation of ion transport (GO:0043271),-0.3318663935307872,-0.9117333377072443,0.6076923076923076,0.9136739216677107,1.0,8/24,14.96%,ACTN2;GPM6B;WNK4;SYT11;ADRA2A;WNK1;SNCA;WNK3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3260462560683542,0.9112824838739849,0.6143057503506312,0.852822303703217,1.0,25/67,25.41%,B2M;IKBKB;TAP2;PSMA2;IKBKG;SNAP23;PSMA8;FCGR1A;PSMA6;VAMP8;PSME1;PSMA4;PSMF1;SEC22B;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;TAP1;CYBA;PSMD3;PSMA3;VAMP3;TAPBP
prerank,positive regulation of protein maturation (GO:1903319),0.4431831867138002,0.9109924120181147,0.5978062157221207,0.8528975882788059,1.0,3/11,9.33%,NKD2;RHBDD1;SOX4
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.4362222729246953,0.9108907184537763,0.5537918871252204,0.8525966950052738,1.0,6/13,19.86%,JAK3;PIGU;IL7R;MGAT5;CRLF2;HES1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.39744965096349727,0.9108260037861551,0.5834738617200674,0.852229640455453,1.0,4/21,10.91%,JAK3;TIGIT;SAMSN1;LST1
prerank,protein deubiquitination (GO:0016579),0.2826587733549784,0.9106068432777996,0.6580135440180587,0.8521910992967303,1.0,73/242,23.27%,ESR1;SMAD1;HIF1A;NFKBIA;MINDY1;USP3;BABAM2;MINDY2;SMAD7;USP15;UCHL5;ATXN3;SNX3;PSMA2;BRCC3;FOXK1;ZRANB1;IKBKG;PSMA8;RAD23A;TNIP1;PSMA6;OTUD4;ENY2;RIPK1;ASXL1;BIRC3;IFIH1;TRAF6;APC;PSME1;MBD5;YY1;KAT2B;USP12;OTULIN;ACTR5;BIRC2;RHOA;ABRAXAS2;WDR48;RHOT1;NEDD8;YOD1;USP8;WDR20;DESI2;NFRKB;PSMA4;USP7;PSMF1;STAM;NLRP3;USP25;USP21;SMAD2;PSMB7;PSMB1;TRRAP;ATXN7;PSMD2;TADA2B;TNIP2;BABAM1;PSMA5;CCNA2;PSMC3;EIF3F;JOSD1;STAM2;UCHL3;ADRM1;TRAF2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.3699058782966885,0.910467915677848,0.6026936026936027,0.851980120848711,1.0,6/31,16.20%,GCH1;GPHN;MOCOS;SRD5A2;STAR;SRD5A1
prerank,Rho protein signal transduction (GO:0007266),0.33623848499035763,0.9101701803097525,0.6071428571428571,0.8520763850270704,1.0,7/53,4.40%,NTN1;EPS8;ARHGEF3;CELSR1;ADGRG1;PLEKHG5;RHOJ
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.442545833611609,0.9097468910357231,0.5703703703703704,0.8519674116229354,1.0,3/11,16.26%,FKBP1A;PKD2;CALM1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.442545833611609,0.9097468910357231,0.5703703703703704,0.8519674116229354,1.0,3/11,16.26%,FKBP1A;PKD2;CALM1
prerank,megakaryocyte differentiation (GO:0030219),0.44386357439592483,0.9097017570124418,0.5686653771760155,0.8515582109769959,1.0,2/11,9.03%,TAL1;ZFPM1
prerank,positive regulation of growth (GO:0045927),0.3274797559854382,0.9094695734191937,0.6090534979423868,0.8515244447208757,1.0,15/64,14.35%,INSR;ADAM10;PPM1F;PLCB1;RPS6KA3;SDCBP;RPS6KA1;H3-3A;RPTOR;RFTN1;SFRP2;MTPN;ADAM17;ERBB2;S100A9
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.33269752746521797,0.9094419894735299,0.5813953488372093,0.8510934989007332,1.0,8/54,7.93%,CAV1;NEDD4L;KCNQ1;GNB1;KCNMB4;KCNE2;NEDD4;NOS1AP
prerank,glycerol metabolic process (GO:0006071),-0.4179442070610554,-0.9092963911398723,0.5928270042194093,0.918570971286245,1.0,4/10,18.11%,GK;GOT1;TPI1;ANGPTL3
prerank,inositol phosphate catabolic process (GO:0071545),0.4362014273505007,0.9092754693098251,0.572972972972973,0.8509107130634193,1.0,4/12,10.62%,INPP5K;SYNJ1;OCRL;INPP1
prerank,endoplasmic reticulum organization (GO:0007029),0.31965818338497737,0.9090679659615447,0.6095238095238096,0.8508118579956304,1.0,12/72,14.33%,APP;REEP1;LPCAT3;CAV2;DOP1B;STX1A;TRAM1;TRAM1L1;RNF112;ATL1;ALDH3A2;RAB18
prerank,diacylglycerol metabolic process (GO:0046339),0.38720764692213844,0.9088671442537227,0.5845896147403685,0.8507149357068768,1.0,9/23,15.79%,DGKZ;LIPE;DGKH;ANG;DGKE;MOGAT1;PNPLA2;DGAT1;MOGAT2
prerank,protein destabilization (GO:0031648),-0.31645933413454,-0.908647376507629,0.6084656084656085,0.9190342458082162,1.0,7/32,14.83%,GSN;PRKN;BTRC;MDM2;KDM8;HTT;SNCA
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3952333525536057,0.9079460506003475,0.5824915824915825,0.8520530616697694,1.0,5/20,14.29%,HHEX;CDKN1B;TFAP4;INCA1;APC
prerank,positive regulation of nervous system development (GO:0051962),-0.29431162067553435,-0.9077695652950917,0.6439169139465876,0.9199706661872896,1.0,12/42,13.08%,NLGN2;CLSTN2;CUX2;PTPRD;IL1RAPL1;NRXN1;NLGN1;SERPINF1;NLGN3;SRPX2;GRID2;GPER1
prerank,cytoplasmic translational initiation (GO:0002183),-0.3617918837579658,-0.9076447165538856,0.5862068965517241,0.9191920771086971,1.0,9/17,31.25%,EIF4A1;EIF2S2;RBM4;EIF3A;EIF2D;EIF4G1;EIF2B3;EIF4A2;EIF4B
prerank,spindle assembly (GO:0051225),0.3194264910545397,0.9074013677766797,0.6077348066298343,0.8526096082586969,1.0,19/67,21.97%,NEK7;RAB11A;STARD9;NEK6;STAG2;STAG1;LSM14A;CHEK2;RHOA;ABRAXAS2;WRAP73;MZT1;NUMA1;BCCIP;RPS3;PIBF1;KPNB1;KIF2A;SAC3D1
prerank,hexose metabolic process (GO:0019318),0.35304522492130236,0.9072157001489947,0.5767511177347243,0.8524676349307259,1.0,7/39,14.02%,PPARD;FUCA2;FBP1;SORD;PMM2;OMA1;GALM
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.29378328745414334,-0.9071817594469227,0.6268656716417911,0.9192148528327393,1.0,9/41,18.45%,IGF1;LBP;SELENOS;SYT11;PTPN22;SIRPA;NR1H4;CACTIN;CHRNA7
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.36988994898466787,0.9071718932154408,0.5893719806763285,0.8520596573788835,1.0,2/32,1.87%,CAV1;PLCG1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.326586003225749,0.9068787736292948,0.5922330097087378,0.8521472979896625,1.0,9/59,6.69%,PRKD1;PRKD2;LMTK2;HIPK1;CDC42BPB;MAPK8;ULK1;ACVR1;DYRK1A
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.36021480364311265,0.9064277153372322,0.5782945736434109,0.8525351411438218,1.0,6/30,10.42%,CAV1;SAMSN1;NF2;INPP5F;SFRP2;SEMA4D
prerank,membrane depolarization (GO:0051899),0.36184485932846955,0.9063789369165792,0.5868544600938967,0.8521447354644334,1.0,3/32,5.86%,CAV1;CACNA1E;CACNA1A
prerank,lipid biosynthetic process (GO:0008610),-0.2619035409516729,-0.9059648105685855,0.6513409961685823,0.9210063648633056,1.0,20/77,21.41%,ACSL1;ABCD3;AGPAT4;PRKAA2;SREBF1;ACACA;PCYT2;GPAM;SCD;PRLR;FDFT1;ACSS2;SCP2;MVK;LPCAT1;AGPAT3;FDXR;LSS;SCD5;CYP51A1
prerank,mRNA metabolic process (GO:0016071),-0.259105697775511,-0.9055442524982139,0.6928838951310862,0.9209766475674133,1.0,16/90,13.74%,SON;DDX5;SRSF5;PPARGC1A;HNRNPA2B1;PRKACA;PCBP2;SRSF2;AKAP8L;AGO3;SRSF11;U2AF2;CNOT10;CELF1;LSM6;HNRNPR
prerank,signal transduction in response to DNA damage (GO:0042770),0.3420774218619154,0.9052621228081554,0.5945945945945946,0.853842418895668,1.0,14/49,20.50%,ACER2;BCL3;BRIP1;MAD2L2;HUS1;BID;MAP3K20;ATRX;E2F7;CHEK2;TIPRL;GRB2;MYO6;RAD17
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3877918896596966,0.9052073273187057,0.5748792270531401,0.8534619659769976,1.0,7/24,14.50%,AQP11;LPCAT3;TMBIM6;XBP1;BCL2L1;RACK1;UBXN1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.38126668836513955,0.9046434710296141,0.5958132045088567,0.8541152303028,1.0,10/25,23.49%,BTBD18;NELFE;BRD4;EAF1;ZMYND11;NELFCD;CDC73;NELFB;NELFA;EAPP
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.3965431631552637,0.9044602940368174,0.5843071786310517,0.8539947355155377,1.0,4/21,5.39%,TOX;DISC1;DLL4;CX3CR1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.41320273917836425,-0.9043756029439098,0.6117136659436009,0.9227191846659232,1.0,1/10,1.35%,APPL2
prerank,RNA modification (GO:0009451),0.333332353617413,0.9043461341160128,0.5920114122681883,0.853716612918493,1.0,16/54,25.64%,ADARB1;CDKAL1;RBM15;ADAR;NSUN4;HENMT1;DTWD2;TRMT6;PUS7L;JMJD6;THUMPD1;TRUB1;NSUN6;PUS7;AARS2;LCMT2
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3929473941142827,0.9032544803553589,0.5837479270315091,0.8553628096945846,1.0,3/22,8.59%,PPARD;SORBS1;CREB1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.39282105935513545,0.9030164706273114,0.5935919055649241,0.8553404500968956,1.0,5/18,16.45%,MFHAS1;CTNNA1;POLR1A;ILRUN;CHP1
prerank,protein polyglutamylation (GO:0018095),0.4512231381164193,0.9029288287450816,0.5996309963099631,0.8550253668472034,1.0,5/11,20.81%,CEP41;TTLL7;TTLL5;TPGS1;TTLL9
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.33541095943318017,0.9024959335108884,0.6005706134094151,0.8554399957739933,1.0,15/51,24.36%,NEK7;HMBOX1;PINX1;ACD;DCP2;HNRNPC;TERF1;CTNNB1;CCT7;CCT2;TEN1;MAP2K7;SMG6;TENT4B;TNKS
prerank,regulation of protein localization to cell periphery (GO:1904375),0.40713073204671824,0.9021404984111332,0.6074600355239786,0.8556427962525589,1.0,4/18,11.53%,SPTBN1;STX7;VAMP8;STX8
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.2890976582780035,-0.9018956545957311,0.6470588235294118,0.9276368900316687,1.0,13/46,21.71%,ZIC1;PRKCD;CDH1;SMAD3;CAMK1;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;TP53;BAG3
prerank,positive regulation of sodium ion transport (GO:0010765),0.4306416335204992,0.9013688894772026,0.564638783269962,0.8566044922512033,1.0,1/12,1.76%,CNKSR3
prerank,negative regulation of viral genome replication (GO:0045071),0.35040114892264407,0.9011059885479583,0.5834609494640123,0.8566426645641486,1.0,12/40,19.34%,ISG20;N4BP1;INPP5K;TASOR;TNIP1;OASL;IFIH1;IFITM3;PLSCR1;BST2;IFITM1;EIF2AK2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2906308991805725,-0.9000620863953602,0.6246056782334385,0.9310154658298653,1.0,9/43,18.45%,IGF1;LBP;SELENOS;SYT11;PTPN22;SIRPA;NR1H4;CACTIN;CHRNA7
prerank,regulation of cholesterol esterification (GO:0010872),-0.41239651916229614,-0.8998152199356572,0.5977777777777777,0.9305031043256123,1.0,4/10,25.16%,AGTR1;APOE;ABCA2;LAMTOR1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.39918907658402597,0.8996533012139225,0.5793103448275863,0.859034704015162,1.0,9/20,18.52%,CASP8;SDCBP;PELI1;MLKL;RIPK1;BIRC3;ASAH1;BIRC2;CDC37
prerank,pre-miRNA processing (GO:0031054),0.4150579799682131,0.8996282999647718,0.5904255319148937,0.8585957841503464,1.0,5/14,21.33%,DROSHA;DICER1;ADAR;MRPL44;PRKRA
prerank,cardiocyte differentiation (GO:0035051),-0.4214987058868846,-0.899561990850835,0.6087912087912087,0.9300104296237566,1.0,6/10,22.54%,AKAP13;TGFB2;MYOCD;KDM6B;EEF1AKMT4-ECE2;CBY1
prerank,nucleus organization (GO:0006997),0.34036952559629774,0.8993801098007544,0.6060606060606061,0.8585770769025557,1.0,11/47,14.27%,RPS19;CHMP2B;SYNE1;CHMP4A;CHMP4B;NUP98;NUP133;NUP205;SPAG4;PITPNB;NUP54
prerank,lymphocyte mediated immunity (GO:0002449),-0.38423213099119197,-0.899105155904316,0.5873362445414847,0.929981027740558,1.0,3/12,14.90%,CD55;JAG1;GNL1
prerank,action potential (GO:0001508),0.3423275569749175,0.8987674821356474,0.6146926536731634,0.8592579149886546,1.0,5/44,7.06%,GNAQ;KCNQ1;KCNB1;KCNMB4;KCNE2
prerank,iron ion homeostasis (GO:0055072),0.32704779182155796,0.898682436576362,0.6181046676096181,0.8589290602564719,1.0,12/58,17.46%,ABCG2;B2M;ABCB7;LCN2;GLRX3;CUL1;PICALM;HMOX2;CP;FRRS1;NEDD8;NUBP1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.32746141243479315,-0.8985193619097528,0.6157894736842106,0.9302853960240983,1.0,6/24,13.37%,DMD;JPH1;AKAP6;PRKACA;GSTM2;JPH2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.4392751136393974,0.8984756078768913,0.5815217391304348,0.8588450446637413,1.0,4/11,12.73%,DCTD;TPK1;NT5C3A;SLC19A3
prerank,ERBB2 signaling pathway (GO:0038128),-0.3103248580840465,-0.8981833575263165,0.6193181818181818,0.9300328134918834,1.0,6/31,9.04%,EGFR;ERBB4;HSP90AA1;SHC1;PRKCA;SRC
prerank,macrophage migration (GO:1905517),-0.38823810742342085,-0.897363249962016,0.6280087527352297,0.9308508882372835,1.0,6/13,34.15%,P2RX4;TAFA4;CCR2;CCL2;CXCL17;CCL5
prerank,indolalkylamine catabolic process (GO:0046218),-0.41723222788881664,-0.8969104122447775,0.5951327433628318,0.9308098320454113,1.0,8/10,51.94%,KYAT1;HAAO;KYNU;AADAT;TDO2;KMO;IDO1;ACMSD
prerank,positive regulation of mRNA processing (GO:0050685),-0.33745634287782444,-0.896868739445422,0.5969387755102041,0.9297865411131718,1.0,5/21,10.10%,CELF4;DAZAP1;PAF1;LEO1;CIRBP
prerank,regulation of organelle assembly (GO:1902115),0.3216440788328211,0.8966044846463208,0.6229508196721312,0.8619284173303393,1.0,13/72,14.04%,TBC1D8;MSN;TBC1D22A;TBC1D15;PLK2;TBC1D12;TBC1D2;RNF4;NPRL2;TBC1D5;EVI5;RAB5A;NPM1
prerank,regulation of mononuclear cell migration (GO:0071675),0.38549188603693396,0.8964168190194286,0.6112903225806452,0.861803989183602,1.0,5/23,9.46%,LYN;STK10;MSN;PTK2;CSF1
prerank,cognition (GO:0050890),0.35398003358857527,0.8962618346902268,0.5967261904761905,0.8616361429243727,1.0,5/42,5.98%,APP;SHROOM4;CHD7;DOP1B;CHMP2B
prerank,"wound healing, spreading of cells (GO:0044319)",0.3771079767867298,0.8956239188625201,0.6029173419773096,0.8624137208722205,1.0,5/24,7.98%,LCP1;ACVRL1;MRTFA;CEACAM1;ITGA5
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3155138898548813,-0.8954300973639011,0.5895316804407713,0.9321830700358936,1.0,7/29,12.80%,GOLGA5;COPZ2;COPB1;COPA;COPG1;TRAPPC10;COG8
prerank,chloride transmembrane transport (GO:1902476),-0.2848947487056547,-0.895207383400965,0.6583333333333333,0.9315478455054026,1.0,20/48,22.93%,SLC1A3;SLC12A2;SLC6A1;GLRB;ANO1;GABRG2;ANO4;GABRA2;GABRB1;ANO3;GABRB3;GABRG3;SLC1A1;CFTR;SLC4A8;CLCN1;GABRA1;SLC12A8;GABRA5;GABRA3
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.342635225683076,0.8950129728889057,0.591044776119403,0.8630950547537765,1.0,14/39,20.49%,PTPN12;DAB2IP;PTPRJ;TGFA;ARHGEF7;CBL;LGMN;ERBB2;SH3GL2;GRB2;STAM;BTC;TSG101;EPS15
prerank,autonomic nervous system development (GO:0048483),-0.356620715444681,-0.8948336105852862,0.6159420289855072,0.931327796396567,1.0,3/17,8.07%,NRP1;NF1;SEMA3A
prerank,response to nutrient levels (GO:0031667),0.4102753231153885,0.8945056461892124,0.609375,0.863573679798104,1.0,3/17,8.46%,KCNB1;ULK1;RPTOR
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.35559406612027233,-0.894364265304613,0.6032863849765259,0.9313132497263666,1.0,6/16,21.38%,AMPD3;LHPP;PAICS;ATIC;PFAS;ADSS1
prerank,membrane raft organization (GO:0031579),-0.3651486552503538,-0.8943432370271917,0.6203703703703703,0.9302578806904737,1.0,7/15,22.68%,ANXA2;S100A10;FLOT2;ABCA7;MYADM;PPT1;CLN3
prerank,positive regulation of proteolysis (GO:0045862),0.32820450133102785,0.8941998037076474,0.6149341142020498,0.863674311268118,1.0,4/55,3.89%,CTSC;TNFRSF1B;CASP8;NKD2
prerank,negative regulation of synaptic transmission (GO:0050805),-0.32129701279766926,-0.8939327188941024,0.5847665847665847,0.9300679662246056,1.0,5/23,10.86%,ATAD1;SYT11;LRRK2;SLC24A2;PRRT1
prerank,maintenance of protein location in nucleus (GO:0051457),0.39389375108565416,0.8932870479435298,0.5897858319604613,0.8649398674409062,1.0,4/20,14.50%,SYNE1;BCL3;TAF3;TOPORS
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.43645071035618754,0.892558822503766,0.6018691588785047,0.8658382671160971,1.0,5/10,23.71%,CDT1;ATRX;E2F7;DBF4;STOML2
prerank,proteasomal protein catabolic process (GO:0010498),0.28111414706145577,0.8923251902863878,0.6765053128689492,0.8657858927842867,1.0,59/201,22.49%,SMURF1;NEDD4L;FBXW7;ZNRF1;KCTD10;PELI1;ATXN3;ARRB1;UBE2G1;PSMA2;NEDD4;ARMC8;RNF139;RHBDD1;SPOPL;RNF4;ZFAND2B;PSMA8;RAD23A;SIAH1;UBE2D3;PSMA6;COP1;DDI1;UBE2K;TOPORS;UBXN1;PSME1;SOCS6;RNF5;DDIT3;DDI2;UBE3D;AREL1;CRBN;BIRC2;NHLRC1;CTNNB1;MAEA;CUL3;CDC34;PSMA4;DNAJB12;PSMF1;ZFAND2A;APPBP2;CCDC47;PSMB7;TRIM71;PSMB1;HACE1;KCTD2;SEL1L;PSMD2;KCTD5;KLHL42;UBXN2A;PSMA5;PSMC3
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.31734315541613306,0.8920267657794235,0.617816091954023,0.8658707933150719,1.0,22/64,25.61%,MLLT3;CCNK;GTF2F2;NELFE;EAF1;ELOC;NELFCD;CTDP1;GTF2H4;CDC73;GTF2H1;NELFB;POLR2L;CCNH;NELFA;RTF1;POLR2J;ADRM1;IWS1;TCEA2;GTF2H5;PCID2
prerank,pulmonary valve morphogenesis (GO:0003184),0.4026977181562708,0.8917952422359684,0.608318890814558,0.8658528927217426,1.0,3/17,2.77%,NOS3;NFATC1;NOTCH1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.37352776995939535,-0.8911912145211082,0.6084070796460177,0.9354672917308287,1.0,4/12,15.88%,SIX1;VEGFA;SMO;PAX8
prerank,transepithelial transport (GO:0070633),0.4129067927341036,0.891097079123275,0.6013745704467354,0.8666811128747832,1.0,2/15,4.74%,ABCG2;BEST1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.4173914485366105,0.8910710326617867,0.5923217550274223,0.8662417431073911,1.0,5/14,22.83%,TSEN34;RTCB;CPSF1;TSEN2;RTRAF
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.4416890293595463,0.8908097927710938,0.5767097966728281,0.8662752263274484,1.0,3/11,15.34%,H3-3A;HAT1;ATRX
prerank,dendrite morphogenesis (GO:0048813),0.3559708346705433,0.8907136674283321,0.6030769230769231,0.865968077947939,1.0,3/35,3.42%,SHANK3;KLF7;TAOK2
prerank,midbody abscission (GO:0061952),0.4040100798105979,0.8898828001028719,0.5975177304964538,0.8671241175441843,1.0,3/17,9.20%,CHMP2B;CHMP4A;CHMP4B
prerank,heterotypic cell-cell adhesion (GO:0034113),0.38663999937811966,0.889709417646568,0.6036789297658863,0.8669677136616677,1.0,5/25,11.77%,VCAM1;CD200;ITGA5;IZUMO1;ITGB3
prerank,organelle transport along microtubule (GO:0072384),-0.30712158651751253,-0.8895424374849406,0.6253602305475504,0.9383063563990537,1.0,8/31,16.42%,BICD1;ARHGAP21;COPG1;DYNC1I1;HTT;BICD2;TRAK1;MAP1S
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2840766656383846,-0.8894929164601362,0.64375,0.9373213510950212,1.0,11/44,16.21%,SH3RF1;THBS1;NGF;FNIP1;SIAH2;CD44;SRC;VEGFA;SNCA;USP47;MT3
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3581497417043782,-0.8892573311701409,0.6059907834101382,0.9367585252017829,1.0,4/16,8.33%,RANBP3L;IGFBP3;BOC;RIPOR2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.37117446175060775,0.8892354391961369,0.6169871794871795,0.8674513147743869,1.0,2/26,3.34%,PDE8A;FYN
prerank,response to peptide hormone (GO:0043434),-0.2907872993175542,-0.8891879416484576,0.6646341463414634,0.9358148935636561,1.0,9/43,10.15%,ROCK2;TGFBR3;IRS1;IGFBP5;OGT;ANXA1;GNAI1;SRC;SLC27A1
prerank,SNARE complex assembly (GO:0035493),0.44822576756517485,0.8891783719974317,0.599644128113879,0.8670715019145696,1.0,3/10,15.22%,VAMP4;VAMP8;STXBP6
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.3295411731747744,-0.8891609643032076,0.6237623762376238,0.9347799105655757,1.0,6/22,15.93%,BMP7;BMP4;INHBA;CDKN1A;CDKN1C;PLEK
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4015749931521965,-0.8886800745535436,0.6100217864923747,0.9348230756377027,1.0,4/11,8.61%,RSPO3;PLEKHA4;DAB2;SFRP1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3756274659681955,0.8880663368200248,0.5859247135842881,0.8687441242469225,1.0,3/23,5.16%,PTK2B;NOTCH1;GHR
prerank,positive regulation of axonogenesis (GO:0050772),0.3429559869959884,0.8879282315816329,0.6074074074074074,0.8685003822385433,1.0,4/43,2.82%,PLXNA4;NTN1;SEMA7A;PLXND1
prerank,vacuolar acidification (GO:0007035),-0.3319565088029583,-0.8876247475876888,0.6291866028708134,0.9362757913277321,1.0,13/21,35.60%,ATP6V0A4;ATP6V0D1;ATP6AP2;PPT1;SLC11A1;CLN3;TMEM199;TMEM9;CCDC115;ATP6V0D2;GRN;DMXL2;TCIRG1
prerank,regulation of endocytic recycling (GO:2001135),-0.3996092730262877,-0.8872575887537262,0.6013215859030837,0.936006693623868,1.0,4/11,13.77%,ACTN2;ATP9A;EHD1;ARHGAP1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.41288868641508436,0.8871928013531001,0.6149825783972126,0.8694505124375853,1.0,3/15,7.06%,KCNQ1;ATP1A1;KCNE2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.4219883228074703,0.8871628796836768,0.5992366412213741,0.8690226664442139,1.0,3/13,12.71%,NCK1;PTPN1;RACK1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.32990235452795075,0.887018475966522,0.6233576642335766,0.8688339876827988,1.0,13/52,13.14%,CNOT6;PAN3;CNOT6L;EDC3;CNOT1;RC3H1;EXOSC1;CNOT2;DCP2;LSM3;HBS1L;ZFP36;CNOT7
prerank,inner ear morphogenesis (GO:0042472),0.38646484645723905,0.8868138098682626,0.580906148867314,0.8687309285139584,1.0,4/22,6.26%,TBX1;CHD7;SOX9;TMIE
prerank,"transcription, DNA-templated (GO:0006351)",0.27690633153657435,0.8858097582537209,0.7183431952662722,0.8701803737575183,1.0,62/207,22.56%,PIR;MLLT3;RREB1;CCNK;XBP1;EPC1;PWP1;GTF2F2;KLF13;TAF1B;GTF2E2;BCL3;GMEB2;NFKB1;TRIP13;NELFE;SMARCA5;TAF3;TRIM24;TAF4B;COPS2;RNGTT;EAF1;TFB2M;RO60;MMS19;RNPS1;CBFB;CEBPD;SNAPC3;RNMT;GTF2A2;PTMA;BTF3;MEF2A;TOPORS;ELOC;NELFCD;CTDP1;MNT;GTF2H4;GTF3C1;CDC73;TAF1A;HIPK3;NR4A2;GTF2H1;TAF9;NELFB;POLR3A;MRPL12;DEK;POLR2L;CCNH;SETX;TAF15;TAF7;NELFA;RTF1;NOCT;POLR2J;ERCC6
prerank,regulation of defense response to virus (GO:0050688),-0.37422837936521813,-0.8851796607741226,0.600896860986547,0.9397784917595503,1.0,8/14,28.90%,PCBP2;ITCH;TRAF3IP1;PPM1B;C1QBP;RNF26;IFNLR1;DHX9
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.44096572432106096,0.8851738565290043,0.620253164556962,0.8708845045019166,1.0,6/11,30.16%,CYCS;UQCRQ;UQCRC1;UQCC3;UQCRC2;UQCR11
prerank,cellular response to hypoxia (GO:0071456),-0.24104147082350275,-0.88472560232181,0.7345971563981043,0.9397596235193043,1.0,20/126,9.80%,CPEB1;BMP7;SLC8A3;CPEB2;SIRT2;NDNF;KCND2;RORA;PSME4;EGLN3;LMNA;P4HB;NPEPPS;MDM4;SFRP1;MDM2;VEGFA;HIPK2;RGCC;ARNT
prerank,positive regulation of catalytic activity (GO:0043085),0.3415666755836271,0.884532860163335,0.6210526315789474,0.8716495929153271,1.0,20/37,29.65%,CAV1;MAPK8;PSEN1;APH1A;ABL2;CIB1;XRCC4;MSH2;ATP7A;PHACTR4;MAPK14;FXN;B3GAT3;SOD1;NOD2;MSH3;MID1IP1;PSEN2;BCAS3;MAPK3
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.28004448971157925,0.8842036916825217,0.7040094339622641,0.8717808641484012,1.0,30/186,10.43%,CAV1;NFATC1;DAB2IP;SOX13;MLLT3;FZD6;FZD4;TLE4;SOX17;WWTR1;STK3;NKD2;ZNRF3;SOX9;STK4;VGLL4;GREM1;TCF7L2;WNT5A;JADE1;TMEM88;SOST;PSMA2;CTNNBIP1;CITED1;PSMA8;MAD2L2;SFRP2;SCYL2;PSMA6
prerank,phosphate ion transmembrane transport (GO:0035435),0.43515853617479294,0.8840860099595281,0.6128440366972477,0.8715143314329552,1.0,4/12,12.60%,SLC37A3;SLC25A30;SLC37A1;XPR1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3622605993655133,0.8838638374216837,0.6203554119547657,0.8714529778583758,1.0,7/32,20.90%,NEK7;HMBOX1;ACD;CTNNB1;CCT7;CCT2;MAP2K7
prerank,acetyl-CoA metabolic process (GO:0006084),0.4084777901528238,0.8837266154560488,0.6168384879725086,0.871206873513367,1.0,2/15,3.00%,HMGCS2;ACACB
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.40408500644809553,-0.8836696155344066,0.6148648648648649,0.941135455493587,1.0,3/10,2.54%,VTN;PRKCB;GRB10
prerank,regulation of protein kinase activity (GO:0045859),0.2989260134167935,0.8834430888470904,0.6624685138539043,0.871285909222334,1.0,21/106,13.61%,GNAQ;IQGAP1;PTK2B;PPM1F;WWTR1;PAK2;CEACAM1;RAPGEF2;INPP5K;TRIB3;PTK2;RAP1A;CSF1;MAP2K3;GAS6;SFN;RB1;GSTP1;WARS1;TRIB1;GSKIP
prerank,positive regulation of cell division (GO:0051781),0.3479848666208336,0.8832047813198928,0.6357827476038339,0.8712640521717836,1.0,3/38,4.00%,PKP4;TAL1;PKN2
prerank,regulation of peptide hormone secretion (GO:0090276),0.31849957105108945,0.8829626375927244,0.6290760869565217,0.8712492484150562,1.0,10/67,8.26%,SLC2A1;CACNA1E;CHD7;KCNB1;CACNA1A;PPP3CB;RAP1A;STX1A;ITPR3;NEUROD1
prerank,regulation of microtubule polymerization (GO:0031113),0.34654225231492425,0.8825887742387367,0.6411042944785276,0.8714774115932151,1.0,12/40,20.57%,OCLN;RAC1;DYRK1A;CAMSAP2;PRUNE1;MET;CDH5;PAK1;CDK5RAP2;CLIP1;NUMA1;RPS3
prerank,mitochondrial translational elongation (GO:0070125),0.30086653001912467,0.8822575587614417,0.6438896189224704,0.8716181417141029,1.0,37/88,26.45%,MRPS18A;MRPL13;MRPS12;MRPL35;MRPL41;MRPL52;MRPL4;MRPS16;MRPL23;MRPS5;MRPL37;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;AURKAIP1;MRPL1;MRPL50;MRPL17;MRPL39;MRPL32;MRPL14;MRPS11;MRPL9;MRPL46;DAP3;MRPL19;MRPL15;MRPL42;GFM1;MRPL24
prerank,fibrinolysis (GO:0042730),-0.3740192625383742,-0.8820445243470483,0.6048780487804878,0.943829425474701,1.0,4/13,27.28%,PLAT;SERPINE1;PLAU;HRG
prerank,regulation of mitochondrial fission (GO:0090140),-0.32532420911063353,-0.8819510132469953,0.6442786069651741,0.9429590664980596,1.0,5/24,7.59%,DCN;PRKN;SPIRE1;MCU;LRRK2
prerank,photoperiodism (GO:0009648),0.36813542696610024,0.8819043288225601,0.603225806451613,0.8717978953277742,1.0,5/28,13.99%,CRTC1;SIK1;OPN5;PDE6B;FBXL3
prerank,regulation of ERBB signaling pathway (GO:1901184),0.40393297121885047,0.8818479410359827,0.6187050359712231,0.871413456909762,1.0,6/15,14.30%,PTPN12;MVB12B;CEACAM1;LGMN;RHBDF2;ERBB2
prerank,negative regulation of RNA splicing (GO:0033119),0.38574638504050135,0.8818322633560975,0.5957792207792207,0.870958765923376,1.0,8/19,27.18%,TMBIM6;PTBP3;RNPS1;RPS13;SRSF10;SRSF4;RBMX;RPS26
prerank,proteoglycan metabolic process (GO:0006029),0.3751116590972481,0.8815235417991432,0.6293103448275862,0.8710819574936557,1.0,2/26,0.68%,CSGALNACT1;BMPR2
prerank,cellular zinc ion homeostasis (GO:0006882),0.3685683395317185,0.8811876126467996,0.6274509803921569,0.8712476063723573,1.0,2/26,7.19%,SLC39A8;LCK
prerank,hepaticobiliary system development (GO:0061008),-0.34089486826320314,-0.881158763662652,0.6339066339066339,0.9437561842331393,1.0,4/20,5.63%,TGFBR3;WNT4;COBL;NF1
prerank,lysosome organization (GO:0007040),-0.293156814068471,-0.8810390069578727,0.65625,0.9429677888900754,1.0,14/36,25.88%,ARSB;LRRK2;GAA;CLVS2;HPS4;HPS1;HOOK2;TPP1;CLN3;ACP3;SNAPIN;LAMTOR1;TMEM165;MTOR
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.3416493189123826,0.8807994846705769,0.6314984709480123,0.8715343677894072,1.0,11/41,14.81%,HIF1A;SCARB2;EIF6;NUP214;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153
prerank,primary neural tube formation (GO:0014020),-0.2987886802269658,-0.8805709674611015,0.6696165191740413,0.9429978517080541,1.0,7/30,11.48%,LMO4;COBL;LRP6;TSC2;FUZ;MTHFD1;TGFB2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3145528661037336,0.8794312021423077,0.6562054208273894,0.8736293365228827,1.0,21/62,25.61%,MLLT3;CCNK;GTF2F2;NELFE;EAF1;ELOC;NELFCD;CTDP1;GTF2H4;CDC73;GTF2H1;NELFB;POLR2L;CCNH;NELFA;RTF1;POLR2J;ADRM1;IWS1;GTF2H5;PCID2
prerank,oligodendrocyte differentiation (GO:0048709),0.3914100628050607,0.8794145393900269,0.6051779935275081,0.8731810849766674,1.0,4/19,8.84%,SOX13;SOX9;EIF2B5;PRDM8
prerank,amyloid precursor protein metabolic process (GO:0042982),0.383148931660547,0.8792920864141396,0.6069565217391304,0.872934765597024,1.0,5/18,13.77%,ADAM10;PSEN1;APH1A;ADAM17;ABCG1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.3463838408209295,-0.8790060400657215,0.6359102244389028,0.94549590063715,1.0,8/18,30.70%,DTNA;KIF1B;FCHSD2;STAC3;TBC1D24;TSPOAP1;SLC5A7;CHRNB2
prerank,regulation of receptor binding (GO:1900120),0.43665127062026615,0.8788018139923495,0.5861386138613861,0.8733951025254657,1.0,2/10,6.17%,B2M;ADAM15
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.4007526853674079,0.8782123749022422,0.6051660516605166,0.8739974092873806,1.0,6/15,19.25%,DDIT4;ZFYVE27;SOS1;GRB2;BCAR1;FRS2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.33689397169045593,0.877980559883179,0.6370716510903427,0.8739498254029543,1.0,9/41,15.26%,PLA2G4A;ELOVL5;PTGS1;EPHX1;DEGS1;ABCD1;GSTP1;PNPLA8;FAAH
prerank,smooth muscle tissue development (GO:0048745),0.44239325636587584,0.8776837325446678,0.6066176470588235,0.8740550712881561,1.0,1/10,0.85%,ENG
prerank,manganese ion transport (GO:0006828),-0.35675187743024217,-0.8772161912217973,0.6437768240343348,0.9485736030184463,1.0,7/14,13.03%,SLC30A10;SLC39A14;TRPC3;TRPC6;TRPC1;TRPC4;TRPC5
prerank,glucose metabolic process (GO:0006006),-0.2663877219587121,-0.8771034320237534,0.6952380952380952,0.9477069321883674,1.0,18/58,18.72%,RBP4;PPARGC1A;APOD;SLC39A14;PER2;ENO2;GAA;SLC25A12;GOT1;TPI1;IRS2;SLC25A13;G6PC3;ENO3;PFKFB1;MDH1;CRY1;PCK2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.394967260335773,-0.8768939667489983,0.6342494714587738,0.9470574900067942,1.0,1/11,1.79%,GRK3
prerank,regulation of primary metabolic process (GO:0080090),-0.23353807977150517,-0.8766636900609135,0.7333333333333333,0.9464575463760201,1.0,35/126,20.67%,CHD9;ROCK2;PPARA;PSAP;LDLR;PSME4;SREBF1;HMGCS1;ACACA;C1QTNF2;OAZ2;SMARCD3;APOE;TNFAIP8L3;FGFR4;ODC1;IRS2;PSMD12;GPAM;SCD;AZIN1;CERS2;FDFT1;MVK;FDPS;ABCA7;CARM1;PRKAB2;PSMC4;PSMB6;LSS;NCOR1;ZFP69;HDAC3;ID2
prerank,tube closure (GO:0060606),-0.2952748610092027,-0.8765631236637558,0.6507462686567164,0.9456265146421768,1.0,7/31,11.48%,LMO4;COBL;LRP6;TSC2;FUZ;MTHFD1;TGFB2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.43099146972760094,0.8763334205171845,0.6163410301953819,0.8761202458465873,1.0,4/12,8.79%,B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,establishment of spindle orientation (GO:0051294),-0.313210683471988,-0.8759685526953082,0.6277173913043478,0.9459052724127583,1.0,15/28,33.68%,GJA1;GPSM2;HTT;UBXN2B;LLGL2;NDC80;MISP;SPDL1;CENPA;FBXW11;CLASP1;DCTN1;INSC;ZW10;PKHD1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.4310636163507421,0.8759493957747789,0.5996343692870201,0.8763692454554678,1.0,2/11,7.93%,ALG10B;NOS1AP
prerank,homotypic cell-cell adhesion (GO:0034109),-0.2884343623415792,-0.8757185461519859,0.6941176470588235,0.9454199922493585,1.0,6/39,8.63%,PLPP3;PDGFRA;MEGF11;GNAS;UBASH3B;MYL9
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.29382870967378627,-0.8756985880824921,0.6580459770114943,0.944393533286189,1.0,13/36,16.52%,VAMP5;ANK3;AFDN;OPTN;GGA2;RAB10;GGA1;SYS1;BBS2;ARFRP1;MACF1;GOLPH3L;GOLGA4
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.4195568631625369,0.8756025974249146,0.6069469835466179,0.8765014023818298,1.0,3/12,9.46%,LYN;PTK2;CSF1
prerank,response to gamma radiation (GO:0010332),0.3695721930667185,0.8754065840473398,0.6200657894736842,0.8763760610599809,1.0,1/24,0.84%,DCUN1D3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3753803027094973,0.8753876855601352,0.6073825503355704,0.8759305022079205,1.0,4/23,7.33%,ENG;SMAD7;TGFB1;ITGA3
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.4117583042844043,0.8749046669546103,0.6189591078066915,0.8763463855537561,1.0,2/15,2.21%,IL6ST;EDN1
prerank,positive regulation of glucose import (GO:0046326),0.38009549124468933,0.8740665370949753,0.6084656084656085,0.8774486907505524,1.0,3/21,4.22%,OCLN;INSR;SORBS1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.36875372567541514,0.8738928033316299,0.6075533661740559,0.8772791499366817,1.0,5/27,13.99%,CRTC1;SIK1;OPN5;PDE6B;FBXL3
prerank,photoreceptor cell development (GO:0042461),-0.3626236083330655,-0.8736563237857764,0.6380090497737556,0.9479227576878156,1.0,5/14,18.06%,AHI1;ARL3;VEGFA;MFSD2A;TULP1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.34626661389252833,0.8736409376648155,0.6348228043143297,0.8773022801348791,1.0,7/35,10.48%,FASN;HMGCS2;ALOX5AP;PAM;LTC4S;FAR2;SLC25A1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.3009075025783631,-0.8736032684925358,0.6545454545454545,0.9469579755928581,1.0,13/30,18.29%,VAMP5;ANK3;OPTN;GGA2;RAB10;GGA1;SYS1;BBS2;ARFRP1;MACF1;GOLPH3L;GOLGA4;SEC16A
prerank,T cell differentiation (GO:0030217),0.3398898259382776,0.8733547838054516,0.6199701937406855,0.8773652473389538,1.0,7/40,10.70%,LFNG;SOX13;CHD7;DLL4;LCK;SOX4;JAG2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4213597282717586,0.8733272639979486,0.6265709156193896,0.8769315824040018,1.0,6/12,29.27%,CDT1;WDR18;TIPIN;GMNN;TICRR;KAT7
prerank,mRNA catabolic process (GO:0006402),0.33065389341057383,0.8733007512526504,0.6550151975683891,0.8765070489567822,1.0,18/44,27.44%,ERN1;NANOS2;NUDT16;NBDY;RC3H1;DCP2;ZFP36;XRN2;PNPT1;DHX34;RNH1;RIDA;NBAS;LSM2;EXOSC4;HSPA1B;METTL16;TUT7
prerank,regulation of establishment of protein localization (GO:0070201),0.415629148663243,0.8728255501660503,0.6117021276595744,0.876927943462543,1.0,5/13,16.92%,DNAJA1;GAPVD1;CEP290;CEP295;SPIDR
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3499448231946828,0.8727409674670951,0.6344410876132931,0.8766036027350573,1.0,4/31,10.91%,LYN;PLA2G2D;RC3H1;LST1
prerank,sulfur compound biosynthetic process (GO:0044272),0.293385605229881,0.8726859399382246,0.667098445595855,0.8762294930781703,1.0,23/104,13.97%,ST3GAL6;CSGALNACT1;ST3GAL1;B3GNT3;MAT2A;B4GALT4;SLC35B3;SLC10A7;B3GNT4;SLC26A1;B4GALT5;GSTO2;GSTA4;B4GAT1;TPK1;SLC35D2;GGCT;GCLM;MPST;GSTP1;CSPG5;NCAN;OPLAH
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3637160558347893,-0.8725457857492963,0.6272727272727273,0.9483062170866617,1.0,2/13,2.95%,GLI2;BMP4
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.37316398928592626,-0.8724278417684289,0.648960739030023,0.9474921098620482,1.0,3/13,10.69%,CYFIP2;ASPH;GRIN2A
prerank,regulation of ERAD pathway (GO:1904292),0.42645187564288506,0.8723358780509793,0.5992844364937389,0.8764247031555009,1.0,4/11,19.17%,AQP11;ATXN3;UBXN1;USP25
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4296245682776779,0.872298316504726,0.6189624329159212,0.8755415847812603,1.0,3/10,7.13%,CBFA2T3;FBP1;TIGAR
prerank,negative regulation of glycolytic process (GO:0045820),0.4296245682776779,0.872298316504726,0.6189624329159212,0.8755415847812603,1.0,3/10,7.13%,CBFA2T3;FBP1;TIGAR
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3845605263034348,-0.8721533898313314,0.6152219873150105,0.9470465548438457,1.0,4/10,19.64%,OGT;SELENOS;DGKQ;PDK2
prerank,regulation of lipid metabolic process (GO:0019216),0.30185149037286935,0.8721171695383384,0.6697860962566845,0.875386750255568,1.0,7/88,5.80%,CAV1;PPARD;PLPP1;FASN;ACACB;NCOA1;TGS1
prerank,nucleotide-excision repair (GO:0006289),0.29028450437476216,0.8721155548900195,0.6658097686375322,0.8749109034343966,1.0,29/101,24.50%,POLK;ATXN3;RPA1;POLA1;BRIP1;COPS2;RAD23A;FAN1;HUS1;COPS4;MMS19;ERCC4;AQR;GTF2H4;RFC3;USP7;CETN2;CHD1L;GTF2H1;POLR2L;CCNH;RNF111;POLR2J;RFC5;ERCC6;CUL4B;COPS8;LIG4;POLL
prerank,copper ion transport (GO:0006825),0.42814135861326363,0.8717314380861862,0.5908221797323135,0.8751315673117809,1.0,2/11,10.25%,SLC31A1;ATP7B
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4151838237032982,0.8716484968624219,0.6172413793103448,0.8748153589324141,1.0,4/13,8.79%,B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.420725583730856,0.8714751614031085,0.6198934280639432,0.8746893649145687,1.0,11/11,57.96%,PKD1L3;RTP3;RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;LPO;PKD2L1
prerank,polyamine metabolic process (GO:0006595),-0.3706729907204462,-0.8709270700512558,0.6268980477223427,0.9487790898591808,1.0,4/13,12.96%,OAZ2;SMS;ODC1;SAT1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.31462923241777635,0.8707234707996744,0.6507042253521127,0.8756298699484248,1.0,18/54,22.89%,RPF1;RSL24D1;RRS1;RPL14;EIF6;NOP53;RPL6;RPL10;NOP16;NPM1;RPL35A;MAK16;RPL11;RPL3;TRAF7;RPL7;RPL26;MRPL1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.40074506845222657,0.8705417542969327,0.603290676416819,0.8755121648926367,1.0,6/17,13.80%,BOK;BCL2L1;GGCT;SFN;BID;SOD2
prerank,regulation of ion transport (GO:0043269),-0.25393835606770815,-0.8701940182388342,0.7445255474452555,0.9493482476494115,1.0,26/76,22.99%,PRKN;SYT1;P2RX4;NKAIN4;ANK3;NKAIN2;SYT9;SYT12;SYT11;SNX6;KCNJ2;KCNJ13;WNK1;DTNBP1;KCNJ10;SNCA;KCNJ8;KCNJ15;SYT3;KCNJ6;NKAIN3;CLDN10;SYT2;SPTBN4;VAMP2;SYT6
prerank,synaptic vesicle membrane organization (GO:0048499),0.3902187267866335,0.8701362275035233,0.6032315978456014,0.8758092149235435,1.0,3/17,9.47%,STX3;STX1A;SNAP23
prerank,regulation of calcium ion import (GO:0090279),0.3787981180906271,0.8697752512711586,0.615257048092869,0.8759748674917252,1.0,3/21,8.09%,PDGFB;FYN;PKD2
prerank,regulation of mitotic nuclear division (GO:0007088),0.31881054302849365,0.8694031619176044,0.6539589442815249,0.8761500652426718,1.0,7/55,7.47%,INSR;PDGFB;EDN1;LRP5;CAV2;AURKA;TGFA
prerank,insulin secretion (GO:0030073),0.37615350308840323,0.8693808972097167,0.6397941680960549,0.8757127214345841,1.0,4/19,12.22%,RAB11FIP5;SNX19;NEUROD1;RAB11B
prerank,myoblast differentiation (GO:0045445),0.40617457678284763,0.8687159155816648,0.6183206106870229,0.8764781754149663,1.0,3/14,5.65%,EPAS1;MBNL1;TCF7L2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4293036543551756,0.8686826499456715,0.6373831775700934,0.8760605466560423,1.0,2/10,15.66%,VSIR;DDIT3
prerank,double-strand break repair (GO:0006302),0.2814377360512353,0.8685381938097059,0.7146311970979444,0.8758568598824144,1.0,37/158,18.10%,TENT4A;SAMHD1;BABAM2;DTX3L;HERC2;MAPK8;MMS22L;RPA1;TRIP13;POLA1;SMARCA5;BRCC3;RAD51D;BRIP1;SEM1;PARP2;RECQL;MEIOB;MAD2L2;FAN1;HUS1;XRCC2;MCM9;RMI1;CYREN;ERCC4;UBXN1;YY1;ACTR5;CHEK2;SPIDR;KDM4A;RAD21;NSMCE1;CIB1;DCLRE1C;PARP9
prerank,protein tetramerization (GO:0051262),0.3116790930731506,0.8685119899712656,0.640990371389271,0.875425757223697,1.0,5/67,3.41%,B2M;GBP5;SAMHD1;ACACB;GLS
prerank,nuclear export (GO:0051168),-0.2529316703509002,-0.8682521919094783,0.796812749003984,0.9527028476595994,1.0,11/80,11.21%,RANBP3L;ATXN1;SRSF5;PKD1;DDX39B;SRSF2;STRADA;SRSF11;U2AF2;RAE1;POM121
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.39063361173474975,0.8682178521474163,0.6030927835051546,0.8754974753456141,1.0,2/19,5.12%,CSGALNACT1;EXTL3
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4293942120683779,0.8680805119253154,0.6011029411764706,0.8752853055204207,1.0,6/10,23.82%,DNAJA1;AIDA;GSTP1;HIPK3;DUSP19;PDCD4
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.42792454166318494,0.8679205121409106,0.6358695652173914,0.8751183629632581,1.0,5/11,15.16%,FYN;ABCB7;COA8;ABCD1;SLC18A2
prerank,positive regulation of cellular protein localization (GO:1903829),0.3111229723583582,0.8668873256303304,0.6727019498607242,0.876566090742004,1.0,10/69,9.89%,STX3;FYN;WWTR1;CARD10;DTX3L;LIMK2;CCDC88A;TGFB1;CDT1;VPS28
prerank,positive regulation of cell cycle (GO:0045787),0.3105012694684647,0.8666433108332969,0.6513629842180775,0.8765334840771739,1.0,13/62,11.80%,APP;PDGFB;TAL1;PKN2;EIF4E;CDKN1B;CCNYL1;PKD2;CCNY;NUDT16;RAD23A;EIF4EBP1;LGMN
prerank,regulation of protein localization to cell surface (GO:2000008),0.34925474571823645,0.8665888540953494,0.6446540880503144,0.8761619856771401,1.0,6/33,12.95%,STX3;NEDD4L;RAB11FIP5;PICALM;RAB11B;HSP90AB1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.42649764562907716,0.8660852982724444,0.6015037593984962,0.8766042149613127,1.0,2/10,2.90%,PTPN12;PTPRJ
prerank,body fluid secretion (GO:0007589),-0.34554456423132873,-0.8658444505687388,0.6286353467561522,0.9569958841716351,1.0,5/15,15.14%,ERBB4;SLC22A4;VEGFA;PRLR;SLC22A2
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.27565181120243726,-0.8657846370706563,0.7522658610271903,0.956037788169032,1.0,15/46,27.50%,HK2;TOMM40;AIFM1;TIMM22;RALA;TIMM17B;GRPEL2;TSPO;TIMM8B;TIMM21;TIMM9;GDAP1;DNAJC15;TIMM10;PAM16
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3978694541499826,0.8653633180167294,0.6344086021505376,0.8774833702525828,1.0,7/15,22.86%,KHNYN;NUDT16;DICER1;RPP30;ZC3H12C;RNASEH1;LACTB2
prerank,positive regulation of embryonic development (GO:0040019),-0.333310439785038,-0.8652736443469364,0.6830985915492958,0.9560626803562925,1.0,2/19,2.02%,WNT4;OSR1
prerank,negative regulation of biosynthetic process (GO:0009890),0.39809398294240994,0.8651241164476171,0.6091549295774648,0.8774435264119878,1.0,6/16,15.16%,ABCB7;CEACAM1;COA8;ABCD1;GSTP1;SLC18A2
prerank,motile cilium assembly (GO:0044458),-0.3622435796712865,-0.8648108192224752,0.6465324384787472,0.9560127051870958,1.0,4/12,15.43%,BBOF1;BBS5;CCDC39;RSPH9
prerank,mitochondrial transport (GO:0006839),-0.266274998359398,-0.8644412908940902,0.725752508361204,0.9557724423168218,1.0,18/53,25.20%,BCL2;HSP90AA1;TOMM40;TIMM22;SLC25A13;FLVCR1;MTX2;COX18;SLC25A4;TIMM17B;MAIP1;TSPO;TIMM8B;TMEM14A;TIMM9;PPIF;GDAP1;TIMM10
prerank,membrane lipid catabolic process (GO:0046466),-0.3908621449666569,-0.8641767002960158,0.6346153846153846,0.9553108362054861,1.0,6/10,27.32%,CYP1B1;PDXDC1;PPT1;SMPD2;NAGA;SGPL1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.29537410264097075,-0.8637363055543184,0.664,0.9552404257647519,1.0,13/31,22.99%,SYT1;CACNA1G;SYT9;SYT12;SYT11;ADRA2A;SCAMP5;SYT3;CBARP;REST;SYT2;RAB3GAP1;SYT6
prerank,sterol biosynthetic process (GO:0016126),-0.2943286925264011,-0.8633619986997042,0.6721311475409836,0.9549936769310383,1.0,13/33,22.50%,INSIG2;PRKAG2;HMGCS1;NSDHL;ACAT2;INSIG1;FDFT1;MVK;FDPS;LSS;DHCR24;CYP51A1;DHCR7
prerank,melanocyte differentiation (GO:0030318),-0.3879342546431544,-0.8620607277894097,0.6556016597510373,0.9567112232781866,1.0,4/11,8.53%,ENPP1;MITF;KIT;USP13
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.2681855451726425,-0.8617236866158634,0.7320872274143302,0.9563361393267519,1.0,12/49,15.84%,SMAD6;IMPACT;DACT1;PRKCZ;SRC;THRA;JAM3;TRAF3IP1;ANKRD27;PYDC1;PPM1A;LCMT1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3159957794966995,0.8615878145094037,0.671830985915493,0.883497504416692,1.0,6/60,7.80%,NEK7;PDGFB;PRKD2;HMBOX1;GREM1;WRAP53
prerank,regulation of DNA replication (GO:0006275),-0.2646098565251924,-0.8615547019288042,0.7071651090342679,0.955594834340213,1.0,6/49,8.84%,EGFR;GLI2;EHMT2;NUCKS1;GLI1;ZBTB38
prerank,DNA repair (GO:0006281),0.2630904714729268,0.8612157575814617,0.7554347826086957,0.8837437053535476,1.0,73/284,22.56%,TENT4A;POLK;USP3;BABAM2;DTX3L;HERC2;MAPK8;ASCC1;RNASEH2A;ATXN3;RPA1;ASCC3;WDR33;TRIP13;PRIMPOL;POLA1;SMARCA5;BRCC3;RAD51D;BRIP1;BACH1;BTG2;PARP2;RECQL;RAD18;RAD23A;MAD2L2;FAN1;HUS1;XRCC2;MC1R;MMS19;UNG;NOP53;ERCC4;NSMCE4A;NPM1;MPG;UBXN1;ENDOV;GTF2H4;ACTR5;CHEK2;PDS5A;WDR48;KDM4A;RAD21;PDS5B;RFC3;NSMCE1;CIB1;KMT5B;DCLRE1C;PARP9;CETN2;MGMT;NUDT1;CHD1L;PMS1;GTF2H1;XRCC4;FAAP100;MSH2;RAD17;RMI2;TRRAP;SETX;UBE2V2;BABAM1;MBD4;RFC5;NSD2;ERCC6
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.37073470575531214,-0.8606435062011425,0.6495726495726496,0.9564985092864394,1.0,7/12,35.74%,CDC14B;BTRC;PTEN;GORASP1;GOLGA2;UBE2C;UBE2S
prerank,regulation of multicellular organism growth (GO:0040014),0.3908465238341061,0.8604284762072392,0.6354515050167224,0.8847435291408885,1.0,2/15,5.16%,APP;GHR
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.3635767140570928,-0.8603628929994362,0.6546610169491526,0.9560112926401786,1.0,6/13,23.45%,CDH13;LDLR;CD81;SYK;ITGB2;PPARG
prerank,negative regulation of neuron death (GO:1901215),0.297418591389405,0.8602248975289843,0.6883963494132985,0.8846250839158657,1.0,14/93,9.87%,MEF2C;CD200;PTK2B;TNFRSF1B;CD34;FOXQ1;TOX3;RASA1;CITED1;CHMP4A;CHMP4B;IKBKG;CSF1;BTBD10
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.37893715227490493,0.8600808507668376,0.6239316239316239,0.8844342894451743,1.0,7/21,13.14%,CNOT6;PAN3;CNOT6L;CNOT1;CNOT2;ZFP36;CNOT7
prerank,activation of protein kinase activity (GO:0032147),0.28878466666939073,0.8600459939473342,0.7187894073139974,0.8840139368131393,1.0,18/106,9.49%,ADCY4;INSR;PDGFB;PTK2B;TAOK2;STK3;PRKAR2B;PAK2;CARD10;TIRAP;STK4;GHR;CCDC88A;WNT5A;TNIK;MALT1;ANG;RICTOR
prerank,histone deacetylation (GO:0016575),0.3293096522553336,0.8589272943286502,0.6521739130434783,0.8856313819869998,1.0,7/43,12.75%,HDAC9;ELK4;RCOR1;RBM14;MIER1;SIRT6;MIDEAS
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2936840156893973,0.858084134820008,0.7066848567530696,0.8866789525223607,1.0,13/85,12.59%,SMURF1;CELSR1;FZD6;FZD4;AP2B1;WNT5A;RAC1;AP2A1;PSMA2;PSMA8;PSMA6;PRICKLE1;VANGL2
prerank,regulation of proteolysis (GO:0030162),-0.2692020222734686,-0.857322786154778,0.7464788732394366,0.961671351385257,1.0,11/48,14.41%,CYFIP2;OGT;ASPH;SERPINE2;CAMK2N1;PLAT;BTRC;FGFR4;CST3;ITCH;LTBP4
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.33414250143402424,0.8572474520304186,0.6646616541353384,0.8876931935754316,1.0,11/40,11.52%,B2M;INSR;HIP1;SELE;GREM1;ARRB1;HNRNPK;SCYL2;CBL;TBC1D5;PICK1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.39862319879924935,0.8567321968698054,0.6583184257602862,0.8881546297361885,1.0,2/14,3.04%,CD200;TNFRSF1B
prerank,regulation of axon guidance (GO:1902667),-0.38883184822467964,-0.8561472858339982,0.6381156316916489,0.9631847425448936,1.0,3/10,9.30%,NRP1;ZSWIM8;VEGFA
prerank,positive regulation of tissue remodeling (GO:0034105),0.4134564079641505,0.8561291080919173,0.621414913957935,0.8887990022445214,1.0,2/10,9.61%,IL15;IL23A
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.38879423749324377,-0.8560319950558934,0.6608315098468271,0.9623074841827621,1.0,3/10,16.71%,PRKACA;APOE;ABCA7
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.39793835735761485,0.8559626369599264,0.6446428571428572,0.8886348925232163,1.0,1/15,2.43%,GBP5
prerank,regulation of ion transmembrane transport (GO:0034765),0.3414051176750634,0.8558434912942998,0.665086887835703,0.888361581590448,1.0,5/33,10.58%,NEDD4L;KCNQ1;KCNE2;NEDD4;ANO6
prerank,negative regulation of lyase activity (GO:0051350),-0.3453879433453923,-0.8558281574072909,0.6651376146788991,0.9616846774176108,1.0,6/16,24.84%,ADGRV1;GRM3;PALM;GABBR2;CCR2;MTRR
prerank,cellular amide metabolic process (GO:0043603),0.2901246549531099,0.8557026723891072,0.6955445544554455,0.8881387143482262,1.0,8/102,5.81%,ST6GAL1;ST3GAL1;PLPP1;CPD;CPE;GLYAT;ASAH2;MTHFD1L
prerank,regulation of protein targeting to membrane (GO:0090313),0.3553012751221131,0.8555192958086588,0.6502384737678856,0.8880067599506083,1.0,9/28,17.66%,FYN;KCNB1;INPP5K;AKT2;MYO1C;TCAF2;ERBB2;CHP1;CIB1
prerank,cellular response to oxidative stress (GO:0034599),0.28626267659034904,0.8553223116331459,0.7289002557544757,0.8879075944885306,1.0,11/118,6.03%,FOXO1;PRKD1;DAPK1;HIF1A;PXN;CAT;PTPRK;MAPK8;GSR;CYCS;PRR5L
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.42321946898542434,0.8552006124235064,0.6382575757575758,0.8876515712889705,1.0,2/11,5.72%,KCNQ1;ATP1A1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3695767279427586,0.855064133464597,0.631404958677686,0.8874357443093119,1.0,4/21,8.96%,LIMCH1;PEAK1;PTK2;SLK
prerank,cellular response to gamma radiation (GO:0071480),-0.34290230049319725,-0.8549283689897991,0.6589327146171694,0.9625221045281956,1.0,8/17,23.99%,MDM2;XRCC5;XRCC6;ATR;TSPYL5;TP53;CRYAB;ATM
prerank,regulation of phosphate metabolic process (GO:0019220),0.3853092192112664,0.8548998448180363,0.6447811447811448,0.8872622971749929,1.0,4/16,9.83%,IKBKB;TIGAR;PSEN1;SMG7
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.33792189685061436,-0.8545033201474729,0.6309794988610479,0.9623690533788125,1.0,7/15,25.90%,RYR2;SPCS3;RAB10;SPCS2;RAB3GAP1;SEC61A1;SRPRB
prerank,protein stabilization (GO:0050821),0.27217853747632337,0.8543824168481499,0.7657766990291263,0.8877293658660705,1.0,50/168,22.13%,GNAQ;TSPAN1;HIP1;HIP1R;EFNA1;FBXW7;SOX17;STK3;STK4;SMAD7;RPS7;ATF7IP;TMEM88;ATP1B3;CREB1;RPL23;SOX4;AFM;EPHA4;GLMP;FKBPL;COA8;NOP53;HSP90AB1;NAA16;STX12;BAG4;IRGM;CHP1;CHEK2;RPL11;BAG1;USP7;CDC37;COG7;MTMR9;ZBED3;SWSAP1;NLK;CCT7;TAF9;PPIB;CCT2;BAG2;CCNH;SEL1L;PRKRA;CDC37L1;MFSD1;TNIP2
prerank,synaptic vesicle cycle (GO:0099504),-0.2949053787039412,-0.8542166786120207,0.6710526315789473,0.9618932055918904,1.0,4/30,6.02%,BRSK1;SNAP25;PCLO;NLGN1
prerank,cellular response to amino acid stimulus (GO:0071230),0.34007019048192827,0.8540602036478169,0.6655896607431341,0.8878428196094723,1.0,6/33,10.32%,SH3BP4;FYN;XBP1;RPTOR;UBR1;LARS1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3164206270628339,0.853973801242932,0.6704384724186704,0.8875280368299995,1.0,11/51,14.62%,VEGFC;IL6R;F7;VEGFD;PTK2;CSF1;ANO6;GAS6;LGMN;ADAM17;PGF
prerank,positive regulation of blood coagulation (GO:0030194),-0.3421800267422114,-0.8539158179358426,0.6800947867298578,0.9614908094075063,1.0,3/17,10.33%,F3;THBS1;SERPINE1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.35402099186322805,0.8538661579086153,0.6401869158878505,0.8872590137927328,1.0,5/28,11.99%,DAB2IP;CASP8;TNFRSF1A;CRADD;BID
prerank,protein targeting (GO:0006605),0.2826048648439393,0.8537641042289572,0.7378277153558053,0.8869852326207825,1.0,25/118,18.98%,RASSF9;PARD3;AQP11;TAOK2;SDCBP;SEC63;ZDHHC18;ZDHHC9;ZFAND2B;MYO1C;ICMT;HOMER3;PITRM1;SPCS1;GIPC1;AP1S3;VPS37C;RPL11;ZDHHC24;TRAK2;ZDHHC1;CDC37;TOMM22;NACA;ZFAND2A
prerank,phosphate ion transport (GO:0006817),0.3935388013870935,0.853752117633657,0.6416083916083916,0.8865341593588897,1.0,4/16,12.60%,SLC37A3;SLC25A30;SLC37A1;XPR1
prerank,negative regulation of macroautophagy (GO:0016242),0.3530015516250645,0.8525713865409246,0.6411092985318108,0.8882089537409593,1.0,6/26,9.20%,LZTS1;MTM1;QSOX1;FEZ2;CHMP4A;CHMP4B
prerank,regulation of defense response to virus by host (GO:0050691),0.35192123522643326,0.8525337807720635,0.6672077922077922,0.8878063952026605,1.0,8/30,18.36%,AIM2;DTX3L;CGAS;IL23A;EIF2AK4;STAT1;PARP9;ZDHHC1
prerank,regulation of axon extension (GO:0030516),0.33273006130152305,0.8524110372666853,0.6646795827123696,0.8875670226658278,1.0,3/37,4.06%,NTN1;SEMA7A;DIP2B
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.3330071240943066,-0.8519351279809197,0.6926713947990544,0.9646419656700002,1.0,8/19,23.69%,PRKN;SREBF1;VDAC1;HTT;HAX1;HTRA2;FZD5;DNM1L
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.36181381432754633,-0.8518955773856736,0.6469248291571754,0.9636434585412554,1.0,3/13,16.49%,CBLB;RGPD1;KPNA2
prerank,positive regulation of protein processing (GO:0010954),0.3821004989819291,0.851892820177486,0.6377551020408163,0.8880177231319692,1.0,4/19,9.09%,MYH9;LPCAT3;NKD2;RHBDD1
prerank,secretion (GO:0046903),0.38382807776945,0.851836162835685,0.6312949640287769,0.887660045116303,1.0,3/14,8.40%,NPR1;TPD52;GUCA1B
prerank,positive regulation of bone resorption (GO:0045780),0.4268611014649443,0.8517519831931399,0.6464088397790055,0.8873546792398354,1.0,3/11,10.76%,TNFRSF11A;DCSTAMP;MC4R
prerank,regulation of urine volume (GO:0035809),0.42144225344891945,0.8517440472733422,0.6333938294010889,0.8869050834905094,1.0,3/10,13.32%,NPR1;INPP5K;HAS2
prerank,cellular response to acid chemical (GO:0071229),0.3507865896808642,0.8516853746358344,0.6313131313131313,0.8865535835759202,1.0,5/27,10.32%,SH3BP4;KLF2;XBP1;RPTOR;LARS1
prerank,cGMP biosynthetic process (GO:0006182),0.41962559343256944,0.8512112098553368,0.63016157989228,0.8869367238805094,1.0,1/10,2.54%,NPR1
prerank,apoptotic cell clearance (GO:0043277),0.3471370084102091,0.8504973332958369,0.6740858505564388,0.8877228974727767,1.0,6/30,11.77%,TGM2;SCARB1;RAC1;RHOBTB1;GAS6;ITGB3
prerank,gonad development (GO:0008406),0.3286792893328365,0.8504749169604897,0.6825153374233128,0.8872863107291543,1.0,9/41,15.33%,KITLG;BIK;SOX9;WNT5A;NCOA4;MAMLD1;ADAM21;SRD5A2;IRX5
prerank,sarcomere organization (GO:0045214),-0.30684923547144133,-0.8504607468496806,0.7178841309823678,0.9656257318379261,1.0,10/27,34.54%,ACTN2;TPM1;FHOD3;MYOM2;KRT19;TNNT3;MYPN;MYLK3;TCAP;OBSCN
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3134573350331367,-0.8496585807734689,0.7025641025641025,0.9662661562248439,1.0,10/24,32.01%,KIF24;MAP7D3;NCKAP5L;TPPP3;CKAP5;KIF18B;STMN4;FGF13;TPPP;STMN2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.3884914484355201,-0.8496251784264512,0.6601307189542484,0.9652721577362292,1.0,2/10,2.47%,OSR1;HECW2
prerank,proteolysis (GO:0006508),-0.209576665823742,-0.8490635513812366,0.9196428571428571,0.9654240952840245,1.0,28/252,9.22%,TRABD2B;ADAMTS12;AEBP1;CPQ;ADGRV1;F3;DPP4;HTRA3;OGT;PCSK5;FAP;GGT5;MMP14;HTRA1;MMP16;NAALAD2;ADAM19;TASP1;CLPX;NPEPPS;ENPEP;CPXM2;ADAM33;PLAT;APH1B;MDM2;CPXM1;MMP2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.36831594436870385,0.8487328174801931,0.6584564860426929,0.8899306687011236,1.0,5/19,16.38%,DDIT4;HIPK1;BCL3;SNW1;TMEM109
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3595454986141994,-0.8484396875297204,0.7210401891252955,0.9656545265000972,1.0,5/14,16.59%,PRKN;SELENOS;LRRK2;CREB3;CREB3L1
prerank,catecholamine biosynthetic process (GO:0042423),0.4158985617926062,0.8482227553729079,0.6413427561837456,0.890356279995655,1.0,1/11,1.55%,GCH1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3301825615923424,-0.8479084673422914,0.6691729323308271,0.9657080331304384,1.0,4/17,9.36%,IL34;PTN;SERPINE2;BIN1
prerank,histone modification (GO:0016570),0.2798269503784944,0.847685911606108,0.722875816993464,0.890880420355098,1.0,16/109,12.99%,RPS6KA5;HDAC9;USP3;PADI4;PHF20;RCOR1;RBM14;KAT6B;AURKC;CDK2;PARP2;PHF20L1;ENY2;MIER1;MIDEAS;PADI1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2941629002138377,0.8471323713416565,0.6809078771695594,0.8914034517665718,1.0,13/72,17.52%,POLK;ISG20;EDC3;RNASE1;RPA1;RNASE4;DICER1;FAN1;PNRC2;ERCC4;XRN2;GTF2H4;RFC3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.3287103777173527,0.84708668413879,0.6610942249240122,0.8910255106861773,1.0,8/39,20.05%,POLK;RPA1;FAN1;ERCC4;GTF2H4;RFC3;CHD1L;GTF2H1
prerank,receptor recycling (GO:0001881),0.4223095564625518,0.8470492952264863,0.6515151515151515,0.8906157676514129,1.0,3/10,12.22%,LMTK2;EHD3;RAB11B
prerank,negative regulation of interferon-beta production (GO:0032688),-0.3873175161722662,-0.8463496991300894,0.6828193832599119,0.9679976013610347,1.0,5/10,20.99%,PTPRS;SIRPA;PPM1B;CACTIN;PYCARD
prerank,glutamate metabolic process (GO:0006536),0.37000241722412175,0.8462923845939984,0.6857610474631751,0.8914643853958342,1.0,3/19,3.41%,DGLUCY;GLS2;GLS
prerank,alcohol catabolic process (GO:0046164),-0.38198152842000865,-0.8461488169145458,0.6351931330472103,0.9673661743391515,1.0,3/10,16.21%,CYP27A1;APOE;MT3
prerank,regulation of multicellular organismal development (GO:2000026),0.3561983612237337,0.845562380775148,0.6699346405228758,0.8923254196652145,1.0,2/25,3.28%,INSR;SOX17
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.3172758529218134,0.845384645041246,0.6831395348837209,0.892186139290089,1.0,12/48,16.25%,HIF1A;TIGAR;EIF6;NUP214;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153;PNPT1
prerank,peptidyl-proline modification (GO:0018208),-0.30059040321110486,-0.8453611345930998,0.6692708333333334,0.967898465177657,1.0,5/25,14.46%,FKBP5;NKTR;FKBP10;PPIC;PPIH
prerank,regulation of smooth muscle contraction (GO:0006940),-0.32392483055762933,-0.8453288227713002,0.7,0.9669132578500839,1.0,10/20,22.58%,PLCE1;KCNB2;SPHK1;CTTN;MYOCD;ZDHHC21;CHRM3;ADRB2;CHRM2;DAPK3
prerank,aminoglycan metabolic process (GO:0006022),-0.3941822569667658,-0.8450628476502584,0.6709677419354839,0.9664079983060343,1.0,6/10,29.58%,XYLT1;B4GALT7;B3GAT2;CHST9;B3GALT6;GAL3ST3
prerank,cell differentiation in spinal cord (GO:0021515),0.4199514030915713,0.845030823568941,0.6354775828460039,0.8923312133000283,1.0,2/10,9.33%,SOX13;SOX4
prerank,cholesterol efflux (GO:0033344),0.373702765742596,0.8448144900981502,0.6632302405498282,0.892287869917665,1.0,5/20,19.36%,SCARB1;SOAT2;ABCG1;STX12;ABCA1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.32382288703612994,-0.8445112925535533,0.6926713947990544,0.9665197467112621,1.0,4/20,19.07%,WNT4;C1QTNF3;CRY1;NCOR1
prerank,synaptic vesicle recycling (GO:0036465),-0.28952062036722137,-0.8440133489145636,0.7,0.9664937632724847,1.0,12/31,23.16%,NLGN2;SYT1;SYNJ2;NLGN1;STON2;NLGN3;AMPH;SNCA;TBC1D24;SYT2;VAMP2;CANX
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.2705150161020541,-0.8439250732247765,0.7387387387387387,0.9656279922652076,1.0,6/43,9.47%,EGFR;ERRFI1;CBLB;ITGA1;SNX6;MVP
prerank,monosaccharide transmembrane transport (GO:0015749),-0.338011530891767,-0.8438596970498935,0.6731707317073171,0.9647117914369273,1.0,4/16,14.19%,SLC5A3;SLC2A12;SLC2A10;SLC45A3
prerank,ubiquinone metabolic process (GO:0006743),-0.35191439565191407,-0.8436675598003487,0.6957494407158836,0.9640558860689523,1.0,7/15,31.37%,COQ8B;COQ5;FDXR;AIFM2;COQ10A;COQ10B;COQ6
prerank,positive regulation of biosynthetic process (GO:0009891),0.3261500335917911,0.8429502775907567,0.6977099236641221,0.89517442603678,1.0,7/40,13.03%,RAB27A;PLCG2;SORBS1;TGFB1;CREB1;GRIN1;MTPN
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.4162269092682771,0.8428272682966671,0.645045045045045,0.8949382489820383,1.0,2/11,4.20%,SCARB1;PLIN5
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4279562512220112,0.8419654387043588,0.6234234234234234,0.8960147813367402,1.0,3/10,10.66%,LYN;RAPGEF2;GAS6
prerank,negative regulation of response to external stimulus (GO:0032102),0.2853868654805566,0.8418596200451696,0.7591623036649214,0.8957319963289333,1.0,17/105,14.29%,TEK;PPARD;MFHAS1;LPCAT3;SIGIRR;TNFRSF1A;CRK;INPP5F;NMI;EPHA4;RB1;CARD16;TRIB1;CDH5;KLK8;ILRUN;PROC
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.38852369915654467,0.8417643991835686,0.6702127659574468,0.8954169240661355,1.0,4/16,8.04%,ESR1;DDX54;NCOA4;ARID1A
prerank,signal peptide processing (GO:0006465),-0.3688522524967065,-0.8412876355873695,0.6658767772511849,0.9678243201502092,1.0,3/11,14.14%,PCSK5;SPCS3;SPCS2
prerank,transition metal ion transport (GO:0000041),0.33334898567453347,0.8410149798151026,0.6893939393939394,0.8963005281931726,1.0,4/35,10.25%,SLC39A8;SLC31A1;ATP2C1;ATP7B
prerank,non-motile cilium assembly (GO:1905515),-0.29123288139398035,-0.8408813779278952,0.6914600550964187,0.9676455641580672,1.0,9/30,19.63%,IFT88;RPGRIP1L;TTC8;CEP89;FUZ;PCM1;C2CD3;TMEM17;IFT57
prerank,skin development (GO:0043588),0.3049154317546,0.8403273799713095,0.7352112676056338,0.8970750754097456,1.0,8/65,7.33%,ITGA6;UGCG;LSR;BCR;DLL1;WNT5A;ASCL4;ITGA3
prerank,protein maturation (GO:0051604),-0.23063728557540114,-0.8401508468001863,0.8613445378151261,0.9680656656691293,1.0,28/95,22.68%,AEBP1;F3;OGT;PCSK5;MMP14;NNAT;MMP16;ADAM19;NAA40;TASP1;CPXM2;APH1B;CPXM1;DNAJB11;CCS;TSPAN15;PCSK6;NCSTN;LMF1;CPM;CIAO1;NFU1;BACE1;PTCH1;CTSS;NAA60;EEF1AKMT4-ECE2;CLN3
prerank,bile acid biosynthetic process (GO:0006699),-0.30936009855967195,-0.8401309789214539,0.7039800995024875,0.9670526328266289,1.0,5/24,15.08%,CYP7B1;CYP27A1;OSBPL3;OSBPL6;SCP2
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.36588552697120685,0.8398545696527255,0.6735042735042736,0.897455111353059,1.0,2/22,6.10%,TNFRSF1B;WNT5A
prerank,regulation of cholesterol transport (GO:0032374),-0.31766714498299375,-0.839547162186067,0.690176322418136,0.9671724068053782,1.0,1/20,0.50%,LRP1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.28733668934398465,-0.8391347102233161,0.75,0.9669598605769788,1.0,4/32,4.64%,MAGI2;PDGFRB;PRKCD;ITGA1
prerank,DNA geometric change (GO:0032392),-0.30189931048408003,-0.8391153130361063,0.6821705426356589,0.9659679235732487,1.0,5/24,11.11%,HNRNPA2B1;ANXA1;RECQL5;RTEL1;RAD50
prerank,mitotic cell cycle phase transition (GO:0044772),0.26325158608034155,0.8385296623989884,0.779601406799531,0.8993695974296058,1.0,47/203,20.99%,EPS8;CDK6;TPD52L1;PLCB1;PRKAR2B;PPP1R12A;EIF4E;CEP41;PLK2;AURKA;PCNT;ACVR1;CDKN1B;FBXL7;DYNLL1;ANAPC7;CCNY;CHMP4B;CDK2;CNTRL;CEP57;ANAPC1;RB1;PPP2R2D;EIF4EBP1;CUL1;MAX;CDC25C;FBXL3;CEP290;CCNJ;CTDP1;CHEK2;CUL3;CEP131;CDC34;CEP72;PPP2R2A;CETN2;CDK5RAP2;CUL2;PPP2R1A;E2F3;TRIM71;DBF4;PLK1;CCNH
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.3313124013713083,-0.8384231953950481,0.7089552238805971,0.9663357667250324,1.0,6/18,29.32%,EHMT2;KMT2D;SETMAR;SETD4;SETD7;SETD1A
prerank,positive regulation of establishment of protein localization (GO:1904951),0.38304200965111096,0.838332514995484,0.6570458404074703,0.8992506416179807,1.0,6/18,22.29%,WRAP53;CHP1;CEP295;CCT7;CCT2;CEP120
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4093748528844696,0.8383065081956396,0.6654676258992805,0.8988257120645928,1.0,5/12,20.18%,NOTCH1;TCF15;ESRRB;HES1;NELFB
prerank,activin receptor signaling pathway (GO:0032924),-0.3434116117380765,-0.838203359862021,0.658256880733945,0.9657352293189261,1.0,4/15,12.07%,TGFBR1;SMAD3;INHBA;ACVR1B
prerank,phospholipid metabolic process (GO:0006644),0.2987883749896109,0.8377474702519256,0.7026315789473684,0.8993366490314787,1.0,8/71,8.50%,PLA2G4A;PLPP1;ENPP2;PLA2G2D;AGPAT1;MBOAT1;LPL;PLAAT3
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.356949557685275,-0.8375740337125213,0.665083135391924,0.9659357513272432,1.0,3/13,13.02%,APOD;SUFU;RAB23
prerank,cortical cytoskeleton organization (GO:0030865),0.32835170917425915,0.8369517441409645,0.6706408345752608,0.9003172692019304,1.0,9/41,8.82%,LCP1;FMNL3;IKBKB;NCKAP1;RAC1;FMNL2;TRPV4;RHOBTB1;LLGL1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.39913355359851993,0.8363796707173812,0.6625659050966608,0.9008928552559043,1.0,4/13,13.43%,PLCG1;AKT3;SIRT6;ADAM17
prerank,telomere maintenance (GO:0000723),-0.2568030448097322,-0.835866933604517,0.7476635514018691,0.9683971584228535,1.0,22/50,31.09%,PARP3;RTEL1;TEP1;RAD50;XRCC5;TERF2;XRCC6;SMC6;ATR;DNA2;TPRKB;TERT;PRKDC;ATM;POLD1;LTO1;XRCC3;POLD2;SMC5;DCLRE1B;RPA2;BLM
prerank,zinc ion transport (GO:0006829),0.36217110269305264,0.8353101011718448,0.6666666666666666,0.9022831317329938,1.0,1/21,0.92%,SLC39A8
prerank,synaptonemal complex assembly (GO:0007130),0.3852130162173952,0.8350041397155893,0.6780238500851788,0.9018893832788855,1.0,3/15,16.98%,RAD21L1;TRIP13;RAD21
prerank,synaptonemal complex organization (GO:0070193),0.3852130162173952,0.8350041397155893,0.6780238500851788,0.9018893832788855,1.0,3/15,16.98%,RAD21L1;TRIP13;RAD21
prerank,establishment of apical/basal cell polarity (GO:0035089),0.38750595795048043,0.8349541576916443,0.6599326599326599,0.9015079623943262,1.0,3/14,10.68%,MSN;OPHN1;FSCN1
prerank,P-body assembly (GO:0033962),0.4052582846604753,0.8348653831774118,0.6344463971880492,0.9011932760747764,1.0,7/12,27.52%,EDC3;RC3H1;LSM3;LSM14A;EIF4ENIF1;DDX6;PATL2
prerank,positive regulation of immune effector process (GO:0002699),0.3511923945825709,0.8345687173270068,0.6870967741935484,0.901245501255959,1.0,4/27,9.61%,PTPRJ;RPS19;XBP1;IL23A
prerank,regulation of Golgi organization (GO:1903358),-0.33406223711299116,-0.8341834784284047,0.6883720930232559,0.9707462382601802,1.0,7/17,24.73%,MYO5A;MAP2K2;RBSN;MAP2K1;PDE4DIP;RAB33B;CAMSAP3
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.35739785886297143,-0.8341603425953011,0.6727688787185355,0.9697430062155815,1.0,3/13,13.84%,ADGRV1;GRM3;PALM
prerank,pore complex assembly (GO:0046931),0.36738273884106787,0.8336517495703689,0.6765188834154351,0.902397947704073,1.0,6/19,15.34%,ADAM10;ANO6;NUP98;NUP205;NUP153;TSPAN33
prerank,modulation by host of viral genome replication (GO:0044827),-0.3568690088943546,-0.8336437805525087,0.6885245901639344,0.969784945874836,1.0,4/13,13.23%,PRKN;IFI27;NUCKS1;TBC1D20
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.24254548797904252,-0.833607993695987,0.8215613382899628,0.9688207757733719,1.0,7/68,8.00%,AMPD3;RHOQ;ENPP1;ACOT11;TPST1;LRRK2;ABHD14B
prerank,positive regulation of protein export from nucleus (GO:0046827),0.3773803514824123,0.8332642404956768,0.6620926243567753,0.9026295833206183,1.0,7/15,27.12%,TCF7L2;GAS6;ANP32B;RAPGEF3;YWHAE;GSK3B;EMD
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.4038713384373264,0.8329837092431164,0.6761061946902654,0.9026716802060106,1.0,6/13,24.87%,DDX20;AAR2;SRSF10;SART3;PRPF3;LSM2
prerank,regulation of RNA splicing (GO:0043484),0.29516144761701135,0.832934216116387,0.7286713286713287,0.9022883072705511,1.0,13/69,10.71%,ERN1;TMBIM6;RBM20;MBNL1;PTBP3;MBNL2;HNRNPF;DYRK1A;MBNL3;HNRNPK;ZNF326;HNRNPLL;YTHDC1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3261314674903338,0.8327112659867925,0.6808510638297872,0.9022163114546365,1.0,6/40,11.99%,TNFSF10;BIK;BCL2L11;BCL2L1;BNIP3;BID
prerank,GTP metabolic process (GO:0046039),-0.35274929291683665,-0.832585519721045,0.6666666666666666,0.9698094423505179,1.0,4/15,17.10%,RHOQ;LRRK2;RAB23;ENTPD7
prerank,epithelial cell development (GO:0002064),0.37559423674503095,0.8322854927695118,0.6741767764298093,0.902490714691888,1.0,3/20,9.67%,EXPH5;SIPA1L3;SLC4A7
prerank,negative regulation of translation (GO:0017148),0.285269607962077,0.8321363023685733,0.7425068119891008,0.9022680009370248,1.0,19/87,15.91%,NANOS3;DAPK1;IGF2BP3;NANOS2;GRB7;RNF139;PUM1;BTG2;RPL13A;CNOT1;MRPL13;EIF4EBP1;RACK1;EIF2AK4;CNOT7;FMR1;LSM14A;YBX1;PAIP2B
prerank,ERAD pathway (GO:0036503),-0.23591564445798274,-0.831786526687208,0.8449612403100775,0.9703865140578681,1.0,19/83,20.60%,PRKN;UGGT2;SELENOS;RCN3;AMFR;USP13;UBXN4;JKAMP;UBE4B;NPLOC4;GET4;UBE2G2;UBE4A;RNF121;USP19;DNAJC18;FAM8A1;DNAJB2;TMEM67
prerank,DNA methylation or demethylation (GO:0044728),0.36587807198433386,0.8317687493953464,0.6603119584055459,0.9019705246012368,1.0,8/19,18.39%,KMT2E;ATF7IP;PPM1D;GATAD2A;SPOCD1;ATRX;TEX15;EHMT1
prerank,DNA alkylation (GO:0006305),0.36587807198433386,0.8317687493953464,0.6603119584055459,0.9019705246012368,1.0,8/19,18.39%,KMT2E;ATF7IP;PPM1D;GATAD2A;SPOCD1;ATRX;TEX15;EHMT1
prerank,regulation of macrophage differentiation (GO:0045649),-0.3439360879228094,-0.831682680377441,0.723744292237443,0.9695611322812083,1.0,4/15,14.36%,IL34;PRKCA;INHBA;PTPN2
prerank,negative regulation of cyclase activity (GO:0031280),-0.35084555640790066,-0.8314336351033519,0.6946386946386947,0.9690282713078485,1.0,3/14,13.84%,ADGRV1;GRM3;PALM
prerank,purine-containing compound catabolic process (GO:0072523),0.4021136354058075,0.8310226666805094,0.6759581881533101,0.9028114138032801,1.0,4/13,14.45%,GDA;NT5C2;XDH;NUDT15
prerank,regulation of axon regeneration (GO:0048679),-0.36038233537853465,-0.8306131204958526,0.6889848812095032,0.9696110893099928,1.0,2/12,2.38%,PTN;PTPRS
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.28497929866310934,0.8304138587655785,0.7305699481865285,0.9034384005374682,1.0,18/88,16.92%,DAB2IP;TAL1;FNIP2;BIK;TIRAP;SDCBP;SH3GLB1;BCL2L11;TGFB1;CDT1;BID;RACK1;WARS1;RAB7A;CDH5;BMF;PIH1D1;SPIDR
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4040728371876209,0.8303532179344482,0.6551094890510949,0.9030807221050474,1.0,2/11,7.27%,LYN;JAK1
prerank,V(D)J recombination (GO:0033151),0.4022470145090309,0.8301083223264745,0.6678321678321678,0.9030216770736699,1.0,5/11,24.15%,TCF3;DCAF1;XRCC4;HMGB1;LIG4
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3729322959371121,-0.8299628193168526,0.6765375854214123,0.9698784225396961,1.0,4/10,23.37%,CAMK1;SMARCB1;CHEK1;SPHK2
prerank,chemical synaptic transmission (GO:0007268),0.2545396965123394,0.8297486731519303,0.8312849162011173,0.9032254429642126,1.0,19/284,6.79%,MPZ;UNC13B;SLC6A2;SLC6A5;SLC12A7;HTR2A;PDE7B;CACNA1E;PRKAR2B;PCDHB4;SYPL1;RPS6KA3;SDCBP;RPS6KA1;SYN3;KCNMB4;CACNA1A;HCRTR1;ATXN3
prerank,regulation of TOR signaling (GO:0032006),0.29432894514826835,0.829235307323169,0.7115646258503401,0.903671495288793,1.0,10/67,10.66%,SH3BP4;DDIT4;TNFAIP8L1;GNA12;RPTOR;UBR1;RICTOR;NPRL2;LARS1;GAS6
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.40139910568928483,0.8288578336257024,0.6660341555977229,0.9038355883211545,1.0,1/12,0.70%,UNC13B
prerank,mRNA destabilization (GO:0061157),-0.27615721038036445,-0.8286478705311346,0.7020057306590258,0.9715491440471908,1.0,12/38,26.50%,ROCK2;CPEB3;MOV10;CELF1;FTO;RC3H2;TUT4;PDE12;RBM24;TARDBP;ZFP36L2;POLR2D
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.39572446372879105,0.8280541182113904,0.6549295774647887,0.904794689612155,1.0,3/13,10.67%,AQP11;LPCAT3;MBTPS2
prerank,RNA stabilization (GO:0043489),-0.28107518852933056,-0.8276825046271542,0.7185792349726776,0.9724593041907368,1.0,9/33,23.09%,TENT5A;AXIN2;CIRBP;HNRNPU;TENT5C;E2F1;PHAX;SLC11A1;RBM24
prerank,regulation of cell death (GO:0010941),0.28154540446558673,0.8276024405450378,0.7608409986859396,0.905092124403926,1.0,6/94,3.44%,ACER2;PDE8A;PRKD1;SRGAP2;TNFRSF1B;NCK1
prerank,nuclear pore organization (GO:0006999),0.384208184333685,0.827247295474406,0.6472602739726028,0.9052226762466027,1.0,5/14,14.81%,NUP98;NUP133;NUP205;NUP54;NUP153
prerank,liver development (GO:0001889),0.33221344443364165,0.8270974353339999,0.6943573667711599,0.905006554368903,1.0,5/32,8.09%,LSR;ZIC3;XBP1;AURKA;PKD2
prerank,intracellular sterol transport (GO:0032366),0.3963442253902844,0.8265488836373924,0.6648936170212766,0.9054725360695213,1.0,9/13,30.70%,ABCG1;STAR;OSBPL2;ABCA1;STARD4;NPC1;RELCH;NPC2;OSBP
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.3083266488991251,-0.8264734624446087,0.7002518891687658,0.9737374850926043,1.0,5/22,13.57%,APOD;LRRK2;SUFU;RAB23;INSIG1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3367573805110665,0.8262620195120192,0.6903633491311216,0.9054726690690619,1.0,5/30,8.10%,FOXP1;PKN1;TRIM68;H3-3A;KDM4C
prerank,ether lipid metabolic process (GO:0046485),-0.35298743866156324,-0.8257698778785341,0.6883408071748879,0.9740722827944809,1.0,1/14,0.33%,AGMO
prerank,kinetochore organization (GO:0051383),-0.3487906058924364,-0.8256325586682337,0.704954954954955,0.9733295644388148,1.0,9/13,37.46%,CENPT;CENPH;NDC80;CENPF;CENPA;DLGAP5;CENPC;CENPW;MIS12
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.3768686949581139,0.825537394120668,0.6770293609671848,0.9062422428805342,1.0,3/17,5.22%,KDR;EPHB4;GREM1
prerank,neutral amino acid transport (GO:0015804),0.34251031344558014,0.824970164427034,0.7161084529505582,0.90675882644751,1.0,7/28,15.20%,SLC38A5;SLC3A2;SLC6A6;SLC43A2;SLC38A1;SLC36A4;SLC7A5
prerank,zinc ion transmembrane transport (GO:0071577),0.35075762405140304,0.8249617091102369,0.6774193548387096,0.9063060875620137,1.0,1/22,0.92%,SLC39A8
prerank,mRNA transport (GO:0051028),0.2762549800415003,0.8249598521794859,0.7570694087403599,0.9058435412534162,1.0,28/101,19.96%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;RNPS1;THOC6;NUP98;ZFP36;UPF2;NUP133;NUP205;FMR1;NUP54;NUP43;NUP153;AGFG1;ZFP36L1;ALYREF;CDC40;THOC3;THOC1;CPSF1;GLE1;THOC5
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.2553839348928247,-0.8248360076553718,0.8260869565217391,0.9738642788222894,1.0,9/56,9.53%,EGFR;ANXA1;CCND2;ANAPC5;RAD51B;ADAMTS1;UBE2E2;TFDP1;RGCC
prerank,positive regulation of macrophage activation (GO:0043032),-0.33030856227908956,-0.8246988039356933,0.6892523364485982,0.973122386185572,1.0,2/17,3.57%,LBP;THBS1
prerank,RNA 3'-end processing (GO:0031123),0.2934000136814043,0.8246166041640419,0.7357954545454546,0.9059677680122457,1.0,26/69,27.57%,TENT4A;WDR33;THOC2;RNPS1;THOC6;RPRD1B;MTPAP;RPRD2;PNPT1;ALYREF;CDC40;THOC3;THOC1;CPSF1;RPRD1A;THOC5;THOC7;SRSF4;TENT4B;SLU7;CPSF2;PCF11;CPSF3;TUT1;TUT7;PAPOLA
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.2983993990294778,-0.8241663472030976,0.7678571428571429,0.9731266562930527,1.0,5/25,18.37%,IGF1;PER2;DOT1L;HEY2;HEY1
prerank,positive regulation of translation (GO:0045727),-0.22758775641383688,-0.8241371025534535,0.8768656716417911,0.9721627096673418,1.0,9/94,10.10%,SAMD4A;PLD1;THBS1;CPEB3;FXR2;PRR16;RMND1;LARP6;CIRBP
prerank,cellular response to leucine (GO:0071233),0.40616396618394374,0.8234570377531519,0.6476190476190476,0.9070363556545827,1.0,3/10,10.32%,RPTOR;UBR1;LARS1
prerank,response to leucine (GO:0043201),0.40616396618394374,0.8234570377531519,0.6476190476190476,0.9070363556545827,1.0,3/10,10.32%,RPTOR;UBR1;LARS1
prerank,negative regulation of bone remodeling (GO:0046851),-0.36264282526584035,-0.8230725907159495,0.6988235294117647,0.9731828615273915,1.0,4/11,18.70%,UBASH3B;SFRP1;GPR137B;TMEM119
prerank,positive regulation of reproductive process (GO:2000243),-0.2819820293433337,-0.8230436752795367,0.7406483790523691,0.972222782515288,1.0,11/31,28.19%,SIRT2;VEGFA;INHBA;SYDE1;ACVR1B;INHBB;CFAP69;SMURF2;CACNA1H;C1QBP;HYAL3
prerank,positive regulation of hormone secretion (GO:0046887),0.3706796546313304,0.8229174397930785,0.6813559322033899,0.9075396142709876,1.0,2/17,10.49%,EDN1;VAMP8
prerank,positive regulation of synaptic transmission (GO:0050806),0.2932171104773052,0.8221232170604927,0.7729138166894665,0.9084370961759488,1.0,3/72,2.59%,SHANK3;APP;PTK2B
prerank,monoacylglycerol metabolic process (GO:0046462),0.3917332771482648,0.8215449823642479,0.6823104693140795,0.9089978721371169,1.0,4/13,15.79%,PLA2G4A;DGAT1;FAAH;MOGAT2
prerank,coenzyme A metabolic process (GO:0015936),0.37787184101279714,0.8211934866889562,0.6792452830188679,0.9091050203227728,1.0,5/14,21.04%,SLC25A16;PANK2;PANK3;PPCDC;CROT
prerank,regulation of Ras protein signal transduction (GO:0046578),0.2867485454362188,0.8206013281623674,0.7594594594594595,0.9096395750502198,1.0,12/85,8.49%,EPS8;DAB2IP;ARHGEF2;LYN;BCR;NOTCH1;DENND4C;ARHGAP17;OPHN1;FBP1;SYNGAP1;SHOC2
prerank,neural tube closure (GO:0001843),-0.2704749120958408,-0.8203339233672542,0.7515527950310559,0.9763713384489439,1.0,7/34,11.48%,LMO4;COBL;LRP6;TSC2;FUZ;MTHFD1;TGFB2
prerank,myoblast fusion (GO:0007520),0.3979500024886353,0.8200226183748491,0.6624775583482945,0.9101606676796382,1.0,2/12,7.97%,JAM2;PTGFRN
prerank,polarized epithelial cell differentiation (GO:0030859),0.3824969544808105,0.8199380492770921,0.6660929432013769,0.909833523811971,1.0,2/13,5.94%,MSN;OPHN1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.32917127371125543,0.8197411809628072,0.6993769470404985,0.9097265959432757,1.0,4/30,11.84%,ELOVL7;ELOVL5;ABCD4;ABCD1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.34065084205207047,0.8194666108650627,0.7113237639553429,0.9097535734831237,1.0,5/27,17.37%,CD200;ARRB1;GAS6;IRAK3;CD200R1
prerank,negative regulation of insulin secretion (GO:0046676),0.37462100544795557,0.8193180058734804,0.6701754385964912,0.909539383334731,1.0,3/17,4.04%,PIM3;KLF7;KCNB1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3417170934116333,0.8179963013571532,0.693200663349917,0.9113201112380431,1.0,6/22,13.77%,LYN;EFNA1;EPHA4;PICALM;RELA;ABCG1
prerank,peptidyl-threonine modification (GO:0018210),0.2914822824566471,0.8173718136386182,0.7415730337078652,0.9119460576853875,1.0,9/66,6.69%,PRKD1;PRKD2;LMTK2;HIPK1;CDC42BPB;MAPK8;ULK1;ACVR1;DYRK1A
prerank,epiboly involved in wound healing (GO:0090505),0.37850577119808804,0.8166597860699575,0.6938405797101449,0.9127188327579178,1.0,3/16,5.12%,LCP1;MRTFA;CEACAM1
prerank,regulation of stem cell differentiation (GO:2000736),0.27989770220159405,0.8162147322617972,0.7610966057441253,0.9130497202288912,1.0,11/89,11.57%,LMO2;GATA2;TAL1;NOTCH1;TCF12;PSMA2;TCF3;TCF15;PSMA8;PSMA6;CBFB
prerank,positive regulation of cellular respiration (GO:1901857),-0.3719441609584485,-0.816101488163006,0.7367205542725174,0.9832734197016557,1.0,1/11,1.98%,NUPR1
prerank,steroid catabolic process (GO:0006706),0.4000919617606889,0.8159773743368428,0.6660412757973734,0.9130149273384269,1.0,2/10,10.26%,FGF23;CYP27B1
prerank,microtubule bundle formation (GO:0001578),0.3105604940532395,0.8153757501239429,0.718475073313783,0.9135835907673602,1.0,12/42,23.58%,NAV1;RP1L1;CFAP46;SPAG16;CHP1;CDK5RAP2;CLIP1;NUMA1;PLK1;GAS2L1;CFAP206;RSPH4A
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.4114606925005693,0.8153661988590205,0.7011070110701108,0.9131386368719395,1.0,2/10,10.79%,BTN2A2;RC3H1
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.26471121270559866,-0.8148742948200184,0.7638483965014577,0.9844971133141831,1.0,4/40,5.86%,PRKCD;KMT5A;FXR2;NEK4
prerank,polyol biosynthetic process (GO:0046173),-0.3294894360885986,-0.8147850594574798,0.7309417040358744,0.9836364538556849,1.0,3/16,8.40%,CYP27A1;FGF2;ISYNA1
prerank,protein modification by small protein removal (GO:0070646),0.253018883455726,0.8146386717949714,0.8576271186440678,0.9139591224877053,1.0,76/252,24.09%,ESR1;SMAD1;HIF1A;NFKBIA;USP3;BABAM2;SMAD7;USP15;UCHL5;ATXN3;SNX3;PSMA2;BRCC3;FOXK1;ZRANB1;IKBKG;COPS2;PSMA8;RAD23A;TNIP1;PSMA6;OTUD4;COPS4;RIPK1;ASXL1;BIRC3;IFIH1;TRAF6;APC;PSME1;MBD5;YY1;KAT2B;USP12;ACTR5;BIRC2;RHOA;ABRAXAS2;WDR48;RHOT1;NEDD8;YOD1;USP8;WDR20;DESI2;DESI1;NFRKB;PSMA4;USP7;PSMF1;STAM;NLRP3;USP25;USP21;SMAD2;PSMB7;PSMB1;TRRAP;ATXN7;PSMD2;TADA2B;TNIP2;BABAM1;PSMA5;CCNA2;PSMC3;EIF3F;JOSD1;STAM2;UCHL3;ADRM1;TRAF2;SENP6;COPS8;UBE2D1;SUDS3
prerank,response to amino acid (GO:0043200),0.32897302043753796,0.8146081709434587,0.7014925373134329,0.9135555944316973,1.0,6/31,11.63%,SH3BP4;TMBIM6;XBP1;RPTOR;LARS1;GRIN1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.4013228115090558,0.8143818992155489,0.6774193548387096,0.9134671995736904,1.0,4/12,15.00%,LPCAT3;SOAT2;APOC4;DGAT1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.33916036507611524,-0.8143123387867427,0.7192982456140351,0.9834524730089348,1.0,4/14,14.19%,IRS1;PPARA;IRS2;MFSD2A
prerank,regulation of stem cell population maintenance (GO:2000036),-0.3177432571107077,-0.814288083205749,0.717391304347826,0.9824744406166643,1.0,4/18,14.40%,PTN;CNOT3;TAF6L;WDR43
prerank,regulation of autophagosome assembly (GO:2000785),0.3315601795344961,0.8142454730739745,0.7045101088646968,0.9132341628189731,1.0,8/33,9.76%,MTM1;RALB;TBC1D12;SH3GLB1;FEZ2;CHMP4A;CHMP4B;NPRL2
prerank,positive regulation of response to wounding (GO:1903036),-0.29440192159219536,-0.8140641660225183,0.7423469387755102,0.981885315827742,1.0,6/24,13.72%,PTN;VTN;ANXA1;ADRA2A;CLDN1;HBEGF
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.28010669811937977,-0.8137971433311835,0.7461538461538462,0.9813560005251776,1.0,8/32,14.83%,CEMIP;AKAP6;TRPC1;GSTM2;GPER1;HTT;JPH2;SNCA
prerank,ubiquinone biosynthetic process (GO:0006744),-0.34104377486012105,-0.813364876027548,0.7413394919168591,0.9811364506875095,1.0,7/15,31.37%,COQ8B;COQ5;FDXR;COQ10A;NDUFA9;COQ10B;COQ6
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.3481334832300582,0.813300667579583,0.6851211072664359,0.9143870916729544,1.0,7/21,23.45%,ARHGEF2;CAMSAP2;APC;CIB1;ATXN7;TAOK1;CLASP2
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.2839534002624322,-0.8131065040890763,0.78125,0.9806269265070485,1.0,7/26,19.13%,OGT;KMT5C;CTR9;KMT2D;SETD4;VCPKMT;BEND3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3535600501626526,0.8129787033172159,0.685337726523888,0.9144878108244275,1.0,7/22,22.27%,MVB12B;NEDD4;VPS28;VPS37C;STAM;TSG101;VPS36
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.34424658772017447,0.8127176621896481,0.7058823529411765,0.914463113406912,1.0,1/25,1.15%,MEF2C
prerank,mitochondrial membrane organization (GO:0007006),-0.28287171016109924,-0.8125796332244306,0.75,0.9806506752683722,1.0,14/32,32.04%,BCL2;MICOS10;CHCHD3;CHCHD6;MTX2;SLC25A4;MAIP1;PPIF;SAMM50;APOO;PMAIP1;DNAJC11;TMEM11;IMMT
prerank,apoptotic mitochondrial changes (GO:0008637),0.32863604626942067,0.8121251637262074,0.7184,0.9150247229964181,1.0,9/32,14.19%,BIK;BOK;BCL2L1;GGCT;BNIP3;SFN;BID;SOD2;THEM4
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.39683524971253975,0.8114649958162797,0.6792114695340502,0.9156688678349542,1.0,2/11,5.22%,RIN3;GREM1
prerank,cilium assembly (GO:0060271),0.2471505073050812,0.8107661084490513,0.8863387978142077,0.9163927605190008,1.0,33/296,12.96%,ABCC4;ABLIM1;FNBP1L;EXOC6;EHD4;RAB11A;NOTCH1;CNGB1;PRKAR2B;SSX2IP;DISC1;CEP41;SPATA6;PCNT;RP1L1;BBIP1;EHD2;DYNLL1;EXOC5;CNTRL;TEKT5;CEP57;EXOC4;OCRL;CEP83;DYNLRB1;ARL13B;EHD3;ACTR2;RILP;VANGL2;WDR11;EXOC8
prerank,UV protection (GO:0009650),-0.36163976638586603,-0.8107592227003344,0.7248322147651006,0.9830362892314353,1.0,3/10,12.97%,SCARA3;MFAP4;ERCC5
prerank,positive regulation of coagulation (GO:0050820),-0.3641547621807235,-0.8106093659440731,0.6776315789473685,0.9812662805095321,1.0,4/10,22.92%,THBS1;SERPINE1;ST3GAL4;HPSE
prerank,positive regulation of hemostasis (GO:1900048),-0.3641547621807235,-0.8106093659440731,0.6776315789473685,0.9812662805095321,1.0,4/10,22.92%,THBS1;SERPINE1;ST3GAL4;HPSE
prerank,spliceosomal snRNP assembly (GO:0000387),0.3189776812814124,0.8103955856504939,0.6992248062015504,0.9165667163207941,1.0,19/38,31.39%,TGS1;WDR77;DDX20;AAR2;STRAP;SRSF10;SART1;SART3;PRPF3;SNRPD3;LSM2;SNUPN;PRMT5;SNRPD2;SNRPD1;COIL;SNRPB;CLNS1A;GEMIN8
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4006470482208754,0.8103223097384842,0.6831501831501832,0.9162213552650211,1.0,5/11,12.94%,SMAD7;USP15;ACVR1;TGFB1;TGFBR2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.27095207889655654,0.8102222072203477,0.7813712807244502,0.9159348231073885,1.0,14/107,11.40%,ERN1;RASGRF2;DAB2IP;CASP4;NCK1;TRIB3;BCL2L11;NIBAN1;RNF139;EIF2B5;RHBDD1;ERO1A;MBTPS2;ATF6
prerank,regulation of protein localization to centrosome (GO:1904779),-0.3731616467883202,-0.8094461812752954,0.7193763919821826,0.9823070973680428,1.0,1/10,2.25%,BICD1
prerank,response to X-ray (GO:0010165),-0.3438522208050917,-0.8091891241133875,0.7417840375586855,0.9817348566600852,1.0,6/14,23.99%,ANXA1;NUCKS1;IKBIP;XRCC5;XRCC6;ATM
prerank,response to organonitrogen compound (GO:0010243),-0.27233414025206515,-0.8091199464197302,0.7796610169491526,0.9808501822836085,1.0,3/38,5.80%,PRKN;GLRB;RCN3
prerank,positive regulation of cell death (GO:0010942),0.29701049857670925,0.808693600488435,0.7433004231311706,0.9180285870887125,1.0,10/59,12.40%,ACER2;DDIT4;FYN;SLC6A6;WNT5A;CDKN1B;BNIP3;PICALM;RIPK1;RIPK2
prerank,negative regulation of lipid metabolic process (GO:0045833),0.34837152842719493,0.8085425933287479,0.7019230769230769,0.9177966671870045,1.0,2/22,5.12%,PPP2R5A;CEACAM1
prerank,water transport (GO:0006833),-0.35920212914619926,-0.8083000082166386,0.7035294117647058,0.9814290350224427,1.0,1/12,1.60%,PDPN
prerank,negative regulation by host of viral process (GO:0044793),0.39976988152057763,0.8080802549608329,0.6776556776556777,0.9181021856072522,1.0,3/10,12.83%,CCNK;PTX3;EIF2AK4
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.36772402715430097,0.8073268631473011,0.6612612612612613,0.9188796009145622,1.0,2/16,2.21%,IL6ST;EDN1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.3674779595940908,0.8068022750540427,0.7001733102253033,0.919320553463663,1.0,2/16,4.20%,SCARB1;PLIN5
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.31600250723349305,0.8055625739687063,0.7132132132132132,0.9209478061882086,1.0,7/35,13.92%,PCDHB4;SELP;ATP2C1;CDH23;PCDHB5;PCDHB11;CDH5
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3778444422464948,0.8054355800930174,0.7253521126760564,0.9206948700412612,1.0,4/15,16.39%,NR3C1;BCL2L11;ZFP36;ZFP36L1
prerank,GPI anchor metabolic process (GO:0006505),0.3424032332725143,0.8053381741146447,0.7117834394904459,0.9203902972202984,1.0,8/26,18.19%,PGAP1;PIGU;PIGQ;PGAP4;PIGG;PIGF;PIGL;PIGC
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.29615468376027,-0.8053193911909943,0.7608142493638677,0.9857034537357017,1.0,1/23,0.34%,IGF1
prerank,negative regulation of leukocyte migration (GO:0002686),0.3976025305973735,0.8046841277998276,0.6911487758945386,0.9210756981040638,1.0,1/10,1.49%,CD200
prerank,cardiac muscle cell differentiation (GO:0055007),0.3499000681068714,0.803638246463336,0.7038917089678511,0.9223692528849127,1.0,3/21,6.28%,MEF2C;SIK1;ACVR1
prerank,female gonad development (GO:0008585),-0.3143713989061993,-0.8030324226037262,0.7301980198019802,0.9887838389850371,1.0,7/19,19.48%,KIT;VEGFA;INHBA;NR2F2;CEBPB;INHBB;NUP107
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3533584977183831,0.802408867366657,0.7068676716917923,0.9239729147780034,1.0,2/21,4.17%,KDR;SOX9
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.37560863558120733,0.8022098733406078,0.7030411449016101,0.9238432781080226,1.0,4/13,15.66%,TMSB4X;PSEN1;MAD2L2;DDIT3
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.36005957628167884,-0.8020830542242042,0.7311320754716981,0.9894618544765924,1.0,4/10,9.04%,DCN;BCL2;LRRK2;SRC
prerank,regulation of wound healing (GO:0061041),0.30863038602337767,0.8019305868637088,0.7282127031019202,0.9238400046584633,1.0,5/42,10.39%,CAV1;OCLN;PTK2;CRK;INSL3
prerank,fatty acid transport (GO:0015908),0.3655408516887182,0.8012208536219266,0.6912028725314183,0.9245705260690243,1.0,1/17,1.07%,PPARD
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.3520898408551162,-0.800958706591214,0.738255033557047,0.9905072992828824,1.0,2/11,3.04%,ACTN2;GPM6B
prerank,mitochondrion distribution (GO:0048311),0.38598770902056045,0.8008631974860462,0.7095588235294118,0.9246734754585714,1.0,4/12,18.22%,MTM1;MEF2A;MSTO1;TRAK2
prerank,histone H4-K5 acetylation (GO:0043981),0.3714280094920597,0.8007570844849272,0.6939890710382514,0.9239170802850228,1.0,4/15,9.15%,PHF20;JADE2;JADE1;JADE3
prerank,histone H4-K8 acetylation (GO:0043982),0.3714280094920597,0.8007570844849272,0.6939890710382514,0.9239170802850228,1.0,4/15,9.15%,PHF20;JADE2;JADE1;JADE3
prerank,steroid biosynthetic process (GO:0006694),-0.24607404549591883,-0.8006001209346413,0.8485804416403786,0.9901447589331175,1.0,15/56,22.72%,CYP7B1;CYP27A1;INSIG2;PRKAG2;OSBPL3;OSBPL6;INSIG1;PRLR;FDFT1;SCP2;FDXR;LSS;CYP51A1;DHCR7;DHRS11
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.3129106242757078,-0.8005450330114822,0.7241379310344828,0.9892392283855956,1.0,1/18,0.53%,FBN1
prerank,regulation of microtubule depolymerization (GO:0031114),0.336118106969693,0.7999623189892862,0.7208904109589042,0.9247114309218939,1.0,8/25,23.45%,ARHGEF2;TRPV4;CAMSAP2;APC;CIB1;ATXN7;TAOK1;CLASP2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.3835815835352171,0.79983420486575,0.696526508226691,0.924464449633558,1.0,1/12,1.99%,FOXP1
prerank,regulation of macrophage activation (GO:0043030),0.32642769050069814,0.7995903540523,0.7256198347107438,0.9243935076458817,1.0,3/30,6.10%,CD200;MFHAS1;WNT5A
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.27695512335566586,0.7994553927165844,0.7942386831275721,0.9241542967598492,1.0,27/84,24.92%,AURKA;PSMA2;ANAPC7;CDK2;ANAPC1;PSMA8;PSMA6;CDC26;RB1;ANAPC16;BUB3;PSME1;CUL3;PSMA4;PSMF1;PSMB7;PSMB1;PLK1;PSMD2;PSMA5;PSMC3;UBE2D1;PSMD3;UBE2E1;FBXO5;FZR1;PSMA3
prerank,synaptic vesicle exocytosis (GO:0016079),0.31066580248935083,0.799332646161663,0.740340030911901,0.923883250978721,1.0,2/40,1.30%,UNC13B;STX3
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3300681466786062,0.7993028123548561,0.739413680781759,0.9234800404368675,1.0,4/28,12.84%,ESAM;RASA1;ARHGAP28;DBNL
prerank,regulation of fibroblast migration (GO:0010762),0.35261264313853663,0.7992474164537967,0.7175043327556326,0.9231087485793277,1.0,7/20,12.01%,PRR5L;RAC1;TGFB1;PTK2;GNA12;ARHGEF7;CORO1C
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.24264539894299839,0.7989910620608108,0.8965141612200436,0.9230685849689744,1.0,76/314,22.49%,STT3B;SMURF1;NEDD4L;FBXW7;ZNRF1;KCTD10;PELI1;FBXL4;AURKA;ATXN3;ARRB1;UBE2G1;PSMA2;FBXL7;NEDD4;TRIM25;ARMC8;UBR1;ANAPC7;FBXL2;CDK2;SPOPL;RNF4;ANAPC1;ZFAND2B;PSMA8;RAD23A;SIAH1;UBE2D3;PSMA6;CDC26;RB1;CUL1;COP1;ANAPC16;FBXL3;UBE2K;BUB3;TOPORS;UBXN1;PSME1;RNF5;DDIT3;UBE3D;AREL1;CRBN;BIRC2;NHLRC1;CTNNB1;MAEA;CUL3;YOD1;CDC34;PSMA4;DNAJB12;PSMF1;CUL2;ZFAND2A;DNAJC10;APPBP2;FBXO17;PSMB7;TRIM71;PSMB1;HACE1;PLK1;KCTD2;SEL1L;DNAJB9;PSMD2;KCTD5;KLHL42;RNF103;UBXN2A;PSMA5;PSMC3
prerank,NAD biosynthetic process (GO:0009435),0.3478513885362853,0.7988668093618967,0.6958762886597938,0.9228169866436571,1.0,3/20,12.73%,PTGS2;NAXE;SLC5A8
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.34179303835675345,0.7981533270602282,0.7142857142857143,0.9235369941754752,1.0,8/24,17.66%,FYN;KCNB1;AKT2;MYO1C;TCAF2;ERBB2;CHP1;CIB1
prerank,regulation of lymphocyte activation (GO:0051249),0.37616949364394636,0.7975140990799481,0.674812030075188,0.9241336153833362,1.0,3/12,16.15%,LCK;DCAF15;LAT
prerank,alanine transport (GO:0032328),0.3993097856535973,0.7971531854313493,0.6974169741697417,0.9242502122169959,1.0,2/10,13.57%,SLC6A6;SLC36A4
prerank,regulation of B cell differentiation (GO:0045577),-0.3142718030799194,-0.7969127781388624,0.7391304347826086,0.9945797527145873,1.0,5/17,20.67%,MMP14;SFRP1;INHBA;SYK;ID2
prerank,cellular response to glucose starvation (GO:0042149),-0.26455205948372773,-0.7967348141903499,0.8328445747800587,0.9939256958122137,1.0,12/41,16.48%,BRSK1;IMPACT;PRKAA2;PRKAG2;CPEB4;EIF2AK3;PRKAG3;SZT2;NUAK2;HNRNPA1;SESN2;PRKAG1
prerank,regulation of mRNA stability (GO:0043488),-0.20845136198082273,-0.7966814956232349,0.9203980099502488,0.9930042544918557,1.0,30/145,20.98%,SAMD4A;ROCK2;PRKCD;FXR2;TENT5A;PSME4;AXIN2;PRKCA;CIRBP;EXOSC7;CELF1;IGF2BP2;PSMD12;CSDC2;EXOSC3;HNRNPU;FTO;RC3H2;TENT5C;PCBP4;E2F1;HSPB1;SAMD4B;TBRG4;PSMC4;PSMB6;EXOSC9;FASTKD3;PDE12;EIF4G1
prerank,DNA recombination (GO:0006310),-0.26086271164334945,-0.7960024586098573,0.7918918918918919,0.9932140069138237,1.0,19/37,32.55%,RECQL5;RAD51B;RTEL1;RAD50;RHNO1;DMC1;IGHMBP2;RAD51C;FBH1;RAD52;GEN1;XRCC3;RAD54L;RPAIN;EXO1;SUPV3L1;ERCC1;BLM;WRN
prerank,regulation of osteoclast differentiation (GO:0045670),-0.2719649994289944,-0.7959969456819542,0.7906976744186046,0.9922082399061911,1.0,6/33,18.16%,FBN1;UBASH3B;PRXL2A;GPR137B;CEBPB;FSTL3
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3109655038430052,0.7957523808298744,0.7136294027565084,0.9260561733266015,1.0,11/37,26.60%,POLK;RPA1;ERCC4;GTF2H4;RFC3;CHD1L;GTF2H1;RFC5;CUL4B;GTF2H5;RPA3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.34544210493063887,0.7953158294493891,0.7322033898305085,0.92633815490952,1.0,8/22,24.92%,PSMA2;PSMA8;PSMA6;PSMA4;PSMB7;PSMB1;PSMA5;PSMA3
prerank,response to sterol (GO:0036314),-0.3474852975345486,-0.7948143225306384,0.7162790697674418,0.9932895073221497,1.0,3/11,13.57%,TGFBR1;RORA;INSIG1
prerank,protein localization to nucleus (GO:0034504),-0.21329507303000367,-0.7945892498157566,0.9154929577464789,0.9926825315195597,1.0,25/102,19.91%,COL1A1;APPL2;BMP7;BMP4;SIX1;LMNA;PAF1;MDM2;TSC2;FAM53C;IPO13;POM121;NUP93;INTS13;CNEP1R1;HNRNPU;TNPO2;DVL1;ABCA7;SYK;CHCHD10;RANBP17;NUP107;NOL8;SEC13
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2547614723911612,0.7937779329540157,0.8348045397225725,0.9283945070601318,1.0,45/148,24.73%,PPP1R13B;JMY;RPS15;HIPK1;PHF20;RPS20;AURKA;RPA1;TAF3;RRS1;TAF4B;RPL23;CDK2;RICTOR;BRIP1;MAPK11;NUAK1;PRKAB1;HUS1;RMI1;NOP53;KAT6A;CHEK2;RPL11;RFC3;PRKAA1;USP7;CSNK2A2;CSNK2A1;EHMT1;TTC5;TAF9;RAD17;RMI2;TAF15;TAF7;MAP2K6;RFC5;MAPK14;MAPKAP1;PDPK1;RFFL;PLK3;PIP4K2B;MBD3
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.3262788039169676,-0.7935343061257167,0.73,0.993417250566433,1.0,5/15,32.65%,SELENOS;NPLOC4;DERL2;HSP90B1;VCP
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3897545361212321,0.7932774096635316,0.7243947858472998,0.9287503491204179,1.0,3/11,12.17%,MAD2L2;TFAP4;MUC1
prerank,bile acid metabolic process (GO:0008206),-0.2854846268709291,-0.7926800670036857,0.788659793814433,0.9938401104167451,1.0,5/27,15.08%,CYP7B1;CYP27A1;OSBPL3;OSBPL6;SCP2
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.29942213049827393,0.7925249394900321,0.7556221889055472,0.9295380842851825,1.0,5/46,7.55%,PLA2G4A;DGKZ;DGKH;PLA2G2D;AGPAT1
prerank,central nervous system neuron differentiation (GO:0021953),-0.26625751152626076,-0.7923304943665921,0.8258575197889182,0.9934285505506575,1.0,16/33,28.80%,MAP2;NTRK2;RYK;LRP6;MDGA1;GRID2;CHD5;FAIM2;MDGA2;SPOCK1;NPY;LHX1;KNDC1;CEND1;LMX1A;WNT2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.2835308095520131,-0.7923212195072806,0.759493670886076,0.9924378595139364,1.0,6/26,10.25%,KANK2;HEYL;DAB2;SFRP1;CRY2;SMARCA4
prerank,histone lysine demethylation (GO:0070076),0.3371276654541392,0.7921982087940574,0.7420965058236273,0.9295973228247396,1.0,4/25,8.10%,KDM3A;KDM6A;JMJD1C;KDM4C
prerank,negative regulation of myotube differentiation (GO:0010832),0.3851761600236828,0.7920960623129019,0.7194492254733219,0.9293071845626867,1.0,2/12,4.97%,NOTCH1;XBP1
prerank,regulation of telomere capping (GO:1904353),0.3384531798528179,0.7912393890743643,0.723292469352014,0.9301780190434429,1.0,2/23,7.80%,NEK7;HNRNPD
prerank,triglyceride metabolic process (GO:0006641),0.2988355613731734,0.7909542602203958,0.772189349112426,0.9301888624303546,1.0,10/48,15.79%,CAV1;LPIN3;LPL;PLAAT3;FABP12;GK5;MOGAT1;PNPLA2;DGAT1;MOGAT2
prerank,glycogen biosynthetic process (GO:0005978),0.37606670191733493,0.7909268532445659,0.6924493554327809,0.9293048171918254,1.0,5/12,23.26%,GBE1;PGM2;NHLRC1;PGM1;PGM2L1
prerank,glucan biosynthetic process (GO:0009250),0.37606670191733493,0.7909268532445659,0.6924493554327809,0.9293048171918254,1.0,5/12,23.26%,GBE1;PGM2;NHLRC1;PGM1;PGM2L1
prerank,regulation of protein polymerization (GO:0032271),0.3166097434963824,0.7904876026738742,0.7357594936708861,0.9295728595318989,1.0,6/35,12.84%,ESAM;RASA1;CAMSAP2;ARHGAP28;PRUNE1;DBNL
prerank,negative regulation of T cell activation (GO:0050868),0.31375266664630985,0.7901979406370983,0.7472527472527473,0.9295777334070807,1.0,4/35,6.40%,JAK3;CEACAM1;PLA2G2D;TIGIT
prerank,regulation of centrosome cycle (GO:0046605),0.3474728255166007,0.7900226732755119,0.742320819112628,0.9294124500707933,1.0,5/21,17.56%,CHMP2B;AURKA;CHMP4B;NPM1;CEP131
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.2927112921766687,-0.7899360479017926,0.7729468599033816,0.995603977713755,1.0,4/20,14.46%,FKBP5;NKTR;PPIC;PPIH
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2561304001463212,-0.7890972369512661,0.8106508875739645,0.9960889671166121,1.0,19/47,32.04%,MICOS10;CHCHD3;CHCHD6;TIMM22;MTX2;ATP5PO;MAIP1;TIMM8B;TIMM9;TIMM10;ATP5PF;ATP5ME;SAMM50;ATP5MG;DMAC2L;APOO;DNAJC11;TMEM11;IMMT
prerank,aggrephagy (GO:0035973),-0.2761628127177414,-0.7883270553575845,0.7669172932330827,0.996359471873536,1.0,4/27,8.90%,PRKN;IFT88;SQSTM1;DYNC1I1
prerank,regulation of intracellular transport (GO:0032386),0.3133451687392159,0.7880657152851228,0.7454545454545455,0.9320942848846878,1.0,8/38,13.90%,LCP1;DNAJC30;RNF139;PTPN1;INPP5F;NUP214;RAB11B;NDEL1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2647417190254919,0.7877949223942917,0.8087291399229781,0.9320802327874155,1.0,25/96,19.96%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;RNPS1;THOC6;NUP98;UPF2;NUP133;NUP205;NUP54;NUP43;NUP153;AGFG1;ALYREF;CDC40;THOC3;THOC1;CPSF1;GLE1;THOC5
prerank,visual system development (GO:0150063),0.3119219094181648,0.7876745163817532,0.7667185069984448,0.9318121230657344,1.0,4/37,5.03%,PBX1;FREM2;HIPK1;SIPA1L3
prerank,mRNA export from nucleus (GO:0006406),0.26328121691086165,0.7874985947311828,0.8290488431876607,0.9316315230748952,1.0,36/102,25.71%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;ENY2;RNPS1;THOC6;NUP98;UPF2;NUP133;NUP205;NUP54;NUP43;NUP153;AGFG1;ALYREF;CDC40;THOC3;THOC1;CPSF1;GLE1;THOC5;THOC7;SRSF4;IWS1;SMG6;NUP42;SLU7;CPSF2;NUP85;PCID2;CPSF3
prerank,regulation of translational initiation (GO:0006446),0.28192521027958395,0.7872762150264295,0.7924791086350975,0.9315165028455198,1.0,16/63,17.27%,NCK1;EIF3H;EIF1;EIF2B5;EIF4EBP1;EIF5B;EIF2AK4;UHMK1;FMR1;EIF2B2;PAIP1;NPM1;PAIP2B;EIF5;CTIF;CSDE1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3544763041666155,-0.7866907369565687,0.7317073170731707,0.9980959275845608,1.0,5/10,18.50%,PRKAA2;KLF15;MYOCD;DIP2A;FLCN
prerank,cellular response to UV (GO:0034644),0.2776954989895942,0.7864973278705802,0.7724137931034483,0.932319882123016,1.0,18/76,19.01%,POLK;PTPRK;N4BP1;NEDD4;RHBDD1;MC1R;CARD16;OPN5;EIF2AK4;ERCC4;FMR1;NPM1;YY1;BMF;ACTR5;KDM1A;BAK1;DHX36
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3627442890828923,0.7861045935049036,0.7261261261261261,0.9324810235481571,1.0,4/15,6.28%,FKBP1A;SMAD7;ACVR2A;ACVR1
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.26272659902230733,-0.7858120953967432,0.796969696969697,0.998602552095087,1.0,10/38,19.81%,MAGI2;PPARA;DAG1;TSC2;PHLPP2;GPER1;PHLDA3;OTUD3;FLCN;PTEN
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.225644562861726,-0.7857205231930955,0.915057915057915,0.9977487578315604,1.0,15/80,15.17%,DENND2A;SGSM2;SNX32;SNX6;STX16;RHOBTB3;RAB29;TMED9;GBF1;SNX5;RGP1;TRAPPC10;GGA1;ARFRP1;RBSN
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3121814035632422,0.7852553118896305,0.7658610271903323,0.9333541438636855,1.0,6/33,12.98%,NET1;RNF112;RIPK1;RHOB;RELA;SIGMAR1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3360176694567331,0.7850849714889006,0.7378964941569283,0.9331773738701992,1.0,7/23,16.26%,APP;TGFB1;RPTOR;RIPK2;UBE2K;IRGM;CALM1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.32766824118378496,0.7850148806973128,0.7129186602870813,0.9328340507646858,1.0,3/23,9.46%,FOXL2;CECR2;DICER1
prerank,arachidonate transport (GO:1903963),-0.34588554501565694,-0.7848720660788345,0.7383966244725738,0.9970966353180605,1.0,2/10,8.13%,ANXA1;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),-0.34588554501565694,-0.7848720660788345,0.7383966244725738,0.9970966353180605,1.0,2/10,8.13%,ANXA1;BDKRB2
prerank,double-strand break repair via homologous recombination (GO:0000724),0.26848873699621584,0.7847661655005163,0.8148648648648649,0.9327575935671992,1.0,20/95,19.10%,SAMHD1;RAD21L1;MMS22L;RPA1;RAD51D;SEM1;RECQL;MEIOB;FAN1;HUS1;XRCC2;MCM9;RMI1;ERCC4;YY1;SPIDR;RAD21;NSMCE1;SWSAP1;GINS2
prerank,histone exchange (GO:0043486),-0.26021116914690023,-0.784212535822634,0.807799442896936,0.997185070726144,1.0,14/37,26.49%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;ZNHIT1;CENPK;RBBP4;CENPH;KNL1;CENPX;CENPQ;CENPA
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3855569666875127,0.7837125262913875,0.702054794520548,0.9340059575081956,1.0,4/11,12.01%,RREB1;ENPP2;ARHGEF7;CORO1C
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.28516054614946795,-0.783242723314035,0.7974358974358975,0.9978210994814622,1.0,6/24,13.21%,NBL1;CCN3;CXCL12;SERPINE1;SLIT2;CREB3
prerank,positive regulation of interferon-beta production (GO:0032728),-0.2598123464702831,-0.7829919183952384,0.7844827586206896,0.9972268777928919,1.0,17/33,39.50%,HSP90AA1;OAS2;MAVS;RNF135;POLR3D;IRF3;PTPN11;DHX9;IRF7;TLR2;TLR8;TRIM56;TOMM70;POLR3C;IRF1;OAS3;IRF5
prerank,response to ionizing radiation (GO:0010212),0.280135498985798,0.7828546953185358,0.7948717948717948,0.9349382288037896,1.0,7/70,12.26%,NET1;DCUN1D3;BABAM2;BRCC3;HUS1;COP1;RHOB
prerank,negative regulation of centrosome duplication (GO:0010826),0.38038258075003933,0.7827675302974555,0.7186932849364791,0.9346184869146137,1.0,4/11,18.62%,RBM14;NPM1;KAT2B;CDK5RAP2
prerank,negative regulation of interleukin-8 production (GO:0032717),0.3488770016154783,0.7825129447409997,0.711304347826087,0.9345769441431941,1.0,3/17,7.51%,TMSB4X;ARRB1;BCL3
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3408864053766463,0.7823093446259074,0.747588424437299,0.9344466449345723,1.0,6/22,14.91%,PPM1F;PPM1D;DUSP16;DUSP7;DUSP2;PDP1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3731316631472581,0.7820678583667523,0.7148014440433214,0.9343809746131443,1.0,4/12,14.03%,ATF7IP;TASOR;PPHLN1;SETDB2
prerank,protein lipidation (GO:0006497),0.2871458935849359,0.7819064981568588,0.784370477568741,0.934174051208252,1.0,16/59,20.92%,UGCG;PIGU;ZDHHC18;ZDHHC9;HHAT;PIGQ;PGAP4;PIGG;PIGF;PIGL;PIGC;ZDHHC1;ATG7;ZDHHC6;SELENOK;ZDHHC8
prerank,macroautophagy (GO:0016236),0.2604667809201065,0.7818962163882412,0.8506900878293601,0.9337363843579027,1.0,37/118,24.44%,KLHL3;ULK1;CHMP2B;PGAM5;TECPR1;DYNLL1;ATG101;CHMP4A;CHMP4B;VPS28;ARL8B;VAMP8;PRKAB1;TBC1D5;GABARAPL1;ILRUN;VPS37C;MFN1;YOD1;PRKAA1;MTERF3;CSNK2A2;CSNK2A1;STAM;TOMM22;ATG7;VTA1;TSG101;PLEKHM1;VTI1B;PIK3R4;VPS36;STAM2;MTMR14;RB1CC1;ZFYVE1;PIP4K2B
prerank,GPI anchor biosynthetic process (GO:0006506),0.324203379322644,0.7807955997991777,0.7465437788018433,0.9350231799186235,1.0,9/30,18.19%,PGAP1;PIGU;PIGK;PIGQ;PGAP4;PIGG;PIGF;PIGL;PIGC
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3087258195862664,0.7806424892771722,0.7669291338582677,0.9348054310250129,1.0,4/37,6.05%,STAT3;GBP5;HIF1A;CUEDC2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.2945829706832842,-0.7805146625155073,0.7715736040609137,1.0,1.0,6/22,22.32%,ERI3;FTSJ3;EXOSC7;EXOSC3;EXOSC9;KRI1
prerank,organophosphate biosynthetic process (GO:0090407),-0.2584339006814706,-0.7804949415299461,0.846820809248555,0.9993831855373009,1.0,15/37,25.93%,FGF2;AGPAT4;GK;PCYT2;TKT;TPI1;GPAM;LPCAT1;AGPAT3;PPIP5K2;IP6K1;PNPO;NFS1;FADS1;MOCS1
prerank,histone mRNA catabolic process (GO:0071044),0.3641477713004613,0.7800236290331134,0.730909090909091,0.9353589884220017,1.0,7/15,27.44%,DCP2;MTPAP;LSM1;TENT4B;EXOSC4;TUT1;TUT7
prerank,regulation of centriole replication (GO:0046599),0.3502386872167893,0.7796333244085982,0.7392055267702936,0.9355297335829931,1.0,6/17,18.62%,PLK2;RBM14;NPM1;KAT2B;CEP295;CDK5RAP2
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.3430867421063588,-0.7795281834764336,0.724373576309795,1.0,1.0,4/12,21.29%,PARP3;PARP11;PARP8;TIPARP
prerank,fluid transport (GO:0042044),-0.3436887180661071,-0.7794975043468356,0.7655172413793103,0.9990854544563246,1.0,1/12,1.60%,PDPN
prerank,dendritic cell differentiation (GO:0097028),0.3425857239514432,0.7794003715174965,0.7512355848434926,0.9354483314906269,1.0,4/22,12.94%,LYN;DCSTAMP;GAS6;TGFBR2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.32849296287886753,0.7790742050463253,0.7536231884057971,0.9355011615394936,1.0,4/26,5.98%,LRP5;PIM3;KLF7;PPP3CB
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.3476780151938471,-0.7785771649266776,0.7440347071583514,0.9996181106883162,1.0,2/11,6.81%,PRKN;P4HB
prerank,cellular response to UV-A (GO:0071492),-0.34797277425904216,-0.7778615769857576,0.7526205450733753,0.9997421906010727,1.0,6/11,35.50%,MMP2;CERS1;PPID;TIMP1;MMP3;MME
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2930352389716491,0.7777193167882205,0.7889518413597734,0.9371604182712399,1.0,8/48,13.14%,NLRC5;SAMHD1;SIGIRR;OTUD4;GAS6;CARD16;GSTP1;CNOT7
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3823034694368592,0.7771329296033107,0.7142857142857143,0.9371662256841474,1.0,5/12,16.45%,HOMER2;ATP2B4;HOMER3;RCAN1;CHP1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3823034694368592,0.7771329296033107,0.7142857142857143,0.9371662256841474,1.0,5/12,16.45%,HOMER2;ATP2B4;HOMER3;RCAN1;CHP1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.3795848198796622,0.7766745334935141,0.7248576850094877,0.9374007417187299,1.0,1/11,4.97%,XBP1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2873415756949702,0.7764438611626362,0.8020378457059679,0.9368256507775236,1.0,12/50,14.81%,H3-3A;PUM1;IPO8;NUP214;PUM2;NUP98;NUP133;NUP205;FMR1;NUP54;NUP43;NUP153
prerank,regulation of gene silencing by RNA (GO:0060966),0.2873415756949702,0.7764438611626362,0.8020378457059679,0.9368256507775236,1.0,12/50,14.81%,H3-3A;PUM1;IPO8;NUP214;PUM2;NUP98;NUP133;NUP205;FMR1;NUP54;NUP43;NUP153
prerank,negative regulation of interleukin-12 production (GO:0032695),0.3636618895054071,0.7763235940474261,0.7264325323475046,0.9365605514113807,1.0,4/14,20.67%,JAK3;TIGIT;IRAK3;PIBF1
prerank,positive regulation of telomere maintenance (GO:0032206),0.318351373728253,0.7762914339521035,0.7595356550580431,0.9361605428660852,1.0,5/31,15.34%,NEK7;PPP1R10;HNRNPD;SIRT6;ATRX
prerank,mRNA stabilization (GO:0048255),0.2965522401979036,0.7760479750143315,0.7777777777777778,0.9360695066015461,1.0,15/40,22.93%,TIRAP;HNRNPA0;YBX3;ANGEL2;HNRNPC;ZFP36;PAIP1;YBX1;FUS;DAZL;ELAVL1;TAF15;NOCT;EIF4ENIF1;MAPK14
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3661462919515819,0.7758621450406189,0.7205623901581723,0.9358977419808402,1.0,2/14,11.84%,CRAT;ABCD1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.30187979945612464,0.7757548728975514,0.7910216718266254,0.9356121352979913,1.0,10/41,14.81%,HIF1A;EIF6;NUP214;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153
prerank,regulation of cilium movement (GO:0003352),-0.3501152851233389,-0.7755783575759492,0.7494736842105263,1.0,1.0,4/10,25.30%,CCDC39;DNAH11;CFAP43;DRC1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.37800927013384944,0.7743602646144901,0.6980108499095841,0.9373370887070182,1.0,4/12,12.62%,EDN1;TGFB1;AP2A1;GSTP1
prerank,fatty acid beta-oxidation (GO:0006635),0.2894058856229159,0.7739879738153725,0.7758620689655172,0.93743770213013,1.0,12/51,19.59%,PPARD;CRAT;HADHA;ECI1;ABCD4;ABCD1;HADH;AUH;ETFDH;ETFB;ETFA;ACAD10
prerank,response to acidic pH (GO:0010447),0.3542235787561425,0.7738472501385707,0.7300177619893428,0.9371793316793549,1.0,4/13,16.45%,RAB11FIP5;LGMN;RAB11B;CHP1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3299971376687715,0.773748328098644,0.7775947281713345,0.9368865139390806,1.0,5/22,14.29%,HHEX;CDKN1B;TFAP4;INCA1;APC
prerank,positive regulation of organelle organization (GO:0010638),-0.26000112622909066,-0.7735082741168724,0.847457627118644,1.0,1.0,14/32,32.06%,C2CD5;PPARGC1A;ANXA1;ANXA2;TMED9;SMCR8;HTRA2;ADRB2;RAB3GAP1;TREM2;ATL3;PLA2G5;P2RX7;KATNBL1
prerank,phosphatidic acid metabolic process (GO:0046473),0.29046193780561524,0.7734361672762855,0.7872023809523809,0.9369214077841886,1.0,5/48,7.55%,PLA2G4A;DGKZ;DGKH;PLA2G2D;AGPAT1
prerank,neutrophil chemotaxis (GO:0030593),0.2848024244853597,0.7728372917646198,0.7921348314606742,0.937423213118997,1.0,5/53,10.41%,EDN1;BSG;PPBP;PIK3CG;CCL14
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.32014344457647304,0.772518991117534,0.7640625,0.9374440565382198,1.0,6/29,12.61%,DAB2IP;EFNA1;SMAD7;MAD2L2;SFRP2;ADIPOR1
prerank,sulfur compound transport (GO:0072348),0.31966266615670547,0.7722053405501249,0.710691823899371,0.937476593068596,1.0,4/27,9.78%,ABCG2;SLC6A6;SLC26A1;SLC25A30
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.33192051224898855,-0.7720070073287398,0.7894736842105263,1.0,1.0,5/12,23.19%,GLI2;SZT2;TSKU;SPTBN4;EPHB2
prerank,cellular response to ATP (GO:0071318),-0.31524752859854943,-0.772002681200698,0.76431718061674,1.0,1.0,2/14,8.19%,P2RX4;TAF1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.35053633479441443,0.7719320501654062,0.7491166077738516,0.9374617586895678,1.0,4/18,16.39%,NR3C1;BCL2L11;ZFP36;ZFP36L1
prerank,mitotic nuclear division (GO:0140014),0.27155811737346935,0.771760504909159,0.8384831460674157,0.9372709005822893,1.0,20/71,21.61%,EPS8;RAB11A;CHMP4B;STAG2;PPP2R2D;NDEL1;STAG1;LSM14A;CTDP1;CHEK2;RHOA;ABRAXAS2;WRAP73;SMC4;MZT1;BCCIP;PIBF1;PLK1;KPNB1;KIF2A
prerank,positive regulation of type 2 immune response (GO:0002830),-0.3205981129628783,-0.7715226493789312,0.7734553775743707,1.0,1.0,3/14,11.16%,IL18;PRKCZ;CD81
prerank,cobalamin metabolic process (GO:0009235),0.3491115819316325,0.7712554191798021,0.7565217391304347,0.9376035091547684,1.0,6/17,22.89%,ABCD4;CD320;TCN2;MTR;MMAA;LMBRD1
prerank,regulation of regulated secretory pathway (GO:1903305),0.3104140621440362,0.7710669271094379,0.7745398773006135,0.9374732533023153,1.0,6/34,15.85%,RAB27A;TRPV6;SYT15;RAB5A;SYT7;RIMS4
prerank,protein targeting to peroxisome (GO:0006625),-0.27656236028776715,-0.7710013445331159,0.839142091152815,1.0,1.0,11/29,27.01%,ABCD3;ATAD1;PEX1;PXMP2;PEX7;PEX11B;ZFAND6;PEX5;GDAP1;ABCD2;PEX16
prerank,negative regulation of protein secretion (GO:0050709),0.2980711654375574,0.7705621976416108,0.786910197869102,0.9377947744366839,1.0,4/38,5.36%,CD200;RAB11FIP1;KCNB1;RAB11FIP5
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.34209862664639995,0.7702484825725635,0.7344827586206897,0.9378204463475053,1.0,4/20,10.58%,PLCG1;ECSCR;CD40;ANO6
prerank,protein monoubiquitination (GO:0006513),-0.25180036259570554,-0.7701726700791975,0.8383561643835616,1.0,1.0,7/36,14.33%,PRKN;KLHL22;CTR9;PAF1;LEO1;UBE2B;ATXN7L3
prerank,acylglycerol homeostasis (GO:0055090),0.3427765160428251,0.769746250243046,0.735144312393888,0.9381384449327604,1.0,6/20,17.93%,SCARB1;LPL;APOC4;PNPLA8;ANGPTL4;MLXIPL
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.2895279755154647,-0.7696893005144492,0.7591240875912408,1.0,1.0,4/20,11.96%,IL18;LBP;PTPN22;TICAM1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.3640837591883281,0.7695472635063411,0.7219152854511971,0.9379807876355879,1.0,5/13,13.34%,WNT5A;AGPAT1;GAS6;IL7;IFIH1
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.3050881174633326,-0.7693955624873131,0.7793103448275862,1.0,1.0,5/17,24.56%,GJA1;HNRNPU;LTBP3;TERT;PTPRC
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2693978439061143,0.7693247863086798,0.8223418573351279,0.9378917360349814,1.0,3/76,1.96%,TGM2;ESR1;HTR2A
prerank,mitochondrial fusion (GO:0008053),-0.308142147911985,-0.7692195881761652,0.7750556792873051,1.0,1.0,5/18,25.13%,MIGA2;CHCHD3;MIEF2;BAX;GDAP1
prerank,histone H4-K16 acetylation (GO:0043984),0.34217290972433734,0.7686576619538604,0.7560553633217993,0.9384667066902078,1.0,6/19,18.43%,PHF20;JADE2;JADE1;JADE3;MSL2;KANSL1
prerank,positive regulation of viral process (GO:0048524),0.2720166176043958,0.768335933112927,0.8139204545454546,0.9385279606989939,1.0,11/60,16.04%,NR5A2;ADARB1;PKN2;GTF2F2;NELFE;RAD23A;ADAR;CNOT7;RAB7A;NELFCD;CTDP1
prerank,organic cation transport (GO:0015695),-0.29682720468790086,-0.7681355141794278,0.7775280898876404,1.0,1.0,2/19,3.63%,SLC47A1;SLC22A4
prerank,regulation of feeding behavior (GO:0060259),0.38213094140868964,0.7675509030351583,0.7356521739130435,0.9392534666249761,1.0,4/11,16.41%,STAT3;UCN;EIF2AK4;AGRP
prerank,cellular response to estrogen stimulus (GO:0071391),0.3613931704635621,0.7675301949889556,0.7347294938917975,0.9388299544654023,1.0,4/14,14.57%,SERPINB9;NCOA4;TRIM24;PELP1
prerank,regulation of viral release from host cell (GO:1902186),0.33221627389452024,0.7674570713305897,0.7487266553480475,0.9384928433098577,1.0,3/21,7.85%,CHMP2B;MID2;TRIM25
prerank,endomembrane system organization (GO:0010256),0.2439878031276568,0.7665739200945246,0.9192399049881235,0.9394038895270308,1.0,14/178,8.75%,MYOF;ATP8B1;SPTBN1;PRKD1;CAV2;ALS2CL;DOP1B;CHMP2B;SYNE1;SRGN;TMED7;RAB2A;TMED5;ARHGEF7
prerank,chromosome condensation (GO:0030261),0.3021566885388281,0.7662272288849474,0.7919876733436055,0.9394812238355532,1.0,7/36,18.26%,TENT4A;MCPH1;NCAPH;RB1;SMC4;CSNK2A2;CSNK2A1
prerank,regulation of ATP metabolic process (GO:1903578),0.28454506858499246,0.7660884185670007,0.8242857142857143,0.9392362172547615,1.0,12/54,14.81%,HIF1A;AK4;EIF6;NUP214;ABCD1;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.2725162664195076,-0.7660706195121092,0.8271276595744681,1.0,1.0,5/27,8.04%,BRSK1;IL1RAPL1;NTNG1;CTNNA2;ULK4
prerank,regulation of fibroblast proliferation (GO:0048145),0.29367242074312816,0.7657983492261731,0.802962962962963,0.9392226797419788,1.0,5/45,7.04%,CDK6;PDGFB;DAB2IP;WNT5A;PDGFC
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.38259665799610615,0.7652807634652044,0.74487895716946,0.9395578587945125,1.0,5/10,22.43%,DISC1;CX3CR1;CTNNB1;KDM1A;CX3CL1
prerank,DNA metabolic process (GO:0006259),0.23323669430729047,0.7648016406927158,0.9284916201117318,0.9398690102535617,1.0,66/270,22.45%,POLK;SAMHD1;USP3;UHRF2;TCF7L2;CNBP;RNASEH2A;MCM10;RPA1;PRIMPOL;POLA1;CDT1;RAD51D;CDK2;BACH1;BTG2;PARP2;RECQL;RAD18;HELB;FAN1;HUS1;XRCC2;ACD;MMS19;UNG;PARG;LONP1;NOP53;GLRX2;ERCC4;TOP1;NSMCE4A;NPM1;MPG;NUDT15;PRIM2;ENDOV;ORC5;ORC3;GTF2H4;TERF1;PDS5A;RAD21;PDS5B;RFC3;CDC34;KMT5B;USP7;MGMT;NUDT1;CHD1L;GTF2H1;MSH2;ENDOG;RAD17;RMI2;PURA;TRRAP;DBF4;UBE2V2;RNASEH1;RIF1;SIRT7;MBD4;RFC5
prerank,cellular iron ion homeostasis (GO:0006879),0.28008443351381146,0.7645514033520964,0.826025459688826,0.9397987241256859,1.0,10/55,17.46%,ABCG2;ABCB7;LCN2;GLRX3;CUL1;HMOX2;CP;FRRS1;NEDD8;NUBP1
prerank,cytoplasmic microtubule organization (GO:0031122),0.2790651262158029,0.764306982576519,0.8216292134831461,0.9397053253140056,1.0,7/54,8.96%,RAB11A;DST;LIMK2;CCDC88A;TRPV4;CAMSAP2;SLK
prerank,entry into host (GO:0044409),0.3663658131817904,0.7640212617987137,0.7531531531531531,0.9396754783596429,1.0,6/13,17.90%,CBLL1;CXCR4;CBL;MET;CTNNB1;GRB2
prerank,recombinational repair (GO:0000725),0.2685770822344392,0.7638827523614388,0.8361344537815126,0.9394191164132466,1.0,14/77,14.61%,SAMHD1;MMS22L;RPA1;RAD51D;SEM1;RECQL;MEIOB;FAN1;HUS1;XRCC2;MCM9;RMI1;ERCC4;YY1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.31881972729600716,0.7634940538728633,0.7922948073701842,0.9395388820153053,1.0,6/26,14.80%,APP;FBXW7;TGFA;CBL;ADAM17;SOCS4
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3204539760374928,0.7628897925109265,0.7637271214642263,0.9399688529015385,1.0,4/26,9.63%,CDK6;CEACAM1;ZFPM1;MAFB
prerank,dendritic cell chemotaxis (GO:0002407),0.3568094893292277,0.7627840616327126,0.7306273062730627,0.9396755175473964,1.0,5/14,23.48%,PIK3CG;CXCR4;CCR1;HMGB1;TRPM2
prerank,regulation of mast cell degranulation (GO:0043304),0.35645515941915096,0.7627506469574615,0.7568555758683729,0.939276441068085,1.0,1/14,2.31%,LYN
prerank,gastrulation (GO:0007369),0.3495975032600086,0.7626108268821704,0.7508896797153025,0.9390078226978792,1.0,2/15,6.89%,LRP5;TASOR
prerank,purine nucleotide metabolic process (GO:0006163),0.3264108139716342,0.762194232214589,0.7751572327044025,0.9391566143510847,1.0,8/24,19.80%,GDA;NT5C2;ADSL;HPRT1;XDH;NUDT15;GART;PNP
prerank,cellular response to estradiol stimulus (GO:0071392),0.33836326304143755,0.7620332526802285,0.7513134851138353,0.9389465121517496,1.0,1/18,0.95%,ESR1
prerank,regulation of cell aging (GO:0090342),-0.3461548097231527,-0.761564655043723,0.7662337662337663,1.0,1.0,2/11,6.51%,NEK4;LMNA
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.32968903059624444,0.7613630132680981,0.7731788079470199,0.9394928904924174,1.0,6/23,12.61%,HDAC7;ADGRG3;TMSB4X;NMI;RELA;ADIPOR1
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3012471012529194,-0.7613505557232695,0.7889908256880734,1.0,1.0,8/15,44.35%,GNAS;ADCY3;GNAL;CD36;UBR3;C5AR1;BBS4;SYT10
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.2850921006874773,-0.7613218938664605,0.8089005235602095,1.0,1.0,11/23,39.55%,SELENOS;TMED9;NPLOC4;SEC16A;SEC13;DERL2;HSP90B1;VCP;TECPR2;DERL1;LMAN1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.33160561962199536,-0.7603128100846815,0.7773019271948608,1.0,1.0,2/12,6.97%,HDAC8;AXIN2
prerank,transition metal ion homeostasis (GO:0055076),0.31476086933608927,0.7600106500694261,0.7729393468118196,0.9410518225209401,1.0,7/28,17.02%,B2M;ABCB7;XIAP;PICALM;HMOX2;CP;TMC8
prerank,mRNA 3'-end processing (GO:0031124),0.26612043012874453,0.7593580662283077,0.8411602209944752,0.9415826504400246,1.0,25/78,26.04%,APP;WDR33;THOC2;RNPS1;THOC6;RPRD1B;MTPAP;RPRD2;CDC73;ALYREF;CDC40;THOC3;THOC1;CPSF1;RPRD1A;THOC5;CPSF6;THOC7;SRSF4;TENT4B;SLU7;CPSF2;PCF11;CPSF3;LSM11
prerank,stress granule assembly (GO:0034063),-0.29121108612158564,-0.7591695196860339,0.8328912466843501,1.0,1.0,6/20,19.50%,BICD1;ATXN2;CIRBP;UBAP2L;DYNC1H1;ATXN2L
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.24641638072687863,-0.7582904729143621,0.8753623188405797,1.0,1.0,13/39,24.91%,TANGO2;RCN3;COPG1;STEAP3;MIA3;RAB10;SCG2;LTBP2;NECAB3;RAB8A;OLFM2;CANX;RAB3C
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.3191080234347042,0.7581499457860681,0.7928221859706363,0.9428826982205305,1.0,4/27,7.04%,CDK6;PDGFB;WNT5A;PDGFC
prerank,hematopoietic stem cell differentiation (GO:0060218),0.3734233603270415,0.7580778897485287,0.7362428842504743,0.9425506896940002,1.0,1/10,2.17%,MLLT3
prerank,lipid droplet organization (GO:0034389),0.32906686235316424,0.758015381071949,0.7761674718196457,0.9421894776766245,1.0,8/22,28.41%,PLIN5;CDS2;RAB18;HILPDA;PPIA;ZFYVE1;AUP1;FAF2
prerank,autophagy of peroxisome (GO:0030242),-0.3285845965220881,-0.7579694473129375,0.7628205128205128,1.0,1.0,4/12,25.01%,SQSTM1;NBR1;ATM;PEX5
prerank,estrogen metabolic process (GO:0008210),-0.3106764181199304,-0.7577424421795897,0.8013245033112583,1.0,1.0,9/15,49.14%,CYP1B1;HSD17B14;HSD17B1;HSD17B2;HSD17B8;CYP1A1;SULT1A1;CYP19A1;HSD17B10
prerank,phagosome maturation (GO:0090382),0.30151589295856346,0.757642216090204,0.7774294670846394,0.9423076886070749,1.0,8/35,14.72%,ATP6V0A1;RAB38;ATP6V1G2;MREG;RAB43;RAB31;RAB7A;RAB32
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.2851605260409289,-0.7572189708041465,0.8181818181818182,1.0,1.0,5/22,17.30%,ROCK2;PPP4R4;CRY2;PTPA;BOD1L1
prerank,negative regulation of leukocyte activation (GO:0002695),0.34720594101833563,0.7572105719292915,0.774822695035461,0.94252075808421,1.0,1/15,1.49%,CD200
prerank,lipid catabolic process (GO:0016042),0.3434564461843781,0.756983445270572,0.7698815566835872,0.9424038834960801,1.0,3/18,8.50%,LIPE;LPL;PLAAT3
prerank,eosinophil migration (GO:0072677),-0.31115768934574817,-0.7559747552752994,0.8193832599118943,1.0,1.0,9/14,45.93%,SCG2;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3
prerank,eosinophil chemotaxis (GO:0048245),-0.31115768934574817,-0.7559747552752994,0.8193832599118943,1.0,1.0,9/14,45.93%,SCG2;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3
prerank,cytosolic transport (GO:0016482),0.25289515462323814,0.7559522118444038,0.8983050847457628,0.9434801196027334,1.0,21/108,16.11%,MYO1D;LMTK2;STX6;DOP1B;EEA1;VTI1A;AP2A1;GCC2;SPAG9;ANKFY1;TBC1D5;STX8;EHD3;RILP;KIF16B;EVI5;RAB5A;RAB7A;ERC1;RAB6A;RIC1
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.2553252824053111,-0.7552732595427492,0.8638888888888889,1.0,1.0,14/36,23.99%,CEP63;CLSPN;DOT1L;RAD9B;RHNO1;E2F1;SETMAR;DONSON;USP28;ATR;INTS7;DNA2;CHEK1;ATM
prerank,regulation of microtubule nucleation (GO:0010968),-0.3443751867561059,-0.7552068252554436,0.7732181425485961,1.0,1.0,1/10,2.14%,EML2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.2145513690821993,-0.7546599986584449,0.9501915708812261,1.0,1.0,23/82,24.86%,NINL;HSP90AA1;YWHAG;ALMS1;ATF5;PRKACA;SDCCAG8;CEP63;CEP192;ODF2;CEP152;PCM1;CEP43;DCTN3;DYNC1H1;CKAP5;TP53;HAUS6;TPX2;HAUS2;SFI1;CENPF;CSNK1E
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.26718887905205657,-0.7536637981192532,0.8387909319899244,1.0,1.0,8/26,21.02%,LARGE1;GK;GBGT1;TKT;TPI1;GAL3ST2;SCCPDH;ST3GAL4
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3110856773560599,-0.7536015280304524,0.7888631090487239,1.0,1.0,3/14,7.15%,IL18;ANXA1;PRKCZ
prerank,RNA biosynthetic process (GO:0032774),0.3041779635223325,0.7533196499349576,0.7750410509031199,0.9468678298639027,1.0,13/31,30.06%,POLA1;SMARCA5;HELB;PRIM2;SETX;TAF7;TCEA2;BRF1;TTF2;PRIM1;PRMT5;POLA2;RSF1
prerank,protein localization to Golgi apparatus (GO:0034067),0.30550995178005497,0.7531358158013532,0.8061889250814332,0.9466622537045667,1.0,4/27,8.81%,GBP5;VPS13D;GCC2;ARL5A
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.36463749619497327,0.7530384806687016,0.7445255474452555,0.9463636222893795,1.0,2/12,9.61%,PAEP;IL23A
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.3182382455384546,-0.7516128762310434,0.7716186252771619,1.0,1.0,8/13,35.42%,SEC16B;CD81;INSIG1;SEC16A;TMEM30B;TM9SF4;SAR1A;SORL1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.26534338080355857,0.751585916079779,0.8462603878116344,0.9480081409329909,1.0,17/69,22.30%,CCNK;GTF2F2;GTF2E2;POU2F1;INTS11;SNAPC3;RPRD1B;GTF2A2;INTS12;RPRD2;POU2F2;RPRD1A;SP1;TAF9;POLR2L;INTS8;POLR2J
prerank,triglyceride homeostasis (GO:0070328),0.3174071259078735,0.7515176396229689,0.8022508038585209,0.9476583399132436,1.0,7/26,17.93%,SCARB1;XBP1;LPL;APOC4;PNPLA8;ANGPTL4;MLXIPL
prerank,regulation of myoblast fusion (GO:1901739),-0.33065169302537556,-0.7515034832732079,0.7726315789473684,1.0,1.0,3/11,14.16%,RIPOR2;EHD1;CD53
prerank,bicarbonate transport (GO:0015701),-0.27488722515178454,-0.7514133326630277,0.8048780487804879,1.0,1.0,8/25,18.10%,SLC4A10;SLC26A7;CA4;SLC4A3;SLC4A2;SLC26A6;CFTR;SLC4A8
prerank,purine-containing compound salvage (GO:0043101),0.3532136584303011,0.7513783711270573,0.7422680412371134,0.9474074648449037,1.0,4/12,19.80%,GMPR;HPRT1;ADA;PNP
prerank,RNA export from nucleus (GO:0006405),0.25404333198691725,0.7508888002663597,0.8670143415906127,0.9476356336125537,1.0,25/100,19.96%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;RNPS1;THOC6;NUP98;UPF2;NUP133;NUP205;NUP54;NUP43;NUP153;AGFG1;ALYREF;CDC40;THOC3;THOC1;CPSF1;GLE1;THOC5
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.30032059249188864,0.7497103145956299,0.7880690737833596,0.9489162650194063,1.0,8/35,20.90%,NEK7;HMBOX1;ACD;CTNNB1;DHX36;CCT7;CCT2;MAP2K7
prerank,regulation of cell cycle phase transition (GO:1901987),0.2559825463564115,0.7496926898803169,0.873202614379085,0.9484950918474753,1.0,29/91,24.92%,FBXW7;ATP2B4;CDKN1B;PSMA2;ANAPC7;ANAPC1;PSMA8;PSMA6;TFAP4;CDC26;CUL1;ANAPC16;BUB3;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;DBF4;PLK1;PSMD2;PSMA5;PSMC3;UBE2D1;PSMD3;UBE2E1;FBXO5;FZR1;PSMA3
prerank,neuron fate commitment (GO:0048663),0.3534938331691502,0.7496627035534079,0.7721088435374149,0.9481016520445368,1.0,2/14,5.28%,DLL1;DLL4
prerank,response to organic cyclic compound (GO:0014070),0.2798858980459723,0.7494990083043214,0.8282208588957055,0.9478730179164101,1.0,3/52,2.42%,ESR1;SOCS2;STAT3
prerank,positive regulation of protein depolymerization (GO:1901881),-0.33274863363735285,-0.748755753999682,0.7907488986784141,1.0,1.0,3/11,15.93%,SEMA5A;NES;PLEK
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.29500183951036313,0.7485208751160997,0.8126888217522659,0.9488194290186813,1.0,14/38,23.16%,GBP5;USP15;SASH1;PUM1;NMI;PUM2;OASL;POLR3B;PLSCR1;CD180;SLC15A4;ZCCHC3;CYBA;RIOK3
prerank,regulation of transposition (GO:0010528),0.3535705468690523,0.7483226223028527,0.7619926199261993,0.9486849715498417,1.0,5/13,25.08%,BTBD18;SPOCD1;TEX15;SIRT7;SMYD5
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3161146051887843,-0.747969710127115,0.7866666666666666,1.0,1.0,4/14,10.15%,LPIN1;ETNK2;PCYT2;SLC27A1
prerank,carnitine shuttle (GO:0006853),-0.3278897058220805,-0.7479191243779626,0.7811158798283262,1.0,1.0,3/11,6.99%,PRKAA2;PRKAG2;ACACA
prerank,histone H2B ubiquitination (GO:0033523),-0.33167163416379775,-0.7474677068995358,0.8018433179723502,1.0,1.0,3/10,9.56%,CTR9;PAF1;LEO1
prerank,regulation of mitotic spindle organization (GO:0060236),-0.2571324575776912,-0.7472333738076968,0.873972602739726,1.0,1.0,13/35,30.58%,PARP3;GNAI1;GPSM2;RAE1;HNRNPU;DYNC1H1;TPX2;FSD1;CHMP1A;EML3;DCTN1;MAP9;CHMP2A
prerank,protein O-linked mannosylation (GO:0035269),0.33790471614432105,0.74672495391021,0.7634228187919463,0.9504893174174017,1.0,3/18,8.88%,TMTC2;B4GAT1;RXYLT1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3083595472377181,0.7449944785247026,0.7944535073409462,0.9524565849586633,1.0,7/27,16.72%,SKAP1;LCK;CYRIB;RELA;HAS2;TRAF6;RHOA
prerank,fat cell differentiation (GO:0045444),0.27283742637903696,0.7445636511737908,0.8297567954220315,0.952613512452167,1.0,6/57,9.63%,FOXO1;TCF7L2;ERAP1;CTBP1;AKT2;MAFB
prerank,DNA damage checkpoint signaling (GO:0000077),-0.2675160157861651,-0.744400751259332,0.8286445012787724,1.0,1.0,11/28,23.99%,CEP63;CLSPN;DOT1L;RHNO1;E2F1;DONSON;USP28;ATR;INTS7;CHEK1;ATM
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.328254123980976,-0.7444006937948097,0.7742663656884876,1.0,1.0,1/11,6.12%,AGTR1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.2988244877318075,-0.74422176086389,0.8126520681265207,1.0,1.0,3/17,8.01%,ANK3;AKAP6;KCNAB1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.32024568610266996,0.7439711837194768,0.7866666666666666,0.9529402073041845,1.0,8/21,22.94%,FOSL1;HNF1B;SUB1;DHX36;SETX;MED12;MED17;JUN
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.27544201673978297,0.743546832628686,0.8301043219076006,0.9530660608110104,1.0,16/55,22.49%,AURKA;AVEN;PSMA2;FBXL7;PINX1;PSMA8;PSMA6;CUL1;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.2856151743537224,-0.7432537403726349,0.8104738154613467,1.0,1.0,3/17,9.84%,FGF1;SREBF1;APOE
prerank,positive regulation of protein transport (GO:0051222),0.27127908536752454,0.7426803364355308,0.8402777777777778,0.9538351834346495,1.0,9/67,9.89%,UNC13B;CD2AP;EXPH5;PRR5L;PCNT;TGFB1;ATP2C1;ANG;VPS28
prerank,negative regulation of autophagosome assembly (GO:1902902),0.3505779537379017,0.7422584333960875,0.7695099818511797,0.9539966100470165,1.0,4/13,9.20%,MTM1;FEZ2;CHMP4A;CHMP4B
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.3665164955459755,0.7413524002021208,0.7544169611307421,0.9548476409900082,1.0,3/11,11.87%,CASP8;RFTN1;RIPK1
prerank,chemical homeostasis (GO:0048878),0.27141926558729146,0.7405757931197213,0.860431654676259,0.9554967270410378,1.0,7/61,10.33%,KLHL3;NEDD4L;FBXW7;AQP11;TLCD3A;SLC4A7;USF2
prerank,histone ubiquitination (GO:0016574),-0.28034250058048216,-0.7405317571925188,0.8411458333333334,1.0,1.0,5/21,14.33%,CTR9;PAF1;LEO1;UBE2B;ATXN7L3
prerank,negative regulation by host of viral transcription (GO:0043922),0.3544960763478098,0.7404416746210699,0.7665441176470589,0.9552471397509018,1.0,4/12,22.94%,INPP5K;TFAP4;PSMC3;JUN
prerank,meiosis I (GO:0007127),0.31593013618798965,0.7394689477798743,0.7972972972972973,0.9561551441039806,1.0,4/23,13.64%,BTBD18;BCL2L11;MEIOB;ZSCAN21
prerank,telomere maintenance via telomerase (GO:0007004),0.3063181656689268,0.7391293303788581,0.8117088607594937,0.9561655682207487,1.0,7/28,16.50%,RPA1;WRAP53;PINX1;CDK2;ACD;HSP90AB1;TERF1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2573500142283697,0.7388791900812497,0.8716577540106952,0.9560862036618745,1.0,13/78,15.62%,PDGFB;HHEX;CCNK;CDKN1B;CCNYL1;PKD2;CCNY;TFAP4;INCA1;CDC25C;ADAM17;APC;CCNJ
prerank,tRNA processing (GO:0008033),0.26650118497899355,0.7386273468873737,0.8581871345029239,0.9559916285613109,1.0,20/61,27.85%,CDKAL1;FARS2;RPP30;TSEN34;RTCB;ADAT1;DTWD2;KARS1;TRMT6;CPSF1;TSEN2;THUMPD1;TRUB1;RTRAF;NSUN6;AARS2;LCMT2;TRMT10C;NSUN2;TSEN15
prerank,inorganic ion transmembrane transport (GO:0098660),-0.3206833657288557,-0.7383859500878992,0.8013245033112583,1.0,1.0,8/12,42.06%,ABCC9;KCNJ8;CACNA1H;P2RX3;TRPM4;KCNJ11;RHAG;PKD2L1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2668380084402401,0.7382320274823424,0.8443526170798898,0.9560553400982619,1.0,12/68,16.09%,SLC2A1;MTHFD1L;SLC52A3;GSTO2;ABCD4;PANK2;TPK1;CD320;SLC19A3;TCN2;RFK;MTR
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.209827478992065,-0.7381721913990337,0.9532374100719424,1.0,1.0,26/78,23.25%,SEC24D;KIF3C;KIF3A;SEC31A;DYNC1I1;SEC23A;ACTR1B;AP2S1;CTSD;KIFAP3;DCTN5;CAPZB;KLC1;DCTN4;KIF5A;DCTN3;DYNC1H1;CTSL;SEC13;CTSS;KLC2;CD74;LAG3;AP1S1;CANX;DYNC1LI2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.209827478992065,-0.7381721913990337,0.9532374100719424,1.0,1.0,26/78,23.25%,SEC24D;KIF3C;KIF3A;SEC31A;DYNC1I1;SEC23A;ACTR1B;AP2S1;CTSD;KIFAP3;DCTN5;CAPZB;KLC1;DCTN4;KIF5A;DCTN3;DYNC1H1;CTSL;SEC13;CTSS;KLC2;CD74;LAG3;AP1S1;CANX;DYNC1LI2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.28282888187311117,-0.7381434210452833,0.8345864661654135,1.0,1.0,4/20,10.15%,PLOD2;GCLC;FPGS;SLC27A1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.2525644311606196,-0.7380512104611305,0.8666666666666667,1.0,1.0,11/31,27.50%,PEX1;TOMM40;AIFM1;PEX7;TIMM17B;GRPEL2;TIMM21;PEX5;DNAJC15;PEX16;PAM16
prerank,snRNA processing (GO:0016180),0.33518826485572845,0.737597883694946,0.789198606271777,0.956484500154173,1.0,6/16,26.80%,INTS11;INTS12;INTS8;TOE1;INTS6L;TUT1
prerank,response to peptide (GO:1901652),0.2940495729773459,0.7368435944679464,0.8200899550224887,0.9570860801935052,1.0,8/33,17.69%,STAT3;FYN;CACNA1A;EIF2B5;EIF2B2;STAT6;ERBIN;STAT1
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.33021642731403167,-0.7365967554394331,0.7761194029850746,1.0,1.0,7/10,47.17%,ASRGL1;KYAT1;PCBD1;KYNU;THAP4;IYD;QDPR
prerank,positive regulation of RNA metabolic process (GO:0051254),0.27855811608756004,0.7358612212421628,0.8282387190684134,0.9580074799568562,1.0,11/45,17.33%,ERN1;RBM20;DYRK1A;TGFB1;NFKB1;HNRNPLL;RIPK1;RELA;RIOK1;PNPT1;HEATR1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.30350820989013255,0.735817909680708,0.834375,0.9576269215322408,1.0,4/29,4.22%,SCARB1;ELOVL5;PLIN5;SORBS1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.29607611454151933,-0.7354420284728802,0.8345679012345679,1.0,1.0,6/17,30.50%,P4HB;HSPB1;HTRA2;NME5;TREM2;VNN1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.33427949964516906,0.7353566084177043,0.7752212389380531,0.9578067404276615,1.0,1/15,1.07%,PPARD
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.23922269983470307,-0.7343829847837887,0.8727810650887574,1.0,1.0,12/38,23.53%,PRKN;SREBF1;NPEPPS;LRRK2;ABLIM3;HPS4;RHOU;HAX1;HTRA2;ATP5IF1;VPS11;FZD5
prerank,intracellular cholesterol transport (GO:0032367),-0.3054577020296308,-0.7337328517619859,0.8013856812933026,1.0,1.0,4/15,17.69%,LDLR;LRP6;SERAC1;VPS4A
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2672782051460069,0.733683929733233,0.85,0.9596489642213544,1.0,9/62,10.31%,ARHGEF2;ARMC10;TMBIM6;XBP1;DNAJA1;YBX3;BCL2L1;DDIAS;SFRP2
prerank,peptidyl-glutamic acid modification (GO:0018200),0.31080642002887177,0.7336508499896125,0.785,0.9592460677768161,1.0,7/24,20.81%,CEP41;TTLL7;TTLL10;NAA11;TTLL5;TPGS1;TTLL9
prerank,snRNA transcription (GO:0009301),0.2583007702955796,0.7329781016418816,0.8684931506849315,0.9596875605124919,1.0,17/70,22.30%,CCNK;GTF2F2;GTF2E2;POU2F1;INTS11;SNAPC3;RPRD1B;GTF2A2;INTS12;RPRD2;POU2F2;RPRD1A;SP1;TAF9;POLR2L;INTS8;POLR2J
prerank,substantia nigra development (GO:0021762),-0.24332722118044603,-0.7321376907561624,0.8910081743869209,1.0,1.0,10/37,18.92%,NDRG2;SIRT2;PLP1;CKB;MBP;COX6B1;S100A1;TTBK1;SEC16A;PADI2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3235809051545321,0.7320316960358948,0.7883333333333333,0.9604991672533005,1.0,6/19,20.76%,PINX1;ACD;DCP2;HNRNPC;TERF1;TEN1
prerank,RNA metabolic process (GO:0016070),0.23944788985074525,0.7319556398683358,0.9245283018867925,0.9601651124864002,1.0,32/127,18.44%,RBPMS;ADARB1;DDX54;ISG20;DROSHA;HNRNPF;RNASE1;GTF2F2;RNASEH2A;HNRNPA0;MTREX;HNRNPK;HNRNPD;RNASE4;LSM8;DICER1;RNGTT;RBM3;ADAR;RNASEH2C;RNASEH2B;HNRNPC;FASTKD2;WTAP;XRN2;DDX20;HNRNPUL1;PNPT1;METTL14;THOC1;PRPF4;HNRNPM
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.31126614567758965,-0.7314891316897414,0.789010989010989,1.0,1.0,6/13,26.39%,CD44;MDM2;SNAI1;CD74;TWIST1;SNAI2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.28284622473993387,-0.731348003987321,0.8271604938271605,1.0,1.0,7/19,23.46%,AXL;MMP14;MDK;SYK;XRCC6;RHOH;PRKDC
prerank,quinone biosynthetic process (GO:1901663),-0.31197217856028536,-0.7312116044788243,0.8307349665924276,1.0,1.0,6/14,31.37%,COQ8B;COQ5;FDXR;COQ10A;COQ10B;COQ6
prerank,iron ion transport (GO:0006826),-0.2324965238198749,-0.730544740830196,0.921875,1.0,1.0,8/47,13.77%,SCARA5;ATP6V0A4;SLC39A14;ATP6V1B2;STEAP3;ATP6V0D1;ATP6V0B;ARHGAP1
prerank,negative regulation of DNA recombination (GO:0045910),0.27663758338683897,0.7305065711304946,0.8348348348348348,0.961714140927761,1.0,13/43,22.30%,SMCHD1;SHLD1;CGAS;MAD2L2;HELB;ACD;ATRX;TERF1;MSH2;RMI2;POLR2L;RIF1;POLR2J
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3115118027822915,0.7305019916583886,0.8113821138211382,0.9612720147256124,1.0,9/24,24.36%,PINX1;ACD;DCP2;HNRNPC;ERCC4;TERF1;TEN1;TENT4B;TNKS
prerank,glycoprotein catabolic process (GO:0006516),0.32601764365453206,0.7300354127735881,0.8056537102473498,0.9614484894369761,1.0,1/17,1.62%,STT3B
prerank,negative regulation of secretion by cell (GO:1903531),0.28812483121212795,0.7298929335487907,0.8248502994011976,0.9611875681306129,1.0,8/38,15.22%,NOTCH1;TNFRSF1B;FGF23;TNFRSF1A;VAMP8;PNKD;RHBDF2;STXBP6
prerank,regulation of telomere maintenance (GO:0032204),0.3075162642625576,0.7296264988953182,0.8139904610492846,0.9611113908182158,1.0,8/26,19.01%,PPP1R10;HNRNPD;SIRT6;ERCC4;YLPM1;ATRX;USP7;DHX36
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3343346473632335,-0.7291945017667921,0.8230088495575221,1.0,1.0,3/10,14.83%,KLF15;THAP7;SNCA
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.25773404912343834,-0.72897514980596,0.8691358024691358,1.0,1.0,8/29,23.09%,TENT5A;AXIN2;CIRBP;HNRNPU;TENT5C;E2F1;SLC11A1;RBM24
prerank,positive regulation of chromosome organization (GO:2001252),0.34151078826397796,0.7285121288749161,0.7953736654804271,0.9621554757762101,1.0,5/15,19.01%,PPP1R10;SIRT6;ATRX;RAD21;DHX36
prerank,regulation of phosphatase activity (GO:0010921),0.3113069935141144,0.7285067536300831,0.8121827411167513,0.9617146599138222,1.0,6/24,18.88%,PPP1R2;CHP2;GPATCH2;CHP1;TIPRL;MTMR9
prerank,Golgi organization (GO:0007030),0.24376416094188144,0.7278843596660395,0.9003931847968545,0.9620860048128242,1.0,11/112,8.75%,ATP8B1;PRKD1;STX6;VAMP4;SYNE1;VTI1A;GCC2;TMED7;RAB2A;TMED5;ARHGEF7
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3018354443068256,-0.7277757344851146,0.8376470588235294,1.0,1.0,5/15,14.16%,RIPOR2;CAMK1;ADAM9;EHD1;CD53
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2515718218922105,0.7275330616386404,0.8834688346883469,0.9621306966293197,1.0,16/84,15.91%,NANOS3;DAPK1;IGF2BP3;NANOS2;GRB7;RNF139;BTG2;RPL13A;CNOT1;MRPL13;RACK1;CNOT7;FMR1;LSM14A;YBX1;PAIP2B
prerank,histone H2A ubiquitination (GO:0033522),-0.29072559553202404,-0.7274776619982496,0.8364928909952607,1.0,1.0,6/17,21.34%,BCOR;DDB2;UBE2B;RING1;DDB1;PCGF1
prerank,autophagosome organization (GO:1905037),0.27121438939297865,0.727176255340757,0.8535502958579881,0.9621416571033286,1.0,16/50,24.22%,ULK1;ATG101;EMC6;GABARAPL1;RAB43;RAB7A;ATG2A;ATG2B;STX12;IRGM;RAB1A;ATG7;UBXN2A;RAB1B;VMP1;RB1CC1
prerank,apoptotic nuclear changes (GO:0030262),0.3113193935142491,0.726895235142214,0.7929292929292929,0.9620554888091178,1.0,3/24,9.46%,FOXL2;CECR2;DICER1
prerank,mitotic nuclear membrane organization (GO:0101024),0.27124774226078757,0.7263166427031543,0.8511278195488722,0.9619243484091766,1.0,21/51,27.12%,LBR;CHMP2B;CHMP4A;CHMP4B;NUP98;NUP133;NUP205;NUP43;UBE2I;PPP2R2A;VRK1;PPP2R1A;KPNB1;REEP3;NUP85;PPP2CA;SUMO1;CHMP3;ANKLE2;CHMP4C;EMD
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.27124774226078757,0.7263166427031543,0.8511278195488722,0.9619243484091766,1.0,21/51,27.12%,LBR;CHMP2B;CHMP4A;CHMP4B;NUP98;NUP133;NUP205;NUP43;UBE2I;PPP2R2A;VRK1;PPP2R1A;KPNB1;REEP3;NUP85;PPP2CA;SUMO1;CHMP3;ANKLE2;CHMP4C;EMD
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.3259932464075169,-0.7263061427202141,0.8239130434782609,1.0,1.0,4/10,22.66%,LBP;PTPN22;NR1H3;IFI35
prerank,response to hexose (GO:0009746),0.3075405994430047,0.7262542588629483,0.8294314381270903,0.9615654811011896,1.0,6/25,13.79%,TCF7L2;LPL;NEUROD1;EIF2B5;PFKL;EIF2B2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.23824584768163704,0.7257471262578298,0.9210850801479655,0.9617491217809597,1.0,30/144,17.66%,PPP1R13B;FBXW7;FYN;CASP8;KCNB1;MAPK8;TCF7L2;PRR5L;CHP2;PCNT;SH3GLB1;TGFB1;PSEN1;AKT2;UBE2D3;MYO1C;GAS6;SFN;BID;TCAF2;SAE1;YWHAQ;ERBB2;ARIH2;CEP290;CHP1;ANP32B;RAPGEF3;CEP131;CIB1
prerank,Golgi inheritance (GO:0048313),-0.31978830969172456,-0.725258151331864,0.8080168776371308,1.0,1.0,2/11,12.24%,GBF1;PLK5
prerank,homologous chromosome segregation (GO:0045143),0.3169798871769115,0.7251603637262123,0.8096026490066225,0.9620377641556527,1.0,6/20,25.04%,MEIOB;TERB1;TERB2;PRDM9;SIRT7;FMN2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.34073667511673333,0.7249846133089405,0.7888086642599278,0.9618331328467092,1.0,2/14,9.61%,PAEP;IL23A
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3205353499871776,0.7248384906890321,0.7943262411347518,0.9615815044113871,1.0,7/19,26.74%,CHMP2B;CHMP4B;PLK1;PDCD6IP;CHMP3;HSPA1B;CHMP4C
prerank,DNA catabolic process (GO:0006308),0.35065782745603735,0.7241999675729719,0.7798507462686567,0.9619597770684237,1.0,2/11,15.02%,ISG20;XRN2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.25124999065161063,0.723788274223393,0.8704453441295547,0.9620480408411775,1.0,20/72,26.60%,POLK;RPA1;COPS2;COPS4;ERCC4;AQR;GTF2H4;RFC3;USP7;GTF2H1;POLR2L;CCNH;POLR2J;RFC5;ERCC6;CUL4B;COPS8;GTF2H5;ISY1;RPA3
prerank,fatty acid catabolic process (GO:0009062),0.2626625687407613,0.7235128718714644,0.8694444444444445,0.961967171004546,1.0,11/67,16.76%,PPARD;ABHD2;LPIN3;HADHA;ECI1;ABCD4;ABCD1;HADH;ALDH3A2;FAAH;AUH
prerank,regulation of mRNA catabolic process (GO:0061013),0.2404831548781606,0.7232278720568743,0.9249061326658323,0.9619004569237805,1.0,32/121,22.49%,ANP32A;IGF2BP3;PRR5L;PSMA2;HNRNPD;XPO1;PUM1;SERBP1;PSMA8;CNOT1;PSMA6;RC3H1;EXOSC1;NUP214;DCP2;PUM2;ZFP36;CNOT7;FMR1;PSME1;PNPT1;ZFP36L1;PSMA4;PSMF1;DHX36;PSMB7;PSMB1;ELAVL1;PSMD2;ZC3H14;PSMA5;PSMC3
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.2998272883477581,-0.7231899421251715,0.8244803695150116,1.0,1.0,3/16,17.76%,WBP4;PSIP1;CACTIN
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.18268894799624974,-0.7229976692233178,0.9867549668874173,1.0,1.0,46/184,25.62%,APPL2;NINL;HECW2;PKD1;SIRT2;HSP90AA1;CDC14B;YWHAG;ALMS1;PSME4;ANAPC5;PRKACA;BTRC;SDCCAG8;RGCC;CEP63;ANAPC15;CEP192;ODF2;PLK5;PSMD12;CEP152;PCM1;CEP43;DDB1;E2F1;XPC;DCTN3;DYNC1H1;PSMC4;NEK11;PSMB6;CDC16;ID2;CKAP5;HAUS6;TPX2;HAUS2;SFI1;PSMD4;UBC;CENPF;PSMC5;CSNK1E;BUB1B;ZFP36L2
prerank,stem cell differentiation (GO:0048863),0.2848803263974272,0.7226231954323264,0.8450920245398773,0.962244882581016,1.0,3/39,5.60%,MEF2C;MLLT3;MTF2
prerank,positive regulation of calcium ion import (GO:0090280),0.3534924029306291,0.7225956976421843,0.7906976744186046,0.9618370691043974,1.0,1/12,1.89%,PDGFB
prerank,B cell mediated immunity (GO:0019724),0.35657201979499514,0.7224427970245462,0.7832699619771863,0.9615959475643076,1.0,4/10,23.11%,SLA2;CARD9;MSH2;FCER1G
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2814787391589416,0.7205438647167097,0.8377952755905512,0.9635631788331224,1.0,3/39,2.87%,UTRN;NEDD4L;FXYD6
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.2889763846698932,-0.7205081403274519,0.8321167883211679,1.0,1.0,4/17,13.42%,PRKN;CD44;MDM2;SNAI1
prerank,positive regulation of vacuole organization (GO:0044090),0.3617499458661385,0.7203591569739713,0.7751371115173674,0.9633752581367024,1.0,2/10,6.64%,RALB;SH3GLB1
prerank,protein export from nucleus (GO:0006611),0.29450589951649614,0.7200483262183205,0.8312693498452013,0.9632988805430083,1.0,8/27,17.36%,SMURF1;TGFB1;DUSP16;XPO1;NUP214;STYX;CHP1;DESI1
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3121827117668,-0.7195682306841754,0.7966101694915254,1.0,1.0,7/12,31.17%,ACSL1;FADS2;SCP2;ELOVL1;FADS1;ACOT8;ELOVL2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.30521645020717003,-0.7192295473075588,0.8151447661469933,1.0,1.0,3/13,10.34%,SYT1;CACNA1G;SCAMP5
prerank,histone H3-K4 trimethylation (GO:0080182),-0.3157720122257573,-0.7190840788935885,0.7848970251716247,1.0,1.0,4/11,19.13%,OGT;CTR9;KMT2D;BEND3
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.29539079511993227,0.7189719717086295,0.8520249221183801,0.9642384811263855,1.0,7/29,16.50%,RPA1;WRAP53;PINX1;CDK2;ACD;HSP90AB1;TERF1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.292689367201152,-0.718501738598473,0.8345323741007195,1.0,1.0,7/15,25.80%,ADRA2A;APOE;ADAM9;GPLD1;PACSIN3;SNX33;NRDC
prerank,tetrapyrrole metabolic process (GO:0033013),0.32124837573823584,0.7184997468358015,0.8169257340241797,0.9643838293804571,1.0,6/18,22.89%,ABCD4;CD320;TCN2;MTR;MMAA;LMBRD1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.2882749934409731,-0.7183471677727732,0.8403755868544601,1.0,1.0,3/16,10.10%,CELF4;DAZAP1;CIRBP
prerank,RNA interference (GO:0016246),0.319119339797793,0.71776655396335,0.8062283737024222,0.9648975105885036,1.0,5/17,21.33%,DROSHA;DICER1;HENMT1;MRPL44;PRKRA
prerank,phospholipid biosynthetic process (GO:0008654),0.2818271965829572,0.7177194996424162,0.8592375366568915,0.9645141434927677,1.0,7/36,19.34%,SGMS1;MBOAT1;NUS1;DPAGT1;DOLK;CPNE3;GNPAT
prerank,endodermal cell fate commitment (GO:0001711),-0.321750016548331,-0.717126133081623,0.8177570093457944,1.0,1.0,3/10,9.56%,CTR9;PAF1;LEO1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.28548440452803564,0.7170170114812368,0.8125984251968504,0.9649601416290562,1.0,4/33,7.41%,HTR2A;EDN1;PIK3C2A;PIK3CG
prerank,negative regulation of B cell activation (GO:0050869),0.31152593796271955,0.716429834256407,0.8169257340241797,0.9652589332528124,1.0,3/21,10.79%,LYN;SAMSN1;RC3H1
prerank,integrated stress response signaling (GO:0140467),-0.2981507658617517,-0.7164285804138086,0.8358862144420132,1.0,1.0,5/14,26.53%,IMPACT;EIF2AK3;EIF2AK1;HSPA5;CCL2
prerank,positive regulation of macrophage differentiation (GO:0045651),0.3470118549632836,0.7162500140993464,0.7887323943661971,0.9650385858104743,1.0,4/11,11.87%,CASP8;TGFB1;CSF1;RIPK1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.2843028093221653,-0.7160323189946541,0.8349282296650717,1.0,1.0,8/18,22.08%,PTPN23;DAB2;EZR;SRC;MAP2K2;MAP2K1;RAB21;VPS11
prerank,regulation of lipase activity (GO:0060191),-0.2990377110252853,-0.7156587722393,0.8004807692307693,1.0,1.0,5/13,18.11%,PCSK5;PCSK6;SNCA;LMF1;ANGPTL3
prerank,regulation of vacuole organization (GO:0044088),0.3158338504096243,0.7155347823798043,0.8171334431630972,0.9654933796760018,1.0,5/20,13.44%,MTM1;TBC1D12;NPRL2;SCARB2;RAB5A
prerank,regulation of chromatin organization (GO:1902275),0.33377805211179923,0.7150193227880781,0.7849462365591398,0.9657177365504994,1.0,4/14,20.64%,MLLT3;PARG;TLK1;SETD5
prerank,ruffle organization (GO:0031529),-0.28368414331597874,-0.7147258118769446,0.8444444444444444,1.0,1.0,5/16,15.93%,TPM1;CARMIL1;AIF1L;ARFIP2;PLEK
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.23464190846178276,-0.7145709363562134,0.9262536873156342,1.0,1.0,18/40,32.55%,NUCKS1;RTEL1;CDK9;SMARCAL1;BOD1L1;SETMAR;DONSON;ATR;FBH1;POLE;GEN1;POLD1;CENPX;BLM;ZRANB3;EXD2;EME2;WRN
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.2922962633162256,0.7143597652271014,0.8325581395348837,0.9660913088702637,1.0,5/31,12.24%,PARD3;MSN;OPHN1;ANK1;PARD3B
prerank,adrenergic receptor signaling pathway (GO:0071875),0.3145424179389792,0.7140705939219203,0.8419243986254296,0.9660111824424893,1.0,3/20,6.12%,PDE4D;ADRB1;RAPGEF2
prerank,nucleic acid-templated transcription (GO:0097659),0.27047005817658865,0.7134339589127326,0.8733233979135618,0.9663866867640286,1.0,9/42,14.50%,EPC1;PWP1;TAF1B;BCL3;MMS19;RNPS1;PTMA;MEF2A;TOPORS
prerank,early endosome to Golgi transport (GO:0034498),-0.3160597469393726,-0.7133845286411359,0.8411633109619687,1.0,1.0,4/11,18.22%,TMED9;TRAPPC10;RBSN;SNX2
prerank,snRNA metabolic process (GO:0016073),0.32172452745408603,0.7124764025245635,0.8096054888507719,0.9671579920811216,1.0,5/17,22.96%,MTREX;INTS11;INTS12;INTS8;RBM7
prerank,regulation of isotype switching (GO:0045191),-0.28741998622116405,-0.7122812785224384,0.8314606741573034,1.0,1.0,2/14,5.28%,PARP3;KMT5C
prerank,negative regulation of TOR signaling (GO:0032007),0.28053131992144165,0.7119719888379756,0.8463949843260188,0.9673671235140578,1.0,5/36,9.76%,SH3BP4;DDIT4;TNFAIP8L1;UBR1;NPRL2
prerank,nuclear pore complex assembly (GO:0051292),-0.32503547169307173,-0.7119503720868705,0.8242009132420092,1.0,1.0,4/10,19.48%,NDC1;NUP93;RTN4;NUP107
prerank,platelet aggregation (GO:0070527),0.2895234199988665,0.7118491947176223,0.8569254185692542,0.9670845819740947,1.0,6/33,12.81%,MYH9;ACTN1;PIK3CG;P2RY12;ITGB3;STXBP3
prerank,"DNA-templated transcription, termination (GO:0006353)",0.24773112024450555,0.711123795715981,0.886002886002886,0.9674978461374808,1.0,28/68,31.05%,CAVIN1;TAF1B;POLR1A;WDR33;POLR1G;POLR1B;GTF2H4;TAF1A;CPSF1;GTF2H1;POLR2L;CCNH;SETX;SNRPD3;CPSF2;PCF11;TTF2;GTF2H5;CPSF3;LSM11;PAPOLA;PRMT5;POLR1F;CSTF3;GTF2H2;CSTF2T;POLR1H;SNRPB
prerank,positive regulation of leukocyte activation (GO:0002696),0.31618847718825666,0.7109202172206545,0.8104347826086956,0.9673053494027791,1.0,4/18,15.50%,NECTIN2;WNT5A;CRLF2;KARS1
prerank,mitochondrial gene expression (GO:0140053),0.27029119874467666,0.7103302078231466,0.8447488584474886,0.9675750232108443,1.0,13/42,24.80%,MRPS18A;NDUFA7;TFB2M;MRPS12;FASTKD2;QRSL1;MRPS16;MRPL23;PTCD3;MRPL12;NOA1;RARS2;MRPS11
prerank,sterol metabolic process (GO:0016125),0.2590494637924721,0.7098782299128538,0.8929088277858177,0.9676841227136864,1.0,10/60,14.73%,PPARD;LBR;CH25H;CYP26A1;CYP26C1;SOAT2;CYP39A1;CLN6;ABCG1;PMVK
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.27229379318777563,-0.7094015474421257,0.8589420654911839,1.0,1.0,5/19,17.41%,ALDH1L1;FPGS;MTHFD1;SLC19A1;MTHFD2L
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.2920291972109379,0.709160871091775,0.8511627906976744,0.9681361845920048,1.0,8/30,20.91%,FBXW7;SH3GLB1;UBE2D3;SAE1;ARIH2;CSNK2A2;UBE2L3;LEPROT
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.31553116194683406,0.7091214138000436,0.8211243611584327,0.9677418411751724,1.0,4/18,17.57%,CFAP53;SPA17;CABYR;RFX3
prerank,ribonucleoprotein complex assembly (GO:0022618),0.23282376566327384,0.7076320261696436,0.9405684754521964,0.9691383033395664,1.0,37/132,21.85%,RPS15;RPS19;RPS14;RPSA;RPL38;SRPK3;TGS1;RSL24D1;RRS1;DICER1;YTHDC1;EIF6;RPS27;MCTS1;NOP53;RPL6;RPL10;HSP90AB1;SCAF11;WDR77;DDX20;EIF5;LUC7L2;RPL11;CDC73;STRAP;SRSF10;SART1;RPL3;TRAF7;SART3;RPS28;SETX;DENR;SF3A2;CPSF6;LUC7L
prerank,protein deneddylation (GO:0000338),0.35711727516368297,0.7071691704015103,0.8092592592592592,0.9692613467769062,1.0,2/10,10.85%,COPS2;COPS4
prerank,regulation of cellular response to stress (GO:0080135),-0.19148325221241827,-0.7066041816253825,0.9852216748768473,1.0,1.0,28/115,23.99%,ROCK2;PRKN;NUPR1;HSP90AA1;NEK4;DNAJC7;AMFR;RAE1;POM121;NDC1;NUP93;HSPH1;CAMK2B;CEBPB;NPAS2;USP19;AIFM2;NUP107;SEC13;ATR;EIF4G1;MLST8;BAG3;ADCY8;CLN3;CRYAB;AKT1S1;ATM
prerank,establishment of protein localization to organelle (GO:0072594),0.24867532958994798,0.7064652310826762,0.8943758573388203,0.9696663703826283,1.0,19/72,22.69%,RAB11A;STAT3;IPO11;PPP1R10;NEURL1B;IPO8;NUP214;PRICKLE1;NUP133;TNPO3;NUP153;PTTG1IP;E2F3;CSE1L;KPNB1;CD68;HIKESHI;EIF4ENIF1;APPL1
prerank,negative regulation of cell cycle process (GO:0010948),-0.21313090448886662,-0.7062897474647307,0.9641693811074918,1.0,1.0,18/61,22.62%,BMP7;BMP4;TOM1L2;EHMT2;RBBP7;TFDP1;PCGF2;CBX5;GPER1;RING1;ZFYVE19;E2F1;PCGF6;VPS4A;TERF2;TFDP2;CHEK1;RBBP4
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.3348840192068878,0.706183519296867,0.7922535211267606,0.969575075781735,1.0,5/12,26.76%,SOX9;STRAP;MUC6;MUC13;NOD2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.25381967908821934,0.7059817352019168,0.8937931034482759,0.9684956728388242,1.0,1/61,0.34%,CTSC
prerank,vesicle coating (GO:0006901),0.25381967908821934,0.7059817352019168,0.8937931034482759,0.9684956728388242,1.0,1/61,0.34%,CTSC
prerank,COPII vesicle coating (GO:0048208),0.25381967908821934,0.7059817352019168,0.8937931034482759,0.9684956728388242,1.0,1/61,0.34%,CTSC
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3150832589513064,0.7059442434117367,0.8186813186813187,0.9680982970617117,1.0,4/18,15.50%,PLCG2;SBNO2;NMI;KARS1
prerank,protein kinase B signaling (GO:0043491),0.30675349662830476,0.7053228202186962,0.8341968911917098,0.9684005330538147,1.0,5/23,16.39%,KDR;TGFB1;GAS6;THEM4;ZFP36L1
prerank,response to amino acid starvation (GO:1990928),0.24973043276355888,0.7052640980304563,0.907103825136612,0.9680374570794292,1.0,18/72,22.15%,PRKD1;FAS;MAPK8;SH3GLB1;RPTOR;ATP6V1G2;NPRL2;LARS1;EIF2AK4;CASTOR1;RHEB;EIF2AK2;ATP6V1F;KPTN;WDR59;ATP6V1D;TFEB;GCN1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2379339918539706,0.7050704647776681,0.9186785260482846,0.967814529100965,1.0,22/104,20.05%,DAB2IP;LRP5;CCNK;RALB;CDKN1B;TRIB3;RPTOR;RB1;TRIB1;CDC25C;CCNJ;IRGM;CALM1;PIH1D1;RHOA;CIB1;CDC37;SYAP1;TSG101;BCCIP;DUSP19;GTF2H1
prerank,regulation of pH (GO:0006885),0.35077989002386184,0.7049643534167553,0.822992700729927,0.9675178708802584,1.0,3/11,12.09%,CLCN3;ATP1A4;SLC9A7
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.28532208796195385,0.7049057734745728,0.8531684698608965,0.9671447219540362,1.0,7/33,16.50%,RPA1;WRAP53;PINX1;CDK2;ACD;HSP90AB1;TERF1
prerank,cellular response to amino acid starvation (GO:0034198),0.2500847596845882,0.70481165002764,0.908344733242134,0.9668062223251046,1.0,18/71,22.15%,PRKD1;FAS;MAPK8;SH3GLB1;RPTOR;ATP6V1G2;NPRL2;LARS1;EIF2AK4;CASTOR1;RHEB;EIF2AK2;ATP6V1F;KPTN;WDR59;ATP6V1D;TFEB;GCN1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.2798363863828527,-0.7041392182248282,0.8610421836228288,1.0,1.0,9/18,37.16%,TOMM40;TIMM17B;GRPEL2;TIMM21;DNAJC15;PAM16;TIMM23;TOMM70;DNAJC19
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.27283831106375284,-0.7041344241105998,0.8248847926267281,1.0,1.0,5/18,25.62%,XRCC6;PRDM1;PRKDC;CCR2;ZFP36L2
prerank,nuclear membrane reassembly (GO:0031468),0.2609642104891771,0.704072537569858,0.8990963855421686,0.9672373091850558,1.0,22/54,27.12%,LBR;CHMP2B;CHMP4A;CHMP4B;NUP98;NUP133;NUP205;NUP43;UBE2I;PPP2R2A;VRK1;PPP2R1A;KPNB1;REEP3;UBXN2A;NUP85;PPP2CA;SUMO1;CHMP3;ANKLE2;CHMP4C;EMD
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.29823205529817165,-0.703414129207653,0.8531317494600432,1.0,1.0,7/14,27.69%,RMND1;UQCC2;FASTKD3;MPV17L2;TRUB2;MRPS27;C1QBP
prerank,regulation of rRNA processing (GO:2000232),0.32558576755854207,0.7029439112641339,0.8287671232876712,0.9681565045788204,1.0,6/16,22.19%,NUDT16;RIOK1;KAT2B;HEATR1;RIOK2;SIRT7
prerank,negative regulation of neurogenesis (GO:0050768),0.2803388035538314,0.7028487713809966,0.8589147286821706,0.9678318078468892,1.0,3/34,6.12%,B2M;NOTCH1;RAPGEF2
prerank,retrograde axonal transport (GO:0008090),-0.2830364757813182,-0.7028368641070483,0.8633093525179856,1.0,1.0,7/16,27.30%,DLG2;KIF1A;KIF5A;DYNC1H1;TMEM108;MAP1A;FBXW11
prerank,granulocyte chemotaxis (GO:0071621),0.2565700754156758,0.7026990529278462,0.8836565096952909,0.9675668655656396,1.0,5/55,10.41%,EDN1;BSG;PPBP;PIK3CG;CCL14
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.3179735100933562,-0.7026062002589228,0.8113207547169812,1.0,1.0,3/10,10.76%,RYK;LRP6;FZD1
prerank,telomere maintenance via recombination (GO:0000722),-0.30955038761578496,-0.702446428070692,0.8580375782881002,1.0,1.0,7/11,30.90%,TEP1;RAD50;SMC6;TPRKB;XRCC3;SMC5;ERCC1
prerank,cellular response to nitrogen compound (GO:1901699),0.31041323086112,0.7024319135153165,0.8395904436860068,0.9674495595580781,1.0,7/20,16.92%,ATP2B4;AOC1;FMR1;DDI1;ATRX;DDI2;SPIDR
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.24240247098394313,0.6996667887222365,0.9234899328859061,0.9701962748846081,1.0,25/88,27.08%,FBXW7;FBXL4;PSMA2;FBXL7;FBXL2;PSMA8;PSMA6;CUL1;FBXL3;PSME1;PSMA4;PSMF1;CUL2;FBXO17;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;CUL4B;PSMD3;PSMA3;FBXW4;FBXL8;FBXL15
prerank,cholesterol metabolic process (GO:0008203),0.2482750024480945,0.6994337683769786,0.9111111111111111,0.9700265837750878,1.0,10/68,14.90%,PPARD;LBR;CH25H;SCARF1;SOAT2;CLN6;ABCG1;PMVK;GGPS1;PLPP6
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.31533251665886625,0.6992874685039401,0.8286219081272085,0.9697668277433379,1.0,4/17,13.84%,STAT3;BACH2;BTN3A3;SLA2
prerank,respiratory electron transport chain (GO:0022904),0.3204977034349545,0.6992862275695696,0.8254545454545454,0.9693307482136498,1.0,1/14,2.31%,GPD2
prerank,regulation of spindle assembly (GO:0090169),0.29258333180679186,0.699184141561409,0.8333333333333334,0.9690188808516467,1.0,10/25,26.74%,CHMP2B;CHMP4B;RNF4;NUMA1;PLK1;PDCD6IP;SENP6;CHMP3;HSPA1B;CHMP4C
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.31691313128412235,-0.6987951151976391,0.8483606557377049,1.0,1.0,2/10,4.40%,SIRT2;IMPACT
prerank,dendrite self-avoidance (GO:0070593),0.32586501190135536,0.6982834256676056,0.8206521739130435,0.96962342913747,1.0,3/16,9.25%,BSG;ROBO4;DSCAM
prerank,calcium import into the mitochondrion (GO:0036444),-0.32002049339644495,-0.6981502251070102,0.8556485355648535,1.0,1.0,5/10,22.61%,MCU;MICU1;SLC25A23;MAIP1;SMDT1
prerank,positive regulation of intracellular transport (GO:0032388),0.27230571452412317,0.6980919568855413,0.867175572519084,0.969396552550001,1.0,15/38,25.81%,PGAP1;PRR5L;PCNT;EHD2;NEDD4;CEP290;CEP131;NUMA1;MLC1;TENM1;RIPOR1;STX18;PLK3;RUFY3;B3GAT3
prerank,regulation of microtubule-based movement (GO:0060632),-0.3061020901197421,-0.6967886392366931,0.856492027334852,1.0,1.0,5/11,33.05%,MAP2;TTC21B;DRC1;NEFH;LAMP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.3117530391642518,-0.6965848201057514,0.827433628318584,1.0,1.0,1/11,0.87%,GSN
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.2996255569567893,0.6958511137798923,0.8311258278145696,0.9715557517572108,1.0,5/22,15.27%,NOTCH1;GHR;IL7R;MGAT5;CRLF2
prerank,cranial nerve development (GO:0021545),0.34401458112394734,0.6958345248243623,0.802536231884058,0.9711364225074379,1.0,1/11,3.59%,CHD7
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2678342739990771,-0.6949146187799125,0.8789346246973365,1.0,1.0,8/19,29.69%,AR;ICE2;CEBPA;BRF2;MAF1;MTOR;NAB2;ZC3H8
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.3201173018681467,-0.6947530231916896,0.8426724137931034,1.0,1.0,3/10,24.48%,CHFR;TUT4;UBC
prerank,DNA-dependent DNA replication (GO:0006261),0.2267099385758135,0.6946325212618361,0.9445843828715366,0.9720873085765038,1.0,31/128,22.49%,MCM10;RPA1;PSMA2;PRIMPOL;POLA1;CDT1;CDK2;RECQL;PSMA8;HELB;PSMA6;PSME1;PRIM2;ORC5;ORC3;BAZ1A;RFC3;CDC34;PSMA4;PSMF1;GINS2;MCMBP;PSMB7;PSMB1;PURA;DBF4;PSMD2;SIRT7;PSMA5;RFC5;PSMC3
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.33785913073812845,0.6940842484633272,0.8260105448154658,0.9722434369780878,1.0,3/12,20.72%,WRAP53;CCT7;CCT2
prerank,regulation of mitochondrial translation (GO:0070129),-0.2672229759349851,-0.6940802892947523,0.8917050691244239,1.0,1.0,9/21,28.61%,RMND1;UQCC2;FASTKD3;MPV17L2;TRUB2;MRPS27;MTG1;C1QBP;TSFM
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.3126052599215438,-0.693973581453546,0.8568232662192393,1.0,1.0,4/11,23.88%,PAF1;LEO1;BARD1;ZC3H3
prerank,regulation of embryonic development (GO:0045995),0.27601224987411105,0.6937377535048558,0.8641390205371248,0.9722078956857685,1.0,14/34,23.45%,INSR;SOX17;PLCB1;B4GALT5;NR2C2;NIBAN2;CFL1;EHMT1;ZBED3;DHX36;RACGAP1;CRB2;NIPBL;CLASP2
prerank,regulation of cellular response to heat (GO:1900034),0.23992868105768525,0.693132982497916,0.9185888738127544,0.9724361529183894,1.0,29/77,26.72%,CD34;RPA1;RPTOR;NUP214;NUP98;HSP90AB1;NUP133;NUP205;NUP54;NUP43;NUP153;BAG4;CHORDC1;HSPB8;BAG1;DNAJB1;IER5;DNAJB6;BAG2;HIKESHI;YWHAE;FKBP4;DNAJC2;NUP42;NUP85;GSK3B;CREBBP;RPA3;HSPA1B
prerank,negative regulation of histone methylation (GO:0031061),0.3427366272518694,0.6926376728631382,0.8192090395480226,0.9725470283278653,1.0,4/10,22.76%,MTF2;JARID2;KDM1A;PHF1
prerank,negative regulation of cholesterol transport (GO:0032375),0.3506456320892797,0.6925620423907352,0.8173258003766478,0.9722006410414962,1.0,1/10,7.86%,NFKB1
prerank,protein heterooligomerization (GO:0051291),0.3111775248297308,0.6923882312700893,0.8250825082508251,0.9719621949609734,1.0,6/17,21.61%,MAT2A;PKD2;GRIN1;CBR4;KRT10;CPSF6
prerank,outer dynein arm assembly (GO:0036158),-0.28271189049714796,-0.6918198793154918,0.8549107142857143,1.0,1.0,7/14,35.21%,DNAL1;DNAH8;ODAD4;DNAAF5;ODAD1;DNAAF4;CCDC63
prerank,AMP metabolic process (GO:0046033),-0.29769799843826045,-0.6916137401227678,0.8450704225352113,1.0,1.0,2/13,8.27%,AMPD3;NT5E
prerank,pre-replicative complex assembly (GO:0036388),0.24648474835992856,0.6912686113050067,0.9135977337110481,0.972780913047812,1.0,19/64,26.31%,PSMA2;CDT1;PSMA8;PSMA6;PSME1;ORC5;ORC3;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;PSMD3;PSMA3;ORC6;GMNN;MCM6
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.22273325393449644,0.6912307686819806,0.9654320987654321,0.9723886655107615,1.0,31/145,21.23%,RAB11A;PRKAR2B;CEP41;AURKA;PCNT;AVEN;PSMA2;FBXL7;DYNLL1;PINX1;BRD4;CDK2;CNTRL;CEP57;PSMA8;PSMA6;CUL1;CDC25C;PSME1;CEP290;CEP131;CEP72;PSMA4;PSMF1;CETN2;CDK5RAP2;PPP2R1A;PSMB7;PSMB1;PLK1;PSMD2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.29964660937179094,0.6910609240194873,0.843103448275862,0.9721485697485205,1.0,9/21,24.91%,RPS7;RPL23;MAD2L2;RPL11;RAB1A;BAG2;PLK1;FBXO5;FZR1
prerank,regulation of mRNA processing (GO:0050684),-0.24101844053632426,-0.6908730782049965,0.8842105263157894,1.0,1.0,8/32,18.84%,SON;SRPK2;TIA1;SF1;KHDRBS3;PABPN1;SRSF3;SAFB2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.26250383069478733,0.6905867610911737,0.8759124087591241,0.9722578625198148,1.0,4/42,10.95%,PTK2B;PPBP;CCL14;RBM15
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.25207058035848284,0.6897635192342508,0.9061166429587483,0.9727466906286606,1.0,8/66,8.83%,WWTR1;CARD10;DTX3L;LIMK2;CHP2;TGFB1;PSEN1;PINX1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.2510469358888362,-0.689478852769802,0.8962025316455696,1.0,1.0,4/24,13.42%,BCL2;CD44;CXCL12;SNAI1
prerank,negative regulation of DNA replication (GO:0008156),0.3254603216137226,0.6894144472933325,0.8049645390070922,0.9727172036247402,1.0,6/13,26.42%,GMNC;TERF1;PDS5A;RAD17;GMNN;GTPBP4
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.3139669110477561,-0.6875250076642017,0.8552915766738661,1.0,1.0,3/10,26.53%,EIF2AK3;HSPA5;CCL2
prerank,myelin maintenance (GO:0043217),-0.3111423614192707,-0.6874610599232942,0.841648590021692,1.0,1.0,1/10,1.47%,EPB41L3
prerank,positive regulation of actin nucleation (GO:0051127),0.334788510188734,0.6873836685533744,0.819047619047619,0.9745616239232201,1.0,2/11,5.07%,WASF2;NCKAP1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.23407288975992074,0.686606710008279,0.9377431906614786,0.9749283514422857,1.0,21/91,18.65%,HIP1;HIP1R;RAB11A;SCARB1;OPHN1;RNF139;PTPN1;INPP5F;RAB12;ABL2;PICALM;RAB26;RAB11B;RAB5A;RAB5B;SYT7;PACSIN2;RAB8B;CPLX2;USP7;STXBP5
prerank,regulation of membrane depolarization (GO:0003254),0.30134035565393014,0.6857069448791564,0.8595890410958904,0.9754292194927051,1.0,2/18,5.17%,NEDD4L;SMAD7
prerank,regulation of astrocyte differentiation (GO:0048710),0.3330411237849013,0.685499071862645,0.82174688057041,0.9752063753111416,1.0,2/12,10.82%,NOTCH1;EPHA4
prerank,mRNA processing (GO:0006397),0.2076098482852483,0.6848584692714533,0.9888517279821628,0.9754633429317479,1.0,87/287,25.97%,NOVA2;ERN1;RSRC1;HNRNPF;SF3B4;GTF2F2;CTNNBL1;HNRNPA0;MTREX;HNRNPK;RBM14;HNRNPD;WDR33;THOC2;LSM8;RNGTT;YTHDC1;SPEN;RBM15;RNPS1;LSM3;THOC6;RPRD1B;HNRNPC;RNMT;ZMAT2;SMU1;SF3B6;DHX15;RPRD2;SNRNP25;SCAF11;CWC27;SNW1;YBX1;AQR;HNRNPUL1;CWC22;GTF2H4;ALYREF;CDC40;LSM7;PRPF40A;THOC3;PHF5A;METTL14;RALY;CWF19L2;THOC1;PRPF4;HNRNPM;CPSF1;RPRD1A;SRSF10;FUS;THOC5;GTF2H1;SART1;SART3;POLR2L;ELAVL1;CCNH;SF3A2;CPSF6;POLR2J;PRPF3;AURKAIP1;THOC7;TRA2B;DBR1;SNRPD3;SRSF4;PSPC1;SLU7;CPSF2;SYF2;LSM2;HNRNPA3;PCF11;GTF2H5;RBMX;SNRNP200;CPSF3;PUF60;PRPF40B;ISY1;GCFC2
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.29619635926102567,-0.6845664699822444,0.8337129840546698,1.0,1.0,3/12,8.37%,CLCN2;SREBF1;H6PD
prerank,glutathione metabolic process (GO:0006749),0.26694087275190964,0.6839244348708129,0.8883792048929664,0.9760670706479051,1.0,8/38,13.97%,GSR;GSTA4;GGCT;GCLM;ETHE1;GLRX2;GSTP1;OPLAH
prerank,protein-DNA complex disassembly (GO:0032986),0.3201641377596459,0.6837830731044676,0.8362676056338029,0.9757926138800161,1.0,8/16,24.69%,ARID1A;RPL23;SMARCE1;GRWD1;SMARCC1;ARID2;SMARCD1;SET
prerank,protein alkylation (GO:0008213),-0.2557710669336908,-0.6832663165021219,0.8988235294117647,1.0,1.0,7/22,26.16%,LCMT1;VCPKMT;EEF1AKMT1;PRMT8;METTL21A;EEF2KMT;PRMT2
prerank,cell cycle checkpoint signaling (GO:0000075),-0.2986328068679398,-0.6826394495238582,0.838495575221239,1.0,1.0,2/12,12.53%,ZWINT;CHFR
prerank,DNA strand elongation (GO:0022616),-0.26949083812595015,-0.6824551353379246,0.8738095238095238,1.0,1.0,9/18,32.58%,RAD50;GINS3;GINS1;TERT;POLD2;GINS4;DCLRE1B;MCMDC2;MCM3
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.2483280151412851,0.6824550015361094,0.9167862266857962,0.976772830024931,1.0,6/61,10.43%,CAV1;SIRT5;PSMA2;PANK2;PSMA8;PSMA6
prerank,C-terminal protein amino acid modification (GO:0018410),-0.3052389167050341,-0.6824060780930103,0.8589473684210527,1.0,1.0,4/11,18.90%,AGBL4;LCMT1;GPLD1;AGBL1
prerank,organonitrogen compound catabolic process (GO:1901565),0.25374680549564754,0.682330983231394,0.9090909090909091,0.9764720443683172,1.0,13/57,17.26%,PLA2G4A;ENPP2;CTRL;ERAP1;TRIM24;SIAH1;GNPDA2;MPST;CLN6;PNPLA8;ACE;ADO;GGACT
prerank,protein mannosylation (GO:0035268),0.2937725292968515,0.6817344318473977,0.8427672955974843,0.9766796005058416,1.0,3/22,8.88%,TMTC2;B4GAT1;RXYLT1
prerank,response to UV-B (GO:0010224),-0.2907451117516893,-0.6806518199301202,0.8524945770065075,1.0,1.0,7/12,37.48%,MFAP4;CDKN1A;HYAL1;CRIP1;HYAL3;MME;IL12A
prerank,steroid metabolic process (GO:0008202),-0.20081600953234216,-0.6805311750545557,0.9657534246575342,1.0,1.0,15/72,22.72%,CYP7B1;CYP27A1;CYP26B1;CYP1B1;FDX1;PRLR;FDFT1;SCP2;FDXR;CUBN;LSS;DHCR24;CYP51A1;TSPO;DHRS11
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.27325424959341005,0.6786728450565416,0.8690095846645367,0.9795035138835608,1.0,7/32,18.26%,LPCAT3;CEPT1;LPIN3;PEMT;CHKA;CSNK2A2;CSNK2A1
prerank,positive regulation of protein sumoylation (GO:0033235),-0.30695473345644464,-0.6783556872642181,0.8523002421307506,1.0,1.0,3/10,11.82%,HDAC4;PIAS1;PIAS3
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.294873068559912,0.6779358879752547,0.8373702422145328,0.9798696914091309,1.0,3/20,9.65%,FAS;BOK;BCL2L1
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.24461218061545942,-0.6777698964849124,0.9042553191489362,1.0,1.0,8/26,18.99%,SIRT2;PCBP2;TRAFD1;ITCH;TRAF3IP1;PPM1B;CACTIN;TYRO3
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.29438927500436207,0.6776270613726548,0.8489326765188834,0.9797627845815267,1.0,4/21,12.74%,AIM2;FYN;GRIN1;BIRC3
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.28696233228718326,0.6770675782424634,0.8723051409618574,0.9799231265893349,1.0,2/23,6.08%,CAV1;DUSP22
prerank,lipid homeostasis (GO:0055088),-0.2066735228616931,-0.6769345392065212,0.9792387543252595,1.0,1.0,16/57,24.30%,RBP1;ZBTB20;TLCD2;PRKAA2;RCN3;APOE;IRS2;TLCD1;ORMDL2;ANGPTL3;ABCA2;DGAT2;NR1H3;PPARG;CEBPA;POLD1
prerank,protein deacylation (GO:0035601),-0.2481841169177612,-0.6758384856659692,0.9095477386934674,1.0,1.0,7/23,20.24%,HDAC4;SIRT2;NOTUM;ABHD10;ABHD17C;PPT1;HDAC3
prerank,mitotic cytokinetic process (GO:1902410),0.29687903535061405,0.6758149171611374,0.841025641025641,0.9807960436666437,1.0,3/20,9.20%,CHMP2B;CHMP4A;CHMP4B
prerank,positive regulation of viral transcription (GO:0050434),0.2751297193637188,0.6751897090207751,0.86709886547812,0.9809632640001613,1.0,8/25,22.30%,GTF2F2;NELFE;NELFCD;CTDP1;NELFB;POLR2L;NELFA;POLR2J
prerank,positive regulation of exosomal secretion (GO:1903543),-0.27658894345863605,-0.6748723175412181,0.8744186046511628,1.0,1.0,5/15,17.69%,SDC4;SMPD3;SDC1;SNF8;VPS4A
prerank,microtubule polymerization (GO:0046785),-0.239609462563106,-0.6737967512865783,0.9099756690997567,1.0,1.0,10/28,31.48%,TUBGCP5;MAP7D3;TPPP3;CKAP5;CCDC57;TPX2;CLASP1;FGF13;GOLGA2;TPPP
prerank,negative regulation of mRNA processing (GO:0050686),-0.26699864775786003,-0.6737138283406888,0.851258581235698,1.0,1.0,6/15,31.79%,U2AF2;PCBP4;BARD1;SRSF6;C1QBP;SRSF9
prerank,serine family amino acid metabolic process (GO:0009069),-0.27336027040713284,-0.6725288296505,0.8852459016393442,1.0,1.0,9/16,34.62%,GCLC;MTHFD1;SARS1;CBS;CTH;SEPSECS;CDO1;THNSL2;PSPH
prerank,regulation of p38MAPK cascade (GO:1900744),0.2697985930432809,0.6720152895657089,0.8765432098765432,0.9837590699372988,1.0,3/35,6.63%,DAB2IP;MFHAS1;SASH1
prerank,import into nucleus (GO:0051170),0.23597918559308895,0.6715730606257164,0.9304589707927677,0.9837763091914121,1.0,21/73,25.16%,STAT3;IPO11;PPP1R10;BACH2;IPO8;NUP214;PRICKLE1;NUP133;TNPO3;NUP153;DDX20;PTTG1IP;E2F3;CSE1L;KPNB1;HIKESHI;EIF4ENIF1;APPL1;SNRPD3;NUP85;SNUPN
prerank,neurogenesis (GO:0022008),0.25396900292620356,0.6712604083878724,0.9223880597014925,0.9836604857025755,1.0,11/43,18.62%,CDK6;BTBD1;BTBD3;NEUROD1;THOC2;CXCR4;NDUFS2;METTL14;TRAK2;BTBD6;CDK5RAP2
prerank,COPII-coated vesicle budding (GO:0090114),0.23696777081062254,0.6692821320432355,0.9358799454297408,0.985253550559887,1.0,1/68,0.34%,CTSC
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.2961371841120667,-0.6688070650301945,0.8903225806451613,1.0,1.0,3/11,10.76%,RYK;LRP6;FZD1
prerank,negative regulation of translational initiation (GO:0045947),0.31367911074775273,0.6683799783374923,0.8345864661654135,0.9857164687024058,1.0,4/13,15.91%,EIF4EBP1;EIF2AK4;FMR1;PAIP2B
prerank,regulation of protein sumoylation (GO:0033233),0.2968847351885971,0.6672809097216296,0.8547854785478548,0.9863510096827532,1.0,4/17,16.74%,RASD2;ZMIZ1;SAE1;CTNNB1
prerank,peroxisomal membrane transport (GO:0015919),-0.23783633981450203,-0.6666776621691811,0.9319371727748691,1.0,1.0,10/27,27.01%,ABCD3;ATAD1;PEX1;PXMP2;PEX7;PEX11B;PEX5;GDAP1;ABCD2;PEX16
prerank,negative regulation of cation channel activity (GO:2001258),-0.23753326861598367,-0.6649321699435986,0.9213197969543148,1.0,1.0,9/26,26.51%,SLC6A9;GNB5;KCNAB1;GSTM2;CASQ2;CBARP;EPHB2;GPR35;EPO
prerank,tRNA transport (GO:0051031),0.26547202380944845,0.6642903479230888,0.9262672811059908,0.9889109958024368,1.0,9/35,17.14%,NUP214;NUP98;NUP133;NUP205;NUP54;NUP43;NUP153;YBX1;XPOT
prerank,chromosome organization (GO:0051276),0.22493556670521192,0.6634415647000197,0.964935064935065,0.9893060041833726,1.0,25/99,24.15%,HHEX;PADI4;TCF7L1;H3-3A;MTF2;TCF7L2;CDT1;EZH1;COPS2;COPS4;PADI1;NUP133;HMG20A;PHF19;EHMT1;CETN2;BAHD1;MSH2;GATAD1;LATS1;SUV39H1;PHF1;CUL4B;COPS8;LIG4
prerank,protein-containing complex disassembly (GO:0032984),0.24407135354719434,0.6633385317347037,0.9251412429378532,0.9889594362142988,1.0,6/54,14.29%,CAV1;TECPR1;RPL23;VAMP8;GABARAPL1;APC
prerank,cellular response to virus (GO:0098586),0.268894930851912,0.6631265867337328,0.8932038834951457,0.9887397603891271,1.0,12/30,25.22%,HIF1A;MAPK11;IFIH1;FMR1;RRP1B;IRGM;POU2F2;POU2AF1;MAPK14;RIOK3;EIF5A;CXCL10
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.310581092595698,0.6624739696793654,0.8330434782608696,0.9889449912556573,1.0,3/12,13.77%,NFKBIA;ITGB3;ABCG1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.259462712207481,-0.6622814361724801,0.905,1.0,1.0,5/18,21.77%,PRKN;NONO;HSPB1;HTRA2;NME5
prerank,peptidyl-arginine modification (GO:0018195),0.30479312175115897,0.6617354000505693,0.839527027027027,0.989190958986801,1.0,4/15,21.16%,PADI4;PADI1;ART4;KRTCAP2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.2922557757257971,-0.6612627159082384,0.8806306306306306,1.0,1.0,4/11,20.05%,PRKN;NONO;REST;NR4A3
prerank,protein heterotetramerization (GO:0051290),0.31487643207441035,0.6609299802012426,0.8397887323943662,0.989542677874259,1.0,7/13,27.55%,PKD2;GRIN1;CBR4;KRT10;CPSF6;FARSB;GRIN2B
prerank,ncRNA metabolic process (GO:0034660),0.2556029653494967,0.6605802611943764,0.9001536098310292,0.989429518455348,1.0,5/37,13.10%,DTD1;DROSHA;NIFK;DICER1;HENMT1
prerank,regulation of lipid catabolic process (GO:0050994),-0.252620701133773,-0.6604725489139749,0.9166666666666666,1.0,1.0,4/19,18.11%,ADRA2A;ALK;RARRES2;ANGPTL3
prerank,regulation of pseudopodium assembly (GO:0031272),0.33124281942767403,0.6601768894779898,0.8634686346863468,0.9889486758214383,1.0,2/10,14.29%,CDC42EP3;APC
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.33124281942767403,0.6601768894779898,0.8634686346863468,0.9889486758214383,1.0,2/10,14.29%,CDC42EP3;APC
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.23311518821668545,-0.6601574667948794,0.9190600522193212,1.0,1.0,4/27,6.74%,SYT1;SYT9;SYT12;SYT11
prerank,base-excision repair (GO:0006284),-0.2051845492344127,-0.6597304756213012,0.9847094801223242,1.0,1.0,21/48,32.70%,ERCC5;RFC1;USP47;APEX2;NEIL3;DNA2;POLE;MUTYH;POLG;TDG;NTHL1;POLD1;POLB;POLD2;NEIL1;LIG1;ADPRS;RPA2;FEN1;WRN;PRMT6
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.2837616191706088,-0.6596713689451263,0.8696682464454977,1.0,1.0,6/14,22.28%,BRCA2;XRCC5;TPP1;TERF2;ATR;TERT
prerank,nuclear envelope organization (GO:0006998),-0.2560915061406883,-0.658888399810037,0.9416243654822335,1.0,1.0,7/20,28.34%,DMPK;NUP93;VPS4A;TMEM43;TOR1B;TOR1A;TOR1AIP1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.31435139099710535,0.6581695195636069,0.8621323529411765,0.9903641922524532,1.0,3/13,11.62%,NFKBIA;PKD2;NFKBIE
prerank,regulation of DNA metabolic process (GO:0051052),0.24916050277441507,0.6579118959846686,0.9201741654571843,0.9901678591990566,1.0,16/44,27.04%,HNRNPD;CDT1;IL7R;SUB1;HELB;PARG;YLPM1;ALYREF;WDR18;THOC1;UBE2V2;SIRT7;SMG6;UBE2N;SMARCAD1;TICRR
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.244846071836248,-0.6577262110446359,0.9373493975903614,1.0,1.0,2/23,9.38%,AXL;INHBA
prerank,cellular response to ionizing radiation (GO:0071479),0.25466591375474923,0.6574608984004376,0.9308270676691729,0.9901691694145701,1.0,13/47,24.15%,NET1;HUS1;RHOB;MAP3K20;TMEM109;SPIDR;GRB2;KDM1A;RPL26;NIPBL;MAPK14;TANK;LIG4
prerank,histone mRNA metabolic process (GO:0008334),0.2728217455958781,0.6571152691186865,0.9,0.9900657632531652,1.0,13/27,31.05%,DCP2;MTPAP;LSM1;SNRPD3;TENT4B;CPSF2;CPSF3;LSM11;EXOSC4;TUT1;TUT7;ERI1;SNRPB
prerank,toxin transport (GO:1901998),0.32668391555952797,0.6568596714778308,0.8515037593984962,0.9898554631733807,1.0,1/10,2.40%,ADAM10
prerank,miRNA mediated inhibition of translation (GO:0035278),0.31570588302955005,0.6550169049633815,0.8431001890359168,0.9906875674066217,1.0,3/11,12.67%,TNRC6C;EIF6;ZFP36
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.31570588302955005,0.6550169049633815,0.8431001890359168,0.9906875674066217,1.0,3/11,12.67%,TNRC6C;EIF6;ZFP36
prerank,regulation of inclusion body assembly (GO:0090083),0.3193558309497546,0.6546689721557847,0.8152380952380952,0.9905730145654921,1.0,3/11,20.03%,SNCAIP;DNAJB1;DNAJB6
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.25906303918307694,-0.6532516280694227,0.9084158415841584,1.0,1.0,2/18,7.20%,UGGT2;AMFR
prerank,cellular response to oxygen levels (GO:0071453),-0.2919609156914307,-0.6527884857568472,0.8662131519274376,1.0,1.0,6/10,35.28%,CPEB4;ATP6V0D1;TMEM199;CCDC115;ATP6V1G1;ATP6AP1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3114713778360699,0.6522430243638745,0.8357400722021661,0.9923272787636128,1.0,7/13,28.93%,NELFE;NELFCD;NELFB;NELFA;EAPP;RNF168;RNF8
prerank,protein K63-linked ubiquitination (GO:0070534),0.2570059894124941,0.650952493329124,0.9169139465875371,0.993084593006021,1.0,9/41,15.54%,TRAF1;PELI1;UBE2G1;NEDD4;RNF4;HECTD1;TRAF6;ARIH2;RNF5
prerank,reticulophagy (GO:0061709),0.3131964633290476,0.6508789653123965,0.8483754512635379,0.9927173936235837,1.0,5/12,25.09%,ULK1;ATG2A;ATG2B;RB1CC1;UFM1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3169266561804947,0.6506615585796176,0.8243992606284658,0.9924654836509548,1.0,7/12,28.93%,NELFE;NELFCD;NELFB;NELFA;EAPP;RNF168;RNF8
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3000299806459942,-0.6503919346306624,0.8702127659574468,1.0,1.0,1/10,4.18%,SIRT2
prerank,microtubule depolymerization (GO:0007019),-0.25520883244560655,-0.6503411028465587,0.902676399026764,1.0,1.0,6/17,32.01%,KIF24;NCKAP5L;CKAP5;KIF18B;STMN4;STMN2
prerank,protein import into nucleus (GO:0006606),0.23285850285818976,0.6499825449532677,0.9528432732316228,0.9926346955199671,1.0,19/66,22.69%,STAT3;IPO11;PPP1R10;RPL23;IPO8;NUP214;PRICKLE1;NUP133;NUP54;TNPO3;NUP153;PTTG1IP;E2F3;CSE1L;KPNB1;KPNA4;HIKESHI;EIF4ENIF1;APPL1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.25317310441123025,-0.6489703876667087,0.9158415841584159,1.0,1.0,3/19,9.30%,RYK;LRP6;VEGFA
prerank,intracellular protein transmembrane transport (GO:0065002),-0.2109871662404292,-0.6481620271410192,0.9642857142857143,1.0,1.0,15/42,27.50%,C2CD5;PEX1;TOMM40;AIFM1;SEC61A2;PEX7;TIMM17B;GRPEL2;TIMM21;SEC61A1;PEX5;DNAJC15;HSPA5;PEX16;PAM16
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.2819764250695867,0.6480777128208561,0.8694214876033057,0.9938841522533217,1.0,3/22,12.53%,MFHAS1;SASH1;XDH
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.20633237687803016,0.647632167508515,0.9870588235294118,0.9938312619244065,1.0,23/173,14.54%,CTSC;SPTBN1;PGAP1;F7;PROS1;VAMP4;COG5;VTI1A;TGFA;TMED7;DYNLL1;RAB2A;DYNC1LI1;TMED5;ANK1;SPTAN1;GAS6;TRAPPC3;PREB;ACTR10;CAPZA1;PROC;NRBP1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.3022241207106582,0.6471390064771687,0.8807017543859649,0.9938392577971464,1.0,4/15,14.43%,PLIN5;LPL;PNPLA2;APOC4
prerank,secondary alcohol metabolic process (GO:1902652),0.2504858828876525,0.6470675429607937,0.9318181818181818,0.9934630172258052,1.0,5/42,13.77%,PPARD;CH25H;SOAT2;CLN6;ABCG1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.301495433338097,0.6469858350379318,0.8683760683760684,0.9931013813450229,1.0,3/15,9.73%,NEK6;ANAPC7;ANAPC1
prerank,regulation of store-operated calcium entry (GO:2001256),0.32184788068060516,0.6467994314402707,0.8619402985074627,0.9928293605666084,1.0,4/10,21.78%,HOMER2;HOMER3;HOMER1;CASQ1
prerank,negative regulation of protein metabolic process (GO:0051248),0.24234526311012825,0.6464911164424029,0.9340329835082459,0.9926675420729196,1.0,11/48,15.63%,EDN1;PTX3;SNX3;NFKB1;MAD2L2;ITGB3;RILP;HSP90AB1;PFDN1;PRKCG;IRAK3
prerank,protein K11-linked ubiquitination (GO:0070979),0.2650165464381749,0.6462395006274614,0.9004739336492891,0.9924405588150541,1.0,6/27,11.25%,UBE2H;ANAPC7;RNF4;ANAPC1;UBE2D3;CDC26
prerank,'de novo' posttranslational protein folding (GO:0051084),0.26535970388602403,0.6451139767453696,0.9,0.9929754987666405,1.0,12/30,28.06%,DNAJB5;ERO1A;UGGT1;BAG1;HSPE1;DNAJB12;DNAJB1;CCT2;GAK;HSPA1B;HSPA13;HSPA14
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.27682790493732384,-0.6444864898006603,0.9133333333333333,1.0,1.0,2/12,9.84%,LDLR;APOE
prerank,rRNA pseudouridine synthesis (GO:0031118),0.3227891796899517,0.6444623938631594,0.8715596330275229,0.9931023947782119,1.0,10/10,67.74%,RPUSD2;RPUSD4;RPUSD1;TSR3;NOP10;DKC1;NAF1;GAR1;RPUSD3;NHP2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.2858941213696046,0.6436185947066043,0.87,0.9933825864225875,1.0,4/19,13.07%,PARD3;FSCN1;PARD3B;CLIC4
prerank,regulation of secretion (GO:0051046),0.30565181565105937,0.6432780421951367,0.855595667870036,0.9932511800743542,1.0,1/13,2.39%,KCNQ1
prerank,folic acid metabolic process (GO:0046655),-0.24645746106544147,-0.6430748584020793,0.9152542372881356,1.0,1.0,5/18,17.41%,ALDH1L1;FPGS;MTHFD1;SLC19A1;MTHFD2L
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3218232154914403,0.6428315299060705,0.8608058608058609,0.9932011135555524,1.0,4/11,22.19%,PWP1;NOP53;PIH1D1;SIRT7
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2670170349195972,0.641883675413856,0.9130434782608695,0.9935964885528662,1.0,6/27,15.03%,CEPT1;LPIN3;PLA2G2D;PLAAT3;CHKA;PNPLA8
prerank,ovarian follicle development (GO:0001541),0.3005613947751936,0.6408012606455207,0.8683274021352313,0.9940809268972169,1.0,4/13,13.79%,FOXL2;EIF2B5;ANG;EIF2B2
prerank,establishment of spindle localization (GO:0051293),0.29589477372512324,0.6407130005889149,0.8816466552315609,0.9937202948934295,1.0,6/14,23.87%,LLGL1;CFL1;ZBED3;KPNB1;CLASP2;MAP4
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.2524262995012631,0.6403972461547799,0.9272445820433437,0.99355925083484,1.0,1/34,1.15%,MEF2C
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.23483279346805142,-0.6403215608571274,0.9306930693069307,1.0,1.0,7/23,24.48%,DDB2;COPS7B;DDB1;XPC;COPS6;CUL4A;UBC
prerank,gas transport (GO:0015669),0.31431619908366293,0.6399645924349991,0.8552875695732839,0.9934935905284815,1.0,10/10,68.59%,CA2;IPCEF1;AQP5;MB;AQP6;CYGB;RHAG;NGB;AQP1;MYC
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.23133340430896662,0.6399382600795879,0.949928469241774,0.9930879136155694,1.0,16/65,22.49%,AURKA;AVEN;PSMA2;FBXL7;PINX1;PSMA8;PSMA6;CUL1;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3
prerank,positive regulation of peptidase activity (GO:0010952),-0.24405747494219665,-0.6387898601230074,0.9386792452830188,1.0,1.0,4/20,17.52%,RCN3;APH1B;NCSTN;DDRGK1
prerank,RNA methylation (GO:0001510),0.23785772524973525,0.6387809468780002,0.9563994374120957,0.9935939384028701,1.0,19/60,27.22%,TGS1;CBLL1;RBM15;TFB2M;NSUN4;FBLL1;HENMT1;WTAP;VIRMA;TRMT6;METTL14;NSUN6;ALKBH8;LCMT2;TRMT10C;TRMT61B;TRMT12;METTL16;NSUN2
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.2396457711295123,-0.6377100606037743,0.9503916449086162,1.0,1.0,10/23,30.00%,HSP90AA1;TIMM22;COX18;MAIP1;TIMM8B;BAX;TIMM9;TIMM10;SAMM50;PMAIP1
prerank,cellular respiration (GO:0045333),-0.2053682552502753,-0.637687599513429,0.9648093841642229,1.0,1.0,15/41,29.84%,PPARGC1A;SLC25A13;SDHAF4;NR4A3;SLC25A14;MTFR1L;COQ10A;SDHC;UQCRB;NDUFS7;MDH2;COQ10B;UQCR10;COX4I2;MTLN
prerank,glutathione biosynthetic process (GO:0006750),0.31250363219606514,0.6375339171747634,0.862708719851577,0.9941859545729184,1.0,3/11,13.97%,GGCT;GCLM;OPLAH
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.26152320300706045,0.6373987511992536,0.8901830282861897,0.993861413407638,1.0,5/27,15.11%,PHF20;KAT6B;PHF20L1;KAT2B;KAT6A
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.28814028792459734,0.6370834135856215,0.9063545150501672,0.9936952444196098,1.0,1/18,2.14%,DAB2IP
prerank,Golgi to lysosome transport (GO:0090160),0.3084902838892515,0.6369086496873413,0.8845437616387337,0.993399970323062,1.0,5/11,27.40%,ANKFY1;EHD3;AP1G1;GAK;SORT1
prerank,regulation of chromosome organization (GO:0033044),0.2750683834053309,0.6361817835388703,0.9115323854660348,0.9935587262121494,1.0,7/22,24.15%,HNRNPD;CDT1;RB1;YLPM1;RMI2;SMG6;LIG4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.23982857527509188,0.6359292190417909,0.9408369408369408,0.9933399717886615,1.0,17/50,24.06%,PAK2;RPS6KA3;RPS6KA1;XIAP;GAS6;SFN;CARD16;PIH1D1;ARL6IP1;MAP2K5;CAAP1;CSNK2A1;DNAJB6;IGBP1;PLAUR;YWHAE;RFFL
prerank,protein localization to centrosome (GO:0071539),-0.25173470371342643,-0.6356281075440492,0.9150485436893204,1.0,1.0,4/17,18.89%,GOLGB1;CEP192;PCM1;C2CD3
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.21701574045628058,-0.6346032218948411,0.9510869565217391,1.0,1.0,7/32,15.89%,EML2;MAP2;CLIP3;NAV3;TTBK2;SNCA;APC2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2208565246218333,0.6341787884450314,0.9604904632152589,0.9943214524150642,1.0,31/79,27.03%,KIF26A;AP2B1;MFSD6;AP2A1;DYNLL1;DYNC1LI1;KIF22;AP1S2;KIF23;LGMN;RILP;ACTR10;CAPZA1;RAB7A;AP1S3;SH3GL2;OSBPL1A;KIF4A;RACGAP1;AP1G1;KIF2A;DCTN6;FCER1G;KIF18A;SAR1B;AP2M1;CAPZA2;CLTA;DNM2;CTSE;SPTBN2
prerank,regulation of superoxide anion generation (GO:0032928),-0.2678171581035082,-0.6333516025385564,0.9084668192219679,1.0,1.0,4/14,22.19%,PRKCD;SYK;ITGB2;AATF
prerank,protein processing (GO:0016485),0.21289389108321047,0.6331092200725318,0.982028241335045,0.9947422132580527,1.0,19/102,16.30%,ADAM10;CASP4;CPD;CPE;F7;SRGN;CASP1;PSEN1;APH1A;PITRM1;LGMN;OMA1;SPCS1;ADAM17;PCSK7;VSIR;SPPL3;ZMPSTE24;DDI2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.2504188949314424,-0.632500419255336,0.9216152019002375,1.0,1.0,1/18,1.56%,BCL2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2785200416788467,0.6317658217080545,0.8986928104575164,0.9953809012452897,1.0,7/20,19.37%,NT5C2;AK4;ADSL;HPRT1;IMPDH1;ADSS2;GART
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.2802560579165004,-0.6315382444853337,0.908883826879271,1.0,1.0,1/11,3.76%,UGGT2
prerank,regulation of interferon-alpha production (GO:0032647),-0.2347368424490129,-0.6315011614023285,0.927536231884058,1.0,1.0,3/23,13.79%,PTPRS;CHUK;MAVS
prerank,autophagosome maturation (GO:0097352),-0.21543554936802708,-0.6310800207086646,0.964769647696477,1.0,1.0,11/32,29.10%,LAMP2;ATP2A2;LIX1;LIX1L;VPS16;VIPAS39;STX17;CLN3;GABARAP;WIPI2;EPG5
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.24841254830780884,-0.6307139627073441,0.9331742243436754,1.0,1.0,4/17,16.79%,ADRA2A;ALK;MFSD2A;GPLD1
prerank,axonemal dynein complex assembly (GO:0070286),-0.2230311536329621,-0.6302122264667837,0.9472222222222222,1.0,1.0,12/27,35.21%,DNAI4;DNAL1;DNAH8;CCDC39;SPAG1;DRC1;TTC12;ODAD4;DNAAF5;ODAD1;DNAAF4;CCDC63
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.28943544999781584,0.6297670040183683,0.9026845637583892,0.9964932391069999,1.0,6/16,23.47%,BCL2L1;DDIAS;SFRP2;TPT1;RPS3;CLU
prerank,myeloid dendritic cell activation (GO:0001773),0.3055756873361307,0.629595766457397,0.878003696857671,0.9961940063068319,1.0,2/12,12.94%,DCSTAMP;TGFBR2
prerank,protein import into peroxisome membrane (GO:0045046),-0.24059340877044322,-0.6291752303841476,0.9501246882793017,1.0,1.0,8/22,27.01%,ABCD3;ATAD1;PXMP2;PEX11B;PEX5;GDAP1;ABCD2;PEX16
prerank,proteasome assembly (GO:0043248),0.30331196345509426,0.6279650029906598,0.8713235294117647,0.99706290110717,1.0,5/11,30.92%,POMP;PSMG2;ADRM1;OTUD6B;PSMG1
prerank,regulation of immunoglobulin production (GO:0002637),-0.2325293336169192,-0.6278682325512698,0.9405684754521964,1.0,1.0,6/23,26.99%,RBP4;STX4;CLCF1;EPHB2;PTPRC;FCGR2B
prerank,telomere organization (GO:0032200),-0.20159799225057817,-0.6276746938044148,0.9760479041916168,1.0,1.0,19/43,32.55%,PARP3;RTEL1;RAD50;DOT1L;XRCC5;TERF2;XRCC6;ATR;DNA2;TERT;PRKDC;ATM;POLD1;LTO1;POLD2;DCLRE1B;RPA2;BLM;WRN
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.20686906481608713,0.6258859358828217,0.9923469387755102,0.9982067361555227,1.0,24/128,18.62%,TPD52L1;PLCB1;PRKAR2B;PPP1R12A;CEP41;AURKA;PCNT;FBXL7;DYNLL1;CCNY;CDK2;CNTRL;CEP57;BACH1;CUL1;CDC25C;FBXL3;CEP290;CHEK2;CEP131;CEP72;PPP2R2A;CETN2;CDK5RAP2
prerank,maturation of 5.8S rRNA (GO:0000460),-0.25604050421918756,-0.6258648286113517,0.919431279620853,1.0,1.0,3/17,14.87%,NSA2;FTSJ3;RRP15
prerank,positive regulation of protein acetylation (GO:1901985),0.2990161611900982,0.6251246531371087,0.9071803852889667,0.9983423363992912,1.0,4/12,17.53%,DIP2B;CEP295;RAPGEF3;PRKAA1
prerank,miRNA metabolic process (GO:0010586),0.273486506921345,0.6248580767410441,0.9107744107744108,0.9981055490363825,1.0,10/20,31.95%,DROSHA;DICER1;TRIM71;PRKRA;SND1;TENT4B;TUT7;PARN;DIS3L2;XPO5
prerank,lysosome localization (GO:0032418),0.24634375132555267,0.6236725670236408,0.9384384384384384,0.9985600273284386,1.0,11/37,24.16%,MYH9;PIK3CG;SPAG9;ARL8B;NDEL1;SYTL4;PLEKHM1;TFEB;HDAC6;RAB3A;BORCS5
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.2428435350657969,-0.62353140758818,0.9122807017543859,1.0,1.0,9/18,32.58%,GINS3;GINS1;POLE;POLD2;GINS4;LIG1;POLE3;MCMDC2;MCM3
prerank,oligodendrocyte development (GO:0014003),0.29218232769114577,0.6234130963419462,0.8916666666666667,0.9983347040775895,1.0,4/15,13.79%,B4GALT5;EIF2B5;PRDM8;EIF2B2
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.23336871898265427,-0.6230341150284677,0.9434889434889435,1.0,1.0,8/20,26.22%,ZWINT;KLHL22;TEX14;IK;ATM;CENPF;BUB1B;KNTC1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.23336871898265427,-0.6230341150284677,0.9434889434889435,1.0,1.0,8/20,26.22%,ZWINT;KLHL22;TEX14;IK;ATM;CENPF;BUB1B;KNTC1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.23336871898265427,-0.6230341150284677,0.9434889434889435,1.0,1.0,8/20,26.22%,ZWINT;KLHL22;TEX14;IK;ATM;CENPF;BUB1B;KNTC1
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.2522345396727783,-0.6226983755348816,0.9099307159353349,1.0,1.0,5/16,24.05%,NUPR1;UQCC2;SLC25A33;PDE12;PPIF
prerank,protein sumoylation (GO:0016925),0.2317579011910346,0.6215881640455778,0.9600570613409415,0.9992381072896069,1.0,12/49,14.81%,STX1A;SUMO2;NUP214;NUP98;SAE1;NUP133;IFIH1;NUP205;NUP54;TOPORS;NUP43;NUP153
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.2966256823060745,0.6215841846756319,0.8853615520282186,0.9988112168536625,1.0,4/13,24.96%,DUT;UNG;MBD4;NEIL2
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.311072056239016,0.6214877904362361,0.8710247349823321,0.998017476524767,1.0,11/11,68.91%,CCT7;CCT2;CCT8;CCT6A;DKC1;LARP7;CCT4;CCT3;CCT5;TCP1;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),0.311072056239016,0.6214877904362361,0.8710247349823321,0.998017476524767,1.0,11/11,68.91%,CCT7;CCT2;CCT8;CCT6A;DKC1;LARP7;CCT4;CCT3;CCT5;TCP1;MEPCE
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2840539148819726,-0.6208626505345258,0.912472647702407,1.0,1.0,4/11,25.20%,TIMM22;TIMM8B;TIMM9;TIMM10
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.27647867321152997,-0.620844206023723,0.9129464285714286,1.0,1.0,6/11,37.55%,SMARCAL1;DONSON;FBH1;BLM;ZRANB3;LIG3
prerank,protein palmitoylation (GO:0018345),-0.21549544767680717,-0.6199637458279885,0.9596774193548387,1.0,1.0,3/30,8.44%,GLUL;CLIP3;ZDHHC20
prerank,cilium-dependent cell motility (GO:0060285),-0.2357602469537451,-0.619938160389459,0.9588377723970944,1.0,1.0,8/22,25.30%,CFAP44;DNAH8;CCDC39;RSPH9;EFHC1;GAS8;DNAH2;DRC1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.2871809722682689,0.61972777850989,0.889267461669506,0.9988841137778559,1.0,11/18,35.21%,DCP2;CCT7;CCT2;RUVBL1;RUVBL2;PARN;CCT8;NOP10;CCT6A;DKC1;EXOSC10
prerank,mitotic spindle organization (GO:0007052),0.1959205680909093,0.6195933603421943,0.9963985594237695,0.9985464408960592,1.0,42/153,24.75%,RAB11A;PLK2;AURKA;PCNT;DYNLL1;XPO1;DYNC1LI1;NEK6;AURKC;STAG2;KIF23;RPS27;NUP98;MAD1L1;NUP133;NDEL1;STAG1;BUB3;NUP43;LSM14A;CHEK2;RHOA;ABRAXAS2;WRAP73;MZT1;PPP1CC;CLIP1;BCCIP;PIBF1;SBDS;PLK1;KIF4A;KPNB1;KIF2A;TAOK1;DCTN6;CLASP2;KIF18A;MAP4;CENPN;TNKS;NUP85
prerank,axonal transport (GO:0098930),0.24519588561477407,0.6195431242192433,0.941717791411043,0.9981515547872862,1.0,2/36,2.90%,HIF1A;DST
prerank,regulation of interferon-beta production (GO:0032648),-0.19136519565013205,-0.6190035358369896,0.987220447284345,1.0,1.0,10/46,20.99%,PTPRS;HSP90AA1;OAS2;MAVS;RNF135;SIRPA;PPM1B;CACTIN;POLR3D;PYCARD
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.2823709699107108,-0.6183981139342452,0.9170305676855895,1.0,1.0,1/10,4.29%,HSP90AA1
prerank,positive regulation of type I interferon production (GO:0032481),0.2166706999157705,0.6174370272688058,0.9732620320855615,0.9992392385681854,1.0,15/73,20.69%,LRRFIP1;NFKB1;G3BP1;CGAS;RELA;RIPK2;IFIH1;NFKB2;STAT6;CTNNB1;STAT1;POLR3B;DHX36;POLR3A;POLR2L
prerank,negative regulation of phosphatase activity (GO:0010923),-0.22518063066536528,-0.617329005720272,0.9533678756476683,1.0,1.0,7/25,19.75%,PPP4R4;SH3RF2;CRY2;TGFB2;PTPA;BOD1L1;SH2D4A
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.28176520929333826,0.6171383011958687,0.8985024958402662,0.9990316856669765,1.0,5/18,15.85%,RAP1B;RAP1A;RAB5A;FMR1;RIMS4
prerank,negative regulation of viral release from host cell (GO:1902187),-0.2646015749858144,-0.6167025615867009,0.9138655462184874,1.0,1.0,4/13,26.58%,TRIM35;TRIM28;TRIM8;TRIM5
prerank,response to light stimulus (GO:0009416),0.22875365707385314,0.6166392668614765,0.9727793696275072,0.9989839378846247,1.0,7/55,12.93%,MAP4K3;MAPK8;OPN4;GNAT1;PRIMPOL;OPN5;ERCC4
prerank,protein import into peroxisome matrix (GO:0016558),-0.26436164679144086,-0.6163527061920968,0.9225941422594143,1.0,1.0,5/12,27.01%,PEX1;PEX7;PEX5L;PEX5;PEX16
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3083623015640082,0.6158052429372208,0.8682745825602969,0.9991477702375079,1.0,5/10,27.73%,PIH1D1;TAF9;RUVBL1;NUFIP1;RUVBL2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.25618748659362506,-0.6156483586633283,0.9193548387096774,1.0,1.0,2/14,8.47%,AUTS2;CTR9
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.238374470176084,0.6155160078854301,0.9473684210526315,0.9989192884945765,1.0,10/36,23.34%,DAB2IP;EPC1;MAX;RYBP;APAF1;PHC3;EHMT1;PHC1;UXT;BMI1
prerank,ESCRT III complex disassembly (GO:1904903),0.3072378154309668,0.6151812970452761,0.8694817658349329,0.998310330799405,1.0,1/10,5.98%,CHMP2B
prerank,ESCRT complex disassembly (GO:1904896),0.3072378154309668,0.6151812970452761,0.8694817658349329,0.998310330799405,1.0,1/10,5.98%,CHMP2B
prerank,protein localization to kinetochore (GO:0034501),-0.25849150088157236,-0.6150985315578477,0.9110070257611241,1.0,1.0,9/14,43.58%,IK;CENPT;KNL1;SPDL1;CDK1;ZW10;MIS12;TTK;ZWILCH
prerank,regulation of response to stress (GO:0080134),-0.27786653140023343,-0.6150372456157241,0.917184265010352,1.0,1.0,5/10,35.34%,EIF4G1;ADCY8;SLC38A2;CORO2B;DYRK3
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.18143703007904394,-0.6148056321624079,0.9886363636363636,1.0,1.0,14/69,20.60%,SELENOS;AMFR;UBXN4;JKAMP;UBE4B;NPLOC4;UBE2G2;UBE4A;RNF121;USP19;DNAJC18;FAM8A1;DNAJB2;TMEM67
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.24771993462020442,0.6135426836612325,0.9518633540372671,0.9985805889008592,1.0,8/32,17.14%,NUP214;NUP98;NUP133;NUP205;NUP54;NUP43;NUP153;XPOT
prerank,tRNA export from nucleus (GO:0006409),0.24771993462020442,0.6135426836612325,0.9518633540372671,0.9985805889008592,1.0,8/32,17.14%,NUP214;NUP98;NUP133;NUP205;NUP54;NUP43;NUP153;XPOT
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.27928750414879894,0.6134302724534542,0.9357142857142857,0.998227503883203,1.0,7/16,26.56%,NAA11;KAT2B;NAA16;NAA30;NAA35;NAA50;CREBBP
prerank,transferrin transport (GO:0033572),-0.20965524077874242,-0.6127942206134394,0.9590163934426229,1.0,1.0,6/33,13.77%,ATP6V0A4;ATP6V1B2;STEAP3;ATP6V0D1;ATP6V0B;ARHGAP1
prerank,response to glucocorticoid (GO:0051384),0.2589242872624553,0.6127433554819646,0.931637519872814,0.998260930517307,1.0,6/26,21.59%,NR3C1;BCL2L11;ZFP36;ZFP36L1;UBE2L3;SLIT3
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.292759636362807,0.609889818065391,0.9045871559633027,0.9998191359507631,1.0,3/13,17.56%,RRS1;RPS21;NOP14
prerank,cellular response to leucine starvation (GO:1990253),-0.2793457666571593,-0.60935156878742,0.9134808853118712,1.0,1.0,4/10,26.17%,IMPACT;SESN2;MTOR;RRAGD
prerank,ncRNA export from nucleus (GO:0097064),0.23842313766826162,0.6087175722247218,0.9504504504504504,1.0,1.0,9/36,17.14%,NUP214;NUP98;NUP133;NUP205;NPM1;NUP54;NUP43;NUP153;XPOT
prerank,amyloid-beta metabolic process (GO:0050435),0.28301342474499885,0.6081407806765095,0.8792184724689165,1.0,1.0,5/16,15.49%,DYRK1A;PSEN1;APH1A;APEH;ACE
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18659189875265408,0.6080558810534497,1.0,0.9997984357607803,1.0,75/264,25.97%,NOVA2;RSRC1;SRPK3;TGS1;HNRNPF;SF3B4;GTF2F2;CTNNBL1;HNRNPA0;MTREX;HNRNPK;RBM14;HNRNPD;WDR33;LSM8;YTHDC1;SPEN;RBM15;RNPS1;LSM3;HNRNPC;ZMAT2;SMU1;SF3B6;DHX15;SNRNP25;SCAF11;WDR77;CWC27;SNW1;YBX1;AQR;DDX20;HNRNPUL1;CWC22;ALYREF;CDC40;LSM7;PRPF40A;PHF5A;METTL14;RALY;CWF19L2;PRPF4;HNRNPM;CPSF1;STRAP;SRSF10;FUS;SART1;SART3;POLR2L;ELAVL1;SF3A2;POLR2J;PRPF3;TRA2B;DBR1;SNRPD3;SRSF4;PSPC1;SLU7;CPSF2;SYF2;LSM2;HNRNPA3;PCF11;SNUPN;RBMX;SNRNP200;CPSF3;PUF60;PRPF40B;ISY1;GCFC2
prerank,linoleic acid metabolic process (GO:0043651),0.2725044048289529,0.6073858539368086,0.8900343642611683,0.9998302208848869,1.0,4/17,15.03%,ELOVL5;ABCD1;GSTP1;PNPLA8
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.2662017032619251,0.6072741736537376,0.9137645107794361,0.9994893443737999,1.0,7/19,25.60%,GMPR;HPRT1;ADA;PNP;TYMS;POLL;ADK
prerank,protein ADP-ribosylation (GO:0006471),-0.2120450660873021,-0.6066055434145741,0.96875,1.0,1.0,3/28,7.77%,SIRT2;PARP3;PARP11
prerank,sensory perception of taste (GO:0050909),0.30157534676457676,0.6054357108418373,0.8903345724907064,1.0,1.0,10/10,69.86%,PKD1L3;ASIC1;ASIC2;TAS1R3;GNAT3;TAS1R2;PKD2L1;TAS1R1;ASIC3;CD36
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.23709407114413944,-0.6053169108095527,0.9325301204819277,1.0,1.0,9/17,37.31%,GET4;EMC8;GET1;EMC4;EMC1;BAG6;GET3;CAMLG;EMC10
prerank,intracellular pH reduction (GO:0051452),0.24308611796593138,0.6052963384427977,0.9511041009463722,0.9999779601094005,1.0,5/33,13.71%,CLCN3;ATP6V0A1;RAB38;ATP6V1G2;RAB7A
prerank,lipid droplet formation (GO:0140042),0.30239081355409847,0.6047596807441584,0.8873239436619719,0.9999121980092937,1.0,1/10,6.96%,CDS2
prerank,histone lysine methylation (GO:0034968),0.2410163418789046,0.6039473070502926,0.9407407407407408,1.0,1.0,13/33,29.24%,KDM6A;SMYD3;SETDB2;ASH2L;CXXC1;RBBP5;PRDM9;SUV39H1;N6AMT1;DYDC2;EZH2;SMYD2;SMYD1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.23869623818340258,-0.6037668024663202,0.9447115384615384,1.0,1.0,2/17,11.90%,SELENOS;NPLOC4
prerank,transcription preinitiation complex assembly (GO:0070897),0.28665487066194306,0.6027434548591555,0.91651865008881,1.0,1.0,2/12,12.88%,TAF1B;GTF2A2
prerank,regulation of phospholipid metabolic process (GO:1903725),0.30311796500160787,0.6019263406223064,0.8905380333951762,1.0,1.0,3/10,19.93%,ABCA3;MTMR9;MTMR2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.2595195426775777,-0.6017858157958937,0.9357798165137615,1.0,1.0,5/12,21.38%,LHPP;PAICS;ATIC;PFAS;ADSS1
prerank,Golgi to endosome transport (GO:0006895),0.27420540729442683,0.6016186926694771,0.9216757741347905,1.0,1.0,5/16,20.49%,DOP1B;AP2A1;KIF16B;AP1AR;EPS15
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.22128815305281216,-0.6010381768230314,0.9681372549019608,1.0,1.0,8/21,26.22%,ZWINT;KLHL22;TEX14;IK;ATM;CENPF;BUB1B;KNTC1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.21943405680436318,-0.6003696263974895,0.9731182795698925,1.0,1.0,11/28,32.64%,MAP2;MAP1S;MAP1A;CAMSAP3;STMN4;CLASP1;SKA3;MAPRE1;GBA2;STMN2;ARL2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.25841179683331705,-0.5985951679965001,0.9182795698924732,1.0,1.0,5/12,24.46%,BDH2;GCLC;HAGH;GGT1;CNDP2
prerank,skeletal muscle contraction (GO:0003009),-0.23192067166328095,-0.598211760785336,0.9559585492227979,1.0,1.0,7/19,39.24%,STAC3;TNNI1;TNNT3;TNNC1;TCAP;STAC2;TNNI2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.23029174776328173,0.5974740741947994,0.9572271386430679,1.0,1.0,6/43,12.25%,TAOK2;BABAM2;BRCC3;FOXN3;HUS1;NOP53
prerank,regulation of exit from mitosis (GO:0007096),-0.1979810570954549,-0.597214588192677,0.9793510324483776,1.0,1.0,5/38,10.88%,SIRT2;CDC14B;ANAPC5;RGCC;ANAPC15
prerank,7-methylguanosine RNA capping (GO:0009452),0.23606708306226765,0.5958307601827042,0.942215088282504,1.0,1.0,8/31,22.30%,GTF2F2;RNGTT;RNMT;GTF2H4;GTF2H1;POLR2L;CCNH;POLR2J
prerank,7-methylguanosine mRNA capping (GO:0006370),0.23606708306226765,0.5958307601827042,0.942215088282504,1.0,1.0,8/31,22.30%,GTF2F2;RNGTT;RNMT;GTF2H4;GTF2H1;POLR2L;CCNH;POLR2J
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2825043916531566,0.5957964772997283,0.9236234458259325,1.0,1.0,5/15,17.95%,PLCG2;NPM1;CDC73;CUL3;KLHL18
prerank,negative regulation of protein depolymerization (GO:1901880),0.24559156214526812,0.5946571577315558,0.933993399339934,1.0,1.0,8/24,23.45%,ARHGEF2;CAMSAP2;LIMA1;APC;CIB1;ATXN7;TAOK1;CLASP2
prerank,immunoglobulin mediated immune response (GO:0016064),-0.26743104857566713,-0.5944127878920482,0.9261603375527426,1.0,1.0,4/10,34.72%,CD81;CD74;FCGR2B;TLR8
prerank,chromatin disassembly (GO:0031498),0.28474228817909786,0.5933569965245965,0.8836363636363637,1.0,1.0,7/14,24.69%,ARID1A;SMARCE1;GRWD1;SMARCC1;ARID2;SMARCD1;SET
prerank,nucleosome disassembly (GO:0006337),0.28474228817909786,0.5933569965245965,0.8836363636363637,1.0,1.0,7/14,24.69%,ARID1A;SMARCE1;GRWD1;SMARCC1;ARID2;SMARCD1;SET
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.265878673899435,0.593097878341127,0.9248251748251748,1.0,1.0,3/17,14.21%,HASPIN;RB1;BUB3
prerank,autophagy of nucleus (GO:0044804),0.2657886743539149,0.5910053683493983,0.9242957746478874,1.0,1.0,4/16,18.72%,ULK1;ATG2A;ATG2B;ATG7
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.18232535558411717,0.5909643881120851,1.0,1.0,1.0,68/241,25.97%,NOVA2;RSRC1;HNRNPF;SF3B4;GTF2F2;CTNNBL1;HNRNPA0;MTREX;HNRNPK;RBM14;HNRNPD;WDR33;LSM8;YTHDC1;SPEN;RBM15;RNPS1;LSM3;HNRNPC;ZMAT2;SMU1;SF3B6;DHX15;SNRNP25;CWC27;SNW1;YBX1;AQR;HNRNPUL1;CWC22;ALYREF;CDC40;LSM7;PRPF40A;PHF5A;METTL14;RALY;CWF19L2;PRPF4;HNRNPM;CPSF1;SRSF10;FUS;SART1;SART3;POLR2L;ELAVL1;SF3A2;POLR2J;PRPF3;TRA2B;DBR1;SNRPD3;SRSF4;PSPC1;SLU7;CPSF2;SYF2;LSM2;HNRNPA3;PCF11;RBMX;SNRNP200;CPSF3;PUF60;PRPF40B;ISY1;GCFC2
prerank,transcription by RNA polymerase III (GO:0006383),-0.20674547568572815,-0.5907526601531611,0.9754768392370572,1.0,1.0,10/27,32.94%,ICE2;POLR2K;POLR3H;GTF3A;GTF3C4;POLR3K;CRCP;ZC3H8;TBP;SNAPC4
prerank,histone H2A acetylation (GO:0043968),-0.24918684339164068,-0.5896255220207982,0.9533169533169533,1.0,1.0,6/16,23.37%,NAA40;MORF4L2;BRD8;ACTL6A;MEAF6;SPHK2
prerank,negative regulation of chemokine production (GO:0032682),0.275450887245714,0.589556725253974,0.896797153024911,1.0,1.0,3/14,16.94%,SIGIRR;GSTP1;MAP2K5
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.2976271879855821,0.5881480378807636,0.9109848484848485,1.0,1.0,3/10,17.93%,ELOVL5;ABCD1;MLXIPL
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.268766247767953,-0.5877491347446063,0.9284210526315789,1.0,1.0,3/10,23.40%,IVD;GCDH;ACADS
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.24059291577266795,0.58768424557252,0.9654088050314465,1.0,1.0,5/32,12.25%,TAOK2;BABAM2;BRCC3;FOXN3;NOP53
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.25392851951384054,-0.5872157527763885,0.9340909090909091,1.0,1.0,1/13,2.78%,PRKCD
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.27956162974883175,0.5867469339675552,0.9177820267686424,1.0,1.0,3/12,20.74%,CDT1;MAD1L1;CHAMP1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.2842590518123287,0.5864660837454572,0.8937282229965157,1.0,1.0,3/12,12.95%,MYCBP2;B4GALT5;HSP90AB1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.29057689195525915,0.5863718756742311,0.9202772963604853,1.0,1.0,3/10,19.82%,EMC6;EMC3;EMC7
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.22727932874568918,0.5850610435957374,0.9552469135802469,1.0,1.0,10/38,24.69%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NDUFS8;NDUFB7
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.23005598161382085,-0.5849515973095726,0.9454976303317536,1.0,1.0,6/16,26.17%,KLHL22;GPR137B;FLCN;GPR137C;PIP4P1;RRAGD
prerank,carnitine metabolic process (GO:0009437),0.2911761130264418,0.5846343436887861,0.9094202898550725,1.0,1.0,4/12,22.25%,CRAT;CPT1A;CROT;ALDH9A1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.24865587003366132,-0.5844205786582769,0.9432314410480349,1.0,1.0,5/13,24.99%,ANAPC15;LCMT1;GEN1;NDC80;XRCC3
prerank,double-strand break repair via break-induced replication (GO:0000727),0.27506120143117196,0.58320258963799,0.9099099099099099,1.0,1.0,12/12,72.51%,GINS2;MCM6;MUS81;MCM7;MCM2;MCM4;MCM5;CDC7;CDC45;MCM3;MCMDC2;GINS4
prerank,DNA replication (GO:0006260),0.19400443205068935,0.5825167595812262,0.9987046632124352,1.0,1.0,37/105,29.56%,RNASEH2A;MCM10;RPA1;POLA1;DUT;CDK2;BRIP1;HELB;HUS1;MCM9;RMI1;TOP1;GRWD1;ORC5;ORC3;BAZ1A;RFC3;MCMBP;RAD17;RMI2;DBF4;TIPIN;RFC5;TBRG1;POLL;SET;ORC6;MCM6;RPA3;TICRR;RBBP8;TIMELESS;RFC2;TOP1MT;KAT7;POLG2;POLA2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.24985582019565658,0.5824838606443339,0.9467084639498433,1.0,1.0,4/25,13.84%,BST1;PLCG2;TMBIM4;SLA2
prerank,peroxisome organization (GO:0007031),0.24336353583584824,0.5822449581458725,0.961352657004831,1.0,1.0,5/25,13.86%,TMEM135;PLAAT3;ABCD4;ABCD1;PEX14
prerank,tRNA methylation (GO:0030488),-0.19598969136966496,-0.5819731333646123,0.9814241486068112,1.0,1.0,34/34,80.45%,TARBP1;GTPBP3;MTO1;THUMPD3;METTL1;BCDIN3D;DALRD3;TRMT61A;METTL2A;METTL2B;THUMPD2;TRMT13;TRMT44;FTSJ1;HSD17B10;TRMT5;TRDMT1;TRMT1;THADA;WDR6;TRMO;METTL6;TYW3;TRMT112;TRMT10A;TRMT1L;NSUN2;TRMT12;TRMT61B;TRMT10C;LCMT2;ALKBH8;NSUN6;PRORP
prerank,regulation of mRNA metabolic process (GO:1903311),0.2850144350005142,0.5818379971729508,0.9089219330855018,1.0,1.0,4/11,23.97%,SRPK3;SLTM;CDK11B;IWS1
prerank,cristae formation (GO:0042407),-0.21486195936555053,-0.581749454206887,0.9526315789473684,1.0,1.0,11/27,32.04%,CHCHD3;CHCHD6;ATP5PO;ATP5PF;ATP5ME;SAMM50;ATP5MG;DMAC2L;APOO;DNAJC11;IMMT
prerank,cell cycle G2/M phase transition (GO:0044839),0.19212518420955524,0.5816036094954683,0.9961783439490446,1.0,1.0,13/129,9.41%,TPD52L1;PLCB1;PRKAR2B;PPP1R12A;CEP41;AURKA;PCNT;FBXL7;DYNLL1;CCNY;CDK2;CNTRL;CEP57
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.19473639054698674,-0.5807632946419535,0.9878419452887538,1.0,1.0,14/38,26.49%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;HIRA;CENPH;KNL1;CENPX;CENPQ;CENPA
prerank,tRNA wobble uridine modification (GO:0002098),-0.23975139682340385,-0.5805969584502451,0.9526881720430107,1.0,1.0,14/14,76.05%,GTPBP3;ELP4;MTO1;URM1;ELP1;TRMT9B;CTU1;CTU2;TRMU;ELP3;MOCS3;DPH3;KTI12;ALKBH8
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.23628098370001835,-0.5801719646490074,0.9466357308584686,1.0,1.0,3/17,17.07%,PRKCZ;CEBPB;SYK
prerank,tRNA wobble base modification (GO:0002097),-0.23975139682340385,-0.5795496374150163,0.9463087248322147,1.0,1.0,14/14,76.05%,GTPBP3;ELP4;MTO1;ADAT2;URM1;TRMT9B;CTU1;CTU2;ALKBH1;ELP3;MOCS3;DPH3;KTI12;ALKBH8
prerank,secretory granule organization (GO:0033363),0.2892002163173748,0.5794343336992548,0.908411214953271,1.0,1.0,2/10,19.36%,SRGN;ABCA1
prerank,rRNA catabolic process (GO:0016075),-0.23566589710779026,-0.5790968205719691,0.9432098765432099,1.0,1.0,3/16,19.17%,EXOSC7;EXOSC3;EXOSC9
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.23419255481431506,0.577646165524999,0.9554531490015361,1.0,1.0,10/30,20.57%,DYRK1A;BCL2L1;DDIAS;SFRP2;TPT1;THOC1;KDM1A;PTTG1IP;THOC5;RPS3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.26848627598095987,0.5775645257540372,0.9309153713298791,1.0,1.0,5/14,19.37%,ADSL;IMPDH1;RFK;ADSS2;GART
prerank,cellular response to copper ion (GO:0071280),-0.2295069415627552,-0.5763439023034218,0.960919540229885,1.0,1.0,2/16,16.21%,SNCA;MT3
prerank,acyl-CoA biosynthetic process (GO:0071616),0.2574900896037332,0.5752217923328923,0.9359190556492412,1.0,1.0,2/16,10.48%,FASN;SLC25A1
prerank,histone H3-K4 methylation (GO:0051568),0.24441863034989936,0.5749678309792434,0.9598070739549839,1.0,1.0,7/26,22.14%,KDM6A;TET3;TET2;ASH2L;CXXC1;RBBP5;PRDM9
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.21730670699172627,-0.5746422204264005,0.9660574412532638,1.0,1.0,2/22,7.20%,UGGT2;AMFR
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.29449295840520184,0.574620236536141,0.9012567324955116,1.0,1.0,3/10,20.74%,ATP5PD;VPS9D1;ATP5MC2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.24393717380300267,0.5739428170990148,0.9460370994940978,1.0,1.0,10/25,28.06%,DNAJB5;ERO1A;BAG1;HSPE1;DNAJB12;DNAJB1;GAK;HSPA1B;HSPA13;HSPA14
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.1961576282478026,-0.5734927752475708,0.9914040114613181,1.0,1.0,8/34,24.56%,RBP4;STX4;PTPN22;LACC1;CLCF1;EPHB2;SPHK2;PTPRC
prerank,cell differentiation in hindbrain (GO:0021533),-0.24616235745354553,-0.5730566895741582,0.9406593406593406,1.0,1.0,6/11,32.16%,GRID2;FAIM2;LHX1;KNDC1;CEND1;NOG
prerank,purine-containing compound biosynthetic process (GO:0072522),0.24048160183923456,0.5722977442031055,0.9466463414634146,1.0,1.0,3/25,9.72%,GMPR;ADSL;HPRT1
prerank,protein import (GO:0017038),0.19769704663164564,0.5714723773907046,0.9933510638297872,1.0,1.0,24/84,23.47%,STAT3;IPO11;PPP1R10;PEX26;IPO8;NUP214;ABCD1;PRICKLE1;NUP133;PEX14;ALDH3A2;TNPO3;NUP153;RAB8B;TOMM22;PTTG1IP;E2F3;CSE1L;KPNB1;HIKESHI;EIF4ENIF1;APPL1;HSPA4;CLU
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.2749274644900461,0.5712334938126683,0.9230769230769231,1.0,1.0,3/11,15.66%,MBTPS2;ATF6;DDIT3
prerank,protein localization to condensed chromosome (GO:1903083),-0.2538911356430273,-0.5698214126341338,0.9383886255924171,1.0,1.0,8/12,43.58%,IK;KNL1;SPDL1;CDK1;ZW10;MIS12;TTK;ZWILCH
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.2668140496352204,0.5692897468011606,0.9428044280442804,1.0,1.0,4/14,21.42%,NIFK;RPL7L1;URB1;RPL7
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.2734333491059565,0.5686724755570262,0.9111531190926276,1.0,1.0,4/12,20.64%,ANAPC7;RB1;CUL3;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.2734333491059565,0.5686724755570262,0.9111531190926276,1.0,1.0,4/12,20.64%,ANAPC7;RB1;CUL3;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.2734333491059565,0.5686724755570262,0.9111531190926276,1.0,1.0,4/12,20.64%,ANAPC7;RB1;CUL3;NSMCE2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.2665242241783285,0.5666097068197052,0.9295774647887324,1.0,1.0,3/14,12.62%,GAS6;CARD16;GSTP1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.2738110358562044,0.5655032308528269,0.9154929577464789,1.0,1.0,3/12,23.51%,IL23A;CARD9;ZBTB1
prerank,regulation of catabolic process (GO:0009894),0.24977626854297613,0.5650320287166077,0.9315068493150684,1.0,1.0,1/18,2.36%,NEDD4L
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.22593331925830498,-0.56498284638231,0.9547619047619048,1.0,1.0,6/16,26.80%,HNRNPA2B1;RTEL1;TERF2;SLX4;ATM;SMG5
prerank,organelle disassembly (GO:1903008),0.22556438061762343,0.5640491198283355,0.9716088328075709,1.0,1.0,12/33,25.09%,ULK1;MCTS1;MRRF;MTIF3;ATG2A;ATG2B;VRK1;DENR;PLK3;RB1CC1;MTIF2;UFM1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.22247919293004492,-0.563782038085445,0.965034965034965,1.0,1.0,6/18,23.03%,COX16;COX19;COX17;COX18;FASTKD3;TIMM21
prerank,microtubule nucleation (GO:0007020),-0.2224835406637472,-0.5637740979642608,0.9788235294117648,1.0,1.0,6/19,31.48%,TUBGCP5;CCDC57;TPX2;CLASP1;GOLGA2;TPPP
prerank,regulation of double-strand break repair (GO:2000779),0.2216601603104602,0.5637213459287549,0.9678407350689127,1.0,1.0,9/39,22.19%,RNF169;WRAP53;ACTR2;SIRT6;SPIDR;MGMT;KDM1A;DEK;SIRT7
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.22686623495030844,-0.5633395688773847,0.9354120267260579,1.0,1.0,5/14,31.79%,U2AF2;PCBP4;SRSF6;C1QBP;SRSF9
prerank,regulation of G0 to G1 transition (GO:0070316),0.21551276929644791,0.5629891855638205,0.9762282091917591,1.0,1.0,10/38,23.34%,DAB2IP;EPC1;MAX;RYBP;APAF1;PHC3;EHMT1;PHC1;UXT;BMI1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.28118045130225133,0.5627476864346534,0.928030303030303,1.0,1.0,2/10,12.17%,TFAP4;MUC1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.25703879116971123,-0.5616913241064819,0.9308176100628931,1.0,1.0,4/10,24.84%,CBS;BLMH;CTH;MTRR
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.25510818401271085,0.5607287775950432,0.9351351351351351,1.0,1.0,2/16,9.99%,RPA1;RECQL
prerank,organelle fusion (GO:0048284),-0.2160258407775525,-0.5606323255362206,0.971764705882353,1.0,1.0,7/22,25.13%,MIGA2;CHCHD3;STX4;MIEF2;VPS11;BAX;GDAP1
prerank,regulation of steroid metabolic process (GO:0019218),0.24326589697091114,0.5604214807381253,0.9540412044374009,1.0,1.0,8/23,21.58%,PANK2;ABCG1;ASAH1;TTC39B;STAR;ABCB11;FMO5;RORC
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.2662071239388914,0.5599753875170488,0.9339285714285714,1.0,1.0,3/13,17.29%,SVIP;UBAC2;YOD1
prerank,positive regulation of phospholipid transport (GO:2001140),0.27820225065388704,0.5591194463643938,0.9267399267399268,1.0,1.0,1/10,5.76%,ABCA3
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.2595440994196821,0.5583797503222071,0.9245960502692998,1.0,1.0,2/13,11.20%,GLRX3;MMS19
prerank,purine nucleotide biosynthetic process (GO:0006164),0.2687691057341156,0.5580323633133732,0.9354838709677419,1.0,1.0,4/12,19.61%,ADSL;HPRT1;GART;ADA
prerank,steroid hormone biosynthetic process (GO:0120178),-0.19294455311257208,-0.5580305266167378,0.9919354838709677,1.0,1.0,6/29,22.75%,AKR1B1;FDX1;FDXR;TSPO;DHCR7;TSPOAP1
prerank,aerobic respiration (GO:0009060),-0.2146620681571466,-0.5574936193323349,0.9708029197080292,1.0,1.0,7/20,28.22%,SLC25A14;MTFR1L;SDHC;UQCRB;NDUFS7;MDH2;UQCR10
prerank,melanosome organization (GO:0032438),0.23702053879278887,0.557065124923355,0.9604612850082372,1.0,1.0,5/26,17.00%,SHROOM2;RAB38;AP3B1;RAB32;BLOC1S5
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.24011884856326868,0.5568257546963082,0.9604612850082372,1.0,1.0,7/20,23.47%,LONP1;HSP90AB1;CCT2;MKKS;PSMG2;HSPA4;CLU
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.20530584532260132,0.556576315019501,0.9914407988587732,1.0,1.0,14/57,22.46%,TAOK2;BABAM2;BRCC3;CDK2;FOXN3;HUS1;NOP53;CHEK2;RAD17;PLK1;RINT1;TIPIN;BABAM1;TAOK1
prerank,mitochondrion disassembly (GO:0061726),0.221303962044022,0.5549305567660119,0.9782608695652174,1.0,1.0,8/34,18.72%,ULK1;CTSK;BNIP3;GABARAPL1;ATG2A;ATG2B;CISD2;ATG7
prerank,prostanoid metabolic process (GO:0006692),0.2561850432040855,0.5544761277301352,0.9460966542750929,1.0,1.0,2/13,12.62%,PTGS1;GSTP1
prerank,maintenance of protein localization in organelle (GO:0072595),0.24587333398176597,0.5534211812955782,0.9442567567567568,1.0,1.0,3/19,14.50%,BCL3;TAF3;TOPORS
prerank,protein targeting to mitochondrion (GO:0006626),-0.17155663019864972,-0.5530262285852898,0.9968253968253968,1.0,1.0,16/52,28.95%,HSP90AA1;TOMM40;AIFM1;TIMM22;TIMM17B;GRPEL2;TSPO;TIMM8B;TIMM21;TIMM9;GDAP1;DNAJC15;TIMM10;PAM16;SAMM50;PMPCB
prerank,negative regulation of T cell proliferation (GO:0042130),0.2308366856340145,0.5522078027333929,0.9648,1.0,1.0,3/28,10.79%,PLA2G2D;BTN2A2;RC3H1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.25538279511610956,0.5492357133770912,0.9486754966887417,1.0,1.0,5/16,18.19%,PIGQ;PIGG;PIGF;PIGL;PIGC
prerank,replication fork processing (GO:0031297),0.217780114876785,0.5458493905113253,0.9864661654135338,1.0,1.0,3/38,8.20%,SAMHD1;MMS22L;PRIMPOL
prerank,regulation of centrosome duplication (GO:0010824),0.22356331461510207,0.5456548356224571,0.9710144927536232,1.0,1.0,6/29,17.56%,PLK2;CHMP2B;CHMP4B;NPM1;CEP295;CEP131
prerank,tetrahydrofolate metabolic process (GO:0046653),0.28175783349836375,0.5454225426895744,0.9255725190839694,1.0,1.0,1/10,5.81%,MTHFD1L
prerank,cellular response to pH (GO:0071467),0.24333266211496002,0.5439156020183143,0.9711191335740073,1.0,1.0,4/17,16.45%,RAB11FIP5;RAB11B;KCNK4;CHP1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.20600385058379822,-0.5427751811456467,0.9765258215962441,1.0,1.0,6/19,26.61%,POLR2B;POLR2K;TERF2;POLR2I;POLR2D;POLR2H
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.20600385058379822,-0.5427751811456467,0.9765258215962441,1.0,1.0,6/19,26.61%,POLR2B;POLR2K;TERF2;POLR2I;POLR2D;POLR2H
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.20041852399374388,-0.5417193706673986,0.974025974025974,1.0,1.0,4/22,14.40%,EIF2AK3;SMARCA4;SMARCB1;WDR43
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.23322823693917832,0.5415915791880815,0.9709897610921502,1.0,1.0,11/21,31.54%,RPA1;ERCC4;GTF2H4;CHD1L;GTF2H1;CUL4B;GTF2H5;RPA3;GTF2H2;XPA;RBX1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.23322823693917832,0.5415915791880815,0.9709897610921502,1.0,1.0,11/21,31.54%,RPA1;ERCC4;GTF2H4;CHD1L;GTF2H1;CUL4B;GTF2H5;RPA3;GTF2H2;XPA;RBX1
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.23940987287640464,-0.5406326866994987,0.9524886877828054,1.0,1.0,3/11,21.68%,FGF2;PPIP5K2;IP6K1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.22735781120716803,0.5404081442709857,0.9620853080568721,1.0,1.0,6/25,17.22%,ATXN3;LONP1;OMA1;UGGT1;RNF5;CUL3
prerank,response to copper ion (GO:0046688),0.24010821222174103,0.5403287945333156,0.9677996422182469,1.0,1.0,2/20,13.27%,ATP7B;AOC1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.20493020827735453,-0.5384354562831036,0.9806763285024155,1.0,1.0,6/21,23.03%,COX16;COX19;COX17;COX18;FASTKD3;TIMM21
prerank,aerobic electron transport chain (GO:0019646),0.19053823979750428,0.5378848613983886,0.994475138121547,1.0,1.0,17/68,24.79%,NDUFA8;CYCS;NDUFA7;NDUFA10;NDUFS2;COX6C;UQCRQ;NDUFS4;SDHAF2;NDUFS6;UQCRC1;NDUFB9;UQCC3;NDUFC1;NDUFS8;NDUFB7;COX6A1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.2239052200793401,-0.5374304221958246,0.9766899766899767,1.0,1.0,4/13,20.55%,FUT9;MDK;ZDHHC21;ITGB2
prerank,mitochondrial transcription (GO:0006390),-0.25212873551914916,-0.5374243110069771,0.9585253456221198,1.0,1.0,3/10,19.83%,TFAM;SLC25A33;POLRMT
prerank,peptidyl-amino acid modification (GO:0018193),-0.24202090093610645,-0.53684612037876,0.9461883408071748,1.0,1.0,4/10,35.68%,FKBP10;TTLL4;FKBP7;METAP1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.18992244244586035,0.5367739478321757,0.9944674965421854,1.0,1.0,17/69,24.79%,NDUFA8;CYCS;NDUFA7;NDUFA10;NDUFS2;COX6C;UQCRQ;NDUFS4;SDHAF2;NDUFS6;UQCRC1;NDUFB9;UQCC3;NDUFC1;NDUFS8;NDUFB7;COX6A1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2639855727212266,0.5358498724397754,0.9314814814814815,1.0,1.0,8/11,35.21%,FBLL1;TENT4B;EXOSC4;PARN;EXOSC5;EXOSC2;DKC1;EXOSC10
prerank,mitotic DNA replication (GO:1902969),-0.24551976983708781,-0.5355500103862921,0.9674620390455532,1.0,1.0,6/10,36.24%,GINS3;GINS1;LIG1;MCMDC2;MCM3;CDC45
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.24335726143994818,-0.5351729162735294,0.9444444444444444,1.0,1.0,2/10,18.46%,DDX39B;CRY1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.1851952642964547,0.534263727509435,0.9945280437756497,1.0,1.0,26/87,26.78%,IMMP2L;NDUFA8;NDUFA7;COA8;NDUFA10;OMA1;COA3;NDUFS2;SURF1;NDUFS4;SDHAF2;NDUFS6;SCO2;PET100;NDUFB9;COA5;UQCC3;NDUFC1;NUBPL;NDUFS8;NDUFB7;SCO1;ECSIT;SDHAF1;NDUFAF8;NDUFA6
prerank,regulation of histone deacetylation (GO:0031063),0.26274553068197193,0.5340364215671387,0.9500924214417745,1.0,1.0,4/13,22.93%,CTBP1;APLNR;SAP30BP;NIPBL
prerank,positive regulation of rRNA processing (GO:2000234),0.26917789688608307,0.5332792946800972,0.9391304347826087,1.0,1.0,4/10,22.19%,RIOK1;HEATR1;RIOK2;SIRT7
prerank,autophagy of mitochondrion (GO:0000422),0.2089807129787672,0.5327928026376082,0.9845679012345679,1.0,1.0,8/38,18.72%,ULK1;CTSK;BNIP3;GABARAPL1;ATG2A;ATG2B;CISD2;ATG7
prerank,protein methylation (GO:0006479),-0.17486811219803317,-0.5323986228629736,0.9914285714285714,1.0,1.0,17/40,38.14%,EHMT2;LCMT1;CARM1;VCPKMT;EEF1AKMT1;PRMT8;METTL21A;EEF2KMT;PRMT2;EEF1AKMT3;NTMT1;PRMT7;PRMT6;GSPT1;NSD1;PRMT1;EEF1AKMT2
prerank,regulation of glycogen metabolic process (GO:0070873),-0.22387651220356444,-0.5307536627515212,0.9713656387665198,1.0,1.0,3/12,20.02%,PPP1R3C;PPP1R3F;PPP1R3B
prerank,mitochondrial genome maintenance (GO:0000002),0.2616053160607408,0.5304129204312582,0.9493006993006993,1.0,1.0,3/11,13.74%,AKT3;LONP1;MEF2A
prerank,positive regulation of TOR signaling (GO:0032008),0.20411740515258273,0.5290907304731612,0.9880597014925373,1.0,1.0,7/40,16.43%,SIK3;RPTOR;RICTOR;LARS1;GAS6;PIH1D1;RHEB
prerank,UV-damage excision repair (GO:0070914),0.2597791707101821,0.5290711592531601,0.9410681399631676,1.0,1.0,3/12,16.59%,POLA1;MC1R;ACTR5
prerank,negative regulation of secretion (GO:0051048),-0.2355364564656323,-0.5284052967979088,0.9572649572649573,1.0,1.0,5/10,29.64%,CD74;NR1H3;ERBB3;NRG1;EGF
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.24431611633230518,0.5281073796356102,0.9692832764505119,1.0,1.0,4/15,21.65%,HUS1;CHEK2;RAD17;TIPIN
prerank,regulation of cholesterol metabolic process (GO:0090181),0.23176278975577735,0.5265658358515943,0.943986820428336,1.0,1.0,7/20,24.45%,LPCAT3;MBTPS2;TTC39B;FMO5;KPNB1;SEC14L2;LDLRAP1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.22262052670122867,-0.5259032218952847,0.9623529411764706,1.0,1.0,4/14,21.28%,TFAM;SLC25A33;POLRMT;FASTKD5
prerank,positive regulation of immunoglobulin production (GO:0002639),0.21481439858757487,0.5258239020115583,0.970125786163522,1.0,1.0,7/31,22.00%,XBP1;SHLD1;MAD2L2;KMT5B;GPI;DNAJB9;RIF1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.26298905839011744,0.5256163603048792,0.9396709323583181,1.0,1.0,3/10,17.29%,SVIP;UBAC2;YOD1
prerank,negative regulation of immune effector process (GO:0002698),0.2472618433298949,0.5255746891627419,0.9541284403669725,1.0,1.0,5/13,24.38%,RPS19;RC3H1;HAVCR2;APPL1;CD47
prerank,male meiosis I (GO:0007141),-0.2093912005608485,-0.5209338958532167,0.9862068965517241,1.0,1.0,8/16,36.21%,FOXJ3;BRDT;HSF2BP;MYBL1;SYCP3;DDX4;TDRD9;SLC25A31
prerank,negative regulation of histone modification (GO:0031057),-0.22176285211226895,-0.5195552085408208,0.9779951100244498,1.0,1.0,5/14,23.90%,THAP7;SNCA;AASS;SPHK2;TWIST1
prerank,negative regulation of protein transport (GO:0051224),0.218473199773694,0.5193815333345551,0.9766277128547579,1.0,1.0,4/25,16.57%,PPM1F;SNX3;RHBDF2;NDFIP2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.18922877316716327,0.517615851547372,0.9986187845303868,1.0,1.0,21/58,27.37%,BABAM2;HERC2;POLA1;BRCC3;CYREN;ERCC4;DCLRE1C;XRCC4;NSMCE2;UBE2V2;RIF1;BABAM1;NSD2;ERCC6;HMGB1;LIG4;POLL;SUMO1;UBE2N;RNF168;UIMC1
prerank,negative regulation of cell division (GO:0051782),-0.2345226706797367,-0.5173641198966793,0.9783549783549783,1.0,1.0,6/11,32.53%,ZFYVE19;VPS4A;SUSD2;BLM;MYC;E2F8
prerank,response to zinc ion (GO:0010043),-0.1844851967191739,-0.5170204607044245,0.9903147699757869,1.0,1.0,1/25,3.65%,P2RX4
prerank,piRNA metabolic process (GO:0034587),0.22598250255950045,0.5163957695102448,0.9630931458699473,1.0,1.0,3/19,17.51%,BTBD18;HENMT1;TEX15
prerank,cellular response to misfolded protein (GO:0071218),0.22861447323763173,0.515266942487675,0.9633943427620633,1.0,1.0,5/20,18.28%,ATXN3;UGGT1;RNF5;CUL3;DNAJB12
prerank,ncRNA catabolic process (GO:0034661),0.21266970855854783,0.5116223952999533,0.9811023622047244,1.0,1.0,9/28,26.28%,MTREX;NUDT16;TRIR;DIS3L;RBM7;SND1;TENT4B;DIS3;EXOSC4
prerank,interstrand cross-link repair (GO:0036297),-0.15470936421566905,-0.5099754284853717,1.0,1.0,1.0,20/53,34.59%,NUCKS1;FANCI;FANCE;MSH6;NEIL3;ATR;SLX4;FANCA;UBC;XRCC3;CENPX;ERCC6L2;DCLRE1B;FANCB;RPA2;ERCC1;FAAP24;VCP;UBE2T;FANCF
prerank,telomere capping (GO:0016233),0.2368309341931456,0.5098604018057405,0.9646643109540636,1.0,1.0,4/16,20.76%,ACD;TERF1;DCLRE1C;TEN1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.21062949531992908,-0.5096551236097945,0.9703703703703703,1.0,1.0,1/15,3.31%,CPEB2
prerank,RNA splicing (GO:0008380),0.17083960624276223,0.5085718067391257,1.0,1.0,1.0,35/95,30.55%,RSRC1;PPP1R9B;MBNL1;SF3B4;RNPS1;HNRNPC;SMU1;DHX15;SNRNP25;SCAF11;PRPF4;SRSF10;FUS;PPP2R1A;LSM1;DDX47;PRPF3;TRA2B;DBR1;SNRPD3;SRSF4;PPIG;SLU7;PPP2CA;RP9;SYNCRIP;DHX8;SFPQ;PRPF18;SMNDC1;IVNS1ABP;SNRPD2;SNRPD1;SF3B2;SF3B1
prerank,snRNA 3'-end processing (GO:0034472),-0.19924249241473937,-0.5068357599817809,0.9853658536585366,1.0,1.0,4/19,20.43%,EXOSC7;EXOSC3;EXOSC9;INTS7
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.19530822599827496,-0.5066170349506697,0.9751243781094527,1.0,1.0,5/18,25.85%,EIF2AK3;WDR43;POLR2K;RASL11A;MAF1
prerank,phagosome acidification (GO:0090383),0.209089209353825,0.5052445804945424,0.9787234042553191,1.0,1.0,6/26,20.72%,ATP6V0A1;RAB38;ATP6V1G2;RAB7A;ATP6V1F;ATP6V1D
prerank,DNA replication checkpoint signaling (GO:0000076),0.22753672604536496,0.5039117731909984,0.9693693693693693,1.0,1.0,6/16,27.96%,CDT1;HUS1;RAD17;TIPIN;TICRR;TIMELESS
prerank,negative regulation of phagocytosis (GO:0050765),0.22380260823472,0.5037987439387309,0.9709618874773139,1.0,1.0,6/17,24.38%,SNX3;RACK1;PLSCR1;APPL1;HMGB1;CD47
prerank,negative regulation of transposition (GO:0010529),0.22811285155006472,0.502200965658771,0.9893238434163701,1.0,1.0,6/16,27.44%,BTBD18;SPOCD1;TEX15;SIRT7;SMYD5;TUT7
prerank,tryptophan metabolic process (GO:0006568),0.24623399447652522,0.5018990049054126,0.9510869565217391,1.0,1.0,11/11,75.39%,ATP7A;IL4I1;IDO2;ACMSD;IDO1;KMO;TDO2;AADAT;KYNU;HAAO;KYAT1
prerank,peptidyl-methionine modification (GO:0018206),0.2425695731249941,0.5015513536650875,0.9574861367837338,1.0,1.0,3/12,22.79%,NAA16;NAA30;PDF
prerank,"base-excision repair, AP site formation (GO:0006285)",0.22943708850901318,0.49884702021676486,0.9742710120068611,1.0,1.0,6/17,24.96%,ACD;UNG;MPG;TERF1;MBD4;NEIL2
prerank,maturation of LSU-rRNA (GO:0000470),0.21021513337848025,0.4987865338194033,0.9846678023850085,1.0,1.0,9/26,24.47%,RPF1;NIFK;EIF6;RPL7L1;MAK16;URB1;RPL7;MRPL1;LAS1L
prerank,isotype switching (GO:0045190),-0.22203209544303476,-0.49865158349223926,0.9820627802690582,1.0,1.0,2/10,17.56%,EXOSC3;MSH6
prerank,positive regulation of lymphocyte activation (GO:0051251),0.20495280316505954,0.4985526485347522,0.9807073954983923,1.0,1.0,3/28,10.01%,LCK;IL23A;CYRIB
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.19734394511124842,-0.49841216129513016,0.9857482185273159,1.0,1.0,3/17,13.21%,CXCL12;SERPINE1;CREB3
prerank,cilium movement (GO:0003341),0.18832817532805676,0.49663020358145865,0.9955686853766618,1.0,1.0,6/47,13.46%,CFAP53;TEKT5;SPA17;CFAP73;DNAH17;CABYR
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.21437140618994927,0.4957647810440748,0.9769503546099291,1.0,1.0,2/19,10.61%,TIRAP;NMI
prerank,regulation of biosynthetic process (GO:0009889),-0.2252181506373571,-0.49470682229079765,0.9573991031390134,1.0,1.0,4/11,31.29%,SNCA;SLC25A33;SPHK2;ALOX5
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2120221283019576,0.49418382491846885,0.9869494290375204,1.0,1.0,7/22,23.64%,ZDHHC18;ZDHHC9;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC8;ZDHHC2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2120221283019576,0.49418382491846885,0.9869494290375204,1.0,1.0,7/22,23.64%,ZDHHC18;ZDHHC9;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC8;ZDHHC2
prerank,sensory perception of smell (GO:0007608),-0.21127290986693448,-0.4908525131563802,0.9811715481171548,1.0,1.0,11/11,78.89%,ADCY3;UBR3;BBS4;SYT10;BEST2;OMP;OBP2B;GFY;DRD2;SLC24A4;MKKS
prerank,rRNA methylation (GO:0031167),0.2102630793079004,0.48820537093288224,0.9832775919732442,1.0,1.0,4/22,15.17%,TFB2M;NSUN4;FBLL1;EMG1
prerank,eye photoreceptor cell development (GO:0042462),0.22322844872387376,0.48644139262822916,0.9735449735449735,1.0,1.0,3/15,15.49%,NRL;TOPORS;CEP290
prerank,regulation of nuclear division (GO:0051783),0.21572031729957164,0.4863673677903102,0.9822695035460993,1.0,1.0,3/20,14.41%,CAV2;CDC25C;PDXP
prerank,microtubule-based transport (GO:0099111),0.22892171429485225,0.48336048403115395,0.9700704225352113,1.0,1.0,2/12,13.46%,SPA17;CABYR
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.19238969453604277,-0.48227747993763176,0.9908883826879271,1.0,1.0,3/17,17.38%,AFG1L;COX6B1;COX7B
prerank,negative regulation of telomere maintenance (GO:0032205),-0.19636121288944197,-0.48058179283491587,0.9690949227373068,1.0,1.0,9/15,38.39%,RTEL1;RAD50;TERF2;SLX4;ATM;ERCC1;TNKS2;PARP1;NBN
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.15574594621275434,0.48033899296767646,1.0,1.0,1.0,33/125,25.67%,PLK2;AURKA;PCNT;DYNLL1;XPO1;DYNC1LI1;NEK6;AURKC;RPS27;NUP98;MAD1L1;NUP133;NDEL1;BUB3;NUP43;PPP1CC;CLIP1;BCCIP;SBDS;PLK1;KIF4A;KPNB1;KIF2A;TAOK1;DCTN6;CLASP2;KIF18A;MAP4;CENPN;TNKS;NUP85;NSL1;RCC2
prerank,DNA modification (GO:0006304),0.21072865894521253,0.479286304447265,0.973421926910299,1.0,1.0,5/22,16.50%,PARP2;ACD;UNG;MPG;TERF1
prerank,positive regulation of translational initiation (GO:0045948),0.2103610675039248,0.47644769037769585,0.9841269841269841,1.0,1.0,18/18,78.99%,EIF2B5;UHMK1;DAZL;YTHDF3;YTHDF1;DDX3X;LARP1;RPS6KB2;KHDRBS1;CDC123;YTHDF2;CCL5;POLR2G;BOLL;POLR2D;MTOR;RPS6KB1;HABP4
prerank,glutathione derivative biosynthetic process (GO:1901687),0.2088778651747425,0.47616064828194804,0.9880749574105622,1.0,1.0,6/20,22.95%,GSTO2;GSTA4;GSTP1;ESD;MGST1;AKR1A1
prerank,glutathione derivative metabolic process (GO:1901685),0.2088778651747425,0.47616064828194804,0.9880749574105622,1.0,1.0,6/20,22.95%,GSTO2;GSTA4;GSTP1;ESD;MGST1;AKR1A1
prerank,DNA biosynthetic process (GO:0071897),0.2149180636654738,0.4748655162674569,0.9800995024875622,1.0,1.0,16/16,78.53%,POLA1;RFC3;PPIA;TYMS;POLL;POLD4;POLH;WRNIP1;POLD3;SIRT1;WRN;POLD2;POLD1;CDKN2D;TERT;POLE
prerank,regulation of T cell differentiation (GO:0045580),0.18820741800311108,0.47148572274306133,0.995398773006135,1.0,1.0,4/33,11.57%,XBP1;IL7;ZMIZ1;CBFB
prerank,pseudouridine synthesis (GO:0001522),-0.20382925298179536,-0.47110935009610677,0.9883177570093458,1.0,1.0,13/13,79.64%,PUS3;TRUB2;NHP2;GAR1;PUS1;DKC1;NOP10;PUS10;PUSL1;PUS7;RPUSD2;TRUB1;PUS7L
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.23640010241779777,0.4710265004141055,0.9745916515426497,1.0,1.0,6/10,31.36%,ACD;DCLRE1C;RIF1;APEX1;TFIP11;DCLRE1A
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.21553210210223103,0.4708584136443031,0.976027397260274,1.0,1.0,5/16,20.46%,RC3H1;ZFP36;ZFP36L1;DHX36;TRIM71
prerank,DNA duplex unwinding (GO:0032508),-0.14390536823476202,-0.46903727407704127,1.0,1.0,1.0,7/50,16.43%,ANXA1;RECQL5;RTEL1;RAD50;DDB2;DDB1;XPC
prerank,ncRNA 3'-end processing (GO:0043628),0.21368734652516058,0.4672101781569774,0.9777015437392796,1.0,1.0,4/14,24.10%,INTS12;INTS8;TOE1;INTS6L
prerank,positive regulation of interferon-alpha production (GO:0032727),0.20895486574831104,0.4658852974766308,0.9843478260869565,1.0,1.0,4/19,19.01%,RIPK2;IFIH1;STAT1;DHX36
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.23135151441215474,0.4652188414758566,0.9752380952380952,1.0,1.0,3/10,16.78%,FMR1;CALM1;CRHR1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.21782799748901427,0.46462028111290404,0.9781420765027322,1.0,1.0,13/13,78.23%,CPSF1;CPSF6;CPSF2;TUT1;CSTF2T;CPSF4L;NUDT21;CPSF7;NCBP1;CSTF2;NCBP2;CPSF4;FIP1L1
prerank,mismatch repair (GO:0006298),0.19172145368066418,0.4638567428860256,0.9884678747940692,1.0,1.0,6/27,22.07%,RNASEH2A;RPA1;MCM9;PMS1;MSH2;MSH5
prerank,axoneme assembly (GO:0035082),-0.16463406338786035,-0.4634101509234176,0.9971988795518207,1.0,1.0,9/30,28.55%,DNAI4;CCDC39;RSPH9;SPAG1;GAS8;DRC1;JHY;FOXJ1;TTC12
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.18644827542541265,-0.46263095868303294,0.9952718676122931,1.0,1.0,8/16,43.69%,PLEKHM2;RAET1E;VAMP2;CORO1A;TUBB4B;KIF5B;SLAMF7;KLRK1
prerank,tRNA 5'-leader removal (GO:0001682),-0.18993027838072704,-0.46219281691881187,0.9953271028037384,1.0,1.0,7/13,34.05%,POP1;POP4;SSB;RPP25L;POP5;RPP40;RPP21
prerank,inner dynein arm assembly (GO:0036159),-0.21056362379467414,-0.45988044244465914,0.9824945295404814,1.0,1.0,7/10,43.79%,CCDC39;DNAAF5;DNAAF4;CFAP100;DNAAF1;DNAI3;DNAH1
prerank,negative regulation of histone acetylation (GO:0035067),0.2264009050595185,0.45745518229377896,0.9840142095914742,1.0,1.0,4/11,26.56%,CTBP1;TAF7;SET;SIN3A
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.1894702773888145,0.4566338201192113,0.9900662251655629,1.0,1.0,8/26,21.00%,NEK6;ANAPC7;RB1;CUL3;CDK5RAP2;NSMCE2;PLK1;RIOK2
prerank,regulation of DNA recombination (GO:0000018),0.18790034899474742,0.4562978240553281,0.9983974358974359,1.0,1.0,7/32,20.19%,IL7R;SIRT6;SPIDR;ALYREF;THOC1;KDM1A;MSH2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.21641135107985912,0.4554555391130036,0.9947826086956522,1.0,1.0,15/15,78.38%,CCT7;CCT2;RUVBL1;RUVBL2;CCT8;NOP10;CCT6A;DKC1;CCT4;NAF1;CCT3;CCT5;TCP1;NHP2;SHQ1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.17818981772470127,0.45258715406320094,0.998324958123953,1.0,1.0,33/33,82.22%,WDR33;CPSF1;SETX;SNRPD3;CPSF2;PCF11;TTF2;CPSF3;LSM11;PAPOLA;CSTF3;CSTF2T;SNRPB;SCAF8;CLP1;LSM10;SLBP;SSU72;NUDT21;CPSF7;NCBP1;CSTF2;NCBP2;CSTF1;SNRPE;SYMPK;SNRPG;CPSF4;MAZ;MED18;FIP1L1;SNRPF;PABPN1
prerank,natural killer cell mediated immunity (GO:0002228),-0.1847563931619773,-0.4515944843888084,0.9930715935334873,1.0,1.0,2/15,17.98%,PLEKHM2;RAET1E
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.16701136466185718,0.4483532734090637,1.0,1.0,1.0,10/50,22.42%,CCNK;CDKN1B;HSP90AB1;CDC25C;CCNJ;CDC37;BCCIP;GTF2H1;CCNH;CCNA2
prerank,tRNA 5'-end processing (GO:0099116),0.2013242881459792,0.4470840744675624,0.9862306368330465,1.0,1.0,6/15,27.99%,RPP30;RPP25;PRORP;TRMT10C;RPP38;RPP14
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.2172451272818428,0.4468954845804886,0.9774859287054409,1.0,1.0,4/10,26.29%,HSP90AB1;FN1;CDH3;FURIN
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.1648765781043904,-0.4465381802317026,0.9975903614457832,1.0,1.0,22/22,83.54%,DDB2;DDB1;XPC;CUL4A;UBC;GTF2H3;PARP1;ERCC2;RAD23B;UBB;ERCC3;UBA52;RPS27A;RBX1;XPA;GTF2H2;GTF2H5;CUL4B;GTF2H1;CHD1L;CETN2;GTF2H4
prerank,regulation of RNA export from nucleus (GO:0046831),-0.19437367382038861,-0.4438445640911212,0.9957173447537473,1.0,1.0,1/11,8.29%,AKAP8L
prerank,B cell activation involved in immune response (GO:0002312),-0.18700564971751413,-0.44366385470813613,0.9789227166276346,1.0,1.0,13/13,81.32%,EXOSC3;MSH6;FCGR2B;BATF;GPR183;CD19;GAPT;CD40LG;RNF8;RNF168;LIG4;MSH2;CD180
prerank,androgen metabolic process (GO:0008209),0.19607239050465297,0.44350872392008567,0.9910233393177738,1.0,1.0,3/18,19.16%,SRD5A2;SRD5A1;HSD17B11
prerank,rRNA modification (GO:0000154),0.19263051283036375,0.44269133696295115,0.9913194444444444,1.0,1.0,3/21,13.09%,TFB2M;NSUN4;FBLL1
prerank,histone methylation (GO:0016571),0.18116610271146538,0.44251751750190643,0.9967793880837359,1.0,1.0,11/26,29.24%,SMYD3;FBLL1;EHMT1;SIRT7;SUV39H1;N6AMT1;CREBBP;PRMT5;EZH2;SMYD2;SMYD1
prerank,error-free translesion synthesis (GO:0070987),-0.16477537272466253,-0.4423927003377958,1.0,1.0,1.0,7/22,32.65%,NPLOC4;POLDIP2;RFC1;POLD1;UBC;RPA2;VCP
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.19852241309332164,0.44057156266988523,0.9852700490998363,1.0,1.0,3/16,12.93%,MEIOB;RMI1;ERCC4
prerank,regulation of oxidoreductase activity (GO:0051341),0.20946910854180475,0.43969487542611424,0.9817850637522769,1.0,1.0,5/13,26.76%,ABL2;ATP7A;HDAC6;ECSIT;NOD2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.1618933719393213,0.43902714280371546,0.9985507246376811,0.9994204940008312,1.0,56/56,83.87%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NUBPL;NDUFS8;NDUFB7;ECSIT;NDUFAF8;NDUFA6;NDUFA2;ACAD9;NDUFA5;DMAC1;NDUFA3;NDUFB2;NDUFAB1;TMEM126B;NDUFAF4;NDUFS1;NDUFA13;NDUFB4;NDUFAF5;NDUFB6;NDUFB8;OXA1L;TMEM126A;NDUFS5;NDUFB5;NDUFS3;NDUFB3;BCS1L;NDUFB11;NDUFA1;NDUFAF2;FOXRED1;NDUFV2;TIMMDC1;NDUFAF3;NDUFB10;NDUFS7;NDUFA9;NDUFC2;TIMM21;NDUFAF1;NDUFV1;NDUFAF6;NDUFA11;NDUFA12;NDUFV3;DMAC2;NDUFAF7
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.1618933719393213,0.43902714280371546,0.9985507246376811,0.9994204940008312,1.0,56/56,83.87%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NUBPL;NDUFS8;NDUFB7;ECSIT;NDUFAF8;NDUFA6;NDUFA2;ACAD9;NDUFA5;DMAC1;NDUFA3;NDUFB2;NDUFAB1;TMEM126B;NDUFAF4;NDUFS1;NDUFA13;NDUFB4;NDUFAF5;NDUFB6;NDUFB8;OXA1L;TMEM126A;NDUFS5;NDUFB5;NDUFS3;NDUFB3;BCS1L;NDUFB11;NDUFA1;NDUFAF2;FOXRED1;NDUFV2;TIMMDC1;NDUFAF3;NDUFB10;NDUFS7;NDUFA9;NDUFC2;TIMM21;NDUFAF1;NDUFV1;NDUFAF6;NDUFA11;NDUFA12;NDUFV3;DMAC2;NDUFAF7
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.1609600613902899,0.43732399861907784,1.0,0.9992252121179621,1.0,14/53,24.92%,PSMA2;PSMA8;PSMA6;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;BCKDK;PSMC3;PSMD3;PSMA3
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.14857301985118654,-0.4294401332540704,1.0,1.0,1.0,10/29,33.81%,ACOT11;ACAT1;ACSF2;DBI;ACOT9;ACOT8;MLYCD;ACOT1;GPAT4;ACOT7
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.14857301985118654,-0.4294401332540704,1.0,1.0,1.0,10/29,33.81%,ACOT11;ACAT1;ACSF2;DBI;ACOT9;ACOT8;MLYCD;ACOT1;GPAT4;ACOT7
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.20719051172535968,0.42930111423317635,0.9848771266540642,0.999734745233036,1.0,3/12,20.50%,HUS1;CHEK2;RAD17
prerank,serine family amino acid catabolic process (GO:0009071),-0.1970251609211084,-0.42685181867715655,0.9959595959595959,1.0,1.0,5/10,40.37%,CBS;GLDC;THNSL2;AMT;SHMT2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.15757470738119395,0.4235618930564014,1.0,0.9999170795163882,1.0,13/50,24.92%,PSMA2;PSMA8;PSMA6;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;PSMD3;PSMA3
prerank,DNA packaging (GO:0006323),0.18888968975698472,0.41840796614575104,0.9928057553956835,1.0,1.0,2/16,15.11%,HAT1;KAT6A
prerank,"base-excision repair, gap-filling (GO:0006287)",0.1640807026268948,0.4127127281436951,1.0,1.0,1.0,34/35,78.53%,RPA1;UNG;PARG;MPG;RFC3;MBD4;RFC5;POLL;RPA3;APEX1;RFC2;POLD4;RFC4;PNKP;PCNA;OGG1;POLD3;XRCC1;SMUG1;LIG3;PARP1;FEN1;RPA2;ADPRS;LIG1;NEIL1;POLD2;POLB;POLD1;NTHL1;TDG;POLG;MUTYH;POLE
prerank,negative regulation of inclusion body assembly (GO:0090084),0.20448126529843727,0.4088555734320393,0.9981203007518797,1.0,1.0,10/10,79.56%,DNAJB1;DNAJB6;HSPA1B;DNAJA4;DNAJB8;HSPA1A;SORL1;SACS;HSPA2;DNAJB2
prerank,peptidyl-lysine acetylation (GO:0018394),0.20090378459800418,0.4068023554424449,0.990791896869245,0.9998174581134737,1.0,10/10,79.92%,KAT2B;CREBBP;KAT7;EP300;KAT2A;ESCO1;SIRT1;BLOC1S1;BAG6;KAT5
prerank,global genome nucleotide-excision repair (GO:0070911),0.1679200899881893,0.40649514444243495,0.9983416252072969,0.9994438676446675,1.0,13/26,32.69%,ERCC4;GTF2H4;CETN2;CHD1L;GTF2H1;RNF111;CUL4B;GTF2H5;GTF2H2;XPA;RBX1;RPS27A;UBA52
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.16539574556337497,0.4058377774354264,0.9967266775777414,0.9990980252112731,1.0,13/29,31.71%,RPA1;GTF2H4;CETN2;CHD1L;GTF2H1;CCNH;CUL4B;GTF2H5;RPA3;GTF2H2;XPA;RBX1;RPS27A
prerank,positive regulation of cilium assembly (GO:0045724),-0.15731643210595786,-0.4055113267229928,0.9976525821596244,1.0,1.0,7/18,35.60%,FUZ;HTT;ARHGAP35;SEPTIN9;CROCC;CCP110;KCTD17
prerank,ATP synthesis coupled proton transport (GO:0015986),0.18505223875101887,0.4046238432848592,0.9932773109243698,0.9987988926015144,1.0,6/17,28.63%,ATP5PD;VPS9D1;ATP5MC2;STOML2;ATP5F1B;ATP5F1C
prerank,anterograde synaptic vesicle transport (GO:0048490),0.18550284358437064,0.403438600680531,0.9948096885813149,0.99809505850879,1.0,3/15,17.00%,AP3B1;AP3S1;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.18550284358437064,0.403438600680531,0.9948096885813149,0.99809505850879,1.0,3/15,17.00%,AP3B1;AP3S1;BLOC1S5
prerank,protein localization to microtubule organizing center (GO:1905508),-0.16428519818835136,-0.40068852628539225,1.0,1.0,1.0,4/15,25.31%,CEP192;PCM1;C2CD3;STIL
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.18007157656809195,0.39112981243426465,1.0,0.9985378727424378,1.0,16/16,82.01%,ATP5PD;ATP5MC2;STOML2;ATP5F1B;ATP5F1C;ATP5F1A;ATP5F1E;ATP5MF;ATP5MC1;ATP5F1D;ATP5MC3;DMAC2L;ATP5MG;ATP5ME;ATP5PF;ATP5PO
prerank,N-terminal protein amino acid modification (GO:0031365),0.17967906901838804,0.38713176903307733,0.9965397923875432,0.9983616603531308,1.0,8/14,32.78%,NAA11;NAA16;NAA35;PDF;NAA50;METAP1D;AANAT;METAP2
prerank,tRNA modification (GO:0006400),-0.11272244845844095,-0.3755961585209966,1.0,1.0,1.0,19/62,35.38%,TARBP1;PUS3;GTPBP3;DUS2;MTO1;TPRKB;ELP5;THUMPD3;ANKRD16;SSB;METTL1;BCDIN3D;ADAT2;QTRT1;TRMT61A;AARS1;METTL2A;METTL2B;URM1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.15904656631857655,-0.36381523868903415,0.9977477477477478,0.9996359644095739,1.0,4/12,30.71%,PLK5;TP53;PRKDC;RPA2
prerank,regulation of protein acetylation (GO:1901983),0.1742259303619692,0.35569011532351213,0.9981851179673321,0.9992252839677593,1.0,4/12,26.52%,CEP295;RAPGEF3;TAOK1;GSK3B
